data_4b2r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4b2r _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . 0.58 ' HG3' ' HB3' ' A' ' 586' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.774 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.566 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 91.5 m -96.39 140.86 30.43 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -126.05 130.26 50.78 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.814 HD12 ' HG3' ' A' ' 580' ' ' PRO . 2.2 tt -53.05 119.27 16.05 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.434 ' HG2' HD22 ' A' ' 620' ' ' LEU . 87.8 Cg_endo -78.72 -157.74 0.08 OUTLIER 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.234 2.623 . . . . 0.0 111.566 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -91.09 107.64 19.34 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.489 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.667 HD11 ' HD3' ' A' ' 580' ' ' PRO . 35.1 pt -79.58 -171.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.477 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.1 t70 -73.74 159.49 32.88 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.17 -31.91 53.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -98.8 6.35 46.94 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.992 -0.443 . . . . 0.0 111.4 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.0 tm? -95.54 150.66 20.08 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.1 m -145.31 118.18 5.33 Favored Pre-proline 0 C--N 1.293 -1.86 0 C-N-CA 125.006 1.322 . . . . 0.0 108.241 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.814 ' HG3' HD12 ' A' ' 571' ' ' LEU . 36.8 Cg_endo -70.23 131.03 19.74 Favored 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 121.255 1.304 . . . . 0.0 110.78 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.15 -34.89 79.07 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 55.0 mmt-85 -88.09 104.83 17.04 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -117.65 97.48 5.88 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.454 ' HG3' ' H ' ' A' ' 585' ' ' ASP 0.288 10.4 ptpt -113.46 -93.39 0.47 Allowed 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.04 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . 0.454 ' H ' ' HG3' ' A' ' 584' ' ' LYS . 5.6 t70 -173.82 -62.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 176.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . 0.58 ' HB3' ' HG3' ' A' ' 568' ' ' GLU . 0.0 OUTLIER -121.14 145.0 48.27 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.963 175.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.763 ' HH ' HD13 ' A' ' 571' ' ' LEU . 23.7 m-85 -114.84 132.57 56.46 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 -171.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 591' ' ' GLU . 33.8 mtmm -90.06 161.11 15.98 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.517 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.41 121.9 16.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.209 0.528 . . . . 0.0 110.309 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 103.29 -0.08 47.16 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.881 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 588' ' ' LYS . 82.0 mm-40 -67.1 122.1 17.05 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 117.756 0.778 . . . . 0.0 109.012 173.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 7.0 m -95.41 117.68 39.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 CA-C-O 122.307 1.051 . . . . 0.0 108.63 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 608' ' ' SER . 17.5 mt -101.85 101.46 11.91 Favored 'General case' 0 C--N 1.274 -2.71 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.059 -174.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 10.3 mtmp? -79.72 113.38 17.83 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.499 ' HB3' HD13 ' A' ' 578' ' ' LEU . 80.4 m-85 -95.91 167.4 11.27 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' SER . . . . . 0.428 ' HA ' HD13 ' A' ' 603' ' ' ILE . 21.4 t -168.18 -179.18 3.95 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 170.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 77.8 m -118.4 177.36 4.85 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 123.68 0.612 . . . . 0.0 112.488 -173.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 30.1 mmtp -50.59 162.36 0.55 Allowed Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 125.372 1.469 . . . . 0.0 112.27 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 76.7 Cg_exo -47.76 -43.47 28.79 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.248 3.299 . . . . 0.0 113.761 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.66 1.64 63.99 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.957 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -105.57 141.01 37.78 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-O 121.961 0.886 . . . . 0.0 112.777 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 9.8 m -102.69 126.84 49.94 Favored 'General case' 0 N--CA 1.393 -3.293 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.338 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.454 HD12 ' HG3' ' A' ' 621' ' ' PRO . 10.8 tt -73.18 123.51 28.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.097 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.14 126.49 70.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.764 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.07 -145.61 18.46 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.41 124.11 4.62 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.773 2.315 . . . . 0.0 110.864 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.26 -42.93 14.21 Favored 'General case' 0 C--O 1.204 -1.313 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.832 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.542 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 18.6 p -114.14 97.86 6.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.14 0.495 . . . . 0.0 111.983 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . 0.404 ' C ' HE21 ' A' ' 610' ' ' GLN . 11.1 m -92.66 163.18 2.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.561 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -113.18 154.1 27.23 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.374 0.607 . . . . 0.0 110.209 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 6.6 t -85.14 108.75 17.84 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.72 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.539 ' CD1' ' HB3' ' A' ' 617' ' ' SER . 55.3 m-85 -91.57 166.79 12.65 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 175.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -7.58 19.55 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -105.97 -10.59 16.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.998 0.427 . . . . 0.0 111.225 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 140.94 -172.49 23.65 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.532 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' A' ' 569' ' ' CYS . 2.8 mm? -79.32 127.82 32.56 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 47.8 t -149.09 147.18 22.99 Favored Pre-proline 0 N--CA 1.429 -1.516 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.33 -175.74 13.4 Favored 'Cis proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.641 -1.4 . . . . 0.0 114.038 1.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -63.26 142.44 58.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.032 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . 0.434 HD22 ' HG2' ' A' ' 572' ' ' PRO . 8.7 mp -57.58 143.6 74.82 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -173.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . 0.454 ' HG3' HD12 ' A' ' 603' ' ' ILE . 38.2 Cg_endo -68.05 -178.53 1.75 Allowed 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 124.748 3.632 . . . . 0.0 113.341 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.1 pt -130.81 -178.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.4 m -129.0 119.5 24.39 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.222 0.534 . . . . 0.0 111.787 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -114.04 126.04 54.67 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.837 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -81.83 -27.05 33.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -123.8 113.63 18.81 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.286 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.23 177.83 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.499 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . 0.434 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 73.0 mt-30 -97.51 167.0 11.25 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.459 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 49.2 m -105.19 -4.92 21.17 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.536 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.1 m 68.15 -31.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 82.31 -139.06 19.32 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -75.9 154.39 38.3 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.449 2.099 . . . . 0.0 111.27 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.552 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 61.7 Cg_endo -92.07 174.12 2.25 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 123.087 2.525 . . . . 0.0 111.532 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.78 -173.72 1.87 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.033 1.822 . . . . 0.0 109.985 172.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.41 159.87 24.22 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.516 ' HB3' ' C ' ' A' ' 639' ' ' GLY . 14.7 tp -70.56 144.8 51.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 638' ' ' ASN . 0.9 OUTLIER -48.96 -71.76 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.585 ' H ' ' HG ' ' A' ' 637' ' ' LEU . 9.5 m120 -94.03 -32.57 13.76 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -85.15 -154.21 21.81 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.497 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . 0.58 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.7 t-20 -152.05 -173.66 4.61 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.8 p -101.72 133.54 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -93.43 -27.34 16.77 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.211 0.529 . . . . 0.0 110.641 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.654 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 38.5 mm-40 -81.56 153.78 26.57 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.245 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -67.12 122.25 17.39 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.257 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.461 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 16.6 p -76.97 110.53 11.67 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.417 0.627 . . . . 0.0 110.242 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.402 ' HZ2' ' HG2' ' A' ' 653' ' ' GLU . 55.2 mtmt -82.32 157.39 23.83 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.186 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.94 -9.29 59.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.724 0.773 . . . . 0.0 109.696 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.629 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 38.4 tt0 -156.1 124.24 5.73 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.552 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 13.9 m-85 -98.44 -63.08 1.16 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 123.471 0.482 . . . . 0.0 111.637 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 112.23 162.04 16.1 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.558 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.3 t60 -63.68 140.56 58.88 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.0 m 75.78 -4.04 2.45 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.417 1.087 . . . . 0.0 113.546 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 649' ' ' TYR . 5.3 tp10 -81.87 120.14 24.82 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.9 m -91.47 159.46 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-O 122.1 0.952 . . . . 0.0 112.564 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.9 t -127.11 102.61 9.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.871 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.654 ' HB2' ' HG2' ' A' ' 643' ' ' GLU . 29.8 mt-10 -67.69 132.66 47.9 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.153 0.978 . . . . 0.0 112.194 175.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 67.9 m-85 -112.7 171.43 7.53 Favored 'General case' 0 C--N 1.28 -2.447 0 C-N-CA 126.372 1.869 . . . . 0.0 109.596 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.58 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 31.4 p90 -151.06 141.9 22.87 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.526 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 7.3 t -105.81 -177.66 3.43 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.746 176.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.429 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 34.6 m-80 -70.35 151.39 95.74 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.409 ' C ' ' HD2' ' A' ' 662' ' ' ARG . 52.7 Cg_endo -68.46 26.24 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 124.31 3.34 . . . . 0.0 114.092 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' A' ' 660' ' ' ASN . 13.3 mmm180 -128.35 5.07 5.72 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 660' ' ' ASN . 44.1 m-85 -123.74 164.84 18.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.309 -172.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.417 HD22 ' OE2' ' A' ' 687' ' ' GLU . 90.3 mt -110.18 143.54 40.15 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.423 1.489 . . . . 0.0 107.31 175.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.9 ttt -114.04 102.52 10.26 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.778 ' HG2' HD12 ' A' ' 685' ' ' ILE . 72.3 mmtt -73.18 -63.22 1.23 Allowed 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.882 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -83.35 -168.52 43.45 Favored Glycine 0 N--CA 1.404 -3.486 0 CA-C-N 114.792 -1.095 . . . . 0.0 113.473 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.0 118.04 5.01 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.108 2.538 . . . . 0.0 112.07 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.574 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 3.7 p-10 -80.34 19.31 0.78 Allowed 'General case' 0 C--O 1.19 -2.028 0 C-N-CA 122.886 0.475 . . . . 0.0 111.426 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.704 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 7.0 ptmt -162.14 111.17 1.46 Allowed 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 124.861 1.264 . . . . 0.0 108.024 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 35.3 pt -107.63 144.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.986 -174.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.528 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -112.67 142.81 44.85 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 123.677 0.611 . . . . 0.0 110.848 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.0 t -67.41 116.89 8.67 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.683 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . 0.558 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 34.1 m -109.18 127.7 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 28.2 t70 54.79 -80.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.538 1.135 . . . . 0.0 112.031 -169.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -157.11 31.67 0.54 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -143.02 156.45 44.84 Favored 'General case' 0 C--O 1.212 -0.88 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.453 ' HB3' HD13 ' A' ' 671' ' ' ILE . 97.7 m95 -93.15 166.1 12.5 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 7.9 p -91.81 -169.72 2.36 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 35.1 m -71.54 126.29 29.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.71 0.29 . . . . 0.0 110.413 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 682' ' ' PRO . 7.0 mp -61.93 160.41 29.32 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.893 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.574 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 24.6 Cg_endo -63.34 -15.33 47.65 Favored 'Trans proline' 0 CA--C 1.498 -1.312 0 C-N-CA 123.663 2.908 . . . . 0.0 115.035 -175.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 22.4 m 43.21 93.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 124.87 1.356 . . . . 0.0 114.411 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 23.3 p -95.75 137.26 35.06 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.662 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.778 HD12 ' HG2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -133.5 147.48 31.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.004 -178.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 98.3 t -52.56 133.27 14.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -172.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . 0.417 ' OE2' HD22 ' A' ' 664' ' ' LEU . 6.9 tp10 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.184 1.394 . . . . 0.0 108.963 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.423 -1.783 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 74.9 m -98.81 112.72 24.72 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-O 121.876 0.846 . . . . 0.0 112.471 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 571' ' ' LEU . 21.3 tt0 -82.97 -23.58 33.31 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.24 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.537 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 32.3 tp 79.02 105.08 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 113.665 -1.607 . . . . 0.0 108.922 -169.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.658 ' HD2' HD13 ' A' ' 616' ' ' LEU . 24.5 Cg_endo -62.94 -172.6 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.062 2.508 . . . . 0.0 113.429 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.89 20.77 0.45 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -170.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.491 ' CG1' ' H ' ' A' ' 575' ' ' ASP . 26.1 pt 35.19 -94.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 126.523 1.929 . . . . 0.0 115.469 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.634 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 15.7 t70 -165.1 179.74 6.17 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.82 -27.57 4.98 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -103.52 10.17 37.23 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.622 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.7 tp -100.14 164.49 11.95 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.65 122.52 1.94 Allowed Pre-proline 0 C--N 1.308 -1.238 0 C-N-CA 124.044 0.938 . . . . 0.0 108.803 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.2 137.51 21.39 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.123 1.882 . . . . 0.0 112.209 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -78.74 -42.11 29.02 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -90.33 113.56 25.46 Favored 'General case' 0 N--CA 1.392 -3.349 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . 0.558 ' HA ' ' OH ' ' A' ' 587' ' ' TYR . 64.1 tttp -135.24 135.44 40.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.311 0.577 . . . . 0.0 111.641 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.602 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 13.1 ptpt -160.43 -160.31 0.76 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.634 1.174 . . . . 0.0 108.489 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -90.34 -64.46 1.13 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.03 0.443 . . . . 0.0 110.656 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.98 134.3 55.29 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.602 ' CE2' ' HG2' ' A' ' 584' ' ' LYS . 69.3 m-85 -96.39 127.5 42.45 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -84.36 145.33 28.28 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.876 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 1.6 p -55.59 111.36 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 122.17 0.986 . . . . 0.0 112.755 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 115.26 -6.29 21.35 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.862 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -70.23 137.95 51.27 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 4.1 m -104.63 123.89 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-O 122.03 0.919 . . . . 0.0 109.499 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.466 HD12 ' CD2' ' A' ' 587' ' ' TYR . 7.4 mp -107.48 104.79 14.44 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.174 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 28.8 mtpp -82.95 119.33 24.29 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.763 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.45 158.62 16.08 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-O 120.957 0.408 . . . . 0.0 110.684 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 19.6 m -150.59 171.74 16.63 Favored 'General case' 0 N--CA 1.398 -3.044 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.554 ' SG ' HD13 ' A' ' 578' ' ' LEU . 95.3 m -112.87 179.84 3.85 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-O 120.656 0.265 . . . . 0.0 110.333 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 65.1 mmtt -52.23 162.07 0.92 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.302 1.441 . . . . 0.0 112.306 173.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 76.2 Cg_exo -49.45 -41.96 42.61 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.268 3.312 . . . . 0.0 114.283 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 625' ' ' GLU . . . -96.52 1.71 62.21 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.627 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -103.84 147.82 26.85 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.876 0.846 . . . . 0.0 112.892 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 602' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 17.8 m -98.83 134.95 40.98 Favored 'General case' 0 C--N 1.272 -2.762 0 CA-C-N 113.728 -1.578 . . . . 0.0 109.104 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.54 HD12 ' HG3' ' A' ' 621' ' ' PRO . 7.6 tt -82.48 115.66 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.831 0.824 . . . . 0.0 109.348 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . 0.422 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 61.9 t -106.72 101.84 13.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.726 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 137.31 -162.38 25.36 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.0 123.44 10.66 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 122.827 2.351 . . . . 0.0 111.963 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.34 -49.46 11.49 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 175.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.4 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 66.5 p -104.31 106.91 17.58 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.58 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.18 161.2 4.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.65 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 22.8 mm-40 -105.08 163.48 12.53 Favored 'General case' 0 CA--C 1.473 -2.003 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.466 ' HA ' HD21 ' A' ' 616' ' ' LEU . 43.4 t -88.01 132.54 34.23 Favored 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 118.646 -1.222 . . . . 0.0 107.78 166.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.65 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 75.2 m-85 -116.61 168.84 9.83 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -67.64 -5.37 15.4 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -111.23 -9.24 14.33 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 122.007 -0.433 . . . . 0.0 110.266 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 138.61 -177.4 20.17 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.658 HD13 ' HD2' ' A' ' 572' ' ' PRO . 94.3 mt -68.57 140.83 55.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 117.037 0.419 . . . . 0.0 109.899 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.428 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 2.5 t -156.31 150.83 20.21 Favored Pre-proline 0 N--CA 1.421 -1.915 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.428 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 59.8 Cg_endo -69.99 -176.64 13.3 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.672 -1.386 . . . . 0.0 112.99 1.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.13 144.98 32.66 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.995 0.426 . . . . 0.0 110.408 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.76 145.56 98.77 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.248 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . 0.54 ' HG3' HD12 ' A' ' 603' ' ' ILE . 72.3 Cg_endo -71.25 170.22 18.82 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 123.452 2.768 . . . . 0.0 112.54 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . 0.422 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 38.8 pt -116.7 -178.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 602' ' ' THR . 73.3 m -126.44 125.8 42.74 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.977 0.418 . . . . 0.0 111.443 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.429 ' O ' ' HB ' ' A' ' 602' ' ' THR . 47.8 mtpt -119.31 140.11 50.83 Favored 'General case' 0 C--O 1.194 -1.862 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 600' ' ' GLY . 1.4 tm-20 -90.67 -43.72 9.96 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -95.76 112.02 23.85 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.471 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 7.4 m -123.21 175.63 5.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.489 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.68 170.15 9.2 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 15.5 m -102.03 -11.11 19.15 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 93.0 m 70.6 8.99 6.79 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 112.376 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 60.58 -144.74 47.72 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -82.38 153.6 16.05 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.481 2.12 . . . . 0.0 110.292 173.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.05 153.53 62.93 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.842 2.362 . . . . 0.0 113.366 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.4 173.99 6.85 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.627 2.884 . . . . 0.0 113.097 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -88.21 153.33 21.32 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 121.173 0.511 . . . . 0.0 110.926 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.557 HD22 ' SG ' ' A' ' 659' ' ' CYS . 23.4 tp -97.04 123.92 40.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 683' ' ' VAL . 0.0 OUTLIER -39.66 -46.8 1.89 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -177.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -137.92 39.99 2.34 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.263 1.03 . . . . 0.0 109.507 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.46 -152.96 6.36 Favored Glycine 0 N--CA 1.397 -3.96 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.67 -176.58 4.35 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 124.087 0.955 . . . . 0.0 108.682 175.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 6.4 p -95.99 130.31 44.85 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.042 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.632 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.5 ptmt -85.25 -27.4 26.05 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.245 0.545 . . . . 0.0 110.255 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 40.2 mm-40 -80.8 143.6 32.72 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.725 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . 0.723 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -52.8 120.76 6.14 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 124.646 1.217 . . . . 0.0 109.39 173.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 4.1 p -101.35 104.96 15.97 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -172.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -85.17 149.55 25.44 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 113.601 -1.636 . . . . 0.0 108.126 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -80.69 16.62 1.34 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -155.48 105.27 2.44 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -90.85 -88.57 0.18 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 143.02 157.08 7.01 Favored Glycine 0 N--CA 1.424 -2.142 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -175.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.407 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 84.6 t60 -67.12 138.72 57.28 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.511 0.196 . . . . 0.0 111.023 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 68.6 m 69.25 5.88 5.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.702 1.201 . . . . 0.0 113.044 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -92.69 117.54 30.1 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.8 m -86.49 159.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.694 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.5 t -129.03 117.54 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.904 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.634 ' HG3' ' HZ3' ' A' ' 670' ' ' LYS . 20.9 mt-10 -73.02 124.38 25.38 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.773 0.797 . . . . 0.0 112.245 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 34.3 m-85 -104.58 172.62 6.69 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.092 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -146.81 137.26 23.71 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.557 ' SG ' HD22 ' A' ' 636' ' ' LEU . 70.9 m -95.43 172.85 7.83 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.429 ' HB2' ' HD1' ' A' ' 663' ' ' PHE . 9.8 m120 -63.73 152.56 86.16 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.85 -4.36 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.411 2.74 . . . . 0.0 112.538 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -96.42 -1.27 47.88 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 124.311 1.044 . . . . 0.0 108.865 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.429 ' HD1' ' HB2' ' A' ' 660' ' ' ASN . 45.4 m-85 -131.75 158.02 42.28 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.103 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 89.1 mt -100.17 158.03 16.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.5 ' HE1' ' SG ' ' A' ' 659' ' ' CYS . 6.2 ttt -124.6 95.08 4.39 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -176.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -86.95 -44.52 11.57 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.351 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -78.65 -179.64 51.5 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.975 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.24 114.85 2.29 Favored 'Trans proline' 0 C--N 1.334 -0.232 0 C-N-CA 123.138 2.558 . . . . 0.0 111.142 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.514 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 17.6 p-10 -73.92 -11.39 60.34 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.731 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 2.3 mtpp -121.3 120.06 34.02 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 33.6 pt -111.12 152.59 13.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.532 -1.267 . . . . 0.0 110.924 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.66 154.05 29.11 Favored 'General case' 0 N--CA 1.425 -1.688 0 O-C-N 123.881 0.738 . . . . 0.0 109.489 -172.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 2.8 t -85.62 122.55 29.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.057 174.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . 0.407 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 77.9 t -114.42 114.68 47.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.211 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.7 t70 55.16 -78.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.25 1.42 . . . . 0.0 111.765 -171.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -149.1 18.2 1.2 Allowed Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -130.07 150.84 51.16 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.532 ' HB3' HD13 ' A' ' 671' ' ' ILE . 95.8 m95 -87.86 162.96 16.66 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 19.2 p -81.68 -178.15 6.85 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 27.3 m -64.39 130.85 45.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.462 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.0 mp -68.56 162.37 63.11 Favored Pre-proline 0 N--CA 1.446 -0.669 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.514 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 31.6 Cg_endo -67.76 -16.06 45.44 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.808 3.005 . . . . 0.0 114.721 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.492 ' HA ' HD12 ' A' ' 637' ' ' LEU 0.304 13.2 m 44.25 92.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 175.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 3.6 m -67.19 139.6 57.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.329 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.17 148.11 33.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.593 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 44.8 t -65.36 135.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 O-C-N 123.39 0.431 . . . . 0.0 110.731 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.25 1.108 0 O-C-N 123.848 0.718 . . . . 0.0 109.856 179.23 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 569' ' ' CYS . 3.9 tp10 . . . . . 0 N--CA 1.432 -1.347 0 N-CA-C 102.039 -3.319 . . . . 0.0 102.039 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.518 ' HB3' ' CD1' ' A' ' 616' ' ' LEU . 87.4 m -138.81 161.16 37.94 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 119.518 1.054 . . . . 0.0 112.669 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -138.34 117.9 13.0 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 104.538 -2.394 . . . . 0.0 104.538 168.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.651 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 2.0 tt -34.57 121.8 0.55 Allowed Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 125.37 1.468 . . . . 0.0 109.56 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.588 ' HD2' HD23 ' A' ' 616' ' ' LEU . 70.6 Cg_endo -69.58 -169.9 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.36 2.04 . . . . 0.0 111.549 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -87.63 101.36 13.58 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.439 -0.905 . . . . 0.0 109.602 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . . . . . . . . . 38.9 pt -67.42 -172.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.987 0 CA-C-O 121.759 0.79 . . . . 0.0 110.674 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 6.4 t70 -66.34 -175.15 0.33 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.046 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.92 -27.3 4.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 O-C-N 121.407 -0.808 . . . . 0.0 109.358 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -109.58 9.94 25.11 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 122.124 -0.36 . . . . 0.0 111.868 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.6 tm? -89.99 151.37 21.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.88 117.16 3.89 Favored Pre-proline 0 C--N 1.294 -1.845 0 C-N-CA 123.907 0.883 . . . . 0.0 109.303 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.61 ' HG3' HD12 ' A' ' 571' ' ' LEU . 64.8 Cg_endo -75.16 148.9 35.31 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.643 2.229 . . . . 0.0 112.909 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.74 -55.99 8.4 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -75.1 108.77 8.06 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.91 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -120.81 97.72 5.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.8 ptpt -133.44 167.43 20.46 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.118 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.28 -67.18 0.44 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 124.052 0.845 . . . . 0.0 110.992 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 144.13 49.04 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.651 ' CE1' ' HB2' ' A' ' 571' ' ' LEU . 45.2 m-85 -103.69 132.47 49.91 Favored 'General case' 0 CA--C 1.467 -2.247 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.843 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . 0.42 ' HA ' ' OE2' ' A' ' 568' ' ' GLU . 19.4 mtpp -81.24 147.36 29.99 Favored 'General case' 0 C--N 1.273 -2.747 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.521 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.72 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 46.6 t -59.44 112.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.178 0.513 . . . . 0.0 110.23 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 113.08 -6.01 25.39 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.416 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.97 135.63 47.99 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 3.8 m -106.33 134.12 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 C-N-CA 119.77 -0.772 . . . . 0.0 108.974 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 608' ' ' SER . 5.4 mp -113.8 103.69 11.45 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.552 ' HG2' ' HB2' ' A' ' 608' ' ' SER . 84.3 mttt -78.6 103.31 8.46 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.509 ' HB3' HD13 ' A' ' 578' ' ' LEU . 44.3 m-85 -86.69 162.94 17.64 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.757 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' SER . . . . . 0.576 ' HA ' HD13 ' A' ' 603' ' ' ILE . 66.5 m -164.18 -175.35 3.94 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 169.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 603' ' ' ILE . 98.0 m -113.02 171.13 7.72 Favored 'General case' 0 C--N 1.259 -3.359 0 O-C-N 123.563 0.54 . . . . 0.0 110.968 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.609 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 29.3 mmtp -56.94 162.21 3.98 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.873 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 44.3 Cg_exo -39.09 -41.37 1.89 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 125.104 3.869 . . . . 0.0 116.644 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -98.42 6.06 60.99 Favored Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.643 -0.789 . . . . 0.0 114.283 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 56.7 m-85 -109.92 150.65 28.14 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 602' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 51.9 m -98.29 125.46 43.4 Favored 'General case' 0 N--CA 1.406 -2.675 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.92 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.576 HD13 ' HA ' ' A' ' 596' ' ' SER . 8.0 tt -76.02 128.24 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . 0.508 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 84.4 t -119.21 105.12 16.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.264 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 134.39 -168.81 23.31 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.697 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.86 116.58 3.54 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 123.519 2.812 . . . . 0.0 110.347 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -81.92 -43.56 17.95 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.624 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.552 ' HB2' ' HG2' ' A' ' 594' ' ' LYS . 15.0 t -111.79 89.76 3.15 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 119.216 -0.993 . . . . 0.0 112.536 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 18.0 m -80.2 165.89 2.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.57 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -109.9 154.54 22.93 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.551 0.691 . . . . 0.0 109.664 177.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.72 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 0.0 OUTLIER -86.41 131.66 34.14 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.132 167.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.452 ' CD1' ' HB3' ' A' ' 617' ' ' SER . 86.2 m-85 -117.62 173.71 6.57 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -72.45 -5.0 33.63 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.36 -0.837 . . . . 0.0 113.091 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -108.02 -3.06 19.1 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.436 0.636 . . . . 0.0 110.417 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 130.31 -171.42 20.6 Favored Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.588 HD23 ' HD2' ' A' ' 572' ' ' PRO . 8.2 mp -82.13 141.69 32.88 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 46.3 t -159.7 153.02 18.57 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.479 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 78.8 Cg_endo -76.45 -167.6 6.03 Favored 'Cis proline' 0 N--CA 1.481 0.788 0 C-N-CA 124.047 -1.23 . . . . 0.0 113.317 1.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -50.16 144.01 7.63 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.442 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . 0.457 HD22 ' HG2' ' A' ' 572' ' ' PRO . 7.7 mp -78.99 148.72 72.4 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.177 -173.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . 0.447 ' HG2' HD22 ' A' ' 578' ' ' LEU . 36.3 Cg_endo -67.35 168.56 17.52 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 124.093 3.195 . . . . 0.0 112.952 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . 0.508 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 45.6 pt -116.25 -179.66 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 78.5 m -124.6 123.13 39.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.969 0.414 . . . . 0.0 111.632 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.43 ' O ' ' HB ' ' A' ' 602' ' ' THR . 6.4 mmmm -115.92 121.97 43.9 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.508 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 1.6 tm-20 -88.96 -36.72 15.71 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -93.23 78.65 4.51 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 11.8 p -88.07 154.99 3.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.265 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . 0.413 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 78.0 mt-30 -84.71 167.4 16.19 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.501 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 21.5 m -108.19 -8.95 15.62 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.3 m 70.15 -55.36 0.61 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.337 1.055 . . . . 0.0 111.903 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 109.14 -143.71 16.4 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.23 132.84 28.79 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.685 1.59 . . . . 0.0 111.423 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.29 164.97 32.06 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 123.505 2.803 . . . . 0.0 112.77 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.08 177.74 4.14 Favored 'Trans proline' 0 C--O 1.254 1.29 0 C-N-CA 122.773 2.315 . . . . 0.0 111.314 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -95.24 165.24 12.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.536 HD21 ' HA3' ' A' ' 639' ' ' GLY . 19.3 tp -91.46 156.46 17.7 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -53.2 -64.27 0.88 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.59 0.632 . . . . 0.0 112.49 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.45 -23.92 11.65 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.384 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -94.67 -152.75 29.68 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.727 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.52 -164.92 1.94 Allowed 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.4 p -104.73 136.18 39.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -94.62 -21.14 19.01 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.299 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 23.9 mm-40 -81.67 154.59 26.02 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -70.3 113.53 7.56 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 1.5 p -70.75 99.89 1.79 Allowed 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.777 0.799 . . . . 0.0 111.837 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -82.85 169.72 15.78 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.166 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.21 -26.41 33.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.049 0.452 . . . . 0.0 111.207 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -128.55 113.61 15.68 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.408 ' HD2' ' CG ' ' A' ' 653' ' ' GLU . 8.2 m-85 -92.3 -93.12 0.15 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 140.04 164.94 10.1 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.136 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.679 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 69.7 t60 -55.67 -58.62 7.04 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 15.1 m -90.43 15.31 10.91 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-O 121.289 0.566 . . . . 0.0 111.22 -173.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.408 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 4.7 tp10 -97.12 117.49 31.43 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 5.9 m -93.96 151.34 3.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.754 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 29.3 m -114.34 102.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.55 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.52 ' CG ' ' HD2' ' A' ' 670' ' ' LYS . 12.1 mt-10 -66.21 121.78 15.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.942 0.877 . . . . 0.0 112.242 176.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 69.4 m-85 -100.06 168.61 9.73 Favored 'General case' 0 C--N 1.271 -2.836 0 C-N-CA 125.28 1.432 . . . . 0.0 109.441 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -152.61 141.7 21.33 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 7.5 t -106.49 -171.19 1.85 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.58 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.479 ' C ' ' H ' ' A' ' 662' ' ' ARG . 39.6 m-80 -77.77 156.39 80.25 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.37 6.16 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 123.797 2.998 . . . . 0.0 113.388 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.479 ' H ' ' C ' ' A' ' 660' ' ' ASN . 32.2 mmt180 -105.7 -0.26 25.67 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.254 -176.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -128.27 158.36 38.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.568 0.699 . . . . 0.0 112.322 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.43 133.39 46.13 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 113.749 -1.569 . . . . 0.0 107.511 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.2 ttt -104.0 109.55 21.37 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -92.9 -49.19 6.16 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -86.23 -171.04 47.56 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.36 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.12 119.12 6.11 Favored 'Trans proline' 0 CA--C 1.526 0.108 0 C-N-CA 123.093 2.529 . . . . 0.0 111.13 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.603 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 23.2 p-10 -81.47 0.28 38.46 Favored 'General case' 0 C--O 1.178 -2.666 0 O-C-N 121.996 -0.44 . . . . 0.0 111.33 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 3.8 ptmt -134.74 110.28 9.13 Favored 'General case' 0 C--N 1.267 -3.0 0 CA-C-O 121.801 0.81 . . . . 0.0 109.704 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 46.5 pt -110.25 151.32 12.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.649 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 651' ' ' HIS . 0.6 OUTLIER -113.73 156.8 23.13 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.541 0.526 . . . . 0.0 111.458 -179.146 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 13.6 t -81.73 99.63 9.05 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.885 0.85 . . . . 0.0 110.624 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . 0.493 ' HA ' ' HD1' ' A' ' 651' ' ' HIS . 36.0 m -90.72 111.66 23.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.975 -1.078 . . . . 0.0 111.878 -177.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 13.1 t70 71.13 -59.5 0.54 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.707 1.203 . . . . 0.0 112.639 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -172.77 22.71 0.07 OUTLIER Glycine 0 C--N 1.295 -1.703 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -142.47 152.0 42.28 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.498 ' HB3' HD13 ' A' ' 671' ' ' ILE . 96.4 m95 -81.12 173.0 12.98 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.558 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 679' ' ' THR . . . . . 0.453 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 0.5 OUTLIER -96.59 -179.92 4.77 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.067 -179.111 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 27.5 m -69.39 126.17 28.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.725 0.298 . . . . 0.0 110.868 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.18 155.94 42.32 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.603 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 10.3 Cg_endo -57.41 -39.67 87.43 Favored 'Trans proline' 0 CA--C 1.5 -1.198 0 C-N-CA 124.434 3.423 . . . . 0.0 115.527 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.275 3.9 m 64.42 122.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.09 0 C-N-CA 125.37 1.468 . . . . 0.0 112.202 -171.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 21.8 p -119.94 129.17 54.2 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.718 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.76 147.84 22.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.353 -174.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.81 128.71 17.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 123.977 0.798 . . . . 0.0 111.1 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 C--N 1.305 -1.369 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.173 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 120.87 0.366 . . . . 0.0 111.529 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.585 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 88.9 m -127.29 149.28 50.09 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.543 0.687 . . . . 0.0 112.331 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.493 ' O ' HD22 ' A' ' 616' ' ' LEU . 40.0 mt-10 -107.55 -157.12 0.6 Allowed 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.462 HD23 ' HD2' ' A' ' 572' ' ' PRO . 3.1 tm? -125.84 107.38 25.68 Favored Pre-proline 0 C--N 1.28 -2.42 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.462 ' HD2' HD23 ' A' ' 571' ' ' LEU . 48.9 Cg_endo -67.45 176.93 4.35 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.647 2.231 . . . . 0.0 111.785 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -79.76 90.02 5.22 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.843 0.83 . . . . 0.0 109.793 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 578' ' ' LEU . 38.6 pt -72.88 -169.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.594 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 7.9 t70 -74.82 146.69 41.82 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.17 -22.63 31.53 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 121.662 0.744 . . . . 0.0 110.515 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -93.7 5.46 51.56 Favored 'General case' 0 C--O 1.204 -1.29 0 O-C-N 121.646 -0.659 . . . . 0.0 110.374 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.559 HD13 ' SG ' ' A' ' 623' ' ' CYS . 1.0 OUTLIER -108.02 154.12 22.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.209 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.39 122.51 5.23 Favored Pre-proline 0 C--N 1.304 -1.383 0 C-N-CA 123.304 0.642 . . . . 0.0 109.62 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.92 137.28 26.53 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.054 1.836 . . . . 0.0 112.534 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 594' ' ' LYS . 10.7 t70 -67.1 -42.52 84.43 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.584 1.154 . . . . 0.0 110.898 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -64.55 -68.94 0.32 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.722 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 53.35 81.49 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.218 1.407 . . . . 0.0 111.315 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 16.5 ptpt -132.89 -177.6 4.57 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.817 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.61 -68.3 0.61 Allowed 'General case' 0 C--N 1.309 -1.164 0 O-C-N 123.158 0.286 . . . . 0.0 111.383 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 131.06 54.48 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.548 0.689 . . . . 0.0 110.582 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.596 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 66.1 m-85 -94.79 140.34 30.04 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.437 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 611' ' ' CYS . 36.8 ttmt -91.13 152.51 20.56 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.194 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.69 118.81 3.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 99.71 2.9 56.29 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.834 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -76.16 130.99 39.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 12.7 t -101.81 120.2 51.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.408 0.623 . . . . 0.0 109.386 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.596 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 4.9 mp -98.52 100.12 11.34 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 581' ' ' ASP . 31.0 mtmm -80.27 142.02 34.98 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 173.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.492 ' CZ ' HD13 ' A' ' 620' ' ' LEU . 91.2 m-85 -116.16 173.95 6.31 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-O 121.321 0.582 . . . . 0.0 110.624 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 8.7 p -161.6 168.38 23.59 Favored 'General case' 0 N--CA 1.392 -3.335 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.528 ' SG ' HD13 ' A' ' 578' ' ' LEU . 94.3 m -117.75 -176.06 2.96 Favored 'General case' 0 C--N 1.265 -3.082 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.546 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 39.3 mmtm -55.03 166.64 0.77 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.406 1.482 . . . . 0.0 111.85 174.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 71.8 Cg_exo -46.91 -42.9 24.94 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 124.112 3.208 . . . . 0.0 114.612 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -102.69 0.16 49.16 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.385 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 28.4 m-85 -93.16 127.28 38.66 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 602' ' ' THR . . . . . 0.427 HG22 ' CG2' ' A' ' 627' ' ' VAL . 90.4 m -86.82 120.55 28.22 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-N 113.075 -1.875 . . . . 0.0 110.67 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 12.3 tt -77.3 133.05 31.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 91.0 t -133.36 130.37 57.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 124.73 -148.55 16.78 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -80.41 102.06 1.38 Allowed 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.322 2.015 . . . . 0.0 110.426 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 1.8 m-20 -73.88 -23.98 59.65 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.709 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 608' ' ' SER . . . . . . . . . . . . . 27.8 p -129.57 96.11 4.17 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.561 0.696 . . . . 0.0 111.284 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.0 m -94.93 164.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.589 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 23.6 mm-40 -107.67 165.38 11.47 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 588' ' ' LYS . 4.1 t -92.79 128.64 38.72 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 114.519 -1.219 . . . . 0.0 107.825 165.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.589 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 54.6 m-85 -115.37 168.71 9.74 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -60.61 -16.04 34.36 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -108.45 -3.65 18.0 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.775 0.321 . . . . 0.0 111.38 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 133.47 -168.72 23.01 Favored Glycine 0 N--CA 1.434 -1.47 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.381 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.493 HD22 ' O ' ' A' ' 570' ' ' GLU . 2.6 mm? -77.03 121.92 24.21 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 123.152 0.581 . . . . 0.0 109.641 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.535 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 35.3 t -147.2 141.47 15.91 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 617' ' ' SER . 13.4 Cg_exo -66.22 -179.57 12.43 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.713 -1.37 . . . . 0.0 112.651 0.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.05 163.48 24.61 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.277 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . 0.492 HD13 ' CZ ' ' A' ' 595' ' ' PHE . 1.1 mm? -67.61 134.75 92.62 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.994 -169.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.22 172.45 7.53 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 123.832 3.021 . . . . 0.0 111.541 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 45.6 pt -114.03 169.6 5.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.032 0.444 . . . . 0.0 111.327 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.559 ' SG ' HD13 ' A' ' 578' ' ' LEU . 81.7 m -115.61 112.54 22.3 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.301 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -95.61 -28.29 14.9 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 21.6 tt0 69.25 -66.73 0.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.223 1.009 . . . . 0.0 109.546 -176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -88.85 112.02 22.75 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.557 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 2.8 p -127.38 174.52 10.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 16.0 mm100 -93.84 155.78 17.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.52 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 16.2 m -104.92 -8.21 18.79 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.015 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 21.9 m 74.77 -3.26 2.63 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 166.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 64.73 -147.76 51.07 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.421 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.82 144.33 24.39 Favored 'Trans proline' 0 C--O 1.253 1.24 0 C-N-CA 122.658 2.238 . . . . 0.0 112.035 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.51 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 68.6 Cg_endo -70.78 167.38 25.94 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.821 3.014 . . . . 0.0 112.996 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.04 -179.5 4.38 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.792 2.328 . . . . 0.0 111.472 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -99.38 158.58 15.62 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.522 HD23 ' HB3' ' A' ' 657' ' ' TYR . 16.0 tp -96.82 133.98 40.72 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 683' ' ' VAL . 2.0 pt? -50.37 -45.4 55.21 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -131.03 33.26 4.19 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.14 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -167.7 -148.32 5.63 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . 0.478 ' ND2' ' H ' ' A' ' 641' ' ' VAL . 2.3 t30 -162.41 177.66 9.34 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.478 ' H ' ' ND2' ' A' ' 640' ' ' ASN . 5.2 t -78.54 133.13 30.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.55 ' HB2' ' NZ ' ' A' ' 642' ' ' LYS . 0.0 OUTLIER -90.78 -2.6 57.78 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.22 0.533 . . . . 0.0 110.563 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.505 ' OE2' ' HE3' ' A' ' 642' ' ' LYS . 74.0 mm-40 -104.19 151.9 22.79 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.694 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 644' ' ' LYS . 21.8 pttm -50.91 109.77 0.36 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 112.545 -2.116 . . . . 0.0 109.871 169.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.597 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 4.1 p -85.33 102.98 13.84 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 121.906 0.86 . . . . 0.0 112.792 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 53.6 pttt -84.19 156.83 21.87 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.646 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.436 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 4.9 mp0 -74.71 -11.29 60.14 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.955 -173.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.502 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 7.4 tp10 -147.66 118.39 7.56 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.597 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 21.6 m-85 -97.64 -94.75 0.22 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 151.34 167.39 14.78 Favored Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.574 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.696 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 67.6 t60 -61.38 -44.16 97.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.343 0.592 . . . . 0.0 111.7 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 14.6 m -98.01 17.22 18.84 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.396 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 649' ' ' TYR . 2.9 tp10 -101.0 111.54 23.77 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.674 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.586 ' CG2' ' HB2' ' A' ' 670' ' ' LYS . 10.8 p -87.91 148.31 4.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.961 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -112.16 105.63 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.76 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.79 170.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.576 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 19.4 mt-10 -72.5 126.06 28.95 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.71 0.767 . . . . 0.0 109.592 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 669' ' ' ASN . 49.7 m-85 -102.59 167.69 9.76 Favored 'General case' 0 C--N 1.268 -2.945 0 C-N-CA 124.311 1.044 . . . . 0.0 110.969 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' A' ' 642' ' ' LYS . 13.6 p90 -148.54 142.47 25.81 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.512 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 33.2 m -107.07 173.83 6.15 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 120.794 0.331 . . . . 0.0 111.861 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.402 ' C ' ' H ' ' A' ' 662' ' ' ARG . 7.2 m120 -61.82 150.79 81.39 Favored Pre-proline 0 C--O 1.243 0.763 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.577 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.55 39.14 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 124.826 3.684 . . . . 0.0 113.822 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 660' ' ' ASN . 11.7 ptm180 -155.83 9.22 0.26 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.817 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.32 150.17 48.68 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 120.96 0.409 . . . . 0.0 109.912 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 85.1 mt -93.49 134.5 35.69 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.742 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 3.3 ttt -96.25 101.39 13.02 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 685' ' ' ILE . 41.3 tptt -69.16 -65.17 0.74 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.69 -169.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.72 -161.69 37.7 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.704 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.43 124.66 14.64 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 123.239 2.626 . . . . 0.0 110.948 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.555 ' O ' ' HB2' ' A' ' 657' ' ' TYR . 5.6 p-10 -76.39 -12.28 60.03 Favored 'General case' 0 C--O 1.171 -3.036 0 CA-C-O 121.672 0.748 . . . . 0.0 110.412 -177.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.586 ' HB2' ' CG2' ' A' ' 654' ' ' VAL . 0.0 OUTLIER -132.97 123.33 25.71 Favored 'General case' 2 N--CA 1.331 -6.424 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -171.397 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 678' ' ' TRP . 43.4 pt -122.0 138.95 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.78 -172.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.57 161.03 15.22 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 38.3 t -94.0 104.58 16.61 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 118.451 -1.3 . . . . 0.0 111.876 -176.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . 0.262 32.7 m -81.62 88.36 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-O 123.017 1.389 . . . . 0.0 113.126 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.603 ' N ' ' HD1' ' A' ' 651' ' ' HIS . 24.9 t70 89.98 -61.25 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.871 0 CA-C-N 112.094 -2.321 . . . . 0.0 111.224 170.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -159.0 12.98 0.21 Allowed Glycine 0 C--N 1.268 -3.207 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.707 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.48 130.58 38.77 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 94.6 m95 -72.95 152.77 41.25 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 2.2 p -74.46 176.91 6.37 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 14.2 m -61.56 125.84 25.23 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.068 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 6.3 mp -62.62 154.83 72.22 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.744 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 17.8 Cg_endo -61.73 -19.68 66.2 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 C-N-CA 123.464 2.776 . . . . 0.0 114.136 -177.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.489 ' HA ' HD22 ' A' ' 637' ' ' LEU . 17.2 m 39.78 83.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 175.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.742 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 62.8 m -79.77 146.75 32.16 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.27 -174.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -127.83 149.34 32.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.483 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.82 139.35 21.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 120.792 0.33 . . . . 0.0 111.318 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--O 1.254 1.323 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.155 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 83.2 m -89.53 148.03 23.63 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.93 0.395 . . . . 0.0 111.237 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.18 134.14 49.01 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 172.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.779 HD13 ' HH ' ' A' ' 587' ' ' TYR . 2.4 tt -52.18 111.4 2.48 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.079 0.952 . . . . 0.0 108.885 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.451 ' HG2' HD22 ' A' ' 620' ' ' LEU . 58.8 Cg_endo -76.68 -174.67 2.24 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.913 2.409 . . . . 0.0 111.417 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -87.4 86.96 7.29 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.751 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.496 ' HB ' HD23 ' A' ' 578' ' ' LEU . 11.1 pt -55.81 -72.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.739 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.1 t70 -173.93 -172.36 0.72 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.39 -30.73 2.99 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . 0.407 ' O ' ' HG2' ' A' ' 598' ' ' LYS . 31.9 m80 -95.63 11.31 33.7 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.242 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.7 tt -111.82 139.89 46.92 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.96 121.28 12.36 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.621 ' HG3' HD12 ' A' ' 571' ' ' LEU . 54.8 Cg_endo -75.05 152.39 40.49 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.603 2.202 . . . . 0.0 111.22 174.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.02 -46.02 62.87 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.34 0.591 . . . . 0.0 109.895 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . 0.464 ' HA ' ' HD3' ' A' ' 582' ' ' ARG . 2.4 mmt180 -84.15 139.54 32.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.872 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -137.48 107.95 6.52 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -146.9 172.77 13.17 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.66 -65.49 0.78 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.22 145.09 44.13 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.5 0.667 . . . . 0.0 110.162 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.779 ' HH ' HD13 ' A' ' 571' ' ' LEU . 39.3 m-85 -105.27 125.88 51.48 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -78.87 153.4 30.59 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.536 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.41 121.16 7.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.326 0.584 . . . . 0.0 110.156 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 105.73 -8.9 43.72 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.747 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.31 126.19 28.48 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 117.876 0.838 . . . . 0.0 109.864 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 608' ' ' SER . 14.3 t -99.67 121.78 50.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 608' ' ' SER . 5.2 mp -104.24 107.9 19.02 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 9.0 mtmp? -82.31 112.02 18.91 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 64.1 m-85 -90.37 164.88 14.15 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 56.3 m -153.97 179.45 8.9 Favored 'General case' 0 N--CA 1.402 -2.869 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 89.4 m -120.22 177.44 5.01 Favored 'General case' 0 C--N 1.26 -3.31 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.576 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 33.0 mmmt -58.17 164.12 3.86 Favored Pre-proline 0 C--N 1.316 -0.89 0 C-N-CA 123.819 0.847 . . . . 0.0 111.676 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 74.3 Cg_exo -47.69 -42.0 30.39 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 124.356 3.37 . . . . 0.0 114.818 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.8 -0.23 62.4 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.513 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -102.93 151.85 21.99 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-O 121.975 0.893 . . . . 0.0 112.545 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 602' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 54.1 m -108.2 128.74 54.98 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.108 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.423 HD12 ' HG3' ' A' ' 621' ' ' PRO . 11.3 tt -80.08 123.39 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 173.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 53.2 t -114.47 118.57 58.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 120.945 0.403 . . . . 0.0 110.61 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 116.23 -156.43 15.64 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.58 124.95 13.54 Favored 'Trans proline' 0 C--O 1.221 -0.352 0 C-N-CA 123.2 2.6 . . . . 0.0 110.989 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.438 HD21 ' N ' ' A' ' 607' ' ' ASN . 0.6 OUTLIER -85.38 -45.66 11.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 35.5 p -100.1 119.73 38.76 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 18.2 m -115.22 155.02 16.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.501 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -100.74 155.62 17.8 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.361 0.601 . . . . 0.0 109.893 178.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 8.3 t -88.05 125.26 34.46 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.64 168.88 9.49 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.66 3.07 6.85 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.003 0.82 . . . . 0.0 111.972 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -115.93 2.15 13.47 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.825 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 125.69 -174.11 17.61 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.973 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.437 HD21 ' HD3' ' A' ' 572' ' ' PRO . 2.8 mm? -77.81 125.33 29.17 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 618' ' ' PRO . 50.4 m -145.58 152.86 50.3 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' A' ' 617' ' ' SER . 73.0 Cg_endo -72.26 -165.48 3.54 Favored 'Cis proline' 0 N--CA 1.486 1.079 0 CA-C-N 119.764 0.952 . . . . 0.0 114.554 4.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -55.24 137.62 46.9 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.107 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . 0.451 HD22 ' HG2' ' A' ' 572' ' ' PRO . 5.7 mp -72.61 147.66 89.64 Favored Pre-proline 0 C--N 1.287 -2.116 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.431 -173.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . 0.492 ' HG2' HD12 ' A' ' 578' ' ' LEU . 72.1 Cg_endo -73.36 178.98 5.94 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 123.103 2.535 . . . . 0.0 113.479 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 45.3 pt -127.37 171.34 15.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 96.8 m -115.77 114.67 25.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.967 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 602' ' ' THR . 27.3 mtpp -108.89 120.45 42.55 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.682 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -84.34 -24.42 29.78 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -108.78 116.76 32.6 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.029 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.59 -178.56 2.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.317 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -97.22 179.44 4.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.54 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 20.0 m -115.73 -7.15 12.12 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.144 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 66.5 m 72.1 -28.78 0.19 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 83.08 -147.73 24.97 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.9 142.79 39.65 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.984 1.789 . . . . 0.0 110.727 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.518 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 72.2 Cg_endo -73.6 168.79 23.88 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 123.189 2.593 . . . . 0.0 112.095 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.66 -179.3 3.63 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 122.695 2.263 . . . . 0.0 111.846 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -100.81 156.27 17.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' ' 657' ' ' TYR . 14.8 tp -87.88 150.47 23.48 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 638' ' ' ASN . 0.0 OUTLIER -57.89 -54.25 49.0 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.492 ' HB2' HD23 ' A' ' 637' ' ' LEU . 5.3 m-80 -130.17 41.49 3.4 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 122.34 1.067 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -161.57 -156.82 8.51 Favored Glycine 0 N--CA 1.411 -2.988 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.6 t-20 -153.12 -176.37 5.75 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.57 136.18 27.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -89.6 -24.61 21.65 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.895 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -79.07 163.29 25.25 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.394 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -84.01 115.17 22.2 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 12.2 p -69.22 97.43 0.93 Allowed 'General case' 0 N--CA 1.413 -2.285 0 O-C-N 124.177 0.923 . . . . 0.0 112.3 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.535 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 48.9 pttt -76.22 160.19 29.93 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.57 -7.0 58.73 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.4 0.619 . . . . 0.0 111.298 -171.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -141.06 105.46 4.85 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.535 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 6.9 m-85 -85.69 -76.31 0.34 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 124.46 163.92 11.8 Favored Glycine 0 C--N 1.284 -2.343 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.158 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.429 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.2 t60 -66.79 142.94 57.19 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.258 5.9 p 62.78 9.74 3.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.889 1.276 . . . . 0.0 114.259 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.448 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 4.2 tp10 -87.58 116.66 25.85 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.58 ' CG2' ' HB2' ' A' ' 670' ' ' LYS . 4.1 p -92.1 152.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.823 0.82 . . . . 0.0 111.22 -176.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 26.9 m -122.27 113.31 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.58 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.691 175.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 21.7 mt-10 -76.85 131.34 38.58 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.681 0.753 . . . . 0.0 111.6 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.545 ' HB3' HD21 ' A' ' 636' ' ' LEU . 56.6 m-85 -111.36 160.76 16.76 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 125.106 1.362 . . . . 0.0 111.389 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.519 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 10.5 p90 -145.03 134.51 23.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.54 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 27.9 m -100.3 171.34 7.84 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.392 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.43 ' C ' ' H ' ' A' ' 662' ' ' ARG . 46.9 m-80 -60.07 154.23 51.58 Favored Pre-proline 0 C--N 1.314 -0.967 0 O-C-N 124.184 0.927 . . . . 0.0 110.917 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 71.8 Cg_endo -73.15 35.69 0.35 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 124.308 3.339 . . . . 0.0 112.864 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 660' ' ' ASN . 14.3 mtt180 -136.83 4.78 2.81 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.575 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 72.0 m-85 -136.23 156.98 47.89 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.1 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.709 ' HG ' ' HG2' ' A' ' 687' ' ' GLU . 80.4 mt -115.07 146.31 41.43 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.772 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -82.52 142.32 31.94 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 118.437 0.562 . . . . 0.0 110.295 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.478 ' HA ' ' HE3' ' A' ' 666' ' ' LYS . 2.0 tpmt? -92.56 -41.62 10.14 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.303 0.573 . . . . 0.0 109.736 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -116.32 -163.25 13.36 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.765 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.96 129.31 26.92 Favored 'Trans proline' 0 C--O 1.22 -0.402 0 C-N-CA 123.934 3.09 . . . . 0.0 110.51 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.54 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 9.5 p-10 -68.66 -14.21 62.87 Favored 'General case' 0 C--O 1.178 -2.696 0 CA-C-O 121.327 0.584 . . . . 0.0 111.534 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.58 ' HB2' ' CG2' ' A' ' 654' ' ' VAL . 12.1 ptmt -130.13 145.57 51.71 Favored 'General case' 0 C--N 1.25 -3.742 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -174.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.635 HD12 ' CD2' ' A' ' 681' ' ' LEU . 35.8 pt -135.22 145.6 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -121.54 148.54 44.35 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.386 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 12.9 t -72.42 113.59 9.62 Favored 'General case' 0 CA--C 1.468 -2.206 0 CA-C-O 122.381 1.086 . . . . 0.0 109.794 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . 0.429 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 44.2 t -105.65 111.58 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.811 0 CA-C-N 112.341 -2.209 . . . . 0.0 108.499 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.78 -75.97 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.619 1.168 . . . . 0.0 111.955 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -157.65 26.29 0.46 Allowed Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.3 143.81 32.96 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.552 ' HB3' HD11 ' A' ' 671' ' ' ILE . 92.4 m95 -87.85 161.48 17.49 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.577 0.626 . . . . 0.0 109.753 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 15.4 p -76.2 172.37 12.96 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.924 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 24.9 m -67.1 135.14 53.14 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.035 0.445 . . . . 0.0 110.931 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.635 ' CD2' HD12 ' A' ' 671' ' ' ILE . 50.9 mt -61.53 151.58 77.21 Favored Pre-proline 0 N--CA 1.42 -1.926 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.154 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.772 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 11.7 Cg_endo -53.25 -18.89 11.31 Favored 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 124.752 3.635 . . . . 0.0 115.362 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.472 ' HA ' HD12 ' A' ' 637' ' ' LEU 0.25 16.9 m 41.89 91.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 174.484 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.575 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 4.3 p -87.33 150.38 23.89 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.58 150.74 34.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.648 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.67 135.83 25.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 O-C-N 123.778 0.673 . . . . 0.0 110.762 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . 0.709 ' HG2' ' HG ' ' A' ' 664' ' ' LEU . 42.2 mt-10 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.526 -0.75 . . . . 0.0 109.567 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 55.8 m -86.11 147.79 25.99 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.1 0.476 . . . . 0.0 111.014 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 571' ' ' LEU . 45.9 tt0 -125.47 -8.36 6.9 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.601 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 63.2 tp 79.06 115.33 0.03 OUTLIER Pre-proline 0 C--O 1.244 0.778 0 C-N-CA 125.239 1.416 . . . . 0.0 110.068 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.512 ' HD2' HD13 ' A' ' 571' ' ' LEU . 69.7 Cg_endo -71.5 -168.31 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.668 2.246 . . . . 0.0 110.134 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -87.37 102.93 15.01 Favored 'General case' 0 N--CA 1.41 -2.452 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.728 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.456 HD13 ' HB3' ' A' ' 578' ' ' LEU . 36.4 pt -70.04 -170.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.973 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 7.9 t70 -70.75 155.57 40.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.42 -28.16 37.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 121.839 0.828 . . . . 0.0 109.412 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -96.65 6.49 48.61 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.275 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.8 tm? -97.3 144.07 27.44 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.37 115.13 7.58 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -76.28 137.71 19.26 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.879 2.386 . . . . 0.0 112.731 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -55.97 -55.95 26.56 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.334 1.454 . . . . 0.0 111.423 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . 0.45 ' HB3' ' HE3' ' A' ' 584' ' ' LYS . 55.0 mmt-85 -59.07 -59.91 4.71 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.856 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 53.57 82.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.647 1.217 . . . . 0.0 111.068 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 582' ' ' ARG . 15.4 ptpt -143.26 163.71 32.21 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.91 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.16 -57.09 14.31 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 123.837 0.71 . . . . 0.0 111.261 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.84 142.82 51.18 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.094 0.473 . . . . 0.0 110.041 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.601 ' CE1' ' HB2' ' A' ' 571' ' ' LEU . 95.0 m-85 -102.59 126.73 49.77 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.847 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -79.74 151.75 30.23 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.092 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 45.6 t -60.87 118.06 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 104.18 -5.76 45.95 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.447 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -69.01 129.47 40.03 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 17.8 m -97.26 118.9 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-O 122.509 1.147 . . . . 0.0 109.867 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.415 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 5.6 mp -95.49 96.87 9.37 Favored 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.615 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 57.2 mtmt -80.75 109.86 15.7 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.485 ' HB3' HD13 ' A' ' 578' ' ' LEU . 64.9 m-85 -92.26 162.72 14.18 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 16.9 t -158.26 176.46 12.44 Favored 'General case' 0 N--CA 1.393 -3.286 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 88.3 m -121.24 172.17 8.19 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.488 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 70.2 mmtt -53.8 159.95 2.38 Favored Pre-proline 0 C--N 1.319 -0.751 0 C-N-CA 124.024 0.929 . . . . 0.0 112.169 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 12.1 Cg_endo -69.27 109.55 2.24 Favored 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.036 1.824 . . . . 0.0 109.366 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 122.52 -17.33 8.37 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -101.07 157.75 16.53 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 122.128 0.966 . . . . 0.0 112.48 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 602' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 18.5 m -109.04 130.55 55.48 Favored 'General case' 0 N--CA 1.402 -2.869 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.777 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 11.2 tt -85.68 122.01 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.72 127.45 69.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 112.95 -166.35 12.13 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.11 126.54 17.37 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.988 2.459 . . . . 0.0 110.761 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -86.13 -38.27 17.91 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.745 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.542 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 34.4 p -114.64 111.27 21.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.995 0.426 . . . . 0.0 110.96 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.2 m -104.79 153.82 6.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.594 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -99.08 147.91 24.58 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.409 ' HA ' HD21 ' A' ' 616' ' ' LEU . 17.6 t -83.23 124.31 30.43 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 170.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 617' ' ' SER . 91.7 m-85 -110.59 171.88 7.2 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.68 7.23 3.18 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -117.58 -9.04 10.87 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 133.07 -174.37 20.61 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 611' ' ' CYS . 91.4 mt -70.9 138.77 50.41 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 122.976 0.51 . . . . 0.0 111.377 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.576 ' HB3' ' CD2' ' A' ' 612' ' ' TYR . 44.7 t -152.55 141.41 14.12 Favored Pre-proline 0 N--CA 1.424 -1.773 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.417 ' C ' ' HA ' ' A' ' 617' ' ' SER . 60.4 Cg_endo -72.94 -172.01 9.15 Favored 'Cis proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.081 -1.633 . . . . 0.0 113.197 0.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.9 151.73 38.43 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.111 0.481 . . . . 0.0 111.255 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 6.1 mp -67.13 145.11 98.69 Favored Pre-proline 0 C--N 1.309 -1.169 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -170.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.68 175.21 8.33 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 123.93 3.087 . . . . 0.0 112.018 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 38.4 pt -127.53 174.05 11.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.6 m -121.89 122.32 39.14 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.956 0.408 . . . . 0.0 111.5 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.478 ' HZ1' ' CG ' ' A' ' 675' ' ' ASP . 53.8 mtpt -119.58 125.74 49.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -82.97 -40.03 20.59 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 121.547 0.689 . . . . 0.0 109.715 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -102.05 100.25 10.49 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.879 0.847 . . . . 0.0 110.45 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 8.0 m -107.76 174.13 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.588 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -98.99 143.99 28.66 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.234 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 38.2 m -97.49 -2.17 42.52 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 98.5 m 74.33 -42.75 0.51 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.958 1.303 . . . . 0.0 113.646 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 105.33 -141.47 15.35 Favored Glycine 0 N--CA 1.417 -2.632 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.8 139.46 13.96 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.259 1.972 . . . . 0.0 110.83 174.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.33 161.57 44.17 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 123.268 2.645 . . . . 0.0 112.707 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.86 176.45 6.06 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.915 2.41 . . . . 0.0 111.677 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.82 163.11 14.55 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 1.059 HD22 ' SG ' ' A' ' 659' ' ' CYS . 9.1 tp -90.27 156.69 18.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 683' ' ' VAL 0.285 2.1 pt? -77.05 -45.46 27.06 Favored 'General case' 0 N--CA 1.406 -2.672 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.495 -178.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.438 HD21 ' HG ' ' A' ' 637' ' ' LEU . 42.5 m-80 -125.64 33.77 5.04 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.558 0.694 . . . . 0.0 110.904 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.658 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -160.75 -140.76 2.96 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.556 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.87 -169.82 2.96 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.0 p -102.97 132.43 49.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.64 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.9 ptmt -87.22 -13.83 42.76 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.831 0.824 . . . . 0.0 110.256 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -88.58 140.39 29.51 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.843 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . 0.664 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -55.8 121.34 9.0 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 124.161 0.913 . . . . 0.0 108.631 171.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 3.7 p -94.67 99.67 11.74 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.466 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 53.4 pttt -82.99 167.5 17.88 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.322 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -88.78 1.81 54.59 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.588 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 34.3 tt0 -151.73 108.4 3.49 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.466 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 4.9 m-85 -84.55 -93.93 0.07 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 151.78 159.79 9.13 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 54.3 t60 -51.61 -59.14 4.6 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 37.2 m -91.67 21.08 4.95 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.364 0.602 . . . . 0.0 110.691 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -104.03 113.37 26.86 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 8.8 p -94.17 159.47 2.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.868 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.7 t -124.07 114.05 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.879 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.64 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 21.7 mt-10 -71.88 128.43 35.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.489 0.661 . . . . 0.0 111.876 174.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 42.0 m-85 -109.33 170.66 7.91 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 123.58 0.752 . . . . 0.0 110.799 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -148.48 132.2 16.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 1.059 ' SG ' HD22 ' A' ' 636' ' ' LEU . 95.9 m -97.1 172.62 7.72 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.948 176.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.433 ' C ' ' H ' ' A' ' 662' ' ' ARG . 49.3 m-80 -64.9 152.95 89.64 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.003 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 72.4 Cg_endo -72.27 35.42 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 124.554 3.503 . . . . 0.0 113.652 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 660' ' ' ASN . 0.3 OUTLIER -149.57 13.48 0.83 Allowed 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.349 -174.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.33 156.56 48.25 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.874 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.444 HD22 ' HG3' ' A' ' 687' ' ' GLU . 83.6 mt -101.07 143.45 31.17 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.712 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 2.5 ttt -107.57 108.88 20.37 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -78.7 -57.82 3.56 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.251 -173.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.24 -174.31 47.56 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.795 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.12 126.38 21.41 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 123.68 2.92 . . . . 0.0 110.868 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.599 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 16.3 p-10 -66.91 -13.05 61.33 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-O 121.026 0.441 . . . . 0.0 110.842 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 16.0 mtpt -118.48 151.38 37.93 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 38.0 pt -138.54 141.43 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.87 151.69 39.34 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.918 0.39 . . . . 0.0 111.073 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 19.0 t -81.73 99.73 9.11 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.752 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . 0.536 ' HA ' ' HD1' ' A' ' 651' ' ' HIS 0.278 20.1 m -88.63 75.89 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 O-C-N 120.541 -1.349 . . . . 0.0 112.064 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.478 ' CG ' ' HZ1' ' A' ' 624' ' ' LYS . 35.1 t70 63.85 66.17 0.67 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.642 175.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 88.34 -20.21 31.52 Favored Glycine 0 C--N 1.311 -0.846 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.173 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -118.01 113.91 22.36 Favored 'General case' 0 N--CA 1.423 -1.803 0 O-C-N 122.201 -0.588 . . . . 0.0 111.857 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -65.88 151.63 46.29 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 20.1 p -77.55 173.59 11.84 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.04 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 6.3 m -62.89 128.43 35.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.154 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.09 161.52 39.04 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.392 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.599 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 20.2 Cg_endo -62.6 -17.81 60.43 Favored 'Trans proline' 0 CA--C 1.507 -0.827 0 C-N-CA 123.416 2.744 . . . . 0.0 115.04 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.513 ' HA ' HD23 ' A' ' 637' ' ' LEU 0.258 30.3 m 41.58 94.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 175.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.712 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 69.9 m -92.84 154.95 17.94 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.1 OUTLIER -140.17 152.46 21.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.609 -177.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.95 136.77 19.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . 0.444 ' HG3' HD22 ' A' ' 664' ' ' LEU . 29.0 tt0 . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . 0.535 ' HG3' ' HB3' ' A' ' 586' ' ' GLN . 13.2 pt-20 . . . . . 0 N--CA 1.428 -1.533 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 71.6 m -62.88 115.76 4.66 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 124.742 1.217 . . . . 0.0 113.201 -174.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.51 -12.85 58.69 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.669 HD23 ' HH ' ' A' ' 587' ' ' TYR . 41.7 tp 73.17 113.61 0.03 OUTLIER Pre-proline 0 CA--C 1.514 -0.442 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.078 -176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.437 ' HD2' HD13 ' A' ' 571' ' ' LEU . 44.3 Cg_endo -67.94 174.25 8.06 Favored 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.33 2.02 . . . . 0.0 111.052 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . 0.531 ' HD2' ' H ' ' A' ' 573' ' ' LYS 0.299 0.0 OUTLIER -73.68 102.2 3.87 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.47 177.217 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.5 HD13 ' HB3' ' A' ' 578' ' ' LEU . 40.7 pt -70.91 -171.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.671 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.9 t70 -72.93 146.35 46.15 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.69 -33.82 50.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.722 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -92.43 6.21 47.87 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.064 -0.398 . . . . 0.0 111.624 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.588 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.4 OUTLIER -101.64 150.11 23.44 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -176.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 9.7 m -143.79 121.83 6.94 Favored Pre-proline 0 C--N 1.306 -1.302 0 C-N-CA 123.932 0.893 . . . . 0.0 110.118 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 595' ' ' PHE . 26.2 Cg_endo -72.83 142.73 35.81 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.378 1.385 . . . . 0.0 109.398 171.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.69 -33.72 68.67 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.552 0.691 . . . . 0.0 110.301 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . 0.404 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 75.5 mmt-85 -75.33 -70.16 0.44 Allowed 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.133 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . 0.504 ' HA ' ' OH ' ' A' ' 587' ' ' TYR 0.296 53.0 tttp 52.29 79.67 0.11 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.768 -170.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.518 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 18.1 ptpt -129.23 164.34 23.67 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.437 -1.711 . . . . 0.0 106.475 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -65.28 -48.32 73.61 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . 0.535 ' HB3' ' HG3' ' A' ' 568' ' ' GLU . 0.0 OUTLIER -131.67 143.44 50.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.153 0.501 . . . . 0.0 110.408 176.224 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.669 ' HH ' HD23 ' A' ' 571' ' ' LEU . 76.9 m-85 -107.72 121.1 44.02 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 124.025 0.93 . . . . 0.0 109.145 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -66.0 144.53 56.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 60.4 t -55.03 120.65 2.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 109.59 -13.83 32.67 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.887 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -71.49 123.74 23.08 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.35 134.45 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.537 0 C-N-CA 119.419 -0.912 . . . . 0.0 108.834 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.449 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.4 mp -108.04 117.47 34.23 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 57.1 mttp -94.48 103.32 15.29 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.461 ' HB3' HD22 ' A' ' 578' ' ' LEU . 64.3 m-85 -78.29 152.6 32.38 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 22.6 t -148.95 161.28 42.2 Favored 'General case' 0 N--CA 1.391 -3.376 0 N-CA-C 103.36 -2.83 . . . . 0.0 103.36 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 90.7 m -107.41 177.88 4.71 Favored 'General case' 0 C--N 1.25 -3.721 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 36.7 mmtm -56.12 161.34 3.84 Favored Pre-proline 0 N--CA 1.441 -0.891 0 C-N-CA 123.086 0.554 . . . . 0.0 111.209 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 93.1 Cg_exo -43.39 -47.26 9.22 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 124.337 3.358 . . . . 0.0 114.475 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -91.41 4.1 79.83 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 121.173 -0.536 . . . . 0.0 112.584 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -108.25 137.09 46.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 121.893 0.854 . . . . 0.0 112.927 -176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 602' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 20.5 m -93.65 131.87 38.53 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.723 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.45 HD12 ' HG3' ' A' ' 621' ' ' PRO . 11.9 tt -82.39 122.02 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.58 108.96 26.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 128.04 -162.4 21.84 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.53 131.0 26.53 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 123.096 2.531 . . . . 0.0 110.928 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.87 -47.86 7.61 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.511 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 62.0 p -106.25 102.62 12.01 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.729 0.776 . . . . 0.0 111.698 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 14.0 m -108.09 140.32 27.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.621 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -85.45 149.11 25.63 Favored 'General case' 0 CA--C 1.486 -1.509 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.38 178.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.424 ' HA ' HD21 ' A' ' 616' ' ' LEU . 35.0 t -78.47 124.97 28.72 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 114.733 -1.122 . . . . 0.0 108.362 169.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.449 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 93.3 m-85 -112.22 171.02 7.76 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -6.4 18.52 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -114.27 -0.25 13.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.285 0.564 . . . . 0.0 110.543 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 129.14 -175.17 18.97 Favored Glycine 0 N--CA 1.425 -2.071 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.721 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' A' ' 611' ' ' CYS . 87.9 mt -70.04 131.22 44.01 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.442 0.297 . . . . 0.0 110.64 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.449 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 73.2 m -149.28 143.71 17.21 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 177.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.404 ' C ' ' HA ' ' A' ' 617' ' ' SER . 59.2 Cg_endo -69.1 -169.63 4.88 Favored 'Cis proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.123 -1.199 . . . . 0.0 113.95 0.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.7 151.66 37.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.828 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.86 143.71 87.11 Favored Pre-proline 0 C--N 1.289 -2.047 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.157 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . 0.45 ' HG3' HD12 ' A' ' 603' ' ' ILE . 98.3 Cg_endo -76.02 179.55 6.2 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.965 3.11 . . . . 0.0 112.917 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 46.3 pt -126.27 177.16 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.084 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.527 ' SG ' HD13 ' A' ' 578' ' ' LEU . 94.4 m -121.11 115.55 23.31 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 123.424 0.689 . . . . 0.0 110.748 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.588 ' O ' ' HB ' ' A' ' 602' ' ' THR . 43.4 mtmt -121.87 128.53 51.71 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.978 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.25 -41.47 25.02 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -98.13 112.81 24.64 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.183 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 1.4 m -120.83 178.1 2.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 124.535 1.134 . . . . 0.0 108.349 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . 0.493 ' NE2' ' HA3' ' A' ' 676' ' ' GLY . 21.2 mt-30 -97.59 167.02 11.23 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 14.0 m -105.05 -15.23 15.15 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.673 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 86.0 m 73.35 7.63 5.2 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.457 1.103 . . . . 0.0 113.052 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 57.65 -136.61 50.57 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.765 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.77 153.58 22.93 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.824 2.349 . . . . 0.0 110.991 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.546 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.7 Cg_endo -79.42 166.75 21.94 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.302 2.001 . . . . 0.0 111.014 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.38 -166.68 0.28 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.399 2.066 . . . . 0.0 110.626 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -113.19 170.78 7.97 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.538 HD21 ' HA3' ' A' ' 639' ' ' GLY . 17.0 tp -85.41 164.05 18.14 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 4.8 mp -56.94 -71.65 0.09 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.083 0.944 . . . . 0.0 110.308 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -105.3 -27.1 11.72 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.764 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.538 ' HA3' HD21 ' A' ' 636' ' ' LEU . . . -86.2 -150.08 14.89 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.699 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -155.1 -171.28 3.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 18.6 t -96.4 127.65 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.729 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -87.64 -21.85 25.06 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.386 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -75.72 169.47 18.06 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.22 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -88.6 131.62 34.88 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.659 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 24.5 p -87.65 118.18 26.97 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.402 0.62 . . . . 0.0 112.222 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -84.6 167.96 15.79 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.407 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 45.2 mt-10 -94.35 -10.14 33.59 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -151.56 101.72 2.82 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.39 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.546 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.7 m-85 -80.66 -85.74 0.09 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 139.05 160.93 8.54 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.3 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.48 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 60.5 t60 -62.54 130.6 45.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 652' ' ' SER . . . . . 0.464 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 39.5 m 69.6 10.24 7.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.67 1.188 . . . . 0.0 113.508 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 7.6 tp10 -88.7 120.71 30.34 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 19.7 m -91.25 160.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-O 122.307 1.051 . . . . 0.0 113.622 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 4.5 t -132.53 112.18 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-N 113.657 -1.61 . . . . 0.0 108.227 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 669' ' ' ASN . 32.5 mt-10 -73.43 135.66 44.18 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.249 1.023 . . . . 0.0 113.226 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 72.3 m-85 -114.75 172.56 6.96 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 126.441 1.896 . . . . 0.0 109.559 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -155.42 143.76 20.23 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.526 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.8 t -112.85 174.26 5.98 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.237 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 46.8 m-80 -64.9 155.96 81.45 Favored Pre-proline 0 C--N 1.317 -0.815 0 O-C-N 123.395 0.435 . . . . 0.0 110.378 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 70.5 Cg_endo -73.16 42.91 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 124.181 3.254 . . . . 0.0 113.39 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 662' ' ' ARG . 2.5 ptt180 -151.25 11.15 0.61 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 124.038 0.935 . . . . 0.0 110.473 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -128.66 152.13 48.73 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.786 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 77.9 mt -101.35 142.04 33.34 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 2.5 ttt -108.71 102.41 11.46 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -79.07 -51.81 9.05 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.262 -170.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.5 -163.42 38.47 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.448 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 670' ' ' LYS . 63.4 Cg_endo -73.33 120.1 6.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.882 2.388 . . . . 0.0 111.387 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 656' ' ' GLU . 3.3 p-10 -81.33 28.18 0.39 Allowed 'General case' 0 C--O 1.19 -2.044 0 O-C-N 121.991 -0.443 . . . . 0.0 111.416 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.767 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 7.7 ptmt -164.04 108.7 1.0 Allowed 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 125.549 1.54 . . . . 0.0 108.336 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.683 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 38.7 pt -109.15 152.6 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.763 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.753 -173.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.464 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 9.7 pt20 -119.07 160.32 22.27 Favored 'General case' 0 N--CA 1.421 -1.919 0 O-C-N 124.094 0.871 . . . . 0.0 110.323 -174.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.5 t -87.17 112.06 21.59 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.399 1.095 . . . . 0.0 110.828 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 84.8 t -103.51 107.04 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.777 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.48 ' H ' ' CE1' ' A' ' 651' ' ' HIS . 25.3 t70 65.1 -69.29 0.1 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 126.456 1.902 . . . . 0.0 111.744 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . 0.493 ' HA3' ' NE2' ' A' ' 628' ' ' GLN . . . -158.16 21.54 0.36 Allowed Glycine 0 N--CA 1.422 -2.252 0 O-C-N 123.831 0.707 . . . . 0.0 111.472 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -136.55 149.74 48.26 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.523 ' HB3' HD13 ' A' ' 671' ' ' ILE . 96.4 m95 -83.0 161.22 21.81 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 11.9 p -81.85 175.32 10.51 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 120.875 0.369 . . . . 0.0 111.715 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 28.4 m -58.39 125.73 24.55 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.835 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 682' ' ' PRO . 6.4 mp -62.34 165.16 9.39 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.554 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.569 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 19.8 Cg_endo -63.32 -21.51 71.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.343 2.029 . . . . 0.0 113.13 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 61.8 t 50.0 96.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.564 1.146 . . . . 0.0 112.376 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 22.5 p -97.21 133.32 41.99 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.235 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.56 147.72 32.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.195 -176.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 47.6 t -55.78 135.35 19.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 O-C-N 123.81 0.694 . . . . 0.0 110.628 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.437 -1.115 0 O-C-N 124.381 1.05 . . . . 0.0 108.828 178.826 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 586' ' ' GLN . 21.3 mt-10 . . . . . 0 C--O 1.245 0.828 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.577 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 20.1 m -63.45 -54.1 41.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.713 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 586' ' ' GLN . 39.3 tt0 70.05 130.2 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 125.4 1.48 . . . . 0.0 111.363 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.489 HD12 ' HG3' ' A' ' 580' ' ' PRO . 2.7 tt -66.01 119.88 64.9 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.407 ' HG2' HD12 ' A' ' 620' ' ' LEU . 72.3 Cg_endo -75.6 178.35 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.026 1.817 . . . . 0.0 111.111 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 573' ' ' LYS . 0.0 OUTLIER -78.37 103.83 8.56 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.416 0.627 . . . . 0.0 109.501 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.666 ' HA ' ' HG ' ' A' ' 620' ' ' LEU . 19.8 pt -75.27 -169.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.121 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.6 t70 -72.66 154.9 40.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.38 -30.03 45.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.262 0.553 . . . . 0.0 110.759 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -108.38 12.57 26.21 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.703 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.7 OUTLIER -92.82 153.69 18.71 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 10.7 t -139.68 121.74 9.98 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.618 ' HD3' HD11 ' A' ' 574' ' ' ILE . 59.9 Cg_endo -80.35 138.32 12.38 Favored 'Trans proline' 0 N--CA 1.431 -2.169 0 C-N-CA 122.09 1.86 . . . . 0.0 111.645 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -65.41 -41.94 93.08 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 125.677 1.591 . . . . 0.0 112.074 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 26.9 mmt-85 -67.49 -65.77 0.65 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . 0.474 ' HB3' ' HZ2' ' A' ' 583' ' ' LYS . 5.5 ttpm? 64.8 74.13 0.4 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.691 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -142.7 146.27 34.22 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.77 -47.64 82.61 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . 0.596 ' HA ' ' HA ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -120.18 145.92 46.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.388 0.614 . . . . 0.0 111.527 179.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.625 ' CZ ' ' HG ' ' A' ' 593' ' ' LEU . 96.7 m-85 -116.64 160.62 20.44 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.893 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 591' ' ' GLU . 52.7 mtpt -94.65 152.88 18.13 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.591 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 14.6 m -63.98 137.52 24.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.333 173.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 91.38 -12.91 67.9 Favored Glycine 0 C--N 1.292 -1.903 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.874 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 588' ' ' LYS . 0.7 OUTLIER -66.37 137.68 57.06 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 609' ' ' VAL . 20.0 m -110.25 128.26 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.618 0 CA-C-O 121.645 0.736 . . . . 0.0 109.252 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.625 ' HG ' ' CZ ' ' A' ' 587' ' ' TYR 0.4 0.0 OUTLIER -114.47 102.66 10.29 Favored 'General case' 0 N--CA 1.383 -3.806 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.427 176.516 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 35.4 mtmm -71.67 146.26 48.36 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 113.547 -1.661 . . . . 0.0 107.787 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.521 ' HB3' HD13 ' A' ' 578' ' ' LEU . 42.7 m-85 -125.17 171.12 10.58 Favored 'General case' 0 C--N 1.262 -3.234 0 CA-C-O 120.836 0.351 . . . . 0.0 111.491 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' SER . . . . . 0.504 ' HA ' HD13 ' A' ' 603' ' ' ILE . 23.1 t -171.68 -176.79 1.85 Allowed 'General case' 0 N--CA 1.41 -2.426 0 O-C-N 124.757 1.286 . . . . 0.0 107.585 166.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 84.9 m -114.05 162.0 17.01 Favored 'General case' 0 C--N 1.263 -3.179 0 O-C-N 123.607 0.567 . . . . 0.0 112.184 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.502 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 32.8 mmtp -52.25 160.64 1.2 Allowed Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 125.457 1.503 . . . . 0.0 113.241 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 37.9 Cg_exo -55.93 112.88 1.2 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.415 2.743 . . . . 0.0 110.576 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 121.93 -27.58 6.14 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.014 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -100.24 163.0 12.6 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-O 122.179 0.99 . . . . 0.0 112.672 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 602' ' ' THR . . . . . 0.416 HG21 ' CD2' ' A' ' 651' ' ' HIS . 19.3 m -119.76 130.47 54.98 Favored 'General case' 0 N--CA 1.394 -3.264 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.563 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 596' ' ' SER . 7.1 tt -82.19 130.39 35.86 Favored 'Isoleucine or valine' 0 C--O 1.256 1.406 0 CA-C-O 121.009 0.433 . . . . 0.0 109.991 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 93.0 t -126.95 131.2 71.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.11 -156.01 15.84 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -67.4 111.81 2.41 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.502 2.135 . . . . 0.0 111.306 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 6.0 m120 -87.2 -12.67 46.12 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.341 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.523 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 9.9 p -146.81 102.79 3.57 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.96 0.41 . . . . 0.0 110.68 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 592' ' ' VAL . 23.8 m -96.95 162.04 2.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.254 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 612' ' ' TYR . 1.8 mp0 -112.35 153.5 27.16 Favored 'General case' 0 CA--C 1.483 -1.63 0 CA-C-O 121.001 0.429 . . . . 0.0 110.214 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 589' ' ' VAL . 41.0 t -83.97 130.65 34.88 Favored 'General case' 0 N--CA 1.415 -2.221 0 C-N-CA 118.146 -1.421 . . . . 0.0 107.393 166.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 83.8 m-85 -114.24 170.34 8.37 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -64.51 -14.16 55.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -106.84 0.25 23.86 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.669 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.08 -176.31 19.36 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.945 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -74.26 124.81 27.11 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.416 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 68.3 m -147.07 144.94 20.56 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 122.084 -0.385 . . . . 0.0 111.7 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 617' ' ' SER . 48.1 Cg_endo -70.04 -168.77 4.76 Favored 'Cis proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.788 -1.338 . . . . 0.0 112.34 -2.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -80.15 -178.84 6.75 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.069 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . 0.666 ' HG ' ' HA ' ' A' ' 574' ' ' ILE . 1.1 mm? -75.44 140.98 72.7 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -169.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . 0.476 ' HG3' HD12 ' A' ' 603' ' ' ILE . 38.5 Cg_endo -67.9 175.39 6.47 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 124.43 3.42 . . . . 0.0 112.456 176.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.9 pt -114.0 173.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.533 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.0 m -117.79 115.58 25.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.185 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.451 ' HE2' ' O ' ' A' ' 626' ' ' GLN . 9.2 mmmm -105.4 120.32 41.29 Favored 'General case' 0 CA--C 1.474 -1.978 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.36 -30.12 33.86 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.336 -1.346 . . . . 0.0 107.872 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.451 ' O ' ' HE2' ' A' ' 624' ' ' LYS . 92.2 mt-30 -111.58 116.99 31.75 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.099 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 9.6 p -124.54 158.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 75.6 mm-40 -89.65 159.8 16.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 53.7 m -101.25 -3.16 29.48 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.515 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 73.2 m 69.42 12.45 8.28 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.309 1.044 . . . . 0.0 112.984 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 53.51 -136.5 40.05 Favored Glycine 0 N--CA 1.448 -0.558 0 O-C-N 123.79 0.681 . . . . 0.0 112.424 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.75 151.39 16.8 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.777 2.318 . . . . 0.0 110.703 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.536 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 63.3 Cg_endo -74.81 163.71 35.08 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.775 2.317 . . . . 0.0 112.788 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.42 ' HG2' HD12 ' A' ' 681' ' ' LEU . 55.3 Cg_endo -73.18 177.8 7.37 Favored 'Trans proline' 0 C--O 1.254 1.315 0 C-N-CA 122.734 2.29 . . . . 0.0 111.526 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -92.42 154.32 18.59 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.789 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' A' ' 639' ' ' GLY . 20.8 tp -89.67 141.3 28.73 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -45.7 -41.84 11.01 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -176.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -129.19 -18.28 3.7 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -99.66 -142.92 13.66 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.795 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . 0.402 HD21 ' H ' ' A' ' 641' ' ' VAL . 0.6 OUTLIER -165.01 -177.12 4.47 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.402 ' H ' HD21 ' A' ' 640' ' ' ASN . 39.5 t -84.45 132.52 31.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.646 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.3 ptmt -88.1 -16.71 32.77 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.715 0.769 . . . . 0.0 109.986 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -81.7 165.37 21.05 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.604 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -78.14 111.41 14.03 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 23.1 p -64.82 116.33 6.21 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.587 0.708 . . . . 0.0 111.487 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -101.1 168.08 9.82 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.975 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.424 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 35.7 mt-10 -90.77 -13.78 33.28 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.609 0.718 . . . . 0.0 109.148 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -144.58 105.6 4.19 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.124 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.536 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.8 m-85 -87.02 -84.73 0.17 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.948 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 143.52 154.04 6.03 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.774 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.439 ' HD1' ' N ' ' A' ' 675' ' ' ASP . 49.2 t60 -60.19 131.12 49.81 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 652' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 50.2 m 76.69 -0.69 2.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.393 1.077 . . . . 0.0 113.533 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.423 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 7.3 tp10 -79.85 122.96 27.3 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.3 OUTLIER -92.06 151.55 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.725 0 CA-C-O 122.215 1.007 . . . . 0.0 110.606 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -114.02 102.69 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.97 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.646 167.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.646 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 4.0 mt-10 -69.27 138.7 54.1 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.514 ' HB3' HD23 ' A' ' 636' ' ' LEU . 40.5 m-85 -113.12 161.02 17.6 Favored 'General case' 0 C--N 1.259 -3.344 0 C-N-CA 124.964 1.306 . . . . 0.0 110.401 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -145.11 135.02 23.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.584 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.2 t -100.56 -178.95 3.95 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.284 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 662' ' ' ARG . 7.3 m120 -63.14 155.79 71.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.63 26.69 0.35 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.627 2.884 . . . . 0.0 113.477 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 660' ' ' ASN . 16.1 mmm180 -129.63 -1.45 4.87 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -118.56 161.38 20.14 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.349 0.595 . . . . 0.0 112.151 -170.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 86.7 mt -124.4 149.0 47.19 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.566 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -92.25 149.47 21.43 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 176.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -108.83 -45.99 3.71 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.177 0.513 . . . . 0.0 109.689 174.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.77 -175.95 42.75 Favored Glycine 0 C--N 1.306 -1.133 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . 0.512 ' O ' ' HB3' ' A' ' 682' ' ' PRO . 27.5 Cg_endo -62.0 124.58 14.7 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.134 2.556 . . . . 0.0 111.765 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.483 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 21.3 p-10 -73.67 31.77 0.08 Allowed 'General case' 0 C--O 1.188 -2.167 0 C-N-CA 123.393 0.677 . . . . 0.0 111.084 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 13.7 ptmt -172.32 138.26 0.93 Allowed 'General case' 0 C--N 1.258 -3.375 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -173.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 37.3 pt -138.69 139.13 41.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.51 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -109.35 151.2 26.92 Favored 'General case' 0 C--N 1.27 -2.857 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.015 -178.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.6 t -69.3 118.07 11.73 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.198 0.999 . . . . 0.0 111.455 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 89.2 t -105.53 82.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.857 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.243 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.563 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 29.1 t70 80.6 -59.24 0.29 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 112.328 -2.215 . . . . 0.0 112.606 171.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -150.36 4.6 0.6 Allowed Glycine 0 C--N 1.292 -1.873 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.285 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.29 153.03 46.34 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.517 ' HB3' HD13 ' A' ' 671' ' ' ILE . 95.7 m95 -84.66 165.55 17.82 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 679' ' ' THR . . . . . 0.455 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 2.1 p -86.61 -178.65 6.44 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 9.6 m -65.57 133.69 51.72 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.574 0.75 . . . . 0.0 110.101 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.42 HD12 ' HG2' ' A' ' 634' ' ' PRO . 8.3 mp -70.83 158.84 87.15 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.566 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 20.8 Cg_endo -61.44 -16.12 45.41 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 124.639 3.559 . . . . 0.0 115.617 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.263 26.9 m 45.24 90.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 18.5 p -92.85 144.96 24.76 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.147 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.2 OUTLIER -134.69 150.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.029 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.34 140.46 19.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 O-C-N 123.409 0.443 . . . . 0.0 110.754 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 C--O 1.248 1.012 0 C-N-CA 124.841 1.256 . . . . 0.0 110.759 -176.591 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 586' ' ' GLN . 17.6 mm-40 . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.65 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 3.1 m 33.73 -67.57 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 130.121 3.368 . . . . 0.0 115.995 -171.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 585' ' ' ASP . 54.3 mt-10 83.47 176.46 0.07 Allowed 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 128.635 2.774 . . . . 0.0 110.536 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.659 HD12 ' HG3' ' A' ' 580' ' ' PRO . 1.2 tt -119.59 105.83 43.05 Favored Pre-proline 0 N--CA 1.398 -3.038 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.522 ' HG2' HD13 ' A' ' 620' ' ' LEU . 36.7 Cg_endo -66.33 -176.97 0.74 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.885 2.39 . . . . 0.0 111.104 177.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -86.18 84.34 7.51 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.347 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.464 ' HB ' HD23 ' A' ' 578' ' ' LEU . 6.8 pt -52.08 -65.68 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.853 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.3 t70 -176.32 -168.55 0.26 Allowed 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.55 -22.66 4.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -104.08 16.7 25.69 Favored 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.147 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.8 tt -115.21 143.36 45.36 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -176.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.39 121.55 7.09 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-O 121.188 0.518 . . . . 0.0 111.015 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.659 ' HG3' HD12 ' A' ' 571' ' ' LEU . 31.8 Cg_endo -69.29 142.01 48.77 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.835 2.357 . . . . 0.0 112.253 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.74 -48.98 22.75 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . 0.743 ' HD2' ' HE3' ' A' ' 584' ' ' LYS . 14.3 tpp180 -88.94 93.65 9.67 Favored 'General case' 0 N--CA 1.379 -3.979 0 N-CA-C 104.864 -2.272 . . . . 0.0 104.864 171.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -112.83 131.64 55.62 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.083 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.743 ' HE3' ' HD2' ' A' ' 582' ' ' ARG . 15.3 ptpt -163.3 -170.49 2.29 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 570' ' ' GLU . 9.2 m-20 -103.4 -39.46 6.77 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 119.332 0.969 . . . . 0.0 110.627 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 568' ' ' GLU . 0.0 OUTLIER -121.62 133.53 54.99 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.65 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 54.5 m-85 -105.59 170.26 8.0 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -172.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -100.87 151.96 21.1 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.3 122.21 16.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 97.58 0.68 59.2 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.251 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -74.11 129.42 37.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 14.1 t -100.74 115.5 42.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.441 0.639 . . . . 0.0 109.831 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.529 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 1.9 mp -95.88 94.05 7.4 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 608' ' ' SER . 0.0 OUTLIER -77.16 122.72 25.41 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 174.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 66.8 m-85 -94.93 177.83 5.77 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-O 121.473 0.654 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 19.9 p -167.3 169.54 12.36 Favored 'General case' 0 N--CA 1.403 -2.797 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 81.5 m -115.56 170.88 8.09 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 599' ' ' PRO . 41.0 mttt -59.43 156.47 30.73 Favored Pre-proline 0 N--CA 1.432 -1.343 0 O-C-N 123.812 0.695 . . . . 0.0 112.748 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 598' ' ' LYS . 47.9 Cg_exo -55.32 110.1 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.475 2.783 . . . . 0.0 110.127 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 123.66 -23.23 6.74 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 625' ' ' GLU . 79.3 m-85 -102.81 160.83 14.25 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 122.381 1.086 . . . . 0.0 113.281 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 602' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 15.6 m -113.41 129.53 56.52 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.399 174.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.434 HD12 ' HG3' ' A' ' 621' ' ' PRO . 8.8 tt -79.57 121.84 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.5 123.44 71.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 122.037 -0.414 . . . . 0.0 110.122 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 122.03 -156.02 16.77 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.97 134.35 27.33 Favored 'Trans proline' 0 C--N 1.327 -0.6 0 C-N-CA 122.509 2.139 . . . . 0.0 110.096 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.41 HD21 ' N ' ' A' ' 607' ' ' ASN . 0.7 OUTLIER -97.74 -44.35 6.78 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.185 -177.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 594' ' ' LYS . 19.3 p -106.74 97.07 6.91 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.329 0.585 . . . . 0.0 112.013 -176.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . 0.452 ' HA ' ' HD2' ' A' ' 618' ' ' PRO . 9.4 m -95.31 147.8 5.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.589 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -102.12 152.33 21.13 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 16.3 t -83.99 116.71 22.96 Favored 'General case' 0 C--N 1.268 -2.956 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.001 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.499 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 90.7 m-85 -102.2 166.4 10.61 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -69.05 -13.52 62.49 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.324 0.583 . . . . 0.0 111.076 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -101.51 -1.49 32.91 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.748 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 136.34 178.28 15.65 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.26 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.66 121.69 19.26 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.499 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 56.5 m -146.35 147.11 29.96 Favored Pre-proline 0 C--N 1.316 -0.886 0 O-C-N 121.959 -0.463 . . . . 0.0 111.458 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 609' ' ' VAL . 41.4 Cg_endo -67.06 -171.9 5.07 Favored 'Cis proline' 0 N--CA 1.488 1.149 0 C-N-CA 124.353 -1.103 . . . . 0.0 112.958 0.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.8 179.99 3.4 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.195 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . 0.522 HD13 ' HG2' ' A' ' 572' ' ' PRO . 18.9 mt -92.52 147.39 34.23 Favored Pre-proline 0 C--N 1.278 -2.541 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -165.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . 0.529 ' HG2' HD12 ' A' ' 578' ' ' LEU . 63.5 Cg_endo -73.82 -173.24 1.31 Allowed 'Trans proline' 0 C--O 1.253 1.249 0 C-N-CA 123.861 3.041 . . . . 0.0 112.076 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.49 173.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.932 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.2 m -117.05 107.47 14.56 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.303 0.573 . . . . 0.0 111.138 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.437 ' HZ2' ' CG ' ' A' ' 675' ' ' ASP . 59.1 mtpt -109.19 126.34 53.16 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.49 ' HB2' ' CE1' ' A' ' 601' ' ' PHE . 26.8 tt0 -87.44 -35.29 18.35 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -175.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -107.5 112.67 25.54 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.611 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 6.7 m -121.21 166.13 16.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.128 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 15.7 mm100 -89.98 170.66 10.17 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.036 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.531 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 74.8 p -108.86 -19.1 13.52 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.387 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 95.4 m 73.7 4.89 4.81 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.884 1.273 . . . . 0.0 111.16 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 62.55 -137.78 44.84 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.94 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.17 156.69 37.93 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.903 2.402 . . . . 0.0 110.82 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.677 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 71.7 Cg_endo -78.77 160.77 27.69 Favored 'Trans proline' 0 N--CA 1.435 -1.956 0 C-N-CA 122.053 1.835 . . . . 0.0 111.222 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.23 -169.26 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.655 2.236 . . . . 0.0 112.763 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -103.31 157.6 16.9 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.51 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.539 HD22 ' HA3' ' A' ' 639' ' ' GLY . 15.7 tp -92.68 155.26 17.83 Favored 'General case' 0 CA--C 1.478 -1.825 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 683' ' ' VAL 0.285 2.0 pt? -66.93 -47.75 70.73 Favored 'General case' 0 N--CA 1.406 -2.653 0 C-N-CA 119.005 -1.078 . . . . 0.0 113.607 -178.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.601 ' HB2' ' SG ' ' A' ' 684' ' ' CYS . 89.9 m-20 -126.36 27.02 6.28 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.049 -173.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -160.08 -146.61 4.64 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.09 177.54 10.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.795 0.298 . . . . 0.0 111.054 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.29 133.97 28.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -90.78 -23.93 20.49 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.338 0.59 . . . . 0.0 110.075 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.485 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 5.6 mm-40 -80.71 163.31 23.64 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.369 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . 0.51 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.1 OUTLIER -76.35 137.95 40.14 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 175.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 20.2 p -87.78 110.42 20.46 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.807 0.813 . . . . 0.0 112.804 -175.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.522 ' HD2' ' HA ' ' A' ' 649' ' ' TYR . 52.1 mttm -72.74 158.19 36.06 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.76 -0.23 56.01 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -152.44 100.58 2.59 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.978 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.677 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 5.3 m-85 -80.44 -81.55 0.12 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 133.35 167.71 11.72 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.158 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.536 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 57.6 t60 -67.45 131.04 44.91 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 120.926 0.393 . . . . 0.0 110.284 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 652' ' ' SER . . . . . 0.551 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 73.8 m 65.06 20.06 11.96 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.235 1.014 . . . . 0.0 112.43 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 5.6 tp10 -89.68 116.59 27.92 Favored 'General case' 0 CA--C 1.478 -1.812 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 16.2 m -89.47 155.77 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-O 122.152 0.977 . . . . 0.0 113.188 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 0.1 OUTLIER -129.3 117.38 43.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-N 112.823 -1.99 . . . . 0.0 109.502 177.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.526 ' HG2' ' HG2' ' A' ' 670' ' ' LYS . 59.1 mt-10 -81.01 130.2 34.9 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 122.389 1.09 . . . . 0.0 113.54 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -108.81 157.91 18.15 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.679 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -134.88 138.55 44.24 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.625 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 26.1 t -105.65 168.69 8.93 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.542 ' HB2' ' CE1' ' A' ' 663' ' ' PHE . 32.0 m-80 -59.72 152.22 58.82 Favored Pre-proline 0 C--O 1.241 0.622 0 O-C-N 123.202 0.314 . . . . 0.0 110.795 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 72.1 Cg_endo -71.2 36.12 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 124.343 3.362 . . . . 0.0 115.549 -170.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.75 11.47 0.66 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.561 0.696 . . . . 0.0 110.539 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 660' ' ' ASN . 73.6 m-85 -118.52 162.86 17.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.386 0.612 . . . . 0.0 110.964 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 96.8 mt -110.13 135.7 50.51 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.653 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.3 OUTLIER -100.64 108.88 20.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -75.77 -52.25 10.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.64 -172.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -101.8 -162.7 26.91 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.341 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.89 123.58 10.54 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.434 2.756 . . . . 0.0 112.761 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 23.0 p-10 -74.4 -7.14 51.92 Favored 'General case' 0 C--O 1.201 -1.5 0 O-C-N 122.1 -0.375 . . . . 0.0 111.503 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.765 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -122.88 118.86 28.87 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 42.3 pt -111.4 158.23 11.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 11.0 pt20 -125.15 154.91 40.76 Favored 'General case' 0 C--N 1.281 -2.396 0 O-C-N 123.43 0.456 . . . . 0.0 109.99 -174.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 8.2 t -84.81 110.85 19.12 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 123.119 1.438 . . . . 0.0 110.045 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 97.7 t -95.26 81.38 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.386 -3.67 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.821 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 628' ' ' GLN . 31.5 t70 80.96 -46.37 0.24 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.631 170.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -171.47 19.31 0.06 OUTLIER Glycine 0 C--N 1.298 -1.554 0 O-C-N 123.882 0.739 . . . . 0.0 111.513 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -143.42 143.9 31.8 Favored 'General case' 0 C--O 1.212 -0.879 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.509 ' HB3' HD13 ' A' ' 671' ' ' ILE . 98.0 m95 -87.12 153.77 21.26 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 3.7 p -72.1 167.34 20.45 Favored 'General case' 0 C--O 1.255 1.358 0 O-C-N 123.009 0.193 . . . . 0.0 111.399 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.0 m -62.86 129.23 39.52 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 682' ' ' PRO . 6.4 mp -60.19 163.78 7.64 Favored Pre-proline 0 N--CA 1.435 -1.223 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.945 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.653 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 19.5 Cg_endo -60.6 -24.33 78.07 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 122.777 2.318 . . . . 0.0 113.135 -176.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 637' ' ' LEU . 58.8 t 52.62 92.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 122.175 0.988 . . . . 0.0 111.072 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.601 ' SG ' ' HB2' ' A' ' 638' ' ' ASN . 27.8 p -98.97 134.51 41.72 Favored 'General case' 0 N--CA 1.411 -2.376 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.703 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.2 OUTLIER -125.91 155.7 35.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.92 -174.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 64.4 t -59.84 129.09 21.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 123.866 0.729 . . . . 0.0 110.562 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.678 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 120.743 0.306 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 587' ' ' TYR . 81.3 m -78.25 140.42 38.88 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -110.01 136.54 49.12 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.48 HD12 ' HG3' ' A' ' 580' ' ' PRO . 2.6 tt -51.37 117.58 9.43 Favored Pre-proline 0 C--O 1.246 0.903 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.19 -179.34 1.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.723 2.282 . . . . 0.0 111.047 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -90.84 93.2 9.12 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 118.953 -1.099 . . . . 0.0 109.092 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 578' ' ' LEU . 36.8 pt -75.78 -175.8 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.189 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.969 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.1 t70 -71.83 163.15 28.34 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.168 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.35 -30.01 17.1 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.262 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -94.23 4.21 54.2 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.814 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.8 OUTLIER -100.03 151.26 21.57 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.39 118.01 6.22 Favored Pre-proline 0 C--N 1.309 -1.181 0 C-N-CA 123.849 0.86 . . . . 0.0 110.603 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.48 ' HG3' HD12 ' A' ' 571' ' ' LEU . 40.7 Cg_endo -75.32 139.45 23.48 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.301 2.001 . . . . 0.0 111.566 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.9 -50.25 63.04 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 125.399 1.48 . . . . 0.0 112.202 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.73 -46.45 85.33 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.135 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm 54.45 58.58 4.8 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 124.364 1.04 . . . . 0.0 109.882 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -121.98 160.17 25.44 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.79 -50.82 54.91 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.54 151.42 41.39 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.667 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 84.9 m-85 -121.53 119.26 31.45 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -71.1 152.69 43.21 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.55 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 58.1 t -55.91 116.26 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-O 121.19 0.519 . . . . 0.0 110.747 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 109.85 -2.99 30.32 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.594 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -76.29 136.98 39.61 Favored 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 122.34 -0.506 . . . . 0.0 110.953 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 12.0 m -101.81 133.28 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.863 0.84 . . . . 0.0 109.686 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.667 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.9 mp -105.41 89.96 3.27 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.484 ' HZ3' ' HB3' ' A' ' 594' ' ' LYS . 3.6 mmmp? -66.43 127.89 34.05 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -107.09 175.12 5.6 Favored 'General case' 0 C--N 1.267 -3.021 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.801 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 14.4 p -166.49 167.32 15.72 Favored 'General case' 0 N--CA 1.398 -3.041 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.499 ' SG ' HD13 ' A' ' 578' ' ' LEU . 98.8 m -114.69 -172.49 2.13 Favored 'General case' 0 C--N 1.259 -3.337 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -56.74 159.27 7.27 Favored Pre-proline 0 N--CA 1.429 -1.51 0 C-N-CA 123.94 0.896 . . . . 0.0 110.764 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.92 -37.93 47.32 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 124.209 3.273 . . . . 0.0 114.78 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -100.3 4.94 57.2 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.436 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 21.3 m-85 -106.35 141.07 38.28 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 121.605 0.717 . . . . 0.0 111.552 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 602' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 40.7 m -97.56 124.99 42.02 Favored 'General case' 0 N--CA 1.398 -3.073 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.89 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 7.2 tt -79.32 122.25 34.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 99.8 t -118.69 139.11 47.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 106.63 -149.3 16.59 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.9 112.74 3.61 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.321 2.014 . . . . 0.0 111.214 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.96 -1.52 57.4 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.614 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 594' ' ' LYS . 33.8 p -150.29 112.89 4.72 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.176 0.512 . . . . 0.0 110.64 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.25 149.8 12.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.623 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -102.61 157.6 16.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.271 0.558 . . . . 0.0 110.055 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 11.3 t -86.56 112.49 21.61 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.494 ' CE2' ' HB2' ' A' ' 610' ' ' GLN . 85.3 m-85 -101.18 169.88 8.63 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -60.62 -18.28 52.24 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -106.78 -1.04 22.98 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.152 0.501 . . . . 0.0 111.608 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.37 -169.7 22.16 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.221 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.413 ' C ' ' HG ' ' A' ' 617' ' ' SER . 2.6 mm? -75.14 122.81 24.17 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.416 ' HA ' ' C ' ' A' ' 618' ' ' PRO . 52.4 m -146.99 146.45 25.96 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 122.401 -0.187 . . . . 0.0 110.578 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 617' ' ' SER . 57.0 Cg_endo -69.5 -169.42 4.94 Favored 'Cis proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.057 -1.226 . . . . 0.0 112.804 0.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.72 172.72 10.19 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.469 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.61 142.65 77.74 Favored Pre-proline 0 C--N 1.292 -1.922 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -169.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.3 176.98 7.16 Favored 'Trans proline' 0 C--O 1.258 1.479 0 C-N-CA 124.049 3.166 . . . . 0.0 111.475 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.1 pt -122.03 165.72 17.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.648 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.546 ' SG ' HD13 ' A' ' 578' ' ' LEU . 85.1 m -110.63 112.25 24.02 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.499 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 602' ' ' THR . 52.6 mtpt -108.84 110.46 21.82 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.472 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 23.2 tt0 -77.77 -31.65 52.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.24 104.71 17.24 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.333 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.83 175.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.088 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.65 159.08 15.2 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.845 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 52.4 m -104.25 -9.16 18.81 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.364 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . 0.465 ' HB3' ' NE1' ' A' ' 678' ' ' TRP . 67.6 m 70.4 1.68 3.71 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.093 0.957 . . . . 0.0 113.514 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 62.99 -136.47 43.54 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -75.79 149.96 34.26 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 121.979 1.786 . . . . 0.0 110.658 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.536 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 78.4 Cg_endo -78.21 165.25 26.01 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.548 2.165 . . . . 0.0 111.013 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.444 ' HG2' HD12 ' A' ' 681' ' ' LEU . 33.0 Cg_endo -70.34 165.91 30.05 Favored 'Trans proline' 0 N--CA 1.435 -1.94 0 C-N-CA 121.408 1.405 . . . . 0.0 110.357 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.46 163.8 21.37 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.602 HD23 ' SG ' ' A' ' 659' ' ' CYS . 11.0 tp -83.33 174.42 10.71 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 683' ' ' VAL 0.342 0.4 OUTLIER -73.85 -69.71 0.42 Allowed 'General case' 0 N--CA 1.393 -3.281 0 C-N-CA 118.027 -1.469 . . . . 0.0 112.935 -179.871 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -95.1 -33.19 12.76 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.599 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -84.33 -143.11 5.73 Favored Glycine 0 N--CA 1.434 -1.455 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.341 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.34 -172.69 3.67 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 20.5 t -95.87 133.08 38.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 176.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.471 ' HB3' ' CD1' ' A' ' 658' ' ' TYR . 35.9 pttt -88.73 -26.35 21.82 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.977 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -78.55 151.91 32.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.389 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -67.08 115.08 6.38 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.534 0.683 . . . . 0.0 110.546 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.2 p -74.46 105.45 5.6 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.848 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 59.7 pttt -87.49 -177.67 5.96 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.77 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.07 -12.36 23.29 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -143.8 108.05 4.78 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.562 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 13.7 m-85 -85.92 -101.19 0.07 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 158.34 162.53 11.9 Favored Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 66.0 t60 -58.49 -52.43 65.67 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 40.0 m -92.53 11.91 24.78 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.177 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -96.57 116.61 29.38 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.482 0.658 . . . . 0.0 109.398 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.3 p -92.86 157.39 2.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.785 -177.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 23.9 m -123.7 111.65 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.56 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -74.39 119.61 18.83 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.798 0.809 . . . . 0.0 112.672 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 87.6 m-85 -100.46 173.44 6.57 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.781 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.471 ' CD1' ' HB3' ' A' ' 642' ' ' LYS . 29.0 p90 -151.22 137.34 18.32 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.602 ' SG ' HD23 ' A' ' 636' ' ' LEU . 68.0 m -96.91 177.07 5.74 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.464 ' C ' ' H ' ' A' ' 662' ' ' ARG . 78.3 m-20 -85.91 157.45 57.32 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.4 24.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 124.504 3.47 . . . . 0.0 114.959 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.464 ' H ' ' C ' ' A' ' 660' ' ' ASN . 23.8 mmt180 -120.35 -6.99 9.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -131.72 156.77 45.33 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.87 -174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 67.8 mt -105.99 166.5 10.45 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.608 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.7 OUTLIER -116.7 112.55 21.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.401 ' HB2' HD13 ' A' ' 685' ' ' ILE . 39.9 ttmt -81.94 -54.02 5.67 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.542 -174.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.13 -173.23 43.63 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.637 -176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.04 122.46 10.97 Favored 'Trans proline' 0 C--N 1.327 -0.557 0 C-N-CA 122.932 2.421 . . . . 0.0 111.141 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.654 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 21.2 p-10 -61.26 -14.66 27.87 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 122.872 0.469 . . . . 0.0 112.051 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -128.5 149.22 50.68 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 678' ' ' TRP . 47.0 pt -140.09 146.44 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -172.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.415 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.3 OUTLIER -114.01 157.0 23.06 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.228 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 11.7 t -80.35 96.56 6.71 Favored 'General case' 0 CA--C 1.472 -2.044 0 CA-C-O 123.197 1.475 . . . . 0.0 110.547 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.03 110.27 17.07 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.599 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.628 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 15.0 t70 59.22 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.616 1.166 . . . . 0.0 111.418 -171.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -153.7 23.47 0.73 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -134.32 131.07 37.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.536 ' HB3' HD13 ' A' ' 671' ' ' ILE . 98.8 m95 -76.4 149.89 36.86 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 7.8 p -83.5 178.75 7.87 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 11.7 m -57.32 122.95 13.76 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.712 0.805 . . . . 0.0 111.085 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.444 HD12 ' HG2' ' A' ' 634' ' ' PRO . 7.3 mp -63.97 163.67 21.77 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.654 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 20.1 Cg_endo -61.53 -15.17 39.66 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.876 3.051 . . . . 0.0 115.345 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.548 ' HA ' HD23 ' A' ' 637' ' ' LEU 0.297 28.7 m 50.7 101.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 177.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.447 ' SG ' ' CD2' ' A' ' 636' ' ' LEU . 12.9 m -78.29 132.54 37.52 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.441 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 666' ' ' LYS . 0.2 OUTLIER -127.68 136.57 60.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.64 130.79 28.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 123.566 0.541 . . . . 0.0 111.218 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 C--O 1.252 1.22 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.223 -177.372 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 N--CA 1.435 -1.224 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . . . . . . . . . 57.6 m -111.34 153.41 26.04 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -167.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.796 ' HG2' ' HG3' ' A' ' 586' ' ' GLN . 49.0 mt-10 -128.77 146.76 50.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 166.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . . . . . . . . . 1.7 tt -53.48 115.13 7.2 Favored Pre-proline 0 C--O 1.245 0.837 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.19 -169.11 0.48 Allowed 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.511 2.141 . . . . 0.0 111.572 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -88.65 92.38 9.17 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.519 HD13 ' HB3' ' A' ' 578' ' ' LEU . 37.2 pt -78.06 -170.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.658 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.4 t70 -77.61 147.4 35.64 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.12 -31.99 38.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 123.445 0.698 . . . . 0.0 111.044 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -98.54 14.63 27.66 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.081 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.587 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 5.5 tp -104.41 150.35 24.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.8 t -139.21 122.54 10.77 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' A' ' 583' ' ' LYS . 50.3 Cg_endo -78.74 144.67 19.65 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.813 2.342 . . . . 0.0 111.737 174.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 594' ' ' LYS . 7.2 t70 -51.86 -53.79 36.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.815 1.646 . . . . 0.0 111.212 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . 0.532 ' HG2' ' HE3' ' A' ' 584' ' ' LYS . 4.5 mpt_? -70.55 -59.86 2.6 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.025 0.44 . . . . 0.0 110.459 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . 0.407 ' HA ' ' HG2' ' A' ' 580' ' ' PRO . 50.2 tttm 60.14 62.29 1.65 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.163 -174.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.532 ' HE3' ' HG2' ' A' ' 582' ' ' ARG . 16.8 ptpt -118.44 160.29 21.97 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.29 -45.33 40.49 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . 0.796 ' HG3' ' HG2' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -118.07 126.98 53.33 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.619 0.247 . . . . 0.0 110.504 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.641 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 86.5 m-85 -100.73 132.51 46.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.675 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -78.09 148.92 34.0 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.486 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 60.0 t -58.65 119.1 2.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 106.04 -1.73 38.21 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.598 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -73.14 134.09 44.32 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 122.362 -0.493 . . . . 0.0 109.731 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 17.6 t -101.0 114.9 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.641 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.4 mp -91.71 92.49 8.45 Favored 'General case' 0 N--CA 1.405 -2.68 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 608' ' ' SER . 58.1 mttp -74.13 136.46 42.92 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 173.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -112.57 163.71 14.18 Favored 'General case' 0 C--N 1.266 -3.026 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.753 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 14.7 m -152.55 172.07 17.15 Favored 'General case' 0 N--CA 1.39 -3.471 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.532 ' SG ' HD13 ' A' ' 578' ' ' LEU . 69.8 m -108.83 178.43 4.48 Favored 'General case' 0 C--N 1.247 -3.862 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 71.0 mmtt -54.29 162.79 1.46 Allowed Pre-proline 0 C--N 1.313 -0.98 0 C-N-CA 124.154 0.982 . . . . 0.0 111.935 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 82.8 Cg_exo -44.58 -44.92 13.53 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.127 3.218 . . . . 0.0 114.358 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -100.09 18.33 55.81 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.822 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -120.11 147.66 44.59 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 121.759 0.79 . . . . 0.0 112.384 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 23.1 m -100.66 133.44 45.11 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.648 175.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.523 HD12 ' HG3' ' A' ' 621' ' ' PRO . 10.1 tt -88.25 129.35 39.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . 0.442 ' CG2' ' HD3' ' A' ' 624' ' ' LYS . 75.4 t -121.93 123.48 69.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 123.62 -150.65 16.94 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -73.12 115.68 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.38 2.053 . . . . 0.0 111.209 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -92.31 7.69 41.7 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 594' ' ' LYS . 58.5 p -156.43 113.61 3.17 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.75 0.42 . . . . 0.0 110.01 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 13.7 m -118.1 151.96 20.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.493 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -101.27 154.35 18.85 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.449 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 6.6 t -85.0 112.67 20.81 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 169.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -104.22 170.17 8.06 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -77.88 14.61 1.05 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -125.81 -1.08 7.3 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 171.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.05 -175.36 19.83 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.926 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -78.8 123.8 27.57 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 5.4 t -150.36 151.91 32.13 Favored Pre-proline 0 C--N 1.309 -1.184 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.616 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.489 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 58.7 Cg_endo -70.03 -178.2 16.64 Favored 'Cis proline' 0 C--N 1.361 1.235 0 C-N-CA 123.812 -1.328 . . . . 0.0 112.717 0.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.13 157.07 23.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.334 0.587 . . . . 0.0 111.103 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . 0.48 HD11 ' HA ' ' A' ' 574' ' ' ILE . 22.6 mt -66.85 152.41 95.7 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 114.229 -1.35 . . . . 0.0 114.146 -168.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . 0.523 ' HG3' HD12 ' A' ' 603' ' ' ILE . 92.8 Cg_endo -81.46 179.74 5.57 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.065 3.177 . . . . 0.0 111.633 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.6 pt -121.46 174.44 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.592 0.234 . . . . 0.0 110.586 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 98.1 m -119.91 128.84 54.0 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.386 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.525 ' HE2' ' OD1' ' A' ' 675' ' ' ASP . 26.4 mtpp -124.0 132.31 53.68 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.98 -41.05 15.21 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -96.94 114.58 26.21 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.01 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 11.8 m -123.49 -175.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.24 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -99.41 165.14 11.8 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.52 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 18.6 m -100.36 -11.93 19.86 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 18.0 m 72.96 -0.42 3.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.36 1.064 . . . . 0.0 113.54 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 63.38 -144.67 49.45 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.6 157.1 24.98 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.612 2.208 . . . . 0.0 110.91 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.586 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.5 Cg_endo -75.15 163.69 34.52 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.857 2.371 . . . . 0.0 112.427 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 681' ' ' LEU . 37.0 Cg_endo -69.61 172.95 11.56 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.589 2.193 . . . . 0.0 111.899 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -86.06 161.23 19.03 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.588 HD22 ' SG ' ' A' ' 659' ' ' CYS . 15.1 tp -99.49 145.34 27.58 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 638' ' ' ASN . 1.3 pp -65.68 -37.69 87.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.432 ' N ' HD13 ' A' ' 637' ' ' LEU . 46.4 m-80 -138.36 33.96 2.3 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.206 1.003 . . . . 0.0 109.677 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.447 ' C ' ' HB3' ' A' ' 636' ' ' LEU . . . -158.1 -150.88 5.88 Favored Glycine 0 N--CA 1.413 -2.841 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.754 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . 0.552 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 2.1 t-20 -160.56 -177.35 6.14 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.55 129.59 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.242 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 658' ' ' TYR . 10.0 ptmm? -90.16 -14.83 32.74 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.604 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -89.84 168.86 11.74 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.877 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -77.72 110.97 13.03 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 17.8 p -71.23 106.49 3.83 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.523 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 42.6 pttt -87.94 153.41 21.32 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.271 175.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.458 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 11.0 pt-20 -68.32 -12.52 61.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.408 0.683 . . . . 0.0 111.607 -176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -151.17 102.37 2.93 Favored 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -171.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.586 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 4.2 m-85 -82.49 -70.75 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 120.63 165.64 12.83 Favored Glycine 0 C--N 1.288 -2.106 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.604 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.2 t60 -74.02 142.16 45.77 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.439 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 49.6 m 71.32 5.46 5.44 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.307 1.043 . . . . 0.0 112.377 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.427 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 5.5 tp10 -84.1 115.37 22.35 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 2.4 p -90.2 152.63 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 30.5 m -120.98 112.05 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.729 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.469 ' HG3' ' HG2' ' A' ' 670' ' ' LYS . 27.3 mt-10 -69.57 119.8 14.37 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.017 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.525 ' HB3' HD23 ' A' ' 636' ' ' LEU . 79.2 m-85 -99.31 173.65 6.68 Favored 'General case' 0 C--N 1.271 -2.809 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.412 173.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.552 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 24.3 p90 -150.88 139.92 21.05 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 173.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.588 ' SG ' HD22 ' A' ' 636' ' ' LEU . 43.6 m -105.1 161.53 14.16 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-O 120.894 0.378 . . . . 0.0 110.521 172.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 662' ' ' ARG . 81.9 m-20 -57.03 152.04 30.96 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.54 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.04 33.69 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 124.738 3.625 . . . . 0.0 113.539 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.429 ' H ' ' C ' ' A' ' 660' ' ' ASN . 23.3 mtp180 -136.63 0.79 2.51 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 124.019 0.928 . . . . 0.0 109.008 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -127.18 159.2 34.99 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.811 -173.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.641 ' HG ' ' HB3' ' A' ' 687' ' ' GLU . 84.2 mt -107.81 136.51 47.42 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.789 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 4.2 ttt -95.32 113.68 25.37 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -78.25 -62.83 1.55 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.34 -170.43 46.82 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.653 -0.785 . . . . 0.0 112.878 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.65 123.71 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.028 2.485 . . . . 0.0 111.536 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -64.15 -17.95 63.98 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 122.915 0.486 . . . . 0.0 111.591 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 1.0 OUTLIER -122.32 153.52 38.84 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.638 HD11 HD13 ' A' ' 681' ' ' LEU . 46.8 pt -143.3 142.53 25.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.25 148.16 34.72 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 48.7 t -82.53 129.14 34.86 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.404 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . 0.604 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 30.7 m -110.4 126.13 67.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 123.061 0.544 . . . . 0.0 110.638 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.525 ' OD1' ' HE2' ' A' ' 624' ' ' LYS . 21.9 t70 60.25 -67.0 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.562 1.145 . . . . 0.0 112.342 -172.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -168.44 21.66 0.09 OUTLIER Glycine 0 C--N 1.301 -1.405 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -132.71 137.9 47.06 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.523 ' HB3' HD13 ' A' ' 671' ' ' ILE . 96.6 m95 -81.73 152.22 27.13 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 8.0 p -77.56 -176.86 4.47 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 19.7 m -70.07 127.4 32.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.567 0.223 . . . . 0.0 111.565 -173.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.638 HD13 HD11 ' A' ' 671' ' ' ILE . 5.8 mp -62.91 155.13 73.44 Favored Pre-proline 0 CA--C 1.514 -0.426 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.519 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 5.6 Cg_endo -52.91 -55.04 4.1 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.795 2.997 . . . . 0.0 113.758 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 88.3 t 69.5 119.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.2 1.0 . . . . 0.0 111.198 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.789 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 33.1 m -117.66 155.87 29.16 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.062 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.59 149.39 25.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 123.783 0.833 . . . . 0.0 109.498 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.6 132.33 28.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 O-C-N 123.326 0.392 . . . . 0.0 110.044 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . 0.641 ' HB3' ' HG ' ' A' ' 664' ' ' LEU . 8.2 pt-20 . . . . . 0 C--O 1.251 1.147 0 O-C-N 124.329 1.018 . . . . 0.0 112.332 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 N--CA 1.443 -0.819 0 CA-C-O 121.717 0.77 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 27.5 m -103.68 -43.18 5.42 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.009 174.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 60.79 -150.27 0.41 Allowed 'General case' 0 C--O 1.246 0.882 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 -171.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.41 HD12 ' HG3' ' A' ' 580' ' ' PRO . 1.0 OUTLIER -147.35 113.14 4.09 Favored Pre-proline 0 C--N 1.281 -2.372 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -177.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.408 ' HD2' HD13 ' A' ' 616' ' ' LEU . 37.2 Cg_endo -66.63 -170.67 0.22 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.253 2.635 . . . . 0.0 112.741 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -86.23 91.28 8.41 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.503 ' HB ' HD23 ' A' ' 578' ' ' LEU . 11.5 pt -59.56 -75.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.472 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 11.8 t70 -174.77 -173.07 0.68 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 10.9 p -106.16 -20.27 6.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -104.96 13.63 30.71 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.555 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.1 tt -114.62 141.61 47.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -175.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.34 116.9 14.31 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-O 121.42 0.629 . . . . 0.0 111.456 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.437 ' HD3' HD11 ' A' ' 574' ' ' ILE . 64.1 Cg_endo -76.9 137.33 17.52 Favored 'Trans proline' 0 C--N 1.328 -0.514 0 C-N-CA 122.764 2.309 . . . . 0.0 111.73 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -56.94 -55.06 39.45 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.61 0.719 . . . . 0.0 109.594 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -78.34 117.54 19.68 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -124.67 93.52 3.92 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -138.74 175.56 9.45 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.505 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -87.57 -52.2 5.47 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.544 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.45 120.46 39.6 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.434 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.52 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 41.2 m-85 -85.09 126.66 33.77 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.832 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -80.04 143.8 33.73 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.898 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.45 118.04 2.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.444 0.64 . . . . 0.0 109.717 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 104.8 1.02 42.61 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.297 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.62 116.66 18.35 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 6.5 p -92.4 121.56 43.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.933 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . . . . . . . . . 5.7 mp -95.78 93.9 7.35 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.009 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 96.2 mttt -78.64 93.82 4.94 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.09 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.463 ' HB3' HD22 ' A' ' 578' ' ' LEU . 65.1 m-85 -78.1 163.87 25.5 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.424 0.63 . . . . 0.0 110.228 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 21.3 m -155.58 171.03 20.63 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 89.1 m -117.59 175.06 5.81 Favored 'General case' 0 C--N 1.259 -3.336 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.3 mmmt -56.48 164.17 2.17 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.573 1.149 . . . . 0.0 112.555 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 94.8 Cg_exo -45.77 -40.17 19.13 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.584 3.522 . . . . 0.0 115.249 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -102.52 7.86 54.22 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.33 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 40.5 m-85 -110.55 132.86 53.82 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-O 121.799 0.809 . . . . 0.0 112.103 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 16.6 m -92.92 126.17 37.88 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.761 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.468 HD12 ' HG3' ' A' ' 621' ' ' PRO . 11.1 tt -78.95 117.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 50.2 t -108.78 117.49 54.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.653 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 122.74 -160.47 17.21 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.22 123.31 10.74 Favored 'Trans proline' 0 C--N 1.328 -0.507 0 C-N-CA 122.733 2.288 . . . . 0.0 110.947 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.404 ' N ' HD21 ' A' ' 607' ' ' ASN . 0.7 OUTLIER -86.21 -50.08 7.24 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.511 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 4.9 p -100.08 95.33 6.77 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 111.783 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.2 150.69 4.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.605 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 22.8 mm-40 -98.26 160.14 14.48 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 10.5 t -84.25 129.89 34.86 Favored 'General case' 1 C--N 1.243 -4.033 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.575 165.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 55.5 m-85 -119.19 170.65 8.9 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.19 -12.84 61.13 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -104.82 -3.84 23.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.63 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 131.54 -170.18 21.62 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.408 HD13 ' HD2' ' A' ' 572' ' ' PRO . 46.6 mt -74.81 131.34 40.7 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.498 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 22.6 t -149.64 143.56 16.91 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.47 -172.5 10.97 Favored 'Cis proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.212 -1.578 . . . . 0.0 113.585 2.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.5 145.42 2.56 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.703 0.801 . . . . 0.0 110.63 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 6.5 mp -77.19 147.7 76.83 Favored Pre-proline 0 C--N 1.298 -1.659 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.262 -172.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . 0.468 ' HG3' HD12 ' A' ' 603' ' ' ILE . 93.8 Cg_endo -74.85 -179.67 5.17 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 123.705 2.937 . . . . 0.0 112.913 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.6 pt -130.4 169.52 21.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 84.1 m -110.24 126.25 53.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.017 0.436 . . . . 0.0 110.832 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.494 ' HE2' ' OD1' ' A' ' 675' ' ' ASP . 28.3 mtpp -124.26 117.54 24.77 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.936 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.468 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 3.2 tm-20 -82.45 -36.77 26.26 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -94.26 98.93 11.27 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.843 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 6.2 m -114.28 171.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . 0.468 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 53.5 mm-40 -98.67 169.12 9.72 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 42.6 m -116.14 -7.88 11.82 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.913 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 96.3 m 67.66 3.27 3.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 62.24 -132.2 45.24 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.91 155.3 38.77 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.023 2.482 . . . . 0.0 111.301 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.565 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 86.2 Cg_endo -83.56 161.88 14.62 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 122.651 2.234 . . . . 0.0 112.572 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.47 173.91 11.72 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.61 2.207 . . . . 0.0 111.388 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -98.23 161.42 13.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.568 HD22 ' SG ' ' A' ' 659' ' ' CYS . 19.7 tp -96.77 128.66 43.94 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -45.66 -42.04 11.04 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 34.5 m-80 -133.35 31.01 3.81 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.475 0.655 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -151.85 -144.77 3.99 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.59 -173.47 2.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 5.2 p -94.54 131.06 42.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.638 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 20.4 ptmt -88.91 -16.15 32.57 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.674 0.75 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.29 166.04 15.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.813 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -84.82 120.26 26.24 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.6 p -74.3 100.57 3.78 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.464 0.649 . . . . 0.0 112.448 -174.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -68.17 175.86 3.02 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.525 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -98.79 -0.85 41.75 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.746 0.784 . . . . 0.0 109.672 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.421 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 26.4 tt0 -157.92 120.72 3.85 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.565 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 7.0 m-85 -91.76 -86.08 0.23 Allowed 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.981 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 145.83 164.23 10.71 Favored Glycine 0 CA--C 1.488 -1.6 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.522 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 57.8 t60 -56.98 -51.77 67.89 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 25.5 m -99.7 21.76 11.94 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.4 0.619 . . . . 0.0 110.835 -174.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.64 115.27 27.59 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 11.6 m -92.2 147.91 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.691 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.441 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.789 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 0.2 OUTLIER -114.73 115.94 51.06 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.843 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.34 177.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.638 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 18.4 mt-10 -77.02 138.52 39.64 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.261 1.029 . . . . 0.0 111.596 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.514 ' HB3' HD23 ' A' ' 636' ' ' LEU . 72.6 m-85 -119.06 167.55 11.67 Favored 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 125.597 1.559 . . . . 0.0 109.589 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -144.91 144.35 31.04 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.568 ' SG ' HD22 ' A' ' 636' ' ' LEU . 71.1 m -100.83 172.25 7.17 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 37.1 m-80 -69.28 153.46 95.9 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 59.3 Cg_endo -68.9 10.5 0.37 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 123.699 2.933 . . . . 0.0 114.396 -174.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.41 3.56 25.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -131.46 164.22 26.24 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.688 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 687' ' ' GLU . 89.0 mt -104.22 165.16 11.23 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.493 ' HE1' ' SG ' ' A' ' 659' ' ' CYS . 4.2 ttt -123.91 103.83 8.57 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -82.65 -45.08 14.96 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -170.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -96.26 -173.73 35.71 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.007 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.51 122.01 10.64 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.416 2.744 . . . . 0.0 111.946 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 656' ' ' GLU . 2.4 p-10 -83.53 23.05 0.98 Allowed 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 122.872 0.469 . . . . 0.0 111.065 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.789 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 8.4 ptmt -163.82 107.09 0.97 Allowed 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 125.007 1.323 . . . . 0.0 108.014 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 37.7 pt -107.91 148.79 11.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.346 -174.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.489 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -113.74 154.17 27.78 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.453 0.47 . . . . 0.0 110.392 179.288 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 5.0 t -80.53 95.53 6.52 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.766 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . 0.485 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 35.1 m -84.52 117.02 29.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 O-C-N 121.402 -0.811 . . . . 0.0 111.39 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.494 ' OD1' ' HE2' ' A' ' 624' ' ' LYS . 17.6 t70 62.23 -76.67 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.39 1.076 . . . . 0.0 111.118 -173.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -151.38 17.77 0.89 Allowed Glycine 0 N--CA 1.434 -1.477 0 O-C-N 123.792 0.683 . . . . 0.0 111.614 177.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -135.5 141.71 45.34 Favored 'General case' 0 CA--C 1.495 -1.158 0 O-C-N 122.29 -0.535 . . . . 0.0 109.94 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.519 ' HB3' HD13 ' A' ' 671' ' ' ILE . 99.0 m95 -74.34 156.03 37.53 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 3.3 p -81.23 -178.72 7.04 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 16.3 m -65.37 125.85 26.4 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.174 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.86 159.92 23.58 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.431 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 26.2 Cg_endo -62.87 -13.22 33.37 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 124.263 3.309 . . . . 0.0 115.284 -176.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.282 30.9 m 48.51 101.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 175.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.9 m -80.74 140.93 35.27 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.56 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.442 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.2 OUTLIER -141.69 146.24 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.352 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 14.8 m -58.07 138.13 19.42 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.504 0 O-C-N 124.439 1.087 . . . . 0.0 112.088 -174.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . 0.544 ' HA ' ' HG ' ' A' ' 664' ' ' LEU . 41.9 tt0 . . . . . 0 C--N 1.314 -0.962 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.5 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.433 -1.317 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 87.2 m -67.3 146.53 54.03 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -117.86 149.24 41.19 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.512 HD23 ' HD2' ' A' ' 572' ' ' PRO . 2.7 tm? -77.76 111.67 19.41 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.512 ' HD2' HD23 ' A' ' 571' ' ' LEU . 84.3 Cg_endo -76.67 -170.02 0.82 Allowed 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.068 2.512 . . . . 0.0 111.625 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -74.43 102.37 4.42 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.526 0.679 . . . . 0.0 110.1 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.54 HD13 ' HB3' ' A' ' 578' ' ' LEU . 27.3 pt -83.53 -166.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.613 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.2 t70 -76.84 143.78 39.5 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.63 -26.91 24.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 C-N-CA 124.048 0.939 . . . . 0.0 111.928 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -103.92 11.02 36.05 Favored 'General case' 0 CA--C 1.494 -1.174 0 O-C-N 121.637 -0.664 . . . . 0.0 111.864 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 5.6 tp -95.87 153.08 17.94 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.44 120.18 6.13 Favored Pre-proline 0 C--N 1.286 -2.185 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.436 ' HB2' ' O ' ' A' ' 582' ' ' ARG . 56.4 Cg_endo -74.7 137.45 22.46 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.24 1.96 . . . . 0.0 112.08 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -70.8 -42.34 70.41 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 580' ' ' PRO . 6.1 mmp_? -82.6 123.81 29.57 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -137.18 91.64 2.64 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -137.92 172.63 12.65 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.578 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.08 -50.1 51.33 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.702 0.287 . . . . 0.0 111.36 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.06 152.85 50.95 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 121.443 0.639 . . . . 0.0 109.827 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.546 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 84.3 m-85 -115.18 119.72 37.32 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.068 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -70.05 142.24 52.72 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.567 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.533 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 1.8 p -61.29 112.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 122.279 1.038 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 121.33 -15.07 9.33 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.541 -174.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -72.03 126.26 29.32 Favored 'General case' 0 CA--C 1.473 -2.017 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 608' ' ' SER . 7.7 p -103.49 118.5 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.34 0 CA-C-O 122.35 1.071 . . . . 0.0 109.709 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.45 HD21 HD21 ' A' ' 571' ' ' LEU . 5.4 mp -91.04 98.52 11.82 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.025 -175.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 607' ' ' ASN . 96.0 mttt -78.21 118.96 20.93 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.546 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -97.9 179.49 4.78 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.387 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 10.5 p -168.67 161.82 11.48 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.586 ' SG ' HD13 ' A' ' 578' ' ' LEU . 90.1 m -105.0 -176.04 2.96 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.3 mmtp -63.27 162.72 22.47 Favored Pre-proline 0 N--CA 1.429 -1.499 0 C-N-CA 123.218 0.607 . . . . 0.0 111.545 175.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 88.8 Cg_exo -45.72 -40.03 18.76 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 124.498 3.465 . . . . 0.0 115.404 -175.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -97.22 3.69 62.0 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.61 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 45.6 m-85 -108.41 151.56 25.87 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.225 1.012 . . . . 0.0 113.379 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 602' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 2.6 m -103.76 123.6 47.35 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.061 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.438 ' HA ' ' SG ' ' A' ' 597' ' ' CYS . 5.7 tt -78.33 122.51 33.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . 0.447 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 55.4 t -115.52 121.0 66.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 122.185 -0.322 . . . . 0.0 110.598 -178.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 119.77 -151.23 17.48 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.132 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.37 115.51 4.37 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.06 2.507 . . . . 0.0 111.214 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 0.2 OUTLIER -82.24 -25.95 33.67 Favored 'General case' 0 C--O 1.197 -1.668 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.835 -178.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.434 ' HB2' ' CG2' ' A' ' 592' ' ' VAL . 64.7 p -123.08 98.54 5.93 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.354 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.1 m -101.21 142.46 15.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.627 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -96.27 151.07 19.86 Favored 'General case' 0 CA--C 1.48 -1.746 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.815 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 35.5 t -75.38 125.07 28.25 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 166.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.481 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 90.7 m-85 -116.36 165.1 13.59 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.95 2.89 4.9 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -177.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -111.11 -4.74 14.94 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.391 0.615 . . . . 0.0 110.422 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.52 -178.52 18.0 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.123 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.509 HD13 ' CD ' ' A' ' 572' ' ' PRO . 45.7 mt -70.92 120.18 16.12 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.481 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 49.9 m -138.42 146.13 49.84 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-O 120.475 0.179 . . . . 0.0 110.672 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.84 -169.16 7.05 Favored 'Cis proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.182 -1.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.37 169.67 7.05 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . 0.496 HD22 ' HG2' ' A' ' 572' ' ' PRO . 1.3 mm? -74.16 145.75 83.65 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.343 -168.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.24 170.59 17.9 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 123.228 2.619 . . . . 0.0 110.668 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . 0.447 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 47.0 pt -113.34 -178.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 602' ' ' THR . 96.1 m -129.13 109.04 10.84 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.425 0.453 . . . . 0.0 111.914 -177.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.579 ' O ' ' HB ' ' A' ' 602' ' ' THR . 18.5 mtmm -97.89 127.12 43.63 Favored 'General case' 0 C--O 1.201 -1.461 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 176.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.499 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 1.4 tm-20 -83.37 -34.5 25.58 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.36 107.54 18.52 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.058 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.552 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 10.4 p -125.22 174.51 9.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -88.16 139.62 30.31 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 118.824 0.738 . . . . 0.0 109.352 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 631' ' ' GLY . 17.4 m -93.87 104.54 16.6 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 173.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 55.9 m -60.9 21.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 629' ' ' SER . . . 54.83 -139.06 40.8 Favored Glycine 0 C--O 1.241 0.579 0 CA-C-O 119.734 -0.481 . . . . 0.0 112.906 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.96 154.68 22.86 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.961 2.441 . . . . 0.0 110.782 175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.48 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 59.9 Cg_endo -74.4 157.71 45.04 Favored 'Trans proline' 0 C--O 1.255 1.355 0 C-N-CA 122.684 2.256 . . . . 0.0 112.922 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.38 -169.47 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 123.47 2.78 . . . . 0.0 111.199 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -109.65 153.08 24.73 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.393 -0.817 . . . . 0.0 110.675 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.526 HD21 ' HA3' ' A' ' 639' ' ' GLY . 18.6 tp -80.67 139.86 35.95 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.435 HD11 ' OD1' ' A' ' 638' ' ' ASN . 0.3 OUTLIER -46.26 -47.79 18.06 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -178.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.435 ' OD1' HD11 ' A' ' 637' ' ' LEU . 16.4 m120 -116.58 -30.43 5.83 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.519 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -91.12 -152.23 27.8 Favored Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.222 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.35 -174.77 5.09 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.995 0.426 . . . . 0.0 110.545 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 6.0 p -92.68 134.71 29.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.536 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.555 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.2 ptmt -93.86 -24.65 17.66 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.046 0.45 . . . . 0.0 110.61 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.442 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 15.2 mm-40 -78.82 151.47 31.89 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.364 -177.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -63.97 109.24 1.72 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 16.7 p -71.59 98.56 1.9 Allowed 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.434 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -81.3 158.03 24.9 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -87.81 0.88 55.2 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.1 108.56 4.84 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.48 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 17.4 m-85 -92.76 -104.75 0.12 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 147.56 168.99 14.48 Favored Glycine 0 CA--C 1.487 -1.657 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.01 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.549 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 18.7 t60 -69.65 142.25 53.47 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 17.8 m 75.72 -1.66 2.95 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.549 1.14 . . . . 0.0 111.422 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -93.72 114.63 26.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 17.8 m -91.84 161.41 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.774 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.622 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.1 m -127.16 110.89 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.512 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.574 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.555 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 17.8 mt-10 -70.16 122.23 19.06 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.105 0.955 . . . . 0.0 111.599 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.519 ' HB3' HD23 ' A' ' 636' ' ' LEU . 76.6 m-85 -102.42 166.89 10.3 Favored 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.032 174.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -146.83 137.04 23.55 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.557 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 8.3 t -102.61 179.09 4.39 Favored 'General case' 0 C--N 1.276 -2.612 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.025 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 662' ' ' ARG . 30.9 m-80 -75.85 155.66 84.81 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.52 33.85 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 124.295 3.33 . . . . 0.0 112.688 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 660' ' ' ASN . 35.4 mtt180 -133.3 4.77 3.74 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -138.42 163.11 32.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.462 -175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.1 147.61 38.49 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.411 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.5 OUTLIER -103.34 118.98 37.99 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -176.067 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -80.21 -59.33 2.75 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -95.53 -160.79 33.4 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.067 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.93 116.34 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.03 2.487 . . . . 0.0 112.237 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.474 ' ND2' ' HG3' ' A' ' 670' ' ' LYS . 4.9 p-10 -63.52 -11.77 26.85 Favored 'General case' 0 C--O 1.195 -1.776 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.946 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -134.62 115.31 13.69 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.238 0.542 . . . . 0.0 111.909 178.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 33.8 pt -109.03 151.58 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.048 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.467 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -115.64 152.12 33.73 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 121.211 0.529 . . . . 0.0 111.399 -179.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 1.5 t -69.72 121.15 16.62 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.03 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . 0.44 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 34.0 m -116.23 86.9 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 CA-C-O 122.293 1.044 . . . . 0.0 113.045 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.552 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 16.5 m-20 75.3 8.05 3.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.795 -1.548 . . . . 0.0 113.913 166.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 142.35 -11.92 2.51 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.285 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -138.63 149.26 45.01 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.505 ' HB3' HD13 ' A' ' 671' ' ' ILE . 93.8 m95 -80.01 158.89 26.41 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 19.0 p -80.17 -180.0 7.35 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.655 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 25.8 m -68.6 126.72 30.55 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 120.717 0.294 . . . . 0.0 110.944 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.452 ' HB3' ' HD2' ' A' ' 682' ' ' PRO . 6.2 mp -57.94 160.3 8.76 Favored Pre-proline 0 N--CA 1.441 -0.904 0 O-C-N 124.461 1.101 . . . . 0.0 113.011 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 681' ' ' LEU . 11.5 Cg_endo -57.31 -42.1 66.0 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.112 2.541 . . . . 0.0 113.283 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 99.8 t 67.55 113.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-O 121.936 0.874 . . . . 0.0 110.467 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 8.1 p -111.54 138.17 48.42 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.996 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.2 OUTLIER -124.89 148.52 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.283 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.469 -176.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 14.8 m -56.3 138.11 17.26 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.558 0 C-N-CA 124.558 1.143 . . . . 0.0 113.759 -171.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 C--N 1.299 -1.62 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.606 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.428 -1.55 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 616' ' ' LEU . 90.5 m -59.28 133.34 56.01 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -174.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 571' ' ' LEU . 35.6 tt0 -94.63 -61.51 1.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.597 HD12 ' HG3' ' A' ' 580' ' ' PRO . 3.4 tt 150.84 129.88 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 177.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.568 ' HD3' HD11 ' A' ' 616' ' ' LEU . 74.5 Cg_endo -70.55 -170.8 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.76 1.64 . . . . 0.0 111.325 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -92.27 102.19 14.69 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.646 HD11 ' HD3' ' A' ' 580' ' ' PRO . 36.7 pt -76.2 -164.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.601 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.676 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 11.3 t70 -80.86 163.84 23.11 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.14 -28.09 22.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.17 0.509 . . . . 0.0 110.793 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -101.6 9.45 41.14 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 121.734 -0.604 . . . . 0.0 111.424 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.676 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.2 tm? -100.79 146.49 27.21 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.74 121.14 8.82 Favored Pre-proline 0 C--N 1.3 -1.578 0 C-N-CA 123.754 0.822 . . . . 0.0 109.326 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.646 ' HD3' HD11 ' A' ' 574' ' ' ILE . 55.8 Cg_endo -73.0 136.33 24.7 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.036 1.824 . . . . 0.0 111.484 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.74 -38.82 92.3 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.537 1.135 . . . . 0.0 110.782 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -67.38 -61.07 2.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.739 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 60.6 tttm 51.84 74.57 0.25 Allowed 'General case' 0 C--O 1.241 0.649 0 O-C-N 124.676 1.235 . . . . 0.0 110.895 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -131.12 156.24 45.61 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.289 -1.323 . . . . 0.0 107.445 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -76.55 -31.51 57.64 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.21 133.08 40.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.875 0.369 . . . . 0.0 110.838 174.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.499 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 96.7 m-85 -110.69 142.29 42.8 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 588' ' ' LYS . 23.6 ttmm -93.13 153.4 18.68 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.597 ' HA ' ' SG ' ' A' ' 611' ' ' CYS 0.269 0.2 OUTLIER -64.64 118.0 6.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 121.839 0.828 . . . . 0.0 111.705 179.493 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 113.34 -3.66 25.11 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.768 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -74.53 134.7 42.19 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 20.3 m -109.82 129.92 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.881 0.848 . . . . 0.0 109.888 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.499 ' HG ' ' CE2' ' A' ' 587' ' ' TYR 0.368 0.0 OUTLIER -116.26 98.56 6.66 Favored 'General case' 0 N--CA 1.385 -3.701 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.269 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 607' ' ' ASN . 24.4 mtpp -61.46 124.6 21.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.044 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.483 ' HB3' HD13 ' A' ' 578' ' ' LEU . 27.7 m-85 -105.44 164.73 11.64 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.702 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 596' ' ' SER . . . . . 0.525 ' HA ' HD13 ' A' ' 603' ' ' ILE . 34.0 p -168.85 166.69 11.31 Favored 'General case' 0 N--CA 1.401 -2.88 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 169.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 70.8 m -98.9 173.26 6.94 Favored 'General case' 0 C--N 1.255 -3.534 0 O-C-N 123.769 0.668 . . . . 0.0 110.831 -177.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.578 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 29.9 mmtp -53.04 163.21 0.9 Allowed Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 124.304 1.041 . . . . 0.0 112.191 176.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 18.7 Cg_endo -60.69 -17.09 47.55 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.852 2.368 . . . . 0.0 115.291 -170.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -110.54 8.63 30.37 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.273 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 30.7 m-85 -113.1 162.43 15.94 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.534 0.683 . . . . 0.0 112.258 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 8.1 m -112.65 131.95 55.4 Favored 'General case' 0 N--CA 1.416 -2.148 0 C-N-CA 125.533 1.533 . . . . 0.0 110.111 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' A' ' 596' ' ' SER . 11.4 tt -83.98 122.4 37.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.439 0.638 . . . . 0.0 109.5 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . 0.413 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 46.1 t -118.07 109.74 28.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.276 0.56 . . . . 0.0 109.856 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 132.82 -164.43 24.07 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.21 128.76 27.39 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.966 2.444 . . . . 0.0 110.786 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 6.8 m120 -94.96 -10.17 31.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 122.182 -0.324 . . . . 0.0 110.947 -175.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 608' ' ' SER . . . . . . . . . . . . . 2.8 p -150.24 98.08 2.63 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.335 0.588 . . . . 0.0 111.637 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 20.3 m -93.21 167.56 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.781 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.552 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 2.0 mp0 -113.97 156.0 24.83 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.288 0.566 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.597 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 0.9 OUTLIER -85.25 130.8 34.53 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 164.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.552 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 77.5 m-85 -115.35 175.0 5.71 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -73.23 -12.94 61.04 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.862 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -101.38 -2.32 31.19 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 111.173 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.25 -171.78 21.35 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.568 HD11 ' HD3' ' A' ' 572' ' ' PRO . 5.2 mp -87.36 137.59 32.21 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 118.091 0.945 . . . . 0.0 110.019 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 618' ' ' PRO . 44.7 m -158.38 157.11 28.67 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.152 -176.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.48 ' O ' ' HA ' ' A' ' 617' ' ' SER . 59.3 Cg_endo -68.92 -168.18 3.85 Favored 'Cis proline' 0 CA--C 1.554 1.498 0 C-N-CA 124.599 -1.001 . . . . 0.0 114.279 1.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.02 160.99 16.78 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.994 0.426 . . . . 0.0 110.748 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . 0.481 ' HG ' ' HA ' ' A' ' 574' ' ' ILE . 2.1 mm? -78.43 144.52 66.11 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.89 162.53 41.78 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.982 2.455 . . . . 0.0 110.924 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . 0.413 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 43.1 pt -110.49 -178.66 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.7 m -129.9 116.63 18.93 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-O 121.28 0.562 . . . . 0.0 111.716 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -104.02 130.42 51.68 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.442 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 25.3 tt0 -86.85 -39.82 15.48 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -98.22 107.54 20.04 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.138 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.6 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 3.5 p -107.13 176.48 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . 0.468 ' NE2' ' HA3' ' A' ' 676' ' ' GLY . 48.2 mt-30 -93.53 156.14 16.91 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 15.4 m -99.02 -7.53 26.71 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.658 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . 0.453 ' SG ' ' HA2' ' A' ' 676' ' ' GLY . 20.9 m 71.1 -12.4 0.59 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 167.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 65.18 -147.25 50.79 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -79.01 148.76 22.08 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 122.66 2.24 . . . . 0.0 111.846 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.42 167.69 25.22 Favored 'Trans proline' 0 CA--C 1.556 1.578 0 C-N-CA 123.49 2.793 . . . . 0.0 113.025 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.97 -167.52 0.24 Allowed 'Trans proline' 0 CA--C 1.55 1.292 0 C-N-CA 123.626 2.884 . . . . 0.0 113.587 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -111.99 166.02 11.59 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 657' ' ' TYR . 18.9 tp -102.55 132.2 48.78 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 638' ' ' ASN . 2.3 pp -51.91 -42.91 63.12 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.776 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 15.3 m120 -131.09 29.91 4.62 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.717 0.77 . . . . 0.0 109.392 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -153.61 -150.4 5.45 Favored Glycine 0 N--CA 1.412 -2.953 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.55 -166.84 1.73 Allowed 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.5 p -107.53 128.37 62.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -85.44 -22.29 28.36 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.348 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.577 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 8.2 mm-40 -86.89 144.43 26.99 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.158 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . 0.564 ' HB3' ' HZ2' ' A' ' 644' ' ' LYS . 5.9 ttpm? -56.8 112.7 1.38 Allowed 'General case' 0 C--N 1.31 -1.136 0 O-C-N 124.353 1.033 . . . . 0.0 109.938 176.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.452 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 4.9 p -83.72 101.43 11.55 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.599 0.714 . . . . 0.0 111.682 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.527 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 49.7 pttt -84.95 160.78 20.02 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.099 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.94 -21.05 60.66 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -152.26 125.01 8.42 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.097 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.527 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 11.3 m-85 -99.27 -75.27 0.57 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 129.19 172.19 13.12 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -175.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -60.44 -63.31 1.34 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 19.3 m -87.9 41.82 1.02 Allowed 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 121.333 0.587 . . . . 0.0 111.172 -172.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -120.3 106.28 11.73 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.8 m -82.19 154.64 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-O 122.066 0.936 . . . . 0.0 111.548 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.8 t -127.45 111.89 26.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 114.13 -1.396 . . . . 0.0 107.995 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.577 ' HB2' ' HG2' ' A' ' 643' ' ' GLU . 36.0 mt-10 -70.09 120.47 15.84 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 122.21 1.005 . . . . 0.0 113.01 175.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 55.4 m-85 -100.21 165.34 11.54 Favored 'General case' 0 C--N 1.263 -3.153 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.717 171.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -146.54 138.29 24.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 80.1 m -92.3 175.92 6.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.463 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 0.8 OUTLIER -67.46 157.55 85.32 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 70.1 Cg_endo -72.89 37.74 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.909 3.073 . . . . 0.0 113.195 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 660' ' ' ASN . 19.1 ptt180 -153.52 11.82 0.45 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.695 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 660' ' ' ASN . 87.0 m-85 -132.88 154.15 50.66 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.37 0.605 . . . . 0.0 110.196 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 85.4 mt -93.68 149.23 21.4 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.528 ' HE1' ' SG ' ' A' ' 659' ' ' CYS . 5.2 ttt -112.11 118.76 36.26 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -75.18 -72.04 0.32 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -172.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -90.67 -151.97 26.95 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 113.663 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.36 119.67 6.74 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.3 2.667 . . . . 0.0 111.919 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -74.96 -12.9 60.45 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 121.201 0.524 . . . . 0.0 110.81 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 9.1 mtpt -119.24 125.88 50.18 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 40.4 pt -116.74 138.14 48.32 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.605 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.536 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -102.61 161.52 13.66 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 42.8 t -102.2 110.93 23.03 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.492 1.139 . . . . 0.0 111.135 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 77.8 t -86.14 110.08 19.47 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.036 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.13 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.6 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 23.0 t70 60.73 -80.27 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 124.799 1.24 . . . . 0.0 112.43 -171.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . 0.468 ' HA3' ' NE2' ' A' ' 628' ' ' GLN . . . -145.67 14.61 1.79 Allowed Glycine 0 C--N 1.301 -1.389 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 176.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -125.41 115.6 20.54 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.529 ' HB3' HD13 ' A' ' 671' ' ' ILE . 98.4 m95 -63.53 146.24 54.08 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 17.8 p -67.36 175.51 2.71 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 2.7 m -60.5 130.2 45.38 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.938 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.438 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 6.0 mp -63.38 152.25 85.6 Favored Pre-proline 0 N--CA 1.433 -1.281 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.462 ' CG ' ' HE3' ' A' ' 665' ' ' MET . 19.3 Cg_endo -58.64 -36.73 96.83 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.648 2.898 . . . . 0.0 114.125 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 66.2 t 69.4 117.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.913 0.885 . . . . 0.0 112.773 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 4.1 m -96.75 135.35 38.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.446 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.1 OUTLIER -136.81 144.04 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.928 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 16.8 m -58.15 139.69 17.47 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.064 0 C-N-CA 124.678 1.191 . . . . 0.0 112.843 -174.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.62 -179.38 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.411 -2.388 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 79.2 m -67.78 119.19 12.09 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.792 0.806 . . . . 0.0 110.943 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.76 -2.31 38.36 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-O 122.419 1.104 . . . . 0.0 108.929 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.63 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 47.4 tp 74.37 115.1 0.03 OUTLIER Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 127.059 2.144 . . . . 0.0 110.337 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.568 ' HG2' HD13 ' A' ' 620' ' ' LEU . 60.8 Cg_endo -67.97 -159.47 0.05 OUTLIER 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 123.696 2.931 . . . . 0.0 111.6 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -89.93 98.98 12.09 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 578' ' ' LEU . 40.7 pt -72.83 175.09 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.153 174.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.7 t70 -65.79 147.81 52.79 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.12 -25.91 31.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 C-N-CA 123.792 0.837 . . . . 0.0 110.786 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -105.9 8.32 32.57 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 122.054 -0.403 . . . . 0.0 111.864 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.629 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 6.5 tp -91.75 148.61 22.12 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 21.7 m -135.66 116.57 11.77 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 583' ' ' LYS . 26.9 Cg_endo -74.23 134.61 19.47 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.472 1.448 . . . . 0.0 109.686 174.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -33.41 75.72 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.76 -64.75 0.84 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.802 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 27.3 ttpp 47.91 82.34 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.691 1.596 . . . . 0.0 112.334 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.66 163.91 28.37 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.975 -1.466 . . . . 0.0 107.412 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -72.69 -46.02 55.84 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.957 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.36 133.88 50.01 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.577 0.703 . . . . 0.0 110.258 177.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.63 ' CE1' ' HB2' ' A' ' 571' ' ' LEU . 92.8 m-85 -107.37 124.76 50.3 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 124.862 1.265 . . . . 0.0 109.509 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -78.79 149.23 32.66 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.576 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 1.3 p -63.8 119.17 7.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.59 0.709 . . . . 0.0 111.33 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 115.2 -10.38 20.21 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.26 -173.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -70.21 125.97 28.32 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 609' ' ' VAL . 18.6 t -99.55 116.7 43.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 608' ' ' SER . 9.7 mt -101.84 115.04 29.66 Favored 'General case' 0 CA--C 1.47 -2.121 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.544 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 34.1 mtmm -91.76 99.38 12.27 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -76.81 161.81 28.15 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-O 122.022 0.915 . . . . 0.0 109.147 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 38.5 m -152.46 169.38 22.74 Favored 'General case' 0 C--N 1.253 -3.619 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.483 ' SG ' HD13 ' A' ' 578' ' ' LEU . 87.6 m -107.43 -178.17 3.56 Favored 'General case' 0 C--N 1.247 -3.887 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.557 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 32.1 mmtm -55.67 163.83 1.83 Allowed Pre-proline 0 C--N 1.313 -1.022 0 C-N-CA 123.018 0.527 . . . . 0.0 110.993 172.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 16.6 Cg_endo -59.03 -28.66 88.49 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.36 2.04 . . . . 0.0 114.701 -171.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.88 -2.65 61.04 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.879 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.557 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 39.9 m-85 -103.62 136.3 43.58 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 602' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 14.4 m -87.87 125.78 34.67 Favored 'General case' 0 N--CA 1.395 -3.201 0 CA-C-N 113.74 -1.573 . . . . 0.0 109.182 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.454 HD12 ' HG3' ' A' ' 621' ' ' PRO . 12.6 tt -80.31 125.69 39.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 82.5 t -117.25 114.58 46.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 123.59 -166.67 16.0 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.178 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.24 115.82 3.37 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.919 2.413 . . . . 0.0 111.535 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.99 -49.51 17.47 Favored 'General case' 0 C--O 1.206 -1.201 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.544 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 57.0 p -99.1 113.7 26.05 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.11 0.481 . . . . 0.0 111.626 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 592' ' ' VAL . 15.8 m -116.86 157.39 17.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.503 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -103.36 151.96 22.14 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 121.011 0.434 . . . . 0.0 109.904 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 42.1 t -80.16 129.46 34.51 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.402 ' HE1' ' O ' ' A' ' 617' ' ' SER . 95.6 m-85 -114.64 165.79 12.41 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -61.92 -18.72 61.24 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -97.79 -5.28 35.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.85 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 134.62 -179.75 17.28 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.508 HD13 ' HD2' ' A' ' 572' ' ' PRO . 71.9 mt -72.99 128.87 36.74 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 618' ' ' PRO . 67.1 m -146.26 147.07 30.07 Favored Pre-proline 0 C--N 1.294 -1.809 0 CA-C-N 116.816 -0.175 . . . . 0.0 110.681 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 617' ' ' SER . 49.5 Cg_endo -66.64 -175.7 7.74 Favored 'Cis proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.728 -1.363 . . . . 0.0 113.111 0.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.19 163.81 9.67 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 121.033 0.444 . . . . 0.0 110.957 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . 0.568 HD13 ' HG2' ' A' ' 572' ' ' PRO . 24.0 mt -77.39 145.91 73.04 Favored Pre-proline 0 C--N 1.293 -1.869 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.972 -170.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . 0.454 ' HG3' HD12 ' A' ' 603' ' ' ILE . 61.8 Cg_endo -70.91 173.68 11.64 Favored 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 123.537 2.824 . . . . 0.0 111.007 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 44.1 pt -117.7 178.23 2.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.8 m -123.89 123.39 40.32 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.114 0.483 . . . . 0.0 110.604 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 602' ' ' THR . 58.2 mtpt -118.92 119.79 35.36 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.557 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 4.3 tm-20 -79.25 -43.12 24.38 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -91.64 91.92 8.23 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.488 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.623 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 5.0 p -109.69 170.82 2.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.275 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . 0.531 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 19.9 mm-40 -91.61 161.17 15.04 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 27.3 m -107.51 -4.9 17.96 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.104 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 80.1 m 71.22 -34.79 0.31 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 88.34 -141.93 17.06 Favored Glycine 0 N--CA 1.415 -2.719 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -74.34 145.7 34.58 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 121.997 1.798 . . . . 0.0 111.831 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -82.43 170.86 12.83 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.085 2.523 . . . . 0.0 111.874 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.14 -166.92 0.15 Allowed 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 123.214 2.61 . . . . 0.0 113.108 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -100.45 169.58 8.99 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 1.589 HD23 ' CD1' ' A' ' 636' ' ' LEU . 14.7 tp -91.33 166.16 13.05 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 117.733 -1.587 . . . . 0.0 110.258 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.401 ' H ' ' CG ' ' A' ' 636' ' ' LEU . 4.9 tt -63.45 -67.64 0.41 Allowed 'General case' 0 N--CA 1.396 -3.162 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.716 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -128.08 40.16 3.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.979 0.895 . . . . 0.0 109.169 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -149.21 -142.13 3.55 Favored Glycine 1 N--CA 1.395 -4.067 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.784 176.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.66 -172.83 4.21 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 9.0 p -104.0 134.55 44.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.7 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.1 ptmt -86.17 -29.85 22.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.661 0.744 . . . . 0.0 110.439 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 642' ' ' LYS . 27.6 mm-40 -88.2 159.24 18.24 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.508 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -72.84 118.86 16.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.664 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 18.1 p -71.6 101.91 2.62 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-O 121.724 0.773 . . . . 0.0 111.21 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -73.29 156.54 38.35 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.484 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 49.2 mt-10 -85.59 -6.19 59.19 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -140.95 113.27 7.99 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 173.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -96.35 -77.85 0.48 Allowed 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.455 174.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 130.09 163.5 11.1 Favored Glycine 0 CA--C 1.497 -1.091 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 71.2 t60 -56.51 -57.86 10.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 44.7 m -86.28 20.62 2.31 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -102.66 120.0 39.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 2.9 p -99.16 161.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.252 0.548 . . . . 0.0 110.143 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.8 t -127.37 113.72 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.724 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.7 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 29.5 mt-10 -71.91 124.15 24.26 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.497 0.665 . . . . 0.0 112.45 176.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.486 ' HB3' HD12 ' A' ' 636' ' ' LEU . 87.5 m-85 -108.1 167.33 10.07 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.621 172.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -150.44 141.23 22.76 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.649 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 9.1 m -100.47 173.85 6.38 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.116 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.426 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 42.3 m-80 -62.89 155.09 73.47 Favored Pre-proline 0 C--O 1.245 0.828 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.618 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 53.5 Cg_endo -71.01 29.41 0.21 Allowed 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 124.218 3.279 . . . . 0.0 114.681 -175.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 660' ' ' ASN . 0.1 OUTLIER -143.3 21.8 1.88 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.176 0.989 . . . . 0.0 110.144 -179.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -135.6 157.38 47.03 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.01 175.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.43 132.36 54.2 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.406 ' HE1' HD13 ' A' ' 636' ' ' LEU . 3.1 ttt -97.0 106.41 18.75 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -90.97 -42.65 10.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -173.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.89 -178.67 46.13 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.183 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.27 113.64 1.63 Allowed 'Trans proline' 0 N--CA 1.476 0.484 0 C-N-CA 123.613 2.876 . . . . 0.0 112.082 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 5.3 p-10 -63.27 -15.42 57.12 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 2.0 mtpt -120.22 155.32 33.41 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 44.5 pt -139.36 145.95 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.584 HE21 ' N ' ' A' ' 672' ' ' GLN . 0.0 OUTLIER -118.64 158.75 24.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.096 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 7.5 t -86.33 104.48 15.88 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.878 1.323 . . . . 0.0 111.344 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.6 106.63 18.07 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.051 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.845 -176.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.623 ' HA ' ' CG2' ' A' ' 627' ' ' VAL 0.253 16.0 t70 64.13 -56.54 0.23 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.7 1.6 . . . . 0.0 114.543 -178.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -161.95 4.97 0.08 OUTLIER Glycine 0 C--N 1.288 -2.095 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.651 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -136.37 154.46 50.82 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 123.115 0.566 . . . . 0.0 109.478 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.42 ' HB3' HD13 ' A' ' 671' ' ' ILE . 96.3 m95 -80.34 174.72 11.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.836 0.826 . . . . 0.0 111.638 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.11 167.85 10.8 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.705 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 26.7 m -57.16 128.46 37.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.22 0.95 . . . . 0.0 110.937 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.505 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 4.5 mp -65.94 154.46 89.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.541 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.505 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 5.9 Cg_endo -53.68 -32.6 65.92 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.962 3.108 . . . . 0.0 114.874 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.315 30.5 m 42.79 94.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 26.9 p -86.79 162.03 18.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.697 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.62 155.99 23.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.5 140.68 13.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 123.686 0.617 . . . . 0.0 110.764 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--O 1.247 0.93 0 C-N-CA 123.55 0.74 . . . . 0.0 110.831 -179.348 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 CA--C 1.514 -0.407 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 89.4 m -100.9 149.6 23.71 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -137.28 14.0 3.02 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.428 ' HA ' ' HD2' ' A' ' 572' ' ' PRO . 1.1 tm? 70.96 101.62 0.04 OUTLIER Pre-proline 0 C--O 1.247 0.935 0 C-N-CA 124.481 1.113 . . . . 0.0 109.881 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 571' ' ' LEU . 62.8 Cg_endo -71.74 -172.34 0.8 Allowed 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.497 2.798 . . . . 0.0 111.613 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.39 95.86 5.2 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.534 HD11 ' HD3' ' A' ' 580' ' ' PRO . 17.2 pt -73.81 -175.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.592 177.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.7 t70 -71.2 148.87 46.87 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.49 -33.0 46.95 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.634 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -98.6 13.02 33.47 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 121.805 -0.56 . . . . 0.0 111.943 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.6 OUTLIER -106.06 150.75 25.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.527 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.55 119.68 7.78 Favored Pre-proline 0 C--N 1.312 -1.045 0 C-N-CA 124.159 0.983 . . . . 0.0 109.197 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.534 ' HD3' HD11 ' A' ' 574' ' ' ILE . 33.3 Cg_endo -71.43 135.31 26.3 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.321 2.014 . . . . 0.0 112.318 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.57 -47.12 79.91 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 123.556 0.742 . . . . 0.0 110.08 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -64.67 -68.43 0.36 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 39.1 ttpt 52.38 70.81 0.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.471 1.129 . . . . 0.0 110.685 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -119.94 157.26 29.16 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.93 -37.27 67.24 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.145 0.498 . . . . 0.0 111.805 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.42 142.74 51.34 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.613 ' CD2' HD23 ' A' ' 593' ' ' LEU . 72.3 m-85 -122.65 126.76 48.28 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . 0.507 ' HB2' ' HG2' ' A' ' 591' ' ' GLU . 36.9 mttp -69.61 149.26 48.33 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.447 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -71.52 120.19 19.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.22 174.299 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 116.57 -11.11 16.21 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.635 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 588' ' ' LYS . 5.8 mm-40 -67.84 142.14 56.23 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 18.7 t -115.64 114.75 47.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.613 HD23 ' CD2' ' A' ' 587' ' ' TYR . 0.2 OUTLIER -105.58 109.64 21.68 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.626 0.727 . . . . 0.0 111.279 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 60.5 mtpt -72.4 141.94 48.7 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.345 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.495 ' HD1' ' HA ' ' A' ' 580' ' ' PRO . 64.1 m-85 -114.23 177.59 4.59 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-O 121.05 0.452 . . . . 0.0 109.955 175.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 10.6 p -163.05 164.46 25.5 Favored 'General case' 0 N--CA 1.405 -2.696 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 94.6 m -111.95 -178.72 3.5 Favored 'General case' 0 C--N 1.266 -3.028 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 598' ' ' LYS . 28.1 mmtp -57.41 159.38 8.91 Favored Pre-proline 0 N--CA 1.436 -1.167 0 C-N-CA 123.281 0.632 . . . . 0.0 110.995 173.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 83.6 Cg_exo -46.6 -45.01 20.52 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 124.195 3.263 . . . . 0.0 114.057 -176.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 625' ' ' GLU . . . -90.25 -2.4 73.98 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.979 -175.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.552 ' CD2' ' HB2' ' A' ' 625' ' ' GLU . 29.3 m-85 -97.41 179.79 4.75 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.613 0.721 . . . . 0.0 112.118 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 602' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 624' ' ' LYS . 89.3 m -136.47 129.38 30.99 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 15.9 tt -86.05 150.23 3.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . 0.595 ' CG1' ' HG2' ' A' ' 624' ' ' LYS . 4.9 m -119.05 154.22 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.384 -171.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 53.72 -123.94 27.92 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 169.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.72 94.75 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.294 2.663 . . . . 0.0 112.194 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -79.98 -28.48 39.53 Favored 'General case' 0 C--O 1.203 -1.385 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.479 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.453 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 34.1 p -112.81 94.7 5.03 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.515 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 23.6 m -98.53 156.74 3.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.549 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -101.56 155.31 18.16 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.066 0.46 . . . . 0.0 110.111 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.447 ' HB3' ' HA ' ' A' ' 589' ' ' VAL . 44.1 t -82.97 120.26 25.48 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 168.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.557 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 19.7 m-85 -100.59 167.55 10.28 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -54.59 -26.61 33.55 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.065 0.546 . . . . 0.0 112.432 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -108.53 8.21 27.15 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.885 0.374 . . . . 0.0 111.446 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 130.19 -177.73 18.02 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.915 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.407 ' C ' ' HG ' ' A' ' 617' ' ' SER . 74.5 mt -69.96 130.05 41.14 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.557 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 70.8 m -146.07 144.51 21.87 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 617' ' ' SER . 53.2 Cg_endo -69.31 -173.82 8.48 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.592 -1.42 . . . . 0.0 112.74 0.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.45 152.14 35.25 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.336 0.588 . . . . 0.0 110.53 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 4.9 mp -71.94 142.26 85.21 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.983 -170.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.9 164.47 34.54 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.832 3.021 . . . . 0.0 113.624 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . 0.465 ' H ' ' CG2' ' A' ' 604' ' ' VAL . 33.0 pt -104.97 -176.34 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.495 ' SG ' HD13 ' A' ' 578' ' ' LEU . 74.3 m -125.58 127.47 46.42 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 121.202 0.525 . . . . 0.0 109.701 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.595 ' HG2' ' CG1' ' A' ' 604' ' ' VAL . 12.7 mmmm -86.63 -59.03 2.39 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.552 ' HB2' ' CD2' ' A' ' 601' ' ' PHE . 1.9 tm-20 80.78 -54.84 0.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.939 1.696 . . . . 0.0 108.508 -172.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -98.73 118.8 36.27 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.328 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 3.9 m -128.32 170.92 17.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.937 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . 0.4 HE21 ' HA3' ' A' ' 676' ' ' GLY . 46.9 mt-30 -88.01 178.04 6.77 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.163 0.506 . . . . 0.0 110.616 -176.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 7.5 m -105.47 -14.38 15.33 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 11.9 m 72.7 -10.16 0.99 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.135 1.374 . . . . 0.0 113.185 169.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 59.55 -141.9 47.26 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.94 154.3 47.92 Favored 'Trans proline' 0 CA--C 1.549 1.254 0 C-N-CA 122.924 2.416 . . . . 0.0 111.901 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 92.7 Cg_endo -81.46 167.39 17.27 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 123.415 2.743 . . . . 0.0 111.855 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.15 -175.92 1.42 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.49 2.127 . . . . 0.0 110.741 174.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.64 161.43 14.87 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.59 HD22 ' SG ' ' A' ' 659' ' ' CYS . 20.4 tp -85.16 128.84 34.82 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.43 HD13 ' N ' ' A' ' 638' ' ' ASN . 1.7 pp -46.88 -37.2 8.47 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.783 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 12.5 m120 -133.16 28.14 4.13 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.134 0.492 . . . . 0.0 109.683 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.21 -142.61 3.48 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -166.11 -179.31 5.07 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.399 0.679 . . . . 0.0 109.483 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 45.9 t -90.03 133.57 31.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.418 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 8.4 ptmm? -90.64 -16.03 29.38 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.548 0.69 . . . . 0.0 110.986 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -91.51 159.8 15.75 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -72.99 123.0 22.63 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.244 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 22.4 p -62.27 110.39 1.62 Allowed 'General case' 0 N--CA 1.411 -2.404 0 O-C-N 123.725 0.64 . . . . 0.0 109.547 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -72.69 151.9 41.98 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.97 -14.51 59.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.92 0.867 . . . . 0.0 109.256 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -149.92 112.66 4.78 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.783 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.581 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.0 m-85 -89.83 -61.94 1.58 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 106.32 156.66 21.52 Favored Glycine 0 N--CA 1.421 -2.304 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.539 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.528 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 79.0 t60 -61.63 136.19 57.91 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 122.596 0.358 . . . . 0.0 110.321 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.5 m 70.82 14.59 6.99 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.334 1.053 . . . . 0.0 112.63 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.46 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 6.0 tp10 -94.93 121.31 36.4 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 174.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.4 p -88.47 160.18 2.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-O 121.156 0.503 . . . . 0.0 110.632 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -129.63 113.53 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.57 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.548 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 13.8 mt-10 -75.97 129.4 36.84 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.852 0.834 . . . . 0.0 111.261 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.515 ' HB3' HD23 ' A' ' 636' ' ' LEU . 95.4 m-85 -111.12 174.38 5.89 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.125 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -148.02 142.46 26.38 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.596 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 85.6 m -97.73 178.3 5.2 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.425 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 36.6 m-80 -71.62 154.55 93.11 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 91.7 Cg_endo -74.38 38.24 0.48 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 124.246 3.298 . . . . 0.0 113.183 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.495 ' HG3' ' CE1' ' A' ' 663' ' ' PHE . 9.0 ptm180 -150.51 13.51 0.74 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.487 -175.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.495 ' CE1' ' HG3' ' A' ' 662' ' ' ARG . 85.2 m-85 -139.13 151.5 46.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.581 0.705 . . . . 0.0 110.772 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 81.1 mt -92.76 152.7 19.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.596 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 1.3 ttt -107.63 109.86 21.59 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.474 ' HB2' HD13 ' A' ' 685' ' ' ILE . 17.1 tppt? -71.57 -61.36 1.81 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.3 -172.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.67 -162.39 30.12 Favored Glycine 0 N--CA 1.431 -1.686 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.498 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.2 119.79 7.06 Favored 'Trans proline' 0 C--N 1.334 -0.198 0 C-N-CA 123.475 2.783 . . . . 0.0 112.407 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 4.6 p-10 -64.29 -2.38 2.14 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 656' ' ' GLU . 0.0 OUTLIER -140.22 143.61 36.1 Favored 'General case' 0 N--CA 1.407 -2.625 0 C-N-CA 122.746 0.419 . . . . 0.0 110.279 177.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.586 ' HB ' ' HG1' ' A' ' 679' ' ' THR . 34.0 pt -136.46 142.39 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.492 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -112.23 149.92 31.63 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 44.0 t -80.16 125.24 29.57 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-O 123.166 1.46 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.52 118.39 57.04 Favored 'Isoleucine or valine' 1 N--CA 1.377 -4.094 0 CA-C-N 111.72 -2.491 . . . . 0.0 109.206 -174.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.528 ' H ' ' CE1' ' A' ' 651' ' ' HIS . 30.4 t70 63.46 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.938 1.295 . . . . 0.0 110.653 -172.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . 0.4 ' HA3' HE21 ' A' ' 628' ' ' GLN . . . -161.03 27.99 0.3 Allowed Glycine 0 C--N 1.29 -1.977 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -138.5 146.48 42.04 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.507 ' HB3' HD13 ' A' ' 671' ' ' ILE . 95.6 m95 -87.18 160.58 18.45 Favored 'General case' 0 C--N 1.273 -2.749 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.93 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 679' ' ' THR . . . . . 0.586 ' HG1' ' HB ' ' A' ' 671' ' ' ILE . 19.2 p -83.52 -179.9 7.47 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 14.2 m -65.69 124.73 23.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.004 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.9 mp -64.05 161.92 35.27 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.515 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 23.6 Cg_endo -62.25 -16.79 53.3 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 123.795 2.997 . . . . 0.0 115.08 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.293 31.6 m 48.21 98.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.783 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.1 m -80.39 142.3 34.52 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.316 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.474 HD13 ' HB2' ' A' ' 666' ' ' LYS . 0.2 OUTLIER -136.95 145.91 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.324 0 C-N-CA 123.765 0.826 . . . . 0.0 108.874 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 28.3 m -50.34 126.26 4.85 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.209 0 C-N-CA 125.473 1.509 . . . . 0.0 114.018 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . 0.422 ' HG2' HD22 ' A' ' 664' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.288 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . . . . . . . . . 76.8 m -85.96 166.63 15.77 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.204 0.526 . . . . 0.0 111.547 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -141.78 150.24 41.45 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.714 HD12 ' HG3' ' A' ' 580' ' ' PRO . 1.0 OUTLIER -73.9 119.17 74.8 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.453 ' HD2' HD21 ' A' ' 571' ' ' LEU . 72.4 Cg_endo -76.07 -162.48 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.658 2.239 . . . . 0.0 111.064 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -87.25 107.4 18.47 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 121.91 -0.494 . . . . 0.0 110.092 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 28.1 pt -70.71 -169.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.346 176.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 10.9 t70 -77.43 152.94 34.06 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.01 -29.94 42.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.282 0.563 . . . . 0.0 110.232 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -103.35 15.3 29.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.577 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.2 OUTLIER -97.63 157.93 15.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 4.9 p -158.62 110.22 1.64 Allowed Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.336 0.654 . . . . 0.0 110.171 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.714 ' HG3' HD12 ' A' ' 571' ' ' LEU . 59.4 Cg_endo -72.08 148.29 50.31 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.392 2.728 . . . . 0.0 113.206 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.41 -45.0 27.25 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -75.39 109.37 8.87 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 173.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 583' ' ' LYS . 35.2 ttmt -121.6 98.02 5.77 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -146.9 177.82 8.82 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . 0.424 ' HB3' ' NE2' ' A' ' 586' ' ' GLN . 7.1 t70 -86.73 -55.73 3.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.705 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . 0.424 ' NE2' ' HB3' ' A' ' 585' ' ' ASP . 0.0 OUTLIER -116.09 142.55 46.66 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.431 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.582 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 27.1 m-85 -110.88 124.57 52.33 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.551 -174.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -62.56 143.41 57.26 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.266 0.978 . . . . 0.0 108.843 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.739 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 3.4 p -61.71 119.58 6.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-O 121.858 0.837 . . . . 0.0 109.998 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 107.21 -10.3 39.67 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.254 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.47 123.35 23.73 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 610' ' ' GLN . 3.6 p -102.48 129.19 54.39 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 CA-C-O 121.863 0.84 . . . . 0.0 111.383 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.582 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 4.3 mp -96.98 101.87 13.54 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.432 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -81.11 103.31 10.83 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.721 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.532 ' HB3' ' CD1' ' A' ' 578' ' ' LEU . 74.0 m-85 -90.1 176.22 6.86 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 122.836 0.455 . . . . 0.0 111.456 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 596' ' ' SER . . . . . 0.531 ' HA ' HD13 ' A' ' 603' ' ' ILE . 33.0 t -177.55 157.99 1.33 Allowed 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 168.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.457 ' SG ' HD23 ' A' ' 578' ' ' LEU . 97.4 m -86.67 177.95 7.19 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.989 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.555 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 72.9 mmtt -57.3 163.12 3.56 Favored Pre-proline 0 N--CA 1.434 -1.265 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.406 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 68.8 Cg_exo -49.31 -45.2 31.16 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.074 3.183 . . . . 0.0 114.129 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -84.03 -3.88 88.81 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.021 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 51.0 m-85 -107.7 154.07 22.01 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.6 0.714 . . . . 0.0 112.101 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 602' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 26.2 m -106.26 130.84 54.04 Favored 'General case' 0 N--CA 1.403 -2.809 0 CA-C-N 114.108 -1.406 . . . . 0.0 108.928 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' A' ' 596' ' ' SER . 6.9 tt -80.17 122.68 35.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 92.2 t -119.62 113.88 42.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.173 0.511 . . . . 0.0 109.922 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 131.39 -164.69 23.4 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.06 112.71 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.713 2.275 . . . . 0.0 111.32 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -79.58 -40.53 29.19 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.126 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.401 ' HB2' ' CG2' ' A' ' 592' ' ' VAL . 31.3 p -114.23 99.45 7.61 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.661 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 11.3 m -98.98 138.69 22.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.553 ' CG ' ' HE1' ' A' ' 612' ' ' TYR . 0.0 OUTLIER -110.18 153.24 25.03 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.954 -178.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.739 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 42.8 t -67.93 120.29 13.97 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.347 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.553 ' HE1' ' CG ' ' A' ' 610' ' ' GLN . 12.9 m-30 -105.68 167.53 9.7 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -67.79 1.55 2.48 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -123.32 -0.26 8.82 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.943 0.402 . . . . 0.0 111.325 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.71 173.7 13.38 Favored Glycine 0 C--N 1.311 -0.851 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.797 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 611' ' ' CYS . 30.6 mt -63.0 121.59 13.95 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.467 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 50.0 m -145.06 150.31 45.14 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' A' ' 617' ' ' SER . 42.5 Cg_endo -70.06 -164.28 2.58 Favored 'Cis proline' 0 CA--C 1.551 1.36 0 C-N-CA 124.615 -0.994 . . . . 0.0 114.599 0.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.16 165.88 24.19 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 122.118 -0.364 . . . . 0.0 111.081 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.67 139.5 66.94 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . 0.503 ' HG3' HD12 ' A' ' 603' ' ' ILE . 73.7 Cg_endo -71.29 167.2 26.91 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 124.157 3.238 . . . . 0.0 112.372 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 46.7 pt -107.84 174.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.44 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 578' ' ' LEU . 88.5 m -116.67 123.27 46.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.156 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . 0.537 ' O ' ' HB ' ' A' ' 602' ' ' THR . 9.0 mmmm -118.81 108.6 15.04 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.207 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.442 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 2.8 tm-20 -73.42 -38.61 65.51 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -100.48 87.03 3.28 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.43 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 7.5 p -95.43 158.68 2.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.079 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -88.33 156.69 19.03 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.962 0.411 . . . . 0.0 110.883 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.559 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 15.0 p -90.58 -12.36 37.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.014 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . 0.509 ' SG ' ' HA2' ' A' ' 676' ' ' GLY . 13.8 m 70.54 7.82 6.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.757 0.823 . . . . 0.0 112.438 172.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 55.64 -140.18 41.17 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.495 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -82.5 151.56 15.25 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 122.435 2.09 . . . . 0.0 110.2 171.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.626 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 96.3 Cg_endo -78.81 172.42 15.07 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 123.129 2.552 . . . . 0.0 111.525 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.08 -162.95 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.438 2.092 . . . . 0.0 112.132 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -113.89 150.02 34.27 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.705 HD23 ' SG ' ' A' ' 659' ' ' CYS . 15.1 tp -78.72 159.54 27.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 683' ' ' VAL 0.433 0.4 OUTLIER -73.45 -48.07 36.51 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 176.943 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.708 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 22.0 m120 -123.08 36.65 4.6 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.462 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.641 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -163.49 -141.28 3.08 Favored Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -165.26 -170.46 1.89 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.23 127.84 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -83.7 -26.06 30.11 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.55 0.69 . . . . 0.0 109.334 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -74.74 171.43 13.94 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -89.38 130.67 35.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 16.2 p -82.35 104.05 12.37 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.613 0.72 . . . . 0.0 112.119 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.543 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 47.0 pttt -89.94 153.88 20.27 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.34 34.76 1.39 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 121.947 0.88 . . . . 0.0 110.729 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -169.49 92.93 0.26 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.494 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.626 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 11.0 m-85 -85.77 -73.76 0.44 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 121.13 167.28 13.22 Favored Glycine 0 C--N 1.291 -1.945 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -177.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.422 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 75.1 t60 -72.0 136.49 46.75 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.799 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 62.7 m 71.32 10.84 6.71 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.516 0.727 . . . . 0.0 112.438 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.42 118.0 27.74 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 174.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.3 p -91.67 154.46 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.713 0 CA-C-O 122.5 1.143 . . . . 0.0 111.26 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.8 t -117.48 101.24 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.995 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.552 ' HG3' ' HG2' ' A' ' 670' ' ' LYS . 5.8 tt0 -77.09 120.42 22.16 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 60.4 m-85 -99.05 167.31 10.8 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.179 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.471 ' O ' ' HA3' ' A' ' 639' ' ' GLY . 5.5 p90 -145.08 143.9 30.67 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 173.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.705 ' SG ' HD23 ' A' ' 636' ' ' LEU . 59.5 m -103.55 170.28 8.04 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 662' ' ' ARG . 61.6 m-80 -64.06 152.42 87.72 Favored Pre-proline 0 C--N 1.317 -0.829 0 O-C-N 123.125 0.266 . . . . 0.0 110.715 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.19 40.11 0.43 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 124.828 3.685 . . . . 0.0 113.393 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.414 ' H ' ' C ' ' A' ' 660' ' ' ASN . 7.6 ptt85 -150.0 10.72 0.71 Allowed 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.537 -178.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.96 158.17 45.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.921 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 90.0 mt -100.93 157.29 16.85 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.59 ' HE1' ' SG ' ' A' ' 659' ' ' CYS . 3.5 ttt -114.83 102.44 9.99 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 685' ' ' ILE . 37.6 ttpt -69.9 -53.22 18.93 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.309 -0.859 . . . . 0.0 113.103 -170.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.42 -170.3 31.79 Favored Glycine 0 C--N 1.293 -1.819 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.036 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.73 122.08 11.1 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.979 3.12 . . . . 0.0 110.858 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.789 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 7.9 p-10 -68.46 -20.0 64.6 Favored 'General case' 0 CA--C 1.469 -2.169 0 CA-C-O 121.533 0.682 . . . . 0.0 111.066 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.552 ' HG2' ' HG3' ' A' ' 656' ' ' GLU . 3.4 mtpt -111.71 157.29 20.67 Favored 'General case' 0 C--N 1.253 -3.615 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -173.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.529 HD13 ' HB3' ' A' ' 678' ' ' TRP . 48.1 pt -139.75 125.43 21.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.499 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -106.44 144.25 33.39 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 28.7 t -81.61 128.95 34.47 Favored 'General case' 0 CA--C 1.465 -2.314 0 CA-C-O 123.142 1.449 . . . . 0.0 111.835 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.4 t -105.33 107.3 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.807 0 CA-C-N 111.263 -2.699 . . . . 0.0 107.655 -175.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.551 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 26.6 t70 55.6 -75.15 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.008 1.723 . . . . 0.0 112.98 -169.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . 0.509 ' HA2' ' SG ' ' A' ' 630' ' ' CYS . . . -149.15 18.54 1.19 Allowed Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -129.61 139.26 51.49 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.529 ' HB3' HD13 ' A' ' 671' ' ' ILE . 92.0 m95 -85.71 164.73 17.46 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.472 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 6.3 p -82.43 -178.54 7.09 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.05 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 44.2 m -71.68 135.81 47.01 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.254 0.55 . . . . 0.0 110.731 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 636' ' ' LEU . 47.5 mt -66.08 153.07 92.71 Favored Pre-proline 0 N--CA 1.425 -1.699 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.237 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.789 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 12.3 Cg_endo -55.49 -20.17 25.62 Favored 'Trans proline' 0 N--CA 1.482 0.802 0 C-N-CA 124.637 3.558 . . . . 0.0 115.972 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.489 ' HA ' HD12 ' A' ' 637' ' ' LEU 0.302 16.4 m 46.11 98.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 N-CA-C 115.664 1.728 . . . . 0.0 115.664 177.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 1.7 m -83.28 147.96 27.66 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.975 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -138.49 146.97 25.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.243 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 32.0 t -58.56 134.77 23.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 123.828 0.705 . . . . 0.0 109.87 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . 0.477 ' HG2' ' HG ' ' A' ' 664' ' ' LEU . 45.0 mt-10 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.21 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 . . . . . 0 N--CA 1.428 -1.531 0 CA-C-O 121.149 0.499 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.633 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 2.6 m -63.72 -55.78 20.64 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 124.786 1.234 . . . . 0.0 111.734 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 61.41 -168.62 0.18 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.064 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.803 HD13 ' HH ' ' A' ' 587' ' ' TYR . 3.5 tt -118.61 118.96 33.17 Favored Pre-proline 0 C--N 1.28 -2.447 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.512 ' HD2' HD13 ' A' ' 616' ' ' LEU . 90.3 Cg_endo -75.41 -165.71 0.31 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.466 2.777 . . . . 0.0 112.335 -177.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . 0.406 ' HZ2' ' HB2' ' A' ' 573' ' ' LYS . 0.1 OUTLIER -82.23 108.05 15.38 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.196 0.522 . . . . 0.0 110.382 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.572 HD11 ' HD3' ' A' ' 580' ' ' PRO . 36.2 pt -78.14 -167.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.319 175.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 10.2 t70 -81.54 162.09 23.32 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.09 -22.58 18.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.473 0.654 . . . . 0.0 110.516 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -106.63 11.83 30.0 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 121.768 -0.582 . . . . 0.0 110.98 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.5 tm? -99.13 153.48 18.86 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.91 113.33 3.38 Favored Pre-proline 0 C--N 1.288 -2.079 0 C-N-CA 124.184 0.994 . . . . 0.0 108.454 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.572 ' HD3' HD11 ' A' ' 574' ' ' ILE . 59.1 Cg_endo -73.82 146.14 37.46 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.509 2.139 . . . . 0.0 112.43 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -77.38 -36.78 53.22 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -79.63 132.55 36.28 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 171.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -143.51 89.94 2.12 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.69 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -137.71 170.21 16.46 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -77.41 -56.8 4.24 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.64 126.43 50.22 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.925 0.393 . . . . 0.0 110.725 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.803 ' HH ' HD13 ' A' ' 571' ' ' LEU . 19.3 m-85 -90.35 155.53 18.9 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.814 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -93.7 147.41 23.05 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.618 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 5.6 p -66.45 131.16 32.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.852 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 87.42 -1.95 86.22 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.211 -173.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -69.28 135.58 50.67 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 11.3 m -98.59 138.91 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.556 HD12 ' CD2' ' A' ' 587' ' ' TYR . 7.1 mp -117.16 111.05 18.93 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.229 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.537 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 92.0 mttt -84.74 122.21 28.78 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 68.7 m-85 -108.08 172.2 6.97 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 596' ' ' SER . . . . . 0.508 ' HA ' HD13 ' A' ' 603' ' ' ILE . 14.2 p -171.21 177.41 3.62 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 76.8 m -110.97 177.79 4.55 Favored 'General case' 0 C--N 1.26 -3.293 0 O-C-N 123.739 0.649 . . . . 0.0 110.712 -176.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.508 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 71.6 mmtt -53.48 160.83 1.7 Allowed Pre-proline 0 N--CA 1.438 -1.034 0 C-N-CA 124.463 1.105 . . . . 0.0 112.564 176.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 51.4 Cg_exo -52.05 -28.11 31.36 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 124.414 3.409 . . . . 0.0 114.575 -175.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -99.61 -4.31 55.98 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.883 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -106.51 159.13 16.4 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 122.328 1.061 . . . . 0.0 113.414 -174.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 6.2 m -109.25 129.57 55.5 Favored 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.861 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.509 HD12 ' HG3' ' A' ' 621' ' ' PRO . 6.4 tt -81.46 119.14 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.363 174.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . 0.434 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 62.0 t -109.97 127.51 66.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.06 -159.66 14.14 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.8 115.33 3.71 Favored 'Trans proline' 0 C--N 1.333 -0.278 0 C-N-CA 122.958 2.439 . . . . 0.0 110.69 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 7.5 m120 -84.3 -26.29 28.65 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.355 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.537 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 27.1 p -127.09 95.59 4.34 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.532 0.682 . . . . 0.0 111.087 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 21.5 m -89.42 169.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.485 -0.779 . . . . 0.0 108.997 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 12.0 mm-40 -114.72 163.8 14.97 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.618 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 18.7 t -85.05 131.39 34.46 Favored 'General case' 0 C--N 1.276 -2.608 0 C-N-CA 117.808 -1.557 . . . . 0.0 108.223 165.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.459 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 7.5 m-85 -109.16 163.0 13.74 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 173.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -68.17 -1.68 6.53 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -117.48 4.47 12.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 120.879 0.371 . . . . 0.0 110.333 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 135.69 -177.45 19.46 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.512 HD13 ' HD2' ' A' ' 572' ' ' PRO . 28.4 mt -73.79 133.51 43.26 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.459 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 68.1 m -150.16 154.39 36.41 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.61 -168.78 5.04 Favored 'Cis proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.043 -1.232 . . . . 0.0 113.214 0.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.76 146.69 35.93 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.091 0.472 . . . . 0.0 111.864 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . 0.496 HD22 ' HG2' ' A' ' 572' ' ' PRO . 6.7 mp -65.14 142.26 98.53 Favored Pre-proline 0 C--N 1.302 -1.47 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.889 -175.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . 0.509 ' HG3' HD12 ' A' ' 603' ' ' ILE . 28.1 Cg_endo -63.9 169.01 10.99 Favored 'Trans proline' 0 C--O 1.252 1.182 0 C-N-CA 124.124 3.216 . . . . 0.0 113.667 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . 0.434 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 36.5 pt -114.94 178.91 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.969 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 95.3 m -127.96 124.94 38.52 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.023 0.44 . . . . 0.0 111.267 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -124.41 130.33 52.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -88.54 -37.87 15.37 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -99.82 101.25 12.34 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.803 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 2.7 m -102.03 178.39 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.088 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . 0.546 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 76.2 mt-30 -94.55 170.64 9.33 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.524 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 41.6 m -102.93 -8.15 20.92 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.039 0.447 . . . . 0.0 110.649 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 81.7 m 67.36 5.78 4.47 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 54.2 -137.22 41.58 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 123.474 0.484 . . . . 0.0 112.947 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.58 147.01 17.36 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.649 2.233 . . . . 0.0 112.055 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.32 156.51 65.9 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.118 2.545 . . . . 0.0 112.591 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.49 ' HG2' HD12 ' A' ' 681' ' ' LEU . 38.3 Cg_endo -69.24 175.36 7.77 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 123.324 2.683 . . . . 0.0 112.522 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.86 145.71 26.48 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 657' ' ' TYR . 14.5 tp -80.59 178.33 8.42 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 637' ' ' LEU . 2.4 mp -84.58 -73.03 0.44 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.821 0.819 . . . . 0.0 108.841 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -108.02 32.71 4.56 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -156.29 -156.79 7.99 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.798 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.08 -172.72 4.21 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 123.685 0.794 . . . . 0.0 109.976 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 53.5 t -93.69 137.87 21.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.647 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 20.1 ptmt -87.22 -22.63 25.12 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.088 0.47 . . . . 0.0 110.904 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.22 146.92 28.31 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -67.75 122.39 18.0 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 22.4 p -73.69 98.09 2.82 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.228 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -83.81 165.33 18.9 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.5 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.4 6.82 35.59 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -171.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -156.24 105.9 2.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -96.19 -82.25 0.4 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 130.77 159.62 9.68 Favored Glycine 0 C--N 1.311 -0.84 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.887 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.829 ' HD1' ' HA ' ' A' ' 674' ' ' VAL . 80.6 t60 -77.14 86.43 3.61 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 652' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 651' ' ' HIS . 22.9 t 155.08 -31.19 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 126.941 2.097 . . . . 0.0 106.101 173.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -68.05 118.24 10.95 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.911 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.1 p -94.74 163.39 2.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.739 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 16.6 m -128.82 115.58 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.442 175.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.647 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 14.7 mt-10 -73.26 126.12 29.37 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.56 0.695 . . . . 0.0 111.111 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.535 ' HB3' HD21 ' A' ' 636' ' ' LEU . 81.4 m-85 -102.12 164.74 11.53 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.022 176.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -148.67 135.63 19.97 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 50.4 m -99.09 165.75 11.58 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.428 172.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.459 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 50.1 m-80 -58.3 155.01 28.98 Favored Pre-proline 0 C--O 1.248 1.021 0 O-C-N 123.677 0.611 . . . . 0.0 109.904 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 59.8 Cg_endo -68.03 24.76 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 124.113 3.209 . . . . 0.0 115.529 -172.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.458 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 24.8 mmm180 -118.11 -4.26 11.02 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 662' ' ' ARG . 51.0 m-85 -128.95 159.76 34.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.723 -170.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.491 HD12 ' HG3' ' A' ' 687' ' ' GLU . 81.8 mt -124.38 153.78 41.36 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 125.145 1.378 . . . . 0.0 107.442 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.543 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -84.27 147.17 27.38 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.125 0.488 . . . . 0.0 111.2 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -95.09 -59.44 1.9 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.214 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.5 -158.11 29.76 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.575 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.78 123.64 10.96 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.978 2.452 . . . . 0.0 111.655 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -64.04 -17.38 63.31 Favored 'General case' 0 C--O 1.207 -1.17 0 C-N-CA 122.902 0.481 . . . . 0.0 111.744 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 1.4 mtpt -122.28 154.4 37.62 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.568 HD11 HD13 ' A' ' 681' ' ' LEU . 29.9 pt -143.92 142.73 24.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.81 153.08 28.4 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.041 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 3.9 t -68.14 121.06 15.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.015 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . 0.829 ' HA ' ' HD1' ' A' ' 651' ' ' HIS . 35.1 m -113.03 113.26 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.55 0.691 . . . . 0.0 111.559 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.411 ' H ' ' ND1' ' A' ' 651' ' ' HIS . 32.7 t70 64.87 -73.89 0.05 Allowed 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 124.56 1.144 . . . . 0.0 111.375 -175.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . 0.546 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -152.56 16.21 0.74 Allowed Glycine 0 N--CA 1.422 -2.297 0 C-N-CA 120.392 -0.908 . . . . 0.0 112.456 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.01 158.08 44.63 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.516 ' HB3' HD13 ' A' ' 671' ' ' ILE . 96.9 m95 -81.71 177.03 9.14 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 120.892 0.377 . . . . 0.0 110.167 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.98 -179.44 3.95 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.863 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 5.7 m -57.72 120.16 7.9 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.897 0.879 . . . . 0.0 110.915 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 671' ' ' ILE . 4.4 mp -64.15 154.26 83.02 Favored Pre-proline 0 N--CA 1.445 -0.719 0 O-C-N 123.761 0.663 . . . . 0.0 112.592 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.543 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 7.5 Cg_endo -55.04 -50.12 14.26 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.206 2.604 . . . . 0.0 113.516 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 92.8 t 68.97 130.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.505 0.722 . . . . 0.0 110.118 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 7.3 p -125.05 154.89 40.63 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.676 -0.64 . . . . 0.0 112.448 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.481 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.2 OUTLIER -139.04 150.58 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.214 0 C-N-CA 125.317 1.447 . . . . 0.0 108.512 -177.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.24 139.25 17.06 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.911 0 C-N-CA 124.76 1.224 . . . . 0.0 112.472 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . 0.491 ' HG3' HD12 ' A' ' 664' ' ' LEU . 45.8 tt0 . . . . . 0 N--CA 1.438 -1.056 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.153 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.6 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 75.9 m -96.61 150.02 21.13 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.657 0.741 . . . . 0.0 112.685 -174.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -124.25 -4.75 7.86 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.073 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.72 HD13 ' HH ' ' A' ' 587' ' ' TYR . 0.9 OUTLIER 77.97 121.22 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 126.006 1.723 . . . . 0.0 107.438 -178.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.558 ' HD3' HD21 ' A' ' 616' ' ' LEU . 56.8 Cg_endo -69.97 -174.65 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.909 1.74 . . . . 0.0 110.931 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 573' ' ' LYS . 0.3 OUTLIER -89.5 104.23 16.81 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.53 HD13 ' HB3' ' A' ' 578' ' ' LEU . 42.0 pt -76.08 -176.57 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.988 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.293 -177.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.6 t70 -72.97 151.94 41.6 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.72 -35.66 68.88 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.363 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -93.54 8.08 42.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.705 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.8 tp -95.89 149.97 20.96 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.03 117.59 9.09 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-O 121.387 0.613 . . . . 0.0 110.41 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.42 131.19 13.55 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.203 1.935 . . . . 0.0 111.053 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.56 -29.84 71.04 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.286 0.565 . . . . 0.0 111.447 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . 0.43 ' HG3' HD23 ' A' ' 593' ' ' LEU . 4.5 mmp_? -72.8 -70.95 0.32 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 176.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm 60.47 84.58 0.12 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.416 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -142.03 174.34 10.69 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.25 -66.16 0.91 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . 0.412 ' N ' HE21 ' A' ' 586' ' ' GLN . 0.0 OUTLIER -105.34 141.04 37.55 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.72 ' HH ' HD13 ' A' ' 571' ' ' LEU . 67.0 m-85 -115.12 125.63 53.69 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.138 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -71.02 144.04 50.55 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.302 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.604 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 32.6 m -63.4 134.66 28.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.576 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 102.0 -18.62 51.76 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.117 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.95 108.84 3.19 Favored 'General case' 0 C--N 1.346 0.451 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 608' ' ' SER . 3.4 p -92.47 125.09 45.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.721 0.772 . . . . 0.0 110.199 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.436 HD22 ' CD2' ' A' ' 587' ' ' TYR . 11.1 mt -102.88 105.05 15.34 Favored 'General case' 0 N--CA 1.402 -2.856 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.882 -172.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 54.7 mtpt -75.06 112.61 11.47 Favored 'General case' 0 N--CA 1.41 -2.425 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -94.36 174.13 7.29 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-O 121.813 0.816 . . . . 0.0 109.548 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 20.1 t -162.32 -178.83 6.56 Favored 'General case' 0 N--CA 1.391 -3.414 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.549 ' SG ' HD13 ' A' ' 578' ' ' LEU . 92.3 m -118.1 -179.12 3.67 Favored 'General case' 0 C--N 1.257 -3.452 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 65.6 mmtt -51.01 162.58 0.58 Allowed Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 124.773 1.229 . . . . 0.0 111.639 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 79.8 Cg_exo -48.2 -45.82 24.66 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.923 3.082 . . . . 0.0 113.403 -176.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -89.76 5.03 83.73 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.424 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.613 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 35.4 m-85 -109.57 133.93 52.52 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 45.5 m -89.04 127.92 35.71 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.5 175.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.493 HD12 ' HG3' ' A' ' 621' ' ' PRO . 8.9 tt -84.65 132.89 30.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 90.9 t -129.7 135.43 61.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 114.67 -161.25 12.81 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.96 116.31 4.52 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.003 1.802 . . . . 0.0 109.886 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.412 HD21 ' N ' ' A' ' 607' ' ' ASN . 0.7 OUTLIER -83.34 -39.22 21.02 Favored 'General case' 0 C--O 1.206 -1.208 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -176.278 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 8.6 p -112.27 98.0 7.01 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.44 0.638 . . . . 0.0 111.96 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.5 m -99.57 145.6 10.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.609 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -96.46 149.24 21.95 Favored 'General case' 0 CA--C 1.472 -2.024 0 O-C-N 121.866 -0.522 . . . . 0.0 110.415 -177.251 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 45.4 t -73.3 122.28 21.74 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.37 168.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.596 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 75.9 m-85 -110.98 162.7 14.58 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 171.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -65.16 -2.25 2.77 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -115.52 1.54 13.64 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.537 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.4 169.73 12.35 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.202 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.558 HD21 ' HD3' ' A' ' 572' ' ' PRO . 3.3 mm? -66.42 118.95 10.79 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.596 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 17.4 m -131.77 144.36 52.94 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.77 -165.13 2.8 Favored 'Cis proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.885 -1.298 . . . . 0.0 113.139 -0.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.12 172.79 11.75 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.194 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . 0.448 HD12 ' HG2' ' A' ' 572' ' ' PRO . 50.8 mt -69.64 148.43 96.78 Favored Pre-proline 0 C--N 1.297 -1.709 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.333 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . 0.493 ' HG3' HD12 ' A' ' 603' ' ' ILE . 72.9 Cg_endo -75.42 -177.85 3.84 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 124.176 3.251 . . . . 0.0 111.362 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.42 166.44 18.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.012 0.434 . . . . 0.0 110.933 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.417 ' HB3' ' CD2' ' A' ' 601' ' ' PHE . 85.7 m -110.64 116.06 30.67 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.376 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -97.03 -22.17 16.96 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 13.6 tt0 68.4 -70.16 0.14 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.178 0.991 . . . . 0.0 108.951 -174.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -103.88 114.51 28.81 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.66 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 7.7 p -111.45 175.25 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . 0.404 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 48.9 mt-30 -84.21 166.64 17.38 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 119.778 1.172 . . . . 0.0 109.311 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.553 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 5.2 p -106.54 -16.95 14.39 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.157 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 71.8 m 70.0 8.55 6.74 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.314 1.046 . . . . 0.0 112.799 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 54.02 -143.84 28.74 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 123.694 0.621 . . . . 0.0 113.093 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.5 148.59 42.87 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.515 2.143 . . . . 0.0 111.215 173.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.544 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 88.1 Cg_endo -82.67 165.1 15.98 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 123.047 2.498 . . . . 0.0 112.442 -178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.16 178.69 4.56 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.952 2.435 . . . . 0.0 111.426 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.92 163.83 12.04 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.611 HD22 ' SG ' ' A' ' 659' ' ' CYS . 17.5 tp -92.52 134.07 35.32 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 636' ' ' LEU . 0.4 OUTLIER -44.54 -61.13 1.66 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.575 1.15 . . . . 0.0 111.349 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 43.7 m-80 -122.63 31.19 6.18 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-O 121.316 0.579 . . . . 0.0 110.819 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.551 ' C ' ' HB3' ' A' ' 636' ' ' LEU . . . -150.48 -158.28 8.17 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 174.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.43 175.07 14.03 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 117.496 0.648 . . . . 0.0 109.87 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 64.3 t -84.44 128.94 38.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.778 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.5 ptmt -84.81 -20.4 30.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.034 0.921 . . . . 0.0 109.643 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.415 ' HG2' ' HG3' ' A' ' 642' ' ' LYS . 48.0 mm-40 -91.25 163.49 14.22 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.806 -177.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -73.9 125.71 28.81 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.182 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.419 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 16.0 p -81.72 114.63 20.5 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-O 121.857 0.837 . . . . 0.0 111.455 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 49.9 mtmt -85.09 161.23 19.77 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -99.67 9.56 42.91 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.065 0.936 . . . . 0.0 109.586 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -157.47 96.97 1.58 Allowed 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 113.956 -1.475 . . . . 0.0 107.696 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.544 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 14.4 m-85 -86.63 -76.77 0.34 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.838 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 115.44 169.01 15.65 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.236 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.617 ' HD1' ' HA ' ' A' ' 674' ' ' VAL . 75.8 t60 -71.33 148.05 47.45 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.311 10.4 p 65.78 2.73 2.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.057 1.343 . . . . 0.0 113.831 -174.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -93.84 112.95 24.88 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 2.5 p -99.16 159.67 3.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-O 121.576 0.703 . . . . 0.0 109.552 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.0 t -121.01 106.97 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.67 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.348 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.778 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 18.4 mt-10 -68.67 124.84 24.74 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.461 0.648 . . . . 0.0 110.457 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.526 ' HB3' HD23 ' A' ' 636' ' ' LEU . 68.2 m-85 -108.92 172.03 7.09 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -150.07 140.72 22.59 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.611 ' SG ' HD22 ' A' ' 636' ' ' LEU . 80.7 m -100.01 163.84 12.26 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.458 ' C ' ' H ' ' A' ' 662' ' ' ARG . 47.4 m-80 -65.3 157.39 77.77 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.401 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 74.2 Cg_endo -71.84 15.6 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 123.931 3.087 . . . . 0.0 113.466 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.458 ' H ' ' C ' ' A' ' 660' ' ' ASN . 10.6 mtp180 -108.34 -3.97 17.85 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -134.15 156.33 48.52 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.289 -173.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.506 HD22 ' HG3' ' A' ' 687' ' ' GLU . 72.1 mt -98.95 165.58 11.69 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 172.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.5 ' HE1' ' SG ' ' A' ' 659' ' ' CYS . 5.5 ttt -119.52 115.14 23.41 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.401 ' HB2' HD13 ' A' ' 685' ' ' ILE . 37.5 ttmt -71.39 -67.85 0.49 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -171.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.76 -161.46 37.49 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 115.551 -0.749 . . . . 0.0 113.18 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.39 123.09 11.81 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.036 2.491 . . . . 0.0 111.133 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -61.48 -16.48 47.59 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 123.263 0.625 . . . . 0.0 111.891 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.586 ' HG2' ' CG ' ' A' ' 656' ' ' GLU . 13.2 mtpt -121.93 153.78 38.02 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 34.9 pt -138.01 144.44 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.455 HE21 ' N ' ' A' ' 672' ' ' GLN . 0.0 OUTLIER -122.55 151.59 41.24 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.268 -176.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 6.8 t -77.3 108.47 10.45 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.042 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . 0.617 ' HA ' ' HD1' ' A' ' 651' ' ' HIS . 35.9 m -102.7 107.9 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.576 0.703 . . . . 0.0 111.569 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.66 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 7.4 t70 68.98 -62.62 0.39 Allowed 'General case' 0 C--O 1.216 -0.67 0 C-N-CA 124.913 1.285 . . . . 0.0 113.057 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -164.12 18.9 0.12 Allowed Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 174.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -138.13 144.04 40.63 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -75.92 158.03 32.5 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 13.5 p -77.52 174.26 11.07 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.964 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.7 m -65.03 131.85 47.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.215 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.526 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 5.0 mp -63.74 150.38 90.97 Favored Pre-proline 0 N--CA 1.435 -1.194 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.138 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.526 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 10.4 Cg_endo -56.22 -43.23 58.13 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 123.573 2.849 . . . . 0.0 113.368 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 81.5 t 66.08 121.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 122.639 1.209 . . . . 0.0 113.341 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.2 m -93.82 145.13 24.82 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.32 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -138.46 145.28 28.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.16 132.98 25.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 O-C-N 123.288 0.367 . . . . 0.0 110.951 -174.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . 0.506 ' HG3' HD22 ' A' ' 664' ' ' LEU . 38.5 tt0 . . . . . 0 C--O 1.249 1.039 0 O-C-N 124.035 0.834 . . . . 0.0 109.914 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 569' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 68.3 m -96.36 121.94 38.7 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.198 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -99.67 140.19 34.23 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 571' ' ' LEU . . . . . 0.811 HD12 ' HG3' ' A' ' 580' ' ' PRO . 3.2 tt -58.21 112.48 4.94 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 572' ' ' PRO . . . . . 0.482 ' HD3' HD21 ' A' ' 616' ' ' LEU . 93.3 Cg_endo -83.94 -158.57 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.527 2.818 . . . . 0.0 112.72 -175.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.8 91.95 6.58 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 574' ' ' ILE . . . . . 0.563 HD11 ' HD3' ' A' ' 580' ' ' PRO . 6.5 pt -72.47 -88.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.827 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.631 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 17.6 t70 -160.26 173.37 15.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 173.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.87 -29.36 8.34 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-O 121.29 0.566 . . . . 0.0 109.543 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -98.94 3.57 47.13 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.461 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.9 tm? -96.0 147.42 23.71 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -177.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . 0.409 ' HA ' ' HD2' ' A' ' 580' ' ' PRO . 6.1 t -139.55 121.21 9.85 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 580' ' ' PRO . . . . . 0.811 ' HG3' HD12 ' A' ' 571' ' ' LEU . 60.4 Cg_endo -73.86 140.89 29.52 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.369 2.046 . . . . 0.0 112.173 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.57 -38.33 86.84 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 125.525 1.53 . . . . 0.0 110.687 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -75.97 -66.8 0.74 Allowed 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.63 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . 0.46 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 38.8 ttpt 57.52 78.23 0.24 Allowed 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.01 -178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.417 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 18.1 ptpt -132.87 175.47 9.32 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.304 -1.316 . . . . 0.0 107.773 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -76.86 -57.53 3.8 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.74 142.05 51.13 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 587' ' ' TYR . . . . . 0.544 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 94.8 m-85 -112.12 126.7 55.47 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -70.21 142.4 52.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.672 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 2.1 p -60.06 116.0 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-O 121.951 0.881 . . . . 0.0 111.329 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 121.29 -22.21 7.97 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.173 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -58.42 139.8 54.84 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.765 0.426 . . . . 0.0 110.416 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 2.1 m -111.6 136.33 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 593' ' ' LEU . . . . . 0.544 ' HG ' ' CE2' ' A' ' 587' ' ' TYR 0.338 0.0 OUTLIER -130.78 113.54 14.23 Favored 'General case' 0 N--CA 1.396 -3.172 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.228 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 594' ' ' LYS . . . . . 0.599 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 64.9 mttm -76.46 147.91 37.57 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.55 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 595' ' ' PHE . . . . . 0.491 ' HB3' HD13 ' A' ' 578' ' ' LEU . 24.8 m-85 -121.61 166.39 14.3 Favored 'General case' 0 C--N 1.261 -3.277 0 C-N-CA 123.822 0.849 . . . . 0.0 110.1 177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 9.5 t -173.59 154.25 2.47 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 170.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 597' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 73.8 m -88.37 176.59 7.13 Favored 'General case' 0 C--N 1.259 -3.352 0 O-C-N 123.863 0.727 . . . . 0.0 110.636 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 598' ' ' LYS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.5 mmtp -55.37 162.38 2.29 Favored Pre-proline 0 N--CA 1.438 -1.061 0 C-N-CA 123.955 0.902 . . . . 0.0 112.257 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 599' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 91.5 Cg_exo -43.79 -44.09 11.67 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 124.51 3.473 . . . . 0.0 115.119 -175.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -88.93 -10.47 66.63 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.27 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 42.1 m-85 -97.54 155.28 17.03 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.893 0.854 . . . . 0.0 112.37 -176.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 10.7 m -107.76 126.88 53.16 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.808 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.448 ' HA ' ' SG ' ' A' ' 597' ' ' CYS . 5.2 tt -74.09 118.6 19.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.076 172.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . 0.456 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 67.4 t -111.64 110.78 33.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 133.7 -154.69 21.41 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.78 122.47 7.78 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.92 2.413 . . . . 0.0 112.315 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 1.2 t-20 -79.24 -36.46 39.92 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.38 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 608' ' ' SER . . . . . 0.599 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 52.8 p -125.49 100.63 6.56 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.884 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.3 m -98.03 161.13 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 610' ' ' GLN . . . . . 0.517 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 1.9 mp0 -115.87 158.6 22.72 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.672 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 37.3 t -80.95 104.61 11.57 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 118.613 -1.235 . . . . 0.0 107.903 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 612' ' ' TYR . . . . . 0.541 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 4.7 m-85 -87.64 167.87 13.51 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -74.9 0.06 16.93 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.648 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -116.65 7.48 13.57 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 131.06 174.52 13.69 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.972 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.484 ' CD2' ' HB3' ' A' ' 569' ' ' CYS . 2.9 mm? -63.73 109.59 1.76 Allowed 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 617' ' ' SER . . . . . 0.541 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 18.8 m -128.05 148.58 68.02 Favored Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -175.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.03 -171.22 8.71 Favored 'Cis proline' 0 CA--C 1.558 1.687 0 C-N-CA 123.644 -1.398 . . . . 0.0 113.476 1.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -57.96 151.58 18.07 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.895 0.379 . . . . 0.0 111.229 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 620' ' ' LEU . . . . . 0.414 HD22 ' HG2' ' A' ' 572' ' ' PRO . 1.9 mm? -66.87 137.21 94.7 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.629 -173.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.8 170.83 10.74 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.802 3.001 . . . . 0.0 111.943 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 622' ' ' ILE . . . . . 0.456 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 43.1 pt -115.62 179.81 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 86.3 m -123.97 126.96 47.23 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.898 0.38 . . . . 0.0 110.971 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -124.08 121.61 35.65 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 14.0 tt0 -81.1 -28.34 35.24 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -100.77 111.53 23.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.555 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.8 172.89 15.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.099 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 628' ' ' GLN . . . . . 0.506 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 25.8 mt-30 -96.32 164.02 12.83 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 37.8 m -110.79 -1.73 16.47 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.044 0.449 . . . . 0.0 110.139 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 69.7 m 70.77 -38.77 0.43 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.086 1.354 . . . . 0.0 114.435 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 100.68 -143.82 16.43 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -72.81 143.1 36.52 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 121.965 1.777 . . . . 0.0 109.81 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.423 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.4 Cg_endo -74.32 163.12 37.09 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.386 2.057 . . . . 0.0 112.302 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.9 173.29 7.19 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.705 2.27 . . . . 0.0 111.451 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -89.8 162.47 15.49 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 1.594 HD22 ' CD1' ' A' ' 636' ' ' LEU . 16.8 tp -92.54 166.89 12.29 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 177.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 683' ' ' VAL 0.303 2.0 pt? -82.76 -48.04 11.28 Favored 'General case' 0 N--CA 1.41 -2.462 0 C-N-CA 117.947 -1.501 . . . . 0.0 113.298 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.641 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 41.9 m-80 -124.82 34.15 5.06 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.734 0.778 . . . . 0.0 109.897 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.621 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -159.52 -139.78 2.75 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.903 174.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . 0.451 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.8 t-20 -162.47 -171.58 2.83 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 11.8 t -96.11 123.57 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.578 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.6 ptmt -79.34 -23.59 43.33 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.18 0.514 . . . . 0.0 109.91 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -78.96 152.27 31.15 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -79.49 121.53 25.31 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.977 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 33.1 p -68.22 99.05 0.86 Allowed 'General case' 0 N--CA 1.419 -1.977 0 CA-C-O 121.805 0.812 . . . . 0.0 112.617 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 54.6 pttt -89.09 160.79 16.87 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -78.73 -5.96 54.59 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -146.1 104.87 3.86 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.471 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 9.3 m-85 -90.64 -111.24 0.09 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.941 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 168.5 161.06 17.74 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 65.1 t60 -53.76 -57.36 11.16 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 32.9 m -89.98 8.28 33.22 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.927 -174.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -93.58 118.2 31.06 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.672 0.749 . . . . 0.0 110.382 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 4.5 m -89.95 151.66 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.516 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 30.2 m -116.67 104.16 16.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.654 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.578 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 23.5 mt-10 -65.36 124.29 21.87 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 122.218 1.009 . . . . 0.0 111.538 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -102.5 165.64 10.98 Favored 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.431 173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 8.8 p90 -146.81 137.32 23.74 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.643 ' SG ' HD13 ' A' ' 636' ' ' LEU . 61.2 m -97.24 165.86 11.84 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -63.6 150.29 90.69 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.41 0.85 1.99 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 124.13 3.22 . . . . 0.0 114.573 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -98.54 -0.98 42.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -130.26 169.19 15.74 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.308 -173.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 88.5 mt -108.88 161.02 15.52 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.59 ' HE1' ' SG ' ' A' ' 659' ' ' CYS . 4.4 ttt -117.8 113.53 21.94 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -68.3 -64.01 0.95 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -102.85 -158.24 25.48 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 121.122 -0.561 . . . . 0.0 114.116 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.93 121.51 9.62 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.767 2.978 . . . . 0.0 111.603 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.523 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 16.9 p-10 -79.4 -11.8 59.91 Favored 'General case' 0 C--O 1.178 -2.709 0 CA-C-O 120.917 0.389 . . . . 0.0 110.856 -177.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 5.3 ptmt -125.82 112.01 15.53 Favored 'General case' 0 C--N 1.27 -2.874 0 C-N-CA 123.932 0.893 . . . . 0.0 109.51 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 34.4 pt -109.92 151.47 12.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.708 -174.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.19 160.83 21.41 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.565 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 16.9 t -82.39 92.79 7.07 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.491 1.139 . . . . 0.0 111.796 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 83.8 t -80.7 113.93 20.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.667 -1.152 . . . . 0.0 110.151 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 19.7 t70 57.3 -69.52 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.582 1.953 . . . . 0.0 112.593 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -157.67 26.86 0.46 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 111.769 -0.532 . . . . 0.0 111.769 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -145.06 151.13 38.05 Favored 'General case' 0 C--O 1.21 -1.022 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.508 ' HB3' HD13 ' A' ' 671' ' ' ILE . 96.3 m95 -82.64 170.7 14.84 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 679' ' ' THR . . . . . 0.454 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 5.5 p -92.65 -174.52 3.67 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 30.0 m -68.94 131.12 44.57 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.792 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.51 157.51 85.58 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 21.9 Cg_endo -62.8 -21.35 72.99 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 124.346 3.364 . . . . 0.0 115.879 -176.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.52 ' HA ' HD23 ' A' ' 637' ' ' LEU 0.357 22.4 m 49.97 109.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -178.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.5 m -88.0 147.36 25.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.549 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.1 OUTLIER -143.4 151.73 16.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.76 141.63 16.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 C--O 1.255 1.373 0 O-C-N 124.09 0.869 . . . . 0.0 110.625 178.901 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 N--CA 1.446 -0.649 0 CA-C-O 120.691 0.282 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.53 75.18 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . 0.702 ' HB1' ' HG3' ' A' ' 566' ' ' GLU . . . -94.46 7.49 45.37 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.586 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 76.53 15.58 81.41 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.702 ' HG3' ' HB1' ' A' ' 564' ' ' ALA . 0.0 OUTLIER -79.11 99.97 7.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.256 0.55 . . . . 0.0 112.215 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -177.07 -63.1 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . 0.58 ' HG3' ' HB3' ' A' ' 586' ' ' GLN . 0.0 OUTLIER 174.79 -173.26 0.07 Allowed 'General case' 0 C--O 1.244 0.774 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 174.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.566 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 91.5 m -96.39 140.86 30.43 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -126.05 130.26 50.78 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.814 HD12 ' HG3' ' A' ' 580' ' ' PRO . 2.2 tt -53.05 119.27 16.05 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.434 ' HG2' HD22 ' A' ' 620' ' ' LEU . 87.8 Cg_endo -78.72 -157.74 0.08 OUTLIER 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.234 2.623 . . . . 0.0 111.566 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -91.09 107.64 19.34 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.489 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.667 HD11 ' HD3' ' A' ' 580' ' ' PRO . 35.1 pt -79.58 -171.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.477 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.1 t70 -73.74 159.49 32.88 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.17 -31.91 53.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -98.8 6.35 46.94 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.992 -0.443 . . . . 0.0 111.4 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.0 tm? -95.54 150.66 20.08 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.1 m -145.31 118.18 5.33 Favored Pre-proline 0 C--N 1.293 -1.86 0 C-N-CA 125.006 1.322 . . . . 0.0 108.241 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.814 ' HG3' HD12 ' A' ' 571' ' ' LEU . 36.8 Cg_endo -70.23 131.03 19.74 Favored 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 121.255 1.304 . . . . 0.0 110.78 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.15 -34.89 79.07 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 55.0 mmt-85 -88.09 104.83 17.04 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -117.65 97.48 5.88 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.454 ' HG3' ' H ' ' A' ' 585' ' ' ASP 0.288 10.4 ptpt -113.46 -93.39 0.47 Allowed 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.04 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . 0.454 ' H ' ' HG3' ' A' ' 584' ' ' LYS . 5.6 t70 -173.82 -62.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 176.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . 0.58 ' HB3' ' HG3' ' A' ' 568' ' ' GLU . 0.0 OUTLIER -121.14 145.0 48.27 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.963 175.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.763 ' HH ' HD13 ' A' ' 571' ' ' LEU . 23.7 m-85 -114.84 132.57 56.46 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 -171.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 591' ' ' GLU . 33.8 mtmm -90.06 161.11 15.98 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.517 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.41 121.9 16.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.209 0.528 . . . . 0.0 110.309 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 103.29 -0.08 47.16 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.881 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 588' ' ' LYS . 82.0 mm-40 -67.1 122.1 17.05 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 117.756 0.778 . . . . 0.0 109.012 173.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 7.0 m -95.41 117.68 39.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 CA-C-O 122.307 1.051 . . . . 0.0 108.63 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 608' ' ' SER . 17.5 mt -101.85 101.46 11.91 Favored 'General case' 0 C--N 1.274 -2.71 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.059 -174.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 10.3 mtmp? -79.72 113.38 17.83 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.499 ' HB3' HD13 ' A' ' 578' ' ' LEU . 80.4 m-85 -95.91 167.4 11.27 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' SER . . . . . 0.428 ' HA ' HD13 ' A' ' 603' ' ' ILE . 21.4 t -168.18 -179.18 3.95 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 170.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 77.8 m -118.4 177.36 4.85 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 123.68 0.612 . . . . 0.0 112.488 -173.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 30.1 mmtp -50.59 162.36 0.55 Allowed Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 125.372 1.469 . . . . 0.0 112.27 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 76.7 Cg_exo -47.76 -43.47 28.79 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.248 3.299 . . . . 0.0 113.761 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.66 1.64 63.99 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.957 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -105.57 141.01 37.78 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-O 121.961 0.886 . . . . 0.0 112.777 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 9.8 m -102.69 126.84 49.94 Favored 'General case' 0 N--CA 1.393 -3.293 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.338 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.454 HD12 ' HG3' ' A' ' 621' ' ' PRO . 10.8 tt -73.18 123.51 28.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.097 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.14 126.49 70.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.764 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.07 -145.61 18.46 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.41 124.11 4.62 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.773 2.315 . . . . 0.0 110.864 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.26 -42.93 14.21 Favored 'General case' 0 C--O 1.204 -1.313 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.832 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.542 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 18.6 p -114.14 97.86 6.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.14 0.495 . . . . 0.0 111.983 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . 0.404 ' C ' HE21 ' A' ' 610' ' ' GLN . 11.1 m -92.66 163.18 2.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.561 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -113.18 154.1 27.23 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.374 0.607 . . . . 0.0 110.209 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 6.6 t -85.14 108.75 17.84 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.72 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.539 ' CD1' ' HB3' ' A' ' 617' ' ' SER . 55.3 m-85 -91.57 166.79 12.65 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 175.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -7.58 19.55 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -105.97 -10.59 16.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.998 0.427 . . . . 0.0 111.225 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 140.94 -172.49 23.65 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.532 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' A' ' 569' ' ' CYS . 2.8 mm? -79.32 127.82 32.56 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 47.8 t -149.09 147.18 22.99 Favored Pre-proline 0 N--CA 1.429 -1.516 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.33 -175.74 13.4 Favored 'Cis proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.641 -1.4 . . . . 0.0 114.038 1.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -63.26 142.44 58.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.032 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . 0.434 HD22 ' HG2' ' A' ' 572' ' ' PRO . 8.7 mp -57.58 143.6 74.82 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -173.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . 0.454 ' HG3' HD12 ' A' ' 603' ' ' ILE . 38.2 Cg_endo -68.05 -178.53 1.75 Allowed 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 124.748 3.632 . . . . 0.0 113.341 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.1 pt -130.81 -178.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.4 m -129.0 119.5 24.39 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.222 0.534 . . . . 0.0 111.787 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -114.04 126.04 54.67 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.837 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -81.83 -27.05 33.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -123.8 113.63 18.81 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.286 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.23 177.83 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.499 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.434 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 73.0 mt-30 -97.51 167.0 11.25 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.459 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 49.2 m -105.19 -4.92 21.17 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.536 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.1 m 68.15 -31.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 82.31 -139.06 19.32 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -75.9 154.39 38.3 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.449 2.099 . . . . 0.0 111.27 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.552 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 61.7 Cg_endo -92.07 174.12 2.25 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 123.087 2.525 . . . . 0.0 111.532 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.78 -173.72 1.87 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.033 1.822 . . . . 0.0 109.985 172.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.41 159.87 24.22 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.516 ' HB3' ' C ' ' A' ' 639' ' ' GLY . 14.7 tp -70.56 144.8 51.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 638' ' ' ASN . 0.9 OUTLIER -48.96 -71.76 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.585 ' H ' ' HG ' ' A' ' 637' ' ' LEU . 9.5 m120 -94.03 -32.57 13.76 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -85.15 -154.21 21.81 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.497 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . 0.58 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.7 t-20 -152.05 -173.66 4.61 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.8 p -101.72 133.54 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -93.43 -27.34 16.77 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.211 0.529 . . . . 0.0 110.641 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.654 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 38.5 mm-40 -81.56 153.78 26.57 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.245 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -67.12 122.25 17.39 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.257 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.461 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 16.6 p -76.97 110.53 11.67 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.417 0.627 . . . . 0.0 110.242 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.402 ' HZ2' ' HG2' ' A' ' 653' ' ' GLU . 55.2 mtmt -82.32 157.39 23.83 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.186 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.94 -9.29 59.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.724 0.773 . . . . 0.0 109.696 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.629 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 38.4 tt0 -156.1 124.24 5.73 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.552 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 13.9 m-85 -98.44 -63.08 1.16 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 123.471 0.482 . . . . 0.0 111.637 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 112.23 162.04 16.1 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.558 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.3 t60 -63.68 140.56 58.88 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.0 m 75.78 -4.04 2.45 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.417 1.087 . . . . 0.0 113.546 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 649' ' ' TYR . 5.3 tp10 -81.87 120.14 24.82 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.9 m -91.47 159.46 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-O 122.1 0.952 . . . . 0.0 112.564 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.9 t -127.11 102.61 9.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.871 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.654 ' HB2' ' HG2' ' A' ' 643' ' ' GLU . 29.8 mt-10 -67.69 132.66 47.9 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.153 0.978 . . . . 0.0 112.194 175.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 67.9 m-85 -112.7 171.43 7.53 Favored 'General case' 0 C--N 1.28 -2.447 0 C-N-CA 126.372 1.869 . . . . 0.0 109.596 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.58 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 31.4 p90 -151.06 141.9 22.87 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.526 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 7.3 t -105.81 -177.66 3.43 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.746 176.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.429 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 34.6 m-80 -70.35 151.39 95.74 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.409 ' C ' ' HD2' ' A' ' 662' ' ' ARG . 52.7 Cg_endo -68.46 26.24 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 124.31 3.34 . . . . 0.0 114.092 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' A' ' 660' ' ' ASN . 13.3 mmm180 -128.35 5.07 5.72 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 660' ' ' ASN . 44.1 m-85 -123.74 164.84 18.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.309 -172.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.417 HD22 ' OE2' ' A' ' 687' ' ' GLU . 90.3 mt -110.18 143.54 40.15 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.423 1.489 . . . . 0.0 107.31 175.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.9 ttt -114.04 102.52 10.26 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.778 ' HG2' HD12 ' A' ' 685' ' ' ILE . 72.3 mmtt -73.18 -63.22 1.23 Allowed 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.882 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -83.35 -168.52 43.45 Favored Glycine 0 N--CA 1.404 -3.486 0 CA-C-N 114.792 -1.095 . . . . 0.0 113.473 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.0 118.04 5.01 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.108 2.538 . . . . 0.0 112.07 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.574 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 3.7 p-10 -80.34 19.31 0.78 Allowed 'General case' 0 C--O 1.19 -2.028 0 C-N-CA 122.886 0.475 . . . . 0.0 111.426 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.704 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 7.0 ptmt -162.14 111.17 1.46 Allowed 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 124.861 1.264 . . . . 0.0 108.024 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 35.3 pt -107.63 144.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.986 -174.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.528 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -112.67 142.81 44.85 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 123.677 0.611 . . . . 0.0 110.848 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.0 t -67.41 116.89 8.67 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.683 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.558 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 34.1 m -109.18 127.7 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 28.2 t70 54.79 -80.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.538 1.135 . . . . 0.0 112.031 -169.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -157.11 31.67 0.54 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -143.02 156.45 44.84 Favored 'General case' 0 C--O 1.212 -0.88 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.453 ' HB3' HD13 ' A' ' 671' ' ' ILE . 97.7 m95 -93.15 166.1 12.5 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 7.9 p -91.81 -169.72 2.36 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 35.1 m -71.54 126.29 29.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.71 0.29 . . . . 0.0 110.413 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 682' ' ' PRO . 7.0 mp -61.93 160.41 29.32 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.893 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.574 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 24.6 Cg_endo -63.34 -15.33 47.65 Favored 'Trans proline' 0 CA--C 1.498 -1.312 0 C-N-CA 123.663 2.908 . . . . 0.0 115.035 -175.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 22.4 m 43.21 93.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 124.87 1.356 . . . . 0.0 114.411 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 23.3 p -95.75 137.26 35.06 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.662 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.778 HD12 ' HG2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -133.5 147.48 31.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.004 -178.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 98.3 t -52.56 133.27 14.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -172.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.417 ' OE2' HD22 ' A' ' 664' ' ' LEU . 6.9 tp10 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.184 1.394 . . . . 0.0 108.963 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . 0.474 ' HA ' ' CD ' ' A' ' 570' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.242 0.69 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 76.4 11.86 2.71 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.491 1.516 . . . . 0.0 112.954 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . 0.798 ' HB1' ' HB2' ' A' ' 570' ' ' GLU . . . -97.52 105.4 17.54 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -77.78 75.83 1.81 Allowed Glycine 0 C--N 1.306 -1.128 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.836 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 55.48 -165.96 0.11 Allowed 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.094 0.958 . . . . 0.0 112.879 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 613' ' ' HIS . 45.5 mtp180 71.37 -5.23 1.63 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.206 1.402 . . . . 0.0 112.808 176.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -161.66 162.72 30.02 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 74.9 m -98.81 112.72 24.72 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-O 121.876 0.846 . . . . 0.0 112.471 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.798 ' HB2' ' HB1' ' A' ' 564' ' ' ALA . 21.3 tt0 -82.97 -23.58 33.31 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.24 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.537 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 32.3 tp 79.02 105.08 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 113.665 -1.607 . . . . 0.0 108.922 -169.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.658 ' HD2' HD13 ' A' ' 616' ' ' LEU . 24.5 Cg_endo -62.94 -172.6 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.062 2.508 . . . . 0.0 113.429 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.89 20.77 0.45 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -170.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.491 ' CG1' ' H ' ' A' ' 575' ' ' ASP . 26.1 pt 35.19 -94.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 126.523 1.929 . . . . 0.0 115.469 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.634 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 15.7 t70 -165.1 179.74 6.17 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.82 -27.57 4.98 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -103.52 10.17 37.23 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.622 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.7 tp -100.14 164.49 11.95 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.65 122.52 1.94 Allowed Pre-proline 0 C--N 1.308 -1.238 0 C-N-CA 124.044 0.938 . . . . 0.0 108.803 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.2 137.51 21.39 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.123 1.882 . . . . 0.0 112.209 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -78.74 -42.11 29.02 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -90.33 113.56 25.46 Favored 'General case' 0 N--CA 1.392 -3.349 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.558 ' HA ' ' OH ' ' A' ' 587' ' ' TYR . 64.1 tttp -135.24 135.44 40.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.311 0.577 . . . . 0.0 111.641 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.602 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 13.1 ptpt -160.43 -160.31 0.76 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.634 1.174 . . . . 0.0 108.489 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -90.34 -64.46 1.13 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.03 0.443 . . . . 0.0 110.656 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.98 134.3 55.29 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.602 ' CE2' ' HG2' ' A' ' 584' ' ' LYS . 69.3 m-85 -96.39 127.5 42.45 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -84.36 145.33 28.28 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.876 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 1.6 p -55.59 111.36 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 122.17 0.986 . . . . 0.0 112.755 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 115.26 -6.29 21.35 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.862 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -70.23 137.95 51.27 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 4.1 m -104.63 123.89 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-O 122.03 0.919 . . . . 0.0 109.499 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.466 HD12 ' CD2' ' A' ' 587' ' ' TYR . 7.4 mp -107.48 104.79 14.44 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.174 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 28.8 mtpp -82.95 119.33 24.29 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.763 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.45 158.62 16.08 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-O 120.957 0.408 . . . . 0.0 110.684 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 19.6 m -150.59 171.74 16.63 Favored 'General case' 0 N--CA 1.398 -3.044 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.554 ' SG ' HD13 ' A' ' 578' ' ' LEU . 95.3 m -112.87 179.84 3.85 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-O 120.656 0.265 . . . . 0.0 110.333 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 65.1 mmtt -52.23 162.07 0.92 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.302 1.441 . . . . 0.0 112.306 173.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 76.2 Cg_exo -49.45 -41.96 42.61 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.268 3.312 . . . . 0.0 114.283 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 625' ' ' GLU . . . -96.52 1.71 62.21 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.627 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -103.84 147.82 26.85 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.876 0.846 . . . . 0.0 112.892 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 17.8 m -98.83 134.95 40.98 Favored 'General case' 0 C--N 1.272 -2.762 0 CA-C-N 113.728 -1.578 . . . . 0.0 109.104 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.54 HD12 ' HG3' ' A' ' 621' ' ' PRO . 7.6 tt -82.48 115.66 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.831 0.824 . . . . 0.0 109.348 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . 0.422 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 61.9 t -106.72 101.84 13.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.726 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 137.31 -162.38 25.36 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.0 123.44 10.66 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 122.827 2.351 . . . . 0.0 111.963 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.34 -49.46 11.49 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 175.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.4 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 66.5 p -104.31 106.91 17.58 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.58 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.18 161.2 4.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.65 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 22.8 mm-40 -105.08 163.48 12.53 Favored 'General case' 0 CA--C 1.473 -2.003 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.466 ' HA ' HD21 ' A' ' 616' ' ' LEU . 43.4 t -88.01 132.54 34.23 Favored 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 118.646 -1.222 . . . . 0.0 107.78 166.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.65 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 75.2 m-85 -116.61 168.84 9.83 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . 0.485 ' O ' ' HA ' ' A' ' 567' ' ' ARG . 3.5 p80 -67.64 -5.37 15.4 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -111.23 -9.24 14.33 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 122.007 -0.433 . . . . 0.0 110.266 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 138.61 -177.4 20.17 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.658 HD13 ' HD2' ' A' ' 572' ' ' PRO . 94.3 mt -68.57 140.83 55.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 117.037 0.419 . . . . 0.0 109.899 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.428 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 2.5 t -156.31 150.83 20.21 Favored Pre-proline 0 N--CA 1.421 -1.915 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.428 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 59.8 Cg_endo -69.99 -176.64 13.3 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.672 -1.386 . . . . 0.0 112.99 1.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.13 144.98 32.66 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.995 0.426 . . . . 0.0 110.408 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.76 145.56 98.77 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.248 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . 0.54 ' HG3' HD12 ' A' ' 603' ' ' ILE . 72.3 Cg_endo -71.25 170.22 18.82 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 123.452 2.768 . . . . 0.0 112.54 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . 0.422 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 38.8 pt -116.7 -178.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 602' ' ' THR . 73.3 m -126.44 125.8 42.74 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.977 0.418 . . . . 0.0 111.443 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.429 ' O ' ' HB ' ' A' ' 602' ' ' THR . 47.8 mtpt -119.31 140.11 50.83 Favored 'General case' 0 C--O 1.194 -1.862 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 600' ' ' GLY . 1.4 tm-20 -90.67 -43.72 9.96 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -95.76 112.02 23.85 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.471 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 7.4 m -123.21 175.63 5.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.489 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.68 170.15 9.2 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 15.5 m -102.03 -11.11 19.15 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 93.0 m 70.6 8.99 6.79 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 112.376 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 60.58 -144.74 47.72 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -82.38 153.6 16.05 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.481 2.12 . . . . 0.0 110.292 173.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.05 153.53 62.93 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.842 2.362 . . . . 0.0 113.366 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.4 173.99 6.85 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.627 2.884 . . . . 0.0 113.097 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -88.21 153.33 21.32 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 121.173 0.511 . . . . 0.0 110.926 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.557 HD22 ' SG ' ' A' ' 659' ' ' CYS . 23.4 tp -97.04 123.92 40.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 683' ' ' VAL . 0.0 OUTLIER -39.66 -46.8 1.89 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -177.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -137.92 39.99 2.34 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.263 1.03 . . . . 0.0 109.507 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.46 -152.96 6.36 Favored Glycine 0 N--CA 1.397 -3.96 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.67 -176.58 4.35 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 124.087 0.955 . . . . 0.0 108.682 175.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 6.4 p -95.99 130.31 44.85 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.042 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.632 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.5 ptmt -85.25 -27.4 26.05 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.245 0.545 . . . . 0.0 110.255 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 40.2 mm-40 -80.8 143.6 32.72 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.725 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . 0.723 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -52.8 120.76 6.14 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 124.646 1.217 . . . . 0.0 109.39 173.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 4.1 p -101.35 104.96 15.97 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -172.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -85.17 149.55 25.44 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 113.601 -1.636 . . . . 0.0 108.126 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -80.69 16.62 1.34 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -155.48 105.27 2.44 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -90.85 -88.57 0.18 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 143.02 157.08 7.01 Favored Glycine 0 N--CA 1.424 -2.142 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -175.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.407 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 84.6 t60 -67.12 138.72 57.28 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.511 0.196 . . . . 0.0 111.023 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 68.6 m 69.25 5.88 5.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.702 1.201 . . . . 0.0 113.044 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -92.69 117.54 30.1 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.8 m -86.49 159.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.694 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.5 t -129.03 117.54 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.904 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.634 ' HG3' ' HZ3' ' A' ' 670' ' ' LYS . 20.9 mt-10 -73.02 124.38 25.38 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.773 0.797 . . . . 0.0 112.245 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 34.3 m-85 -104.58 172.62 6.69 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.092 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -146.81 137.26 23.71 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.557 ' SG ' HD22 ' A' ' 636' ' ' LEU . 70.9 m -95.43 172.85 7.83 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.429 ' HB2' ' HD1' ' A' ' 663' ' ' PHE . 9.8 m120 -63.73 152.56 86.16 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.85 -4.36 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.411 2.74 . . . . 0.0 112.538 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -96.42 -1.27 47.88 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 124.311 1.044 . . . . 0.0 108.865 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.429 ' HD1' ' HB2' ' A' ' 660' ' ' ASN . 45.4 m-85 -131.75 158.02 42.28 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.103 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 89.1 mt -100.17 158.03 16.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.5 ' HE1' ' SG ' ' A' ' 659' ' ' CYS . 6.2 ttt -124.6 95.08 4.39 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -176.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -86.95 -44.52 11.57 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.351 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -78.65 -179.64 51.5 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.975 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.24 114.85 2.29 Favored 'Trans proline' 0 C--N 1.334 -0.232 0 C-N-CA 123.138 2.558 . . . . 0.0 111.142 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.514 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 17.6 p-10 -73.92 -11.39 60.34 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.731 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 2.3 mtpp -121.3 120.06 34.02 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 33.6 pt -111.12 152.59 13.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.532 -1.267 . . . . 0.0 110.924 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.66 154.05 29.11 Favored 'General case' 0 N--CA 1.425 -1.688 0 O-C-N 123.881 0.738 . . . . 0.0 109.489 -172.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 2.8 t -85.62 122.55 29.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.057 174.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.407 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 77.9 t -114.42 114.68 47.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.211 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.7 t70 55.16 -78.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.25 1.42 . . . . 0.0 111.765 -171.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -149.1 18.2 1.2 Allowed Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -130.07 150.84 51.16 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.532 ' HB3' HD13 ' A' ' 671' ' ' ILE . 95.8 m95 -87.86 162.96 16.66 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 19.2 p -81.68 -178.15 6.85 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 27.3 m -64.39 130.85 45.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.462 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.0 mp -68.56 162.37 63.11 Favored Pre-proline 0 N--CA 1.446 -0.669 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.514 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 31.6 Cg_endo -67.76 -16.06 45.44 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.808 3.005 . . . . 0.0 114.721 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.492 ' HA ' HD12 ' A' ' 637' ' ' LEU 0.304 13.2 m 44.25 92.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 175.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 3.6 m -67.19 139.6 57.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.329 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.17 148.11 33.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.593 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 44.8 t -65.36 135.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 O-C-N 123.39 0.431 . . . . 0.0 110.731 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.25 1.108 0 O-C-N 123.848 0.718 . . . . 0.0 109.856 179.23 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -96.59 -51.16 4.43 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.394 0.616 . . . . 0.0 109.391 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -136.5 142.8 43.53 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.36 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -80.62 90.76 1.36 Allowed Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.19 -39.29 15.62 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -111.93 23.26 13.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.512 1.149 . . . . 0.0 108.098 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 569' ' ' CYS . 3.9 tp10 -142.06 -161.93 1.32 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 102.039 -3.319 . . . . 0.0 102.039 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.518 ' HB3' ' CD1' ' A' ' 616' ' ' LEU . 87.4 m -138.81 161.16 37.94 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 119.518 1.054 . . . . 0.0 112.669 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -138.34 117.9 13.0 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 104.538 -2.394 . . . . 0.0 104.538 168.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.651 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 2.0 tt -34.57 121.8 0.55 Allowed Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 125.37 1.468 . . . . 0.0 109.56 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.588 ' HD2' HD23 ' A' ' 616' ' ' LEU . 70.6 Cg_endo -69.58 -169.9 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.36 2.04 . . . . 0.0 111.549 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -87.63 101.36 13.58 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.439 -0.905 . . . . 0.0 109.602 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . . . . . . . . . 38.9 pt -67.42 -172.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.987 0 CA-C-O 121.759 0.79 . . . . 0.0 110.674 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 6.4 t70 -66.34 -175.15 0.33 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.046 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.92 -27.3 4.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 O-C-N 121.407 -0.808 . . . . 0.0 109.358 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -109.58 9.94 25.11 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 122.124 -0.36 . . . . 0.0 111.868 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.6 tm? -89.99 151.37 21.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.88 117.16 3.89 Favored Pre-proline 0 C--N 1.294 -1.845 0 C-N-CA 123.907 0.883 . . . . 0.0 109.303 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.61 ' HG3' HD12 ' A' ' 571' ' ' LEU . 64.8 Cg_endo -75.16 148.9 35.31 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.643 2.229 . . . . 0.0 112.909 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.74 -55.99 8.4 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -75.1 108.77 8.06 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.91 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -120.81 97.72 5.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.8 ptpt -133.44 167.43 20.46 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.118 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.28 -67.18 0.44 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 124.052 0.845 . . . . 0.0 110.992 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 144.13 49.04 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.651 ' CE1' ' HB2' ' A' ' 571' ' ' LEU . 45.2 m-85 -103.69 132.47 49.91 Favored 'General case' 0 CA--C 1.467 -2.247 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.843 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . 0.42 ' HA ' ' OE2' ' A' ' 568' ' ' GLU . 19.4 mtpp -81.24 147.36 29.99 Favored 'General case' 0 C--N 1.273 -2.747 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.521 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.72 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 46.6 t -59.44 112.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.178 0.513 . . . . 0.0 110.23 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 113.08 -6.01 25.39 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.416 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.97 135.63 47.99 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 3.8 m -106.33 134.12 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 C-N-CA 119.77 -0.772 . . . . 0.0 108.974 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 608' ' ' SER . 5.4 mp -113.8 103.69 11.45 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.552 ' HG2' ' HB2' ' A' ' 608' ' ' SER . 84.3 mttt -78.6 103.31 8.46 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.509 ' HB3' HD13 ' A' ' 578' ' ' LEU . 44.3 m-85 -86.69 162.94 17.64 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.757 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' SER . . . . . 0.576 ' HA ' HD13 ' A' ' 603' ' ' ILE . 66.5 m -164.18 -175.35 3.94 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 169.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 603' ' ' ILE . 98.0 m -113.02 171.13 7.72 Favored 'General case' 0 C--N 1.259 -3.359 0 O-C-N 123.563 0.54 . . . . 0.0 110.968 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.609 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 29.3 mmtp -56.94 162.21 3.98 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.873 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 44.3 Cg_exo -39.09 -41.37 1.89 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 125.104 3.869 . . . . 0.0 116.644 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -98.42 6.06 60.99 Favored Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.643 -0.789 . . . . 0.0 114.283 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 56.7 m-85 -109.92 150.65 28.14 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 51.9 m -98.29 125.46 43.4 Favored 'General case' 0 N--CA 1.406 -2.675 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.92 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.576 HD13 ' HA ' ' A' ' 596' ' ' SER . 8.0 tt -76.02 128.24 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . 0.508 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 84.4 t -119.21 105.12 16.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.264 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 134.39 -168.81 23.31 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.697 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.86 116.58 3.54 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 123.519 2.812 . . . . 0.0 110.347 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -81.92 -43.56 17.95 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.624 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.552 ' HB2' ' HG2' ' A' ' 594' ' ' LYS . 15.0 t -111.79 89.76 3.15 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 119.216 -0.993 . . . . 0.0 112.536 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 18.0 m -80.2 165.89 2.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.57 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -109.9 154.54 22.93 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.551 0.691 . . . . 0.0 109.664 177.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.72 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 0.0 OUTLIER -86.41 131.66 34.14 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.132 167.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.452 ' CD1' ' HB3' ' A' ' 617' ' ' SER . 86.2 m-85 -117.62 173.71 6.57 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -72.45 -5.0 33.63 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.36 -0.837 . . . . 0.0 113.091 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -108.02 -3.06 19.1 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.436 0.636 . . . . 0.0 110.417 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 130.31 -171.42 20.6 Favored Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.588 HD23 ' HD2' ' A' ' 572' ' ' PRO . 8.2 mp -82.13 141.69 32.88 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 46.3 t -159.7 153.02 18.57 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.479 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 78.8 Cg_endo -76.45 -167.6 6.03 Favored 'Cis proline' 0 N--CA 1.481 0.788 0 C-N-CA 124.047 -1.23 . . . . 0.0 113.317 1.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -50.16 144.01 7.63 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.442 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . 0.457 HD22 ' HG2' ' A' ' 572' ' ' PRO . 7.7 mp -78.99 148.72 72.4 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.177 -173.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . 0.447 ' HG2' HD22 ' A' ' 578' ' ' LEU . 36.3 Cg_endo -67.35 168.56 17.52 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 124.093 3.195 . . . . 0.0 112.952 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . 0.508 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 45.6 pt -116.25 -179.66 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 78.5 m -124.6 123.13 39.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.969 0.414 . . . . 0.0 111.632 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.43 ' O ' ' HB ' ' A' ' 602' ' ' THR . 6.4 mmmm -115.92 121.97 43.9 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.508 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 1.6 tm-20 -88.96 -36.72 15.71 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -93.23 78.65 4.51 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 11.8 p -88.07 154.99 3.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.265 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.413 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 78.0 mt-30 -84.71 167.4 16.19 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.501 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 21.5 m -108.19 -8.95 15.62 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.3 m 70.15 -55.36 0.61 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.337 1.055 . . . . 0.0 111.903 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 109.14 -143.71 16.4 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.23 132.84 28.79 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.685 1.59 . . . . 0.0 111.423 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.29 164.97 32.06 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 123.505 2.803 . . . . 0.0 112.77 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.08 177.74 4.14 Favored 'Trans proline' 0 C--O 1.254 1.29 0 C-N-CA 122.773 2.315 . . . . 0.0 111.314 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -95.24 165.24 12.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.536 HD21 ' HA3' ' A' ' 639' ' ' GLY . 19.3 tp -91.46 156.46 17.7 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -53.2 -64.27 0.88 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.59 0.632 . . . . 0.0 112.49 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.45 -23.92 11.65 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.384 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -94.67 -152.75 29.68 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.727 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.52 -164.92 1.94 Allowed 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.4 p -104.73 136.18 39.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -94.62 -21.14 19.01 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.299 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 23.9 mm-40 -81.67 154.59 26.02 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -70.3 113.53 7.56 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 1.5 p -70.75 99.89 1.79 Allowed 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.777 0.799 . . . . 0.0 111.837 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -82.85 169.72 15.78 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.166 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.21 -26.41 33.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.049 0.452 . . . . 0.0 111.207 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -128.55 113.61 15.68 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.408 ' HD2' ' CG ' ' A' ' 653' ' ' GLU . 8.2 m-85 -92.3 -93.12 0.15 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 140.04 164.94 10.1 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.136 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.679 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 69.7 t60 -55.67 -58.62 7.04 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 15.1 m -90.43 15.31 10.91 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-O 121.289 0.566 . . . . 0.0 111.22 -173.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.408 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 4.7 tp10 -97.12 117.49 31.43 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 5.9 m -93.96 151.34 3.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.754 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 29.3 m -114.34 102.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.55 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.52 ' CG ' ' HD2' ' A' ' 670' ' ' LYS . 12.1 mt-10 -66.21 121.78 15.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.942 0.877 . . . . 0.0 112.242 176.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 69.4 m-85 -100.06 168.61 9.73 Favored 'General case' 0 C--N 1.271 -2.836 0 C-N-CA 125.28 1.432 . . . . 0.0 109.441 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -152.61 141.7 21.33 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 7.5 t -106.49 -171.19 1.85 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.58 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.479 ' C ' ' H ' ' A' ' 662' ' ' ARG . 39.6 m-80 -77.77 156.39 80.25 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.37 6.16 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 123.797 2.998 . . . . 0.0 113.388 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.479 ' H ' ' C ' ' A' ' 660' ' ' ASN . 32.2 mmt180 -105.7 -0.26 25.67 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.254 -176.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -128.27 158.36 38.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.568 0.699 . . . . 0.0 112.322 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.43 133.39 46.13 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 113.749 -1.569 . . . . 0.0 107.511 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.2 ttt -104.0 109.55 21.37 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -92.9 -49.19 6.16 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -86.23 -171.04 47.56 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.36 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.12 119.12 6.11 Favored 'Trans proline' 0 CA--C 1.526 0.108 0 C-N-CA 123.093 2.529 . . . . 0.0 111.13 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.603 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 23.2 p-10 -81.47 0.28 38.46 Favored 'General case' 0 C--O 1.178 -2.666 0 O-C-N 121.996 -0.44 . . . . 0.0 111.33 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 3.8 ptmt -134.74 110.28 9.13 Favored 'General case' 0 C--N 1.267 -3.0 0 CA-C-O 121.801 0.81 . . . . 0.0 109.704 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 46.5 pt -110.25 151.32 12.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.649 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 651' ' ' HIS . 0.6 OUTLIER -113.73 156.8 23.13 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.541 0.526 . . . . 0.0 111.458 -179.146 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 13.6 t -81.73 99.63 9.05 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.885 0.85 . . . . 0.0 110.624 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.493 ' HA ' ' HD1' ' A' ' 651' ' ' HIS . 36.0 m -90.72 111.66 23.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.975 -1.078 . . . . 0.0 111.878 -177.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 13.1 t70 71.13 -59.5 0.54 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.707 1.203 . . . . 0.0 112.639 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -172.77 22.71 0.07 OUTLIER Glycine 0 C--N 1.295 -1.703 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -142.47 152.0 42.28 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.498 ' HB3' HD13 ' A' ' 671' ' ' ILE . 96.4 m95 -81.12 173.0 12.98 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.558 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 679' ' ' THR . . . . . 0.453 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 0.5 OUTLIER -96.59 -179.92 4.77 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.067 -179.111 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 27.5 m -69.39 126.17 28.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.725 0.298 . . . . 0.0 110.868 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.18 155.94 42.32 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.603 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 10.3 Cg_endo -57.41 -39.67 87.43 Favored 'Trans proline' 0 CA--C 1.5 -1.198 0 C-N-CA 124.434 3.423 . . . . 0.0 115.527 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.275 3.9 m 64.42 122.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.09 0 C-N-CA 125.37 1.468 . . . . 0.0 112.202 -171.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 21.8 p -119.94 129.17 54.2 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.718 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.76 147.84 22.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.353 -174.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.81 128.71 17.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 123.977 0.798 . . . . 0.0 111.1 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 C--N 1.305 -1.369 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.173 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 . . . . . 0 CA--C 1.511 -0.534 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -99.67 85.98 3.23 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -158.09 -171.62 3.58 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.929 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 135.7 -29.56 2.86 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -129.46 124.41 33.97 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . 0.414 ' HA ' ' HE ' ' A' ' 567' ' ' ARG . 2.6 mmp_? -113.66 -105.21 0.39 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 58.53 -174.09 0.09 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.699 0.8 . . . . 0.0 111.529 -172.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.585 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 88.9 m -127.29 149.28 50.09 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.543 0.687 . . . . 0.0 112.331 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.493 ' O ' HD22 ' A' ' 616' ' ' LEU . 40.0 mt-10 -107.55 -157.12 0.6 Allowed 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.462 HD23 ' HD2' ' A' ' 572' ' ' PRO . 3.1 tm? -125.84 107.38 25.68 Favored Pre-proline 0 C--N 1.28 -2.42 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.462 ' HD2' HD23 ' A' ' 571' ' ' LEU . 48.9 Cg_endo -67.45 176.93 4.35 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.647 2.231 . . . . 0.0 111.785 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -79.76 90.02 5.22 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.843 0.83 . . . . 0.0 109.793 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 578' ' ' LEU . 38.6 pt -72.88 -169.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.594 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 7.9 t70 -74.82 146.69 41.82 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.17 -22.63 31.53 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 121.662 0.744 . . . . 0.0 110.515 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -93.7 5.46 51.56 Favored 'General case' 0 C--O 1.204 -1.29 0 O-C-N 121.646 -0.659 . . . . 0.0 110.374 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.559 HD13 ' SG ' ' A' ' 623' ' ' CYS . 1.0 OUTLIER -108.02 154.12 22.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.209 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.39 122.51 5.23 Favored Pre-proline 0 C--N 1.304 -1.383 0 C-N-CA 123.304 0.642 . . . . 0.0 109.62 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.92 137.28 26.53 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.054 1.836 . . . . 0.0 112.534 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 594' ' ' LYS . 10.7 t70 -67.1 -42.52 84.43 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.584 1.154 . . . . 0.0 110.898 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -64.55 -68.94 0.32 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.722 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 53.35 81.49 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.218 1.407 . . . . 0.0 111.315 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 16.5 ptpt -132.89 -177.6 4.57 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.817 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.61 -68.3 0.61 Allowed 'General case' 0 C--N 1.309 -1.164 0 O-C-N 123.158 0.286 . . . . 0.0 111.383 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 131.06 54.48 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.548 0.689 . . . . 0.0 110.582 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.596 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 66.1 m-85 -94.79 140.34 30.04 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.437 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 611' ' ' CYS . 36.8 ttmt -91.13 152.51 20.56 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.194 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.69 118.81 3.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 99.71 2.9 56.29 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.834 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -76.16 130.99 39.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 12.7 t -101.81 120.2 51.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.408 0.623 . . . . 0.0 109.386 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.596 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 4.9 mp -98.52 100.12 11.34 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 581' ' ' ASP . 31.0 mtmm -80.27 142.02 34.98 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 173.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.492 ' CZ ' HD13 ' A' ' 620' ' ' LEU . 91.2 m-85 -116.16 173.95 6.31 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-O 121.321 0.582 . . . . 0.0 110.624 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 8.7 p -161.6 168.38 23.59 Favored 'General case' 0 N--CA 1.392 -3.335 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.528 ' SG ' HD13 ' A' ' 578' ' ' LEU . 94.3 m -117.75 -176.06 2.96 Favored 'General case' 0 C--N 1.265 -3.082 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.546 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 39.3 mmtm -55.03 166.64 0.77 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.406 1.482 . . . . 0.0 111.85 174.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 71.8 Cg_exo -46.91 -42.9 24.94 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 124.112 3.208 . . . . 0.0 114.612 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -102.69 0.16 49.16 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.385 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 28.4 m-85 -93.16 127.28 38.66 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' THR . . . . . 0.427 HG22 ' CG2' ' A' ' 627' ' ' VAL . 90.4 m -86.82 120.55 28.22 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-N 113.075 -1.875 . . . . 0.0 110.67 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 12.3 tt -77.3 133.05 31.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 91.0 t -133.36 130.37 57.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 124.73 -148.55 16.78 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -80.41 102.06 1.38 Allowed 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.322 2.015 . . . . 0.0 110.426 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 1.8 m-20 -73.88 -23.98 59.65 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.709 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' SER . . . . . . . . . . . . . 27.8 p -129.57 96.11 4.17 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.561 0.696 . . . . 0.0 111.284 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.0 m -94.93 164.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.589 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 23.6 mm-40 -107.67 165.38 11.47 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 588' ' ' LYS . 4.1 t -92.79 128.64 38.72 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 114.519 -1.219 . . . . 0.0 107.825 165.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.589 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 54.6 m-85 -115.37 168.71 9.74 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -60.61 -16.04 34.36 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -108.45 -3.65 18.0 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.775 0.321 . . . . 0.0 111.38 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 133.47 -168.72 23.01 Favored Glycine 0 N--CA 1.434 -1.47 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.381 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.493 HD22 ' O ' ' A' ' 570' ' ' GLU . 2.6 mm? -77.03 121.92 24.21 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 123.152 0.581 . . . . 0.0 109.641 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.535 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 35.3 t -147.2 141.47 15.91 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 617' ' ' SER . 13.4 Cg_exo -66.22 -179.57 12.43 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.713 -1.37 . . . . 0.0 112.651 0.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.05 163.48 24.61 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.277 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . 0.492 HD13 ' CZ ' ' A' ' 595' ' ' PHE . 1.1 mm? -67.61 134.75 92.62 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.994 -169.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.22 172.45 7.53 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 123.832 3.021 . . . . 0.0 111.541 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 45.6 pt -114.03 169.6 5.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.032 0.444 . . . . 0.0 111.327 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.559 ' SG ' HD13 ' A' ' 578' ' ' LEU . 81.7 m -115.61 112.54 22.3 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.301 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -95.61 -28.29 14.9 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 21.6 tt0 69.25 -66.73 0.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.223 1.009 . . . . 0.0 109.546 -176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -88.85 112.02 22.75 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.557 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 2.8 p -127.38 174.52 10.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 16.0 mm100 -93.84 155.78 17.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.52 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 16.2 m -104.92 -8.21 18.79 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.015 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 21.9 m 74.77 -3.26 2.63 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 166.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 64.73 -147.76 51.07 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.421 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.82 144.33 24.39 Favored 'Trans proline' 0 C--O 1.253 1.24 0 C-N-CA 122.658 2.238 . . . . 0.0 112.035 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.51 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 68.6 Cg_endo -70.78 167.38 25.94 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.821 3.014 . . . . 0.0 112.996 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.04 -179.5 4.38 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.792 2.328 . . . . 0.0 111.472 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -99.38 158.58 15.62 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.522 HD23 ' HB3' ' A' ' 657' ' ' TYR . 16.0 tp -96.82 133.98 40.72 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 683' ' ' VAL . 2.0 pt? -50.37 -45.4 55.21 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -131.03 33.26 4.19 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.14 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -167.7 -148.32 5.63 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . 0.478 ' ND2' ' H ' ' A' ' 641' ' ' VAL . 2.3 t30 -162.41 177.66 9.34 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.478 ' H ' ' ND2' ' A' ' 640' ' ' ASN . 5.2 t -78.54 133.13 30.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.55 ' HB2' ' NZ ' ' A' ' 642' ' ' LYS . 0.0 OUTLIER -90.78 -2.6 57.78 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.22 0.533 . . . . 0.0 110.563 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.505 ' OE2' ' HE3' ' A' ' 642' ' ' LYS . 74.0 mm-40 -104.19 151.9 22.79 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.694 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 644' ' ' LYS . 21.8 pttm -50.91 109.77 0.36 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 112.545 -2.116 . . . . 0.0 109.871 169.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.597 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 4.1 p -85.33 102.98 13.84 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 121.906 0.86 . . . . 0.0 112.792 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 53.6 pttt -84.19 156.83 21.87 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.646 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.436 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 4.9 mp0 -74.71 -11.29 60.14 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.955 -173.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.502 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 7.4 tp10 -147.66 118.39 7.56 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.597 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 21.6 m-85 -97.64 -94.75 0.22 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 151.34 167.39 14.78 Favored Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.574 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.696 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 67.6 t60 -61.38 -44.16 97.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.343 0.592 . . . . 0.0 111.7 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 14.6 m -98.01 17.22 18.84 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.396 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 649' ' ' TYR . 2.9 tp10 -101.0 111.54 23.77 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.674 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.586 ' CG2' ' HB2' ' A' ' 670' ' ' LYS . 10.8 p -87.91 148.31 4.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.961 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -112.16 105.63 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.76 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.79 170.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.576 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 19.4 mt-10 -72.5 126.06 28.95 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.71 0.767 . . . . 0.0 109.592 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 669' ' ' ASN . 49.7 m-85 -102.59 167.69 9.76 Favored 'General case' 0 C--N 1.268 -2.945 0 C-N-CA 124.311 1.044 . . . . 0.0 110.969 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' A' ' 642' ' ' LYS . 13.6 p90 -148.54 142.47 25.81 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.512 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 33.2 m -107.07 173.83 6.15 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 120.794 0.331 . . . . 0.0 111.861 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.402 ' C ' ' H ' ' A' ' 662' ' ' ARG . 7.2 m120 -61.82 150.79 81.39 Favored Pre-proline 0 C--O 1.243 0.763 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.577 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.55 39.14 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 124.826 3.684 . . . . 0.0 113.822 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 660' ' ' ASN . 11.7 ptm180 -155.83 9.22 0.26 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.817 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.32 150.17 48.68 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 120.96 0.409 . . . . 0.0 109.912 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 85.1 mt -93.49 134.5 35.69 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.742 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 3.3 ttt -96.25 101.39 13.02 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 685' ' ' ILE . 41.3 tptt -69.16 -65.17 0.74 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.69 -169.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.72 -161.69 37.7 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.704 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.43 124.66 14.64 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 123.239 2.626 . . . . 0.0 110.948 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.555 ' O ' ' HB2' ' A' ' 657' ' ' TYR . 5.6 p-10 -76.39 -12.28 60.03 Favored 'General case' 0 C--O 1.171 -3.036 0 CA-C-O 121.672 0.748 . . . . 0.0 110.412 -177.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.586 ' HB2' ' CG2' ' A' ' 654' ' ' VAL . 0.0 OUTLIER -132.97 123.33 25.71 Favored 'General case' 2 N--CA 1.331 -6.424 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -171.397 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 678' ' ' TRP . 43.4 pt -122.0 138.95 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.78 -172.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.57 161.03 15.22 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 38.3 t -94.0 104.58 16.61 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 118.451 -1.3 . . . . 0.0 111.876 -176.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . 0.262 32.7 m -81.62 88.36 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-O 123.017 1.389 . . . . 0.0 113.126 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.603 ' N ' ' HD1' ' A' ' 651' ' ' HIS . 24.9 t70 89.98 -61.25 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.871 0 CA-C-N 112.094 -2.321 . . . . 0.0 111.224 170.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -159.0 12.98 0.21 Allowed Glycine 0 C--N 1.268 -3.207 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.707 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.48 130.58 38.77 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 94.6 m95 -72.95 152.77 41.25 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 2.2 p -74.46 176.91 6.37 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 14.2 m -61.56 125.84 25.23 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.068 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 6.3 mp -62.62 154.83 72.22 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.744 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 17.8 Cg_endo -61.73 -19.68 66.2 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 C-N-CA 123.464 2.776 . . . . 0.0 114.136 -177.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.489 ' HA ' HD22 ' A' ' 637' ' ' LEU . 17.2 m 39.78 83.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 175.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.742 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 62.8 m -79.77 146.75 32.16 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.27 -174.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -127.83 149.34 32.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.483 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.82 139.35 21.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 120.792 0.33 . . . . 0.0 111.318 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--O 1.254 1.323 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.155 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 . . . . . 0 C--O 1.236 0.376 0 CA-C-O 120.228 0.061 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 62.0 98.46 0.03 OUTLIER 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.667 1.187 . . . . 0.0 113.623 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -81.34 -13.51 58.3 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.515 176.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 172.26 -126.28 1.26 Allowed Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -167.75 -63.22 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -89.36 69.08 8.06 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.915 0.864 . . . . 0.0 110.78 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.29 171.65 8.79 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 83.2 m -89.53 148.03 23.63 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.93 0.395 . . . . 0.0 111.237 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.18 134.14 49.01 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 172.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.779 HD13 ' HH ' ' A' ' 587' ' ' TYR . 2.4 tt -52.18 111.4 2.48 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.079 0.952 . . . . 0.0 108.885 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.451 ' HG2' HD22 ' A' ' 620' ' ' LEU . 58.8 Cg_endo -76.68 -174.67 2.24 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.913 2.409 . . . . 0.0 111.417 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -87.4 86.96 7.29 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.751 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.496 ' HB ' HD23 ' A' ' 578' ' ' LEU . 11.1 pt -55.81 -72.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.739 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.1 t70 -173.93 -172.36 0.72 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.39 -30.73 2.99 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . 0.407 ' O ' ' HG2' ' A' ' 598' ' ' LYS . 31.9 m80 -95.63 11.31 33.7 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.242 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.7 tt -111.82 139.89 46.92 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.96 121.28 12.36 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.621 ' HG3' HD12 ' A' ' 571' ' ' LEU . 54.8 Cg_endo -75.05 152.39 40.49 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.603 2.202 . . . . 0.0 111.22 174.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.02 -46.02 62.87 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.34 0.591 . . . . 0.0 109.895 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . 0.464 ' HA ' ' HD3' ' A' ' 582' ' ' ARG . 2.4 mmt180 -84.15 139.54 32.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.872 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -137.48 107.95 6.52 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -146.9 172.77 13.17 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.66 -65.49 0.78 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.22 145.09 44.13 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.5 0.667 . . . . 0.0 110.162 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.779 ' HH ' HD13 ' A' ' 571' ' ' LEU . 39.3 m-85 -105.27 125.88 51.48 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -78.87 153.4 30.59 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.536 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.41 121.16 7.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.326 0.584 . . . . 0.0 110.156 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 105.73 -8.9 43.72 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.747 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.31 126.19 28.48 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 117.876 0.838 . . . . 0.0 109.864 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 608' ' ' SER . 14.3 t -99.67 121.78 50.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 608' ' ' SER . 5.2 mp -104.24 107.9 19.02 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 9.0 mtmp? -82.31 112.02 18.91 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 64.1 m-85 -90.37 164.88 14.15 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 56.3 m -153.97 179.45 8.9 Favored 'General case' 0 N--CA 1.402 -2.869 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 89.4 m -120.22 177.44 5.01 Favored 'General case' 0 C--N 1.26 -3.31 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.576 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 33.0 mmmt -58.17 164.12 3.86 Favored Pre-proline 0 C--N 1.316 -0.89 0 C-N-CA 123.819 0.847 . . . . 0.0 111.676 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 74.3 Cg_exo -47.69 -42.0 30.39 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 124.356 3.37 . . . . 0.0 114.818 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.8 -0.23 62.4 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.513 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -102.93 151.85 21.99 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-O 121.975 0.893 . . . . 0.0 112.545 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 54.1 m -108.2 128.74 54.98 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.108 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.423 HD12 ' HG3' ' A' ' 621' ' ' PRO . 11.3 tt -80.08 123.39 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 173.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 53.2 t -114.47 118.57 58.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 120.945 0.403 . . . . 0.0 110.61 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 116.23 -156.43 15.64 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.58 124.95 13.54 Favored 'Trans proline' 0 C--O 1.221 -0.352 0 C-N-CA 123.2 2.6 . . . . 0.0 110.989 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.438 HD21 ' N ' ' A' ' 607' ' ' ASN . 0.6 OUTLIER -85.38 -45.66 11.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 35.5 p -100.1 119.73 38.76 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 18.2 m -115.22 155.02 16.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.501 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -100.74 155.62 17.8 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.361 0.601 . . . . 0.0 109.893 178.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 8.3 t -88.05 125.26 34.46 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.64 168.88 9.49 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.66 3.07 6.85 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.003 0.82 . . . . 0.0 111.972 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -115.93 2.15 13.47 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.825 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 125.69 -174.11 17.61 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.973 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.437 HD21 ' HD3' ' A' ' 572' ' ' PRO . 2.8 mm? -77.81 125.33 29.17 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 618' ' ' PRO . 50.4 m -145.58 152.86 50.3 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' A' ' 617' ' ' SER . 73.0 Cg_endo -72.26 -165.48 3.54 Favored 'Cis proline' 0 N--CA 1.486 1.079 0 CA-C-N 119.764 0.952 . . . . 0.0 114.554 4.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -55.24 137.62 46.9 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.107 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . 0.451 HD22 ' HG2' ' A' ' 572' ' ' PRO . 5.7 mp -72.61 147.66 89.64 Favored Pre-proline 0 C--N 1.287 -2.116 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.431 -173.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . 0.492 ' HG2' HD12 ' A' ' 578' ' ' LEU . 72.1 Cg_endo -73.36 178.98 5.94 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 123.103 2.535 . . . . 0.0 113.479 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 45.3 pt -127.37 171.34 15.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 96.8 m -115.77 114.67 25.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.967 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.493 ' O ' ' HB ' ' A' ' 602' ' ' THR . 27.3 mtpp -108.89 120.45 42.55 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.682 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -84.34 -24.42 29.78 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -108.78 116.76 32.6 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.029 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.59 -178.56 2.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.317 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -97.22 179.44 4.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.54 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 20.0 m -115.73 -7.15 12.12 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.144 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 66.5 m 72.1 -28.78 0.19 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 83.08 -147.73 24.97 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.9 142.79 39.65 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.984 1.789 . . . . 0.0 110.727 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.518 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 72.2 Cg_endo -73.6 168.79 23.88 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 123.189 2.593 . . . . 0.0 112.095 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.66 -179.3 3.63 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 122.695 2.263 . . . . 0.0 111.846 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -100.81 156.27 17.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' ' 657' ' ' TYR . 14.8 tp -87.88 150.47 23.48 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 638' ' ' ASN . 0.0 OUTLIER -57.89 -54.25 49.0 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.492 ' HB2' HD23 ' A' ' 637' ' ' LEU . 5.3 m-80 -130.17 41.49 3.4 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 122.34 1.067 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -161.57 -156.82 8.51 Favored Glycine 0 N--CA 1.411 -2.988 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.6 t-20 -153.12 -176.37 5.75 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.57 136.18 27.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -89.6 -24.61 21.65 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.895 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -79.07 163.29 25.25 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.394 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -84.01 115.17 22.2 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 12.2 p -69.22 97.43 0.93 Allowed 'General case' 0 N--CA 1.413 -2.285 0 O-C-N 124.177 0.923 . . . . 0.0 112.3 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.535 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 48.9 pttt -76.22 160.19 29.93 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.57 -7.0 58.73 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.4 0.619 . . . . 0.0 111.298 -171.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -141.06 105.46 4.85 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.535 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 6.9 m-85 -85.69 -76.31 0.34 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 124.46 163.92 11.8 Favored Glycine 0 C--N 1.284 -2.343 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.158 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.429 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.2 t60 -66.79 142.94 57.19 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.258 5.9 p 62.78 9.74 3.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.889 1.276 . . . . 0.0 114.259 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.448 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 4.2 tp10 -87.58 116.66 25.85 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.58 ' CG2' ' HB2' ' A' ' 670' ' ' LYS . 4.1 p -92.1 152.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.823 0.82 . . . . 0.0 111.22 -176.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 26.9 m -122.27 113.31 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.58 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.691 175.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 21.7 mt-10 -76.85 131.34 38.58 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.681 0.753 . . . . 0.0 111.6 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.545 ' HB3' HD21 ' A' ' 636' ' ' LEU . 56.6 m-85 -111.36 160.76 16.76 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 125.106 1.362 . . . . 0.0 111.389 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.519 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 10.5 p90 -145.03 134.51 23.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.54 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 27.9 m -100.3 171.34 7.84 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.392 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.43 ' C ' ' H ' ' A' ' 662' ' ' ARG . 46.9 m-80 -60.07 154.23 51.58 Favored Pre-proline 0 C--N 1.314 -0.967 0 O-C-N 124.184 0.927 . . . . 0.0 110.917 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 71.8 Cg_endo -73.15 35.69 0.35 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 124.308 3.339 . . . . 0.0 112.864 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 660' ' ' ASN . 14.3 mtt180 -136.83 4.78 2.81 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.575 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 72.0 m-85 -136.23 156.98 47.89 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.1 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.709 ' HG ' ' HG2' ' A' ' 687' ' ' GLU . 80.4 mt -115.07 146.31 41.43 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.772 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -82.52 142.32 31.94 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 118.437 0.562 . . . . 0.0 110.295 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.478 ' HA ' ' HE3' ' A' ' 666' ' ' LYS . 2.0 tpmt? -92.56 -41.62 10.14 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.303 0.573 . . . . 0.0 109.736 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -116.32 -163.25 13.36 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.765 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.96 129.31 26.92 Favored 'Trans proline' 0 C--O 1.22 -0.402 0 C-N-CA 123.934 3.09 . . . . 0.0 110.51 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.54 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 9.5 p-10 -68.66 -14.21 62.87 Favored 'General case' 0 C--O 1.178 -2.696 0 CA-C-O 121.327 0.584 . . . . 0.0 111.534 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.58 ' HB2' ' CG2' ' A' ' 654' ' ' VAL . 12.1 ptmt -130.13 145.57 51.71 Favored 'General case' 0 C--N 1.25 -3.742 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -174.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.635 HD12 ' CD2' ' A' ' 681' ' ' LEU . 35.8 pt -135.22 145.6 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -121.54 148.54 44.35 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.386 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 12.9 t -72.42 113.59 9.62 Favored 'General case' 0 CA--C 1.468 -2.206 0 CA-C-O 122.381 1.086 . . . . 0.0 109.794 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.429 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 44.2 t -105.65 111.58 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.811 0 CA-C-N 112.341 -2.209 . . . . 0.0 108.499 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.78 -75.97 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.619 1.168 . . . . 0.0 111.955 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -157.65 26.29 0.46 Allowed Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.3 143.81 32.96 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.552 ' HB3' HD11 ' A' ' 671' ' ' ILE . 92.4 m95 -87.85 161.48 17.49 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.577 0.626 . . . . 0.0 109.753 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 15.4 p -76.2 172.37 12.96 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.924 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 24.9 m -67.1 135.14 53.14 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.035 0.445 . . . . 0.0 110.931 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.635 ' CD2' HD12 ' A' ' 671' ' ' ILE . 50.9 mt -61.53 151.58 77.21 Favored Pre-proline 0 N--CA 1.42 -1.926 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.154 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.772 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 11.7 Cg_endo -53.25 -18.89 11.31 Favored 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 124.752 3.635 . . . . 0.0 115.362 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.472 ' HA ' HD12 ' A' ' 637' ' ' LEU 0.25 16.9 m 41.89 91.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 174.484 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.575 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 4.3 p -87.33 150.38 23.89 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.58 150.74 34.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.648 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.67 135.83 25.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 O-C-N 123.778 0.673 . . . . 0.0 110.762 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.709 ' HG2' ' HG ' ' A' ' 664' ' ' LEU . 42.2 mt-10 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.526 -0.75 . . . . 0.0 109.567 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -49.98 -32.3 14.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.092 0.957 . . . . 0.0 113.034 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -89.31 75.73 7.68 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 121.6 -0.688 . . . . 0.0 109.167 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -92.0 -20.88 34.86 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.749 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -109.28 151.06 27.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.35 142.51 53.97 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.348 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -133.96 -179.96 5.87 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 55.8 m -86.11 147.79 25.99 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.1 0.476 . . . . 0.0 111.014 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 571' ' ' LEU . 45.9 tt0 -125.47 -8.36 6.9 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.601 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 63.2 tp 79.06 115.33 0.03 OUTLIER Pre-proline 0 C--O 1.244 0.778 0 C-N-CA 125.239 1.416 . . . . 0.0 110.068 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.512 ' HD2' HD13 ' A' ' 571' ' ' LEU . 69.7 Cg_endo -71.5 -168.31 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.668 2.246 . . . . 0.0 110.134 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -87.37 102.93 15.01 Favored 'General case' 0 N--CA 1.41 -2.452 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.728 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.456 HD13 ' HB3' ' A' ' 578' ' ' LEU . 36.4 pt -70.04 -170.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.973 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 7.9 t70 -70.75 155.57 40.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.42 -28.16 37.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 121.839 0.828 . . . . 0.0 109.412 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -96.65 6.49 48.61 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.275 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.8 tm? -97.3 144.07 27.44 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.37 115.13 7.58 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -76.28 137.71 19.26 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.879 2.386 . . . . 0.0 112.731 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -55.97 -55.95 26.56 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.334 1.454 . . . . 0.0 111.423 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . 0.45 ' HB3' ' HE3' ' A' ' 584' ' ' LYS . 55.0 mmt-85 -59.07 -59.91 4.71 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.856 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 53.57 82.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.647 1.217 . . . . 0.0 111.068 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 582' ' ' ARG . 15.4 ptpt -143.26 163.71 32.21 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.91 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.16 -57.09 14.31 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 123.837 0.71 . . . . 0.0 111.261 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.84 142.82 51.18 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.094 0.473 . . . . 0.0 110.041 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.601 ' CE1' ' HB2' ' A' ' 571' ' ' LEU . 95.0 m-85 -102.59 126.73 49.77 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.847 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -79.74 151.75 30.23 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.092 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 45.6 t -60.87 118.06 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 104.18 -5.76 45.95 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.447 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -69.01 129.47 40.03 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 17.8 m -97.26 118.9 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-O 122.509 1.147 . . . . 0.0 109.867 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.415 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 5.6 mp -95.49 96.87 9.37 Favored 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.615 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 57.2 mtmt -80.75 109.86 15.7 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.485 ' HB3' HD13 ' A' ' 578' ' ' LEU . 64.9 m-85 -92.26 162.72 14.18 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 16.9 t -158.26 176.46 12.44 Favored 'General case' 0 N--CA 1.393 -3.286 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 88.3 m -121.24 172.17 8.19 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.488 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 70.2 mmtt -53.8 159.95 2.38 Favored Pre-proline 0 C--N 1.319 -0.751 0 C-N-CA 124.024 0.929 . . . . 0.0 112.169 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 12.1 Cg_endo -69.27 109.55 2.24 Favored 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.036 1.824 . . . . 0.0 109.366 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 122.52 -17.33 8.37 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -101.07 157.75 16.53 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 122.128 0.966 . . . . 0.0 112.48 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 18.5 m -109.04 130.55 55.48 Favored 'General case' 0 N--CA 1.402 -2.869 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.777 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 11.2 tt -85.68 122.01 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 54.0 t -112.72 127.45 69.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 112.95 -166.35 12.13 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.11 126.54 17.37 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.988 2.459 . . . . 0.0 110.761 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -86.13 -38.27 17.91 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.745 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.542 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 34.4 p -114.64 111.27 21.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.995 0.426 . . . . 0.0 110.96 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.2 m -104.79 153.82 6.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.594 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -99.08 147.91 24.58 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.409 ' HA ' HD21 ' A' ' 616' ' ' LEU . 17.6 t -83.23 124.31 30.43 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 170.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 617' ' ' SER . 91.7 m-85 -110.59 171.88 7.2 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.68 7.23 3.18 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -117.58 -9.04 10.87 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 133.07 -174.37 20.61 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 611' ' ' CYS . 91.4 mt -70.9 138.77 50.41 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 122.976 0.51 . . . . 0.0 111.377 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.576 ' HB3' ' CD2' ' A' ' 612' ' ' TYR . 44.7 t -152.55 141.41 14.12 Favored Pre-proline 0 N--CA 1.424 -1.773 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.417 ' C ' ' HA ' ' A' ' 617' ' ' SER . 60.4 Cg_endo -72.94 -172.01 9.15 Favored 'Cis proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.081 -1.633 . . . . 0.0 113.197 0.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.9 151.73 38.43 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.111 0.481 . . . . 0.0 111.255 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 6.1 mp -67.13 145.11 98.69 Favored Pre-proline 0 C--N 1.309 -1.169 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -170.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.68 175.21 8.33 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 123.93 3.087 . . . . 0.0 112.018 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 38.4 pt -127.53 174.05 11.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.6 m -121.89 122.32 39.14 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.956 0.408 . . . . 0.0 111.5 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.478 ' HZ1' ' CG ' ' A' ' 675' ' ' ASP . 53.8 mtpt -119.58 125.74 49.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -82.97 -40.03 20.59 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 121.547 0.689 . . . . 0.0 109.715 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -102.05 100.25 10.49 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.879 0.847 . . . . 0.0 110.45 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 8.0 m -107.76 174.13 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.588 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -98.99 143.99 28.66 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.234 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 38.2 m -97.49 -2.17 42.52 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 98.5 m 74.33 -42.75 0.51 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.958 1.303 . . . . 0.0 113.646 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 105.33 -141.47 15.35 Favored Glycine 0 N--CA 1.417 -2.632 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.8 139.46 13.96 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.259 1.972 . . . . 0.0 110.83 174.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.33 161.57 44.17 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 123.268 2.645 . . . . 0.0 112.707 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.86 176.45 6.06 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.915 2.41 . . . . 0.0 111.677 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.82 163.11 14.55 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 1.059 HD22 ' SG ' ' A' ' 659' ' ' CYS . 9.1 tp -90.27 156.69 18.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 683' ' ' VAL 0.285 2.1 pt? -77.05 -45.46 27.06 Favored 'General case' 0 N--CA 1.406 -2.672 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.495 -178.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.438 HD21 ' HG ' ' A' ' 637' ' ' LEU . 42.5 m-80 -125.64 33.77 5.04 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.558 0.694 . . . . 0.0 110.904 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.658 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -160.75 -140.76 2.96 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.556 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.87 -169.82 2.96 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.0 p -102.97 132.43 49.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.64 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.9 ptmt -87.22 -13.83 42.76 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.831 0.824 . . . . 0.0 110.256 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -88.58 140.39 29.51 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.843 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . 0.664 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -55.8 121.34 9.0 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 124.161 0.913 . . . . 0.0 108.631 171.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 3.7 p -94.67 99.67 11.74 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.466 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 53.4 pttt -82.99 167.5 17.88 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.322 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -88.78 1.81 54.59 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.588 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 34.3 tt0 -151.73 108.4 3.49 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.466 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 4.9 m-85 -84.55 -93.93 0.07 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 151.78 159.79 9.13 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 54.3 t60 -51.61 -59.14 4.6 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 37.2 m -91.67 21.08 4.95 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.364 0.602 . . . . 0.0 110.691 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -104.03 113.37 26.86 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 8.8 p -94.17 159.47 2.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.868 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.7 t -124.07 114.05 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.879 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.64 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 21.7 mt-10 -71.88 128.43 35.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.489 0.661 . . . . 0.0 111.876 174.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 42.0 m-85 -109.33 170.66 7.91 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 123.58 0.752 . . . . 0.0 110.799 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -148.48 132.2 16.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 1.059 ' SG ' HD22 ' A' ' 636' ' ' LEU . 95.9 m -97.1 172.62 7.72 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.948 176.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.433 ' C ' ' H ' ' A' ' 662' ' ' ARG . 49.3 m-80 -64.9 152.95 89.64 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.003 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 72.4 Cg_endo -72.27 35.42 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 124.554 3.503 . . . . 0.0 113.652 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 660' ' ' ASN . 0.3 OUTLIER -149.57 13.48 0.83 Allowed 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.349 -174.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.33 156.56 48.25 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.874 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.444 HD22 ' HG3' ' A' ' 687' ' ' GLU . 83.6 mt -101.07 143.45 31.17 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.712 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 2.5 ttt -107.57 108.88 20.37 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -78.7 -57.82 3.56 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.251 -173.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.24 -174.31 47.56 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.795 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.12 126.38 21.41 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 123.68 2.92 . . . . 0.0 110.868 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.599 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 16.3 p-10 -66.91 -13.05 61.33 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-O 121.026 0.441 . . . . 0.0 110.842 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 16.0 mtpt -118.48 151.38 37.93 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 38.0 pt -138.54 141.43 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.87 151.69 39.34 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.918 0.39 . . . . 0.0 111.073 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 19.0 t -81.73 99.73 9.11 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.752 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.536 ' HA ' ' HD1' ' A' ' 651' ' ' HIS 0.278 20.1 m -88.63 75.89 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 O-C-N 120.541 -1.349 . . . . 0.0 112.064 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.478 ' CG ' ' HZ1' ' A' ' 624' ' ' LYS . 35.1 t70 63.85 66.17 0.67 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.642 175.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 88.34 -20.21 31.52 Favored Glycine 0 C--N 1.311 -0.846 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.173 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -118.01 113.91 22.36 Favored 'General case' 0 N--CA 1.423 -1.803 0 O-C-N 122.201 -0.588 . . . . 0.0 111.857 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -65.88 151.63 46.29 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 20.1 p -77.55 173.59 11.84 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.04 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 6.3 m -62.89 128.43 35.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.154 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.09 161.52 39.04 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.392 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.599 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 20.2 Cg_endo -62.6 -17.81 60.43 Favored 'Trans proline' 0 CA--C 1.507 -0.827 0 C-N-CA 123.416 2.744 . . . . 0.0 115.04 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.513 ' HA ' HD23 ' A' ' 637' ' ' LEU 0.258 30.3 m 41.58 94.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 175.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.712 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 69.9 m -92.84 154.95 17.94 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.1 OUTLIER -140.17 152.46 21.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.609 -177.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.95 136.77 19.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.444 ' HG3' HD22 ' A' ' 664' ' ' LEU . 29.0 tt0 . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--O 1.237 0.435 0 CA-C-O 120.84 0.352 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -87.27 129.2 35.08 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -62.09 121.78 13.91 Favored 'General case' 0 C--O 1.254 1.322 0 O-C-N 123.668 0.605 . . . . 0.0 111.172 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -72.09 123.49 9.56 Favored Glycine 0 N--CA 1.436 -1.348 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.834 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -131.35 167.32 19.47 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -48.29 137.4 11.07 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 125.447 1.499 . . . . 0.0 112.495 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . 0.535 ' HG3' ' HB3' ' A' ' 586' ' ' GLN . 13.2 pt-20 -101.41 154.46 18.79 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 71.6 m -62.88 115.76 4.66 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 124.742 1.217 . . . . 0.0 113.201 -174.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.51 -12.85 58.69 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.669 HD23 ' HH ' ' A' ' 587' ' ' TYR . 41.7 tp 73.17 113.61 0.03 OUTLIER Pre-proline 0 CA--C 1.514 -0.442 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.078 -176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.437 ' HD2' HD13 ' A' ' 571' ' ' LEU . 44.3 Cg_endo -67.94 174.25 8.06 Favored 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.33 2.02 . . . . 0.0 111.052 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . 0.531 ' HD2' ' H ' ' A' ' 573' ' ' LYS 0.299 0.0 OUTLIER -73.68 102.2 3.87 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.47 177.217 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.5 HD13 ' HB3' ' A' ' 578' ' ' LEU . 40.7 pt -70.91 -171.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.671 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.9 t70 -72.93 146.35 46.15 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.69 -33.82 50.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.722 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -92.43 6.21 47.87 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.064 -0.398 . . . . 0.0 111.624 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.588 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.4 OUTLIER -101.64 150.11 23.44 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -176.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 9.7 m -143.79 121.83 6.94 Favored Pre-proline 0 C--N 1.306 -1.302 0 C-N-CA 123.932 0.893 . . . . 0.0 110.118 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 595' ' ' PHE . 26.2 Cg_endo -72.83 142.73 35.81 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.378 1.385 . . . . 0.0 109.398 171.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.69 -33.72 68.67 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.552 0.691 . . . . 0.0 110.301 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . 0.404 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 75.5 mmt-85 -75.33 -70.16 0.44 Allowed 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.133 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.504 ' HA ' ' OH ' ' A' ' 587' ' ' TYR 0.296 53.0 tttp 52.29 79.67 0.11 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.768 -170.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.518 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 18.1 ptpt -129.23 164.34 23.67 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.437 -1.711 . . . . 0.0 106.475 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -65.28 -48.32 73.61 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . 0.535 ' HB3' ' HG3' ' A' ' 568' ' ' GLU . 0.0 OUTLIER -131.67 143.44 50.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.153 0.501 . . . . 0.0 110.408 176.224 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.669 ' HH ' HD23 ' A' ' 571' ' ' LEU . 76.9 m-85 -107.72 121.1 44.02 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 124.025 0.93 . . . . 0.0 109.145 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -66.0 144.53 56.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 60.4 t -55.03 120.65 2.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 109.59 -13.83 32.67 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.887 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -71.49 123.74 23.08 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.35 134.45 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.537 0 C-N-CA 119.419 -0.912 . . . . 0.0 108.834 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.449 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.4 mp -108.04 117.47 34.23 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 57.1 mttp -94.48 103.32 15.29 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.461 ' HB3' HD22 ' A' ' 578' ' ' LEU . 64.3 m-85 -78.29 152.6 32.38 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 22.6 t -148.95 161.28 42.2 Favored 'General case' 0 N--CA 1.391 -3.376 0 N-CA-C 103.36 -2.83 . . . . 0.0 103.36 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 90.7 m -107.41 177.88 4.71 Favored 'General case' 0 C--N 1.25 -3.721 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 36.7 mmtm -56.12 161.34 3.84 Favored Pre-proline 0 N--CA 1.441 -0.891 0 C-N-CA 123.086 0.554 . . . . 0.0 111.209 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 93.1 Cg_exo -43.39 -47.26 9.22 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 124.337 3.358 . . . . 0.0 114.475 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -91.41 4.1 79.83 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 121.173 -0.536 . . . . 0.0 112.584 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -108.25 137.09 46.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 121.893 0.854 . . . . 0.0 112.927 -176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 20.5 m -93.65 131.87 38.53 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.723 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.45 HD12 ' HG3' ' A' ' 621' ' ' PRO . 11.9 tt -82.39 122.02 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.58 108.96 26.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 128.04 -162.4 21.84 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.53 131.0 26.53 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 123.096 2.531 . . . . 0.0 110.928 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.87 -47.86 7.61 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.511 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 62.0 p -106.25 102.62 12.01 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.729 0.776 . . . . 0.0 111.698 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 14.0 m -108.09 140.32 27.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.621 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -85.45 149.11 25.63 Favored 'General case' 0 CA--C 1.486 -1.509 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.38 178.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.424 ' HA ' HD21 ' A' ' 616' ' ' LEU . 35.0 t -78.47 124.97 28.72 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 114.733 -1.122 . . . . 0.0 108.362 169.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.449 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 93.3 m-85 -112.22 171.02 7.76 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -6.4 18.52 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -114.27 -0.25 13.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.285 0.564 . . . . 0.0 110.543 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 129.14 -175.17 18.97 Favored Glycine 0 N--CA 1.425 -2.071 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.721 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' A' ' 611' ' ' CYS . 87.9 mt -70.04 131.22 44.01 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.442 0.297 . . . . 0.0 110.64 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.449 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 73.2 m -149.28 143.71 17.21 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 177.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.404 ' C ' ' HA ' ' A' ' 617' ' ' SER . 59.2 Cg_endo -69.1 -169.63 4.88 Favored 'Cis proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.123 -1.199 . . . . 0.0 113.95 0.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.7 151.66 37.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.828 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.86 143.71 87.11 Favored Pre-proline 0 C--N 1.289 -2.047 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.157 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . 0.45 ' HG3' HD12 ' A' ' 603' ' ' ILE . 98.3 Cg_endo -76.02 179.55 6.2 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.965 3.11 . . . . 0.0 112.917 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 46.3 pt -126.27 177.16 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.084 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.527 ' SG ' HD13 ' A' ' 578' ' ' LEU . 94.4 m -121.11 115.55 23.31 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 123.424 0.689 . . . . 0.0 110.748 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.588 ' O ' ' HB ' ' A' ' 602' ' ' THR . 43.4 mtmt -121.87 128.53 51.71 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.978 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.25 -41.47 25.02 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -98.13 112.81 24.64 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.183 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 1.4 m -120.83 178.1 2.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 124.535 1.134 . . . . 0.0 108.349 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.493 ' NE2' ' HA3' ' A' ' 676' ' ' GLY . 21.2 mt-30 -97.59 167.02 11.23 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 14.0 m -105.05 -15.23 15.15 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.673 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 86.0 m 73.35 7.63 5.2 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.457 1.103 . . . . 0.0 113.052 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 57.65 -136.61 50.57 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.765 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.77 153.58 22.93 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.824 2.349 . . . . 0.0 110.991 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.546 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.7 Cg_endo -79.42 166.75 21.94 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.302 2.001 . . . . 0.0 111.014 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.38 -166.68 0.28 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.399 2.066 . . . . 0.0 110.626 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -113.19 170.78 7.97 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.538 HD21 ' HA3' ' A' ' 639' ' ' GLY . 17.0 tp -85.41 164.05 18.14 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 4.8 mp -56.94 -71.65 0.09 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.083 0.944 . . . . 0.0 110.308 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -105.3 -27.1 11.72 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.764 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.538 ' HA3' HD21 ' A' ' 636' ' ' LEU . . . -86.2 -150.08 14.89 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.699 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -155.1 -171.28 3.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 18.6 t -96.4 127.65 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.729 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -87.64 -21.85 25.06 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.386 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -75.72 169.47 18.06 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.22 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -88.6 131.62 34.88 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.659 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 24.5 p -87.65 118.18 26.97 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.402 0.62 . . . . 0.0 112.222 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -84.6 167.96 15.79 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.407 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 45.2 mt-10 -94.35 -10.14 33.59 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -151.56 101.72 2.82 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.39 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.546 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.7 m-85 -80.66 -85.74 0.09 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 139.05 160.93 8.54 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.3 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.48 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 60.5 t60 -62.54 130.6 45.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' SER . . . . . 0.464 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 39.5 m 69.6 10.24 7.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.67 1.188 . . . . 0.0 113.508 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 7.6 tp10 -88.7 120.71 30.34 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 19.7 m -91.25 160.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-O 122.307 1.051 . . . . 0.0 113.622 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 4.5 t -132.53 112.18 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-N 113.657 -1.61 . . . . 0.0 108.227 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 669' ' ' ASN . 32.5 mt-10 -73.43 135.66 44.18 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.249 1.023 . . . . 0.0 113.226 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 72.3 m-85 -114.75 172.56 6.96 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 126.441 1.896 . . . . 0.0 109.559 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -155.42 143.76 20.23 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.526 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.8 t -112.85 174.26 5.98 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.237 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 46.8 m-80 -64.9 155.96 81.45 Favored Pre-proline 0 C--N 1.317 -0.815 0 O-C-N 123.395 0.435 . . . . 0.0 110.378 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 70.5 Cg_endo -73.16 42.91 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 124.181 3.254 . . . . 0.0 113.39 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 662' ' ' ARG . 2.5 ptt180 -151.25 11.15 0.61 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 124.038 0.935 . . . . 0.0 110.473 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -128.66 152.13 48.73 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.786 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 77.9 mt -101.35 142.04 33.34 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 2.5 ttt -108.71 102.41 11.46 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -79.07 -51.81 9.05 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.262 -170.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.5 -163.42 38.47 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.448 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 670' ' ' LYS . 63.4 Cg_endo -73.33 120.1 6.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.882 2.388 . . . . 0.0 111.387 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 656' ' ' GLU . 3.3 p-10 -81.33 28.18 0.39 Allowed 'General case' 0 C--O 1.19 -2.044 0 O-C-N 121.991 -0.443 . . . . 0.0 111.416 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.767 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 7.7 ptmt -164.04 108.7 1.0 Allowed 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 125.549 1.54 . . . . 0.0 108.336 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.683 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 38.7 pt -109.15 152.6 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.763 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.753 -173.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.464 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 9.7 pt20 -119.07 160.32 22.27 Favored 'General case' 0 N--CA 1.421 -1.919 0 O-C-N 124.094 0.871 . . . . 0.0 110.323 -174.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.5 t -87.17 112.06 21.59 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.399 1.095 . . . . 0.0 110.828 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 84.8 t -103.51 107.04 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.777 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.48 ' H ' ' CE1' ' A' ' 651' ' ' HIS . 25.3 t70 65.1 -69.29 0.1 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 126.456 1.902 . . . . 0.0 111.744 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.493 ' HA3' ' NE2' ' A' ' 628' ' ' GLN . . . -158.16 21.54 0.36 Allowed Glycine 0 N--CA 1.422 -2.252 0 O-C-N 123.831 0.707 . . . . 0.0 111.472 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -136.55 149.74 48.26 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.523 ' HB3' HD13 ' A' ' 671' ' ' ILE . 96.4 m95 -83.0 161.22 21.81 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 11.9 p -81.85 175.32 10.51 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 120.875 0.369 . . . . 0.0 111.715 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 28.4 m -58.39 125.73 24.55 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.835 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 682' ' ' PRO . 6.4 mp -62.34 165.16 9.39 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.554 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.569 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 19.8 Cg_endo -63.32 -21.51 71.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.343 2.029 . . . . 0.0 113.13 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 61.8 t 50.0 96.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.564 1.146 . . . . 0.0 112.376 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 22.5 p -97.21 133.32 41.99 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.235 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.56 147.72 32.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.195 -176.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 47.6 t -55.78 135.35 19.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 O-C-N 123.81 0.694 . . . . 0.0 110.628 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.437 -1.115 0 O-C-N 124.381 1.05 . . . . 0.0 108.828 178.826 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.24 0.583 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -140.84 113.95 8.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -96.48 148.04 23.22 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.547 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -155.13 17.92 0.54 Allowed Glycine 0 C--N 1.299 -1.511 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.06 10.4 6.93 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.064 0.459 . . . . 0.0 111.688 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -130.34 83.36 2.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 586' ' ' GLN . 21.3 mt-10 60.3 -170.27 0.15 Allowed 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.746 1.218 . . . . 0.0 112.803 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.577 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 20.1 m -63.45 -54.1 41.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.713 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 586' ' ' GLN . 39.3 tt0 70.05 130.2 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 125.4 1.48 . . . . 0.0 111.363 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.489 HD12 ' HG3' ' A' ' 580' ' ' PRO . 2.7 tt -66.01 119.88 64.9 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.407 ' HG2' HD12 ' A' ' 620' ' ' LEU . 72.3 Cg_endo -75.6 178.35 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.026 1.817 . . . . 0.0 111.111 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 573' ' ' LYS . 0.0 OUTLIER -78.37 103.83 8.56 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.416 0.627 . . . . 0.0 109.501 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.666 ' HA ' ' HG ' ' A' ' 620' ' ' LEU . 19.8 pt -75.27 -169.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.121 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.6 t70 -72.66 154.9 40.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.38 -30.03 45.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.262 0.553 . . . . 0.0 110.759 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -108.38 12.57 26.21 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.703 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.7 OUTLIER -92.82 153.69 18.71 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 10.7 t -139.68 121.74 9.98 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.618 ' HD3' HD11 ' A' ' 574' ' ' ILE . 59.9 Cg_endo -80.35 138.32 12.38 Favored 'Trans proline' 0 N--CA 1.431 -2.169 0 C-N-CA 122.09 1.86 . . . . 0.0 111.645 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -65.41 -41.94 93.08 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 125.677 1.591 . . . . 0.0 112.074 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 26.9 mmt-85 -67.49 -65.77 0.65 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.474 ' HB3' ' HZ2' ' A' ' 583' ' ' LYS . 5.5 ttpm? 64.8 74.13 0.4 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.691 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -142.7 146.27 34.22 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.77 -47.64 82.61 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . 0.596 ' HA ' ' HA ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -120.18 145.92 46.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.388 0.614 . . . . 0.0 111.527 179.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.625 ' CZ ' ' HG ' ' A' ' 593' ' ' LEU . 96.7 m-85 -116.64 160.62 20.44 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.893 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 591' ' ' GLU . 52.7 mtpt -94.65 152.88 18.13 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.591 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 14.6 m -63.98 137.52 24.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.333 173.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 91.38 -12.91 67.9 Favored Glycine 0 C--N 1.292 -1.903 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.874 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 588' ' ' LYS . 0.7 OUTLIER -66.37 137.68 57.06 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 609' ' ' VAL . 20.0 m -110.25 128.26 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.618 0 CA-C-O 121.645 0.736 . . . . 0.0 109.252 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.625 ' HG ' ' CZ ' ' A' ' 587' ' ' TYR 0.4 0.0 OUTLIER -114.47 102.66 10.29 Favored 'General case' 0 N--CA 1.383 -3.806 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.427 176.516 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 35.4 mtmm -71.67 146.26 48.36 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 113.547 -1.661 . . . . 0.0 107.787 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.521 ' HB3' HD13 ' A' ' 578' ' ' LEU . 42.7 m-85 -125.17 171.12 10.58 Favored 'General case' 0 C--N 1.262 -3.234 0 CA-C-O 120.836 0.351 . . . . 0.0 111.491 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' SER . . . . . 0.504 ' HA ' HD13 ' A' ' 603' ' ' ILE . 23.1 t -171.68 -176.79 1.85 Allowed 'General case' 0 N--CA 1.41 -2.426 0 O-C-N 124.757 1.286 . . . . 0.0 107.585 166.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 84.9 m -114.05 162.0 17.01 Favored 'General case' 0 C--N 1.263 -3.179 0 O-C-N 123.607 0.567 . . . . 0.0 112.184 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.502 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 32.8 mmtp -52.25 160.64 1.2 Allowed Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 125.457 1.503 . . . . 0.0 113.241 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 37.9 Cg_exo -55.93 112.88 1.2 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.415 2.743 . . . . 0.0 110.576 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 121.93 -27.58 6.14 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.014 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -100.24 163.0 12.6 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-O 122.179 0.99 . . . . 0.0 112.672 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' THR . . . . . 0.416 HG21 ' CD2' ' A' ' 651' ' ' HIS . 19.3 m -119.76 130.47 54.98 Favored 'General case' 0 N--CA 1.394 -3.264 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.563 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 596' ' ' SER . 7.1 tt -82.19 130.39 35.86 Favored 'Isoleucine or valine' 0 C--O 1.256 1.406 0 CA-C-O 121.009 0.433 . . . . 0.0 109.991 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 93.0 t -126.95 131.2 71.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.11 -156.01 15.84 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -67.4 111.81 2.41 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.502 2.135 . . . . 0.0 111.306 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 6.0 m120 -87.2 -12.67 46.12 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.341 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.523 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 9.9 p -146.81 102.79 3.57 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.96 0.41 . . . . 0.0 110.68 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 592' ' ' VAL . 23.8 m -96.95 162.04 2.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.254 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 612' ' ' TYR . 1.8 mp0 -112.35 153.5 27.16 Favored 'General case' 0 CA--C 1.483 -1.63 0 CA-C-O 121.001 0.429 . . . . 0.0 110.214 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 589' ' ' VAL . 41.0 t -83.97 130.65 34.88 Favored 'General case' 0 N--CA 1.415 -2.221 0 C-N-CA 118.146 -1.421 . . . . 0.0 107.393 166.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 83.8 m-85 -114.24 170.34 8.37 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -64.51 -14.16 55.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -106.84 0.25 23.86 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.669 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.08 -176.31 19.36 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.945 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -74.26 124.81 27.11 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.416 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 68.3 m -147.07 144.94 20.56 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 122.084 -0.385 . . . . 0.0 111.7 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 617' ' ' SER . 48.1 Cg_endo -70.04 -168.77 4.76 Favored 'Cis proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.788 -1.338 . . . . 0.0 112.34 -2.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -80.15 -178.84 6.75 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.069 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . 0.666 ' HG ' ' HA ' ' A' ' 574' ' ' ILE . 1.1 mm? -75.44 140.98 72.7 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -169.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . 0.476 ' HG3' HD12 ' A' ' 603' ' ' ILE . 38.5 Cg_endo -67.9 175.39 6.47 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 124.43 3.42 . . . . 0.0 112.456 176.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.9 pt -114.0 173.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.533 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.0 m -117.79 115.58 25.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.185 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.451 ' HE2' ' O ' ' A' ' 626' ' ' GLN . 9.2 mmmm -105.4 120.32 41.29 Favored 'General case' 0 CA--C 1.474 -1.978 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.36 -30.12 33.86 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.336 -1.346 . . . . 0.0 107.872 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.451 ' O ' ' HE2' ' A' ' 624' ' ' LYS . 92.2 mt-30 -111.58 116.99 31.75 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.099 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 9.6 p -124.54 158.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 75.6 mm-40 -89.65 159.8 16.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 53.7 m -101.25 -3.16 29.48 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.515 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 73.2 m 69.42 12.45 8.28 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.309 1.044 . . . . 0.0 112.984 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 53.51 -136.5 40.05 Favored Glycine 0 N--CA 1.448 -0.558 0 O-C-N 123.79 0.681 . . . . 0.0 112.424 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.75 151.39 16.8 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.777 2.318 . . . . 0.0 110.703 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.536 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 63.3 Cg_endo -74.81 163.71 35.08 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.775 2.317 . . . . 0.0 112.788 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.42 ' HG2' HD12 ' A' ' 681' ' ' LEU . 55.3 Cg_endo -73.18 177.8 7.37 Favored 'Trans proline' 0 C--O 1.254 1.315 0 C-N-CA 122.734 2.29 . . . . 0.0 111.526 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -92.42 154.32 18.59 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.789 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' A' ' 639' ' ' GLY . 20.8 tp -89.67 141.3 28.73 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -45.7 -41.84 11.01 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -176.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -129.19 -18.28 3.7 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -99.66 -142.92 13.66 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.795 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . 0.402 HD21 ' H ' ' A' ' 641' ' ' VAL . 0.6 OUTLIER -165.01 -177.12 4.47 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.402 ' H ' HD21 ' A' ' 640' ' ' ASN . 39.5 t -84.45 132.52 31.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.646 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.3 ptmt -88.1 -16.71 32.77 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.715 0.769 . . . . 0.0 109.986 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -81.7 165.37 21.05 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.604 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -78.14 111.41 14.03 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 23.1 p -64.82 116.33 6.21 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.587 0.708 . . . . 0.0 111.487 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -101.1 168.08 9.82 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.975 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.424 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 35.7 mt-10 -90.77 -13.78 33.28 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.609 0.718 . . . . 0.0 109.148 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -144.58 105.6 4.19 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.124 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.536 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.8 m-85 -87.02 -84.73 0.17 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.948 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 143.52 154.04 6.03 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.774 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.439 ' HD1' ' N ' ' A' ' 675' ' ' ASP . 49.2 t60 -60.19 131.12 49.81 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 50.2 m 76.69 -0.69 2.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.393 1.077 . . . . 0.0 113.533 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.423 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 7.3 tp10 -79.85 122.96 27.3 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.3 OUTLIER -92.06 151.55 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.725 0 CA-C-O 122.215 1.007 . . . . 0.0 110.606 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -114.02 102.69 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.97 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.646 167.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.646 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 4.0 mt-10 -69.27 138.7 54.1 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.514 ' HB3' HD23 ' A' ' 636' ' ' LEU . 40.5 m-85 -113.12 161.02 17.6 Favored 'General case' 0 C--N 1.259 -3.344 0 C-N-CA 124.964 1.306 . . . . 0.0 110.401 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -145.11 135.02 23.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.584 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.2 t -100.56 -178.95 3.95 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.284 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 662' ' ' ARG . 7.3 m120 -63.14 155.79 71.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.63 26.69 0.35 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.627 2.884 . . . . 0.0 113.477 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 660' ' ' ASN . 16.1 mmm180 -129.63 -1.45 4.87 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -118.56 161.38 20.14 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.349 0.595 . . . . 0.0 112.151 -170.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 86.7 mt -124.4 149.0 47.19 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.566 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -92.25 149.47 21.43 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 176.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -108.83 -45.99 3.71 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.177 0.513 . . . . 0.0 109.689 174.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.77 -175.95 42.75 Favored Glycine 0 C--N 1.306 -1.133 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . 0.512 ' O ' ' HB3' ' A' ' 682' ' ' PRO . 27.5 Cg_endo -62.0 124.58 14.7 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.134 2.556 . . . . 0.0 111.765 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.483 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 21.3 p-10 -73.67 31.77 0.08 Allowed 'General case' 0 C--O 1.188 -2.167 0 C-N-CA 123.393 0.677 . . . . 0.0 111.084 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 13.7 ptmt -172.32 138.26 0.93 Allowed 'General case' 0 C--N 1.258 -3.375 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -173.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 37.3 pt -138.69 139.13 41.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.51 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -109.35 151.2 26.92 Favored 'General case' 0 C--N 1.27 -2.857 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.015 -178.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.6 t -69.3 118.07 11.73 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.198 0.999 . . . . 0.0 111.455 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 89.2 t -105.53 82.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.857 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.243 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.563 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 29.1 t70 80.6 -59.24 0.29 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 112.328 -2.215 . . . . 0.0 112.606 171.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -150.36 4.6 0.6 Allowed Glycine 0 C--N 1.292 -1.873 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.285 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.29 153.03 46.34 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.517 ' HB3' HD13 ' A' ' 671' ' ' ILE . 95.7 m95 -84.66 165.55 17.82 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 679' ' ' THR . . . . . 0.455 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 2.1 p -86.61 -178.65 6.44 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 9.6 m -65.57 133.69 51.72 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.574 0.75 . . . . 0.0 110.101 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.42 HD12 ' HG2' ' A' ' 634' ' ' PRO . 8.3 mp -70.83 158.84 87.15 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.566 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 20.8 Cg_endo -61.44 -16.12 45.41 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 124.639 3.559 . . . . 0.0 115.617 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.263 26.9 m 45.24 90.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 18.5 p -92.85 144.96 24.76 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.147 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.2 OUTLIER -134.69 150.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.029 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.34 140.46 19.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 O-C-N 123.409 0.443 . . . . 0.0 110.754 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 C--O 1.248 1.012 0 C-N-CA 124.841 1.256 . . . . 0.0 110.759 -176.591 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.225 -0.233 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -70.04 -42.24 73.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.022 0.439 . . . . 0.0 110.146 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -94.28 83.19 4.18 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 95.43 104.69 2.02 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -112.25 116.97 31.28 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -133.64 139.21 46.35 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 586' ' ' GLN . 17.6 mm-40 -78.74 104.03 9.09 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.65 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 3.1 m 33.73 -67.57 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 130.121 3.368 . . . . 0.0 115.995 -171.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 585' ' ' ASP . 54.3 mt-10 83.47 176.46 0.07 Allowed 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 128.635 2.774 . . . . 0.0 110.536 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.659 HD12 ' HG3' ' A' ' 580' ' ' PRO . 1.2 tt -119.59 105.83 43.05 Favored Pre-proline 0 N--CA 1.398 -3.038 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.522 ' HG2' HD13 ' A' ' 620' ' ' LEU . 36.7 Cg_endo -66.33 -176.97 0.74 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.885 2.39 . . . . 0.0 111.104 177.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -86.18 84.34 7.51 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.347 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.464 ' HB ' HD23 ' A' ' 578' ' ' LEU . 6.8 pt -52.08 -65.68 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.853 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.3 t70 -176.32 -168.55 0.26 Allowed 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.55 -22.66 4.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -104.08 16.7 25.69 Favored 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.147 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.8 tt -115.21 143.36 45.36 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -176.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.39 121.55 7.09 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-O 121.188 0.518 . . . . 0.0 111.015 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.659 ' HG3' HD12 ' A' ' 571' ' ' LEU . 31.8 Cg_endo -69.29 142.01 48.77 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.835 2.357 . . . . 0.0 112.253 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.74 -48.98 22.75 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . 0.743 ' HD2' ' HE3' ' A' ' 584' ' ' LYS . 14.3 tpp180 -88.94 93.65 9.67 Favored 'General case' 0 N--CA 1.379 -3.979 0 N-CA-C 104.864 -2.272 . . . . 0.0 104.864 171.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -112.83 131.64 55.62 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.083 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.743 ' HE3' ' HD2' ' A' ' 582' ' ' ARG . 15.3 ptpt -163.3 -170.49 2.29 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 570' ' ' GLU . 9.2 m-20 -103.4 -39.46 6.77 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 119.332 0.969 . . . . 0.0 110.627 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 568' ' ' GLU . 0.0 OUTLIER -121.62 133.53 54.99 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.65 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 54.5 m-85 -105.59 170.26 8.0 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -172.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -100.87 151.96 21.1 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.3 122.21 16.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 97.58 0.68 59.2 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.251 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -74.11 129.42 37.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 14.1 t -100.74 115.5 42.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.441 0.639 . . . . 0.0 109.831 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.529 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 1.9 mp -95.88 94.05 7.4 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 608' ' ' SER . 0.0 OUTLIER -77.16 122.72 25.41 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 174.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 66.8 m-85 -94.93 177.83 5.77 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-O 121.473 0.654 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 19.9 p -167.3 169.54 12.36 Favored 'General case' 0 N--CA 1.403 -2.797 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 81.5 m -115.56 170.88 8.09 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 599' ' ' PRO . 41.0 mttt -59.43 156.47 30.73 Favored Pre-proline 0 N--CA 1.432 -1.343 0 O-C-N 123.812 0.695 . . . . 0.0 112.748 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 598' ' ' LYS . 47.9 Cg_exo -55.32 110.1 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.475 2.783 . . . . 0.0 110.127 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 123.66 -23.23 6.74 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 625' ' ' GLU . 79.3 m-85 -102.81 160.83 14.25 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 122.381 1.086 . . . . 0.0 113.281 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 15.6 m -113.41 129.53 56.52 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.399 174.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.434 HD12 ' HG3' ' A' ' 621' ' ' PRO . 8.8 tt -79.57 121.84 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 91.4 t -117.5 123.44 71.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 122.037 -0.414 . . . . 0.0 110.122 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 122.03 -156.02 16.77 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.97 134.35 27.33 Favored 'Trans proline' 0 C--N 1.327 -0.6 0 C-N-CA 122.509 2.139 . . . . 0.0 110.096 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.41 HD21 ' N ' ' A' ' 607' ' ' ASN . 0.7 OUTLIER -97.74 -44.35 6.78 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.185 -177.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 594' ' ' LYS . 19.3 p -106.74 97.07 6.91 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.329 0.585 . . . . 0.0 112.013 -176.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . 0.452 ' HA ' ' HD2' ' A' ' 618' ' ' PRO . 9.4 m -95.31 147.8 5.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.589 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -102.12 152.33 21.13 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 16.3 t -83.99 116.71 22.96 Favored 'General case' 0 C--N 1.268 -2.956 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.001 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.499 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 90.7 m-85 -102.2 166.4 10.61 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -69.05 -13.52 62.49 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.324 0.583 . . . . 0.0 111.076 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -101.51 -1.49 32.91 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.748 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 136.34 178.28 15.65 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.26 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.66 121.69 19.26 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.499 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 56.5 m -146.35 147.11 29.96 Favored Pre-proline 0 C--N 1.316 -0.886 0 O-C-N 121.959 -0.463 . . . . 0.0 111.458 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 609' ' ' VAL . 41.4 Cg_endo -67.06 -171.9 5.07 Favored 'Cis proline' 0 N--CA 1.488 1.149 0 C-N-CA 124.353 -1.103 . . . . 0.0 112.958 0.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.8 179.99 3.4 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.195 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . 0.522 HD13 ' HG2' ' A' ' 572' ' ' PRO . 18.9 mt -92.52 147.39 34.23 Favored Pre-proline 0 C--N 1.278 -2.541 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -165.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . 0.529 ' HG2' HD12 ' A' ' 578' ' ' LEU . 63.5 Cg_endo -73.82 -173.24 1.31 Allowed 'Trans proline' 0 C--O 1.253 1.249 0 C-N-CA 123.861 3.041 . . . . 0.0 112.076 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.49 173.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.932 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.2 m -117.05 107.47 14.56 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.303 0.573 . . . . 0.0 111.138 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.437 ' HZ2' ' CG ' ' A' ' 675' ' ' ASP . 59.1 mtpt -109.19 126.34 53.16 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.49 ' HB2' ' CE1' ' A' ' 601' ' ' PHE . 26.8 tt0 -87.44 -35.29 18.35 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -175.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -107.5 112.67 25.54 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.611 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 6.7 m -121.21 166.13 16.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.128 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 15.7 mm100 -89.98 170.66 10.17 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.036 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.531 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 74.8 p -108.86 -19.1 13.52 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.387 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 95.4 m 73.7 4.89 4.81 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.884 1.273 . . . . 0.0 111.16 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 62.55 -137.78 44.84 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.94 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.17 156.69 37.93 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.903 2.402 . . . . 0.0 110.82 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.677 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 71.7 Cg_endo -78.77 160.77 27.69 Favored 'Trans proline' 0 N--CA 1.435 -1.956 0 C-N-CA 122.053 1.835 . . . . 0.0 111.222 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.23 -169.26 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.655 2.236 . . . . 0.0 112.763 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -103.31 157.6 16.9 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.51 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.539 HD22 ' HA3' ' A' ' 639' ' ' GLY . 15.7 tp -92.68 155.26 17.83 Favored 'General case' 0 CA--C 1.478 -1.825 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 683' ' ' VAL 0.285 2.0 pt? -66.93 -47.75 70.73 Favored 'General case' 0 N--CA 1.406 -2.653 0 C-N-CA 119.005 -1.078 . . . . 0.0 113.607 -178.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.601 ' HB2' ' SG ' ' A' ' 684' ' ' CYS . 89.9 m-20 -126.36 27.02 6.28 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.049 -173.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -160.08 -146.61 4.64 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.09 177.54 10.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.795 0.298 . . . . 0.0 111.054 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.29 133.97 28.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -90.78 -23.93 20.49 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.338 0.59 . . . . 0.0 110.075 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.485 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 5.6 mm-40 -80.71 163.31 23.64 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.369 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . 0.51 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.1 OUTLIER -76.35 137.95 40.14 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 175.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 20.2 p -87.78 110.42 20.46 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.807 0.813 . . . . 0.0 112.804 -175.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.522 ' HD2' ' HA ' ' A' ' 649' ' ' TYR . 52.1 mttm -72.74 158.19 36.06 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.76 -0.23 56.01 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -152.44 100.58 2.59 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.978 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.677 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 5.3 m-85 -80.44 -81.55 0.12 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 133.35 167.71 11.72 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.158 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.536 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 57.6 t60 -67.45 131.04 44.91 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 120.926 0.393 . . . . 0.0 110.284 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' SER . . . . . 0.551 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 73.8 m 65.06 20.06 11.96 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.235 1.014 . . . . 0.0 112.43 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 5.6 tp10 -89.68 116.59 27.92 Favored 'General case' 0 CA--C 1.478 -1.812 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 16.2 m -89.47 155.77 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-O 122.152 0.977 . . . . 0.0 113.188 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.765 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 0.1 OUTLIER -129.3 117.38 43.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-N 112.823 -1.99 . . . . 0.0 109.502 177.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.526 ' HG2' ' HG2' ' A' ' 670' ' ' LYS . 59.1 mt-10 -81.01 130.2 34.9 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 122.389 1.09 . . . . 0.0 113.54 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -108.81 157.91 18.15 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.679 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -134.88 138.55 44.24 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.625 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 26.1 t -105.65 168.69 8.93 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.542 ' HB2' ' CE1' ' A' ' 663' ' ' PHE . 32.0 m-80 -59.72 152.22 58.82 Favored Pre-proline 0 C--O 1.241 0.622 0 O-C-N 123.202 0.314 . . . . 0.0 110.795 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 72.1 Cg_endo -71.2 36.12 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 124.343 3.362 . . . . 0.0 115.549 -170.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.75 11.47 0.66 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.561 0.696 . . . . 0.0 110.539 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 660' ' ' ASN . 73.6 m-85 -118.52 162.86 17.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.386 0.612 . . . . 0.0 110.964 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 96.8 mt -110.13 135.7 50.51 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.653 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.3 OUTLIER -100.64 108.88 20.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -75.77 -52.25 10.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.64 -172.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -101.8 -162.7 26.91 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.341 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.89 123.58 10.54 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.434 2.756 . . . . 0.0 112.761 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 23.0 p-10 -74.4 -7.14 51.92 Favored 'General case' 0 C--O 1.201 -1.5 0 O-C-N 122.1 -0.375 . . . . 0.0 111.503 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.765 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -122.88 118.86 28.87 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 42.3 pt -111.4 158.23 11.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 11.0 pt20 -125.15 154.91 40.76 Favored 'General case' 0 C--N 1.281 -2.396 0 O-C-N 123.43 0.456 . . . . 0.0 109.99 -174.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 8.2 t -84.81 110.85 19.12 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 123.119 1.438 . . . . 0.0 110.045 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 97.7 t -95.26 81.38 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.386 -3.67 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.821 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 628' ' ' GLN . 31.5 t70 80.96 -46.37 0.24 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.631 170.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -171.47 19.31 0.06 OUTLIER Glycine 0 C--N 1.298 -1.554 0 O-C-N 123.882 0.739 . . . . 0.0 111.513 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -143.42 143.9 31.8 Favored 'General case' 0 C--O 1.212 -0.879 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.509 ' HB3' HD13 ' A' ' 671' ' ' ILE . 98.0 m95 -87.12 153.77 21.26 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 3.7 p -72.1 167.34 20.45 Favored 'General case' 0 C--O 1.255 1.358 0 O-C-N 123.009 0.193 . . . . 0.0 111.399 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.0 m -62.86 129.23 39.52 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 682' ' ' PRO . 6.4 mp -60.19 163.78 7.64 Favored Pre-proline 0 N--CA 1.435 -1.223 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.945 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.653 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 19.5 Cg_endo -60.6 -24.33 78.07 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 122.777 2.318 . . . . 0.0 113.135 -176.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 637' ' ' LEU . 58.8 t 52.62 92.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 122.175 0.988 . . . . 0.0 111.072 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.601 ' SG ' ' HB2' ' A' ' 638' ' ' ASN . 27.8 p -98.97 134.51 41.72 Favored 'General case' 0 N--CA 1.411 -2.376 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.703 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.2 OUTLIER -125.91 155.7 35.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.92 -174.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 64.4 t -59.84 129.09 21.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 123.866 0.729 . . . . 0.0 110.562 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.678 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.239 0.542 0 N-CA-C 113.097 0.776 . . . . 0.0 113.097 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -74.53 -16.93 60.81 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . 69.53 32.42 3.4 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 125.151 1.381 . . . . 0.0 112.597 174.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 150.66 155.56 6.94 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.201 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -125.06 101.63 7.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -103.83 -21.89 13.6 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.056 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 56.54 -157.08 0.27 Allowed 'General case' 0 C--N 1.348 0.511 0 C-N-CA 124.12 0.968 . . . . 0.0 110.888 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 587' ' ' TYR . 81.3 m -78.25 140.42 38.88 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -110.01 136.54 49.12 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.48 HD12 ' HG3' ' A' ' 580' ' ' PRO . 2.6 tt -51.37 117.58 9.43 Favored Pre-proline 0 C--O 1.246 0.903 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.19 -179.34 1.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.723 2.282 . . . . 0.0 111.047 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -90.84 93.2 9.12 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 118.953 -1.099 . . . . 0.0 109.092 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 578' ' ' LEU . 36.8 pt -75.78 -175.8 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.189 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.969 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.1 t70 -71.83 163.15 28.34 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.168 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.35 -30.01 17.1 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.262 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -94.23 4.21 54.2 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.814 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.8 OUTLIER -100.03 151.26 21.57 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.39 118.01 6.22 Favored Pre-proline 0 C--N 1.309 -1.181 0 C-N-CA 123.849 0.86 . . . . 0.0 110.603 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.48 ' HG3' HD12 ' A' ' 571' ' ' LEU . 40.7 Cg_endo -75.32 139.45 23.48 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.301 2.001 . . . . 0.0 111.566 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.9 -50.25 63.04 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 125.399 1.48 . . . . 0.0 112.202 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.73 -46.45 85.33 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.135 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm 54.45 58.58 4.8 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 124.364 1.04 . . . . 0.0 109.882 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -121.98 160.17 25.44 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.79 -50.82 54.91 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.54 151.42 41.39 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.667 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 84.9 m-85 -121.53 119.26 31.45 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -71.1 152.69 43.21 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.55 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 58.1 t -55.91 116.26 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-O 121.19 0.519 . . . . 0.0 110.747 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 109.85 -2.99 30.32 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.594 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -76.29 136.98 39.61 Favored 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 122.34 -0.506 . . . . 0.0 110.953 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 12.0 m -101.81 133.28 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.863 0.84 . . . . 0.0 109.686 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.667 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.9 mp -105.41 89.96 3.27 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.484 ' HZ3' ' HB3' ' A' ' 594' ' ' LYS . 3.6 mmmp? -66.43 127.89 34.05 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -107.09 175.12 5.6 Favored 'General case' 0 C--N 1.267 -3.021 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.801 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 14.4 p -166.49 167.32 15.72 Favored 'General case' 0 N--CA 1.398 -3.041 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.499 ' SG ' HD13 ' A' ' 578' ' ' LEU . 98.8 m -114.69 -172.49 2.13 Favored 'General case' 0 C--N 1.259 -3.337 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -56.74 159.27 7.27 Favored Pre-proline 0 N--CA 1.429 -1.51 0 C-N-CA 123.94 0.896 . . . . 0.0 110.764 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.92 -37.93 47.32 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 124.209 3.273 . . . . 0.0 114.78 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -100.3 4.94 57.2 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.436 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 21.3 m-85 -106.35 141.07 38.28 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 121.605 0.717 . . . . 0.0 111.552 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 40.7 m -97.56 124.99 42.02 Favored 'General case' 0 N--CA 1.398 -3.073 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.89 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 7.2 tt -79.32 122.25 34.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 99.8 t -118.69 139.11 47.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 106.63 -149.3 16.59 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.9 112.74 3.61 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.321 2.014 . . . . 0.0 111.214 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.96 -1.52 57.4 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.614 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 594' ' ' LYS . 33.8 p -150.29 112.89 4.72 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.176 0.512 . . . . 0.0 110.64 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.25 149.8 12.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.623 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -102.61 157.6 16.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.271 0.558 . . . . 0.0 110.055 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 11.3 t -86.56 112.49 21.61 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.494 ' CE2' ' HB2' ' A' ' 610' ' ' GLN . 85.3 m-85 -101.18 169.88 8.63 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -60.62 -18.28 52.24 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -106.78 -1.04 22.98 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.152 0.501 . . . . 0.0 111.608 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.37 -169.7 22.16 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.221 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.413 ' C ' ' HG ' ' A' ' 617' ' ' SER . 2.6 mm? -75.14 122.81 24.17 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.416 ' HA ' ' C ' ' A' ' 618' ' ' PRO . 52.4 m -146.99 146.45 25.96 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 122.401 -0.187 . . . . 0.0 110.578 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 617' ' ' SER . 57.0 Cg_endo -69.5 -169.42 4.94 Favored 'Cis proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.057 -1.226 . . . . 0.0 112.804 0.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.72 172.72 10.19 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.469 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.61 142.65 77.74 Favored Pre-proline 0 C--N 1.292 -1.922 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -169.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.3 176.98 7.16 Favored 'Trans proline' 0 C--O 1.258 1.479 0 C-N-CA 124.049 3.166 . . . . 0.0 111.475 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.1 pt -122.03 165.72 17.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.648 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.546 ' SG ' HD13 ' A' ' 578' ' ' LEU . 85.1 m -110.63 112.25 24.02 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.499 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 602' ' ' THR . 52.6 mtpt -108.84 110.46 21.82 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.472 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 23.2 tt0 -77.77 -31.65 52.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.24 104.71 17.24 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.333 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.83 175.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.088 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.65 159.08 15.2 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.845 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 52.4 m -104.25 -9.16 18.81 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.364 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . 0.465 ' HB3' ' NE1' ' A' ' 678' ' ' TRP . 67.6 m 70.4 1.68 3.71 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.093 0.957 . . . . 0.0 113.514 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 62.99 -136.47 43.54 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -75.79 149.96 34.26 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 121.979 1.786 . . . . 0.0 110.658 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.536 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 78.4 Cg_endo -78.21 165.25 26.01 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.548 2.165 . . . . 0.0 111.013 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.444 ' HG2' HD12 ' A' ' 681' ' ' LEU . 33.0 Cg_endo -70.34 165.91 30.05 Favored 'Trans proline' 0 N--CA 1.435 -1.94 0 C-N-CA 121.408 1.405 . . . . 0.0 110.357 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.46 163.8 21.37 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.602 HD23 ' SG ' ' A' ' 659' ' ' CYS . 11.0 tp -83.33 174.42 10.71 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 683' ' ' VAL 0.342 0.4 OUTLIER -73.85 -69.71 0.42 Allowed 'General case' 0 N--CA 1.393 -3.281 0 C-N-CA 118.027 -1.469 . . . . 0.0 112.935 -179.871 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -95.1 -33.19 12.76 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.599 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -84.33 -143.11 5.73 Favored Glycine 0 N--CA 1.434 -1.455 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.341 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.34 -172.69 3.67 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 20.5 t -95.87 133.08 38.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 176.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.471 ' HB3' ' CD1' ' A' ' 658' ' ' TYR . 35.9 pttt -88.73 -26.35 21.82 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.977 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -78.55 151.91 32.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.389 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -67.08 115.08 6.38 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.534 0.683 . . . . 0.0 110.546 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.2 p -74.46 105.45 5.6 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.848 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 59.7 pttt -87.49 -177.67 5.96 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.77 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.07 -12.36 23.29 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -143.8 108.05 4.78 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.562 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 13.7 m-85 -85.92 -101.19 0.07 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 158.34 162.53 11.9 Favored Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 66.0 t60 -58.49 -52.43 65.67 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 40.0 m -92.53 11.91 24.78 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.177 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -96.57 116.61 29.38 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.482 0.658 . . . . 0.0 109.398 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.3 p -92.86 157.39 2.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.785 -177.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 23.9 m -123.7 111.65 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.56 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -74.39 119.61 18.83 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.798 0.809 . . . . 0.0 112.672 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 87.6 m-85 -100.46 173.44 6.57 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.781 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.471 ' CD1' ' HB3' ' A' ' 642' ' ' LYS . 29.0 p90 -151.22 137.34 18.32 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.602 ' SG ' HD23 ' A' ' 636' ' ' LEU . 68.0 m -96.91 177.07 5.74 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.464 ' C ' ' H ' ' A' ' 662' ' ' ARG . 78.3 m-20 -85.91 157.45 57.32 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.4 24.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 124.504 3.47 . . . . 0.0 114.959 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.464 ' H ' ' C ' ' A' ' 660' ' ' ASN . 23.8 mmt180 -120.35 -6.99 9.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -131.72 156.77 45.33 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.87 -174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 67.8 mt -105.99 166.5 10.45 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.608 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.7 OUTLIER -116.7 112.55 21.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.401 ' HB2' HD13 ' A' ' 685' ' ' ILE . 39.9 ttmt -81.94 -54.02 5.67 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.542 -174.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.13 -173.23 43.63 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.637 -176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.04 122.46 10.97 Favored 'Trans proline' 0 C--N 1.327 -0.557 0 C-N-CA 122.932 2.421 . . . . 0.0 111.141 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.654 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 21.2 p-10 -61.26 -14.66 27.87 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 122.872 0.469 . . . . 0.0 112.051 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -128.5 149.22 50.68 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 678' ' ' TRP . 47.0 pt -140.09 146.44 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -172.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.415 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.3 OUTLIER -114.01 157.0 23.06 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.228 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 11.7 t -80.35 96.56 6.71 Favored 'General case' 0 CA--C 1.472 -2.044 0 CA-C-O 123.197 1.475 . . . . 0.0 110.547 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.03 110.27 17.07 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.599 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.628 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 15.0 t70 59.22 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.616 1.166 . . . . 0.0 111.418 -171.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -153.7 23.47 0.73 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -134.32 131.07 37.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.536 ' HB3' HD13 ' A' ' 671' ' ' ILE . 98.8 m95 -76.4 149.89 36.86 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 7.8 p -83.5 178.75 7.87 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 11.7 m -57.32 122.95 13.76 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.712 0.805 . . . . 0.0 111.085 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.444 HD12 ' HG2' ' A' ' 634' ' ' PRO . 7.3 mp -63.97 163.67 21.77 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.654 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 20.1 Cg_endo -61.53 -15.17 39.66 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.876 3.051 . . . . 0.0 115.345 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.548 ' HA ' HD23 ' A' ' 637' ' ' LEU 0.297 28.7 m 50.7 101.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 177.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.447 ' SG ' ' CD2' ' A' ' 636' ' ' LEU . 12.9 m -78.29 132.54 37.52 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.441 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 666' ' ' LYS . 0.2 OUTLIER -127.68 136.57 60.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.64 130.79 28.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 123.566 0.541 . . . . 0.0 111.218 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 C--O 1.252 1.22 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.223 -177.372 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.246 0.878 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 71.68 143.16 0.06 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.34 1.456 . . . . 0.0 111.439 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . 0.697 ' HB1' ' HG2' ' A' ' 566' ' ' GLU . . . -84.25 -166.6 1.48 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -77.33 -11.22 85.71 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.697 ' HG2' ' HB1' ' A' ' 564' ' ' ALA . 11.8 pt-20 -61.7 162.32 8.73 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.127 1.371 . . . . 0.0 112.307 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -155.69 97.47 1.85 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -85.48 177.74 7.66 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.725 -170.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . . . . . . . . . 57.6 m -111.34 153.41 26.04 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -167.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.796 ' HG2' ' HG3' ' A' ' 586' ' ' GLN . 49.0 mt-10 -128.77 146.76 50.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 166.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . . . . . . . . . 1.7 tt -53.48 115.13 7.2 Favored Pre-proline 0 C--O 1.245 0.837 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.19 -169.11 0.48 Allowed 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.511 2.141 . . . . 0.0 111.572 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -88.65 92.38 9.17 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.519 HD13 ' HB3' ' A' ' 578' ' ' LEU . 37.2 pt -78.06 -170.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.658 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.4 t70 -77.61 147.4 35.64 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.12 -31.99 38.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 123.445 0.698 . . . . 0.0 111.044 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -98.54 14.63 27.66 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.081 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.587 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 5.5 tp -104.41 150.35 24.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.8 t -139.21 122.54 10.77 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' A' ' 583' ' ' LYS . 50.3 Cg_endo -78.74 144.67 19.65 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.813 2.342 . . . . 0.0 111.737 174.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 594' ' ' LYS . 7.2 t70 -51.86 -53.79 36.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.815 1.646 . . . . 0.0 111.212 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . 0.532 ' HG2' ' HE3' ' A' ' 584' ' ' LYS . 4.5 mpt_? -70.55 -59.86 2.6 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.025 0.44 . . . . 0.0 110.459 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.407 ' HA ' ' HG2' ' A' ' 580' ' ' PRO . 50.2 tttm 60.14 62.29 1.65 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.163 -174.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.532 ' HE3' ' HG2' ' A' ' 582' ' ' ARG . 16.8 ptpt -118.44 160.29 21.97 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.29 -45.33 40.49 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . 0.796 ' HG3' ' HG2' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -118.07 126.98 53.33 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.619 0.247 . . . . 0.0 110.504 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.641 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 86.5 m-85 -100.73 132.51 46.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.675 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -78.09 148.92 34.0 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.486 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 60.0 t -58.65 119.1 2.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 106.04 -1.73 38.21 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.598 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -73.14 134.09 44.32 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 122.362 -0.493 . . . . 0.0 109.731 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 17.6 t -101.0 114.9 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.641 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.4 mp -91.71 92.49 8.45 Favored 'General case' 0 N--CA 1.405 -2.68 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 608' ' ' SER . 58.1 mttp -74.13 136.46 42.92 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 173.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -112.57 163.71 14.18 Favored 'General case' 0 C--N 1.266 -3.026 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.753 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 14.7 m -152.55 172.07 17.15 Favored 'General case' 0 N--CA 1.39 -3.471 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.532 ' SG ' HD13 ' A' ' 578' ' ' LEU . 69.8 m -108.83 178.43 4.48 Favored 'General case' 0 C--N 1.247 -3.862 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 71.0 mmtt -54.29 162.79 1.46 Allowed Pre-proline 0 C--N 1.313 -0.98 0 C-N-CA 124.154 0.982 . . . . 0.0 111.935 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 82.8 Cg_exo -44.58 -44.92 13.53 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.127 3.218 . . . . 0.0 114.358 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -100.09 18.33 55.81 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.822 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -120.11 147.66 44.59 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 121.759 0.79 . . . . 0.0 112.384 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 23.1 m -100.66 133.44 45.11 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.648 175.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.523 HD12 ' HG3' ' A' ' 621' ' ' PRO . 10.1 tt -88.25 129.35 39.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . 0.442 ' CG2' ' HD3' ' A' ' 624' ' ' LYS . 75.4 t -121.93 123.48 69.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 123.62 -150.65 16.94 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -73.12 115.68 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.38 2.053 . . . . 0.0 111.209 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -92.31 7.69 41.7 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 594' ' ' LYS . 58.5 p -156.43 113.61 3.17 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.75 0.42 . . . . 0.0 110.01 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 13.7 m -118.1 151.96 20.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.493 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -101.27 154.35 18.85 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.449 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 6.6 t -85.0 112.67 20.81 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 169.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -104.22 170.17 8.06 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -77.88 14.61 1.05 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -125.81 -1.08 7.3 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 171.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.05 -175.36 19.83 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.926 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -78.8 123.8 27.57 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 5.4 t -150.36 151.91 32.13 Favored Pre-proline 0 C--N 1.309 -1.184 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.616 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.489 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 58.7 Cg_endo -70.03 -178.2 16.64 Favored 'Cis proline' 0 C--N 1.361 1.235 0 C-N-CA 123.812 -1.328 . . . . 0.0 112.717 0.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.13 157.07 23.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.334 0.587 . . . . 0.0 111.103 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . 0.48 HD11 ' HA ' ' A' ' 574' ' ' ILE . 22.6 mt -66.85 152.41 95.7 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 114.229 -1.35 . . . . 0.0 114.146 -168.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . 0.523 ' HG3' HD12 ' A' ' 603' ' ' ILE . 92.8 Cg_endo -81.46 179.74 5.57 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.065 3.177 . . . . 0.0 111.633 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.6 pt -121.46 174.44 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.592 0.234 . . . . 0.0 110.586 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 98.1 m -119.91 128.84 54.0 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.386 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.525 ' HE2' ' OD1' ' A' ' 675' ' ' ASP . 26.4 mtpp -124.0 132.31 53.68 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.98 -41.05 15.21 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -96.94 114.58 26.21 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.01 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 11.8 m -123.49 -175.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.24 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -99.41 165.14 11.8 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.52 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 18.6 m -100.36 -11.93 19.86 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 18.0 m 72.96 -0.42 3.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.36 1.064 . . . . 0.0 113.54 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 63.38 -144.67 49.45 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.6 157.1 24.98 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.612 2.208 . . . . 0.0 110.91 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.586 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.5 Cg_endo -75.15 163.69 34.52 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.857 2.371 . . . . 0.0 112.427 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 681' ' ' LEU . 37.0 Cg_endo -69.61 172.95 11.56 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.589 2.193 . . . . 0.0 111.899 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -86.06 161.23 19.03 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.588 HD22 ' SG ' ' A' ' 659' ' ' CYS . 15.1 tp -99.49 145.34 27.58 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 638' ' ' ASN . 1.3 pp -65.68 -37.69 87.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.432 ' N ' HD13 ' A' ' 637' ' ' LEU . 46.4 m-80 -138.36 33.96 2.3 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.206 1.003 . . . . 0.0 109.677 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.447 ' C ' ' HB3' ' A' ' 636' ' ' LEU . . . -158.1 -150.88 5.88 Favored Glycine 0 N--CA 1.413 -2.841 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.754 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . 0.552 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 2.1 t-20 -160.56 -177.35 6.14 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 17.9 t -91.55 129.59 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.242 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 658' ' ' TYR . 10.0 ptmm? -90.16 -14.83 32.74 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.604 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -89.84 168.86 11.74 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.877 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -77.72 110.97 13.03 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 17.8 p -71.23 106.49 3.83 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.523 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 42.6 pttt -87.94 153.41 21.32 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.271 175.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.458 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 11.0 pt-20 -68.32 -12.52 61.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.408 0.683 . . . . 0.0 111.607 -176.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -151.17 102.37 2.93 Favored 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -171.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.586 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 4.2 m-85 -82.49 -70.75 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 120.63 165.64 12.83 Favored Glycine 0 C--N 1.288 -2.106 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.604 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.2 t60 -74.02 142.16 45.77 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.439 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 49.6 m 71.32 5.46 5.44 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.307 1.043 . . . . 0.0 112.377 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.427 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 5.5 tp10 -84.1 115.37 22.35 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 2.4 p -90.2 152.63 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 30.5 m -120.98 112.05 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.729 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.469 ' HG3' ' HG2' ' A' ' 670' ' ' LYS . 27.3 mt-10 -69.57 119.8 14.37 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.017 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.525 ' HB3' HD23 ' A' ' 636' ' ' LEU . 79.2 m-85 -99.31 173.65 6.68 Favored 'General case' 0 C--N 1.271 -2.809 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.412 173.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.552 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 24.3 p90 -150.88 139.92 21.05 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 173.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.588 ' SG ' HD22 ' A' ' 636' ' ' LEU . 43.6 m -105.1 161.53 14.16 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-O 120.894 0.378 . . . . 0.0 110.521 172.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 662' ' ' ARG . 81.9 m-20 -57.03 152.04 30.96 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.54 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.04 33.69 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 124.738 3.625 . . . . 0.0 113.539 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.429 ' H ' ' C ' ' A' ' 660' ' ' ASN . 23.3 mtp180 -136.63 0.79 2.51 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 124.019 0.928 . . . . 0.0 109.008 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -127.18 159.2 34.99 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.811 -173.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.641 ' HG ' ' HB3' ' A' ' 687' ' ' GLU . 84.2 mt -107.81 136.51 47.42 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.789 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 4.2 ttt -95.32 113.68 25.37 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -78.25 -62.83 1.55 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.34 -170.43 46.82 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.653 -0.785 . . . . 0.0 112.878 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.65 123.71 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.028 2.485 . . . . 0.0 111.536 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -64.15 -17.95 63.98 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 122.915 0.486 . . . . 0.0 111.591 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 1.0 OUTLIER -122.32 153.52 38.84 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.638 HD11 HD13 ' A' ' 681' ' ' LEU . 46.8 pt -143.3 142.53 25.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.25 148.16 34.72 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 48.7 t -82.53 129.14 34.86 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.404 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.604 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 30.7 m -110.4 126.13 67.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 123.061 0.544 . . . . 0.0 110.638 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.525 ' OD1' ' HE2' ' A' ' 624' ' ' LYS . 21.9 t70 60.25 -67.0 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.562 1.145 . . . . 0.0 112.342 -172.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -168.44 21.66 0.09 OUTLIER Glycine 0 C--N 1.301 -1.405 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -132.71 137.9 47.06 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.523 ' HB3' HD13 ' A' ' 671' ' ' ILE . 96.6 m95 -81.73 152.22 27.13 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 8.0 p -77.56 -176.86 4.47 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 19.7 m -70.07 127.4 32.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.567 0.223 . . . . 0.0 111.565 -173.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.638 HD13 HD11 ' A' ' 671' ' ' ILE . 5.8 mp -62.91 155.13 73.44 Favored Pre-proline 0 CA--C 1.514 -0.426 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.519 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 5.6 Cg_endo -52.91 -55.04 4.1 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.795 2.997 . . . . 0.0 113.758 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 88.3 t 69.5 119.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.2 1.0 . . . . 0.0 111.198 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.789 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 33.1 m -117.66 155.87 29.16 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.062 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.59 149.39 25.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 123.783 0.833 . . . . 0.0 109.498 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.6 132.33 28.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 O-C-N 123.326 0.392 . . . . 0.0 110.044 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.641 ' HB3' ' HG ' ' A' ' 664' ' ' LEU . 8.2 pt-20 . . . . . 0 C--O 1.251 1.147 0 O-C-N 124.329 1.018 . . . . 0.0 112.332 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -135.24 94.0 3.06 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 121.305 0.574 . . . . 0.0 110.108 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -91.0 -31.92 16.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -141.81 120.27 1.61 Allowed Glycine 0 N--CA 1.41 -3.093 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.262 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.4 -49.34 67.12 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . 0.465 ' HD2' ' HB2' ' A' ' 613' ' ' HIS . 88.2 mtt180 -118.53 104.21 10.46 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 172.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -93.75 167.11 11.86 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.717 0.77 . . . . 0.0 111.876 -172.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 27.5 m -103.68 -43.18 5.42 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.009 174.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 60.79 -150.27 0.41 Allowed 'General case' 0 C--O 1.246 0.882 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 -171.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.41 HD12 ' HG3' ' A' ' 580' ' ' PRO . 1.0 OUTLIER -147.35 113.14 4.09 Favored Pre-proline 0 C--N 1.281 -2.372 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -177.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.408 ' HD2' HD13 ' A' ' 616' ' ' LEU . 37.2 Cg_endo -66.63 -170.67 0.22 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.253 2.635 . . . . 0.0 112.741 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -86.23 91.28 8.41 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.503 ' HB ' HD23 ' A' ' 578' ' ' LEU . 11.5 pt -59.56 -75.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.472 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 11.8 t70 -174.77 -173.07 0.68 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 10.9 p -106.16 -20.27 6.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -104.96 13.63 30.71 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.555 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.1 tt -114.62 141.61 47.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -175.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.34 116.9 14.31 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-O 121.42 0.629 . . . . 0.0 111.456 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.437 ' HD3' HD11 ' A' ' 574' ' ' ILE . 64.1 Cg_endo -76.9 137.33 17.52 Favored 'Trans proline' 0 C--N 1.328 -0.514 0 C-N-CA 122.764 2.309 . . . . 0.0 111.73 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -56.94 -55.06 39.45 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.61 0.719 . . . . 0.0 109.594 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -78.34 117.54 19.68 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -124.67 93.52 3.92 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -138.74 175.56 9.45 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.505 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -87.57 -52.2 5.47 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.544 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.45 120.46 39.6 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.434 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.52 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 41.2 m-85 -85.09 126.66 33.77 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.832 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -80.04 143.8 33.73 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.898 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.45 118.04 2.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.444 0.64 . . . . 0.0 109.717 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 104.8 1.02 42.61 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.297 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.62 116.66 18.35 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 6.5 p -92.4 121.56 43.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.933 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . . . . . . . . . 5.7 mp -95.78 93.9 7.35 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.009 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 96.2 mttt -78.64 93.82 4.94 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.09 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.463 ' HB3' HD22 ' A' ' 578' ' ' LEU . 65.1 m-85 -78.1 163.87 25.5 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.424 0.63 . . . . 0.0 110.228 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 21.3 m -155.58 171.03 20.63 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 89.1 m -117.59 175.06 5.81 Favored 'General case' 0 C--N 1.259 -3.336 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.3 mmmt -56.48 164.17 2.17 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.573 1.149 . . . . 0.0 112.555 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 94.8 Cg_exo -45.77 -40.17 19.13 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.584 3.522 . . . . 0.0 115.249 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -102.52 7.86 54.22 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.33 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 40.5 m-85 -110.55 132.86 53.82 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-O 121.799 0.809 . . . . 0.0 112.103 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 16.6 m -92.92 126.17 37.88 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.761 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.468 HD12 ' HG3' ' A' ' 621' ' ' PRO . 11.1 tt -78.95 117.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 50.2 t -108.78 117.49 54.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.653 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 122.74 -160.47 17.21 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.22 123.31 10.74 Favored 'Trans proline' 0 C--N 1.328 -0.507 0 C-N-CA 122.733 2.288 . . . . 0.0 110.947 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.404 ' N ' HD21 ' A' ' 607' ' ' ASN . 0.7 OUTLIER -86.21 -50.08 7.24 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.511 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 4.9 p -100.08 95.33 6.77 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 111.783 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.2 150.69 4.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.605 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 22.8 mm-40 -98.26 160.14 14.48 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 10.5 t -84.25 129.89 34.86 Favored 'General case' 1 C--N 1.243 -4.033 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.575 165.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 55.5 m-85 -119.19 170.65 8.9 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . 0.465 ' HB2' ' HD2' ' A' ' 567' ' ' ARG . 1.0 OUTLIER -67.19 -12.84 61.13 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -104.82 -3.84 23.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.63 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 131.54 -170.18 21.62 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.408 HD13 ' HD2' ' A' ' 572' ' ' PRO . 46.6 mt -74.81 131.34 40.7 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.498 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 22.6 t -149.64 143.56 16.91 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.47 -172.5 10.97 Favored 'Cis proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.212 -1.578 . . . . 0.0 113.585 2.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.5 145.42 2.56 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.703 0.801 . . . . 0.0 110.63 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 6.5 mp -77.19 147.7 76.83 Favored Pre-proline 0 C--N 1.298 -1.659 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.262 -172.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . 0.468 ' HG3' HD12 ' A' ' 603' ' ' ILE . 93.8 Cg_endo -74.85 -179.67 5.17 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 123.705 2.937 . . . . 0.0 112.913 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.6 pt -130.4 169.52 21.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 84.1 m -110.24 126.25 53.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.017 0.436 . . . . 0.0 110.832 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.494 ' HE2' ' OD1' ' A' ' 675' ' ' ASP . 28.3 mtpp -124.26 117.54 24.77 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.936 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.468 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 3.2 tm-20 -82.45 -36.77 26.26 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -94.26 98.93 11.27 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.843 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 6.2 m -114.28 171.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.468 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 53.5 mm-40 -98.67 169.12 9.72 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 42.6 m -116.14 -7.88 11.82 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.913 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 96.3 m 67.66 3.27 3.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 62.24 -132.2 45.24 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.91 155.3 38.77 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.023 2.482 . . . . 0.0 111.301 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.565 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 86.2 Cg_endo -83.56 161.88 14.62 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 122.651 2.234 . . . . 0.0 112.572 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.47 173.91 11.72 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.61 2.207 . . . . 0.0 111.388 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -98.23 161.42 13.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.568 HD22 ' SG ' ' A' ' 659' ' ' CYS . 19.7 tp -96.77 128.66 43.94 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -45.66 -42.04 11.04 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 34.5 m-80 -133.35 31.01 3.81 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.475 0.655 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -151.85 -144.77 3.99 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.59 -173.47 2.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 5.2 p -94.54 131.06 42.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.638 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 20.4 ptmt -88.91 -16.15 32.57 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.674 0.75 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.29 166.04 15.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.813 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -84.82 120.26 26.24 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.6 p -74.3 100.57 3.78 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.464 0.649 . . . . 0.0 112.448 -174.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -68.17 175.86 3.02 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.525 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -98.79 -0.85 41.75 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.746 0.784 . . . . 0.0 109.672 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.421 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 26.4 tt0 -157.92 120.72 3.85 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.565 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 7.0 m-85 -91.76 -86.08 0.23 Allowed 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.981 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 145.83 164.23 10.71 Favored Glycine 0 CA--C 1.488 -1.6 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.522 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 57.8 t60 -56.98 -51.77 67.89 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 25.5 m -99.7 21.76 11.94 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.4 0.619 . . . . 0.0 110.835 -174.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.64 115.27 27.59 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 11.6 m -92.2 147.91 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.691 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.441 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.789 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 0.2 OUTLIER -114.73 115.94 51.06 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.843 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.34 177.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.638 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 18.4 mt-10 -77.02 138.52 39.64 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.261 1.029 . . . . 0.0 111.596 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.514 ' HB3' HD23 ' A' ' 636' ' ' LEU . 72.6 m-85 -119.06 167.55 11.67 Favored 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 125.597 1.559 . . . . 0.0 109.589 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -144.91 144.35 31.04 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.568 ' SG ' HD22 ' A' ' 636' ' ' LEU . 71.1 m -100.83 172.25 7.17 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 37.1 m-80 -69.28 153.46 95.9 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 59.3 Cg_endo -68.9 10.5 0.37 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 123.699 2.933 . . . . 0.0 114.396 -174.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.41 3.56 25.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -131.46 164.22 26.24 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.688 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 687' ' ' GLU . 89.0 mt -104.22 165.16 11.23 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.493 ' HE1' ' SG ' ' A' ' 659' ' ' CYS . 4.2 ttt -123.91 103.83 8.57 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -82.65 -45.08 14.96 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -170.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -96.26 -173.73 35.71 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.007 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.51 122.01 10.64 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.416 2.744 . . . . 0.0 111.946 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 656' ' ' GLU . 2.4 p-10 -83.53 23.05 0.98 Allowed 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 122.872 0.469 . . . . 0.0 111.065 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.789 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 8.4 ptmt -163.82 107.09 0.97 Allowed 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 125.007 1.323 . . . . 0.0 108.014 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 37.7 pt -107.91 148.79 11.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.346 -174.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.489 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -113.74 154.17 27.78 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.453 0.47 . . . . 0.0 110.392 179.288 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 5.0 t -80.53 95.53 6.52 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.766 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.485 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 35.1 m -84.52 117.02 29.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 O-C-N 121.402 -0.811 . . . . 0.0 111.39 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.494 ' OD1' ' HE2' ' A' ' 624' ' ' LYS . 17.6 t70 62.23 -76.67 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.39 1.076 . . . . 0.0 111.118 -173.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -151.38 17.77 0.89 Allowed Glycine 0 N--CA 1.434 -1.477 0 O-C-N 123.792 0.683 . . . . 0.0 111.614 177.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -135.5 141.71 45.34 Favored 'General case' 0 CA--C 1.495 -1.158 0 O-C-N 122.29 -0.535 . . . . 0.0 109.94 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.519 ' HB3' HD13 ' A' ' 671' ' ' ILE . 99.0 m95 -74.34 156.03 37.53 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 3.3 p -81.23 -178.72 7.04 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 16.3 m -65.37 125.85 26.4 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.174 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.86 159.92 23.58 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.431 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 26.2 Cg_endo -62.87 -13.22 33.37 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 124.263 3.309 . . . . 0.0 115.284 -176.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.282 30.9 m 48.51 101.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 175.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.9 m -80.74 140.93 35.27 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.56 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.442 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.2 OUTLIER -141.69 146.24 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.352 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 14.8 m -58.07 138.13 19.42 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.504 0 O-C-N 124.439 1.087 . . . . 0.0 112.088 -174.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.544 ' HA ' ' HG ' ' A' ' 664' ' ' LEU . 41.9 tt0 . . . . . 0 C--N 1.314 -0.962 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.5 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 CA--C 1.511 -0.558 0 CA-C-O 121.593 0.711 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -150.07 157.86 43.56 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -83.28 93.7 7.76 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -66.35 -56.89 11.58 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -95.77 104.7 16.64 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 169.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.98 123.25 17.05 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.56 -171.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.22 138.59 40.72 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 172.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 87.2 m -67.3 146.53 54.03 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -117.86 149.24 41.19 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.512 HD23 ' HD2' ' A' ' 572' ' ' PRO . 2.7 tm? -77.76 111.67 19.41 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.512 ' HD2' HD23 ' A' ' 571' ' ' LEU . 84.3 Cg_endo -76.67 -170.02 0.82 Allowed 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.068 2.512 . . . . 0.0 111.625 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -74.43 102.37 4.42 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.526 0.679 . . . . 0.0 110.1 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.54 HD13 ' HB3' ' A' ' 578' ' ' LEU . 27.3 pt -83.53 -166.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.613 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.2 t70 -76.84 143.78 39.5 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.63 -26.91 24.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 C-N-CA 124.048 0.939 . . . . 0.0 111.928 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -103.92 11.02 36.05 Favored 'General case' 0 CA--C 1.494 -1.174 0 O-C-N 121.637 -0.664 . . . . 0.0 111.864 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 5.6 tp -95.87 153.08 17.94 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.44 120.18 6.13 Favored Pre-proline 0 C--N 1.286 -2.185 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.436 ' HB2' ' O ' ' A' ' 582' ' ' ARG . 56.4 Cg_endo -74.7 137.45 22.46 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.24 1.96 . . . . 0.0 112.08 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -70.8 -42.34 70.41 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 580' ' ' PRO . 6.1 mmp_? -82.6 123.81 29.57 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -137.18 91.64 2.64 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -137.92 172.63 12.65 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.578 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.08 -50.1 51.33 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.702 0.287 . . . . 0.0 111.36 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.06 152.85 50.95 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 121.443 0.639 . . . . 0.0 109.827 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.546 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 84.3 m-85 -115.18 119.72 37.32 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.068 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -70.05 142.24 52.72 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.567 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.533 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 1.8 p -61.29 112.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 122.279 1.038 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 121.33 -15.07 9.33 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.541 -174.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -72.03 126.26 29.32 Favored 'General case' 0 CA--C 1.473 -2.017 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 608' ' ' SER . 7.7 p -103.49 118.5 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.34 0 CA-C-O 122.35 1.071 . . . . 0.0 109.709 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.45 HD21 HD21 ' A' ' 571' ' ' LEU . 5.4 mp -91.04 98.52 11.82 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.025 -175.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 607' ' ' ASN . 96.0 mttt -78.21 118.96 20.93 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.546 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -97.9 179.49 4.78 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.387 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 10.5 p -168.67 161.82 11.48 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.586 ' SG ' HD13 ' A' ' 578' ' ' LEU . 90.1 m -105.0 -176.04 2.96 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.3 mmtp -63.27 162.72 22.47 Favored Pre-proline 0 N--CA 1.429 -1.499 0 C-N-CA 123.218 0.607 . . . . 0.0 111.545 175.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 88.8 Cg_exo -45.72 -40.03 18.76 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 124.498 3.465 . . . . 0.0 115.404 -175.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -97.22 3.69 62.0 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.61 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 45.6 m-85 -108.41 151.56 25.87 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.225 1.012 . . . . 0.0 113.379 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 2.6 m -103.76 123.6 47.35 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.061 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.438 ' HA ' ' SG ' ' A' ' 597' ' ' CYS . 5.7 tt -78.33 122.51 33.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . 0.447 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 55.4 t -115.52 121.0 66.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 122.185 -0.322 . . . . 0.0 110.598 -178.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 119.77 -151.23 17.48 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.132 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.37 115.51 4.37 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.06 2.507 . . . . 0.0 111.214 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 0.2 OUTLIER -82.24 -25.95 33.67 Favored 'General case' 0 C--O 1.197 -1.668 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.835 -178.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.434 ' HB2' ' CG2' ' A' ' 592' ' ' VAL . 64.7 p -123.08 98.54 5.93 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.354 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.1 m -101.21 142.46 15.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.627 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -96.27 151.07 19.86 Favored 'General case' 0 CA--C 1.48 -1.746 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.815 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 35.5 t -75.38 125.07 28.25 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 166.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.481 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 90.7 m-85 -116.36 165.1 13.59 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.95 2.89 4.9 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -177.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -111.11 -4.74 14.94 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.391 0.615 . . . . 0.0 110.422 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.52 -178.52 18.0 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.123 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.509 HD13 ' CD ' ' A' ' 572' ' ' PRO . 45.7 mt -70.92 120.18 16.12 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.481 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 49.9 m -138.42 146.13 49.84 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-O 120.475 0.179 . . . . 0.0 110.672 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.84 -169.16 7.05 Favored 'Cis proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.182 -1.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.37 169.67 7.05 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . 0.496 HD22 ' HG2' ' A' ' 572' ' ' PRO . 1.3 mm? -74.16 145.75 83.65 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.343 -168.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.24 170.59 17.9 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 123.228 2.619 . . . . 0.0 110.668 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . 0.447 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 47.0 pt -113.34 -178.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 602' ' ' THR . 96.1 m -129.13 109.04 10.84 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.425 0.453 . . . . 0.0 111.914 -177.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.579 ' O ' ' HB ' ' A' ' 602' ' ' THR . 18.5 mtmm -97.89 127.12 43.63 Favored 'General case' 0 C--O 1.201 -1.461 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 176.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.499 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 1.4 tm-20 -83.37 -34.5 25.58 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.36 107.54 18.52 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.058 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.552 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 10.4 p -125.22 174.51 9.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -88.16 139.62 30.31 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 118.824 0.738 . . . . 0.0 109.352 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 631' ' ' GLY . 17.4 m -93.87 104.54 16.6 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 173.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 55.9 m -60.9 21.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 629' ' ' SER . . . 54.83 -139.06 40.8 Favored Glycine 0 C--O 1.241 0.579 0 CA-C-O 119.734 -0.481 . . . . 0.0 112.906 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.96 154.68 22.86 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.961 2.441 . . . . 0.0 110.782 175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.48 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 59.9 Cg_endo -74.4 157.71 45.04 Favored 'Trans proline' 0 C--O 1.255 1.355 0 C-N-CA 122.684 2.256 . . . . 0.0 112.922 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.38 -169.47 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 123.47 2.78 . . . . 0.0 111.199 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -109.65 153.08 24.73 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.393 -0.817 . . . . 0.0 110.675 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.526 HD21 ' HA3' ' A' ' 639' ' ' GLY . 18.6 tp -80.67 139.86 35.95 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.435 HD11 ' OD1' ' A' ' 638' ' ' ASN . 0.3 OUTLIER -46.26 -47.79 18.06 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -178.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.435 ' OD1' HD11 ' A' ' 637' ' ' LEU . 16.4 m120 -116.58 -30.43 5.83 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.519 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -91.12 -152.23 27.8 Favored Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.222 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.35 -174.77 5.09 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.995 0.426 . . . . 0.0 110.545 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 6.0 p -92.68 134.71 29.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.536 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.555 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.2 ptmt -93.86 -24.65 17.66 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.046 0.45 . . . . 0.0 110.61 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.442 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 15.2 mm-40 -78.82 151.47 31.89 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.364 -177.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -63.97 109.24 1.72 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 16.7 p -71.59 98.56 1.9 Allowed 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.434 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -81.3 158.03 24.9 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -87.81 0.88 55.2 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.1 108.56 4.84 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.48 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 17.4 m-85 -92.76 -104.75 0.12 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 147.56 168.99 14.48 Favored Glycine 0 CA--C 1.487 -1.657 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.01 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.549 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 18.7 t60 -69.65 142.25 53.47 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 17.8 m 75.72 -1.66 2.95 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.549 1.14 . . . . 0.0 111.422 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -93.72 114.63 26.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 17.8 m -91.84 161.41 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.774 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.622 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.1 m -127.16 110.89 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.512 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.574 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.555 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 17.8 mt-10 -70.16 122.23 19.06 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.105 0.955 . . . . 0.0 111.599 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.519 ' HB3' HD23 ' A' ' 636' ' ' LEU . 76.6 m-85 -102.42 166.89 10.3 Favored 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.032 174.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -146.83 137.04 23.55 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.557 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 8.3 t -102.61 179.09 4.39 Favored 'General case' 0 C--N 1.276 -2.612 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.025 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 662' ' ' ARG . 30.9 m-80 -75.85 155.66 84.81 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.52 33.85 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 124.295 3.33 . . . . 0.0 112.688 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 660' ' ' ASN . 35.4 mtt180 -133.3 4.77 3.74 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -138.42 163.11 32.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.462 -175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.1 147.61 38.49 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.411 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.5 OUTLIER -103.34 118.98 37.99 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -176.067 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -80.21 -59.33 2.75 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -95.53 -160.79 33.4 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.067 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.93 116.34 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.03 2.487 . . . . 0.0 112.237 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.474 ' ND2' ' HG3' ' A' ' 670' ' ' LYS . 4.9 p-10 -63.52 -11.77 26.85 Favored 'General case' 0 C--O 1.195 -1.776 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.946 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -134.62 115.31 13.69 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.238 0.542 . . . . 0.0 111.909 178.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 33.8 pt -109.03 151.58 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.048 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.467 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -115.64 152.12 33.73 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 121.211 0.529 . . . . 0.0 111.399 -179.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 1.5 t -69.72 121.15 16.62 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.03 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.44 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 34.0 m -116.23 86.9 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 CA-C-O 122.293 1.044 . . . . 0.0 113.045 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.552 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 16.5 m-20 75.3 8.05 3.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.795 -1.548 . . . . 0.0 113.913 166.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 142.35 -11.92 2.51 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.285 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -138.63 149.26 45.01 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.505 ' HB3' HD13 ' A' ' 671' ' ' ILE . 93.8 m95 -80.01 158.89 26.41 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 19.0 p -80.17 -180.0 7.35 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.655 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 25.8 m -68.6 126.72 30.55 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 120.717 0.294 . . . . 0.0 110.944 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.452 ' HB3' ' HD2' ' A' ' 682' ' ' PRO . 6.2 mp -57.94 160.3 8.76 Favored Pre-proline 0 N--CA 1.441 -0.904 0 O-C-N 124.461 1.101 . . . . 0.0 113.011 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 681' ' ' LEU . 11.5 Cg_endo -57.31 -42.1 66.0 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.112 2.541 . . . . 0.0 113.283 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 99.8 t 67.55 113.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-O 121.936 0.874 . . . . 0.0 110.467 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 8.1 p -111.54 138.17 48.42 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.996 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.2 OUTLIER -124.89 148.52 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.283 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.469 -176.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 14.8 m -56.3 138.11 17.26 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.558 0 C-N-CA 124.558 1.143 . . . . 0.0 113.759 -171.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 C--N 1.299 -1.62 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.606 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -175.62 26.46 0.0 OUTLIER 'General case' 0 C--O 1.247 0.958 0 C-N-CA 123.576 0.75 . . . . 0.0 110.549 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -73.6 140.07 45.97 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.208 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 80.84 -41.91 2.62 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 116.243 -0.435 . . . . 0.0 113.991 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.1 72.96 0.62 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.262 1.03 . . . . 0.0 113.669 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -90.87 -23.63 20.48 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.449 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -147.99 -158.37 0.91 Allowed 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.407 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 616' ' ' LEU . 90.5 m -59.28 133.34 56.01 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -174.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 571' ' ' LEU . 35.6 tt0 -94.63 -61.51 1.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.597 HD12 ' HG3' ' A' ' 580' ' ' PRO . 3.4 tt 150.84 129.88 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 177.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.568 ' HD3' HD11 ' A' ' 616' ' ' LEU . 74.5 Cg_endo -70.55 -170.8 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.76 1.64 . . . . 0.0 111.325 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -92.27 102.19 14.69 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.646 HD11 ' HD3' ' A' ' 580' ' ' PRO . 36.7 pt -76.2 -164.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.601 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.676 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 11.3 t70 -80.86 163.84 23.11 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.14 -28.09 22.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.17 0.509 . . . . 0.0 110.793 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -101.6 9.45 41.14 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 121.734 -0.604 . . . . 0.0 111.424 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.676 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.2 tm? -100.79 146.49 27.21 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.3 m -140.74 121.14 8.82 Favored Pre-proline 0 C--N 1.3 -1.578 0 C-N-CA 123.754 0.822 . . . . 0.0 109.326 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.646 ' HD3' HD11 ' A' ' 574' ' ' ILE . 55.8 Cg_endo -73.0 136.33 24.7 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.036 1.824 . . . . 0.0 111.484 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.74 -38.82 92.3 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.537 1.135 . . . . 0.0 110.782 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -67.38 -61.07 2.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.739 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 60.6 tttm 51.84 74.57 0.25 Allowed 'General case' 0 C--O 1.241 0.649 0 O-C-N 124.676 1.235 . . . . 0.0 110.895 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -131.12 156.24 45.61 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.289 -1.323 . . . . 0.0 107.445 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -76.55 -31.51 57.64 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.21 133.08 40.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.875 0.369 . . . . 0.0 110.838 174.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.499 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 96.7 m-85 -110.69 142.29 42.8 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 588' ' ' LYS . 23.6 ttmm -93.13 153.4 18.68 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.597 ' HA ' ' SG ' ' A' ' 611' ' ' CYS 0.269 0.2 OUTLIER -64.64 118.0 6.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 121.839 0.828 . . . . 0.0 111.705 179.493 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 113.34 -3.66 25.11 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.768 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -74.53 134.7 42.19 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 20.3 m -109.82 129.92 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.881 0.848 . . . . 0.0 109.888 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.499 ' HG ' ' CE2' ' A' ' 587' ' ' TYR 0.368 0.0 OUTLIER -116.26 98.56 6.66 Favored 'General case' 0 N--CA 1.385 -3.701 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.269 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 607' ' ' ASN . 24.4 mtpp -61.46 124.6 21.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.044 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.483 ' HB3' HD13 ' A' ' 578' ' ' LEU . 27.7 m-85 -105.44 164.73 11.64 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.702 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 596' ' ' SER . . . . . 0.525 ' HA ' HD13 ' A' ' 603' ' ' ILE . 34.0 p -168.85 166.69 11.31 Favored 'General case' 0 N--CA 1.401 -2.88 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 169.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 70.8 m -98.9 173.26 6.94 Favored 'General case' 0 C--N 1.255 -3.534 0 O-C-N 123.769 0.668 . . . . 0.0 110.831 -177.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.578 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 29.9 mmtp -53.04 163.21 0.9 Allowed Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 124.304 1.041 . . . . 0.0 112.191 176.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 18.7 Cg_endo -60.69 -17.09 47.55 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.852 2.368 . . . . 0.0 115.291 -170.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -110.54 8.63 30.37 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.273 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 30.7 m-85 -113.1 162.43 15.94 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.534 0.683 . . . . 0.0 112.258 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 8.1 m -112.65 131.95 55.4 Favored 'General case' 0 N--CA 1.416 -2.148 0 C-N-CA 125.533 1.533 . . . . 0.0 110.111 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' A' ' 596' ' ' SER . 11.4 tt -83.98 122.4 37.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.439 0.638 . . . . 0.0 109.5 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . 0.413 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 46.1 t -118.07 109.74 28.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.276 0.56 . . . . 0.0 109.856 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 132.82 -164.43 24.07 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.21 128.76 27.39 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.966 2.444 . . . . 0.0 110.786 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 6.8 m120 -94.96 -10.17 31.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 122.182 -0.324 . . . . 0.0 110.947 -175.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 608' ' ' SER . . . . . . . . . . . . . 2.8 p -150.24 98.08 2.63 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.335 0.588 . . . . 0.0 111.637 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 20.3 m -93.21 167.56 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.781 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.552 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 2.0 mp0 -113.97 156.0 24.83 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.288 0.566 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.597 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 0.9 OUTLIER -85.25 130.8 34.53 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 164.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.552 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 77.5 m-85 -115.35 175.0 5.71 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -73.23 -12.94 61.04 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.862 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -101.38 -2.32 31.19 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 111.173 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.25 -171.78 21.35 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.568 HD11 ' HD3' ' A' ' 572' ' ' PRO . 5.2 mp -87.36 137.59 32.21 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 118.091 0.945 . . . . 0.0 110.019 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 618' ' ' PRO . 44.7 m -158.38 157.11 28.67 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.152 -176.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.48 ' O ' ' HA ' ' A' ' 617' ' ' SER . 59.3 Cg_endo -68.92 -168.18 3.85 Favored 'Cis proline' 0 CA--C 1.554 1.498 0 C-N-CA 124.599 -1.001 . . . . 0.0 114.279 1.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.02 160.99 16.78 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.994 0.426 . . . . 0.0 110.748 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . 0.481 ' HG ' ' HA ' ' A' ' 574' ' ' ILE . 2.1 mm? -78.43 144.52 66.11 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.89 162.53 41.78 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.982 2.455 . . . . 0.0 110.924 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . 0.413 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 43.1 pt -110.49 -178.66 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.7 m -129.9 116.63 18.93 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-O 121.28 0.562 . . . . 0.0 111.716 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -104.02 130.42 51.68 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.442 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 25.3 tt0 -86.85 -39.82 15.48 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -98.22 107.54 20.04 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.138 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.6 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 3.5 p -107.13 176.48 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.468 ' NE2' ' HA3' ' A' ' 676' ' ' GLY . 48.2 mt-30 -93.53 156.14 16.91 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 15.4 m -99.02 -7.53 26.71 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.658 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . 0.453 ' SG ' ' HA2' ' A' ' 676' ' ' GLY . 20.9 m 71.1 -12.4 0.59 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 167.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 65.18 -147.25 50.79 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -79.01 148.76 22.08 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 122.66 2.24 . . . . 0.0 111.846 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.42 167.69 25.22 Favored 'Trans proline' 0 CA--C 1.556 1.578 0 C-N-CA 123.49 2.793 . . . . 0.0 113.025 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.97 -167.52 0.24 Allowed 'Trans proline' 0 CA--C 1.55 1.292 0 C-N-CA 123.626 2.884 . . . . 0.0 113.587 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -111.99 166.02 11.59 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 657' ' ' TYR . 18.9 tp -102.55 132.2 48.78 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 638' ' ' ASN . 2.3 pp -51.91 -42.91 63.12 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.776 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 15.3 m120 -131.09 29.91 4.62 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.717 0.77 . . . . 0.0 109.392 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -153.61 -150.4 5.45 Favored Glycine 0 N--CA 1.412 -2.953 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.55 -166.84 1.73 Allowed 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.5 p -107.53 128.37 62.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -85.44 -22.29 28.36 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.348 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.577 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 8.2 mm-40 -86.89 144.43 26.99 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.158 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . 0.564 ' HB3' ' HZ2' ' A' ' 644' ' ' LYS . 5.9 ttpm? -56.8 112.7 1.38 Allowed 'General case' 0 C--N 1.31 -1.136 0 O-C-N 124.353 1.033 . . . . 0.0 109.938 176.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.452 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 4.9 p -83.72 101.43 11.55 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.599 0.714 . . . . 0.0 111.682 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.527 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 49.7 pttt -84.95 160.78 20.02 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.099 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.94 -21.05 60.66 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -152.26 125.01 8.42 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.097 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.527 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 11.3 m-85 -99.27 -75.27 0.57 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 129.19 172.19 13.12 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -175.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -60.44 -63.31 1.34 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 19.3 m -87.9 41.82 1.02 Allowed 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 121.333 0.587 . . . . 0.0 111.172 -172.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -120.3 106.28 11.73 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.8 m -82.19 154.64 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-O 122.066 0.936 . . . . 0.0 111.548 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.8 t -127.45 111.89 26.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 114.13 -1.396 . . . . 0.0 107.995 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.577 ' HB2' ' HG2' ' A' ' 643' ' ' GLU . 36.0 mt-10 -70.09 120.47 15.84 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 122.21 1.005 . . . . 0.0 113.01 175.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 55.4 m-85 -100.21 165.34 11.54 Favored 'General case' 0 C--N 1.263 -3.153 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.717 171.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -146.54 138.29 24.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 80.1 m -92.3 175.92 6.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.463 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 0.8 OUTLIER -67.46 157.55 85.32 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 70.1 Cg_endo -72.89 37.74 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.909 3.073 . . . . 0.0 113.195 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 660' ' ' ASN . 19.1 ptt180 -153.52 11.82 0.45 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.695 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 660' ' ' ASN . 87.0 m-85 -132.88 154.15 50.66 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.37 0.605 . . . . 0.0 110.196 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 85.4 mt -93.68 149.23 21.4 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.528 ' HE1' ' SG ' ' A' ' 659' ' ' CYS . 5.2 ttt -112.11 118.76 36.26 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -75.18 -72.04 0.32 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -172.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -90.67 -151.97 26.95 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 113.663 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.36 119.67 6.74 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.3 2.667 . . . . 0.0 111.919 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -74.96 -12.9 60.45 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 121.201 0.524 . . . . 0.0 110.81 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 9.1 mtpt -119.24 125.88 50.18 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 40.4 pt -116.74 138.14 48.32 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.605 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.536 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -102.61 161.52 13.66 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 42.8 t -102.2 110.93 23.03 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.492 1.139 . . . . 0.0 111.135 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 77.8 t -86.14 110.08 19.47 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.036 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.13 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.6 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 23.0 t70 60.73 -80.27 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 124.799 1.24 . . . . 0.0 112.43 -171.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.468 ' HA3' ' NE2' ' A' ' 628' ' ' GLN . . . -145.67 14.61 1.79 Allowed Glycine 0 C--N 1.301 -1.389 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 176.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -125.41 115.6 20.54 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.529 ' HB3' HD13 ' A' ' 671' ' ' ILE . 98.4 m95 -63.53 146.24 54.08 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 17.8 p -67.36 175.51 2.71 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 2.7 m -60.5 130.2 45.38 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.938 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.438 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 6.0 mp -63.38 152.25 85.6 Favored Pre-proline 0 N--CA 1.433 -1.281 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.462 ' CG ' ' HE3' ' A' ' 665' ' ' MET . 19.3 Cg_endo -58.64 -36.73 96.83 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.648 2.898 . . . . 0.0 114.125 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 66.2 t 69.4 117.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.913 0.885 . . . . 0.0 112.773 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 4.1 m -96.75 135.35 38.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.446 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.1 OUTLIER -136.81 144.04 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.928 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 16.8 m -58.15 139.69 17.47 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.064 0 C-N-CA 124.678 1.191 . . . . 0.0 112.843 -174.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.62 -179.38 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -121.04 170.78 9.19 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -60.95 107.56 0.73 Allowed 'General case' 0 C--O 1.254 1.3 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -99.23 -148.49 23.24 Favored Glycine 0 N--CA 1.422 -2.251 0 CA-C-N 115.375 -0.83 . . . . 0.0 113.753 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 47.06 65.57 1.21 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.826 1.65 . . . . 0.0 111.717 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -107.02 4.41 27.02 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.226 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -157.31 162.86 39.15 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 79.2 m -67.78 119.19 12.09 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.792 0.806 . . . . 0.0 110.943 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.76 -2.31 38.36 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-O 122.419 1.104 . . . . 0.0 108.929 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.63 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 47.4 tp 74.37 115.1 0.03 OUTLIER Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 127.059 2.144 . . . . 0.0 110.337 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.568 ' HG2' HD13 ' A' ' 620' ' ' LEU . 60.8 Cg_endo -67.97 -159.47 0.05 OUTLIER 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 123.696 2.931 . . . . 0.0 111.6 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -89.93 98.98 12.09 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 578' ' ' LEU . 40.7 pt -72.83 175.09 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.153 174.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.7 t70 -65.79 147.81 52.79 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.12 -25.91 31.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 C-N-CA 123.792 0.837 . . . . 0.0 110.786 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -105.9 8.32 32.57 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 122.054 -0.403 . . . . 0.0 111.864 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.629 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 6.5 tp -91.75 148.61 22.12 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 21.7 m -135.66 116.57 11.77 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 583' ' ' LYS . 26.9 Cg_endo -74.23 134.61 19.47 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.472 1.448 . . . . 0.0 109.686 174.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -33.41 75.72 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.76 -64.75 0.84 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.802 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 27.3 ttpp 47.91 82.34 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.691 1.596 . . . . 0.0 112.334 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.66 163.91 28.37 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.975 -1.466 . . . . 0.0 107.412 -178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -72.69 -46.02 55.84 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.957 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.36 133.88 50.01 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.577 0.703 . . . . 0.0 110.258 177.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.63 ' CE1' ' HB2' ' A' ' 571' ' ' LEU . 92.8 m-85 -107.37 124.76 50.3 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 124.862 1.265 . . . . 0.0 109.509 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -78.79 149.23 32.66 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.576 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 1.3 p -63.8 119.17 7.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.59 0.709 . . . . 0.0 111.33 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 115.2 -10.38 20.21 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.26 -173.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -70.21 125.97 28.32 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 609' ' ' VAL . 18.6 t -99.55 116.7 43.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 608' ' ' SER . 9.7 mt -101.84 115.04 29.66 Favored 'General case' 0 CA--C 1.47 -2.121 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.544 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 34.1 mtmm -91.76 99.38 12.27 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -76.81 161.81 28.15 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-O 122.022 0.915 . . . . 0.0 109.147 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 38.5 m -152.46 169.38 22.74 Favored 'General case' 0 C--N 1.253 -3.619 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.483 ' SG ' HD13 ' A' ' 578' ' ' LEU . 87.6 m -107.43 -178.17 3.56 Favored 'General case' 0 C--N 1.247 -3.887 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.557 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 32.1 mmtm -55.67 163.83 1.83 Allowed Pre-proline 0 C--N 1.313 -1.022 0 C-N-CA 123.018 0.527 . . . . 0.0 110.993 172.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 16.6 Cg_endo -59.03 -28.66 88.49 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.36 2.04 . . . . 0.0 114.701 -171.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.88 -2.65 61.04 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.879 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.557 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 39.9 m-85 -103.62 136.3 43.58 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 14.4 m -87.87 125.78 34.67 Favored 'General case' 0 N--CA 1.395 -3.201 0 CA-C-N 113.74 -1.573 . . . . 0.0 109.182 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.454 HD12 ' HG3' ' A' ' 621' ' ' PRO . 12.6 tt -80.31 125.69 39.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 82.5 t -117.25 114.58 46.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 123.59 -166.67 16.0 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.178 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.24 115.82 3.37 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.919 2.413 . . . . 0.0 111.535 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.99 -49.51 17.47 Favored 'General case' 0 C--O 1.206 -1.201 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.544 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 57.0 p -99.1 113.7 26.05 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.11 0.481 . . . . 0.0 111.626 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 592' ' ' VAL . 15.8 m -116.86 157.39 17.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 175.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.503 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -103.36 151.96 22.14 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 121.011 0.434 . . . . 0.0 109.904 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 42.1 t -80.16 129.46 34.51 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.402 ' HE1' ' O ' ' A' ' 617' ' ' SER . 95.6 m-85 -114.64 165.79 12.41 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -61.92 -18.72 61.24 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -97.79 -5.28 35.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.85 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 134.62 -179.75 17.28 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.508 HD13 ' HD2' ' A' ' 572' ' ' PRO . 71.9 mt -72.99 128.87 36.74 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 618' ' ' PRO . 67.1 m -146.26 147.07 30.07 Favored Pre-proline 0 C--N 1.294 -1.809 0 CA-C-N 116.816 -0.175 . . . . 0.0 110.681 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 617' ' ' SER . 49.5 Cg_endo -66.64 -175.7 7.74 Favored 'Cis proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.728 -1.363 . . . . 0.0 113.111 0.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.19 163.81 9.67 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 121.033 0.444 . . . . 0.0 110.957 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . 0.568 HD13 ' HG2' ' A' ' 572' ' ' PRO . 24.0 mt -77.39 145.91 73.04 Favored Pre-proline 0 C--N 1.293 -1.869 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.972 -170.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . 0.454 ' HG3' HD12 ' A' ' 603' ' ' ILE . 61.8 Cg_endo -70.91 173.68 11.64 Favored 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 123.537 2.824 . . . . 0.0 111.007 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 44.1 pt -117.7 178.23 2.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.8 m -123.89 123.39 40.32 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.114 0.483 . . . . 0.0 110.604 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 602' ' ' THR . 58.2 mtpt -118.92 119.79 35.36 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.557 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 4.3 tm-20 -79.25 -43.12 24.38 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -91.64 91.92 8.23 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.488 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.623 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 5.0 p -109.69 170.82 2.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.275 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.531 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 19.9 mm-40 -91.61 161.17 15.04 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 27.3 m -107.51 -4.9 17.96 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.104 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 80.1 m 71.22 -34.79 0.31 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 88.34 -141.93 17.06 Favored Glycine 0 N--CA 1.415 -2.719 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -74.34 145.7 34.58 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 121.997 1.798 . . . . 0.0 111.831 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -82.43 170.86 12.83 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.085 2.523 . . . . 0.0 111.874 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.14 -166.92 0.15 Allowed 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 123.214 2.61 . . . . 0.0 113.108 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -100.45 169.58 8.99 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 1.589 HD23 ' CD1' ' A' ' 636' ' ' LEU . 14.7 tp -91.33 166.16 13.05 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 117.733 -1.587 . . . . 0.0 110.258 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.401 ' H ' ' CG ' ' A' ' 636' ' ' LEU . 4.9 tt -63.45 -67.64 0.41 Allowed 'General case' 0 N--CA 1.396 -3.162 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.716 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -128.08 40.16 3.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.979 0.895 . . . . 0.0 109.169 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -149.21 -142.13 3.55 Favored Glycine 1 N--CA 1.395 -4.067 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.784 176.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.66 -172.83 4.21 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 9.0 p -104.0 134.55 44.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.7 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.1 ptmt -86.17 -29.85 22.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.661 0.744 . . . . 0.0 110.439 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 642' ' ' LYS . 27.6 mm-40 -88.2 159.24 18.24 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.508 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -72.84 118.86 16.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.664 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 18.1 p -71.6 101.91 2.62 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-O 121.724 0.773 . . . . 0.0 111.21 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -73.29 156.54 38.35 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.484 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 49.2 mt-10 -85.59 -6.19 59.19 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -140.95 113.27 7.99 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 173.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -96.35 -77.85 0.48 Allowed 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.455 174.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 130.09 163.5 11.1 Favored Glycine 0 CA--C 1.497 -1.091 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 71.2 t60 -56.51 -57.86 10.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 44.7 m -86.28 20.62 2.31 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -102.66 120.0 39.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 2.9 p -99.16 161.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.252 0.548 . . . . 0.0 110.143 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.8 t -127.37 113.72 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.724 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.7 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 29.5 mt-10 -71.91 124.15 24.26 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.497 0.665 . . . . 0.0 112.45 176.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.486 ' HB3' HD12 ' A' ' 636' ' ' LEU . 87.5 m-85 -108.1 167.33 10.07 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.621 172.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -150.44 141.23 22.76 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.649 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 9.1 m -100.47 173.85 6.38 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.116 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.426 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 42.3 m-80 -62.89 155.09 73.47 Favored Pre-proline 0 C--O 1.245 0.828 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.618 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 53.5 Cg_endo -71.01 29.41 0.21 Allowed 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 124.218 3.279 . . . . 0.0 114.681 -175.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 660' ' ' ASN . 0.1 OUTLIER -143.3 21.8 1.88 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.176 0.989 . . . . 0.0 110.144 -179.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -135.6 157.38 47.03 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.01 175.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.43 132.36 54.2 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.406 ' HE1' HD13 ' A' ' 636' ' ' LEU . 3.1 ttt -97.0 106.41 18.75 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -90.97 -42.65 10.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -173.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.89 -178.67 46.13 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.183 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.27 113.64 1.63 Allowed 'Trans proline' 0 N--CA 1.476 0.484 0 C-N-CA 123.613 2.876 . . . . 0.0 112.082 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 5.3 p-10 -63.27 -15.42 57.12 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 2.0 mtpt -120.22 155.32 33.41 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 44.5 pt -139.36 145.95 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.584 HE21 ' N ' ' A' ' 672' ' ' GLN . 0.0 OUTLIER -118.64 158.75 24.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.096 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 7.5 t -86.33 104.48 15.88 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.878 1.323 . . . . 0.0 111.344 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.6 106.63 18.07 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.051 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.845 -176.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.623 ' HA ' ' CG2' ' A' ' 627' ' ' VAL 0.253 16.0 t70 64.13 -56.54 0.23 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.7 1.6 . . . . 0.0 114.543 -178.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -161.95 4.97 0.08 OUTLIER Glycine 0 C--N 1.288 -2.095 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.651 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -136.37 154.46 50.82 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 123.115 0.566 . . . . 0.0 109.478 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.42 ' HB3' HD13 ' A' ' 671' ' ' ILE . 96.3 m95 -80.34 174.72 11.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.836 0.826 . . . . 0.0 111.638 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.11 167.85 10.8 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.705 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 26.7 m -57.16 128.46 37.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.22 0.95 . . . . 0.0 110.937 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.505 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 4.5 mp -65.94 154.46 89.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.541 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.505 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 5.9 Cg_endo -53.68 -32.6 65.92 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.962 3.108 . . . . 0.0 114.874 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.315 30.5 m 42.79 94.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 26.9 p -86.79 162.03 18.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.697 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.62 155.99 23.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.5 140.68 13.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 123.686 0.617 . . . . 0.0 110.764 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--O 1.247 0.93 0 C-N-CA 123.55 0.74 . . . . 0.0 110.831 -179.348 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 CA--C 1.509 -0.611 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 61.75 -179.48 0.12 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.259 1.024 . . . . 0.0 111.402 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -102.58 151.67 22.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -75.9 121.94 6.45 Favored Glycine 0 N--CA 1.441 -1.011 0 O-C-N 123.907 0.754 . . . . 0.0 111.825 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.706 ' HG3' ' HG2' ' A' ' 567' ' ' ARG . 11.2 tp10 -78.29 128.38 33.61 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.423 0.689 . . . . 0.0 111.399 -177.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . 0.706 ' HG2' ' HG3' ' A' ' 566' ' ' GLU . 22.2 mmm180 68.18 57.41 0.48 Allowed 'General case' 0 C--O 1.247 0.941 0 C-N-CA 125.809 1.643 . . . . 0.0 114.423 173.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -143.06 -175.94 4.72 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.778 0.831 . . . . 0.0 109.07 175.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 89.4 m -100.9 149.6 23.71 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -137.28 14.0 3.02 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.428 ' HA ' ' HD2' ' A' ' 572' ' ' PRO . 1.1 tm? 70.96 101.62 0.04 OUTLIER Pre-proline 0 C--O 1.247 0.935 0 C-N-CA 124.481 1.113 . . . . 0.0 109.881 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 571' ' ' LEU . 62.8 Cg_endo -71.74 -172.34 0.8 Allowed 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.497 2.798 . . . . 0.0 111.613 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.39 95.86 5.2 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.534 HD11 ' HD3' ' A' ' 580' ' ' PRO . 17.2 pt -73.81 -175.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.592 177.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.7 t70 -71.2 148.87 46.87 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.49 -33.0 46.95 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.634 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -98.6 13.02 33.47 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 121.805 -0.56 . . . . 0.0 111.943 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.6 OUTLIER -106.06 150.75 25.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.527 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.55 119.68 7.78 Favored Pre-proline 0 C--N 1.312 -1.045 0 C-N-CA 124.159 0.983 . . . . 0.0 109.197 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.534 ' HD3' HD11 ' A' ' 574' ' ' ILE . 33.3 Cg_endo -71.43 135.31 26.3 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.321 2.014 . . . . 0.0 112.318 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.57 -47.12 79.91 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 123.556 0.742 . . . . 0.0 110.08 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -64.67 -68.43 0.36 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 39.1 ttpt 52.38 70.81 0.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.471 1.129 . . . . 0.0 110.685 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -119.94 157.26 29.16 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.93 -37.27 67.24 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.145 0.498 . . . . 0.0 111.805 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.42 142.74 51.34 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.613 ' CD2' HD23 ' A' ' 593' ' ' LEU . 72.3 m-85 -122.65 126.76 48.28 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . 0.507 ' HB2' ' HG2' ' A' ' 591' ' ' GLU . 36.9 mttp -69.61 149.26 48.33 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.447 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -71.52 120.19 19.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.22 174.299 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 116.57 -11.11 16.21 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.635 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 588' ' ' LYS . 5.8 mm-40 -67.84 142.14 56.23 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 18.7 t -115.64 114.75 47.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.613 HD23 ' CD2' ' A' ' 587' ' ' TYR . 0.2 OUTLIER -105.58 109.64 21.68 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.626 0.727 . . . . 0.0 111.279 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 60.5 mtpt -72.4 141.94 48.7 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.345 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.495 ' HD1' ' HA ' ' A' ' 580' ' ' PRO . 64.1 m-85 -114.23 177.59 4.59 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-O 121.05 0.452 . . . . 0.0 109.955 175.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 10.6 p -163.05 164.46 25.5 Favored 'General case' 0 N--CA 1.405 -2.696 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 94.6 m -111.95 -178.72 3.5 Favored 'General case' 0 C--N 1.266 -3.028 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 598' ' ' LYS . 28.1 mmtp -57.41 159.38 8.91 Favored Pre-proline 0 N--CA 1.436 -1.167 0 C-N-CA 123.281 0.632 . . . . 0.0 110.995 173.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 83.6 Cg_exo -46.6 -45.01 20.52 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 124.195 3.263 . . . . 0.0 114.057 -176.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 625' ' ' GLU . . . -90.25 -2.4 73.98 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.979 -175.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.552 ' CD2' ' HB2' ' A' ' 625' ' ' GLU . 29.3 m-85 -97.41 179.79 4.75 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.613 0.721 . . . . 0.0 112.118 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 602' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 624' ' ' LYS . 89.3 m -136.47 129.38 30.99 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 15.9 tt -86.05 150.23 3.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . 0.595 ' CG1' ' HG2' ' A' ' 624' ' ' LYS . 4.9 m -119.05 154.22 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.384 -171.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 53.72 -123.94 27.92 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 169.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.72 94.75 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.294 2.663 . . . . 0.0 112.194 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -79.98 -28.48 39.53 Favored 'General case' 0 C--O 1.203 -1.385 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.479 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.453 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 34.1 p -112.81 94.7 5.03 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.515 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 23.6 m -98.53 156.74 3.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.549 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -101.56 155.31 18.16 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.066 0.46 . . . . 0.0 110.111 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.447 ' HB3' ' HA ' ' A' ' 589' ' ' VAL . 44.1 t -82.97 120.26 25.48 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 168.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.557 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 19.7 m-85 -100.59 167.55 10.28 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -54.59 -26.61 33.55 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.065 0.546 . . . . 0.0 112.432 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -108.53 8.21 27.15 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.885 0.374 . . . . 0.0 111.446 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 130.19 -177.73 18.02 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.915 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.407 ' C ' ' HG ' ' A' ' 617' ' ' SER . 74.5 mt -69.96 130.05 41.14 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.557 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 70.8 m -146.07 144.51 21.87 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 617' ' ' SER . 53.2 Cg_endo -69.31 -173.82 8.48 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.592 -1.42 . . . . 0.0 112.74 0.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.45 152.14 35.25 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.336 0.588 . . . . 0.0 110.53 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 4.9 mp -71.94 142.26 85.21 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.983 -170.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.9 164.47 34.54 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.832 3.021 . . . . 0.0 113.624 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . 0.465 ' H ' ' CG2' ' A' ' 604' ' ' VAL . 33.0 pt -104.97 -176.34 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.495 ' SG ' HD13 ' A' ' 578' ' ' LEU . 74.3 m -125.58 127.47 46.42 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 121.202 0.525 . . . . 0.0 109.701 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.595 ' HG2' ' CG1' ' A' ' 604' ' ' VAL . 12.7 mmmm -86.63 -59.03 2.39 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.552 ' HB2' ' CD2' ' A' ' 601' ' ' PHE . 1.9 tm-20 80.78 -54.84 0.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.939 1.696 . . . . 0.0 108.508 -172.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -98.73 118.8 36.27 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.328 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 3.9 m -128.32 170.92 17.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.937 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.4 HE21 ' HA3' ' A' ' 676' ' ' GLY . 46.9 mt-30 -88.01 178.04 6.77 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.163 0.506 . . . . 0.0 110.616 -176.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 7.5 m -105.47 -14.38 15.33 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 11.9 m 72.7 -10.16 0.99 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.135 1.374 . . . . 0.0 113.185 169.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 59.55 -141.9 47.26 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.94 154.3 47.92 Favored 'Trans proline' 0 CA--C 1.549 1.254 0 C-N-CA 122.924 2.416 . . . . 0.0 111.901 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 92.7 Cg_endo -81.46 167.39 17.27 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 123.415 2.743 . . . . 0.0 111.855 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.15 -175.92 1.42 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.49 2.127 . . . . 0.0 110.741 174.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.64 161.43 14.87 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.59 HD22 ' SG ' ' A' ' 659' ' ' CYS . 20.4 tp -85.16 128.84 34.82 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.43 HD13 ' N ' ' A' ' 638' ' ' ASN . 1.7 pp -46.88 -37.2 8.47 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.783 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 12.5 m120 -133.16 28.14 4.13 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.134 0.492 . . . . 0.0 109.683 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.21 -142.61 3.48 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -166.11 -179.31 5.07 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.399 0.679 . . . . 0.0 109.483 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 45.9 t -90.03 133.57 31.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.418 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 8.4 ptmm? -90.64 -16.03 29.38 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.548 0.69 . . . . 0.0 110.986 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -91.51 159.8 15.75 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -72.99 123.0 22.63 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.244 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 22.4 p -62.27 110.39 1.62 Allowed 'General case' 0 N--CA 1.411 -2.404 0 O-C-N 123.725 0.64 . . . . 0.0 109.547 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -72.69 151.9 41.98 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.97 -14.51 59.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.92 0.867 . . . . 0.0 109.256 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -149.92 112.66 4.78 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.783 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.581 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.0 m-85 -89.83 -61.94 1.58 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 106.32 156.66 21.52 Favored Glycine 0 N--CA 1.421 -2.304 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.539 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.528 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 79.0 t60 -61.63 136.19 57.91 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 122.596 0.358 . . . . 0.0 110.321 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.5 m 70.82 14.59 6.99 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.334 1.053 . . . . 0.0 112.63 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.46 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 6.0 tp10 -94.93 121.31 36.4 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 174.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.4 p -88.47 160.18 2.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-O 121.156 0.503 . . . . 0.0 110.632 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -129.63 113.53 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.57 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.548 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 13.8 mt-10 -75.97 129.4 36.84 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.852 0.834 . . . . 0.0 111.261 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.515 ' HB3' HD23 ' A' ' 636' ' ' LEU . 95.4 m-85 -111.12 174.38 5.89 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.125 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -148.02 142.46 26.38 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.596 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 85.6 m -97.73 178.3 5.2 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.425 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 36.6 m-80 -71.62 154.55 93.11 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 91.7 Cg_endo -74.38 38.24 0.48 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 124.246 3.298 . . . . 0.0 113.183 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.495 ' HG3' ' CE1' ' A' ' 663' ' ' PHE . 9.0 ptm180 -150.51 13.51 0.74 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.487 -175.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.495 ' CE1' ' HG3' ' A' ' 662' ' ' ARG . 85.2 m-85 -139.13 151.5 46.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.581 0.705 . . . . 0.0 110.772 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 81.1 mt -92.76 152.7 19.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.596 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 1.3 ttt -107.63 109.86 21.59 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.474 ' HB2' HD13 ' A' ' 685' ' ' ILE . 17.1 tppt? -71.57 -61.36 1.81 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.3 -172.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.67 -162.39 30.12 Favored Glycine 0 N--CA 1.431 -1.686 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.498 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.2 119.79 7.06 Favored 'Trans proline' 0 C--N 1.334 -0.198 0 C-N-CA 123.475 2.783 . . . . 0.0 112.407 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 4.6 p-10 -64.29 -2.38 2.14 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 656' ' ' GLU . 0.0 OUTLIER -140.22 143.61 36.1 Favored 'General case' 0 N--CA 1.407 -2.625 0 C-N-CA 122.746 0.419 . . . . 0.0 110.279 177.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.586 ' HB ' ' HG1' ' A' ' 679' ' ' THR . 34.0 pt -136.46 142.39 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.492 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -112.23 149.92 31.63 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 44.0 t -80.16 125.24 29.57 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-O 123.166 1.46 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.52 118.39 57.04 Favored 'Isoleucine or valine' 1 N--CA 1.377 -4.094 0 CA-C-N 111.72 -2.491 . . . . 0.0 109.206 -174.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.528 ' H ' ' CE1' ' A' ' 651' ' ' HIS . 30.4 t70 63.46 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.938 1.295 . . . . 0.0 110.653 -172.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.4 ' HA3' HE21 ' A' ' 628' ' ' GLN . . . -161.03 27.99 0.3 Allowed Glycine 0 C--N 1.29 -1.977 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -138.5 146.48 42.04 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.507 ' HB3' HD13 ' A' ' 671' ' ' ILE . 95.6 m95 -87.18 160.58 18.45 Favored 'General case' 0 C--N 1.273 -2.749 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.93 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 679' ' ' THR . . . . . 0.586 ' HG1' ' HB ' ' A' ' 671' ' ' ILE . 19.2 p -83.52 -179.9 7.47 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 14.2 m -65.69 124.73 23.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.004 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.9 mp -64.05 161.92 35.27 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.515 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 23.6 Cg_endo -62.25 -16.79 53.3 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 123.795 2.997 . . . . 0.0 115.08 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.293 31.6 m 48.21 98.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.783 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.1 m -80.39 142.3 34.52 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.316 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.474 HD13 ' HB2' ' A' ' 666' ' ' LYS . 0.2 OUTLIER -136.95 145.91 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.324 0 C-N-CA 123.765 0.826 . . . . 0.0 108.874 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 28.3 m -50.34 126.26 4.85 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.209 0 C-N-CA 125.473 1.509 . . . . 0.0 114.018 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.422 ' HG2' HD22 ' A' ' 664' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.288 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.629 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -145.18 -7.29 0.63 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.609 177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -144.4 152.23 40.39 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 120.825 0.345 . . . . 0.0 110.413 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -157.11 67.83 0.29 Allowed Glycine 0 C--N 1.298 -1.543 0 N-CA-C 107.719 -2.152 . . . . 0.0 107.719 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.4 -34.65 28.23 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.664 -0.768 . . . . 0.0 111.206 -171.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 567' ' ' ARG . 0.0 OUTLIER -153.43 153.05 31.76 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.214 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -93.36 -170.8 2.47 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . . . . . . . . . 76.8 m -85.96 166.63 15.77 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.204 0.526 . . . . 0.0 111.547 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -141.78 150.24 41.45 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.714 HD12 ' HG3' ' A' ' 580' ' ' PRO . 1.0 OUTLIER -73.9 119.17 74.8 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.453 ' HD2' HD21 ' A' ' 571' ' ' LEU . 72.4 Cg_endo -76.07 -162.48 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.658 2.239 . . . . 0.0 111.064 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -87.25 107.4 18.47 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 121.91 -0.494 . . . . 0.0 110.092 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 28.1 pt -70.71 -169.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.346 176.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 10.9 t70 -77.43 152.94 34.06 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.01 -29.94 42.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.282 0.563 . . . . 0.0 110.232 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -103.35 15.3 29.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.577 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.2 OUTLIER -97.63 157.93 15.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 4.9 p -158.62 110.22 1.64 Allowed Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.336 0.654 . . . . 0.0 110.171 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.714 ' HG3' HD12 ' A' ' 571' ' ' LEU . 59.4 Cg_endo -72.08 148.29 50.31 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.392 2.728 . . . . 0.0 113.206 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.41 -45.0 27.25 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -75.39 109.37 8.87 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 173.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 583' ' ' LYS . 35.2 ttmt -121.6 98.02 5.77 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -146.9 177.82 8.82 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . 0.424 ' HB3' ' NE2' ' A' ' 586' ' ' GLN . 7.1 t70 -86.73 -55.73 3.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.705 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . 0.424 ' NE2' ' HB3' ' A' ' 585' ' ' ASP . 0.0 OUTLIER -116.09 142.55 46.66 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.431 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.582 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 27.1 m-85 -110.88 124.57 52.33 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.551 -174.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -62.56 143.41 57.26 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.266 0.978 . . . . 0.0 108.843 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.739 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 3.4 p -61.71 119.58 6.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-O 121.858 0.837 . . . . 0.0 109.998 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 107.21 -10.3 39.67 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.254 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.47 123.35 23.73 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 610' ' ' GLN . 3.6 p -102.48 129.19 54.39 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 CA-C-O 121.863 0.84 . . . . 0.0 111.383 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.582 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 4.3 mp -96.98 101.87 13.54 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.432 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -81.11 103.31 10.83 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.721 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.532 ' HB3' ' CD1' ' A' ' 578' ' ' LEU . 74.0 m-85 -90.1 176.22 6.86 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 122.836 0.455 . . . . 0.0 111.456 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 596' ' ' SER . . . . . 0.531 ' HA ' HD13 ' A' ' 603' ' ' ILE . 33.0 t -177.55 157.99 1.33 Allowed 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 168.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.457 ' SG ' HD23 ' A' ' 578' ' ' LEU . 97.4 m -86.67 177.95 7.19 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.989 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.555 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 72.9 mmtt -57.3 163.12 3.56 Favored Pre-proline 0 N--CA 1.434 -1.265 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.406 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 68.8 Cg_exo -49.31 -45.2 31.16 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.074 3.183 . . . . 0.0 114.129 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -84.03 -3.88 88.81 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.021 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 51.0 m-85 -107.7 154.07 22.01 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.6 0.714 . . . . 0.0 112.101 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 602' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 26.2 m -106.26 130.84 54.04 Favored 'General case' 0 N--CA 1.403 -2.809 0 CA-C-N 114.108 -1.406 . . . . 0.0 108.928 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' A' ' 596' ' ' SER . 6.9 tt -80.17 122.68 35.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 92.2 t -119.62 113.88 42.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.173 0.511 . . . . 0.0 109.922 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 131.39 -164.69 23.4 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.06 112.71 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.713 2.275 . . . . 0.0 111.32 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -79.58 -40.53 29.19 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.126 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.401 ' HB2' ' CG2' ' A' ' 592' ' ' VAL . 31.3 p -114.23 99.45 7.61 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.661 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 11.3 m -98.98 138.69 22.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.553 ' CG ' ' HE1' ' A' ' 612' ' ' TYR . 0.0 OUTLIER -110.18 153.24 25.03 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.954 -178.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.739 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 42.8 t -67.93 120.29 13.97 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.347 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.553 ' HE1' ' CG ' ' A' ' 610' ' ' GLN . 12.9 m-30 -105.68 167.53 9.7 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -67.79 1.55 2.48 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -123.32 -0.26 8.82 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.943 0.402 . . . . 0.0 111.325 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.71 173.7 13.38 Favored Glycine 0 C--N 1.311 -0.851 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.797 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 611' ' ' CYS . 30.6 mt -63.0 121.59 13.95 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.467 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 50.0 m -145.06 150.31 45.14 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' A' ' 617' ' ' SER . 42.5 Cg_endo -70.06 -164.28 2.58 Favored 'Cis proline' 0 CA--C 1.551 1.36 0 C-N-CA 124.615 -0.994 . . . . 0.0 114.599 0.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.16 165.88 24.19 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 122.118 -0.364 . . . . 0.0 111.081 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.67 139.5 66.94 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . 0.503 ' HG3' HD12 ' A' ' 603' ' ' ILE . 73.7 Cg_endo -71.29 167.2 26.91 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 124.157 3.238 . . . . 0.0 112.372 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 46.7 pt -107.84 174.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.44 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 578' ' ' LEU . 88.5 m -116.67 123.27 46.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.156 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.537 ' O ' ' HB ' ' A' ' 602' ' ' THR . 9.0 mmmm -118.81 108.6 15.04 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.207 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.442 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 2.8 tm-20 -73.42 -38.61 65.51 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -100.48 87.03 3.28 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.43 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 7.5 p -95.43 158.68 2.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.079 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -88.33 156.69 19.03 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.962 0.411 . . . . 0.0 110.883 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.559 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 15.0 p -90.58 -12.36 37.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.014 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . 0.509 ' SG ' ' HA2' ' A' ' 676' ' ' GLY . 13.8 m 70.54 7.82 6.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.757 0.823 . . . . 0.0 112.438 172.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 55.64 -140.18 41.17 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.495 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -82.5 151.56 15.25 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 122.435 2.09 . . . . 0.0 110.2 171.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.626 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 96.3 Cg_endo -78.81 172.42 15.07 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 123.129 2.552 . . . . 0.0 111.525 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.08 -162.95 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.438 2.092 . . . . 0.0 112.132 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -113.89 150.02 34.27 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.705 HD23 ' SG ' ' A' ' 659' ' ' CYS . 15.1 tp -78.72 159.54 27.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 683' ' ' VAL 0.433 0.4 OUTLIER -73.45 -48.07 36.51 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 176.943 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.708 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 22.0 m120 -123.08 36.65 4.6 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.462 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.641 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -163.49 -141.28 3.08 Favored Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -165.26 -170.46 1.89 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.23 127.84 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -83.7 -26.06 30.11 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.55 0.69 . . . . 0.0 109.334 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -74.74 171.43 13.94 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -89.38 130.67 35.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 16.2 p -82.35 104.05 12.37 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.613 0.72 . . . . 0.0 112.119 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.543 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 47.0 pttt -89.94 153.88 20.27 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.34 34.76 1.39 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 121.947 0.88 . . . . 0.0 110.729 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -169.49 92.93 0.26 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.494 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.626 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 11.0 m-85 -85.77 -73.76 0.44 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 121.13 167.28 13.22 Favored Glycine 0 C--N 1.291 -1.945 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -177.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.422 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 75.1 t60 -72.0 136.49 46.75 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.799 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 62.7 m 71.32 10.84 6.71 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.516 0.727 . . . . 0.0 112.438 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.42 118.0 27.74 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 174.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.3 p -91.67 154.46 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.713 0 CA-C-O 122.5 1.143 . . . . 0.0 111.26 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.8 t -117.48 101.24 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.995 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.552 ' HG3' ' HG2' ' A' ' 670' ' ' LYS . 5.8 tt0 -77.09 120.42 22.16 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 60.4 m-85 -99.05 167.31 10.8 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.179 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.471 ' O ' ' HA3' ' A' ' 639' ' ' GLY . 5.5 p90 -145.08 143.9 30.67 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 173.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.705 ' SG ' HD23 ' A' ' 636' ' ' LEU . 59.5 m -103.55 170.28 8.04 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 662' ' ' ARG . 61.6 m-80 -64.06 152.42 87.72 Favored Pre-proline 0 C--N 1.317 -0.829 0 O-C-N 123.125 0.266 . . . . 0.0 110.715 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.19 40.11 0.43 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 124.828 3.685 . . . . 0.0 113.393 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.414 ' H ' ' C ' ' A' ' 660' ' ' ASN . 7.6 ptt85 -150.0 10.72 0.71 Allowed 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.537 -178.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.96 158.17 45.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.921 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 90.0 mt -100.93 157.29 16.85 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.59 ' HE1' ' SG ' ' A' ' 659' ' ' CYS . 3.5 ttt -114.83 102.44 9.99 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 685' ' ' ILE . 37.6 ttpt -69.9 -53.22 18.93 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.309 -0.859 . . . . 0.0 113.103 -170.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.42 -170.3 31.79 Favored Glycine 0 C--N 1.293 -1.819 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.036 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.73 122.08 11.1 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.979 3.12 . . . . 0.0 110.858 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.789 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 7.9 p-10 -68.46 -20.0 64.6 Favored 'General case' 0 CA--C 1.469 -2.169 0 CA-C-O 121.533 0.682 . . . . 0.0 111.066 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.552 ' HG2' ' HG3' ' A' ' 656' ' ' GLU . 3.4 mtpt -111.71 157.29 20.67 Favored 'General case' 0 C--N 1.253 -3.615 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -173.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.529 HD13 ' HB3' ' A' ' 678' ' ' TRP . 48.1 pt -139.75 125.43 21.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.499 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -106.44 144.25 33.39 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 28.7 t -81.61 128.95 34.47 Favored 'General case' 0 CA--C 1.465 -2.314 0 CA-C-O 123.142 1.449 . . . . 0.0 111.835 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.4 t -105.33 107.3 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.807 0 CA-C-N 111.263 -2.699 . . . . 0.0 107.655 -175.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.551 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 26.6 t70 55.6 -75.15 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.008 1.723 . . . . 0.0 112.98 -169.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.509 ' HA2' ' SG ' ' A' ' 630' ' ' CYS . . . -149.15 18.54 1.19 Allowed Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -129.61 139.26 51.49 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.529 ' HB3' HD13 ' A' ' 671' ' ' ILE . 92.0 m95 -85.71 164.73 17.46 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.472 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 6.3 p -82.43 -178.54 7.09 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.05 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 44.2 m -71.68 135.81 47.01 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.254 0.55 . . . . 0.0 110.731 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 636' ' ' LEU . 47.5 mt -66.08 153.07 92.71 Favored Pre-proline 0 N--CA 1.425 -1.699 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.237 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.789 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 12.3 Cg_endo -55.49 -20.17 25.62 Favored 'Trans proline' 0 N--CA 1.482 0.802 0 C-N-CA 124.637 3.558 . . . . 0.0 115.972 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.489 ' HA ' HD12 ' A' ' 637' ' ' LEU 0.302 16.4 m 46.11 98.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 N-CA-C 115.664 1.728 . . . . 0.0 115.664 177.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 1.7 m -83.28 147.96 27.66 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.975 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -138.49 146.97 25.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.243 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 32.0 t -58.56 134.77 23.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 123.828 0.705 . . . . 0.0 109.87 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.477 ' HG2' ' HG ' ' A' ' 664' ' ' LEU . 45.0 mt-10 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.21 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . 0.419 ' H2 ' ' CD ' ' A' ' 562' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.761 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 62.9 14.34 7.37 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.418 1.087 . . . . 0.0 112.897 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -93.82 -60.06 1.84 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -154.06 68.38 0.3 Allowed Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.65 -47.52 85.3 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.011 -0.595 . . . . 0.0 110.457 -173.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . 0.437 ' HG2' ' HG3' ' A' ' 568' ' ' GLU . 53.1 ttt180 71.6 -64.12 0.4 Allowed 'General case' 0 C--N 1.344 0.369 0 O-C-N 124.302 1.001 . . . . 0.0 111.285 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . 0.437 ' HG3' ' HG2' ' A' ' 567' ' ' ARG . 52.0 mt-10 -110.88 147.46 34.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 121.149 0.499 . . . . 0.0 109.85 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.633 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 2.6 m -63.72 -55.78 20.64 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 124.786 1.234 . . . . 0.0 111.734 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 61.41 -168.62 0.18 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.064 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.803 HD13 ' HH ' ' A' ' 587' ' ' TYR . 3.5 tt -118.61 118.96 33.17 Favored Pre-proline 0 C--N 1.28 -2.447 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.512 ' HD2' HD13 ' A' ' 616' ' ' LEU . 90.3 Cg_endo -75.41 -165.71 0.31 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.466 2.777 . . . . 0.0 112.335 -177.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . 0.406 ' HZ2' ' HB2' ' A' ' 573' ' ' LYS . 0.1 OUTLIER -82.23 108.05 15.38 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.196 0.522 . . . . 0.0 110.382 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.572 HD11 ' HD3' ' A' ' 580' ' ' PRO . 36.2 pt -78.14 -167.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.319 175.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 10.2 t70 -81.54 162.09 23.32 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.09 -22.58 18.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.473 0.654 . . . . 0.0 110.516 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -106.63 11.83 30.0 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 121.768 -0.582 . . . . 0.0 110.98 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.5 tm? -99.13 153.48 18.86 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.91 113.33 3.38 Favored Pre-proline 0 C--N 1.288 -2.079 0 C-N-CA 124.184 0.994 . . . . 0.0 108.454 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.572 ' HD3' HD11 ' A' ' 574' ' ' ILE . 59.1 Cg_endo -73.82 146.14 37.46 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.509 2.139 . . . . 0.0 112.43 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -77.38 -36.78 53.22 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -79.63 132.55 36.28 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 171.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -143.51 89.94 2.12 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.69 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -137.71 170.21 16.46 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -77.41 -56.8 4.24 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.64 126.43 50.22 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.925 0.393 . . . . 0.0 110.725 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.803 ' HH ' HD13 ' A' ' 571' ' ' LEU . 19.3 m-85 -90.35 155.53 18.9 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.814 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -93.7 147.41 23.05 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.618 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 5.6 p -66.45 131.16 32.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.852 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 87.42 -1.95 86.22 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.211 -173.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -69.28 135.58 50.67 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 11.3 m -98.59 138.91 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.556 HD12 ' CD2' ' A' ' 587' ' ' TYR . 7.1 mp -117.16 111.05 18.93 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.229 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.537 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 92.0 mttt -84.74 122.21 28.78 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 68.7 m-85 -108.08 172.2 6.97 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 596' ' ' SER . . . . . 0.508 ' HA ' HD13 ' A' ' 603' ' ' ILE . 14.2 p -171.21 177.41 3.62 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 76.8 m -110.97 177.79 4.55 Favored 'General case' 0 C--N 1.26 -3.293 0 O-C-N 123.739 0.649 . . . . 0.0 110.712 -176.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.508 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 71.6 mmtt -53.48 160.83 1.7 Allowed Pre-proline 0 N--CA 1.438 -1.034 0 C-N-CA 124.463 1.105 . . . . 0.0 112.564 176.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 51.4 Cg_exo -52.05 -28.11 31.36 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 124.414 3.409 . . . . 0.0 114.575 -175.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -99.61 -4.31 55.98 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.883 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -106.51 159.13 16.4 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 122.328 1.061 . . . . 0.0 113.414 -174.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 6.2 m -109.25 129.57 55.5 Favored 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.861 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.509 HD12 ' HG3' ' A' ' 621' ' ' PRO . 6.4 tt -81.46 119.14 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.363 174.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . 0.434 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 62.0 t -109.97 127.51 66.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.06 -159.66 14.14 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.8 115.33 3.71 Favored 'Trans proline' 0 C--N 1.333 -0.278 0 C-N-CA 122.958 2.439 . . . . 0.0 110.69 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 7.5 m120 -84.3 -26.29 28.65 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.355 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.537 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 27.1 p -127.09 95.59 4.34 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.532 0.682 . . . . 0.0 111.087 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 21.5 m -89.42 169.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.485 -0.779 . . . . 0.0 108.997 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 12.0 mm-40 -114.72 163.8 14.97 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.618 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 18.7 t -85.05 131.39 34.46 Favored 'General case' 0 C--N 1.276 -2.608 0 C-N-CA 117.808 -1.557 . . . . 0.0 108.223 165.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.459 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 7.5 m-85 -109.16 163.0 13.74 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 173.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -68.17 -1.68 6.53 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -117.48 4.47 12.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 120.879 0.371 . . . . 0.0 110.333 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 135.69 -177.45 19.46 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.512 HD13 ' HD2' ' A' ' 572' ' ' PRO . 28.4 mt -73.79 133.51 43.26 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.459 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 68.1 m -150.16 154.39 36.41 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.61 -168.78 5.04 Favored 'Cis proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.043 -1.232 . . . . 0.0 113.214 0.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.76 146.69 35.93 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.091 0.472 . . . . 0.0 111.864 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . 0.496 HD22 ' HG2' ' A' ' 572' ' ' PRO . 6.7 mp -65.14 142.26 98.53 Favored Pre-proline 0 C--N 1.302 -1.47 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.889 -175.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . 0.509 ' HG3' HD12 ' A' ' 603' ' ' ILE . 28.1 Cg_endo -63.9 169.01 10.99 Favored 'Trans proline' 0 C--O 1.252 1.182 0 C-N-CA 124.124 3.216 . . . . 0.0 113.667 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . 0.434 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 36.5 pt -114.94 178.91 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.969 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 95.3 m -127.96 124.94 38.52 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.023 0.44 . . . . 0.0 111.267 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -124.41 130.33 52.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -88.54 -37.87 15.37 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -99.82 101.25 12.34 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.803 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 2.7 m -102.03 178.39 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.088 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.546 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 76.2 mt-30 -94.55 170.64 9.33 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.524 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 41.6 m -102.93 -8.15 20.92 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.039 0.447 . . . . 0.0 110.649 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 81.7 m 67.36 5.78 4.47 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 54.2 -137.22 41.58 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 123.474 0.484 . . . . 0.0 112.947 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.58 147.01 17.36 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.649 2.233 . . . . 0.0 112.055 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.32 156.51 65.9 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.118 2.545 . . . . 0.0 112.591 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.49 ' HG2' HD12 ' A' ' 681' ' ' LEU . 38.3 Cg_endo -69.24 175.36 7.77 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 123.324 2.683 . . . . 0.0 112.522 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.86 145.71 26.48 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 657' ' ' TYR . 14.5 tp -80.59 178.33 8.42 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 637' ' ' LEU . 2.4 mp -84.58 -73.03 0.44 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.821 0.819 . . . . 0.0 108.841 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -108.02 32.71 4.56 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -156.29 -156.79 7.99 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.798 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.08 -172.72 4.21 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 123.685 0.794 . . . . 0.0 109.976 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 53.5 t -93.69 137.87 21.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.647 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 20.1 ptmt -87.22 -22.63 25.12 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.088 0.47 . . . . 0.0 110.904 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.22 146.92 28.31 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -67.75 122.39 18.0 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 22.4 p -73.69 98.09 2.82 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.228 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -83.81 165.33 18.9 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.5 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.4 6.82 35.59 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -171.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -156.24 105.9 2.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -96.19 -82.25 0.4 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 130.77 159.62 9.68 Favored Glycine 0 C--N 1.311 -0.84 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.887 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.829 ' HD1' ' HA ' ' A' ' 674' ' ' VAL . 80.6 t60 -77.14 86.43 3.61 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 651' ' ' HIS . 22.9 t 155.08 -31.19 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 126.941 2.097 . . . . 0.0 106.101 173.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -68.05 118.24 10.95 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.911 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.1 p -94.74 163.39 2.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.739 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 16.6 m -128.82 115.58 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.442 175.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.647 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 14.7 mt-10 -73.26 126.12 29.37 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.56 0.695 . . . . 0.0 111.111 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.535 ' HB3' HD21 ' A' ' 636' ' ' LEU . 81.4 m-85 -102.12 164.74 11.53 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.022 176.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -148.67 135.63 19.97 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 50.4 m -99.09 165.75 11.58 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.428 172.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.459 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 50.1 m-80 -58.3 155.01 28.98 Favored Pre-proline 0 C--O 1.248 1.021 0 O-C-N 123.677 0.611 . . . . 0.0 109.904 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 59.8 Cg_endo -68.03 24.76 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 124.113 3.209 . . . . 0.0 115.529 -172.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.458 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 24.8 mmm180 -118.11 -4.26 11.02 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 662' ' ' ARG . 51.0 m-85 -128.95 159.76 34.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.723 -170.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.491 HD12 ' HG3' ' A' ' 687' ' ' GLU . 81.8 mt -124.38 153.78 41.36 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 125.145 1.378 . . . . 0.0 107.442 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.543 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -84.27 147.17 27.38 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.125 0.488 . . . . 0.0 111.2 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -95.09 -59.44 1.9 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.214 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.5 -158.11 29.76 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.575 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.78 123.64 10.96 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.978 2.452 . . . . 0.0 111.655 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -64.04 -17.38 63.31 Favored 'General case' 0 C--O 1.207 -1.17 0 C-N-CA 122.902 0.481 . . . . 0.0 111.744 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 1.4 mtpt -122.28 154.4 37.62 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.568 HD11 HD13 ' A' ' 681' ' ' LEU . 29.9 pt -143.92 142.73 24.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.81 153.08 28.4 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.041 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 3.9 t -68.14 121.06 15.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.015 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.829 ' HA ' ' HD1' ' A' ' 651' ' ' HIS . 35.1 m -113.03 113.26 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.55 0.691 . . . . 0.0 111.559 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.411 ' H ' ' ND1' ' A' ' 651' ' ' HIS . 32.7 t70 64.87 -73.89 0.05 Allowed 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 124.56 1.144 . . . . 0.0 111.375 -175.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.546 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -152.56 16.21 0.74 Allowed Glycine 0 N--CA 1.422 -2.297 0 C-N-CA 120.392 -0.908 . . . . 0.0 112.456 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.01 158.08 44.63 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.516 ' HB3' HD13 ' A' ' 671' ' ' ILE . 96.9 m95 -81.71 177.03 9.14 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 120.892 0.377 . . . . 0.0 110.167 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.98 -179.44 3.95 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.863 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 5.7 m -57.72 120.16 7.9 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.897 0.879 . . . . 0.0 110.915 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 671' ' ' ILE . 4.4 mp -64.15 154.26 83.02 Favored Pre-proline 0 N--CA 1.445 -0.719 0 O-C-N 123.761 0.663 . . . . 0.0 112.592 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.543 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 7.5 Cg_endo -55.04 -50.12 14.26 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.206 2.604 . . . . 0.0 113.516 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 92.8 t 68.97 130.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.505 0.722 . . . . 0.0 110.118 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 7.3 p -125.05 154.89 40.63 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.676 -0.64 . . . . 0.0 112.448 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.481 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.2 OUTLIER -139.04 150.58 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.214 0 C-N-CA 125.317 1.447 . . . . 0.0 108.512 -177.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.24 139.25 17.06 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.911 0 C-N-CA 124.76 1.224 . . . . 0.0 112.472 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.491 ' HG3' HD12 ' A' ' 664' ' ' LEU . 45.8 tt0 . . . . . 0 N--CA 1.438 -1.056 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.153 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 CA--C 1.516 -0.353 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -120.01 -170.47 1.97 Allowed 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -67.09 -43.49 82.4 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -72.19 86.51 0.49 Allowed Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.407 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -93.05 27.99 2.28 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.715 0.806 . . . . 0.0 109.388 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 567' ' ' ARG . 37.5 mmt180 83.66 71.43 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 125.553 1.541 . . . . 0.0 110.552 -173.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -126.05 -162.84 1.16 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.735 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.6 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 75.9 m -96.61 150.02 21.13 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.657 0.741 . . . . 0.0 112.685 -174.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -124.25 -4.75 7.86 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.073 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.72 HD13 ' HH ' ' A' ' 587' ' ' TYR . 0.9 OUTLIER 77.97 121.22 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 126.006 1.723 . . . . 0.0 107.438 -178.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.558 ' HD3' HD21 ' A' ' 616' ' ' LEU . 56.8 Cg_endo -69.97 -174.65 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.909 1.74 . . . . 0.0 110.931 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 573' ' ' LYS . 0.3 OUTLIER -89.5 104.23 16.81 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.53 HD13 ' HB3' ' A' ' 578' ' ' LEU . 42.0 pt -76.08 -176.57 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.988 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.293 -177.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.6 t70 -72.97 151.94 41.6 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.72 -35.66 68.88 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.363 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -93.54 8.08 42.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.705 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.8 tp -95.89 149.97 20.96 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.03 117.59 9.09 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-O 121.387 0.613 . . . . 0.0 110.41 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.42 131.19 13.55 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.203 1.935 . . . . 0.0 111.053 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.56 -29.84 71.04 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.286 0.565 . . . . 0.0 111.447 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . 0.43 ' HG3' HD23 ' A' ' 593' ' ' LEU . 4.5 mmp_? -72.8 -70.95 0.32 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 176.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm 60.47 84.58 0.12 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.416 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -142.03 174.34 10.69 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.25 -66.16 0.91 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . 0.412 ' N ' HE21 ' A' ' 586' ' ' GLN . 0.0 OUTLIER -105.34 141.04 37.55 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.72 ' HH ' HD13 ' A' ' 571' ' ' LEU . 67.0 m-85 -115.12 125.63 53.69 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.138 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -71.02 144.04 50.55 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.302 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.604 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 32.6 m -63.4 134.66 28.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.576 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 102.0 -18.62 51.76 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.117 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.95 108.84 3.19 Favored 'General case' 0 C--N 1.346 0.451 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 608' ' ' SER . 3.4 p -92.47 125.09 45.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.721 0.772 . . . . 0.0 110.199 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.436 HD22 ' CD2' ' A' ' 587' ' ' TYR . 11.1 mt -102.88 105.05 15.34 Favored 'General case' 0 N--CA 1.402 -2.856 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.882 -172.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 54.7 mtpt -75.06 112.61 11.47 Favored 'General case' 0 N--CA 1.41 -2.425 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -94.36 174.13 7.29 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-O 121.813 0.816 . . . . 0.0 109.548 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 20.1 t -162.32 -178.83 6.56 Favored 'General case' 0 N--CA 1.391 -3.414 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.549 ' SG ' HD13 ' A' ' 578' ' ' LEU . 92.3 m -118.1 -179.12 3.67 Favored 'General case' 0 C--N 1.257 -3.452 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 65.6 mmtt -51.01 162.58 0.58 Allowed Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 124.773 1.229 . . . . 0.0 111.639 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 79.8 Cg_exo -48.2 -45.82 24.66 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.923 3.082 . . . . 0.0 113.403 -176.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -89.76 5.03 83.73 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.424 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.613 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 35.4 m-85 -109.57 133.93 52.52 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 45.5 m -89.04 127.92 35.71 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.5 175.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.493 HD12 ' HG3' ' A' ' 621' ' ' PRO . 8.9 tt -84.65 132.89 30.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 90.9 t -129.7 135.43 61.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 114.67 -161.25 12.81 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.96 116.31 4.52 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.003 1.802 . . . . 0.0 109.886 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.412 HD21 ' N ' ' A' ' 607' ' ' ASN . 0.7 OUTLIER -83.34 -39.22 21.02 Favored 'General case' 0 C--O 1.206 -1.208 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -176.278 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 8.6 p -112.27 98.0 7.01 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.44 0.638 . . . . 0.0 111.96 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.5 m -99.57 145.6 10.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.609 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -96.46 149.24 21.95 Favored 'General case' 0 CA--C 1.472 -2.024 0 O-C-N 121.866 -0.522 . . . . 0.0 110.415 -177.251 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 45.4 t -73.3 122.28 21.74 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.37 168.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.596 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 75.9 m-85 -110.98 162.7 14.58 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 171.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -65.16 -2.25 2.77 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -115.52 1.54 13.64 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.537 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.4 169.73 12.35 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.202 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.558 HD21 ' HD3' ' A' ' 572' ' ' PRO . 3.3 mm? -66.42 118.95 10.79 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.596 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 17.4 m -131.77 144.36 52.94 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.77 -165.13 2.8 Favored 'Cis proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.885 -1.298 . . . . 0.0 113.139 -0.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.12 172.79 11.75 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.194 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . 0.448 HD12 ' HG2' ' A' ' 572' ' ' PRO . 50.8 mt -69.64 148.43 96.78 Favored Pre-proline 0 C--N 1.297 -1.709 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.333 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . 0.493 ' HG3' HD12 ' A' ' 603' ' ' ILE . 72.9 Cg_endo -75.42 -177.85 3.84 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 124.176 3.251 . . . . 0.0 111.362 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.42 166.44 18.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.012 0.434 . . . . 0.0 110.933 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.417 ' HB3' ' CD2' ' A' ' 601' ' ' PHE . 85.7 m -110.64 116.06 30.67 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.376 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -97.03 -22.17 16.96 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 13.6 tt0 68.4 -70.16 0.14 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.178 0.991 . . . . 0.0 108.951 -174.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -103.88 114.51 28.81 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.66 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 7.7 p -111.45 175.25 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.404 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 48.9 mt-30 -84.21 166.64 17.38 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 119.778 1.172 . . . . 0.0 109.311 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.553 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 5.2 p -106.54 -16.95 14.39 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.157 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 71.8 m 70.0 8.55 6.74 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.314 1.046 . . . . 0.0 112.799 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 54.02 -143.84 28.74 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 123.694 0.621 . . . . 0.0 113.093 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.5 148.59 42.87 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.515 2.143 . . . . 0.0 111.215 173.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.544 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 88.1 Cg_endo -82.67 165.1 15.98 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 123.047 2.498 . . . . 0.0 112.442 -178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.16 178.69 4.56 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.952 2.435 . . . . 0.0 111.426 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.92 163.83 12.04 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.611 HD22 ' SG ' ' A' ' 659' ' ' CYS . 17.5 tp -92.52 134.07 35.32 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 636' ' ' LEU . 0.4 OUTLIER -44.54 -61.13 1.66 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.575 1.15 . . . . 0.0 111.349 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 43.7 m-80 -122.63 31.19 6.18 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-O 121.316 0.579 . . . . 0.0 110.819 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.551 ' C ' ' HB3' ' A' ' 636' ' ' LEU . . . -150.48 -158.28 8.17 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 174.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.43 175.07 14.03 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 117.496 0.648 . . . . 0.0 109.87 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 64.3 t -84.44 128.94 38.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.778 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.5 ptmt -84.81 -20.4 30.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.034 0.921 . . . . 0.0 109.643 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.415 ' HG2' ' HG3' ' A' ' 642' ' ' LYS . 48.0 mm-40 -91.25 163.49 14.22 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.806 -177.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -73.9 125.71 28.81 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.182 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.419 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 16.0 p -81.72 114.63 20.5 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-O 121.857 0.837 . . . . 0.0 111.455 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 49.9 mtmt -85.09 161.23 19.77 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -99.67 9.56 42.91 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.065 0.936 . . . . 0.0 109.586 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -157.47 96.97 1.58 Allowed 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 113.956 -1.475 . . . . 0.0 107.696 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.544 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 14.4 m-85 -86.63 -76.77 0.34 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.838 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 115.44 169.01 15.65 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.236 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.617 ' HD1' ' HA ' ' A' ' 674' ' ' VAL . 75.8 t60 -71.33 148.05 47.45 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.311 10.4 p 65.78 2.73 2.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.057 1.343 . . . . 0.0 113.831 -174.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -93.84 112.95 24.88 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 2.5 p -99.16 159.67 3.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-O 121.576 0.703 . . . . 0.0 109.552 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.0 t -121.01 106.97 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.67 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.348 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.778 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 18.4 mt-10 -68.67 124.84 24.74 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.461 0.648 . . . . 0.0 110.457 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.526 ' HB3' HD23 ' A' ' 636' ' ' LEU . 68.2 m-85 -108.92 172.03 7.09 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -150.07 140.72 22.59 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.611 ' SG ' HD22 ' A' ' 636' ' ' LEU . 80.7 m -100.01 163.84 12.26 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.458 ' C ' ' H ' ' A' ' 662' ' ' ARG . 47.4 m-80 -65.3 157.39 77.77 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.401 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 74.2 Cg_endo -71.84 15.6 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 123.931 3.087 . . . . 0.0 113.466 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.458 ' H ' ' C ' ' A' ' 660' ' ' ASN . 10.6 mtp180 -108.34 -3.97 17.85 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -134.15 156.33 48.52 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.289 -173.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.506 HD22 ' HG3' ' A' ' 687' ' ' GLU . 72.1 mt -98.95 165.58 11.69 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 172.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.5 ' HE1' ' SG ' ' A' ' 659' ' ' CYS . 5.5 ttt -119.52 115.14 23.41 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.401 ' HB2' HD13 ' A' ' 685' ' ' ILE . 37.5 ttmt -71.39 -67.85 0.49 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -171.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.76 -161.46 37.49 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 115.551 -0.749 . . . . 0.0 113.18 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.39 123.09 11.81 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.036 2.491 . . . . 0.0 111.133 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -61.48 -16.48 47.59 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 123.263 0.625 . . . . 0.0 111.891 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.586 ' HG2' ' CG ' ' A' ' 656' ' ' GLU . 13.2 mtpt -121.93 153.78 38.02 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 34.9 pt -138.01 144.44 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.455 HE21 ' N ' ' A' ' 672' ' ' GLN . 0.0 OUTLIER -122.55 151.59 41.24 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.268 -176.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 6.8 t -77.3 108.47 10.45 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.042 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.617 ' HA ' ' HD1' ' A' ' 651' ' ' HIS . 35.9 m -102.7 107.9 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.576 0.703 . . . . 0.0 111.569 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.66 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 7.4 t70 68.98 -62.62 0.39 Allowed 'General case' 0 C--O 1.216 -0.67 0 C-N-CA 124.913 1.285 . . . . 0.0 113.057 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -164.12 18.9 0.12 Allowed Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 174.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -138.13 144.04 40.63 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -75.92 158.03 32.5 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 13.5 p -77.52 174.26 11.07 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.964 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.7 m -65.03 131.85 47.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.215 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.526 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 5.0 mp -63.74 150.38 90.97 Favored Pre-proline 0 N--CA 1.435 -1.194 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.138 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.526 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 10.4 Cg_endo -56.22 -43.23 58.13 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 123.573 2.849 . . . . 0.0 113.368 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 81.5 t 66.08 121.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 122.639 1.209 . . . . 0.0 113.341 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.2 m -93.82 145.13 24.82 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.32 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -138.46 145.28 28.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.16 132.98 25.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 O-C-N 123.288 0.367 . . . . 0.0 110.951 -174.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.506 ' HG3' HD22 ' A' ' 664' ' ' LEU . 38.5 tt0 . . . . . 0 C--O 1.249 1.039 0 O-C-N 124.035 0.834 . . . . 0.0 109.914 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 CA--C 1.504 -0.824 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -82.45 99.9 9.72 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -107.74 115.35 29.98 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.915 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 142.97 88.01 0.1 OUTLIER Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.773 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.66 86.26 7.37 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.577 0.703 . . . . 0.0 109.175 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . 0.259 16.3 ptt180 -83.72 79.26 9.52 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 122.526 1.155 . . . . 0.0 113.278 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -131.51 171.9 12.87 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 112.843 -1.981 . . . . 0.0 107.18 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 569' ' ' CYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 68.3 m -96.36 121.94 38.7 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.198 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -99.67 140.19 34.23 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 571' ' ' LEU . . . . . 0.811 HD12 ' HG3' ' A' ' 580' ' ' PRO . 3.2 tt -58.21 112.48 4.94 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 572' ' ' PRO . . . . . 0.482 ' HD3' HD21 ' A' ' 616' ' ' LEU . 93.3 Cg_endo -83.94 -158.57 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.527 2.818 . . . . 0.0 112.72 -175.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.8 91.95 6.58 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 574' ' ' ILE . . . . . 0.563 HD11 ' HD3' ' A' ' 580' ' ' PRO . 6.5 pt -72.47 -88.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.827 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.631 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 17.6 t70 -160.26 173.37 15.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 173.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.87 -29.36 8.34 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-O 121.29 0.566 . . . . 0.0 109.543 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -98.94 3.57 47.13 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.461 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.9 tm? -96.0 147.42 23.71 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -177.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . 0.409 ' HA ' ' HD2' ' A' ' 580' ' ' PRO . 6.1 t -139.55 121.21 9.85 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 580' ' ' PRO . . . . . 0.811 ' HG3' HD12 ' A' ' 571' ' ' LEU . 60.4 Cg_endo -73.86 140.89 29.52 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.369 2.046 . . . . 0.0 112.173 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.57 -38.33 86.84 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 125.525 1.53 . . . . 0.0 110.687 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -75.97 -66.8 0.74 Allowed 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.63 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.46 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 38.8 ttpt 57.52 78.23 0.24 Allowed 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.01 -178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.417 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 18.1 ptpt -132.87 175.47 9.32 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.304 -1.316 . . . . 0.0 107.773 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -76.86 -57.53 3.8 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.74 142.05 51.13 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 587' ' ' TYR . . . . . 0.544 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 94.8 m-85 -112.12 126.7 55.47 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -70.21 142.4 52.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.672 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 2.1 p -60.06 116.0 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-O 121.951 0.881 . . . . 0.0 111.329 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 121.29 -22.21 7.97 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.173 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -58.42 139.8 54.84 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.765 0.426 . . . . 0.0 110.416 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 2.1 m -111.6 136.33 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 593' ' ' LEU . . . . . 0.544 ' HG ' ' CE2' ' A' ' 587' ' ' TYR 0.338 0.0 OUTLIER -130.78 113.54 14.23 Favored 'General case' 0 N--CA 1.396 -3.172 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.228 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 594' ' ' LYS . . . . . 0.599 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 64.9 mttm -76.46 147.91 37.57 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.55 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 595' ' ' PHE . . . . . 0.491 ' HB3' HD13 ' A' ' 578' ' ' LEU . 24.8 m-85 -121.61 166.39 14.3 Favored 'General case' 0 C--N 1.261 -3.277 0 C-N-CA 123.822 0.849 . . . . 0.0 110.1 177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 9.5 t -173.59 154.25 2.47 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 170.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 597' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 73.8 m -88.37 176.59 7.13 Favored 'General case' 0 C--N 1.259 -3.352 0 O-C-N 123.863 0.727 . . . . 0.0 110.636 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 598' ' ' LYS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.5 mmtp -55.37 162.38 2.29 Favored Pre-proline 0 N--CA 1.438 -1.061 0 C-N-CA 123.955 0.902 . . . . 0.0 112.257 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 599' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 91.5 Cg_exo -43.79 -44.09 11.67 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 124.51 3.473 . . . . 0.0 115.119 -175.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -88.93 -10.47 66.63 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.27 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 42.1 m-85 -97.54 155.28 17.03 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.893 0.854 . . . . 0.0 112.37 -176.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 10.7 m -107.76 126.88 53.16 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.808 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.448 ' HA ' ' SG ' ' A' ' 597' ' ' CYS . 5.2 tt -74.09 118.6 19.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.076 172.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . 0.456 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 67.4 t -111.64 110.78 33.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 133.7 -154.69 21.41 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.78 122.47 7.78 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.92 2.413 . . . . 0.0 112.315 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 1.2 t-20 -79.24 -36.46 39.92 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.38 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 608' ' ' SER . . . . . 0.599 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 52.8 p -125.49 100.63 6.56 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.884 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.3 m -98.03 161.13 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 610' ' ' GLN . . . . . 0.517 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 1.9 mp0 -115.87 158.6 22.72 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.672 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 37.3 t -80.95 104.61 11.57 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 118.613 -1.235 . . . . 0.0 107.903 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.541 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 4.7 m-85 -87.64 167.87 13.51 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -74.9 0.06 16.93 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.648 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -116.65 7.48 13.57 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 131.06 174.52 13.69 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.972 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.484 ' CD2' ' HB3' ' A' ' 569' ' ' CYS . 2.9 mm? -63.73 109.59 1.76 Allowed 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' SER . . . . . 0.541 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 18.8 m -128.05 148.58 68.02 Favored Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -175.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.03 -171.22 8.71 Favored 'Cis proline' 0 CA--C 1.558 1.687 0 C-N-CA 123.644 -1.398 . . . . 0.0 113.476 1.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -57.96 151.58 18.07 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.895 0.379 . . . . 0.0 111.229 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' LEU . . . . . 0.414 HD22 ' HG2' ' A' ' 572' ' ' PRO . 1.9 mm? -66.87 137.21 94.7 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.629 -173.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.8 170.83 10.74 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.802 3.001 . . . . 0.0 111.943 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' ILE . . . . . 0.456 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 43.1 pt -115.62 179.81 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 86.3 m -123.97 126.96 47.23 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.898 0.38 . . . . 0.0 110.971 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -124.08 121.61 35.65 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 14.0 tt0 -81.1 -28.34 35.24 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -100.77 111.53 23.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.555 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.8 172.89 15.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.099 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.506 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 25.8 mt-30 -96.32 164.02 12.83 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 37.8 m -110.79 -1.73 16.47 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.044 0.449 . . . . 0.0 110.139 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 69.7 m 70.77 -38.77 0.43 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.086 1.354 . . . . 0.0 114.435 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 100.68 -143.82 16.43 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -72.81 143.1 36.52 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 121.965 1.777 . . . . 0.0 109.81 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.423 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.4 Cg_endo -74.32 163.12 37.09 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.386 2.057 . . . . 0.0 112.302 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.9 173.29 7.19 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.705 2.27 . . . . 0.0 111.451 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -89.8 162.47 15.49 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 1.594 HD22 ' CD1' ' A' ' 636' ' ' LEU . 16.8 tp -92.54 166.89 12.29 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 177.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 683' ' ' VAL 0.303 2.0 pt? -82.76 -48.04 11.28 Favored 'General case' 0 N--CA 1.41 -2.462 0 C-N-CA 117.947 -1.501 . . . . 0.0 113.298 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.641 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 41.9 m-80 -124.82 34.15 5.06 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.734 0.778 . . . . 0.0 109.897 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.621 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -159.52 -139.78 2.75 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.903 174.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . 0.451 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.8 t-20 -162.47 -171.58 2.83 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 11.8 t -96.11 123.57 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.578 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.6 ptmt -79.34 -23.59 43.33 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.18 0.514 . . . . 0.0 109.91 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -78.96 152.27 31.15 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -79.49 121.53 25.31 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.977 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 33.1 p -68.22 99.05 0.86 Allowed 'General case' 0 N--CA 1.419 -1.977 0 CA-C-O 121.805 0.812 . . . . 0.0 112.617 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 54.6 pttt -89.09 160.79 16.87 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -78.73 -5.96 54.59 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -146.1 104.87 3.86 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.471 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 9.3 m-85 -90.64 -111.24 0.09 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.941 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 168.5 161.06 17.74 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 65.1 t60 -53.76 -57.36 11.16 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 32.9 m -89.98 8.28 33.22 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.927 -174.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -93.58 118.2 31.06 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.672 0.749 . . . . 0.0 110.382 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 4.5 m -89.95 151.66 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.516 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 30.2 m -116.67 104.16 16.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.654 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.578 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 23.5 mt-10 -65.36 124.29 21.87 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 122.218 1.009 . . . . 0.0 111.538 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -102.5 165.64 10.98 Favored 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.431 173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 8.8 p90 -146.81 137.32 23.74 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.643 ' SG ' HD13 ' A' ' 636' ' ' LEU . 61.2 m -97.24 165.86 11.84 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -63.6 150.29 90.69 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.41 0.85 1.99 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 124.13 3.22 . . . . 0.0 114.573 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -98.54 -0.98 42.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -130.26 169.19 15.74 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.308 -173.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 88.5 mt -108.88 161.02 15.52 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.59 ' HE1' ' SG ' ' A' ' 659' ' ' CYS . 4.4 ttt -117.8 113.53 21.94 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -68.3 -64.01 0.95 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -102.85 -158.24 25.48 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 121.122 -0.561 . . . . 0.0 114.116 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.93 121.51 9.62 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.767 2.978 . . . . 0.0 111.603 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.523 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 16.9 p-10 -79.4 -11.8 59.91 Favored 'General case' 0 C--O 1.178 -2.709 0 CA-C-O 120.917 0.389 . . . . 0.0 110.856 -177.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 5.3 ptmt -125.82 112.01 15.53 Favored 'General case' 0 C--N 1.27 -2.874 0 C-N-CA 123.932 0.893 . . . . 0.0 109.51 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 34.4 pt -109.92 151.47 12.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.708 -174.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.19 160.83 21.41 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.565 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 16.9 t -82.39 92.79 7.07 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.491 1.139 . . . . 0.0 111.796 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 83.8 t -80.7 113.93 20.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.667 -1.152 . . . . 0.0 110.151 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 19.7 t70 57.3 -69.52 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.582 1.953 . . . . 0.0 112.593 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -157.67 26.86 0.46 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 111.769 -0.532 . . . . 0.0 111.769 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -145.06 151.13 38.05 Favored 'General case' 0 C--O 1.21 -1.022 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.508 ' HB3' HD13 ' A' ' 671' ' ' ILE . 96.3 m95 -82.64 170.7 14.84 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 679' ' ' THR . . . . . 0.454 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 5.5 p -92.65 -174.52 3.67 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 30.0 m -68.94 131.12 44.57 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.792 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.51 157.51 85.58 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 21.9 Cg_endo -62.8 -21.35 72.99 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 124.346 3.364 . . . . 0.0 115.879 -176.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.52 ' HA ' HD23 ' A' ' 637' ' ' LEU 0.357 22.4 m 49.97 109.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -178.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.5 m -88.0 147.36 25.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.549 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 685' ' ' ILE . 0.1 OUTLIER -143.4 151.73 16.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.76 141.63 16.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 C--O 1.255 1.373 0 O-C-N 124.09 0.869 . . . . 0.0 110.625 178.901 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 568' ' ' GLU . . . . . 0.593 ' HG3' ' HB3' ' A' ' 586' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.774 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 91.5 m -96.39 140.86 30.43 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -126.05 130.26 50.78 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.848 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.2 tt -53.05 119.27 16.05 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.524 ' HG2' HD21 ' A' ' 620' ' ' LEU . 87.8 Cg_endo -78.72 -157.74 0.08 OUTLIER 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.234 2.623 . . . . 0.0 111.566 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -91.09 107.64 19.34 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.489 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.738 HG22 HD23 ' A' ' 620' ' ' LEU . 35.1 pt -79.58 -171.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.477 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.936 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.1 t70 -73.74 159.49 32.88 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.17 -31.91 53.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -98.8 6.35 46.94 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.992 -0.443 . . . . 0.0 111.4 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.936 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.0 tm? -95.54 150.66 20.08 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.486 ' N ' HD13 ' A' ' 578' ' ' LEU . 7.1 m -145.31 118.18 5.33 Favored Pre-proline 0 C--N 1.293 -1.86 0 C-N-CA 125.006 1.322 . . . . 0.0 108.241 176.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.848 ' HG3' HD11 ' A' ' 571' ' ' LEU . 36.8 Cg_endo -70.23 131.03 19.74 Favored 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 121.255 1.304 . . . . 0.0 110.78 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.15 -34.89 79.07 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 582' ' ' ARG . . . . . 0.443 ' HB2' HD22 ' A' ' 593' ' ' LEU . 55.0 mmt-85 -88.09 104.83 17.04 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 171.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -117.65 97.48 5.88 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.454 ' HG3' ' H ' ' A' ' 585' ' ' ASP 0.288 10.4 ptpt -113.46 -93.39 0.47 Allowed 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.04 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.454 ' H ' ' HG3' ' A' ' 584' ' ' LYS . 5.6 t70 -173.82 -62.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 176.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 586' ' ' GLN . . . . . 0.593 ' HB3' ' HG3' ' A' ' 568' ' ' GLU . 14.0 mp0 -121.14 145.0 48.27 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.963 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.658 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 23.7 m-85 -114.84 132.57 56.46 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 -171.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 588' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' A' ' 591' ' ' GLU . 33.8 mtmm -90.06 161.11 15.98 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.517 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.41 121.9 16.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.209 0.528 . . . . 0.0 110.309 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 103.29 -0.08 47.16 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.881 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 591' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 588' ' ' LYS . 82.0 mm-40 -67.1 122.1 17.05 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 117.756 0.778 . . . . 0.0 109.012 173.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.585 HG12 ' HG3' ' A' ' 610' ' ' GLN . 7.0 m -95.41 117.68 39.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 CA-C-O 122.307 1.051 . . . . 0.0 108.63 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.623 HD21 ' HD2' ' A' ' 587' ' ' TYR . 17.5 mt -101.85 101.46 11.91 Favored 'General case' 0 C--N 1.274 -2.71 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.059 -174.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.599 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 10.3 mtmp? -79.72 113.38 17.83 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.782 ' HB3' HD11 ' A' ' 578' ' ' LEU . 80.4 m-85 -95.91 167.4 11.27 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 596' ' ' SER . . . . . 0.415 ' O ' HD22 ' A' ' 578' ' ' LEU . 21.4 t -168.18 -179.18 3.95 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 170.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 77.8 m -118.4 177.36 4.85 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 123.68 0.612 . . . . 0.0 112.488 -173.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 30.1 mmtp -50.59 162.36 0.55 Allowed Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 125.372 1.469 . . . . 0.0 112.27 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 76.7 Cg_exo -47.76 -43.47 28.79 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.248 3.299 . . . . 0.0 113.761 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.66 1.64 63.99 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.957 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 37.4 m-85 -105.57 141.01 37.78 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-O 121.961 0.886 . . . . 0.0 112.777 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.662 HG21 HG11 ' A' ' 627' ' ' VAL . 9.8 m -102.69 126.84 49.94 Favored 'General case' 0 N--CA 1.393 -3.293 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.338 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.451 HD11 ' HG3' ' A' ' 621' ' ' PRO . 10.8 tt -73.18 123.51 28.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.097 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.486 HG21 ' HD3' ' A' ' 624' ' ' LYS . 86.6 t -113.14 126.49 70.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.764 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.07 -145.61 18.46 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.41 124.11 4.62 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.773 2.315 . . . . 0.0 110.864 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.26 -42.93 14.21 Favored 'General case' 0 C--O 1.204 -1.313 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.832 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.599 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 18.6 p -114.14 97.86 6.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.14 0.495 . . . . 0.0 111.983 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 609' ' ' VAL . . . . . 0.409 ' HA ' ' HD2' ' A' ' 618' ' ' PRO . 11.1 m -92.66 163.18 2.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.585 ' HG3' HG12 ' A' ' 592' ' ' VAL . 2.3 mp0 -113.18 154.1 27.23 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.374 0.607 . . . . 0.0 110.209 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 6.6 t -85.14 108.75 17.84 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.72 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' ' 617' ' ' SER . 55.3 m-85 -91.57 166.79 12.65 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 175.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -7.58 19.55 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -105.97 -10.59 16.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.998 0.427 . . . . 0.0 111.225 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 140.94 -172.49 23.65 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.532 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.443 ' CD2' ' HB3' ' A' ' 569' ' ' CYS . 2.8 mm? -79.32 127.82 32.56 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.55 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 47.8 t -149.09 147.18 22.99 Favored Pre-proline 0 N--CA 1.429 -1.516 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 609' ' ' VAL . 57.3 Cg_endo -71.33 -175.74 13.4 Favored 'Cis proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.641 -1.4 . . . . 0.0 114.038 1.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -63.26 142.44 58.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.032 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.738 HD23 HG22 ' A' ' 574' ' ' ILE . 8.7 mp -57.58 143.6 74.82 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -173.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.451 ' HG3' HD11 ' A' ' 603' ' ' ILE . 38.2 Cg_endo -68.05 -178.53 1.75 Allowed 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 124.748 3.632 . . . . 0.0 113.341 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 622' ' ' ILE . . . . . 0.431 HG13 ' HB ' ' A' ' 604' ' ' VAL . 40.1 pt -130.81 -178.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.4 m -129.0 119.5 24.39 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.222 0.534 . . . . 0.0 111.787 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.486 ' HD3' HG21 ' A' ' 604' ' ' VAL . 47.8 mtpt -114.04 126.04 54.67 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.837 177.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 18.3 tt0 -81.83 -27.05 33.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -123.8 113.63 18.81 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.286 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.662 HG11 HG21 ' A' ' 602' ' ' THR . 3.2 m -106.23 177.83 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.499 176.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 628' ' ' GLN . . . . . 0.476 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 73.0 mt-30 -97.51 167.0 11.25 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 49.2 m -105.19 -4.92 21.17 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.536 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.1 m 68.15 -31.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 82.31 -139.06 19.32 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 633' ' ' PRO . 46.8 Cg_endo -75.9 154.39 38.3 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.449 2.099 . . . . 0.0 111.27 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.553 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 61.7 Cg_endo -92.07 174.12 2.25 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 123.087 2.525 . . . . 0.0 111.532 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.78 -173.72 1.87 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.033 1.822 . . . . 0.0 109.985 172.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.41 159.87 24.22 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.526 ' HB3' ' C ' ' A' ' 639' ' ' GLY . 14.7 tp -70.56 144.8 51.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.574 ' HG ' ' H ' ' A' ' 638' ' ' ASN . 0.9 OUTLIER -48.96 -71.76 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.574 ' H ' ' HG ' ' A' ' 637' ' ' LEU . 9.5 m120 -94.03 -32.57 13.76 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.622 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -85.15 -154.21 21.81 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.497 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 640' ' ' ASN . . . . . 0.594 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 54.5 t30 -152.05 -173.66 4.61 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.8 p -101.72 133.54 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -93.43 -27.34 16.77 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.211 0.529 . . . . 0.0 110.641 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.714 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 38.5 mm-40 -81.56 153.78 26.57 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.245 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -67.12 122.25 17.39 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.257 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.463 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 16.6 p -76.97 110.53 11.67 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.417 0.627 . . . . 0.0 110.242 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -82.32 157.39 23.83 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.186 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.94 -9.29 59.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.724 0.773 . . . . 0.0 109.696 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 648' ' ' GLU . . . . . 0.642 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 38.4 tt0 -156.1 124.24 5.73 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.558 ' CE2' HG22 ' A' ' 655' ' ' VAL . 13.9 m-85 -98.44 -63.08 1.16 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 123.471 0.482 . . . . 0.0 111.637 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 112.23 162.04 16.1 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.435 ' CD2' ' HA ' ' A' ' 674' ' ' VAL . 51.6 t-80 -63.68 140.56 58.88 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.0 m 75.78 -4.04 2.45 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.417 1.087 . . . . 0.0 113.546 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 649' ' ' TYR . 5.3 tp10 -81.87 120.14 24.82 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.9 m -91.47 159.46 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-O 122.1 0.952 . . . . 0.0 112.564 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.9 t -127.11 102.61 9.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.871 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.714 ' HB2' ' HG2' ' A' ' 643' ' ' GLU . 29.8 mt-10 -67.69 132.66 47.9 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.153 0.978 . . . . 0.0 112.194 175.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 67.9 m-85 -112.7 171.43 7.53 Favored 'General case' 0 C--N 1.28 -2.447 0 C-N-CA 126.372 1.869 . . . . 0.0 109.596 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 31.4 p90 -151.06 141.9 22.87 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.622 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 7.3 t -105.81 -177.66 3.43 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.746 176.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 34.6 m-80 -70.35 151.39 95.74 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.41 ' C ' ' HD2' ' A' ' 662' ' ' ARG . 52.7 Cg_endo -68.46 26.24 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 124.31 3.34 . . . . 0.0 114.092 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.41 ' HD2' ' C ' ' A' ' 661' ' ' PRO . 13.3 mmm180 -128.35 5.07 5.72 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 660' ' ' ASN . 44.1 m-85 -123.74 164.84 18.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.309 -172.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.428 HD21 ' OE2' ' A' ' 687' ' ' GLU . 90.3 mt -110.18 143.54 40.15 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.423 1.489 . . . . 0.0 107.31 175.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.9 ttt -114.04 102.52 10.26 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.788 ' HG2' HD11 ' A' ' 685' ' ' ILE . 72.3 mmtt -73.18 -63.22 1.23 Allowed 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.882 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -83.35 -168.52 43.45 Favored Glycine 0 N--CA 1.404 -3.486 0 CA-C-N 114.792 -1.095 . . . . 0.0 113.473 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.0 118.04 5.01 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.108 2.538 . . . . 0.0 112.07 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 3.7 p-10 -80.34 19.31 0.78 Allowed 'General case' 0 C--O 1.19 -2.028 0 C-N-CA 122.886 0.475 . . . . 0.0 111.426 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.72 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 7.0 ptmt -162.14 111.17 1.46 Allowed 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 124.861 1.264 . . . . 0.0 108.024 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 35.3 pt -107.63 144.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.986 -174.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.443 ' HB3' ' CG1' ' A' ' 654' ' ' VAL . 0.0 OUTLIER -112.67 142.81 44.85 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 123.677 0.611 . . . . 0.0 110.848 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.0 t -67.41 116.89 8.67 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.683 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 674' ' ' VAL . . . . . 0.435 ' HA ' ' CD2' ' A' ' 651' ' ' HIS . 34.1 m -109.18 127.7 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 28.2 t70 54.79 -80.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.538 1.135 . . . . 0.0 112.031 -169.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 676' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -157.11 31.67 0.54 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -143.02 156.45 44.84 Favored 'General case' 0 C--O 1.212 -0.88 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.463 ' HB3' HD12 ' A' ' 671' ' ' ILE . 97.7 m95 -93.15 166.1 12.5 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 7.9 p -91.81 -169.72 2.36 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 35.1 m -71.54 126.29 29.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.71 0.29 . . . . 0.0 110.413 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.93 160.41 29.32 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.893 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.611 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 24.6 Cg_endo -63.34 -15.33 47.65 Favored 'Trans proline' 0 CA--C 1.498 -1.312 0 C-N-CA 123.663 2.908 . . . . 0.0 115.035 -175.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 22.4 m 43.21 93.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 124.87 1.356 . . . . 0.0 114.411 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 23.3 p -95.75 137.26 35.06 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.662 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.788 HD11 ' HG2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -133.5 147.48 31.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.004 -178.006 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 98.3 t -52.56 133.27 14.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -172.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 687' ' ' GLU . . . . . 0.428 ' OE2' HD21 ' A' ' 664' ' ' LEU . 6.9 tp10 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.184 1.394 . . . . 0.0 108.963 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.423 -1.783 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 74.9 m -98.81 112.72 24.72 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-O 121.876 0.846 . . . . 0.0 112.471 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 571' ' ' LEU . 21.3 tt0 -82.97 -23.58 33.31 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.24 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 32.3 tp 79.02 105.08 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 113.665 -1.607 . . . . 0.0 108.922 -169.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.711 ' HD2' HD12 ' A' ' 616' ' ' LEU . 24.5 Cg_endo -62.94 -172.6 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.062 2.508 . . . . 0.0 113.429 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.89 20.77 0.45 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -170.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.779 HG13 ' H ' ' A' ' 575' ' ' ASP . 26.1 pt 35.19 -94.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 126.523 1.929 . . . . 0.0 115.469 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.779 ' H ' HG13 ' A' ' 574' ' ' ILE . 15.7 t70 -165.1 179.74 6.17 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.82 -27.57 4.98 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -103.52 10.17 37.23 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.622 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.739 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.7 tp -100.14 164.49 11.95 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.65 122.52 1.94 Allowed Pre-proline 0 C--N 1.308 -1.238 0 C-N-CA 124.044 0.938 . . . . 0.0 108.803 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.2 137.51 21.39 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.123 1.882 . . . . 0.0 112.209 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -78.74 -42.11 29.02 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -90.33 113.56 25.46 Favored 'General case' 0 N--CA 1.392 -3.349 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 583' ' ' LYS . . . . . 0.58 ' HA ' ' OH ' ' A' ' 587' ' ' TYR . 64.1 tttp -135.24 135.44 40.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.311 0.577 . . . . 0.0 111.641 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.621 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 13.1 ptpt -160.43 -160.31 0.76 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.634 1.174 . . . . 0.0 108.489 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -90.34 -64.46 1.13 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.03 0.443 . . . . 0.0 110.656 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -119.98 134.3 55.29 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.645 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 69.3 m-85 -96.39 127.5 42.45 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -84.36 145.33 28.28 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.876 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 1.6 p -55.59 111.36 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 122.17 0.986 . . . . 0.0 112.755 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 115.26 -6.29 21.35 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.862 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -70.23 137.95 51.27 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 4.1 m -104.63 123.89 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-O 122.03 0.919 . . . . 0.0 109.499 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.477 HD11 ' CD2' ' A' ' 587' ' ' TYR . 7.4 mp -107.48 104.79 14.44 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.174 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 28.8 mtpp -82.95 119.33 24.29 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.763 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.45 158.62 16.08 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-O 120.957 0.408 . . . . 0.0 110.684 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 19.6 m -150.59 171.74 16.63 Favored 'General case' 0 N--CA 1.398 -3.044 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.555 ' SG ' HD12 ' A' ' 578' ' ' LEU . 95.3 m -112.87 179.84 3.85 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-O 120.656 0.265 . . . . 0.0 110.333 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -52.23 162.07 0.92 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.302 1.441 . . . . 0.0 112.306 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.45 -41.96 42.61 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.268 3.312 . . . . 0.0 114.283 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 600' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 625' ' ' GLU . . . -96.52 1.71 62.21 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.627 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -103.84 147.82 26.85 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.876 0.846 . . . . 0.0 112.892 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.602 HG21 HG11 ' A' ' 627' ' ' VAL . 17.8 m -98.83 134.95 40.98 Favored 'General case' 0 C--N 1.272 -2.762 0 CA-C-N 113.728 -1.578 . . . . 0.0 109.104 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.579 HD11 ' HG3' ' A' ' 621' ' ' PRO . 7.6 tt -82.48 115.66 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.831 0.824 . . . . 0.0 109.348 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.537 ' HB ' HG13 ' A' ' 622' ' ' ILE . 61.9 t -106.72 101.84 13.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.726 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 137.31 -162.38 25.36 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.0 123.44 10.66 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 122.827 2.351 . . . . 0.0 111.963 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.34 -49.46 11.49 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 175.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 66.5 p -104.31 106.91 17.58 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.58 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.18 161.2 4.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.642 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 22.8 mm-40 -105.08 163.48 12.53 Favored 'General case' 0 CA--C 1.473 -2.003 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.537 ' HA ' HD23 ' A' ' 616' ' ' LEU . 43.4 t -88.01 132.54 34.23 Favored 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 118.646 -1.222 . . . . 0.0 107.78 166.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.642 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 75.2 m-85 -116.61 168.84 9.83 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -67.64 -5.37 15.4 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -111.23 -9.24 14.33 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 122.007 -0.433 . . . . 0.0 110.266 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 138.61 -177.4 20.17 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.711 HD12 ' HD2' ' A' ' 572' ' ' PRO . 94.3 mt -68.57 140.83 55.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 117.037 0.419 . . . . 0.0 109.899 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 2.5 t -156.31 150.83 20.21 Favored Pre-proline 0 N--CA 1.421 -1.915 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.457 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 59.8 Cg_endo -69.99 -176.64 13.3 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.672 -1.386 . . . . 0.0 112.99 1.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.13 144.98 32.66 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.995 0.426 . . . . 0.0 110.408 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.563 HD23 HG22 ' A' ' 574' ' ' ILE . 8.4 mp -64.76 145.56 98.77 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.248 -172.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.579 ' HG3' HD11 ' A' ' 603' ' ' ILE . 72.3 Cg_endo -71.25 170.22 18.82 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 123.452 2.768 . . . . 0.0 112.54 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 622' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 604' ' ' VAL . 38.8 pt -116.7 -178.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 602' ' ' THR . 73.3 m -126.44 125.8 42.74 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.977 0.418 . . . . 0.0 111.443 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 624' ' ' LYS . 47.8 mtpt -119.31 140.11 50.83 Favored 'General case' 0 C--O 1.194 -1.862 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 600' ' ' GLY . 1.4 tm-20 -90.67 -43.72 9.96 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -95.76 112.02 23.85 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.471 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.602 HG11 HG21 ' A' ' 602' ' ' THR . 7.4 m -123.21 175.63 5.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.489 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.68 170.15 9.2 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 15.5 m -102.03 -11.11 19.15 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 93.0 m 70.6 8.99 6.79 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 112.376 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 60.58 -144.74 47.72 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -82.38 153.6 16.05 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.481 2.12 . . . . 0.0 110.292 173.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.68 ' HG3' HG11 ' A' ' 655' ' ' VAL . 57.0 Cg_endo -71.05 153.53 62.93 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.842 2.362 . . . . 0.0 113.366 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.4 173.99 6.85 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.627 2.884 . . . . 0.0 113.097 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -88.21 153.33 21.32 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 121.173 0.511 . . . . 0.0 110.926 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.59 HD22 ' HB3' ' A' ' 657' ' ' TYR . 23.4 tp -97.04 123.92 40.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' A' ' 683' ' ' VAL . 0.0 OUTLIER -39.66 -46.8 1.89 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -177.59 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.4 ' N ' HD22 ' A' ' 637' ' ' LEU . 72.2 m-20 -137.92 39.99 2.34 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.263 1.03 . . . . 0.0 109.507 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.629 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.46 -152.96 6.36 Favored Glycine 0 N--CA 1.397 -3.96 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -164.67 -176.58 4.35 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 124.087 0.955 . . . . 0.0 108.682 175.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.601 HG11 HG21 ' A' ' 645' ' ' THR . 6.4 p -95.99 130.31 44.85 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.042 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.637 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.5 ptmt -85.25 -27.4 26.05 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.245 0.545 . . . . 0.0 110.255 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 40.2 mm-40 -80.8 143.6 32.72 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.725 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 644' ' ' LYS . . . . . 0.781 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -52.8 120.76 6.14 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 124.646 1.217 . . . . 0.0 109.39 173.183 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.601 HG21 HG11 ' A' ' 641' ' ' VAL . 4.1 p -101.35 104.96 15.97 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -172.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -85.17 149.55 25.44 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 113.601 -1.636 . . . . 0.0 108.126 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -80.69 16.62 1.34 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -155.48 105.27 2.44 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.484 ' CE2' HG22 ' A' ' 655' ' ' VAL . 3.4 m-85 -90.85 -88.57 0.18 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 143.02 157.08 7.01 Favored Glycine 0 N--CA 1.424 -2.142 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -175.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.415 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 84.6 t60 -67.12 138.72 57.28 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.511 0.196 . . . . 0.0 111.023 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 68.6 m 69.25 5.88 5.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.702 1.201 . . . . 0.0 113.044 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -92.69 117.54 30.1 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.646 HG21 ' HE3' ' A' ' 670' ' ' LYS . 12.8 m -86.49 159.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.694 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.5 t -129.03 117.54 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.904 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.637 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 20.9 mt-10 -73.02 124.38 25.38 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.773 0.797 . . . . 0.0 112.245 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.59 ' HB3' HD22 ' A' ' 636' ' ' LEU . 34.3 m-85 -104.58 172.62 6.69 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.092 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -146.81 137.26 23.71 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.629 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 70.9 m -95.43 172.85 7.83 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.46 ' HB2' ' HD1' ' A' ' 663' ' ' PHE . 9.8 m120 -63.73 152.56 86.16 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.85 -4.36 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.411 2.74 . . . . 0.0 112.538 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -96.42 -1.27 47.88 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 124.311 1.044 . . . . 0.0 108.865 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.46 ' HD1' ' HB2' ' A' ' 660' ' ' ASN . 45.4 m-85 -131.75 158.02 42.28 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.103 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 89.1 mt -100.17 158.03 16.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.421 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 6.2 ttt -124.6 95.08 4.39 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -176.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -86.95 -44.52 11.57 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.351 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -78.65 -179.64 51.5 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.975 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.24 114.85 2.29 Favored 'Trans proline' 0 C--N 1.334 -0.232 0 C-N-CA 123.138 2.558 . . . . 0.0 111.142 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 17.6 p-10 -73.92 -11.39 60.34 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 2.3 mtpp -121.3 120.06 34.02 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 33.6 pt -111.12 152.59 13.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.532 -1.267 . . . . 0.0 110.924 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -114.66 154.05 29.11 Favored 'General case' 0 N--CA 1.425 -1.688 0 O-C-N 123.881 0.738 . . . . 0.0 109.489 -172.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 2.8 t -85.62 122.55 29.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.057 174.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 674' ' ' VAL . . . . . 0.415 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 77.9 t -114.42 114.68 47.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.211 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.7 t70 55.16 -78.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.25 1.42 . . . . 0.0 111.765 -171.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -149.1 18.2 1.2 Allowed Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -130.07 150.84 51.16 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.561 ' HB3' HD12 ' A' ' 671' ' ' ILE . 95.8 m95 -87.86 162.96 16.66 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 19.2 p -81.68 -178.15 6.85 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 27.3 m -64.39 130.85 45.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.462 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.0 mp -68.56 162.37 63.11 Favored Pre-proline 0 N--CA 1.446 -0.669 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.573 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 31.6 Cg_endo -67.76 -16.06 45.44 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.808 3.005 . . . . 0.0 114.721 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.513 ' HA ' HD11 ' A' ' 637' ' ' LEU 0.304 13.2 m 44.25 92.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 175.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 3.6 m -67.19 139.6 57.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.329 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.17 148.11 33.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.593 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 44.8 t -65.36 135.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 O-C-N 123.39 0.431 . . . . 0.0 110.731 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.25 1.108 0 O-C-N 123.848 0.718 . . . . 0.0 109.856 179.23 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 568' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 569' ' ' CYS . 3.9 tp10 . . . . . 0 N--CA 1.432 -1.347 0 N-CA-C 102.039 -3.319 . . . . 0.0 102.039 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 616' ' ' LEU . 87.4 m -138.81 161.16 37.94 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 119.518 1.054 . . . . 0.0 112.669 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -138.34 117.9 13.0 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 104.538 -2.394 . . . . 0.0 104.538 168.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.659 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 2.0 tt -34.57 121.8 0.55 Allowed Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 125.37 1.468 . . . . 0.0 109.56 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.625 ' HD2' HD22 ' A' ' 616' ' ' LEU . 70.6 Cg_endo -69.58 -169.9 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.36 2.04 . . . . 0.0 111.549 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -87.63 101.36 13.58 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.439 -0.905 . . . . 0.0 109.602 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.813 HG22 HD23 ' A' ' 620' ' ' LEU . 38.9 pt -67.42 -172.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.987 0 CA-C-O 121.759 0.79 . . . . 0.0 110.674 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.805 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 6.4 t70 -66.34 -175.15 0.33 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.046 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.92 -27.3 4.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 O-C-N 121.407 -0.808 . . . . 0.0 109.358 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -109.58 9.94 25.11 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 122.124 -0.36 . . . . 0.0 111.868 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.879 HD11 ' HB3' ' A' ' 595' ' ' PHE . 1.6 tm? -89.99 151.37 21.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.51 ' N ' HD13 ' A' ' 578' ' ' LEU . 7.6 p -148.88 117.16 3.89 Favored Pre-proline 0 C--N 1.294 -1.845 0 C-N-CA 123.907 0.883 . . . . 0.0 109.303 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.612 ' HG3' HD11 ' A' ' 571' ' ' LEU . 64.8 Cg_endo -75.16 148.9 35.31 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.643 2.229 . . . . 0.0 112.909 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.74 -55.99 8.4 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -75.1 108.77 8.06 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.91 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -120.81 97.72 5.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.51 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.8 ptpt -133.44 167.43 20.46 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.118 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.28 -67.18 0.44 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 124.052 0.845 . . . . 0.0 110.992 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -121.92 144.13 49.04 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.659 ' CE1' ' HB2' ' A' ' 571' ' ' LEU . 45.2 m-85 -103.69 132.47 49.91 Favored 'General case' 0 CA--C 1.467 -2.247 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.843 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 588' ' ' LYS . . . . . 0.432 ' HA ' ' OE2' ' A' ' 568' ' ' GLU . 19.4 mtpp -81.24 147.36 29.99 Favored 'General case' 0 C--N 1.273 -2.747 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.521 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.707 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 46.6 t -59.44 112.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.178 0.513 . . . . 0.0 110.23 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 113.08 -6.01 25.39 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.416 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.97 135.63 47.99 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.532 HG12 ' HG3' ' A' ' 610' ' ' GLN . 3.8 m -106.33 134.12 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 C-N-CA 119.77 -0.772 . . . . 0.0 108.974 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 608' ' ' SER . 5.4 mp -113.8 103.69 11.45 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.563 ' HG2' ' HB2' ' A' ' 608' ' ' SER . 84.3 mttt -78.6 103.31 8.46 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.879 ' HB3' HD11 ' A' ' 578' ' ' LEU . 44.3 m-85 -86.69 162.94 17.64 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.757 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 596' ' ' SER . . . . . 0.666 ' HA ' HD12 ' A' ' 603' ' ' ILE . 66.5 m -164.18 -175.35 3.94 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 169.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 603' ' ' ILE . 98.0 m -113.02 171.13 7.72 Favored 'General case' 0 C--N 1.259 -3.359 0 O-C-N 123.563 0.54 . . . . 0.0 110.968 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.601 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 29.3 mmtp -56.94 162.21 3.98 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.873 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 44.3 Cg_exo -39.09 -41.37 1.89 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 125.104 3.869 . . . . 0.0 116.644 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -98.42 6.06 60.99 Favored Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.643 -0.789 . . . . 0.0 114.283 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 56.7 m-85 -109.92 150.65 28.14 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 51.9 m -98.29 125.46 43.4 Favored 'General case' 0 N--CA 1.406 -2.675 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.92 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 596' ' ' SER . 8.0 tt -76.02 128.24 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.586 ' HB ' HG13 ' A' ' 622' ' ' ILE . 84.4 t -119.21 105.12 16.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.264 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 134.39 -168.81 23.31 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.697 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.86 116.58 3.54 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 123.519 2.812 . . . . 0.0 110.347 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -81.92 -43.56 17.95 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.624 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.563 ' HB2' ' HG2' ' A' ' 594' ' ' LYS . 15.0 t -111.79 89.76 3.15 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 119.216 -0.993 . . . . 0.0 112.536 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 609' ' ' VAL . . . . . 0.403 HG22 ' CE2' ' A' ' 595' ' ' PHE . 18.0 m -80.2 165.89 2.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.532 ' HG3' HG12 ' A' ' 592' ' ' VAL . 2.2 mp0 -109.9 154.54 22.93 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.551 0.691 . . . . 0.0 109.664 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 0.0 OUTLIER -86.41 131.66 34.14 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.132 167.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.466 ' CD1' ' HB3' ' A' ' 617' ' ' SER . 86.2 m-85 -117.62 173.71 6.57 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -72.45 -5.0 33.63 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.36 -0.837 . . . . 0.0 113.091 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -108.02 -3.06 19.1 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.436 0.636 . . . . 0.0 110.417 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 130.31 -171.42 20.6 Favored Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.625 HD22 ' HD2' ' A' ' 572' ' ' PRO . 8.2 mp -82.13 141.69 32.88 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 46.3 t -159.7 153.02 18.57 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.48 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 78.8 Cg_endo -76.45 -167.6 6.03 Favored 'Cis proline' 0 N--CA 1.481 0.788 0 C-N-CA 124.047 -1.23 . . . . 0.0 113.317 1.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -50.16 144.01 7.63 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.442 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.813 HD23 HG22 ' A' ' 574' ' ' ILE . 7.7 mp -78.99 148.72 72.4 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.177 -173.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.462 ' HG3' HD11 ' A' ' 603' ' ' ILE . 36.3 Cg_endo -67.35 168.56 17.52 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 124.093 3.195 . . . . 0.0 112.952 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 622' ' ' ILE . . . . . 0.586 HG13 ' HB ' ' A' ' 604' ' ' VAL . 45.6 pt -116.25 -179.66 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 78.5 m -124.6 123.13 39.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.969 0.414 . . . . 0.0 111.632 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.517 ' HG3' HG21 ' A' ' 604' ' ' VAL . 6.4 mmmm -115.92 121.97 43.9 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.517 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 1.6 tm-20 -88.96 -36.72 15.71 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -93.23 78.65 4.51 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.62 HG23 ' HA ' ' A' ' 675' ' ' ASP . 11.8 p -88.07 154.99 3.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.265 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 628' ' ' GLN . . . . . 0.465 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 78.0 mt-30 -84.71 167.4 16.19 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.488 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 21.5 m -108.19 -8.95 15.62 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.3 m 70.15 -55.36 0.61 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.337 1.055 . . . . 0.0 111.903 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 109.14 -143.71 16.4 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.23 132.84 28.79 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.685 1.59 . . . . 0.0 111.423 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.438 ' HG3' HG11 ' A' ' 655' ' ' VAL . 56.8 Cg_endo -69.29 164.97 32.06 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 123.505 2.803 . . . . 0.0 112.77 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.08 177.74 4.14 Favored 'Trans proline' 0 C--O 1.254 1.29 0 C-N-CA 122.773 2.315 . . . . 0.0 111.314 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -95.24 165.24 12.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.551 HD22 ' HB3' ' A' ' 657' ' ' TYR . 19.3 tp -91.46 156.46 17.7 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.464 HD21 ' H ' ' A' ' 684' ' ' CYS . 1.7 pt? -53.2 -64.27 0.88 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.59 0.632 . . . . 0.0 112.49 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.45 -23.92 11.65 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.384 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -94.67 -152.75 29.68 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.727 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -154.52 -164.92 1.94 Allowed 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.4 p -104.73 136.18 39.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -94.62 -21.14 19.01 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.299 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.508 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 23.9 mm-40 -81.67 154.59 26.02 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -70.3 113.53 7.56 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.435 ' CG2' HG11 ' A' ' 641' ' ' VAL . 1.5 p -70.75 99.89 1.79 Allowed 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.777 0.799 . . . . 0.0 111.837 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -82.85 169.72 15.78 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.166 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.21 -26.41 33.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.049 0.452 . . . . 0.0 111.207 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -128.55 113.61 15.68 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.513 ' CE2' HG12 ' A' ' 655' ' ' VAL . 8.2 m-85 -92.3 -93.12 0.15 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 140.04 164.94 10.1 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.136 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.676 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 69.7 t60 -55.67 -58.62 7.04 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 15.1 m -90.43 15.31 10.91 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-O 121.289 0.566 . . . . 0.0 111.22 -173.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.421 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 4.7 tp10 -97.12 117.49 31.43 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 5.9 m -93.96 151.34 3.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.754 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 29.3 m -114.34 102.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.55 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.523 ' CG ' ' HD2' ' A' ' 670' ' ' LYS . 12.1 mt-10 -66.21 121.78 15.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.942 0.877 . . . . 0.0 112.242 176.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 69.4 m-85 -100.06 168.61 9.73 Favored 'General case' 0 C--N 1.271 -2.836 0 C-N-CA 125.28 1.432 . . . . 0.0 109.441 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -152.61 141.7 21.33 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.679 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 7.5 t -106.49 -171.19 1.85 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.58 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 662' ' ' ARG . 23.9 m120 -77.77 156.39 80.25 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.37 6.16 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 123.797 2.998 . . . . 0.0 113.388 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 660' ' ' ASN . 32.2 mmt180 -105.7 -0.26 25.67 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.254 -176.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -128.27 158.36 38.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.568 0.699 . . . . 0.0 112.322 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.43 133.39 46.13 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 113.749 -1.569 . . . . 0.0 107.511 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.2 ttt -104.0 109.55 21.37 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -92.9 -49.19 6.16 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -86.23 -171.04 47.56 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.36 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.12 119.12 6.11 Favored 'Trans proline' 0 CA--C 1.526 0.108 0 C-N-CA 123.093 2.529 . . . . 0.0 111.13 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.636 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 23.2 p-10 -81.47 0.28 38.46 Favored 'General case' 0 C--O 1.178 -2.666 0 O-C-N 121.996 -0.44 . . . . 0.0 111.33 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 3.8 ptmt -134.74 110.28 9.13 Favored 'General case' 0 C--N 1.267 -3.0 0 CA-C-O 121.801 0.81 . . . . 0.0 109.704 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 46.5 pt -110.25 151.32 12.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.649 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 651' ' ' HIS . 0.3 OUTLIER -113.73 156.8 23.13 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.541 0.526 . . . . 0.0 111.458 -179.146 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.676 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 13.6 t -81.73 99.63 9.05 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.885 0.85 . . . . 0.0 110.624 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 674' ' ' VAL . . . . . 0.524 ' HA ' ' HD1' ' A' ' 651' ' ' HIS . 36.0 m -90.72 111.66 23.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.975 -1.078 . . . . 0.0 111.878 -177.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 675' ' ' ASP . . . . . 0.62 ' HA ' HG23 ' A' ' 627' ' ' VAL . 13.1 t70 71.13 -59.5 0.54 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.707 1.203 . . . . 0.0 112.639 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 676' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -172.77 22.71 0.07 OUTLIER Glycine 0 C--N 1.295 -1.703 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -142.47 152.0 42.28 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.4 m95 -81.12 173.0 12.98 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.558 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 679' ' ' THR . . . . . 0.458 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 0.5 OUTLIER -96.59 -179.92 4.77 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.067 -179.111 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 27.5 m -69.39 126.17 28.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.725 0.298 . . . . 0.0 110.868 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.4 ' CB ' ' HD2' ' A' ' 682' ' ' PRO . 7.1 mp -60.18 155.94 42.32 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.636 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 10.3 Cg_endo -57.41 -39.67 87.43 Favored 'Trans proline' 0 CA--C 1.5 -1.198 0 C-N-CA 124.434 3.423 . . . . 0.0 115.527 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 682' ' ' PRO 0.275 3.9 m 64.42 122.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.09 0 C-N-CA 125.37 1.468 . . . . 0.0 112.202 -171.8 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.464 ' H ' HD21 ' A' ' 637' ' ' LEU . 21.8 p -119.94 129.17 54.2 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.718 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.409 ' H ' HD13 ' A' ' 685' ' ' ILE . 0.2 OUTLIER -118.76 147.84 22.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.353 -174.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.81 128.71 17.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 123.977 0.798 . . . . 0.0 111.1 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 C--N 1.305 -1.369 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.173 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 120.87 0.366 . . . . 0.0 111.529 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.673 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 88.9 m -127.29 149.28 50.09 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.543 0.687 . . . . 0.0 112.331 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.495 ' O ' HD21 ' A' ' 616' ' ' LEU . 40.0 mt-10 -107.55 -157.12 0.6 Allowed 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.477 HD22 ' HD2' ' A' ' 572' ' ' PRO . 3.1 tm? -125.84 107.38 25.68 Favored Pre-proline 0 C--N 1.28 -2.42 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.477 ' HD2' HD22 ' A' ' 571' ' ' LEU . 48.9 Cg_endo -67.45 176.93 4.35 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.647 2.231 . . . . 0.0 111.785 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -79.76 90.02 5.22 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.843 0.83 . . . . 0.0 109.793 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.817 HG22 ' HG ' ' A' ' 620' ' ' LEU . 38.6 pt -72.88 -169.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.594 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 7.9 t70 -74.82 146.69 41.82 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.17 -22.63 31.53 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 121.662 0.744 . . . . 0.0 110.515 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -93.7 5.46 51.56 Favored 'General case' 0 C--O 1.204 -1.29 0 O-C-N 121.646 -0.659 . . . . 0.0 110.374 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.554 HD12 ' SG ' ' A' ' 623' ' ' CYS . 1.0 OUTLIER -108.02 154.12 22.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.209 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.39 122.51 5.23 Favored Pre-proline 0 C--N 1.304 -1.383 0 C-N-CA 123.304 0.642 . . . . 0.0 109.62 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.92 137.28 26.53 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.054 1.836 . . . . 0.0 112.534 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 581' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 594' ' ' LYS . 10.7 t70 -67.1 -42.52 84.43 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.584 1.154 . . . . 0.0 110.898 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -64.55 -68.94 0.32 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.722 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 53.35 81.49 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.218 1.407 . . . . 0.0 111.315 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 16.5 ptpt -132.89 -177.6 4.57 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.817 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.61 -68.3 0.61 Allowed 'General case' 0 C--N 1.309 -1.164 0 O-C-N 123.158 0.286 . . . . 0.0 111.383 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -120.56 131.06 54.48 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.548 0.689 . . . . 0.0 110.582 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.673 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 66.1 m-85 -94.79 140.34 30.04 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.437 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -91.13 152.51 20.56 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.194 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.69 118.81 3.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 99.71 2.9 56.29 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.834 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -76.16 130.99 39.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 12.7 t -101.81 120.2 51.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.408 0.623 . . . . 0.0 109.386 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.594 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 4.9 mp -98.52 100.12 11.34 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 581' ' ' ASP . 31.0 mtmm -80.27 142.02 34.98 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 173.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.501 ' CZ ' HD12 ' A' ' 620' ' ' LEU . 91.2 m-85 -116.16 173.95 6.31 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-O 121.321 0.582 . . . . 0.0 110.624 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 8.7 p -161.6 168.38 23.59 Favored 'General case' 0 N--CA 1.392 -3.335 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.54 ' SG ' HD12 ' A' ' 578' ' ' LEU . 94.3 m -117.75 -176.06 2.96 Favored 'General case' 0 C--N 1.265 -3.082 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 39.3 mmtm -55.03 166.64 0.77 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.406 1.482 . . . . 0.0 111.85 174.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 71.8 Cg_exo -46.91 -42.9 24.94 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 124.112 3.208 . . . . 0.0 114.612 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -102.69 0.16 49.16 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.385 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 28.4 m-85 -93.16 127.28 38.66 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.53 HG21 HG21 ' A' ' 627' ' ' VAL . 90.4 m -86.82 120.55 28.22 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-N 113.075 -1.875 . . . . 0.0 110.67 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 12.3 tt -77.3 133.05 31.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.715 HG21 ' HD3' ' A' ' 624' ' ' LYS . 91.0 t -133.36 130.37 57.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 124.73 -148.55 16.78 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -80.41 102.06 1.38 Allowed 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.322 2.015 . . . . 0.0 110.426 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 1.8 m-20 -73.88 -23.98 59.65 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.709 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 608' ' ' SER . . . . . . . . . . . . . 27.8 p -129.57 96.11 4.17 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.561 0.696 . . . . 0.0 111.284 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 609' ' ' VAL . . . . . 0.496 HG12 ' HD2' ' A' ' 618' ' ' PRO . 17.0 m -94.93 164.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.593 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 11.6 mm100 -107.67 165.38 11.47 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 4.1 t -92.79 128.64 38.72 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 114.519 -1.219 . . . . 0.0 107.825 165.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 54.6 m-85 -115.37 168.71 9.74 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -60.61 -16.04 34.36 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -108.45 -3.65 18.0 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.775 0.321 . . . . 0.0 111.38 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 133.47 -168.72 23.01 Favored Glycine 0 N--CA 1.434 -1.47 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.381 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.495 HD21 ' O ' ' A' ' 570' ' ' GLU . 2.6 mm? -77.03 121.92 24.21 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 123.152 0.581 . . . . 0.0 109.641 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 35.3 t -147.2 141.47 15.91 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.496 ' HD2' HG12 ' A' ' 609' ' ' VAL . 13.4 Cg_exo -66.22 -179.57 12.43 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.713 -1.37 . . . . 0.0 112.651 0.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.05 163.48 24.61 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.277 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.817 ' HG ' HG22 ' A' ' 574' ' ' ILE . 1.1 mm? -67.61 134.75 92.62 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.994 -169.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.22 172.45 7.53 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 123.832 3.021 . . . . 0.0 111.541 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 45.6 pt -114.03 169.6 5.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.032 0.444 . . . . 0.0 111.327 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.554 ' SG ' HD12 ' A' ' 578' ' ' LEU . 81.7 m -115.61 112.54 22.3 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.301 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.715 ' HD3' HG21 ' A' ' 604' ' ' VAL . 51.9 mtpt -95.61 -28.29 14.9 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 21.6 tt0 69.25 -66.73 0.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.223 1.009 . . . . 0.0 109.546 -176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -88.85 112.02 22.75 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.59 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 2.8 p -127.38 174.52 10.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 628' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 16.0 mm100 -93.84 155.78 17.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.564 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 16.2 m -104.92 -8.21 18.79 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.015 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 21.9 m 74.77 -3.26 2.63 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 166.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 64.73 -147.76 51.07 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.421 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.82 144.33 24.39 Favored 'Trans proline' 0 C--O 1.253 1.24 0 C-N-CA 122.658 2.238 . . . . 0.0 112.035 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.553 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 68.6 Cg_endo -70.78 167.38 25.94 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.821 3.014 . . . . 0.0 112.996 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.04 -179.5 4.38 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.792 2.328 . . . . 0.0 111.472 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -99.38 158.58 15.62 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 657' ' ' TYR . 16.0 tp -96.82 133.98 40.72 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 683' ' ' VAL . 2.0 pt? -50.37 -45.4 55.21 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -131.03 33.26 4.19 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.14 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -167.7 -148.32 5.63 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -162.41 177.66 9.34 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.573 HG22 ' CE1' ' A' ' 657' ' ' TYR . 5.2 t -78.54 133.13 30.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.536 ' HB2' ' NZ ' ' A' ' 642' ' ' LYS . 0.0 OUTLIER -90.78 -2.6 57.78 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.22 0.533 . . . . 0.0 110.563 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.514 ' OE2' ' HE3' ' A' ' 642' ' ' LYS . 74.0 mm-40 -104.19 151.9 22.79 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.694 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -50.91 109.77 0.36 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 112.545 -2.116 . . . . 0.0 109.871 169.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.601 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 4.1 p -85.33 102.98 13.84 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 121.906 0.86 . . . . 0.0 112.792 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 53.6 pttt -84.19 156.83 21.87 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.646 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.446 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 4.9 mp0 -74.71 -11.29 60.14 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.955 -173.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 648' ' ' GLU . . . . . 0.503 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 7.4 tp10 -147.66 118.39 7.56 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.601 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 21.6 m-85 -97.64 -94.75 0.22 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 151.34 167.39 14.78 Favored Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.574 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.712 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 67.6 t60 -61.38 -44.16 97.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.343 0.592 . . . . 0.0 111.7 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 14.6 m -98.01 17.22 18.84 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.396 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 649' ' ' TYR . 2.9 tp10 -101.0 111.54 23.77 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.674 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.803 HG21 ' HB2' ' A' ' 670' ' ' LYS . 10.8 p -87.91 148.31 4.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.961 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -112.16 105.63 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.76 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.79 170.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 19.4 mt-10 -72.5 126.06 28.95 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.71 0.767 . . . . 0.0 109.592 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.586 ' HB3' HD22 ' A' ' 636' ' ' LEU . 49.7 m-85 -102.59 167.69 9.76 Favored 'General case' 0 C--N 1.268 -2.945 0 C-N-CA 124.311 1.044 . . . . 0.0 110.969 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.444 ' CD1' ' HB3' ' A' ' 642' ' ' LYS . 13.6 p90 -148.54 142.47 25.81 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.568 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 33.2 m -107.07 173.83 6.15 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 120.794 0.331 . . . . 0.0 111.861 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.443 ' HB2' ' HD1' ' A' ' 663' ' ' PHE . 7.2 m120 -61.82 150.79 81.39 Favored Pre-proline 0 C--O 1.243 0.763 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.577 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.55 39.14 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 124.826 3.684 . . . . 0.0 113.822 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -155.83 9.22 0.26 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.817 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 87.9 m-85 -126.32 150.17 48.68 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 120.96 0.409 . . . . 0.0 109.912 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 85.1 mt -93.49 134.5 35.69 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.742 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 3.3 ttt -96.25 101.39 13.02 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 685' ' ' ILE . 41.3 tptt -69.16 -65.17 0.74 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.69 -169.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.72 -161.69 37.7 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.704 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.43 124.66 14.64 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 123.239 2.626 . . . . 0.0 110.948 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 5.6 p-10 -76.39 -12.28 60.03 Favored 'General case' 0 C--O 1.171 -3.036 0 CA-C-O 121.672 0.748 . . . . 0.0 110.412 -177.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.803 ' HB2' HG21 ' A' ' 654' ' ' VAL . 0.0 OUTLIER -132.97 123.33 25.71 Favored 'General case' 2 N--CA 1.331 -6.424 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -171.397 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.612 HD12 ' HB3' ' A' ' 678' ' ' TRP . 43.4 pt -122.0 138.95 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.78 -172.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.57 161.03 15.22 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 38.3 t -94.0 104.58 16.61 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 118.451 -1.3 . . . . 0.0 111.876 -176.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . 0.262 32.7 m -81.62 88.36 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-O 123.017 1.389 . . . . 0.0 113.126 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 675' ' ' ASP . . . . . 0.59 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 24.9 t70 89.98 -61.25 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.871 0 CA-C-N 112.094 -2.321 . . . . 0.0 111.224 170.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -159.0 12.98 0.21 Allowed Glycine 0 C--N 1.268 -3.207 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.707 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.48 130.58 38.77 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.612 ' HB3' HD12 ' A' ' 671' ' ' ILE . 94.6 m95 -72.95 152.77 41.25 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 2.2 p -74.46 176.91 6.37 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 14.2 m -61.56 125.84 25.23 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.068 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 6.3 mp -62.62 154.83 72.22 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.744 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 17.8 Cg_endo -61.73 -19.68 66.2 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 C-N-CA 123.464 2.776 . . . . 0.0 114.136 -177.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.522 ' HA ' HD21 ' A' ' 637' ' ' LEU . 17.2 m 39.78 83.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 175.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.742 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 62.8 m -79.77 146.75 32.16 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.27 -174.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -127.83 149.34 32.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.483 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.82 139.35 21.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 120.792 0.33 . . . . 0.0 111.318 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--O 1.254 1.323 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.155 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.614 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 83.2 m -89.53 148.03 23.63 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.93 0.395 . . . . 0.0 111.237 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.18 134.14 49.01 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 172.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.657 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.4 tt -52.18 111.4 2.48 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.079 0.952 . . . . 0.0 108.885 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.497 ' HG2' HD21 ' A' ' 620' ' ' LEU . 58.8 Cg_endo -76.68 -174.67 2.24 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.913 2.409 . . . . 0.0 111.417 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -87.4 86.96 7.29 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.751 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.877 HG13 ' H ' ' A' ' 575' ' ' ASP . 11.1 pt -55.81 -72.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.739 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.877 ' H ' HG13 ' A' ' 574' ' ' ILE . 12.1 t70 -173.93 -172.36 0.72 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.39 -30.73 2.99 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -95.63 11.31 33.7 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.242 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.7 tt -111.82 139.89 46.92 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.96 121.28 12.36 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.657 ' HG3' HD11 ' A' ' 571' ' ' LEU . 54.8 Cg_endo -75.05 152.39 40.49 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.603 2.202 . . . . 0.0 111.22 174.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.02 -46.02 62.87 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.34 0.591 . . . . 0.0 109.895 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 582' ' ' ARG . . . . . 0.481 ' HA ' ' HD3' ' A' ' 582' ' ' ARG . 2.4 mmt180 -84.15 139.54 32.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.872 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -137.48 107.95 6.52 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 14.2 ptpt -146.9 172.77 13.17 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.66 -65.49 0.78 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -117.22 145.09 44.13 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.5 0.667 . . . . 0.0 110.162 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.614 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 39.3 m-85 -105.27 125.88 51.48 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -78.87 153.4 30.59 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.536 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.41 121.16 7.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.326 0.584 . . . . 0.0 110.156 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 105.73 -8.9 43.72 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.747 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.31 126.19 28.48 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 117.876 0.838 . . . . 0.0 109.864 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 608' ' ' SER . 14.3 t -99.67 121.78 50.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 608' ' ' SER . 5.2 mp -104.24 107.9 19.02 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 9.0 mtmp? -82.31 112.02 18.91 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 64.1 m-85 -90.37 164.88 14.15 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 56.3 m -153.97 179.45 8.9 Favored 'General case' 0 N--CA 1.402 -2.869 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 89.4 m -120.22 177.44 5.01 Favored 'General case' 0 C--N 1.26 -3.31 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.561 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 33.0 mmmt -58.17 164.12 3.86 Favored Pre-proline 0 C--N 1.316 -0.89 0 C-N-CA 123.819 0.847 . . . . 0.0 111.676 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 74.3 Cg_exo -47.69 -42.0 30.39 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 124.356 3.37 . . . . 0.0 114.818 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.8 -0.23 62.4 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.513 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -102.93 151.85 21.99 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-O 121.975 0.893 . . . . 0.0 112.545 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.556 HG21 HG11 ' A' ' 627' ' ' VAL . 54.1 m -108.2 128.74 54.98 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.108 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.451 HD11 ' HG3' ' A' ' 621' ' ' PRO . 11.3 tt -80.08 123.39 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 173.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.782 HG21 ' HD3' ' A' ' 624' ' ' LYS . 53.2 t -114.47 118.57 58.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 120.945 0.403 . . . . 0.0 110.61 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 116.23 -156.43 15.64 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.58 124.95 13.54 Favored 'Trans proline' 0 C--O 1.221 -0.352 0 C-N-CA 123.2 2.6 . . . . 0.0 110.989 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.38 -45.66 11.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.577 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 35.5 p -100.1 119.73 38.76 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 18.2 m -115.22 155.02 16.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 610' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.74 155.62 17.8 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.361 0.601 . . . . 0.0 109.893 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 8.3 t -88.05 125.26 34.46 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.64 168.88 9.49 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.66 3.07 6.85 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.003 0.82 . . . . 0.0 111.972 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -115.93 2.15 13.47 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.825 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 125.69 -174.11 17.61 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.973 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.475 HD23 ' HD3' ' A' ' 572' ' ' PRO . 2.8 mm? -77.81 125.33 29.17 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 618' ' ' PRO . 50.4 m -145.58 152.86 50.3 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.409 ' O ' ' HA ' ' A' ' 617' ' ' SER . 73.0 Cg_endo -72.26 -165.48 3.54 Favored 'Cis proline' 0 N--CA 1.486 1.079 0 CA-C-N 119.764 0.952 . . . . 0.0 114.554 4.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -55.24 137.62 46.9 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.107 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.639 HD23 HG22 ' A' ' 574' ' ' ILE . 5.7 mp -72.61 147.66 89.64 Favored Pre-proline 0 C--N 1.287 -2.116 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.431 -173.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.509 ' HG2' HD11 ' A' ' 578' ' ' LEU . 72.1 Cg_endo -73.36 178.98 5.94 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 123.103 2.535 . . . . 0.0 113.479 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 45.3 pt -127.37 171.34 15.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 96.8 m -115.77 114.67 25.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.967 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.782 ' HD3' HG21 ' A' ' 604' ' ' VAL . 27.3 mtpp -108.89 120.45 42.55 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.682 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -84.34 -24.42 29.78 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -108.78 116.76 32.6 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.029 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 602' ' ' THR . 4.8 m -129.59 -178.56 2.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.317 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -97.22 179.44 4.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.554 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 20.0 m -115.73 -7.15 12.12 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.144 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 66.5 m 72.1 -28.78 0.19 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 83.08 -147.73 24.97 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.9 142.79 39.65 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.984 1.789 . . . . 0.0 110.727 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.538 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 72.2 Cg_endo -73.6 168.79 23.88 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 123.189 2.593 . . . . 0.0 112.095 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.66 -179.3 3.63 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 122.695 2.263 . . . . 0.0 111.846 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -100.81 156.27 17.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.727 HD22 ' HB3' ' A' ' 657' ' ' TYR . 14.8 tp -87.88 150.47 23.48 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 683' ' ' VAL . 0.0 OUTLIER -57.89 -54.25 49.0 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.494 ' HB2' HD22 ' A' ' 637' ' ' LEU . 5.3 m-80 -130.17 41.49 3.4 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 122.34 1.067 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -161.57 -156.82 8.51 Favored Glycine 0 N--CA 1.411 -2.988 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 640' ' ' ASN . . . . . 0.557 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 57.7 t30 -153.12 -176.37 5.75 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.432 HG11 ' CG2' ' A' ' 645' ' ' THR . 7.6 p -95.57 136.18 27.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -89.6 -24.61 21.65 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.895 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -79.07 163.29 25.25 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.394 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -84.01 115.17 22.2 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.432 ' CG2' HG11 ' A' ' 641' ' ' VAL . 12.2 p -69.22 97.43 0.93 Allowed 'General case' 0 N--CA 1.413 -2.285 0 O-C-N 124.177 0.923 . . . . 0.0 112.3 -177.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 48.9 pttt -76.22 160.19 29.93 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.57 -7.0 58.73 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.4 0.619 . . . . 0.0 111.298 -171.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -141.06 105.46 4.85 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.555 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 6.9 m-85 -85.69 -76.31 0.34 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 124.46 163.92 11.8 Favored Glycine 0 C--N 1.284 -2.343 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.158 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.451 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.2 t60 -66.79 142.94 57.19 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.258 5.9 p 62.78 9.74 3.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.889 1.276 . . . . 0.0 114.259 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.453 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 4.2 tp10 -87.58 116.66 25.85 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.618 ' CG2' ' HB2' ' A' ' 670' ' ' LYS . 4.1 p -92.1 152.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.823 0.82 . . . . 0.0 111.22 -176.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 26.9 m -122.27 113.31 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.58 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.691 175.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.538 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 21.7 mt-10 -76.85 131.34 38.58 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.681 0.753 . . . . 0.0 111.6 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.727 ' HB3' HD22 ' A' ' 636' ' ' LEU . 56.6 m-85 -111.36 160.76 16.76 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 125.106 1.362 . . . . 0.0 111.389 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.557 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 10.5 p90 -145.03 134.51 23.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.625 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 27.9 m -100.3 171.34 7.84 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.392 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -60.07 154.23 51.58 Favored Pre-proline 0 C--N 1.314 -0.967 0 O-C-N 124.184 0.927 . . . . 0.0 110.917 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.15 35.69 0.35 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 124.308 3.339 . . . . 0.0 112.864 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -136.83 4.78 2.81 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.674 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 72.0 m-85 -136.23 156.98 47.89 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.1 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.73 ' HG ' ' HG2' ' A' ' 687' ' ' GLU . 80.4 mt -115.07 146.31 41.43 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.816 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -82.52 142.32 31.94 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 118.437 0.562 . . . . 0.0 110.295 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.569 ' HB3' HG23 ' A' ' 683' ' ' VAL . 2.0 tpmt? -92.56 -41.62 10.14 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.303 0.573 . . . . 0.0 109.736 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -116.32 -163.25 13.36 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.765 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.96 129.31 26.92 Favored 'Trans proline' 0 C--O 1.22 -0.402 0 C-N-CA 123.934 3.09 . . . . 0.0 110.51 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 9.5 p-10 -68.66 -14.21 62.87 Favored 'General case' 0 C--O 1.178 -2.696 0 CA-C-O 121.327 0.584 . . . . 0.0 111.534 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.618 ' HB2' ' CG2' ' A' ' 654' ' ' VAL . 12.1 ptmt -130.13 145.57 51.71 Favored 'General case' 0 C--N 1.25 -3.742 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -174.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.663 HD12 ' HB3' ' A' ' 678' ' ' TRP . 35.8 pt -135.22 145.6 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -121.54 148.54 44.35 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.386 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 12.9 t -72.42 113.59 9.62 Favored 'General case' 0 CA--C 1.468 -2.206 0 CA-C-O 122.381 1.086 . . . . 0.0 109.794 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 674' ' ' VAL . . . . . 0.451 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 44.2 t -105.65 111.58 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.811 0 CA-C-N 112.341 -2.209 . . . . 0.0 108.499 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.78 -75.97 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.619 1.168 . . . . 0.0 111.955 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -157.65 26.29 0.46 Allowed Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.3 143.81 32.96 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.663 ' HB3' HD12 ' A' ' 671' ' ' ILE . 92.4 m95 -87.85 161.48 17.49 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.577 0.626 . . . . 0.0 109.753 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 15.4 p -76.2 172.37 12.96 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.924 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 24.9 m -67.1 135.14 53.14 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.035 0.445 . . . . 0.0 110.931 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.6 ' CD2' HD13 ' A' ' 671' ' ' ILE . 50.9 mt -61.53 151.58 77.21 Favored Pre-proline 0 N--CA 1.42 -1.926 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.154 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.816 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 11.7 Cg_endo -53.25 -18.89 11.31 Favored 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 124.752 3.635 . . . . 0.0 115.362 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 666' ' ' LYS 0.25 16.9 m 41.89 91.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 174.484 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.674 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 4.3 p -87.33 150.38 23.89 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.58 150.74 34.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.648 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.67 135.83 25.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 O-C-N 123.778 0.673 . . . . 0.0 110.762 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 687' ' ' GLU . . . . . 0.73 ' HG2' ' HG ' ' A' ' 664' ' ' LEU . 42.2 mt-10 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.526 -0.75 . . . . 0.0 109.567 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.686 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 55.8 m -86.11 147.79 25.99 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.1 0.476 . . . . 0.0 111.014 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 571' ' ' LEU . 45.9 tt0 -125.47 -8.36 6.9 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.636 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 63.2 tp 79.06 115.33 0.03 OUTLIER Pre-proline 0 C--O 1.244 0.778 0 C-N-CA 125.239 1.416 . . . . 0.0 110.068 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.521 ' HD2' HD12 ' A' ' 571' ' ' LEU . 69.7 Cg_endo -71.5 -168.31 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.668 2.246 . . . . 0.0 110.134 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 573' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 573' ' ' LYS . 32.2 mmtp -87.37 102.93 15.01 Favored 'General case' 0 N--CA 1.41 -2.452 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.728 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.758 HG22 HD23 ' A' ' 620' ' ' LEU . 36.4 pt -70.04 -170.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.973 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.91 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 7.9 t70 -70.75 155.57 40.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.42 -28.16 37.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 121.839 0.828 . . . . 0.0 109.412 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -96.65 6.49 48.61 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.275 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.91 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.8 tm? -97.3 144.07 27.44 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.413 ' N ' HD13 ' A' ' 578' ' ' LEU . 2.3 t -140.37 115.13 7.58 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -76.28 137.71 19.26 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.879 2.386 . . . . 0.0 112.731 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -55.97 -55.95 26.56 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.334 1.454 . . . . 0.0 111.423 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 582' ' ' ARG . . . . . 0.52 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 55.0 mmt-85 -59.07 -59.91 4.71 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.856 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 53.57 82.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.647 1.217 . . . . 0.0 111.068 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.504 ' HE3' ' HB3' ' A' ' 582' ' ' ARG . 15.4 ptpt -143.26 163.71 32.21 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.91 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.16 -57.09 14.31 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 123.837 0.71 . . . . 0.0 111.261 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -124.84 142.82 51.18 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.094 0.473 . . . . 0.0 110.041 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.686 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 95.0 m-85 -102.59 126.73 49.77 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.847 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -79.74 151.75 30.23 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.092 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 45.6 t -60.87 118.06 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 104.18 -5.76 45.95 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.447 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -69.01 129.47 40.03 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 17.8 m -97.26 118.9 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-O 122.509 1.147 . . . . 0.0 109.867 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.403 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 5.6 mp -95.49 96.87 9.37 Favored 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.615 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 57.2 mtmt -80.75 109.86 15.7 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.643 ' HB3' HD11 ' A' ' 578' ' ' LEU . 64.9 m-85 -92.26 162.72 14.18 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 16.9 t -158.26 176.46 12.44 Favored 'General case' 0 N--CA 1.393 -3.286 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 88.3 m -121.24 172.17 8.19 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 70.2 mmtt -53.8 159.95 2.38 Favored Pre-proline 0 C--N 1.319 -0.751 0 C-N-CA 124.024 0.929 . . . . 0.0 112.169 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 12.1 Cg_endo -69.27 109.55 2.24 Favored 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.036 1.824 . . . . 0.0 109.366 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 122.52 -17.33 8.37 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -101.07 157.75 16.53 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 122.128 0.966 . . . . 0.0 112.48 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.56 HG21 HG11 ' A' ' 627' ' ' VAL . 18.5 m -109.04 130.55 55.48 Favored 'General case' 0 N--CA 1.402 -2.869 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.777 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 11.2 tt -85.68 122.01 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.476 HG21 ' HD3' ' A' ' 624' ' ' LYS . 54.0 t -112.72 127.45 69.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 112.95 -166.35 12.13 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.11 126.54 17.37 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.988 2.459 . . . . 0.0 110.761 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -86.13 -38.27 17.91 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.745 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.603 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 34.4 p -114.64 111.27 21.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.995 0.426 . . . . 0.0 110.96 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.2 m -104.79 153.82 6.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 610' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -99.08 147.91 24.58 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.452 ' HA ' HD23 ' A' ' 616' ' ' LEU . 17.6 t -83.23 124.31 30.43 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 170.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.587 ' CD2' ' HB3' ' A' ' 617' ' ' SER . 91.7 m-85 -110.59 171.88 7.2 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.68 7.23 3.18 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -117.58 -9.04 10.87 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 133.07 -174.37 20.61 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 611' ' ' CYS . 91.4 mt -70.9 138.77 50.41 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 122.976 0.51 . . . . 0.0 111.377 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.587 ' HB3' ' CD2' ' A' ' 612' ' ' TYR . 44.7 t -152.55 141.41 14.12 Favored Pre-proline 0 N--CA 1.424 -1.773 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 617' ' ' SER . 60.4 Cg_endo -72.94 -172.01 9.15 Favored 'Cis proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.081 -1.633 . . . . 0.0 113.197 0.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.9 151.73 38.43 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.111 0.481 . . . . 0.0 111.255 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.758 HD23 HG22 ' A' ' 574' ' ' ILE . 6.1 mp -67.13 145.11 98.69 Favored Pre-proline 0 C--N 1.309 -1.169 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -170.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.68 175.21 8.33 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 123.93 3.087 . . . . 0.0 112.018 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 38.4 pt -127.53 174.05 11.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.6 m -121.89 122.32 39.14 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.956 0.408 . . . . 0.0 111.5 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.476 ' HD3' HG21 ' A' ' 604' ' ' VAL . 53.8 mtpt -119.58 125.74 49.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -82.97 -40.03 20.59 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 121.547 0.689 . . . . 0.0 109.715 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -102.05 100.25 10.49 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.879 0.847 . . . . 0.0 110.45 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 602' ' ' THR . 8.0 m -107.76 174.13 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.588 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -98.99 143.99 28.66 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.234 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 38.2 m -97.49 -2.17 42.52 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 98.5 m 74.33 -42.75 0.51 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.958 1.303 . . . . 0.0 113.646 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 105.33 -141.47 15.35 Favored Glycine 0 N--CA 1.417 -2.632 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.8 139.46 13.96 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.259 1.972 . . . . 0.0 110.83 174.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.579 ' HG3' HG11 ' A' ' 655' ' ' VAL . 57.6 Cg_endo -68.33 161.57 44.17 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 123.268 2.645 . . . . 0.0 112.707 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.86 176.45 6.06 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.915 2.41 . . . . 0.0 111.677 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.82 163.11 14.55 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 1.044 HD21 ' SG ' ' A' ' 659' ' ' CYS . 9.1 tp -90.27 156.69 18.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 637' ' ' LEU 0.285 2.1 pt? -77.05 -45.46 27.06 Favored 'General case' 0 N--CA 1.406 -2.672 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.495 -178.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -125.64 33.77 5.04 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.558 0.694 . . . . 0.0 110.904 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.775 ' HA3' HD23 ' A' ' 636' ' ' LEU . . . -160.75 -140.76 2.96 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.556 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -157.87 -169.82 2.96 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.0 p -102.97 132.43 49.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.645 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.9 ptmt -87.22 -13.83 42.76 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.831 0.824 . . . . 0.0 110.256 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.402 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 40.0 mm-40 -88.58 140.39 29.51 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.843 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 644' ' ' LYS . . . . . 0.764 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -55.8 121.34 9.0 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 124.161 0.913 . . . . 0.0 108.631 171.419 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.41 HG21 HG11 ' A' ' 641' ' ' VAL . 3.7 p -94.67 99.67 11.74 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 53.4 pttt -82.99 167.5 17.88 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.322 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -88.78 1.81 54.59 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 648' ' ' GLU . . . . . 0.61 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 34.3 tt0 -151.73 108.4 3.49 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.487 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 4.9 m-85 -84.55 -93.93 0.07 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 151.78 159.79 9.13 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 54.3 t60 -51.61 -59.14 4.6 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 37.2 m -91.67 21.08 4.95 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.364 0.602 . . . . 0.0 110.691 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -104.03 113.37 26.86 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 670' ' ' LYS . 8.8 p -94.17 159.47 2.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.868 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.7 t -124.07 114.05 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.879 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.645 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 21.7 mt-10 -71.88 128.43 35.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.489 0.661 . . . . 0.0 111.876 174.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 42.0 m-85 -109.33 170.66 7.91 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 123.58 0.752 . . . . 0.0 110.799 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -148.48 132.2 16.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 1.044 ' SG ' HD21 ' A' ' 636' ' ' LEU . 95.9 m -97.1 172.62 7.72 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.948 176.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -64.9 152.95 89.64 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.003 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.27 35.42 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 124.554 3.503 . . . . 0.0 113.652 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.57 13.48 0.83 Allowed 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.349 -174.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.33 156.56 48.25 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.874 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.449 HD21 ' HG3' ' A' ' 687' ' ' GLU . 83.6 mt -101.07 143.45 31.17 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.716 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 2.5 ttt -107.57 108.88 20.37 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -78.7 -57.82 3.56 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.251 -173.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.24 -174.31 47.56 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.795 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.12 126.38 21.41 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 123.68 2.92 . . . . 0.0 110.868 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.664 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 16.3 p-10 -66.91 -13.05 61.33 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-O 121.026 0.441 . . . . 0.0 110.842 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 16.0 mtpt -118.48 151.38 37.93 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 38.0 pt -138.54 141.43 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -120.87 151.69 39.34 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.918 0.39 . . . . 0.0 111.073 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 19.0 t -81.73 99.73 9.11 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.752 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . 0.278 20.1 m -88.63 75.89 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 O-C-N 120.541 -1.349 . . . . 0.0 112.064 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.1 t70 63.85 66.17 0.67 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.642 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 88.34 -20.21 31.52 Favored Glycine 0 C--N 1.311 -0.846 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.173 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -118.01 113.91 22.36 Favored 'General case' 0 N--CA 1.423 -1.803 0 O-C-N 122.201 -0.588 . . . . 0.0 111.857 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.401 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.9 m95 -65.88 151.63 46.29 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 20.1 p -77.55 173.59 11.84 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.04 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 6.3 m -62.89 128.43 35.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.154 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.09 161.52 39.04 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.392 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.664 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 20.2 Cg_endo -62.6 -17.81 60.43 Favored 'Trans proline' 0 CA--C 1.507 -0.827 0 C-N-CA 123.416 2.744 . . . . 0.0 115.04 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.487 ' HA ' HD21 ' A' ' 637' ' ' LEU 0.258 30.3 m 41.58 94.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 175.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.716 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 69.9 m -92.84 154.95 17.94 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 685' ' ' ILE . 0.1 OUTLIER -140.17 152.46 21.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.609 -177.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.95 136.77 19.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 687' ' ' GLU . . . . . 0.449 ' HG3' HD21 ' A' ' 664' ' ' LEU . 29.0 tt0 . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 568' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 586' ' ' GLN . 13.2 pt-20 . . . . . 0 N--CA 1.428 -1.533 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.719 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 71.6 m -62.88 115.76 4.66 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 124.742 1.217 . . . . 0.0 113.201 -174.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.51 -12.85 58.69 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.505 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 41.7 tp 73.17 113.61 0.03 OUTLIER Pre-proline 0 CA--C 1.514 -0.442 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.078 -176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.453 ' HD2' HD12 ' A' ' 616' ' ' LEU . 44.3 Cg_endo -67.94 174.25 8.06 Favored 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.33 2.02 . . . . 0.0 111.052 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 573' ' ' LYS . . . . . 0.595 ' HD2' ' H ' ' A' ' 573' ' ' LYS 0.299 0.0 OUTLIER -73.68 102.2 3.87 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.47 177.217 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.579 HG22 HD23 ' A' ' 620' ' ' LEU . 40.7 pt -70.91 -171.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.671 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.9 t70 -72.93 146.35 46.15 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.69 -33.82 50.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.722 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -92.43 6.21 47.87 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.064 -0.398 . . . . 0.0 111.624 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.638 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.4 OUTLIER -101.64 150.11 23.44 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -176.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 9.7 m -143.79 121.83 6.94 Favored Pre-proline 0 C--N 1.306 -1.302 0 C-N-CA 123.932 0.893 . . . . 0.0 110.118 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 595' ' ' PHE . 26.2 Cg_endo -72.83 142.73 35.81 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.378 1.385 . . . . 0.0 109.398 171.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.69 -33.72 68.67 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.552 0.691 . . . . 0.0 110.301 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 582' ' ' ARG . . . . . 0.499 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 75.5 mmt-85 -75.33 -70.16 0.44 Allowed 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.133 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 583' ' ' LYS . . . . . 0.442 ' HB2' ' HG2' ' A' ' 580' ' ' PRO 0.296 53.0 tttp 52.29 79.67 0.11 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.768 -170.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.578 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 18.1 ptpt -129.23 164.34 23.67 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.437 -1.711 . . . . 0.0 106.475 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -65.28 -48.32 73.61 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 586' ' ' GLN . . . . . 0.546 ' HB3' ' HG3' ' A' ' 568' ' ' GLU . 22.0 mp0 -131.67 143.44 50.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.153 0.501 . . . . 0.0 110.408 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.719 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 76.9 m-85 -107.72 121.1 44.02 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 124.025 0.93 . . . . 0.0 109.145 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -66.0 144.53 56.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 60.4 t -55.03 120.65 2.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 109.59 -13.83 32.67 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.887 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -71.49 123.74 23.08 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 10.0 p -94.35 134.45 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.537 0 C-N-CA 119.419 -0.912 . . . . 0.0 108.834 174.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 608' ' ' SER . 3.4 mp -108.04 117.47 34.23 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.561 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 57.1 mttp -94.48 103.32 15.29 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.458 ' HB3' HD21 ' A' ' 578' ' ' LEU . 64.3 m-85 -78.29 152.6 32.38 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 22.6 t -148.95 161.28 42.2 Favored 'General case' 0 N--CA 1.391 -3.376 0 N-CA-C 103.36 -2.83 . . . . 0.0 103.36 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 90.7 m -107.41 177.88 4.71 Favored 'General case' 0 C--N 1.25 -3.721 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 36.7 mmtm -56.12 161.34 3.84 Favored Pre-proline 0 N--CA 1.441 -0.891 0 C-N-CA 123.086 0.554 . . . . 0.0 111.209 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 93.1 Cg_exo -43.39 -47.26 9.22 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 124.337 3.358 . . . . 0.0 114.475 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -91.41 4.1 79.83 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 121.173 -0.536 . . . . 0.0 112.584 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -108.25 137.09 46.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 121.893 0.854 . . . . 0.0 112.927 -176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 627' ' ' VAL . 20.5 m -93.65 131.87 38.53 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.723 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.479 HD11 ' HG3' ' A' ' 621' ' ' PRO . 11.9 tt -82.39 122.02 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.424 ' HB ' HG13 ' A' ' 622' ' ' ILE . 59.3 t -110.58 108.96 26.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 128.04 -162.4 21.84 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.53 131.0 26.53 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 123.096 2.531 . . . . 0.0 110.928 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -89.87 -47.86 7.61 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.561 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 62.0 p -106.25 102.62 12.01 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.729 0.776 . . . . 0.0 111.698 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 14.0 m -108.09 140.32 27.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 592' ' ' VAL . 2.0 mp0 -85.45 149.11 25.63 Favored 'General case' 0 CA--C 1.486 -1.509 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.38 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.468 ' HA ' HD23 ' A' ' 616' ' ' LEU . 35.0 t -78.47 124.97 28.72 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 114.733 -1.122 . . . . 0.0 108.362 169.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 93.3 m-85 -112.22 171.02 7.76 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -6.4 18.52 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -114.27 -0.25 13.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.285 0.564 . . . . 0.0 110.543 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 129.14 -175.17 18.97 Favored Glycine 0 N--CA 1.425 -2.071 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.721 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 611' ' ' CYS . 87.9 mt -70.04 131.22 44.01 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.442 0.297 . . . . 0.0 110.64 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.464 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 73.2 m -149.28 143.71 17.21 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 177.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 617' ' ' SER . 59.2 Cg_endo -69.1 -169.63 4.88 Favored 'Cis proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.123 -1.199 . . . . 0.0 113.95 0.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.7 151.66 37.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.828 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.579 HD23 HG22 ' A' ' 574' ' ' ILE . 6.4 mp -71.86 143.71 87.11 Favored Pre-proline 0 C--N 1.289 -2.047 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.157 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.479 ' HG3' HD11 ' A' ' 603' ' ' ILE . 98.3 Cg_endo -76.02 179.55 6.2 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.965 3.11 . . . . 0.0 112.917 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 622' ' ' ILE . . . . . 0.424 HG13 ' HB ' ' A' ' 604' ' ' VAL . 46.3 pt -126.27 177.16 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.084 176.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.541 ' SG ' HD12 ' A' ' 578' ' ' LEU . 94.4 m -121.11 115.55 23.31 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 123.424 0.689 . . . . 0.0 110.748 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.582 ' O ' ' HB ' ' A' ' 602' ' ' THR . 43.4 mtmt -121.87 128.53 51.71 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.978 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.25 -41.47 25.02 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -98.13 112.81 24.64 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.183 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 602' ' ' THR . 1.4 m -120.83 178.1 2.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 124.535 1.134 . . . . 0.0 108.349 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -97.59 167.02 11.23 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 14.0 m -105.05 -15.23 15.15 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.673 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 86.0 m 73.35 7.63 5.2 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.457 1.103 . . . . 0.0 113.052 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 57.65 -136.61 50.57 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.765 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.77 153.58 22.93 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.824 2.349 . . . . 0.0 110.991 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.569 ' HG3' HG11 ' A' ' 655' ' ' VAL . 73.7 Cg_endo -79.42 166.75 21.94 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.302 2.001 . . . . 0.0 111.014 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.38 -166.68 0.28 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.399 2.066 . . . . 0.0 110.626 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -113.19 170.78 7.97 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.527 HD23 ' HA3' ' A' ' 639' ' ' GLY . 17.0 tp -85.41 164.05 18.14 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.439 ' H ' HD12 ' A' ' 637' ' ' LEU . 4.8 mp -56.94 -71.65 0.09 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.083 0.944 . . . . 0.0 110.308 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -105.3 -27.1 11.72 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.764 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.632 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -86.2 -150.08 14.89 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.699 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 640' ' ' ASN . . . . . 0.416 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 48.5 t30 -155.1 -171.28 3.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.655 HG22 ' CE2' ' A' ' 657' ' ' TYR . 18.6 t -96.4 127.65 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.729 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -87.64 -21.85 25.06 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.386 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -75.72 169.47 18.06 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.22 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -88.6 131.62 34.88 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.659 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 24.5 p -87.65 118.18 26.97 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.402 0.62 . . . . 0.0 112.222 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -84.6 167.96 15.79 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.417 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 45.2 mt-10 -94.35 -10.14 33.59 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -151.56 101.72 2.82 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.39 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.56 ' CE2' HG22 ' A' ' 655' ' ' VAL . 6.7 m-85 -80.66 -85.74 0.09 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 139.05 160.93 8.54 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.3 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.541 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 60.5 t60 -62.54 130.6 45.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 652' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 39.5 m 69.6 10.24 7.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.67 1.188 . . . . 0.0 113.508 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 7.6 tp10 -88.7 120.71 30.34 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 19.7 m -91.25 160.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-O 122.307 1.051 . . . . 0.0 113.622 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 4.5 t -132.53 112.18 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-N 113.657 -1.61 . . . . 0.0 108.227 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 669' ' ' ASN . 32.5 mt-10 -73.43 135.66 44.18 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.249 1.023 . . . . 0.0 113.226 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.655 ' CE2' HG22 ' A' ' 641' ' ' VAL . 72.3 m-85 -114.75 172.56 6.96 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 126.441 1.896 . . . . 0.0 109.559 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 6.2 p90 -155.42 143.76 20.23 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.632 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.8 t -112.85 174.26 5.98 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.237 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 46.8 m-80 -64.9 155.96 81.45 Favored Pre-proline 0 C--N 1.317 -0.815 0 O-C-N 123.395 0.435 . . . . 0.0 110.378 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 70.5 Cg_endo -73.16 42.91 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 124.181 3.254 . . . . 0.0 113.39 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 662' ' ' ARG . 2.5 ptt180 -151.25 11.15 0.61 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 124.038 0.935 . . . . 0.0 110.473 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.436 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 89.3 m-85 -128.66 152.13 48.73 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.786 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 77.9 mt -101.35 142.04 33.34 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 2.5 ttt -108.71 102.41 11.46 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -79.07 -51.81 9.05 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.262 -170.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.5 -163.42 38.47 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.448 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 668' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 670' ' ' LYS . 63.4 Cg_endo -73.33 120.1 6.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.882 2.388 . . . . 0.0 111.387 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 656' ' ' GLU . 3.3 p-10 -81.33 28.18 0.39 Allowed 'General case' 0 C--O 1.19 -2.044 0 O-C-N 121.991 -0.443 . . . . 0.0 111.416 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.783 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 7.7 ptmt -164.04 108.7 1.0 Allowed 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 125.549 1.54 . . . . 0.0 108.336 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.661 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 38.7 pt -109.15 152.6 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.763 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.753 -173.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 9.7 pt20 -119.07 160.32 22.27 Favored 'General case' 0 N--CA 1.421 -1.919 0 O-C-N 124.094 0.871 . . . . 0.0 110.323 -174.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.5 t -87.17 112.06 21.59 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.399 1.095 . . . . 0.0 110.828 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 84.8 t -103.51 107.04 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.777 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 675' ' ' ASP . . . . . 0.541 ' H ' ' CE1' ' A' ' 651' ' ' HIS . 25.3 t70 65.1 -69.29 0.1 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 126.456 1.902 . . . . 0.0 111.744 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -158.16 21.54 0.36 Allowed Glycine 0 N--CA 1.422 -2.252 0 O-C-N 123.831 0.707 . . . . 0.0 111.472 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -136.55 149.74 48.26 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.525 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.4 m95 -83.0 161.22 21.81 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 11.9 p -81.85 175.32 10.51 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 120.875 0.369 . . . . 0.0 111.715 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 28.4 m -58.39 125.73 24.55 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.835 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.446 ' HA ' HG21 ' A' ' 671' ' ' ILE . 6.4 mp -62.34 165.16 9.39 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.554 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.606 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 19.8 Cg_endo -63.32 -21.51 71.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.343 2.029 . . . . 0.0 113.13 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 61.8 t 50.0 96.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.564 1.146 . . . . 0.0 112.376 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 22.5 p -97.21 133.32 41.99 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.235 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.56 147.72 32.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.195 -176.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 47.6 t -55.78 135.35 19.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 O-C-N 123.81 0.694 . . . . 0.0 110.628 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.437 -1.115 0 O-C-N 124.381 1.05 . . . . 0.0 108.828 178.826 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 568' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 586' ' ' GLN . 21.3 mt-10 . . . . . 0 C--O 1.245 0.828 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 20.1 m -63.45 -54.1 41.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.713 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 586' ' ' GLN . 39.3 tt0 70.05 130.2 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 125.4 1.48 . . . . 0.0 111.363 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.7 tt -66.01 119.88 64.9 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.474 ' HG2' HD11 ' A' ' 620' ' ' LEU . 72.3 Cg_endo -75.6 178.35 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.026 1.817 . . . . 0.0 111.111 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 573' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 573' ' ' LYS . 0.0 OUTLIER -78.37 103.83 8.56 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.416 0.627 . . . . 0.0 109.501 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.693 ' HA ' ' HG ' ' A' ' 620' ' ' LEU . 19.8 pt -75.27 -169.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.121 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.966 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.6 t70 -72.66 154.9 40.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.38 -30.03 45.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.262 0.553 . . . . 0.0 110.759 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -108.38 12.57 26.21 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.966 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.7 OUTLIER -92.82 153.69 18.71 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.511 ' N ' HD13 ' A' ' 578' ' ' LEU . 10.7 t -139.68 121.74 9.98 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.61 ' HD3' HD13 ' A' ' 574' ' ' ILE . 59.9 Cg_endo -80.35 138.32 12.38 Favored 'Trans proline' 0 N--CA 1.431 -2.169 0 C-N-CA 122.09 1.86 . . . . 0.0 111.645 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -65.41 -41.94 93.08 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 125.677 1.591 . . . . 0.0 112.074 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 26.9 mmt-85 -67.49 -65.77 0.65 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 64.8 74.13 0.4 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.691 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -142.7 146.27 34.22 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.77 -47.64 82.61 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 586' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 570' ' ' GLU . 23.3 mp0 -120.18 145.92 46.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.388 0.614 . . . . 0.0 111.527 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.659 ' CZ ' ' HG ' ' A' ' 593' ' ' LEU . 96.7 m-85 -116.64 160.62 20.44 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.893 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 588' ' ' LYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 591' ' ' GLU . 52.7 mtpt -94.65 152.88 18.13 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.478 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 14.6 m -63.98 137.52 24.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.333 173.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 91.38 -12.91 67.9 Favored Glycine 0 C--N 1.292 -1.903 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.874 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 591' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 588' ' ' LYS . 0.7 OUTLIER -66.37 137.68 57.06 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.551 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.589 HG12 ' HG3' ' A' ' 610' ' ' GLN . 20.0 m -110.25 128.26 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.618 0 CA-C-O 121.645 0.736 . . . . 0.0 109.252 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.659 ' HG ' ' CZ ' ' A' ' 587' ' ' TYR 0.4 0.0 OUTLIER -114.47 102.66 10.29 Favored 'General case' 0 N--CA 1.383 -3.806 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.427 176.516 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 35.4 mtmm -71.67 146.26 48.36 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 113.547 -1.661 . . . . 0.0 107.787 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.826 ' HB3' HD11 ' A' ' 578' ' ' LEU . 42.7 m-85 -125.17 171.12 10.58 Favored 'General case' 0 C--N 1.262 -3.234 0 CA-C-O 120.836 0.351 . . . . 0.0 111.491 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 596' ' ' SER . . . . . 0.412 ' HA ' HD12 ' A' ' 603' ' ' ILE . 23.1 t -171.68 -176.79 1.85 Allowed 'General case' 0 N--CA 1.41 -2.426 0 O-C-N 124.757 1.286 . . . . 0.0 107.585 166.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 84.9 m -114.05 162.0 17.01 Favored 'General case' 0 C--N 1.263 -3.179 0 O-C-N 123.607 0.567 . . . . 0.0 112.184 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 32.8 mmtp -52.25 160.64 1.2 Allowed Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 125.457 1.503 . . . . 0.0 113.241 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 37.9 Cg_exo -55.93 112.88 1.2 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.415 2.743 . . . . 0.0 110.576 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 121.93 -27.58 6.14 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.014 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -100.24 163.0 12.6 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-O 122.179 0.99 . . . . 0.0 112.672 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.42 HG23 ' CD2' ' A' ' 651' ' ' HIS . 19.3 m -119.76 130.47 54.98 Favored 'General case' 0 N--CA 1.394 -3.264 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.563 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.496 HD11 ' HG3' ' A' ' 621' ' ' PRO . 7.1 tt -82.19 130.39 35.86 Favored 'Isoleucine or valine' 0 C--O 1.256 1.406 0 CA-C-O 121.009 0.433 . . . . 0.0 109.991 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.468 HG21 ' HG3' ' A' ' 624' ' ' LYS . 93.0 t -126.95 131.2 71.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.11 -156.01 15.84 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -67.4 111.81 2.41 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.502 2.135 . . . . 0.0 111.306 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 5.7 m-80 -87.2 -12.67 46.12 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.341 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.564 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 9.9 p -146.81 102.79 3.57 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.96 0.41 . . . . 0.0 110.68 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 609' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 592' ' ' VAL . 23.8 m -96.95 162.04 2.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.254 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.589 ' HG3' HG12 ' A' ' 592' ' ' VAL . 1.4 mp0 -112.35 153.5 27.16 Favored 'General case' 0 CA--C 1.483 -1.63 0 CA-C-O 121.001 0.429 . . . . 0.0 110.214 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 589' ' ' VAL . 41.0 t -83.97 130.65 34.88 Favored 'General case' 0 N--CA 1.415 -2.221 0 C-N-CA 118.146 -1.421 . . . . 0.0 107.393 166.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 83.8 m-85 -114.24 170.34 8.37 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -64.51 -14.16 55.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -106.84 0.25 23.86 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.669 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.08 -176.31 19.36 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.945 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.407 HD12 HD11 ' A' ' 593' ' ' LEU . 3.0 mm? -74.26 124.81 27.11 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.425 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 68.3 m -147.07 144.94 20.56 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 122.084 -0.385 . . . . 0.0 111.7 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 617' ' ' SER . 48.1 Cg_endo -70.04 -168.77 4.76 Favored 'Cis proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.788 -1.338 . . . . 0.0 112.34 -2.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -80.15 -178.84 6.75 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.069 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.693 ' HG ' ' HA ' ' A' ' 574' ' ' ILE . 1.1 mm? -75.44 140.98 72.7 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -169.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.496 ' HG3' HD11 ' A' ' 603' ' ' ILE . 38.5 Cg_endo -67.9 175.39 6.47 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 124.43 3.42 . . . . 0.0 112.456 176.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.9 pt -114.0 173.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.533 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.0 m -117.79 115.58 25.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.185 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 626' ' ' GLN . 9.2 mmmm -105.4 120.32 41.29 Favored 'General case' 0 CA--C 1.474 -1.978 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.36 -30.12 33.86 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.336 -1.346 . . . . 0.0 107.872 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.475 ' O ' ' HE2' ' A' ' 624' ' ' LYS . 92.2 mt-30 -111.58 116.99 31.75 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.099 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.569 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 9.6 p -124.54 158.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 628' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 75.6 mm-40 -89.65 159.8 16.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 53.7 m -101.25 -3.16 29.48 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.515 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 73.2 m 69.42 12.45 8.28 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.309 1.044 . . . . 0.0 112.984 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 53.51 -136.5 40.05 Favored Glycine 0 N--CA 1.448 -0.558 0 O-C-N 123.79 0.681 . . . . 0.0 112.424 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.75 151.39 16.8 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.777 2.318 . . . . 0.0 110.703 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.553 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 63.3 Cg_endo -74.81 163.71 35.08 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.775 2.317 . . . . 0.0 112.788 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.448 ' HG2' HD11 ' A' ' 681' ' ' LEU . 55.3 Cg_endo -73.18 177.8 7.37 Favored 'Trans proline' 0 C--O 1.254 1.315 0 C-N-CA 122.734 2.29 . . . . 0.0 111.526 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -92.42 154.32 18.59 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.789 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 657' ' ' TYR . 20.8 tp -89.67 141.3 28.73 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -45.7 -41.84 11.01 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -176.017 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -129.19 -18.28 3.7 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -99.66 -142.92 13.66 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.795 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.01 -177.12 4.47 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.423 HG22 ' CE1' ' A' ' 657' ' ' TYR . 39.5 t -84.45 132.52 31.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.644 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.3 ptmt -88.1 -16.71 32.77 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.715 0.769 . . . . 0.0 109.986 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.421 ' H ' HG12 ' A' ' 641' ' ' VAL . 6.7 mm-40 -81.7 165.37 21.05 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.604 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -78.14 111.41 14.03 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 23.1 p -64.82 116.33 6.21 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.587 0.708 . . . . 0.0 111.487 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -101.1 168.08 9.82 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.975 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.427 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 35.7 mt-10 -90.77 -13.78 33.28 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.609 0.718 . . . . 0.0 109.148 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -144.58 105.6 4.19 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.124 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.553 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.8 m-85 -87.02 -84.73 0.17 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.948 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 143.52 154.04 6.03 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.774 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.42 ' CD2' HG23 ' A' ' 602' ' ' THR . 49.2 t60 -60.19 131.12 49.81 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 652' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 50.2 m 76.69 -0.69 2.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.393 1.077 . . . . 0.0 113.533 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.427 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 7.3 tp10 -79.85 122.96 27.3 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.729 HG11 ' HE3' ' A' ' 670' ' ' LYS . 0.3 OUTLIER -92.06 151.55 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.725 0 CA-C-O 122.215 1.007 . . . . 0.0 110.606 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -114.02 102.69 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.97 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.646 167.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.644 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 4.0 mt-10 -69.27 138.7 54.1 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.544 ' HB3' HD22 ' A' ' 636' ' ' LEU . 40.5 m-85 -113.12 161.02 17.6 Favored 'General case' 0 C--N 1.259 -3.344 0 C-N-CA 124.964 1.306 . . . . 0.0 110.401 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -145.11 135.02 23.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.666 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.2 t -100.56 -178.95 3.95 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.284 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -63.14 155.79 71.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.63 26.69 0.35 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.627 2.884 . . . . 0.0 113.477 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 662' ' ' ARG . 16.1 mmm180 -129.63 -1.45 4.87 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -118.56 161.38 20.14 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.349 0.595 . . . . 0.0 112.151 -170.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.406 HD11 ' HG3' ' A' ' 687' ' ' GLU . 86.7 mt -124.4 149.0 47.19 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.628 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -92.25 149.47 21.43 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 176.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -108.83 -45.99 3.71 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.177 0.513 . . . . 0.0 109.689 174.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.77 -175.95 42.75 Favored Glycine 0 C--N 1.306 -1.133 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 668' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 682' ' ' PRO . 27.5 Cg_endo -62.0 124.58 14.7 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.134 2.556 . . . . 0.0 111.765 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.601 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 21.3 p-10 -73.67 31.77 0.08 Allowed 'General case' 0 C--O 1.188 -2.167 0 C-N-CA 123.393 0.677 . . . . 0.0 111.084 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.729 ' HE3' HG11 ' A' ' 654' ' ' VAL . 13.7 ptmt -172.32 138.26 0.93 Allowed 'General case' 0 C--N 1.258 -3.375 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -173.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.607 ' N ' HG22 ' A' ' 654' ' ' VAL . 37.3 pt -138.69 139.13 41.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 0.1 OUTLIER -109.35 151.2 26.92 Favored 'General case' 0 C--N 1.27 -2.857 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.015 -178.266 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 3.6 t -69.3 118.07 11.73 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.198 0.999 . . . . 0.0 111.455 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 89.2 t -105.53 82.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.857 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.243 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 675' ' ' ASP . . . . . 0.569 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 29.1 t70 80.6 -59.24 0.29 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 112.328 -2.215 . . . . 0.0 112.606 171.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -150.36 4.6 0.6 Allowed Glycine 0 C--N 1.292 -1.873 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.285 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.29 153.03 46.34 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.588 ' HB3' HD12 ' A' ' 671' ' ' ILE . 95.7 m95 -84.66 165.55 17.82 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 679' ' ' THR . . . . . 0.459 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 2.1 p -86.61 -178.65 6.44 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 9.6 m -65.57 133.69 51.72 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.574 0.75 . . . . 0.0 110.101 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.448 HD11 ' HG2' ' A' ' 634' ' ' PRO . 8.3 mp -70.83 158.84 87.15 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.628 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 20.8 Cg_endo -61.44 -16.12 45.41 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 124.639 3.559 . . . . 0.0 115.617 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.263 26.9 m 45.24 90.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 18.5 p -92.85 144.96 24.76 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.147 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.69 150.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.029 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.34 140.46 19.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 O-C-N 123.409 0.443 . . . . 0.0 110.754 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 687' ' ' GLU . . . . . 0.406 ' HG3' HD11 ' A' ' 664' ' ' LEU . 43.6 tt0 . . . . . 0 C--O 1.248 1.012 0 C-N-CA 124.841 1.256 . . . . 0.0 110.759 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 568' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 586' ' ' GLN . 17.6 mm-40 . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.688 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 3.1 m 33.73 -67.57 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 130.121 3.368 . . . . 0.0 115.995 -171.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 585' ' ' ASP . 54.3 mt-10 83.47 176.46 0.07 Allowed 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 128.635 2.774 . . . . 0.0 110.536 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.699 HD11 ' HG3' ' A' ' 580' ' ' PRO . 1.2 tt -119.59 105.83 43.05 Favored Pre-proline 0 N--CA 1.398 -3.038 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.697 ' HG2' HD11 ' A' ' 620' ' ' LEU . 36.7 Cg_endo -66.33 -176.97 0.74 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.885 2.39 . . . . 0.0 111.104 177.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -86.18 84.34 7.51 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.347 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.798 HG13 ' H ' ' A' ' 575' ' ' ASP . 6.8 pt -52.08 -65.68 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.853 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.798 ' H ' HG13 ' A' ' 574' ' ' ILE . 13.3 t70 -176.32 -168.55 0.26 Allowed 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.55 -22.66 4.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -104.08 16.7 25.69 Favored 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.147 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.8 tt -115.21 143.36 45.36 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -176.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.39 121.55 7.09 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-O 121.188 0.518 . . . . 0.0 111.015 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.699 ' HG3' HD11 ' A' ' 571' ' ' LEU . 31.8 Cg_endo -69.29 142.01 48.77 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.835 2.357 . . . . 0.0 112.253 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.74 -48.98 22.75 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 582' ' ' ARG . . . . . 0.814 ' HD2' ' HE3' ' A' ' 584' ' ' LYS . 14.3 tpp180 -88.94 93.65 9.67 Favored 'General case' 0 N--CA 1.379 -3.979 0 N-CA-C 104.864 -2.272 . . . . 0.0 104.864 171.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -112.83 131.64 55.62 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.083 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.814 ' HE3' ' HD2' ' A' ' 582' ' ' ARG . 15.3 ptpt -163.3 -170.49 2.29 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 570' ' ' GLU . 9.2 m-20 -103.4 -39.46 6.77 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 119.332 0.969 . . . . 0.0 110.627 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 586' ' ' GLN . . . . . 0.562 ' HB3' ' HB2' ' A' ' 568' ' ' GLU . 21.2 mp0 -121.62 133.53 54.99 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.688 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 54.5 m-85 -105.59 170.26 8.0 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -172.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -100.87 151.96 21.1 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.3 122.21 16.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 97.58 0.68 59.2 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.251 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 591' ' ' GLU . . . . . 0.467 ' HG2' ' HD2' ' A' ' 587' ' ' TYR . 6.3 tp10 -74.11 129.42 37.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.565 HG22 ' HG3' ' A' ' 610' ' ' GLN . 14.1 t -100.74 115.5 42.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.441 0.639 . . . . 0.0 109.831 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 1.9 mp -95.88 94.05 7.4 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 608' ' ' SER . 0.0 OUTLIER -77.16 122.72 25.41 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 174.724 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 66.8 m-85 -94.93 177.83 5.77 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-O 121.473 0.654 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 19.9 p -167.3 169.54 12.36 Favored 'General case' 0 N--CA 1.403 -2.797 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 81.5 m -115.56 170.88 8.09 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 41.0 mttt -59.43 156.47 30.73 Favored Pre-proline 0 N--CA 1.432 -1.343 0 O-C-N 123.812 0.695 . . . . 0.0 112.748 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.32 110.1 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.475 2.783 . . . . 0.0 110.127 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 123.66 -23.23 6.74 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.492 ' CE1' ' HB2' ' A' ' 625' ' ' GLU . 79.3 m-85 -102.81 160.83 14.25 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 122.381 1.086 . . . . 0.0 113.281 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 627' ' ' VAL . 15.6 m -113.41 129.53 56.52 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.399 174.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.457 HD11 ' HG3' ' A' ' 621' ' ' PRO . 8.8 tt -79.57 121.84 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.843 HG21 ' HD3' ' A' ' 624' ' ' LYS . 91.4 t -117.5 123.44 71.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 122.037 -0.414 . . . . 0.0 110.122 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 122.03 -156.02 16.77 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.97 134.35 27.33 Favored 'Trans proline' 0 C--N 1.327 -0.6 0 C-N-CA 122.509 2.139 . . . . 0.0 110.096 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.74 -44.35 6.78 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.185 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 594' ' ' LYS . 19.3 p -106.74 97.07 6.91 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.329 0.585 . . . . 0.0 112.013 -176.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 609' ' ' VAL . . . . . 0.494 ' HA ' ' HD2' ' A' ' 618' ' ' PRO . 9.4 m -95.31 147.8 5.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.565 ' HG3' HG22 ' A' ' 592' ' ' VAL . 1.0 OUTLIER -102.12 152.33 21.13 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 16.3 t -83.99 116.71 22.96 Favored 'General case' 0 C--N 1.268 -2.956 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.001 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.505 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 90.7 m-85 -102.2 166.4 10.61 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -69.05 -13.52 62.49 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.324 0.583 . . . . 0.0 111.076 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -101.51 -1.49 32.91 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.748 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 136.34 178.28 15.65 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.26 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 616' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.66 121.69 19.26 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.505 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 56.5 m -146.35 147.11 29.96 Favored Pre-proline 0 C--N 1.316 -0.886 0 O-C-N 121.959 -0.463 . . . . 0.0 111.458 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.494 ' HD2' ' HA ' ' A' ' 609' ' ' VAL . 41.4 Cg_endo -67.06 -171.9 5.07 Favored 'Cis proline' 0 N--CA 1.488 1.149 0 C-N-CA 124.353 -1.103 . . . . 0.0 112.958 0.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.8 179.99 3.4 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.195 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.697 HD11 ' HG2' ' A' ' 572' ' ' PRO . 18.9 mt -92.52 147.39 34.23 Favored Pre-proline 0 C--N 1.278 -2.541 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -165.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.556 ' HG2' HD11 ' A' ' 578' ' ' LEU . 63.5 Cg_endo -73.82 -173.24 1.31 Allowed 'Trans proline' 0 C--O 1.253 1.249 0 C-N-CA 123.861 3.041 . . . . 0.0 112.076 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.49 173.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.932 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.2 m -117.05 107.47 14.56 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.303 0.573 . . . . 0.0 111.138 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.843 ' HD3' HG21 ' A' ' 604' ' ' VAL . 59.1 mtpt -109.19 126.34 53.16 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.492 ' HB2' ' CE1' ' A' ' 601' ' ' PHE . 26.8 tt0 -87.44 -35.29 18.35 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -175.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -107.5 112.67 25.54 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.611 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 602' ' ' THR . 6.7 m -121.21 166.13 16.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.128 -177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 628' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 15.7 mm100 -89.98 170.66 10.17 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.036 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.521 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 74.8 p -108.86 -19.1 13.52 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.387 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 95.4 m 73.7 4.89 4.81 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.884 1.273 . . . . 0.0 111.16 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 62.55 -137.78 44.84 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.94 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.17 156.69 37.93 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.903 2.402 . . . . 0.0 110.82 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.677 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 71.7 Cg_endo -78.77 160.77 27.69 Favored 'Trans proline' 0 N--CA 1.435 -1.956 0 C-N-CA 122.053 1.835 . . . . 0.0 111.222 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.23 -169.26 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.655 2.236 . . . . 0.0 112.763 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -103.31 157.6 16.9 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.51 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.634 HD23 ' HA3' ' A' ' 639' ' ' GLY . 15.7 tp -92.68 155.26 17.83 Favored 'General case' 0 CA--C 1.478 -1.825 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 637' ' ' LEU 0.285 2.0 pt? -66.93 -47.75 70.73 Favored 'General case' 0 N--CA 1.406 -2.653 0 C-N-CA 119.005 -1.078 . . . . 0.0 113.607 -178.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.616 ' HB2' ' SG ' ' A' ' 684' ' ' CYS . 89.9 m-20 -126.36 27.02 6.28 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.049 -173.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.732 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -160.08 -146.61 4.64 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -161.09 177.54 10.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.795 0.298 . . . . 0.0 111.054 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 655' ' ' VAL . 7.2 p -80.29 133.97 28.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -90.78 -23.93 20.49 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.338 0.59 . . . . 0.0 110.075 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.549 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 5.6 mm-40 -80.71 163.31 23.64 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.369 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 644' ' ' LYS . . . . . 0.596 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.1 OUTLIER -76.35 137.95 40.14 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 175.371 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.413 ' CG2' HG11 ' A' ' 641' ' ' VAL . 20.2 p -87.78 110.42 20.46 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.807 0.813 . . . . 0.0 112.804 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.55 ' HD2' ' HA ' ' A' ' 649' ' ' TYR . 52.1 mttm -72.74 158.19 36.06 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.76 -0.23 56.01 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -152.44 100.58 2.59 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.978 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.677 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 5.3 m-85 -80.44 -81.55 0.12 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 133.35 167.71 11.72 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.158 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 57.6 t60 -67.45 131.04 44.91 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 120.926 0.393 . . . . 0.0 110.284 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 652' ' ' SER . . . . . 0.574 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 73.8 m 65.06 20.06 11.96 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.235 1.014 . . . . 0.0 112.43 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 5.6 tp10 -89.68 116.59 27.92 Favored 'General case' 0 CA--C 1.478 -1.812 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 16.2 m -89.47 155.77 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-O 122.152 0.977 . . . . 0.0 113.188 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.75 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 0.1 OUTLIER -129.3 117.38 43.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-N 112.823 -1.99 . . . . 0.0 109.502 177.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.604 ' HG2' ' HG2' ' A' ' 670' ' ' LYS . 59.1 mt-10 -81.01 130.2 34.9 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 122.389 1.09 . . . . 0.0 113.54 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.572 ' CE1' HG22 ' A' ' 655' ' ' VAL . 75.3 m-85 -108.81 157.91 18.15 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.679 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -134.88 138.55 44.24 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.732 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 26.1 t -105.65 168.69 8.93 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.552 ' HB2' ' CE1' ' A' ' 663' ' ' PHE . 32.0 m-80 -59.72 152.22 58.82 Favored Pre-proline 0 C--O 1.241 0.622 0 O-C-N 123.202 0.314 . . . . 0.0 110.795 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.2 36.12 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 124.343 3.362 . . . . 0.0 115.549 -170.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.75 11.47 0.66 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.561 0.696 . . . . 0.0 110.539 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 660' ' ' ASN . 73.6 m-85 -118.52 162.86 17.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.386 0.612 . . . . 0.0 110.964 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 96.8 mt -110.13 135.7 50.51 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.737 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.3 OUTLIER -100.64 108.88 20.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -75.77 -52.25 10.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.64 -172.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -101.8 -162.7 26.91 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.341 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.89 123.58 10.54 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.434 2.756 . . . . 0.0 112.761 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.474 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 23.0 p-10 -74.4 -7.14 51.92 Favored 'General case' 0 C--O 1.201 -1.5 0 O-C-N 122.1 -0.375 . . . . 0.0 111.503 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -122.88 118.86 28.87 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 42.3 pt -111.4 158.23 11.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 11.0 pt20 -125.15 154.91 40.76 Favored 'General case' 0 C--N 1.281 -2.396 0 O-C-N 123.43 0.456 . . . . 0.0 109.99 -174.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 8.2 t -84.81 110.85 19.12 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 123.119 1.438 . . . . 0.0 110.045 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 97.7 t -95.26 81.38 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.386 -3.67 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.821 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 675' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 628' ' ' GLN . 31.5 t70 80.96 -46.37 0.24 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.631 170.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -171.47 19.31 0.06 OUTLIER Glycine 0 C--N 1.298 -1.554 0 O-C-N 123.882 0.739 . . . . 0.0 111.513 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -143.42 143.9 31.8 Favored 'General case' 0 C--O 1.212 -0.879 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.521 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.0 m95 -87.12 153.77 21.26 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 3.7 p -72.1 167.34 20.45 Favored 'General case' 0 C--O 1.255 1.358 0 O-C-N 123.009 0.193 . . . . 0.0 111.399 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.0 m -62.86 129.23 39.52 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 682' ' ' PRO . 6.4 mp -60.19 163.78 7.64 Favored Pre-proline 0 N--CA 1.435 -1.223 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.945 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.737 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 19.5 Cg_endo -60.6 -24.33 78.07 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 122.777 2.318 . . . . 0.0 113.135 -176.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.421 ' HA ' HD21 ' A' ' 637' ' ' LEU . 58.8 t 52.62 92.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 122.175 0.988 . . . . 0.0 111.072 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 638' ' ' ASN . 27.8 p -98.97 134.51 41.72 Favored 'General case' 0 N--CA 1.411 -2.376 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.703 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.91 155.7 35.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.92 -174.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 64.4 t -59.84 129.09 21.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 123.866 0.729 . . . . 0.0 110.562 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.678 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 120.743 0.306 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 587' ' ' TYR . 81.3 m -78.25 140.42 38.88 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -110.01 136.54 49.12 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.6 tt -51.37 117.58 9.43 Favored Pre-proline 0 C--O 1.246 0.903 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.19 -179.34 1.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.723 2.282 . . . . 0.0 111.047 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -90.84 93.2 9.12 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 118.953 -1.099 . . . . 0.0 109.092 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.48 HG22 HD13 ' A' ' 620' ' ' LEU . 36.8 pt -75.78 -175.8 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.189 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.969 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.618 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.1 t70 -71.83 163.15 28.34 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.168 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.35 -30.01 17.1 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.262 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -94.23 4.21 54.2 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.814 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.618 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.8 OUTLIER -100.03 151.26 21.57 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.39 118.01 6.22 Favored Pre-proline 0 C--N 1.309 -1.181 0 C-N-CA 123.849 0.86 . . . . 0.0 110.603 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.51 ' HG3' HD11 ' A' ' 571' ' ' LEU . 40.7 Cg_endo -75.32 139.45 23.48 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.301 2.001 . . . . 0.0 111.566 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.9 -50.25 63.04 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 125.399 1.48 . . . . 0.0 112.202 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 582' ' ' ARG . . . . . 0.405 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 8.7 mpt_? -63.73 -46.45 85.33 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.135 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm 54.45 58.58 4.8 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 124.364 1.04 . . . . 0.0 109.882 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -121.98 160.17 25.44 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.79 -50.82 54.91 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -122.54 151.42 41.39 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.669 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 84.9 m-85 -121.53 119.26 31.45 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -71.1 152.69 43.21 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.561 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 58.1 t -55.91 116.26 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-O 121.19 0.519 . . . . 0.0 110.747 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 109.85 -2.99 30.32 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.594 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -76.29 136.98 39.61 Favored 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 122.34 -0.506 . . . . 0.0 110.953 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.586 HG12 ' HG3' ' A' ' 610' ' ' GLN . 12.0 m -101.81 133.28 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.863 0.84 . . . . 0.0 109.686 176.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.669 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.9 mp -105.41 89.96 3.27 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.557 ' HD2' ' HB3' ' A' ' 608' ' ' SER . 3.6 mmmp? -66.43 127.89 34.05 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -107.09 175.12 5.6 Favored 'General case' 0 C--N 1.267 -3.021 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.801 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 14.4 p -166.49 167.32 15.72 Favored 'General case' 0 N--CA 1.398 -3.041 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.508 ' SG ' HD12 ' A' ' 578' ' ' LEU . 98.8 m -114.69 -172.49 2.13 Favored 'General case' 0 C--N 1.259 -3.337 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -56.74 159.27 7.27 Favored Pre-proline 0 N--CA 1.429 -1.51 0 C-N-CA 123.94 0.896 . . . . 0.0 110.764 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.92 -37.93 47.32 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 124.209 3.273 . . . . 0.0 114.78 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -100.3 4.94 57.2 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.436 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 21.3 m-85 -106.35 141.07 38.28 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 121.605 0.717 . . . . 0.0 111.552 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.499 HG21 HG11 ' A' ' 627' ' ' VAL . 40.7 m -97.56 124.99 42.02 Favored 'General case' 0 N--CA 1.398 -3.073 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.89 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 7.2 tt -79.32 122.25 34.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.805 HG21 ' HD3' ' A' ' 624' ' ' LYS . 99.8 t -118.69 139.11 47.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 106.63 -149.3 16.59 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.9 112.74 3.61 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.321 2.014 . . . . 0.0 111.214 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -85.96 -1.52 57.4 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.614 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.557 ' HB3' ' HD2' ' A' ' 594' ' ' LYS . 33.8 p -150.29 112.89 4.72 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.176 0.512 . . . . 0.0 110.64 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.25 149.8 12.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.586 ' HG3' HG12 ' A' ' 592' ' ' VAL . 2.5 mp0 -102.61 157.6 16.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.271 0.558 . . . . 0.0 110.055 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.561 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 11.3 t -86.56 112.49 21.61 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 610' ' ' GLN . 85.3 m-85 -101.18 169.88 8.63 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -60.62 -18.28 52.24 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -106.78 -1.04 22.98 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.152 0.501 . . . . 0.0 111.608 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.37 -169.7 22.16 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.221 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 569' ' ' CYS . 2.6 mm? -75.14 122.81 24.17 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.439 ' HA ' ' C ' ' A' ' 618' ' ' PRO . 52.4 m -146.99 146.45 25.96 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 122.401 -0.187 . . . . 0.0 110.578 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 617' ' ' SER . 57.0 Cg_endo -69.5 -169.42 4.94 Favored 'Cis proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.057 -1.226 . . . . 0.0 112.804 0.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.72 172.72 10.19 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.469 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.48 HD13 HG22 ' A' ' 574' ' ' ILE . 38.8 mt -74.61 142.65 77.74 Favored Pre-proline 0 C--N 1.292 -1.922 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -169.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.3 176.98 7.16 Favored 'Trans proline' 0 C--O 1.258 1.479 0 C-N-CA 124.049 3.166 . . . . 0.0 111.475 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.1 pt -122.03 165.72 17.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.648 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.557 ' SG ' HD12 ' A' ' 578' ' ' LEU . 85.1 m -110.63 112.25 24.02 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.499 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.805 ' HD3' HG21 ' A' ' 604' ' ' VAL . 52.6 mtpt -108.84 110.46 21.82 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 23.2 tt0 -77.77 -31.65 52.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.24 104.71 17.24 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.333 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 602' ' ' THR . 3.7 m -129.83 175.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.088 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 628' ' ' GLN . . . . . 0.401 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 1.9 mp0 -98.65 159.08 15.2 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.845 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 52.4 m -104.25 -9.16 18.81 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.364 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 630' ' ' CYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 678' ' ' TRP . 67.6 m 70.4 1.68 3.71 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.093 0.957 . . . . 0.0 113.514 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 62.99 -136.47 43.54 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -75.79 149.96 34.26 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 121.979 1.786 . . . . 0.0 110.658 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.55 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 78.4 Cg_endo -78.21 165.25 26.01 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.548 2.165 . . . . 0.0 111.013 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.464 ' HG2' HD11 ' A' ' 681' ' ' LEU . 33.0 Cg_endo -70.34 165.91 30.05 Favored 'Trans proline' 0 N--CA 1.435 -1.94 0 C-N-CA 121.408 1.405 . . . . 0.0 110.357 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.46 163.8 21.37 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.774 HD21 ' SG ' ' A' ' 659' ' ' CYS . 11.0 tp -83.33 174.42 10.71 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' A' ' 683' ' ' VAL 0.342 0.4 OUTLIER -73.85 -69.71 0.42 Allowed 'General case' 0 N--CA 1.393 -3.281 0 C-N-CA 118.027 -1.469 . . . . 0.0 112.935 -179.871 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -95.1 -33.19 12.76 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -84.33 -143.11 5.73 Favored Glycine 0 N--CA 1.434 -1.455 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.341 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -160.34 -172.69 3.67 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.627 HG22 ' CE2' ' A' ' 657' ' ' TYR . 20.5 t -95.87 133.08 38.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 176.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 658' ' ' TYR . 35.9 pttt -88.73 -26.35 21.82 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.977 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -78.55 151.91 32.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.389 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -67.08 115.08 6.38 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.534 0.683 . . . . 0.0 110.546 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.2 p -74.46 105.45 5.6 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.848 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.633 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 59.7 pttt -87.49 -177.67 5.96 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.77 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.07 -12.36 23.29 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -143.8 108.05 4.78 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.633 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 13.7 m-85 -85.92 -101.19 0.07 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 158.34 162.53 11.9 Favored Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 66.0 t60 -58.49 -52.43 65.67 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 40.0 m -92.53 11.91 24.78 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.177 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -96.57 116.61 29.38 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.482 0.658 . . . . 0.0 109.398 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.725 HG21 ' HE2' ' A' ' 670' ' ' LYS . 1.3 p -92.86 157.39 2.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.785 -177.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 23.9 m -123.7 111.65 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.56 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -74.39 119.61 18.83 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.798 0.809 . . . . 0.0 112.672 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.627 ' CE2' HG22 ' A' ' 641' ' ' VAL . 87.6 m-85 -100.46 173.44 6.57 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.781 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' A' ' 642' ' ' LYS . 29.0 p90 -151.22 137.34 18.32 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.774 ' SG ' HD21 ' A' ' 636' ' ' LEU . 68.0 m -96.91 177.07 5.74 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 662' ' ' ARG . 78.3 m-20 -85.91 157.45 57.32 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.4 24.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 124.504 3.47 . . . . 0.0 114.959 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.415 ' H ' ' C ' ' A' ' 660' ' ' ASN . 23.8 mmt180 -120.35 -6.99 9.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 662' ' ' ARG . 31.1 m-85 -131.72 156.77 45.33 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.87 -174.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 67.8 mt -105.99 166.5 10.45 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.65 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.7 OUTLIER -116.7 112.55 21.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.44 ' HB3' HG23 ' A' ' 683' ' ' VAL . 39.9 ttmt -81.94 -54.02 5.67 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.542 -174.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.13 -173.23 43.63 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.637 -176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.04 122.46 10.97 Favored 'Trans proline' 0 C--N 1.327 -0.557 0 C-N-CA 122.932 2.421 . . . . 0.0 111.141 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.717 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 21.2 p-10 -61.26 -14.66 27.87 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 122.872 0.469 . . . . 0.0 112.051 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.725 ' HE2' HG21 ' A' ' 654' ' ' VAL . 0.0 OUTLIER -128.5 149.22 50.68 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.588 HD12 ' HB3' ' A' ' 678' ' ' TRP . 47.0 pt -140.09 146.44 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -172.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.01 157.0 23.06 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.228 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 11.7 t -80.35 96.56 6.71 Favored 'General case' 0 CA--C 1.472 -2.044 0 CA-C-O 123.197 1.475 . . . . 0.0 110.547 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.03 110.27 17.07 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.599 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.628 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 15.0 t70 59.22 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.616 1.166 . . . . 0.0 111.418 -171.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 676' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -153.7 23.47 0.73 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -134.32 131.07 37.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.588 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.8 m95 -76.4 149.89 36.86 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 7.8 p -83.5 178.75 7.87 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 11.7 m -57.32 122.95 13.76 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.712 0.805 . . . . 0.0 111.085 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.464 HD11 ' HG2' ' A' ' 634' ' ' PRO . 7.3 mp -63.97 163.67 21.77 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.717 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 20.1 Cg_endo -61.53 -15.17 39.66 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.876 3.051 . . . . 0.0 115.345 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.548 ' HA ' HD21 ' A' ' 637' ' ' LEU 0.297 28.7 m 50.7 101.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 177.278 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.687 ' SG ' HD21 ' A' ' 636' ' ' LEU . 12.9 m -78.29 132.54 37.52 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.441 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.427 HD12 ' HB2' ' A' ' 666' ' ' LYS . 0.2 OUTLIER -127.68 136.57 60.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.074 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.64 130.79 28.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 123.566 0.541 . . . . 0.0 111.218 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 C--O 1.252 1.22 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.223 -177.372 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 568' ' ' GLU . . . . . 0.47 ' HG3' HG23 ' A' ' 589' ' ' VAL . 17.8 tt0 . . . . . 0 N--CA 1.435 -1.224 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.475 ' HB3' HD21 ' A' ' 616' ' ' LEU . 57.6 m -111.34 153.41 26.04 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -167.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.812 ' HG2' ' HG3' ' A' ' 586' ' ' GLN . 49.0 mt-10 -128.77 146.76 50.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 166.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 571' ' ' LEU . . . . . . . . . . . . . 1.7 tt -53.48 115.13 7.2 Favored Pre-proline 0 C--O 1.245 0.837 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.19 -169.11 0.48 Allowed 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.511 2.141 . . . . 0.0 111.572 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -88.65 92.38 9.17 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 578' ' ' LEU . 37.2 pt -78.06 -170.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.658 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.649 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.4 t70 -77.61 147.4 35.64 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.12 -31.99 38.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 123.445 0.698 . . . . 0.0 111.044 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -98.54 14.63 27.66 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.081 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 5.5 tp -104.41 150.35 24.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.8 t -139.21 122.54 10.77 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.513 ' HG2' ' HA ' ' A' ' 583' ' ' LYS . 50.3 Cg_endo -78.74 144.67 19.65 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.813 2.342 . . . . 0.0 111.737 174.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 581' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 594' ' ' LYS . 7.2 t70 -51.86 -53.79 36.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.815 1.646 . . . . 0.0 111.212 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 582' ' ' ARG . . . . . 0.628 ' HG2' ' HE3' ' A' ' 584' ' ' LYS . 4.5 mpt_? -70.55 -59.86 2.6 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.025 0.44 . . . . 0.0 110.459 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 583' ' ' LYS . . . . . 0.513 ' HA ' ' HG2' ' A' ' 580' ' ' PRO . 50.2 tttm 60.14 62.29 1.65 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.163 -174.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.628 ' HE3' ' HG2' ' A' ' 582' ' ' ARG . 16.8 ptpt -118.44 160.29 21.97 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.29 -45.33 40.49 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 586' ' ' GLN . . . . . 0.812 ' HG3' ' HG2' ' A' ' 570' ' ' GLU . 18.7 mp0 -118.07 126.98 53.33 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.619 0.247 . . . . 0.0 110.504 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.63 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 86.5 m-85 -100.73 132.51 46.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.675 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -78.09 148.92 34.0 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.496 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 60.0 t -58.65 119.1 2.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 106.04 -1.73 38.21 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.598 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -73.14 134.09 44.32 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 122.362 -0.493 . . . . 0.0 109.731 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.493 HG22 ' HG3' ' A' ' 610' ' ' GLN . 17.6 t -101.0 114.9 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.63 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.4 mp -91.71 92.49 8.45 Favored 'General case' 0 N--CA 1.405 -2.68 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 608' ' ' SER . 58.1 mttp -74.13 136.46 42.92 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 173.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -112.57 163.71 14.18 Favored 'General case' 0 C--N 1.266 -3.026 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.753 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 14.7 m -152.55 172.07 17.15 Favored 'General case' 0 N--CA 1.39 -3.471 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.539 ' SG ' HD12 ' A' ' 578' ' ' LEU . 69.8 m -108.83 178.43 4.48 Favored 'General case' 0 C--N 1.247 -3.862 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 71.0 mmtt -54.29 162.79 1.46 Allowed Pre-proline 0 C--N 1.313 -0.98 0 C-N-CA 124.154 0.982 . . . . 0.0 111.935 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 82.8 Cg_exo -44.58 -44.92 13.53 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.127 3.218 . . . . 0.0 114.358 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -100.09 18.33 55.81 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.822 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -120.11 147.66 44.59 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 121.759 0.79 . . . . 0.0 112.384 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.665 HG21 HG11 ' A' ' 627' ' ' VAL . 23.1 m -100.66 133.44 45.11 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.648 175.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.566 HD11 ' HG3' ' A' ' 621' ' ' PRO . 10.1 tt -88.25 129.35 39.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.891 HG21 ' HD3' ' A' ' 624' ' ' LYS . 75.4 t -121.93 123.48 69.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 123.62 -150.65 16.94 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -73.12 115.68 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.38 2.053 . . . . 0.0 111.209 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -92.31 7.69 41.7 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 594' ' ' LYS . 58.5 p -156.43 113.61 3.17 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.75 0.42 . . . . 0.0 110.01 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 13.7 m -118.1 151.96 20.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.493 ' HG3' HG22 ' A' ' 592' ' ' VAL . 1.5 mp0 -101.27 154.35 18.85 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.449 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.496 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 6.6 t -85.0 112.67 20.81 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 169.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -104.22 170.17 8.06 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -77.88 14.61 1.05 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -125.81 -1.08 7.3 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 171.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.05 -175.36 19.83 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.926 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 569' ' ' CYS . 2.5 mm? -78.8 123.8 27.57 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 5.4 t -150.36 151.91 32.13 Favored Pre-proline 0 C--N 1.309 -1.184 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.616 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.507 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 58.7 Cg_endo -70.03 -178.2 16.64 Favored 'Cis proline' 0 C--N 1.361 1.235 0 C-N-CA 123.812 -1.328 . . . . 0.0 112.717 0.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.13 157.07 23.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.334 0.587 . . . . 0.0 111.103 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.506 HD13 HG22 ' A' ' 574' ' ' ILE . 22.6 mt -66.85 152.41 95.7 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 114.229 -1.35 . . . . 0.0 114.146 -168.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.566 ' HG3' HD11 ' A' ' 603' ' ' ILE . 92.8 Cg_endo -81.46 179.74 5.57 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.065 3.177 . . . . 0.0 111.633 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.6 pt -121.46 174.44 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.592 0.234 . . . . 0.0 110.586 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 98.1 m -119.91 128.84 54.0 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.386 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.891 ' HD3' HG21 ' A' ' 604' ' ' VAL . 26.4 mtpp -124.0 132.31 53.68 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.98 -41.05 15.21 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -96.94 114.58 26.21 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.01 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.665 HG11 HG21 ' A' ' 602' ' ' THR . 11.8 m -123.49 -175.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.24 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -99.41 165.14 11.8 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.557 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 18.6 m -100.36 -11.93 19.86 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 18.0 m 72.96 -0.42 3.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.36 1.064 . . . . 0.0 113.54 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 63.38 -144.67 49.45 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.6 157.1 24.98 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.612 2.208 . . . . 0.0 110.91 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.608 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.5 Cg_endo -75.15 163.69 34.52 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.857 2.371 . . . . 0.0 112.427 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.462 ' HG2' HD11 ' A' ' 681' ' ' LEU . 37.0 Cg_endo -69.61 172.95 11.56 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.589 2.193 . . . . 0.0 111.899 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -86.06 161.23 19.03 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 657' ' ' TYR . 15.1 tp -99.49 145.34 27.58 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 638' ' ' ASN . 1.3 pp -65.68 -37.69 87.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.45 ' N ' HD12 ' A' ' 637' ' ' LEU . 16.7 m120 -138.36 33.96 2.3 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.206 1.003 . . . . 0.0 109.677 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.51 ' HA3' HD23 ' A' ' 636' ' ' LEU . . . -158.1 -150.88 5.88 Favored Glycine 0 N--CA 1.413 -2.841 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.754 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 640' ' ' ASN . . . . . 0.63 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 63.6 t30 -160.56 -177.35 6.14 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.539 HG22 ' CE1' ' A' ' 657' ' ' TYR . 17.9 t -91.55 129.59 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.242 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 174.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.444 ' HB3' ' CD1' ' A' ' 658' ' ' TYR . 10.0 ptmm? -90.16 -14.83 32.74 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.604 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -89.84 168.86 11.74 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.877 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -77.72 110.97 13.03 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 17.8 p -71.23 106.49 3.83 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.523 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 42.6 pttt -87.94 153.41 21.32 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.271 175.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.471 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 11.0 pt-20 -68.32 -12.52 61.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.408 0.683 . . . . 0.0 111.607 -176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -151.17 102.37 2.93 Favored 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -171.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.608 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 4.2 m-85 -82.49 -70.75 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 120.63 165.64 12.83 Favored Glycine 0 C--N 1.288 -2.106 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.2 t60 -74.02 142.16 45.77 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.439 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 49.6 m 71.32 5.46 5.44 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.307 1.043 . . . . 0.0 112.377 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.435 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 5.5 tp10 -84.1 115.37 22.35 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 670' ' ' LYS . 2.4 p -90.2 152.63 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 30.5 m -120.98 112.05 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.729 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.531 ' CG ' ' HG2' ' A' ' 670' ' ' LYS . 27.3 mt-10 -69.57 119.8 14.37 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.017 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.671 ' HB3' HD22 ' A' ' 636' ' ' LEU . 79.2 m-85 -99.31 173.65 6.68 Favored 'General case' 0 C--N 1.271 -2.809 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.412 173.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.63 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 24.3 p90 -150.88 139.92 21.05 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 173.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.503 ' SG ' HD21 ' A' ' 636' ' ' LEU . 43.6 m -105.1 161.53 14.16 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-O 120.894 0.378 . . . . 0.0 110.521 172.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -57.03 152.04 30.96 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.54 -177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.04 33.69 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 124.738 3.625 . . . . 0.0 113.539 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -136.63 0.79 2.51 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 124.019 0.928 . . . . 0.0 109.008 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -127.18 159.2 34.99 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.811 -173.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.65 ' HG ' ' HB3' ' A' ' 687' ' ' GLU . 84.2 mt -107.81 136.51 47.42 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.793 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 4.2 ttt -95.32 113.68 25.37 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -78.25 -62.83 1.55 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.34 -170.43 46.82 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.653 -0.785 . . . . 0.0 112.878 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.65 123.71 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.028 2.485 . . . . 0.0 111.536 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -64.15 -17.95 63.98 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 122.915 0.486 . . . . 0.0 111.591 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 1.0 OUTLIER -122.32 153.52 38.84 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 681' ' ' LEU . 46.8 pt -143.3 142.53 25.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.25 148.16 34.72 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 48.7 t -82.53 129.14 34.86 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.404 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 674' ' ' VAL . . . . . 0.613 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 30.7 m -110.4 126.13 67.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 123.061 0.544 . . . . 0.0 110.638 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 675' ' ' ASP . . . . . 0.535 ' OD1' ' HE2' ' A' ' 624' ' ' LYS . 21.9 t70 60.25 -67.0 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.562 1.145 . . . . 0.0 112.342 -172.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -168.44 21.66 0.09 OUTLIER Glycine 0 C--N 1.301 -1.405 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -132.71 137.9 47.06 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.548 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.6 m95 -81.73 152.22 27.13 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 8.0 p -77.56 -176.86 4.47 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 19.7 m -70.07 127.4 32.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.567 0.223 . . . . 0.0 111.565 -173.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.572 HD12 HD13 ' A' ' 671' ' ' ILE . 5.8 mp -62.91 155.13 73.44 Favored Pre-proline 0 CA--C 1.514 -0.426 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.564 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 5.6 Cg_endo -52.91 -55.04 4.1 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.795 2.997 . . . . 0.0 113.758 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 88.3 t 69.5 119.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.2 1.0 . . . . 0.0 111.198 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.793 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 33.1 m -117.66 155.87 29.16 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.062 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.59 149.39 25.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 123.783 0.833 . . . . 0.0 109.498 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.6 132.33 28.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 O-C-N 123.326 0.392 . . . . 0.0 110.044 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 687' ' ' GLU . . . . . 0.65 ' HB3' ' HG ' ' A' ' 664' ' ' LEU . 8.2 pt-20 . . . . . 0 C--O 1.251 1.147 0 O-C-N 124.329 1.018 . . . . 0.0 112.332 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 N--CA 1.443 -0.819 0 CA-C-O 121.717 0.77 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.631 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 27.5 m -103.68 -43.18 5.42 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.009 174.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 571' ' ' LEU . 19.9 tt0 60.79 -150.27 0.41 Allowed 'General case' 0 C--O 1.246 0.882 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 -171.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.428 HD11 ' HG3' ' A' ' 580' ' ' PRO . 1.0 OUTLIER -147.35 113.14 4.09 Favored Pre-proline 0 C--N 1.281 -2.372 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -177.65 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.402 ' HD2' HD12 ' A' ' 616' ' ' LEU . 37.2 Cg_endo -66.63 -170.67 0.22 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.253 2.635 . . . . 0.0 112.741 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -86.23 91.28 8.41 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.876 HG13 ' H ' ' A' ' 575' ' ' ASP . 11.5 pt -59.56 -75.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.472 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.876 ' H ' HG13 ' A' ' 574' ' ' ILE . 11.8 t70 -174.77 -173.07 0.68 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 10.9 p -106.16 -20.27 6.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -104.96 13.63 30.71 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.555 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.1 tt -114.62 141.61 47.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -175.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.34 116.9 14.31 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-O 121.42 0.629 . . . . 0.0 111.456 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 574' ' ' ILE . 64.1 Cg_endo -76.9 137.33 17.52 Favored 'Trans proline' 0 C--N 1.328 -0.514 0 C-N-CA 122.764 2.309 . . . . 0.0 111.73 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -56.94 -55.06 39.45 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.61 0.719 . . . . 0.0 109.594 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 582' ' ' ARG . . . . . 0.42 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 75.1 mmt-85 -78.34 117.54 19.68 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -124.67 93.52 3.92 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 10.6 ptpt -138.74 175.56 9.45 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.505 -174.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -87.57 -52.2 5.47 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.544 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -115.45 120.46 39.6 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.434 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.631 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 41.2 m-85 -85.09 126.66 33.77 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.832 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -80.04 143.8 33.73 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.898 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.45 118.04 2.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.444 0.64 . . . . 0.0 109.717 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 104.8 1.02 42.61 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.297 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.62 116.66 18.35 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 6.5 p -92.4 121.56 43.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.933 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 593' ' ' LEU . . . . . . . . . . . . . 5.7 mp -95.78 93.9 7.35 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.009 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 96.2 mttt -78.64 93.82 4.94 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.09 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.539 ' HB3' HD21 ' A' ' 578' ' ' LEU . 65.1 m-85 -78.1 163.87 25.5 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.424 0.63 . . . . 0.0 110.228 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 21.3 m -155.58 171.03 20.63 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 89.1 m -117.59 175.06 5.81 Favored 'General case' 0 C--N 1.259 -3.336 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.3 mmmt -56.48 164.17 2.17 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.573 1.149 . . . . 0.0 112.555 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 94.8 Cg_exo -45.77 -40.17 19.13 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.584 3.522 . . . . 0.0 115.249 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -102.52 7.86 54.22 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.33 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 40.5 m-85 -110.55 132.86 53.82 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-O 121.799 0.809 . . . . 0.0 112.103 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 16.6 m -92.92 126.17 37.88 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.761 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.487 HD11 ' HG3' ' A' ' 621' ' ' PRO . 11.1 tt -78.95 117.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.774 HG21 ' HD3' ' A' ' 624' ' ' LYS . 50.2 t -108.78 117.49 54.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.653 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 122.74 -160.47 17.21 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.22 123.31 10.74 Favored 'Trans proline' 0 C--N 1.328 -0.507 0 C-N-CA 122.733 2.288 . . . . 0.0 110.947 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -86.21 -50.08 7.24 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 4.9 p -100.08 95.33 6.77 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 111.783 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.2 150.69 4.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.607 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 22.8 mm-40 -98.26 160.14 14.48 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 10.5 t -84.25 129.89 34.86 Favored 'General case' 1 C--N 1.243 -4.033 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.575 165.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.607 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 55.5 m-85 -119.19 170.65 8.9 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -12.84 61.13 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -104.82 -3.84 23.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.63 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 131.54 -170.18 21.62 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.402 HD12 ' HD2' ' A' ' 572' ' ' PRO . 46.6 mt -74.81 131.34 40.7 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.513 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 22.6 t -149.64 143.56 16.91 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.47 -172.5 10.97 Favored 'Cis proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.212 -1.578 . . . . 0.0 113.585 2.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.5 145.42 2.56 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.703 0.801 . . . . 0.0 110.63 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.654 HD23 HG22 ' A' ' 574' ' ' ILE . 6.5 mp -77.19 147.7 76.83 Favored Pre-proline 0 C--N 1.298 -1.659 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.262 -172.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.487 ' HG3' HD11 ' A' ' 603' ' ' ILE . 93.8 Cg_endo -74.85 -179.67 5.17 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 123.705 2.937 . . . . 0.0 112.913 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.6 pt -130.4 169.52 21.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 84.1 m -110.24 126.25 53.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.017 0.436 . . . . 0.0 110.832 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.774 ' HD3' HG21 ' A' ' 604' ' ' VAL . 28.3 mtpp -124.26 117.54 24.77 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.936 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 3.2 tm-20 -82.45 -36.77 26.26 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -94.26 98.93 11.27 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.843 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 6.2 m -114.28 171.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 628' ' ' GLN . . . . . 0.514 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 53.5 mm-40 -98.67 169.12 9.72 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 42.6 m -116.14 -7.88 11.82 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.913 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 96.3 m 67.66 3.27 3.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 62.24 -132.2 45.24 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.91 155.3 38.77 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.023 2.482 . . . . 0.0 111.301 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.702 ' HB3' HG11 ' A' ' 655' ' ' VAL . 86.2 Cg_endo -83.56 161.88 14.62 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 122.651 2.234 . . . . 0.0 112.572 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.47 173.91 11.72 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.61 2.207 . . . . 0.0 111.388 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -98.23 161.42 13.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 657' ' ' TYR . 19.7 tp -96.77 128.66 43.94 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -45.66 -42.04 11.04 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.432 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 11.7 m120 -133.35 31.01 3.81 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.475 0.655 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.607 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -151.85 -144.77 3.99 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -165.59 -173.47 2.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 655' ' ' VAL . 5.2 p -94.54 131.06 42.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.649 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 20.4 ptmt -88.91 -16.15 32.57 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.674 0.75 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.29 166.04 15.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.813 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -84.82 120.26 26.24 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.434 ' CG2' HG11 ' A' ' 641' ' ' VAL . 5.6 p -74.3 100.57 3.78 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.464 0.649 . . . . 0.0 112.448 -174.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -68.17 175.86 3.02 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.525 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -98.79 -0.85 41.75 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.746 0.784 . . . . 0.0 109.672 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 648' ' ' GLU . . . . . 0.438 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 26.4 tt0 -157.92 120.72 3.85 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.564 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 7.0 m-85 -91.76 -86.08 0.23 Allowed 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.981 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 145.83 164.23 10.71 Favored Glycine 0 CA--C 1.488 -1.6 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.522 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 57.8 t60 -56.98 -51.77 67.89 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 25.5 m -99.7 21.76 11.94 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.4 0.619 . . . . 0.0 110.835 -174.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.64 115.27 27.59 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.612 HG21 ' HE3' ' A' ' 670' ' ' LYS . 11.6 m -92.2 147.91 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.691 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.441 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 0.2 OUTLIER -114.73 115.94 51.06 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.843 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.34 177.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.649 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 18.4 mt-10 -77.02 138.52 39.64 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.261 1.029 . . . . 0.0 111.596 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.641 ' CE1' HG22 ' A' ' 655' ' ' VAL . 72.6 m-85 -119.06 167.55 11.67 Favored 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 125.597 1.559 . . . . 0.0 109.589 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -144.91 144.35 31.04 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.607 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 71.1 m -100.83 172.25 7.17 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -69.28 153.46 95.9 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.9 10.5 0.37 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 123.699 2.933 . . . . 0.0 114.396 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.41 3.56 25.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -131.46 164.22 26.24 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.688 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 687' ' ' GLU . 89.0 mt -104.22 165.16 11.23 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.2 ttt -123.91 103.83 8.57 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -82.65 -45.08 14.96 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -170.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -96.26 -173.73 35.71 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.007 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.51 122.01 10.64 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.416 2.744 . . . . 0.0 111.946 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 656' ' ' GLU . 2.4 p-10 -83.53 23.05 0.98 Allowed 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 122.872 0.469 . . . . 0.0 111.065 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.798 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 8.4 ptmt -163.82 107.09 0.97 Allowed 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 125.007 1.323 . . . . 0.0 108.014 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 37.7 pt -107.91 148.79 11.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.346 -174.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.74 154.17 27.78 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.453 0.47 . . . . 0.0 110.392 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 5.0 t -80.53 95.53 6.52 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.766 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 674' ' ' VAL . . . . . 0.508 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 35.1 m -84.52 117.02 29.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 O-C-N 121.402 -0.811 . . . . 0.0 111.39 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 675' ' ' ASP . . . . . 0.506 ' OD1' ' HE2' ' A' ' 624' ' ' LYS . 17.6 t70 62.23 -76.67 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.39 1.076 . . . . 0.0 111.118 -173.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 676' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -151.38 17.77 0.89 Allowed Glycine 0 N--CA 1.434 -1.477 0 O-C-N 123.792 0.683 . . . . 0.0 111.614 177.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -135.5 141.71 45.34 Favored 'General case' 0 CA--C 1.495 -1.158 0 O-C-N 122.29 -0.535 . . . . 0.0 109.94 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.532 ' HB3' HD12 ' A' ' 671' ' ' ILE . 99.0 m95 -74.34 156.03 37.53 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 3.3 p -81.23 -178.72 7.04 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 16.3 m -65.37 125.85 26.4 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.174 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.86 159.92 23.58 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 26.2 Cg_endo -62.87 -13.22 33.37 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 124.263 3.309 . . . . 0.0 115.284 -176.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.282 30.9 m 48.51 101.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 175.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.9 m -80.74 140.93 35.27 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.56 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.69 146.24 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.352 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 14.8 m -58.07 138.13 19.42 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.504 0 O-C-N 124.439 1.087 . . . . 0.0 112.088 -174.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 687' ' ' GLU . . . . . 0.544 ' HA ' ' HG ' ' A' ' 664' ' ' LEU . 41.9 tt0 . . . . . 0 C--N 1.314 -0.962 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.5 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.433 -1.317 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.64 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 87.2 m -67.3 146.53 54.03 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -117.86 149.24 41.19 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.533 HD22 ' HD2' ' A' ' 572' ' ' PRO . 2.7 tm? -77.76 111.67 19.41 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.533 ' HD2' HD22 ' A' ' 571' ' ' LEU . 84.3 Cg_endo -76.67 -170.02 0.82 Allowed 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.068 2.512 . . . . 0.0 111.625 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -74.43 102.37 4.42 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.526 0.679 . . . . 0.0 110.1 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.674 HG22 ' HG ' ' A' ' 620' ' ' LEU . 27.3 pt -83.53 -166.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.613 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.2 t70 -76.84 143.78 39.5 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.63 -26.91 24.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 C-N-CA 124.048 0.939 . . . . 0.0 111.928 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -103.92 11.02 36.05 Favored 'General case' 0 CA--C 1.494 -1.174 0 O-C-N 121.637 -0.664 . . . . 0.0 111.864 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.674 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 5.6 tp -95.87 153.08 17.94 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.44 120.18 6.13 Favored Pre-proline 0 C--N 1.286 -2.185 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.448 ' HB2' ' O ' ' A' ' 582' ' ' ARG . 56.4 Cg_endo -74.7 137.45 22.46 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.24 1.96 . . . . 0.0 112.08 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -70.8 -42.34 70.41 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 582' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 580' ' ' PRO . 6.1 mmp_? -82.6 123.81 29.57 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 583' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 583' ' ' LYS . 34.5 ttmt -137.18 91.64 2.64 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 10.3 ptpt -137.92 172.63 12.65 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.578 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.08 -50.1 51.33 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.702 0.287 . . . . 0.0 111.36 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -132.06 152.85 50.95 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 121.443 0.639 . . . . 0.0 109.827 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.64 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 84.3 m-85 -115.18 119.72 37.32 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.068 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -70.05 142.24 52.72 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.567 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.531 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 1.8 p -61.29 112.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 122.279 1.038 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 121.33 -15.07 9.33 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.541 -174.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -72.03 126.26 29.32 Favored 'General case' 0 CA--C 1.473 -2.017 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 608' ' ' SER . 7.7 p -103.49 118.5 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.34 0 CA-C-O 122.35 1.071 . . . . 0.0 109.709 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.446 HD23 HD23 ' A' ' 571' ' ' LEU . 5.4 mp -91.04 98.52 11.82 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.025 -175.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 607' ' ' ASN . 96.0 mttt -78.21 118.96 20.93 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.546 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -97.9 179.49 4.78 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.387 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 10.5 p -168.67 161.82 11.48 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.586 ' SG ' HD12 ' A' ' 578' ' ' LEU . 90.1 m -105.0 -176.04 2.96 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.504 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.3 mmtp -63.27 162.72 22.47 Favored Pre-proline 0 N--CA 1.429 -1.499 0 C-N-CA 123.218 0.607 . . . . 0.0 111.545 175.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 88.8 Cg_exo -45.72 -40.03 18.76 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 124.498 3.465 . . . . 0.0 115.404 -175.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -97.22 3.69 62.0 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.61 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 45.6 m-85 -108.41 151.56 25.87 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.225 1.012 . . . . 0.0 113.379 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.553 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 2.6 m -103.76 123.6 47.35 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.061 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.457 ' HA ' ' SG ' ' A' ' 597' ' ' CYS . 5.7 tt -78.33 122.51 33.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.697 HG21 ' HG3' ' A' ' 624' ' ' LYS . 55.4 t -115.52 121.0 66.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 122.185 -0.322 . . . . 0.0 110.598 -178.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 119.77 -151.23 17.48 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.132 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.37 115.51 4.37 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.06 2.507 . . . . 0.0 111.214 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 0.2 OUTLIER -82.24 -25.95 33.67 Favored 'General case' 0 C--O 1.197 -1.668 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.835 -178.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.46 ' HB2' ' CG2' ' A' ' 592' ' ' VAL . 64.7 p -123.08 98.54 5.93 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.354 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.1 m -101.21 142.46 15.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 610' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -96.27 151.07 19.86 Favored 'General case' 0 CA--C 1.48 -1.746 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.815 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 35.5 t -75.38 125.07 28.25 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 166.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.488 ' HA ' HG23 ' A' ' 589' ' ' VAL . 90.7 m-85 -116.36 165.1 13.59 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.95 2.89 4.9 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -177.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -111.11 -4.74 14.94 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.391 0.615 . . . . 0.0 110.422 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.52 -178.52 18.0 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.123 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.513 HD12 ' CD ' ' A' ' 572' ' ' PRO . 45.7 mt -70.92 120.18 16.12 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.488 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 49.9 m -138.42 146.13 49.84 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-O 120.475 0.179 . . . . 0.0 110.672 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.84 -169.16 7.05 Favored 'Cis proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.182 -1.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.37 169.67 7.05 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.674 ' HG ' HG22 ' A' ' 574' ' ' ILE . 1.3 mm? -74.16 145.75 83.65 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.343 -168.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.24 170.59 17.9 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 123.228 2.619 . . . . 0.0 110.668 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 622' ' ' ILE . . . . . 0.454 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 47.0 pt -113.34 -178.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 602' ' ' THR . 96.1 m -129.13 109.04 10.84 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.425 0.453 . . . . 0.0 111.914 -177.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.697 ' HG3' HG21 ' A' ' 604' ' ' VAL . 18.5 mtmm -97.89 127.12 43.63 Favored 'General case' 0 C--O 1.201 -1.461 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 176.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.504 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 1.4 tm-20 -83.37 -34.5 25.58 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -104.36 107.54 18.52 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.058 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.567 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 10.4 p -125.22 174.51 9.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 628' ' ' GLN . . . . . 0.402 ' H ' HG22 ' A' ' 627' ' ' VAL . 13.1 mm-40 -88.16 139.62 30.31 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 118.824 0.738 . . . . 0.0 109.352 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 631' ' ' GLY . 17.4 m -93.87 104.54 16.6 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 173.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 55.9 m -60.9 21.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 629' ' ' SER . . . 54.83 -139.06 40.8 Favored Glycine 0 C--O 1.241 0.579 0 CA-C-O 119.734 -0.481 . . . . 0.0 112.906 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.96 154.68 22.86 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.961 2.441 . . . . 0.0 110.782 175.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.505 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 59.9 Cg_endo -74.4 157.71 45.04 Favored 'Trans proline' 0 C--O 1.255 1.355 0 C-N-CA 122.684 2.256 . . . . 0.0 112.922 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.38 -169.47 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 123.47 2.78 . . . . 0.0 111.199 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -109.65 153.08 24.73 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.393 -0.817 . . . . 0.0 110.675 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 657' ' ' TYR . 18.6 tp -80.67 139.86 35.95 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.423 HD13 ' OD1' ' A' ' 638' ' ' ASN . 0.3 OUTLIER -46.26 -47.79 18.06 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -178.578 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.423 ' OD1' HD13 ' A' ' 637' ' ' LEU . 16.4 m120 -116.58 -30.43 5.83 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.519 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.642 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -91.12 -152.23 27.8 Favored Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.222 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -156.35 -174.77 5.09 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.995 0.426 . . . . 0.0 110.545 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 6.0 p -92.68 134.71 29.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.536 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.56 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.2 ptmt -93.86 -24.65 17.66 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.046 0.45 . . . . 0.0 110.61 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 15.2 mm-40 -78.82 151.47 31.89 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.364 -177.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -63.97 109.24 1.72 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.438 ' CG2' HG11 ' A' ' 641' ' ' VAL . 16.7 p -71.59 98.56 1.9 Allowed 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.434 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -81.3 158.03 24.9 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -87.81 0.88 55.2 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.1 108.56 4.84 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.505 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 17.4 m-85 -92.76 -104.75 0.12 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 147.56 168.99 14.48 Favored Glycine 0 CA--C 1.487 -1.657 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.01 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 18.7 t60 -69.65 142.25 53.47 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 17.8 m 75.72 -1.66 2.95 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.549 1.14 . . . . 0.0 111.422 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.433 ' HG3' ' HD2' ' A' ' 649' ' ' TYR . 7.3 tp10 -93.72 114.63 26.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 670' ' ' LYS . 17.8 m -91.84 161.41 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.774 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.622 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.1 m -127.16 110.89 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.512 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.574 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.56 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 17.8 mt-10 -70.16 122.23 19.06 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.105 0.955 . . . . 0.0 111.599 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.537 ' HB3' HD22 ' A' ' 636' ' ' LEU . 76.6 m-85 -102.42 166.89 10.3 Favored 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.032 174.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -146.83 137.04 23.55 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.642 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 8.3 t -102.61 179.09 4.39 Favored 'General case' 0 C--N 1.276 -2.612 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.025 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 662' ' ' ARG . 30.9 m-80 -75.85 155.66 84.81 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.52 33.85 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 124.295 3.33 . . . . 0.0 112.688 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 660' ' ' ASN . 35.4 mtt180 -133.3 4.77 3.74 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.411 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 76.9 m-85 -138.42 163.11 32.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.462 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.1 147.61 38.49 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.467 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.5 OUTLIER -103.34 118.98 37.99 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -176.067 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -80.21 -59.33 2.75 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -95.53 -160.79 33.4 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.067 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.93 116.34 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.03 2.487 . . . . 0.0 112.237 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -63.52 -11.77 26.85 Favored 'General case' 0 C--O 1.195 -1.776 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.946 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -134.62 115.31 13.69 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.238 0.542 . . . . 0.0 111.909 178.69 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 33.8 pt -109.03 151.58 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.048 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.64 152.12 33.73 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 121.211 0.529 . . . . 0.0 111.399 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 1.5 t -69.72 121.15 16.62 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.03 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 674' ' ' VAL . . . . . 0.432 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 34.0 m -116.23 86.9 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 CA-C-O 122.293 1.044 . . . . 0.0 113.045 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 675' ' ' ASP . . . . . 0.567 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 16.5 m-20 75.3 8.05 3.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.795 -1.548 . . . . 0.0 113.913 166.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 142.35 -11.92 2.51 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.285 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -138.63 149.26 45.01 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.52 ' HB3' HD12 ' A' ' 671' ' ' ILE . 93.8 m95 -80.01 158.89 26.41 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 19.0 p -80.17 -180.0 7.35 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.655 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 25.8 m -68.6 126.72 30.55 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 120.717 0.294 . . . . 0.0 110.944 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.441 ' HA ' HG21 ' A' ' 671' ' ' ILE . 6.2 mp -57.94 160.3 8.76 Favored Pre-proline 0 N--CA 1.441 -0.904 0 O-C-N 124.461 1.101 . . . . 0.0 113.011 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.467 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 11.5 Cg_endo -57.31 -42.1 66.0 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.112 2.541 . . . . 0.0 113.283 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 99.8 t 67.55 113.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-O 121.936 0.874 . . . . 0.0 110.467 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 8.1 p -111.54 138.17 48.42 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.996 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.89 148.52 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.283 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.469 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 14.8 m -56.3 138.11 17.26 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.558 0 C-N-CA 124.558 1.143 . . . . 0.0 113.759 -171.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 C--N 1.299 -1.62 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.606 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.428 -1.55 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.851 ' HB3' HD11 ' A' ' 616' ' ' LEU . 90.5 m -59.28 133.34 56.01 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -174.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 571' ' ' LEU . 35.6 tt0 -94.63 -61.51 1.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.624 HD11 ' HG3' ' A' ' 580' ' ' PRO . 3.4 tt 150.84 129.88 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 177.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.703 ' HD3' HD13 ' A' ' 616' ' ' LEU . 74.5 Cg_endo -70.55 -170.8 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.76 1.64 . . . . 0.0 111.325 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -92.27 102.19 14.69 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.662 HD13 ' HD3' ' A' ' 580' ' ' PRO . 36.7 pt -76.2 -164.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.601 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.862 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 11.3 t70 -80.86 163.84 23.11 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.14 -28.09 22.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.17 0.509 . . . . 0.0 110.793 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -101.6 9.45 41.14 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 121.734 -0.604 . . . . 0.0 111.424 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.862 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.2 tm? -100.79 146.49 27.21 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.438 ' N ' HD13 ' A' ' 578' ' ' LEU . 16.3 m -140.74 121.14 8.82 Favored Pre-proline 0 C--N 1.3 -1.578 0 C-N-CA 123.754 0.822 . . . . 0.0 109.326 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.662 ' HD3' HD13 ' A' ' 574' ' ' ILE . 55.8 Cg_endo -73.0 136.33 24.7 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.036 1.824 . . . . 0.0 111.484 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.74 -38.82 92.3 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.537 1.135 . . . . 0.0 110.782 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -67.38 -61.07 2.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.739 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 60.6 tttm 51.84 74.57 0.25 Allowed 'General case' 0 C--O 1.241 0.649 0 O-C-N 124.676 1.235 . . . . 0.0 110.895 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 16.9 ptpt -131.12 156.24 45.61 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.289 -1.323 . . . . 0.0 107.445 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -76.55 -31.51 57.64 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -134.21 133.08 40.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.875 0.369 . . . . 0.0 110.838 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.52 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 96.7 m-85 -110.69 142.29 42.8 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -93.13 153.4 18.68 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.602 ' HA ' ' SG ' ' A' ' 611' ' ' CYS 0.269 0.2 OUTLIER -64.64 118.0 6.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 121.839 0.828 . . . . 0.0 111.705 179.493 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 113.34 -3.66 25.11 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.768 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -74.53 134.7 42.19 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.628 HG12 ' HG3' ' A' ' 610' ' ' GLN . 20.3 m -109.82 129.92 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.881 0.848 . . . . 0.0 109.888 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.52 ' HG ' ' CE2' ' A' ' 587' ' ' TYR 0.368 0.0 OUTLIER -116.26 98.56 6.66 Favored 'General case' 0 N--CA 1.385 -3.701 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.269 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 607' ' ' ASN . 24.4 mtpp -61.46 124.6 21.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.044 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.698 ' HB3' HD11 ' A' ' 578' ' ' LEU . 27.7 m-85 -105.44 164.73 11.64 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.702 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 596' ' ' SER . . . . . 0.477 ' HA ' HD12 ' A' ' 603' ' ' ILE . 34.0 p -168.85 166.69 11.31 Favored 'General case' 0 N--CA 1.401 -2.88 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 169.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 70.8 m -98.9 173.26 6.94 Favored 'General case' 0 C--N 1.255 -3.534 0 O-C-N 123.769 0.668 . . . . 0.0 110.831 -177.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.611 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 29.9 mmtp -53.04 163.21 0.9 Allowed Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 124.304 1.041 . . . . 0.0 112.191 176.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 18.7 Cg_endo -60.69 -17.09 47.55 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.852 2.368 . . . . 0.0 115.291 -170.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -110.54 8.63 30.37 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.273 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 30.7 m-85 -113.1 162.43 15.94 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.534 0.683 . . . . 0.0 112.258 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.409 HG21 HG21 ' A' ' 627' ' ' VAL . 8.1 m -112.65 131.95 55.4 Favored 'General case' 0 N--CA 1.416 -2.148 0 C-N-CA 125.533 1.533 . . . . 0.0 110.111 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 596' ' ' SER . 11.4 tt -83.98 122.4 37.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.439 0.638 . . . . 0.0 109.5 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 46.1 t -118.07 109.74 28.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.276 0.56 . . . . 0.0 109.856 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 132.82 -164.43 24.07 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.21 128.76 27.39 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.966 2.444 . . . . 0.0 110.786 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 29.6 m-20 -94.96 -10.17 31.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 122.182 -0.324 . . . . 0.0 110.947 -175.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 608' ' ' SER . . . . . . . . . . . . . 2.8 p -150.24 98.08 2.63 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.335 0.588 . . . . 0.0 111.637 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 20.3 m -93.21 167.56 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.781 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.628 ' HG3' HG12 ' A' ' 592' ' ' VAL . 1.9 mp0 -113.97 156.0 24.83 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.288 0.566 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 0.9 OUTLIER -85.25 130.8 34.53 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 164.441 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.565 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 77.5 m-85 -115.35 175.0 5.71 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -73.23 -12.94 61.04 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.862 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -101.38 -2.32 31.19 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 111.173 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.25 -171.78 21.35 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.851 HD11 ' HB3' ' A' ' 569' ' ' CYS . 5.2 mp -87.36 137.59 32.21 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 118.091 0.945 . . . . 0.0 110.019 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 618' ' ' PRO . 44.7 m -158.38 157.11 28.67 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.152 -176.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 617' ' ' SER . 59.3 Cg_endo -68.92 -168.18 3.85 Favored 'Cis proline' 0 CA--C 1.554 1.498 0 C-N-CA 124.599 -1.001 . . . . 0.0 114.279 1.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.02 160.99 16.78 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.994 0.426 . . . . 0.0 110.748 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 572' ' ' PRO . 2.1 mm? -78.43 144.52 66.11 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.89 162.53 41.78 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.982 2.455 . . . . 0.0 110.924 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 622' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 43.1 pt -110.49 -178.66 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.7 m -129.9 116.63 18.93 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-O 121.28 0.562 . . . . 0.0 111.716 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 624' ' ' LYS . 46.3 mtpt -104.02 130.42 51.68 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 25.3 tt0 -86.85 -39.82 15.48 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -98.22 107.54 20.04 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.138 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 3.5 p -107.13 176.48 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 628' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 47.8 mt-30 -93.53 156.14 16.91 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.478 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 15.4 m -99.02 -7.53 26.71 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.658 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 630' ' ' CYS . . . . . 0.452 ' SG ' ' HA2' ' A' ' 676' ' ' GLY . 20.9 m 71.1 -12.4 0.59 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 167.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 65.18 -147.25 50.79 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -79.01 148.76 22.08 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 122.66 2.24 . . . . 0.0 111.846 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.641 ' HG3' HG11 ' A' ' 655' ' ' VAL . 71.6 Cg_endo -76.42 167.69 25.22 Favored 'Trans proline' 0 CA--C 1.556 1.578 0 C-N-CA 123.49 2.793 . . . . 0.0 113.025 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.97 -167.52 0.24 Allowed 'Trans proline' 0 CA--C 1.55 1.292 0 C-N-CA 123.626 2.884 . . . . 0.0 113.587 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -111.99 166.02 11.59 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.605 HD22 ' HB3' ' A' ' 657' ' ' TYR . 18.9 tp -102.55 132.2 48.78 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 638' ' ' ASN . 2.3 pp -51.91 -42.91 63.12 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.778 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 92.6 m-20 -131.09 29.91 4.62 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.717 0.77 . . . . 0.0 109.392 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.662 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -153.61 -150.4 5.45 Favored Glycine 0 N--CA 1.412 -2.953 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -160.55 -166.84 1.73 Allowed 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.5 p -107.53 128.37 62.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -85.44 -22.29 28.36 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.348 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.624 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 8.2 mm-40 -86.89 144.43 26.99 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.158 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 644' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 644' ' ' LYS . 5.9 ttpm? -56.8 112.7 1.38 Allowed 'General case' 0 C--N 1.31 -1.136 0 O-C-N 124.353 1.033 . . . . 0.0 109.938 176.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.46 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 4.9 p -83.72 101.43 11.55 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.599 0.714 . . . . 0.0 111.682 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 49.7 pttt -84.95 160.78 20.02 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.099 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.94 -21.05 60.66 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -152.26 125.01 8.42 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.097 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.551 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 11.3 m-85 -99.27 -75.27 0.57 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 129.19 172.19 13.12 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -175.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.503 ' HB2' HG11 ' A' ' 627' ' ' VAL . 64.6 t60 -60.44 -63.31 1.34 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 19.3 m -87.9 41.82 1.02 Allowed 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 121.333 0.587 . . . . 0.0 111.172 -172.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -120.3 106.28 11.73 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.631 HG21 ' HE2' ' A' ' 670' ' ' LYS . 15.8 m -82.19 154.64 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-O 122.066 0.936 . . . . 0.0 111.548 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.641 HG11 ' HG3' ' A' ' 633' ' ' PRO . 2.8 t -127.45 111.89 26.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 114.13 -1.396 . . . . 0.0 107.995 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.701 ' HG2' ' HG2' ' A' ' 670' ' ' LYS . 36.0 mt-10 -70.09 120.47 15.84 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 122.21 1.005 . . . . 0.0 113.01 175.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.605 ' HB3' HD22 ' A' ' 636' ' ' LEU . 55.4 m-85 -100.21 165.34 11.54 Favored 'General case' 0 C--N 1.263 -3.153 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.717 171.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -146.54 138.29 24.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.662 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 80.1 m -92.3 175.92 6.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 0.8 OUTLIER -67.46 157.55 85.32 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.348 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 70.1 Cg_endo -72.89 37.74 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.909 3.073 . . . . 0.0 113.195 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -153.52 11.82 0.45 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.695 -175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 660' ' ' ASN . 87.0 m-85 -132.88 154.15 50.66 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.37 0.605 . . . . 0.0 110.196 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 85.4 mt -93.68 149.23 21.4 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.2 ttt -112.11 118.76 36.26 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -75.18 -72.04 0.32 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -172.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -90.67 -151.97 26.95 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 113.663 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.36 119.67 6.74 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.3 2.667 . . . . 0.0 111.919 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -74.96 -12.9 60.45 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 121.201 0.524 . . . . 0.0 110.81 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.701 ' HG2' ' HG2' ' A' ' 656' ' ' GLU . 9.1 mtpt -119.24 125.88 50.18 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 40.4 pt -116.74 138.14 48.32 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.605 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.61 161.52 13.66 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 42.8 t -102.2 110.93 23.03 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.492 1.139 . . . . 0.0 111.135 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 77.8 t -86.14 110.08 19.47 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.036 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.13 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 675' ' ' ASP . . . . . 0.593 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 23.0 t70 60.73 -80.27 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 124.799 1.24 . . . . 0.0 112.43 -171.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 676' ' ' GLY . . . . . 0.452 ' HA2' ' SG ' ' A' ' 630' ' ' CYS . . . -145.67 14.61 1.79 Allowed Glycine 0 C--N 1.301 -1.389 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 176.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -125.41 115.6 20.54 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.558 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.4 m95 -63.53 146.24 54.08 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 17.8 p -67.36 175.51 2.71 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 2.7 m -60.5 130.2 45.38 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.938 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.48 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 6.0 mp -63.38 152.25 85.6 Favored Pre-proline 0 N--CA 1.433 -1.281 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.48 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 19.3 Cg_endo -58.64 -36.73 96.83 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.648 2.898 . . . . 0.0 114.125 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 66.2 t 69.4 117.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.913 0.885 . . . . 0.0 112.773 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.778 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 4.1 m -96.75 135.35 38.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.446 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.81 144.04 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.928 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 16.8 m -58.15 139.69 17.47 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.064 0 C-N-CA 124.678 1.191 . . . . 0.0 112.843 -174.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.62 -179.38 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.411 -2.388 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.741 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 79.2 m -67.78 119.19 12.09 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.792 0.806 . . . . 0.0 110.943 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.76 -2.31 38.36 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-O 122.419 1.104 . . . . 0.0 108.929 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.675 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 47.4 tp 74.37 115.1 0.03 OUTLIER Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 127.059 2.144 . . . . 0.0 110.337 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.708 ' HG2' HD11 ' A' ' 620' ' ' LEU . 60.8 Cg_endo -67.97 -159.47 0.05 OUTLIER 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 123.696 2.931 . . . . 0.0 111.6 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -89.93 98.98 12.09 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.563 HG22 HD13 ' A' ' 620' ' ' LEU . 40.7 pt -72.83 175.09 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.153 174.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.726 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.7 t70 -65.79 147.81 52.79 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.12 -25.91 31.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 C-N-CA 123.792 0.837 . . . . 0.0 110.786 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -105.9 8.32 32.57 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 122.054 -0.403 . . . . 0.0 111.864 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.726 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 6.5 tp -91.75 148.61 22.12 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 21.7 m -135.66 116.57 11.77 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.492 ' HG2' ' HB2' ' A' ' 583' ' ' LYS . 26.9 Cg_endo -74.23 134.61 19.47 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.472 1.448 . . . . 0.0 109.686 174.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -33.41 75.72 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 582' ' ' ARG . . . . . 0.434 ' HB3' ' HE3' ' A' ' 584' ' ' LYS . 27.0 mmt180 -70.76 -64.75 0.84 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.802 177.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 583' ' ' LYS . . . . . 0.492 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 27.3 ttpp 47.91 82.34 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.691 1.596 . . . . 0.0 112.334 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.477 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.9 ptpt -133.66 163.91 28.37 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.975 -1.466 . . . . 0.0 107.412 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -72.69 -46.02 55.84 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.957 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -127.36 133.88 50.01 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.577 0.703 . . . . 0.0 110.258 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.741 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 92.8 m-85 -107.37 124.76 50.3 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 124.862 1.265 . . . . 0.0 109.509 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -78.79 149.23 32.66 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.586 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 1.3 p -63.8 119.17 7.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.59 0.709 . . . . 0.0 111.33 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 115.2 -10.38 20.21 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.26 -173.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -70.21 125.97 28.32 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 18.6 t -99.55 116.7 43.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 608' ' ' SER . 9.7 mt -101.84 115.04 29.66 Favored 'General case' 0 CA--C 1.47 -2.121 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.598 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 34.1 mtmm -91.76 99.38 12.27 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -76.81 161.81 28.15 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-O 122.022 0.915 . . . . 0.0 109.147 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 38.5 m -152.46 169.38 22.74 Favored 'General case' 0 C--N 1.253 -3.619 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.483 ' SG ' HD12 ' A' ' 578' ' ' LEU . 87.6 m -107.43 -178.17 3.56 Favored 'General case' 0 C--N 1.247 -3.887 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.594 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 32.1 mmtm -55.67 163.83 1.83 Allowed Pre-proline 0 C--N 1.313 -1.022 0 C-N-CA 123.018 0.527 . . . . 0.0 110.993 172.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 16.6 Cg_endo -59.03 -28.66 88.49 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.36 2.04 . . . . 0.0 114.701 -171.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.88 -2.65 61.04 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.879 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 39.9 m-85 -103.62 136.3 43.58 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 14.4 m -87.87 125.78 34.67 Favored 'General case' 0 N--CA 1.395 -3.201 0 CA-C-N 113.74 -1.573 . . . . 0.0 109.182 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.475 HD11 ' HG3' ' A' ' 621' ' ' PRO . 12.6 tt -80.31 125.69 39.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.67 HG21 ' HD3' ' A' ' 624' ' ' LYS . 82.5 t -117.25 114.58 46.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 123.59 -166.67 16.0 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.178 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.24 115.82 3.37 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.919 2.413 . . . . 0.0 111.535 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -75.99 -49.51 17.47 Favored 'General case' 0 C--O 1.206 -1.201 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.598 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 57.0 p -99.1 113.7 26.05 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.11 0.481 . . . . 0.0 111.626 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.86 157.39 17.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 610' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.36 151.96 22.14 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 121.011 0.434 . . . . 0.0 109.904 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 42.1 t -80.16 129.46 34.51 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.446 ' HA ' HG23 ' A' ' 589' ' ' VAL . 95.6 m-85 -114.64 165.79 12.41 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -61.92 -18.72 61.24 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -97.79 -5.28 35.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.85 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 134.62 -179.75 17.28 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 611' ' ' CYS . 71.9 mt -72.99 128.87 36.74 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 618' ' ' PRO . 67.1 m -146.26 147.07 30.07 Favored Pre-proline 0 C--N 1.294 -1.809 0 CA-C-N 116.816 -0.175 . . . . 0.0 110.681 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 617' ' ' SER . 49.5 Cg_endo -66.64 -175.7 7.74 Favored 'Cis proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.728 -1.363 . . . . 0.0 113.111 0.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.19 163.81 9.67 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 121.033 0.444 . . . . 0.0 110.957 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.708 HD11 ' HG2' ' A' ' 572' ' ' PRO . 24.0 mt -77.39 145.91 73.04 Favored Pre-proline 0 C--N 1.293 -1.869 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.972 -170.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.475 ' HG3' HD11 ' A' ' 603' ' ' ILE . 61.8 Cg_endo -70.91 173.68 11.64 Favored 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 123.537 2.824 . . . . 0.0 111.007 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 622' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 604' ' ' VAL . 44.1 pt -117.7 178.23 2.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.8 m -123.89 123.39 40.32 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.114 0.483 . . . . 0.0 110.604 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.67 ' HD3' HG21 ' A' ' 604' ' ' VAL . 58.2 mtpt -118.92 119.79 35.36 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.563 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 4.3 tm-20 -79.25 -43.12 24.38 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -91.64 91.92 8.23 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.488 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.622 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 5.0 p -109.69 170.82 2.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.275 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 628' ' ' GLN . . . . . 0.588 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 19.9 mm-40 -91.61 161.17 15.04 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 27.3 m -107.51 -4.9 17.96 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.104 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 80.1 m 71.22 -34.79 0.31 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 88.34 -141.93 17.06 Favored Glycine 0 N--CA 1.415 -2.719 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -74.34 145.7 34.58 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 121.997 1.798 . . . . 0.0 111.831 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.533 ' HG3' HG11 ' A' ' 655' ' ' VAL . 92.2 Cg_endo -82.43 170.86 12.83 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.085 2.523 . . . . 0.0 111.874 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.14 -166.92 0.15 Allowed 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 123.214 2.61 . . . . 0.0 113.108 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -100.45 169.58 8.99 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.56 ' CD2' ' SG ' ' A' ' 659' ' ' CYS . 14.7 tp -91.33 166.16 13.05 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 117.733 -1.587 . . . . 0.0 110.258 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.509 ' N ' ' HG ' ' A' ' 636' ' ' LEU . 4.9 tt -63.45 -67.64 0.41 Allowed 'General case' 0 N--CA 1.396 -3.162 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.716 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -128.08 40.16 3.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.979 0.895 . . . . 0.0 109.169 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -149.21 -142.13 3.55 Favored Glycine 1 N--CA 1.395 -4.067 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.784 176.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -156.66 -172.83 4.21 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.457 HG11 HG23 ' A' ' 645' ' ' THR . 9.0 p -104.0 134.55 44.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.705 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.1 ptmt -86.17 -29.85 22.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.661 0.744 . . . . 0.0 110.439 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 27.6 mm-40 -88.2 159.24 18.24 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.508 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -72.84 118.86 16.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.664 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.457 HG23 HG11 ' A' ' 641' ' ' VAL . 18.1 p -71.6 101.91 2.62 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-O 121.724 0.773 . . . . 0.0 111.21 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -73.29 156.54 38.35 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.484 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.51 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 49.2 mt-10 -85.59 -6.19 59.19 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -140.95 113.27 7.99 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 173.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.531 ' CE2' HG22 ' A' ' 655' ' ' VAL . 4.5 m-85 -96.35 -77.85 0.48 Allowed 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.455 174.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 130.09 163.5 11.1 Favored Glycine 0 CA--C 1.497 -1.091 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.628 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 71.2 t60 -56.51 -57.86 10.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 44.7 m -86.28 20.62 2.31 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -102.66 120.0 39.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 2.9 p -99.16 161.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.252 0.548 . . . . 0.0 110.143 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.8 t -127.37 113.72 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.724 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.705 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 29.5 mt-10 -71.91 124.15 24.26 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.497 0.665 . . . . 0.0 112.45 176.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.549 ' HB3' HD22 ' A' ' 636' ' ' LEU . 87.5 m-85 -108.1 167.33 10.07 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.621 172.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -150.44 141.23 22.76 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.79 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 9.1 m -100.47 173.85 6.38 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.116 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -62.89 155.09 73.47 Favored Pre-proline 0 C--O 1.245 0.828 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.618 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -71.01 29.41 0.21 Allowed 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 124.218 3.279 . . . . 0.0 114.681 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.3 21.8 1.88 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.176 0.989 . . . . 0.0 110.144 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -135.6 157.38 47.03 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.01 175.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.43 132.36 54.2 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 3.1 ttt -97.0 106.41 18.75 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 666' ' ' LYS . 35.9 ttmt -90.97 -42.65 10.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -173.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.89 -178.67 46.13 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.183 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.27 113.64 1.63 Allowed 'Trans proline' 0 N--CA 1.476 0.484 0 C-N-CA 123.613 2.876 . . . . 0.0 112.082 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.532 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 3.1 p30 -63.27 -15.42 57.12 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 2.0 mtpt -120.22 155.32 33.41 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 44.5 pt -139.36 145.95 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 19.6 pm0 -118.64 158.75 24.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.628 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 7.5 t -86.33 104.48 15.88 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.878 1.323 . . . . 0.0 111.344 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.6 106.63 18.07 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.051 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.845 -176.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 675' ' ' ASP . . . . . 0.622 ' HA ' ' CG2' ' A' ' 627' ' ' VAL 0.253 16.0 t70 64.13 -56.54 0.23 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.7 1.6 . . . . 0.0 114.543 -178.035 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 676' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -161.95 4.97 0.08 OUTLIER Glycine 0 C--N 1.288 -2.095 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.651 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -136.37 154.46 50.82 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 123.115 0.566 . . . . 0.0 109.478 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.435 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.3 m95 -80.34 174.72 11.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.836 0.826 . . . . 0.0 111.638 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.11 167.85 10.8 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.705 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 26.7 m -57.16 128.46 37.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.22 0.95 . . . . 0.0 110.937 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.55 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 4.5 mp -65.94 154.46 89.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.541 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.55 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 5.9 Cg_endo -53.68 -32.6 65.92 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.962 3.108 . . . . 0.0 114.874 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.315 30.5 m 42.79 94.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 26.9 p -86.79 162.03 18.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.697 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.62 155.99 23.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.5 140.68 13.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 123.686 0.617 . . . . 0.0 110.764 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--O 1.247 0.93 0 C-N-CA 123.55 0.74 . . . . 0.0 110.831 -179.348 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 CA--C 1.514 -0.407 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.74 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 89.4 m -100.9 149.6 23.71 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -137.28 14.0 3.02 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 571' ' ' LEU . 1.1 tm? 70.96 101.62 0.04 OUTLIER Pre-proline 0 C--O 1.247 0.935 0 C-N-CA 124.481 1.113 . . . . 0.0 109.881 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.74 -172.34 0.8 Allowed 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.497 2.798 . . . . 0.0 111.613 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.39 95.86 5.2 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.555 HD13 ' HD3' ' A' ' 580' ' ' PRO . 17.2 pt -73.81 -175.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.592 177.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.7 t70 -71.2 148.87 46.87 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.49 -33.0 46.95 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.634 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -98.6 13.02 33.47 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 121.805 -0.56 . . . . 0.0 111.943 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.63 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.6 OUTLIER -106.06 150.75 25.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.527 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.55 119.68 7.78 Favored Pre-proline 0 C--N 1.312 -1.045 0 C-N-CA 124.159 0.983 . . . . 0.0 109.197 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.555 ' HD3' HD13 ' A' ' 574' ' ' ILE . 33.3 Cg_endo -71.43 135.31 26.3 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.321 2.014 . . . . 0.0 112.318 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.57 -47.12 79.91 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 123.556 0.742 . . . . 0.0 110.08 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -64.67 -68.43 0.36 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 583' ' ' LYS . . . . . 0.466 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 39.1 ttpt 52.38 70.81 0.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.471 1.129 . . . . 0.0 110.685 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -119.94 157.26 29.16 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.93 -37.27 67.24 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.145 0.498 . . . . 0.0 111.805 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -127.42 142.74 51.34 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.74 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 72.3 m-85 -122.65 126.76 48.28 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 588' ' ' LYS . . . . . 0.52 ' HB2' ' HG2' ' A' ' 591' ' ' GLU . 36.9 mttp -69.61 149.26 48.33 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.436 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -71.52 120.19 19.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.22 174.299 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 116.57 -11.11 16.21 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.635 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 591' ' ' GLU . . . . . 0.52 ' HG2' ' HB2' ' A' ' 588' ' ' LYS . 5.8 mm-40 -67.84 142.14 56.23 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.555 HG22 ' HG3' ' A' ' 610' ' ' GLN . 18.7 t -115.64 114.75 47.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.639 HD22 ' CD2' ' A' ' 587' ' ' TYR . 0.2 OUTLIER -105.58 109.64 21.68 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.626 0.727 . . . . 0.0 111.279 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 60.5 mtpt -72.4 141.94 48.7 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.345 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 580' ' ' PRO . 64.1 m-85 -114.23 177.59 4.59 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-O 121.05 0.452 . . . . 0.0 109.955 175.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 10.6 p -163.05 164.46 25.5 Favored 'General case' 0 N--CA 1.405 -2.696 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 94.6 m -111.95 -178.72 3.5 Favored 'General case' 0 C--N 1.266 -3.028 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 598' ' ' LYS . 28.1 mmtp -57.41 159.38 8.91 Favored Pre-proline 0 N--CA 1.436 -1.167 0 C-N-CA 123.281 0.632 . . . . 0.0 110.995 173.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -46.6 -45.01 20.52 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 124.195 3.263 . . . . 0.0 114.057 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 600' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 625' ' ' GLU . . . -90.25 -2.4 73.98 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.979 -175.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 29.3 m-85 -97.41 179.79 4.75 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.613 0.721 . . . . 0.0 112.118 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.677 HG21 HG11 ' A' ' 627' ' ' VAL . 89.3 m -136.47 129.38 30.99 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 595' ' ' PHE . 15.9 tt -86.05 150.23 3.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 1.012 HG21 HG12 ' A' ' 622' ' ' ILE . 4.9 m -119.05 154.22 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.384 -171.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 53.72 -123.94 27.92 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 169.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.72 94.75 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.294 2.663 . . . . 0.0 112.194 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -79.98 -28.48 39.53 Favored 'General case' 0 C--O 1.203 -1.385 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.479 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.501 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 34.1 p -112.81 94.7 5.03 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.515 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 23.6 m -98.53 156.74 3.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.555 ' HG3' HG22 ' A' ' 592' ' ' VAL . 1.5 mp0 -101.56 155.31 18.16 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.066 0.46 . . . . 0.0 110.111 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.484 ' HA ' HD23 ' A' ' 616' ' ' LEU . 44.1 t -82.97 120.26 25.48 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 168.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.577 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 19.7 m-85 -100.59 167.55 10.28 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -54.59 -26.61 33.55 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.065 0.546 . . . . 0.0 112.432 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -108.53 8.21 27.15 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.885 0.374 . . . . 0.0 111.446 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 130.19 -177.73 18.02 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.915 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 611' ' ' CYS . 74.5 mt -69.96 130.05 41.14 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.577 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 70.8 m -146.07 144.51 21.87 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 617' ' ' SER . 53.2 Cg_endo -69.31 -173.82 8.48 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.592 -1.42 . . . . 0.0 112.74 0.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.45 152.14 35.25 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.336 0.588 . . . . 0.0 110.53 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.429 ' CD2' HG22 ' A' ' 574' ' ' ILE . 4.9 mp -71.94 142.26 85.21 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.983 -170.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.9 164.47 34.54 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.832 3.021 . . . . 0.0 113.624 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 622' ' ' ILE . . . . . 1.012 HG12 HG21 ' A' ' 604' ' ' VAL . 33.0 pt -104.97 -176.34 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.506 ' SG ' HD12 ' A' ' 578' ' ' LEU . 74.3 m -125.58 127.47 46.42 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 121.202 0.525 . . . . 0.0 109.701 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.63 ' HG2' ' CG1' ' A' ' 604' ' ' VAL . 12.7 mmmm -86.63 -59.03 2.39 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 1.9 tm-20 80.78 -54.84 0.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.939 1.696 . . . . 0.0 108.508 -172.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -98.73 118.8 36.27 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.328 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.677 HG11 HG21 ' A' ' 602' ' ' THR . 3.9 m -128.32 170.92 17.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.937 178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -88.01 178.04 6.77 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.163 0.506 . . . . 0.0 110.616 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.444 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 7.5 m -105.47 -14.38 15.33 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 11.9 m 72.7 -10.16 0.99 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.135 1.374 . . . . 0.0 113.185 169.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 59.55 -141.9 47.26 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.94 154.3 47.92 Favored 'Trans proline' 0 CA--C 1.549 1.254 0 C-N-CA 122.924 2.416 . . . . 0.0 111.901 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.598 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 92.7 Cg_endo -81.46 167.39 17.27 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 123.415 2.743 . . . . 0.0 111.855 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.15 -175.92 1.42 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.49 2.127 . . . . 0.0 110.741 174.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.64 161.43 14.87 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 657' ' ' TYR . 20.4 tp -85.16 128.84 34.82 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.518 HD21 HG12 ' A' ' 683' ' ' VAL . 1.7 pp -46.88 -37.2 8.47 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.809 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 90.8 m-20 -133.16 28.14 4.13 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.134 0.492 . . . . 0.0 109.683 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.21 -142.61 3.48 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -166.11 -179.31 5.07 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.399 0.679 . . . . 0.0 109.483 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.502 HG22 ' CE1' ' A' ' 657' ' ' TYR . 45.9 t -90.03 133.57 31.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 8.4 ptmm? -90.64 -16.03 29.38 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.548 0.69 . . . . 0.0 110.986 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -91.51 159.8 15.75 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -72.99 123.0 22.63 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.244 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 22.4 p -62.27 110.39 1.62 Allowed 'General case' 0 N--CA 1.411 -2.404 0 O-C-N 123.725 0.64 . . . . 0.0 109.547 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.408 ' HE2' ' CE2' ' A' ' 649' ' ' TYR . 43.8 mtmt -72.69 151.9 41.98 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.97 -14.51 59.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.92 0.867 . . . . 0.0 109.256 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -149.92 112.66 4.78 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.783 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.598 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.0 m-85 -89.83 -61.94 1.58 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 106.32 156.66 21.52 Favored Glycine 0 N--CA 1.421 -2.304 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.539 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.522 ' CD2' ' H ' ' A' ' 675' ' ' ASP . 55.7 t-80 -61.63 136.19 57.91 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 122.596 0.358 . . . . 0.0 110.321 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.5 m 70.82 14.59 6.99 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.334 1.053 . . . . 0.0 112.63 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.466 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 6.0 tp10 -94.93 121.31 36.4 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 174.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.653 HG21 ' HE2' ' A' ' 670' ' ' LYS . 1.4 p -88.47 160.18 2.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-O 121.156 0.503 . . . . 0.0 110.632 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -129.63 113.53 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.57 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 13.8 mt-10 -75.97 129.4 36.84 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.852 0.834 . . . . 0.0 111.261 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.607 ' HB3' HD22 ' A' ' 636' ' ' LEU . 95.4 m-85 -111.12 174.38 5.89 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.125 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -148.02 142.46 26.38 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.652 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 85.6 m -97.73 178.3 5.2 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.403 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 36.6 m-80 -71.62 154.55 93.11 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.38 38.24 0.48 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 124.246 3.298 . . . . 0.0 113.183 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.506 ' HG3' ' CE1' ' A' ' 663' ' ' PHE . 9.0 ptm180 -150.51 13.51 0.74 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.487 -175.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.506 ' CE1' ' HG3' ' A' ' 662' ' ' ARG . 85.2 m-85 -139.13 151.5 46.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.581 0.705 . . . . 0.0 110.772 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 81.1 mt -92.76 152.7 19.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.598 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 1.3 ttt -107.63 109.86 21.59 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.546 ' HB3' HG23 ' A' ' 683' ' ' VAL . 17.1 tppt? -71.57 -61.36 1.81 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.3 -172.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.67 -162.39 30.12 Favored Glycine 0 N--CA 1.431 -1.686 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.498 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.2 119.79 7.06 Favored 'Trans proline' 0 C--N 1.334 -0.198 0 C-N-CA 123.475 2.783 . . . . 0.0 112.407 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 4.4 p30 -64.29 -2.38 2.14 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.653 ' HE2' HG21 ' A' ' 654' ' ' VAL . 0.0 OUTLIER -140.22 143.61 36.1 Favored 'General case' 0 N--CA 1.407 -2.625 0 C-N-CA 122.746 0.419 . . . . 0.0 110.279 177.699 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 678' ' ' TRP . 34.0 pt -136.46 142.39 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.23 149.92 31.63 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 44.0 t -80.16 125.24 29.57 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-O 123.166 1.46 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.52 118.39 57.04 Favored 'Isoleucine or valine' 1 N--CA 1.377 -4.094 0 CA-C-N 111.72 -2.491 . . . . 0.0 109.206 -174.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 675' ' ' ASP . . . . . 0.522 ' H ' ' CD2' ' A' ' 651' ' ' HIS . 30.4 t70 63.46 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.938 1.295 . . . . 0.0 110.653 -172.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -161.03 27.99 0.3 Allowed Glycine 0 C--N 1.29 -1.977 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -138.5 146.48 42.04 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.563 ' HB3' HD12 ' A' ' 671' ' ' ILE . 95.6 m95 -87.18 160.58 18.45 Favored 'General case' 0 C--N 1.273 -2.749 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.93 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 679' ' ' THR . . . . . 0.529 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 19.2 p -83.52 -179.9 7.47 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 14.2 m -65.69 124.73 23.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.004 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.446 ' HA ' HG21 ' A' ' 671' ' ' ILE . 7.9 mp -64.05 161.92 35.27 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.557 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 23.6 Cg_endo -62.25 -16.79 53.3 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 123.795 2.997 . . . . 0.0 115.08 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 666' ' ' LYS 0.293 31.6 m 48.21 98.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 177.635 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.809 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.1 m -80.39 142.3 34.52 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.316 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 666' ' ' LYS . 0.2 OUTLIER -136.95 145.91 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.324 0 C-N-CA 123.765 0.826 . . . . 0.0 108.874 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 28.3 m -50.34 126.26 4.85 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.209 0 C-N-CA 125.473 1.509 . . . . 0.0 114.018 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 687' ' ' GLU . . . . . 0.438 ' HG2' HD21 ' A' ' 664' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.288 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 569' ' ' CYS . . . . . . . . . . . . . 76.8 m -85.96 166.63 15.77 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.204 0.526 . . . . 0.0 111.547 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -141.78 150.24 41.45 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.747 HD11 ' HG3' ' A' ' 580' ' ' PRO . 1.0 OUTLIER -73.9 119.17 74.8 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.504 ' HD3' HD12 ' A' ' 616' ' ' LEU . 72.4 Cg_endo -76.07 -162.48 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.658 2.239 . . . . 0.0 111.064 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -87.25 107.4 18.47 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 121.91 -0.494 . . . . 0.0 110.092 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.498 HG22 HD23 ' A' ' 620' ' ' LEU . 28.1 pt -70.71 -169.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.346 176.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 10.9 t70 -77.43 152.94 34.06 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.01 -29.94 42.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.282 0.563 . . . . 0.0 110.232 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -103.35 15.3 29.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.577 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.2 OUTLIER -97.63 157.93 15.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 4.9 p -158.62 110.22 1.64 Allowed Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.336 0.654 . . . . 0.0 110.171 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.747 ' HG3' HD11 ' A' ' 571' ' ' LEU . 59.4 Cg_endo -72.08 148.29 50.31 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.392 2.728 . . . . 0.0 113.206 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.41 -45.0 27.25 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -75.39 109.37 8.87 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 173.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 583' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 583' ' ' LYS . 35.2 ttmt -121.6 98.02 5.77 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -146.9 177.82 8.82 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -86.73 -55.73 3.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.705 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -116.09 142.55 46.66 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.58 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 27.1 m-85 -110.88 124.57 52.33 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.551 -174.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -62.56 143.41 57.26 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.266 0.978 . . . . 0.0 108.843 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.748 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 3.4 p -61.71 119.58 6.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-O 121.858 0.837 . . . . 0.0 109.998 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 107.21 -10.3 39.67 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.254 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.47 123.35 23.73 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 3.6 p -102.48 129.19 54.39 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 CA-C-O 121.863 0.84 . . . . 0.0 111.383 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.58 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 4.3 mp -96.98 101.87 13.54 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.432 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 594' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -81.11 103.31 10.83 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.721 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 578' ' ' LEU . 74.0 m-85 -90.1 176.22 6.86 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 122.836 0.455 . . . . 0.0 111.456 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 596' ' ' SER . . . . . 0.505 ' HA ' HD12 ' A' ' 603' ' ' ILE . 33.0 t -177.55 157.99 1.33 Allowed 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 168.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.469 ' SG ' HD22 ' A' ' 578' ' ' LEU . 97.4 m -86.67 177.95 7.19 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.989 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.52 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 72.9 mmtt -57.3 163.12 3.56 Favored Pre-proline 0 N--CA 1.434 -1.265 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.406 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 68.8 Cg_exo -49.31 -45.2 31.16 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.074 3.183 . . . . 0.0 114.129 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -84.03 -3.88 88.81 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.021 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 51.0 m-85 -107.7 154.07 22.01 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.6 0.714 . . . . 0.0 112.101 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 26.2 m -106.26 130.84 54.04 Favored 'General case' 0 N--CA 1.403 -2.809 0 CA-C-N 114.108 -1.406 . . . . 0.0 108.928 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.541 HD11 ' HG3' ' A' ' 621' ' ' PRO . 6.9 tt -80.17 122.68 35.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.428 HG21 ' HG3' ' A' ' 624' ' ' LYS . 92.2 t -119.62 113.88 42.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.173 0.511 . . . . 0.0 109.922 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 131.39 -164.69 23.4 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.06 112.71 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.713 2.275 . . . . 0.0 111.32 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.58 -40.53 29.19 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.126 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.464 ' HB2' HG21 ' A' ' 592' ' ' VAL . 31.3 p -114.23 99.45 7.61 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.661 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 11.3 m -98.98 138.69 22.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 592' ' ' VAL . 2.5 pm0 -110.18 153.24 25.03 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.954 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.748 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 42.8 t -67.93 120.29 13.97 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.347 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.557 ' HE1' ' CG ' ' A' ' 610' ' ' GLN . 12.9 m-30 -105.68 167.53 9.7 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -67.79 1.55 2.48 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -123.32 -0.26 8.82 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.943 0.402 . . . . 0.0 111.325 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.71 173.7 13.38 Favored Glycine 0 C--N 1.311 -0.851 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.797 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 611' ' ' CYS . 30.6 mt -63.0 121.59 13.95 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.48 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 50.0 m -145.06 150.31 45.14 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 617' ' ' SER . 42.5 Cg_endo -70.06 -164.28 2.58 Favored 'Cis proline' 0 CA--C 1.551 1.36 0 C-N-CA 124.615 -0.994 . . . . 0.0 114.599 0.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.16 165.88 24.19 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 122.118 -0.364 . . . . 0.0 111.081 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.498 HD23 HG22 ' A' ' 574' ' ' ILE . 5.6 mp -76.67 139.5 66.94 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.541 ' HG3' HD11 ' A' ' 603' ' ' ILE . 73.7 Cg_endo -71.29 167.2 26.91 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 124.157 3.238 . . . . 0.0 112.372 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 46.7 pt -107.84 174.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.44 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.473 ' SG ' HD22 ' A' ' 578' ' ' LEU . 88.5 m -116.67 123.27 46.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.156 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 602' ' ' THR . 9.0 mmmm -118.81 108.6 15.04 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.207 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.458 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 2.8 tm-20 -73.42 -38.61 65.51 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -100.48 87.03 3.28 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.43 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 7.5 p -95.43 158.68 2.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.079 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -88.33 156.69 19.03 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.962 0.411 . . . . 0.0 110.883 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.598 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 15.0 p -90.58 -12.36 37.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.014 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 630' ' ' CYS . . . . . 0.5 ' SG ' ' HA2' ' A' ' 676' ' ' GLY . 13.8 m 70.54 7.82 6.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.757 0.823 . . . . 0.0 112.438 172.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 55.64 -140.18 41.17 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.495 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -82.5 151.56 15.25 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 122.435 2.09 . . . . 0.0 110.2 171.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.647 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 96.3 Cg_endo -78.81 172.42 15.07 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 123.129 2.552 . . . . 0.0 111.525 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.08 -162.95 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.438 2.092 . . . . 0.0 112.132 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -113.89 150.02 34.27 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.812 HD21 ' SG ' ' A' ' 684' ' ' CYS . 15.1 tp -78.72 159.54 27.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.528 HD11 ' HA ' ' A' ' 683' ' ' VAL 0.433 0.4 OUTLIER -73.45 -48.07 36.51 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 176.943 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 22.0 m120 -123.08 36.65 4.6 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.462 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.739 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -163.49 -141.28 3.08 Favored Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -165.26 -170.46 1.89 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 655' ' ' VAL . 48.5 t -89.23 127.84 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 175.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -83.7 -26.06 30.11 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.55 0.69 . . . . 0.0 109.334 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -74.74 171.43 13.94 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -89.38 130.67 35.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 16.2 p -82.35 104.05 12.37 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.613 0.72 . . . . 0.0 112.119 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.564 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 47.0 pttt -89.94 153.88 20.27 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.34 34.76 1.39 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 121.947 0.88 . . . . 0.0 110.729 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -169.49 92.93 0.26 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.494 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.647 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 11.0 m-85 -85.77 -73.76 0.44 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 121.13 167.28 13.22 Favored Glycine 0 C--N 1.291 -1.945 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -177.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.446 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 75.1 t60 -72.0 136.49 46.75 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.799 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 62.7 m 71.32 10.84 6.71 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.516 0.727 . . . . 0.0 112.438 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.42 118.0 27.74 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 174.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.543 HG11 ' HE2' ' A' ' 670' ' ' LYS . 1.3 p -91.67 154.46 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.713 0 CA-C-O 122.5 1.143 . . . . 0.0 111.26 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.556 HG21 ' HB3' ' A' ' 633' ' ' PRO . 3.8 t -117.48 101.24 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.995 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.592 ' HG3' ' HG2' ' A' ' 670' ' ' LYS . 5.8 tt0 -77.09 120.42 22.16 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 60.4 m-85 -99.05 167.31 10.8 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.179 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.481 ' O ' ' HA3' ' A' ' 639' ' ' GLY . 5.5 p90 -145.08 143.9 30.67 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 173.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.762 ' SG ' HD21 ' A' ' 636' ' ' LEU . 59.5 m -103.55 170.28 8.04 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -64.06 152.42 87.72 Favored Pre-proline 0 C--N 1.317 -0.829 0 O-C-N 123.125 0.266 . . . . 0.0 110.715 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.19 40.11 0.43 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 124.828 3.685 . . . . 0.0 113.393 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 7.6 ptt85 -150.0 10.72 0.71 Allowed 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.537 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.96 158.17 45.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.921 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.491 ' HG ' ' HG2' ' A' ' 687' ' ' GLU . 90.0 mt -100.93 157.29 16.85 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.479 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 3.5 ttt -114.83 102.44 9.99 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.506 ' HE2' HG23 ' A' ' 683' ' ' VAL . 37.6 ttpt -69.9 -53.22 18.93 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.309 -0.859 . . . . 0.0 113.103 -170.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.42 -170.3 31.79 Favored Glycine 0 C--N 1.293 -1.819 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.036 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.73 122.08 11.1 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.979 3.12 . . . . 0.0 110.858 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.876 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 7.9 p-10 -68.46 -20.0 64.6 Favored 'General case' 0 CA--C 1.469 -2.169 0 CA-C-O 121.533 0.682 . . . . 0.0 111.066 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.592 ' HG2' ' HG3' ' A' ' 656' ' ' GLU . 3.4 mtpt -111.71 157.29 20.67 Favored 'General case' 0 C--N 1.253 -3.615 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -173.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.613 HG21 HD23 ' A' ' 681' ' ' LEU . 48.1 pt -139.75 125.43 21.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.44 144.25 33.39 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 28.7 t -81.61 128.95 34.47 Favored 'General case' 0 CA--C 1.465 -2.314 0 CA-C-O 123.142 1.449 . . . . 0.0 111.835 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.4 t -105.33 107.3 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.807 0 CA-C-N 111.263 -2.699 . . . . 0.0 107.655 -175.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 675' ' ' ASP . . . . . 0.541 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 26.6 t70 55.6 -75.15 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.008 1.723 . . . . 0.0 112.98 -169.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 676' ' ' GLY . . . . . 0.5 ' HA2' ' SG ' ' A' ' 630' ' ' CYS . . . -149.15 18.54 1.19 Allowed Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -129.61 139.26 51.49 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.546 ' HB3' HD12 ' A' ' 671' ' ' ILE . 92.0 m95 -85.71 164.73 17.46 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.472 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 6.3 p -82.43 -178.54 7.09 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.05 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 44.2 m -71.68 135.81 47.01 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.254 0.55 . . . . 0.0 110.731 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.613 HD23 HG21 ' A' ' 671' ' ' ILE . 47.5 mt -66.08 153.07 92.71 Favored Pre-proline 0 N--CA 1.425 -1.699 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.237 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.876 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 12.3 Cg_endo -55.49 -20.17 25.62 Favored 'Trans proline' 0 N--CA 1.482 0.802 0 C-N-CA 124.637 3.558 . . . . 0.0 115.972 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.528 ' HA ' HD11 ' A' ' 637' ' ' LEU 0.302 16.4 m 46.11 98.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 N-CA-C 115.664 1.728 . . . . 0.0 115.664 177.754 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.812 ' SG ' HD21 ' A' ' 636' ' ' LEU . 1.7 m -83.28 147.96 27.66 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.975 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.479 ' CD1' ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -138.49 146.97 25.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.243 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 32.0 t -58.56 134.77 23.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 123.828 0.705 . . . . 0.0 109.87 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 687' ' ' GLU . . . . . 0.491 ' HG2' ' HG ' ' A' ' 664' ' ' LEU . 45.0 mt-10 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.21 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 . . . . . 0 N--CA 1.428 -1.531 0 CA-C-O 121.149 0.499 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 2.6 m -63.72 -55.78 20.64 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 124.786 1.234 . . . . 0.0 111.734 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 61.41 -168.62 0.18 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.064 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.5 HD11 ' HG3' ' A' ' 580' ' ' PRO . 3.5 tt -118.61 118.96 33.17 Favored Pre-proline 0 C--N 1.28 -2.447 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.616 ' HG2' HD21 ' A' ' 620' ' ' LEU . 90.3 Cg_endo -75.41 -165.71 0.31 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.466 2.777 . . . . 0.0 112.335 -177.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.23 108.05 15.38 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.196 0.522 . . . . 0.0 110.382 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.648 HG22 HD23 ' A' ' 620' ' ' LEU . 36.2 pt -78.14 -167.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.319 175.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.95 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 10.2 t70 -81.54 162.09 23.32 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.09 -22.58 18.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.473 0.654 . . . . 0.0 110.516 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -106.63 11.83 30.0 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 121.768 -0.582 . . . . 0.0 110.98 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.95 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.5 tm? -99.13 153.48 18.86 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.485 ' N ' HD13 ' A' ' 578' ' ' LEU . 5.8 p -149.91 113.33 3.38 Favored Pre-proline 0 C--N 1.288 -2.079 0 C-N-CA 124.184 0.994 . . . . 0.0 108.454 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.597 ' HD3' HD13 ' A' ' 574' ' ' ILE . 59.1 Cg_endo -73.82 146.14 37.46 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.509 2.139 . . . . 0.0 112.43 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -77.38 -36.78 53.22 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 582' ' ' ARG . . . . . 0.433 ' HB3' ' HE2' ' A' ' 587' ' ' TYR . 25.3 mmt180 -79.63 132.55 36.28 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 171.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -143.51 89.94 2.12 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.69 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 587' ' ' TYR . 11.1 ptpt -137.71 170.21 16.46 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -77.41 -56.8 4.24 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 14.8 mp0 -120.64 126.43 50.22 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.925 0.393 . . . . 0.0 110.725 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.73 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 19.3 m-85 -90.35 155.53 18.9 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.814 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -93.7 147.41 23.05 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.65 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 5.6 p -66.45 131.16 32.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.852 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 87.42 -1.95 86.22 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.211 -173.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -69.28 135.58 50.67 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 609' ' ' VAL . 11.3 m -98.59 138.91 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.563 HD11 ' CD2' ' A' ' 587' ' ' TYR . 7.1 mp -117.16 111.05 18.93 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.229 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.614 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 92.0 mttt -84.74 122.21 28.78 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.857 ' HB3' HD11 ' A' ' 578' ' ' LEU . 68.7 m-85 -108.08 172.2 6.97 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 596' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 603' ' ' ILE . 14.2 p -171.21 177.41 3.62 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 76.8 m -110.97 177.79 4.55 Favored 'General case' 0 C--N 1.26 -3.293 0 O-C-N 123.739 0.649 . . . . 0.0 110.712 -176.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 598' ' ' LYS . 71.6 mmtt -53.48 160.83 1.7 Allowed Pre-proline 0 N--CA 1.438 -1.034 0 C-N-CA 124.463 1.105 . . . . 0.0 112.564 176.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 51.4 Cg_exo -52.05 -28.11 31.36 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 124.414 3.409 . . . . 0.0 114.575 -175.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -99.61 -4.31 55.98 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.883 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -106.51 159.13 16.4 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 122.328 1.061 . . . . 0.0 113.414 -174.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.614 HG21 HG11 ' A' ' 627' ' ' VAL . 6.2 m -109.25 129.57 55.5 Favored 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.861 174.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.537 HD11 ' HG3' ' A' ' 621' ' ' PRO . 6.4 tt -81.46 119.14 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.363 174.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.737 HG21 ' HD3' ' A' ' 624' ' ' LYS . 62.0 t -109.97 127.51 66.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.06 -159.66 14.14 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.8 115.33 3.71 Favored 'Trans proline' 0 C--N 1.333 -0.278 0 C-N-CA 122.958 2.439 . . . . 0.0 110.69 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 7.5 m120 -84.3 -26.29 28.65 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.355 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.614 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 27.1 p -127.09 95.59 4.34 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.532 0.682 . . . . 0.0 111.087 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 609' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 592' ' ' VAL . 21.5 m -89.42 169.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.485 -0.779 . . . . 0.0 108.997 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.407 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 6.0 mm100 -114.72 163.8 14.97 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 18.7 t -85.05 131.39 34.46 Favored 'General case' 0 C--N 1.276 -2.608 0 C-N-CA 117.808 -1.557 . . . . 0.0 108.223 165.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 7.5 m-85 -109.16 163.0 13.74 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 173.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -68.17 -1.68 6.53 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -117.48 4.47 12.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 120.879 0.371 . . . . 0.0 110.333 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 135.69 -177.45 19.46 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 572' ' ' PRO . 28.4 mt -73.79 133.51 43.26 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.481 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 68.1 m -150.16 154.39 36.41 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.61 -168.78 5.04 Favored 'Cis proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.043 -1.232 . . . . 0.0 113.214 0.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.76 146.69 35.93 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.091 0.472 . . . . 0.0 111.864 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.648 HD23 HG22 ' A' ' 574' ' ' ILE . 6.7 mp -65.14 142.26 98.53 Favored Pre-proline 0 C--N 1.302 -1.47 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.889 -175.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.537 ' HG3' HD11 ' A' ' 603' ' ' ILE . 28.1 Cg_endo -63.9 169.01 10.99 Favored 'Trans proline' 0 C--O 1.252 1.182 0 C-N-CA 124.124 3.216 . . . . 0.0 113.667 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 622' ' ' ILE . . . . . 0.445 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 36.5 pt -114.94 178.91 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.969 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 95.3 m -127.96 124.94 38.52 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.023 0.44 . . . . 0.0 111.267 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.737 ' HD3' HG21 ' A' ' 604' ' ' VAL . 57.9 mtpt -124.41 130.33 52.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -88.54 -37.87 15.37 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -99.82 101.25 12.34 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.803 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.614 HG11 HG21 ' A' ' 602' ' ' THR . 2.7 m -102.03 178.39 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.088 174.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 628' ' ' GLN . . . . . 0.612 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 76.2 mt-30 -94.55 170.64 9.33 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.559 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 41.6 m -102.93 -8.15 20.92 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.039 0.447 . . . . 0.0 110.649 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 81.7 m 67.36 5.78 4.47 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 54.2 -137.22 41.58 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 123.474 0.484 . . . . 0.0 112.947 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.58 147.01 17.36 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.649 2.233 . . . . 0.0 112.055 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.536 ' HB3' HG21 ' A' ' 655' ' ' VAL . 31.7 Cg_endo -67.32 156.51 65.9 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.118 2.545 . . . . 0.0 112.591 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.501 ' HG2' HD11 ' A' ' 681' ' ' LEU . 38.3 Cg_endo -69.24 175.36 7.77 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 123.324 2.683 . . . . 0.0 112.522 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.86 145.71 26.48 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 657' ' ' TYR . 14.5 tp -80.59 178.33 8.42 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 637' ' ' LEU . 2.4 mp -84.58 -73.03 0.44 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.821 0.819 . . . . 0.0 108.841 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -108.02 32.71 4.56 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.667 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -156.29 -156.79 7.99 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.798 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -156.08 -172.72 4.21 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 123.685 0.794 . . . . 0.0 109.976 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.485 HG22 ' CE1' ' A' ' 657' ' ' TYR . 53.5 t -93.69 137.87 21.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.659 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 20.1 ptmt -87.22 -22.63 25.12 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.088 0.47 . . . . 0.0 110.904 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.22 146.92 28.31 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -67.75 122.39 18.0 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 22.4 p -73.69 98.09 2.82 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.228 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -83.81 165.33 18.9 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.5 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.4 6.82 35.59 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -171.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -156.24 105.9 2.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -96.19 -82.25 0.4 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 130.77 159.62 9.68 Favored Glycine 0 C--N 1.311 -0.84 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.887 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.678 ' ND1' ' HA ' ' A' ' 674' ' ' VAL . 80.6 t60 -77.14 86.43 3.61 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 652' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 651' ' ' HIS . 22.9 t 155.08 -31.19 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 126.941 2.097 . . . . 0.0 106.101 173.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -68.05 118.24 10.95 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.911 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 671' ' ' ILE . 1.1 p -94.74 163.39 2.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.739 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 16.6 m -128.82 115.58 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.442 175.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.659 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 14.7 mt-10 -73.26 126.12 29.37 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.56 0.695 . . . . 0.0 111.111 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.665 ' HB3' HD22 ' A' ' 636' ' ' LEU . 81.4 m-85 -102.12 164.74 11.53 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.022 176.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -148.67 135.63 19.97 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.667 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 50.4 m -99.09 165.75 11.58 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.428 172.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 50.1 m-80 -58.3 155.01 28.98 Favored Pre-proline 0 C--O 1.248 1.021 0 O-C-N 123.677 0.611 . . . . 0.0 109.904 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 59.8 Cg_endo -68.03 24.76 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 124.113 3.209 . . . . 0.0 115.529 -172.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.463 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 24.8 mmm180 -118.11 -4.26 11.02 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 662' ' ' ARG . 51.0 m-85 -128.95 159.76 34.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.723 -170.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 687' ' ' GLU . 81.8 mt -124.38 153.78 41.36 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 125.145 1.378 . . . . 0.0 107.442 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.558 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -84.27 147.17 27.38 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.125 0.488 . . . . 0.0 111.2 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -95.09 -59.44 1.9 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.214 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.5 -158.11 29.76 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.575 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.78 123.64 10.96 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.978 2.452 . . . . 0.0 111.655 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 12.1 p-10 -64.04 -17.38 63.31 Favored 'General case' 0 C--O 1.207 -1.17 0 C-N-CA 122.902 0.481 . . . . 0.0 111.744 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 1.4 mtpt -122.28 154.4 37.62 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.57 HD12 ' HB3' ' A' ' 678' ' ' TRP . 29.9 pt -143.92 142.73 24.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.81 153.08 28.4 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.041 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 3.9 t -68.14 121.06 15.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.015 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 674' ' ' VAL . . . . . 0.678 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 35.1 m -113.03 113.26 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.55 0.691 . . . . 0.0 111.559 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 32.7 t70 64.87 -73.89 0.05 Allowed 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 124.56 1.144 . . . . 0.0 111.375 -175.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 676' ' ' GLY . . . . . 0.612 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -152.56 16.21 0.74 Allowed Glycine 0 N--CA 1.422 -2.297 0 C-N-CA 120.392 -0.908 . . . . 0.0 112.456 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.01 158.08 44.63 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.57 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.9 m95 -81.71 177.03 9.14 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 120.892 0.377 . . . . 0.0 110.167 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.98 -179.44 3.95 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.863 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 5.7 m -57.72 120.16 7.9 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.897 0.879 . . . . 0.0 110.915 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.535 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 4.4 mp -64.15 154.26 83.02 Favored Pre-proline 0 N--CA 1.445 -0.719 0 O-C-N 123.761 0.663 . . . . 0.0 112.592 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.558 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 7.5 Cg_endo -55.04 -50.12 14.26 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.206 2.604 . . . . 0.0 113.516 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 92.8 t 68.97 130.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.505 0.722 . . . . 0.0 110.118 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 7.3 p -125.05 154.89 40.63 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.676 -0.64 . . . . 0.0 112.448 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 685' ' ' ILE . 0.2 OUTLIER -139.04 150.58 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.214 0 C-N-CA 125.317 1.447 . . . . 0.0 108.512 -177.775 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.24 139.25 17.06 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.911 0 C-N-CA 124.76 1.224 . . . . 0.0 112.472 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 687' ' ' GLU . . . . . 0.51 ' HG3' HD11 ' A' ' 664' ' ' LEU . 45.8 tt0 . . . . . 0 N--CA 1.438 -1.056 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.153 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.764 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 75.9 m -96.61 150.02 21.13 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.657 0.741 . . . . 0.0 112.685 -174.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -124.25 -4.75 7.86 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.073 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.547 HD23 ' HD2' ' A' ' 572' ' ' PRO . 0.9 OUTLIER 77.97 121.22 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 126.006 1.723 . . . . 0.0 107.438 -178.074 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.614 ' HD3' HD23 ' A' ' 616' ' ' LEU . 56.8 Cg_endo -69.97 -174.65 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.909 1.74 . . . . 0.0 110.931 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 573' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 573' ' ' LYS . 0.3 OUTLIER -89.5 104.23 16.81 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.679 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 578' ' ' LEU . 42.0 pt -76.08 -176.57 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.988 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.293 -177.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.6 t70 -72.97 151.94 41.6 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.72 -35.66 68.88 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.363 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -93.54 8.08 42.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.705 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.8 tp -95.89 149.97 20.96 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.03 117.59 9.09 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-O 121.387 0.613 . . . . 0.0 110.41 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.42 131.19 13.55 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.203 1.935 . . . . 0.0 111.053 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.56 -29.84 71.04 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.286 0.565 . . . . 0.0 111.447 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 582' ' ' ARG . . . . . 0.452 ' HG3' HD22 ' A' ' 593' ' ' LEU . 4.5 mmp_? -72.8 -70.95 0.32 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 176.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm 60.47 84.58 0.12 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.416 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.6 ptpt -142.03 174.34 10.69 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.25 -66.16 0.91 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -105.34 141.04 37.55 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.764 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 67.0 m-85 -115.12 125.63 53.69 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.138 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -71.02 144.04 50.55 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.302 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.637 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 32.6 m -63.4 134.66 28.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.576 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 102.0 -18.62 51.76 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.117 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.95 108.84 3.19 Favored 'General case' 0 C--N 1.346 0.451 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 3.4 p -92.47 125.09 45.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.721 0.772 . . . . 0.0 110.199 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 587' ' ' TYR . 11.1 mt -102.88 105.05 15.34 Favored 'General case' 0 N--CA 1.402 -2.856 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.882 -172.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.535 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 54.7 mtpt -75.06 112.61 11.47 Favored 'General case' 0 N--CA 1.41 -2.425 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -94.36 174.13 7.29 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-O 121.813 0.816 . . . . 0.0 109.548 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 20.1 t -162.32 -178.83 6.56 Favored 'General case' 0 N--CA 1.391 -3.414 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.556 ' SG ' HD12 ' A' ' 578' ' ' LEU . 92.3 m -118.1 -179.12 3.67 Favored 'General case' 0 C--N 1.257 -3.452 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -51.01 162.58 0.58 Allowed Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 124.773 1.229 . . . . 0.0 111.639 174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.2 -45.82 24.66 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.923 3.082 . . . . 0.0 113.403 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -89.76 5.03 83.73 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.424 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.64 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 35.4 m-85 -109.57 133.93 52.52 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 45.5 m -89.04 127.92 35.71 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.5 175.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.505 HD11 ' HG3' ' A' ' 621' ' ' PRO . 8.9 tt -84.65 132.89 30.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.834 HG21 ' HD3' ' A' ' 624' ' ' LYS . 90.9 t -129.7 135.43 61.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 114.67 -161.25 12.81 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.96 116.31 4.52 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.003 1.802 . . . . 0.0 109.886 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -83.34 -39.22 21.02 Favored 'General case' 0 C--O 1.206 -1.208 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -176.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.535 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 8.6 p -112.27 98.0 7.01 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.44 0.638 . . . . 0.0 111.96 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.5 m -99.57 145.6 10.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 592' ' ' VAL . 2.6 mp0 -96.46 149.24 21.95 Favored 'General case' 0 CA--C 1.472 -2.024 0 O-C-N 121.866 -0.522 . . . . 0.0 110.415 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 45.4 t -73.3 122.28 21.74 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.37 168.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.596 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 75.9 m-85 -110.98 162.7 14.58 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 171.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -65.16 -2.25 2.77 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -115.52 1.54 13.64 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.537 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.4 169.73 12.35 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.202 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.614 HD23 ' HD3' ' A' ' 572' ' ' PRO . 3.3 mm? -66.42 118.95 10.79 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.596 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 17.4 m -131.77 144.36 52.94 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 618' ' ' PRO . . . . . 0.418 ' C ' ' HA ' ' A' ' 617' ' ' SER . 56.6 Cg_endo -69.77 -165.13 2.8 Favored 'Cis proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.885 -1.298 . . . . 0.0 113.139 -0.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.12 172.79 11.75 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.194 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.522 HD13 HG22 ' A' ' 574' ' ' ILE . 50.8 mt -69.64 148.43 96.78 Favored Pre-proline 0 C--N 1.297 -1.709 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.333 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.505 ' HG3' HD11 ' A' ' 603' ' ' ILE . 72.9 Cg_endo -75.42 -177.85 3.84 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 124.176 3.251 . . . . 0.0 111.362 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.42 166.44 18.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.012 0.434 . . . . 0.0 110.933 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.423 ' HB3' ' CD2' ' A' ' 601' ' ' PHE . 85.7 m -110.64 116.06 30.67 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.376 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.834 ' HD3' HG21 ' A' ' 604' ' ' VAL . 21.0 mtpp -97.03 -22.17 16.96 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 13.6 tt0 68.4 -70.16 0.14 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.178 0.991 . . . . 0.0 108.951 -174.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -103.88 114.51 28.81 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.644 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 7.7 p -111.45 175.25 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 628' ' ' GLN . . . . . 0.451 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 48.9 mt-30 -84.21 166.64 17.38 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 119.778 1.172 . . . . 0.0 109.311 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.613 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 5.2 p -106.54 -16.95 14.39 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.157 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 71.8 m 70.0 8.55 6.74 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.314 1.046 . . . . 0.0 112.799 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 54.02 -143.84 28.74 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 123.694 0.621 . . . . 0.0 113.093 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.5 148.59 42.87 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.515 2.143 . . . . 0.0 111.215 173.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.555 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 88.1 Cg_endo -82.67 165.1 15.98 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 123.047 2.498 . . . . 0.0 112.442 -178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.16 178.69 4.56 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.952 2.435 . . . . 0.0 111.426 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.92 163.83 12.04 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.636 HD22 ' HB3' ' A' ' 657' ' ' TYR . 17.5 tp -92.52 134.07 35.32 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.575 ' H ' HD12 ' A' ' 637' ' ' LEU . 0.4 OUTLIER -44.54 -61.13 1.66 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.575 1.15 . . . . 0.0 111.349 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.511 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 43.7 m-80 -122.63 31.19 6.18 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-O 121.316 0.579 . . . . 0.0 110.819 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.561 ' C ' ' HB3' ' A' ' 636' ' ' LEU . . . -150.48 -158.28 8.17 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 174.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -154.43 175.07 14.03 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 117.496 0.648 . . . . 0.0 109.87 178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 655' ' ' VAL . 64.3 t -84.44 128.94 38.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.792 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.5 ptmt -84.81 -20.4 30.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.034 0.921 . . . . 0.0 109.643 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' A' ' 642' ' ' LYS . 48.0 mm-40 -91.25 163.49 14.22 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.806 -177.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -73.9 125.71 28.81 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.182 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.425 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 16.0 p -81.72 114.63 20.5 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-O 121.857 0.837 . . . . 0.0 111.455 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 49.9 mtmt -85.09 161.23 19.77 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -99.67 9.56 42.91 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.065 0.936 . . . . 0.0 109.586 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -157.47 96.97 1.58 Allowed 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 113.956 -1.475 . . . . 0.0 107.696 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.555 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 14.4 m-85 -86.63 -76.77 0.34 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.838 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 115.44 169.01 15.65 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.236 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.579 ' HB2' HG11 ' A' ' 627' ' ' VAL . 75.8 t60 -71.33 148.05 47.45 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.311 10.4 p 65.78 2.73 2.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.057 1.343 . . . . 0.0 113.831 -174.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -93.84 112.95 24.88 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.554 HG11 ' CE ' ' A' ' 670' ' ' LYS . 2.5 p -99.16 159.67 3.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-O 121.576 0.703 . . . . 0.0 109.552 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.0 t -121.01 106.97 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.67 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.348 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.792 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 18.4 mt-10 -68.67 124.84 24.74 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.461 0.648 . . . . 0.0 110.457 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.636 ' HB3' HD22 ' A' ' 636' ' ' LEU . 68.2 m-85 -108.92 172.03 7.09 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -150.07 140.72 22.59 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.57 ' SG ' HD21 ' A' ' 636' ' ' LEU . 80.7 m -100.01 163.84 12.26 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 47.4 m-80 -65.3 157.39 77.77 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.401 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 74.2 Cg_endo -71.84 15.6 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 123.931 3.087 . . . . 0.0 113.466 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -108.34 -3.97 17.85 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -134.15 156.33 48.52 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.289 -173.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 687' ' ' GLU . 72.1 mt -98.95 165.58 11.69 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 172.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.5 ttt -119.52 115.14 23.41 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.413 ' HB2' HD12 ' A' ' 685' ' ' ILE . 37.5 ttmt -71.39 -67.85 0.49 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -171.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.76 -161.46 37.49 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 115.551 -0.749 . . . . 0.0 113.18 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.39 123.09 11.81 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.036 2.491 . . . . 0.0 111.133 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 10.4 p-10 -61.48 -16.48 47.59 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 123.263 0.625 . . . . 0.0 111.891 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.62 ' HG2' ' CG ' ' A' ' 656' ' ' GLU . 13.2 mtpt -121.93 153.78 38.02 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 34.9 pt -138.01 144.44 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 17.8 pm0 -122.55 151.59 41.24 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.268 -176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 6.8 t -77.3 108.47 10.45 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.042 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 674' ' ' VAL . . . . . 0.442 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 35.9 m -102.7 107.9 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.576 0.703 . . . . 0.0 111.569 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 675' ' ' ASP . . . . . 0.644 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 7.4 t70 68.98 -62.62 0.39 Allowed 'General case' 0 C--O 1.216 -0.67 0 C-N-CA 124.913 1.285 . . . . 0.0 113.057 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 676' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -164.12 18.9 0.12 Allowed Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 174.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -138.13 144.04 40.63 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.401 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.3 m95 -75.92 158.03 32.5 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 13.5 p -77.52 174.26 11.07 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.964 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.7 m -65.03 131.85 47.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.215 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.559 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 5.0 mp -63.74 150.38 90.97 Favored Pre-proline 0 N--CA 1.435 -1.194 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.138 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.559 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 10.4 Cg_endo -56.22 -43.23 58.13 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 123.573 2.849 . . . . 0.0 113.368 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 81.5 t 66.08 121.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 122.639 1.209 . . . . 0.0 113.341 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.2 m -93.82 145.13 24.82 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.32 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -138.46 145.28 28.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.222 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.16 132.98 25.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 O-C-N 123.288 0.367 . . . . 0.0 110.951 -174.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 687' ' ' GLU . . . . . 0.519 ' HG3' HD21 ' A' ' 664' ' ' LEU . 38.5 tt0 . . . . . 0 C--O 1.249 1.039 0 O-C-N 124.035 0.834 . . . . 0.0 109.914 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 569' ' ' CYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 68.3 m -96.36 121.94 38.7 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.198 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -99.67 140.19 34.23 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 571' ' ' LEU . . . . . 0.838 HD11 ' HG3' ' A' ' 580' ' ' PRO . 3.2 tt -58.21 112.48 4.94 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 572' ' ' PRO . . . . . 0.532 ' HD3' HD23 ' A' ' 616' ' ' LEU . 93.3 Cg_endo -83.94 -158.57 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.527 2.818 . . . . 0.0 112.72 -175.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.8 91.95 6.58 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 574' ' ' ILE . . . . . 0.739 HG13 ' H ' ' A' ' 575' ' ' ASP . 6.5 pt -72.47 -88.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.827 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.825 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 17.6 t70 -160.26 173.37 15.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 173.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.87 -29.36 8.34 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-O 121.29 0.566 . . . . 0.0 109.543 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -98.94 3.57 47.13 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.461 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.9 tm? -96.0 147.42 23.71 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -177.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.47 ' N ' HD13 ' A' ' 578' ' ' LEU . 6.1 t -139.55 121.21 9.85 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 580' ' ' PRO . . . . . 0.838 ' HG3' HD11 ' A' ' 571' ' ' LEU . 60.4 Cg_endo -73.86 140.89 29.52 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.369 2.046 . . . . 0.0 112.173 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.57 -38.33 86.84 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 125.525 1.53 . . . . 0.0 110.687 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -75.97 -66.8 0.74 Allowed 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.63 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 583' ' ' LYS . . . . . 0.454 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 38.8 ttpt 57.52 78.23 0.24 Allowed 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.01 -178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.501 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 18.1 ptpt -132.87 175.47 9.32 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.304 -1.316 . . . . 0.0 107.773 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -76.86 -57.53 3.8 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -122.74 142.05 51.13 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 587' ' ' TYR . . . . . 0.608 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 94.8 m-85 -112.12 126.7 55.47 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -70.21 142.4 52.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.691 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 2.1 p -60.06 116.0 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-O 121.951 0.881 . . . . 0.0 111.329 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 121.29 -22.21 7.97 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.173 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -58.42 139.8 54.84 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.765 0.426 . . . . 0.0 110.416 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 592' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 610' ' ' GLN . 2.1 m -111.6 136.33 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 593' ' ' LEU . . . . . 0.581 ' HG ' ' CE2' ' A' ' 587' ' ' TYR 0.338 0.0 OUTLIER -130.78 113.54 14.23 Favored 'General case' 0 N--CA 1.396 -3.172 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.228 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 594' ' ' LYS . . . . . 0.683 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 64.9 mttm -76.46 147.91 37.57 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.55 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 595' ' ' PHE . . . . . 0.767 ' HB3' HD11 ' A' ' 578' ' ' LEU . 24.8 m-85 -121.61 166.39 14.3 Favored 'General case' 0 C--N 1.261 -3.277 0 C-N-CA 123.822 0.849 . . . . 0.0 110.1 177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 9.5 t -173.59 154.25 2.47 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 170.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 597' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 73.8 m -88.37 176.59 7.13 Favored 'General case' 0 C--N 1.259 -3.352 0 O-C-N 123.863 0.727 . . . . 0.0 110.636 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 598' ' ' LYS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.5 mmtp -55.37 162.38 2.29 Favored Pre-proline 0 N--CA 1.438 -1.061 0 C-N-CA 123.955 0.902 . . . . 0.0 112.257 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 599' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 91.5 Cg_exo -43.79 -44.09 11.67 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 124.51 3.473 . . . . 0.0 115.119 -175.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -88.93 -10.47 66.63 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.27 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 42.1 m-85 -97.54 155.28 17.03 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.893 0.854 . . . . 0.0 112.37 -176.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 602' ' ' THR . . . . . 0.578 HG21 HG11 ' A' ' 627' ' ' VAL . 10.7 m -107.76 126.88 53.16 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.808 174.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.465 ' HA ' ' SG ' ' A' ' 597' ' ' CYS . 5.2 tt -74.09 118.6 19.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.076 172.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 604' ' ' VAL . . . . . 0.672 HG21 ' HD3' ' A' ' 624' ' ' LYS . 67.4 t -111.64 110.78 33.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 133.7 -154.69 21.41 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.78 122.47 7.78 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.92 2.413 . . . . 0.0 112.315 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 1.2 t-20 -79.24 -36.46 39.92 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.38 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 608' ' ' SER . . . . . 0.683 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 52.8 p -125.49 100.63 6.56 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.884 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.3 m -98.03 161.13 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 610' ' ' GLN . . . . . 0.707 ' HG3' HG12 ' A' ' 592' ' ' VAL . 1.9 mp0 -115.87 158.6 22.72 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.691 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 37.3 t -80.95 104.61 11.57 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 118.613 -1.235 . . . . 0.0 107.903 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 612' ' ' TYR . . . . . 0.548 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 4.7 m-85 -87.64 167.87 13.51 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -74.9 0.06 16.93 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.648 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -116.65 7.48 13.57 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 131.06 174.52 13.69 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.972 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.532 HD23 ' HD3' ' A' ' 572' ' ' PRO . 2.9 mm? -63.73 109.59 1.76 Allowed 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 617' ' ' SER . . . . . 0.548 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 18.8 m -128.05 148.58 68.02 Favored Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -175.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.03 -171.22 8.71 Favored 'Cis proline' 0 CA--C 1.558 1.687 0 C-N-CA 123.644 -1.398 . . . . 0.0 113.476 1.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -57.96 151.58 18.07 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.895 0.379 . . . . 0.0 111.229 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 620' ' ' LEU . . . . . 0.525 ' H ' HD22 ' A' ' 620' ' ' LEU . 1.9 mm? -66.87 137.21 94.7 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.629 -173.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.8 170.83 10.74 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.802 3.001 . . . . 0.0 111.943 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 622' ' ' ILE . . . . . 0.541 HG13 ' HB ' ' A' ' 604' ' ' VAL . 43.1 pt -115.62 179.81 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 86.3 m -123.97 126.96 47.23 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.898 0.38 . . . . 0.0 110.971 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 624' ' ' LYS . . . . . 0.672 ' HD3' HG21 ' A' ' 604' ' ' VAL . 51.7 mtpt -124.08 121.61 35.65 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 14.0 tt0 -81.1 -28.34 35.24 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -100.77 111.53 23.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.555 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.578 HG11 HG21 ' A' ' 602' ' ' THR . 9.8 m -130.8 172.89 15.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.099 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 628' ' ' GLN . . . . . 0.545 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 75.1 mt-30 -96.32 164.02 12.83 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 37.8 m -110.79 -1.73 16.47 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.044 0.449 . . . . 0.0 110.139 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 69.7 m 70.77 -38.77 0.43 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.086 1.354 . . . . 0.0 114.435 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 100.68 -143.82 16.43 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -72.81 143.1 36.52 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 121.965 1.777 . . . . 0.0 109.81 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.444 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.4 Cg_endo -74.32 163.12 37.09 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.386 2.057 . . . . 0.0 112.302 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.9 173.29 7.19 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.705 2.27 . . . . 0.0 111.451 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -89.8 162.47 15.49 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.732 HD21 ' SG ' ' A' ' 659' ' ' CYS . 16.8 tp -92.54 166.89 12.29 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 177.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.609 ' H ' HD23 ' A' ' 637' ' ' LEU 0.303 2.0 pt? -82.76 -48.04 11.28 Favored 'General case' 0 N--CA 1.41 -2.462 0 C-N-CA 117.947 -1.501 . . . . 0.0 113.298 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.61 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 16.2 m120 -124.82 34.15 5.06 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.734 0.778 . . . . 0.0 109.897 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -159.52 -139.78 2.75 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.903 174.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 640' ' ' ASN . . . . . 0.499 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 61.7 t30 -162.47 -171.58 2.83 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.598 HG22 ' CE1' ' A' ' 657' ' ' TYR . 11.8 t -96.11 123.57 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.579 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.6 ptmt -79.34 -23.59 43.33 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.18 0.514 . . . . 0.0 109.91 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 12.1 mm-40 -78.96 152.27 31.15 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -79.49 121.53 25.31 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.977 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 33.1 p -68.22 99.05 0.86 Allowed 'General case' 0 N--CA 1.419 -1.977 0 CA-C-O 121.805 0.812 . . . . 0.0 112.617 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 54.6 pttt -89.09 160.79 16.87 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.408 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 40.4 mm-40 -78.73 -5.96 54.59 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -174.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -146.1 104.87 3.86 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' A' ' 655' ' ' VAL . 9.3 m-85 -90.64 -111.24 0.09 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.941 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 168.5 161.06 17.74 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 65.1 t60 -53.76 -57.36 11.16 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 32.9 m -89.98 8.28 33.22 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.927 -174.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -93.58 118.2 31.06 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.672 0.749 . . . . 0.0 110.382 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.609 HG21 ' HE3' ' A' ' 670' ' ' LYS . 4.5 m -89.95 151.66 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.516 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 30.2 m -116.67 104.16 16.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.654 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.579 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 23.5 mt-10 -65.36 124.29 21.87 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 122.218 1.009 . . . . 0.0 111.538 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.598 ' CE1' HG22 ' A' ' 641' ' ' VAL . 65.6 m-85 -102.5 165.64 10.98 Favored 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.431 173.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.499 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 8.8 p90 -146.81 137.32 23.74 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.732 ' SG ' HD21 ' A' ' 636' ' ' LEU . 61.2 m -97.24 165.86 11.84 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -63.6 150.29 90.69 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.41 0.85 1.99 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 124.13 3.22 . . . . 0.0 114.573 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 662' ' ' ARG . 9.6 mmm180 -98.54 -0.98 42.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -130.26 169.19 15.74 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.308 -173.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 88.5 mt -108.88 161.02 15.52 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.4 ttt -117.8 113.53 21.94 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.434 ' HB3' HG23 ' A' ' 683' ' ' VAL . 24.8 ttmm -68.3 -64.01 0.95 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -102.85 -158.24 25.48 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 121.122 -0.561 . . . . 0.0 114.116 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.93 121.51 9.62 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.767 2.978 . . . . 0.0 111.603 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 16.9 p-10 -79.4 -11.8 59.91 Favored 'General case' 0 C--O 1.178 -2.709 0 CA-C-O 120.917 0.389 . . . . 0.0 110.856 -177.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 5.3 ptmt -125.82 112.01 15.53 Favored 'General case' 0 C--N 1.27 -2.874 0 C-N-CA 123.932 0.893 . . . . 0.0 109.51 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 34.4 pt -109.92 151.47 12.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.708 -174.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.19 160.83 21.41 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.565 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 16.9 t -82.39 92.79 7.07 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.491 1.139 . . . . 0.0 111.796 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 83.8 t -80.7 113.93 20.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.667 -1.152 . . . . 0.0 110.151 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 19.7 t70 57.3 -69.52 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.582 1.953 . . . . 0.0 112.593 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 676' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -157.67 26.86 0.46 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 111.769 -0.532 . . . . 0.0 111.769 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -145.06 151.13 38.05 Favored 'General case' 0 C--O 1.21 -1.022 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.54 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.3 m95 -82.64 170.7 14.84 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 679' ' ' THR . . . . . 0.453 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 5.5 p -92.65 -174.52 3.67 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 30.0 m -68.94 131.12 44.57 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.792 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.413 HD23 HD12 ' A' ' 636' ' ' LEU . 7.3 mp -67.51 157.51 85.58 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 21.9 Cg_endo -62.8 -21.35 72.99 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 124.346 3.364 . . . . 0.0 115.879 -176.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.533 ' HA ' HD21 ' A' ' 637' ' ' LEU 0.357 22.4 m 49.97 109.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -178.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.705 ' SG ' HD21 ' A' ' 636' ' ' LEU . 3.5 m -88.0 147.36 25.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.549 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.4 151.73 16.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.76 141.63 16.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 C--O 1.255 1.373 0 O-C-N 124.09 0.869 . . . . 0.0 110.625 178.901 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 N--CA 1.446 -0.649 0 CA-C-O 120.691 0.282 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.53 75.18 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 564' ' ' ALA . . . . . 0.706 ' HB3' ' HG3' ' A' ' 566' ' ' GLU . . . -94.46 7.49 45.37 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.586 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 76.53 15.58 81.41 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.706 ' HG3' ' HB3' ' A' ' 564' ' ' ALA . 0.0 OUTLIER -79.11 99.97 7.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.256 0.55 . . . . 0.0 112.215 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -177.07 -63.1 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 175.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 568' ' ' GLU . . . . . 0.593 ' HG3' ' HB3' ' A' ' 586' ' ' GLN . 0.0 OUTLIER 174.79 -173.26 0.07 Allowed 'General case' 0 C--O 1.244 0.774 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 174.078 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 91.5 m -96.39 140.86 30.43 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -126.05 130.26 50.78 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.848 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.2 tt -53.05 119.27 16.05 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.524 ' HG2' HD21 ' A' ' 620' ' ' LEU . 87.8 Cg_endo -78.72 -157.74 0.08 OUTLIER 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.234 2.623 . . . . 0.0 111.566 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -91.09 107.64 19.34 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.489 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.738 HG22 HD23 ' A' ' 620' ' ' LEU . 35.1 pt -79.58 -171.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.477 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.936 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.1 t70 -73.74 159.49 32.88 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.17 -31.91 53.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -98.8 6.35 46.94 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.992 -0.443 . . . . 0.0 111.4 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.936 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.0 tm? -95.54 150.66 20.08 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.486 ' N ' HD13 ' A' ' 578' ' ' LEU . 7.1 m -145.31 118.18 5.33 Favored Pre-proline 0 C--N 1.293 -1.86 0 C-N-CA 125.006 1.322 . . . . 0.0 108.241 176.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.848 ' HG3' HD11 ' A' ' 571' ' ' LEU . 36.8 Cg_endo -70.23 131.03 19.74 Favored 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 121.255 1.304 . . . . 0.0 110.78 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.15 -34.89 79.07 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 582' ' ' ARG . . . . . 0.443 ' HB2' HD22 ' A' ' 593' ' ' LEU . 55.0 mmt-85 -88.09 104.83 17.04 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 171.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -117.65 97.48 5.88 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.454 ' HG3' ' H ' ' A' ' 585' ' ' ASP 0.288 10.4 ptpt -113.46 -93.39 0.47 Allowed 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.04 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.454 ' H ' ' HG3' ' A' ' 584' ' ' LYS . 5.6 t70 -173.82 -62.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 176.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 586' ' ' GLN . . . . . 0.593 ' HB3' ' HG3' ' A' ' 568' ' ' GLU . 14.0 mp0 -121.14 145.0 48.27 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.963 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.658 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 23.7 m-85 -114.84 132.57 56.46 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 -171.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 588' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' A' ' 591' ' ' GLU . 33.8 mtmm -90.06 161.11 15.98 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.517 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.41 121.9 16.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.209 0.528 . . . . 0.0 110.309 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 103.29 -0.08 47.16 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.881 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 591' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 588' ' ' LYS . 82.0 mm-40 -67.1 122.1 17.05 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 117.756 0.778 . . . . 0.0 109.012 173.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.585 HG12 ' HG3' ' A' ' 610' ' ' GLN . 7.0 m -95.41 117.68 39.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 CA-C-O 122.307 1.051 . . . . 0.0 108.63 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.623 HD21 ' HD2' ' A' ' 587' ' ' TYR . 17.5 mt -101.85 101.46 11.91 Favored 'General case' 0 C--N 1.274 -2.71 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.059 -174.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.599 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 10.3 mtmp? -79.72 113.38 17.83 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.782 ' HB3' HD11 ' A' ' 578' ' ' LEU . 80.4 m-85 -95.91 167.4 11.27 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 596' ' ' SER . . . . . 0.415 ' O ' HD22 ' A' ' 578' ' ' LEU . 21.4 t -168.18 -179.18 3.95 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 170.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 77.8 m -118.4 177.36 4.85 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 123.68 0.612 . . . . 0.0 112.488 -173.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 30.1 mmtp -50.59 162.36 0.55 Allowed Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 125.372 1.469 . . . . 0.0 112.27 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 76.7 Cg_exo -47.76 -43.47 28.79 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.248 3.299 . . . . 0.0 113.761 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.66 1.64 63.99 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.957 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 37.4 m-85 -105.57 141.01 37.78 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-O 121.961 0.886 . . . . 0.0 112.777 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.662 HG21 HG11 ' A' ' 627' ' ' VAL . 9.8 m -102.69 126.84 49.94 Favored 'General case' 0 N--CA 1.393 -3.293 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.338 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.451 HD11 ' HG3' ' A' ' 621' ' ' PRO . 10.8 tt -73.18 123.51 28.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.097 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.486 HG21 ' HD3' ' A' ' 624' ' ' LYS . 86.6 t -113.14 126.49 70.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.764 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.07 -145.61 18.46 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.41 124.11 4.62 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.773 2.315 . . . . 0.0 110.864 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.26 -42.93 14.21 Favored 'General case' 0 C--O 1.204 -1.313 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.832 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.599 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 18.6 p -114.14 97.86 6.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.14 0.495 . . . . 0.0 111.983 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 609' ' ' VAL . . . . . 0.409 ' HA ' ' HD2' ' A' ' 618' ' ' PRO . 11.1 m -92.66 163.18 2.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.585 ' HG3' HG12 ' A' ' 592' ' ' VAL . 2.3 mp0 -113.18 154.1 27.23 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.374 0.607 . . . . 0.0 110.209 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 6.6 t -85.14 108.75 17.84 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.72 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' ' 617' ' ' SER . 55.3 m-85 -91.57 166.79 12.65 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 175.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -7.58 19.55 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -105.97 -10.59 16.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.998 0.427 . . . . 0.0 111.225 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 140.94 -172.49 23.65 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.532 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.443 ' CD2' ' HB3' ' A' ' 569' ' ' CYS . 2.8 mm? -79.32 127.82 32.56 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.55 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 47.8 t -149.09 147.18 22.99 Favored Pre-proline 0 N--CA 1.429 -1.516 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 609' ' ' VAL . 57.3 Cg_endo -71.33 -175.74 13.4 Favored 'Cis proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.641 -1.4 . . . . 0.0 114.038 1.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -63.26 142.44 58.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.032 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.738 HD23 HG22 ' A' ' 574' ' ' ILE . 8.7 mp -57.58 143.6 74.82 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -173.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.451 ' HG3' HD11 ' A' ' 603' ' ' ILE . 38.2 Cg_endo -68.05 -178.53 1.75 Allowed 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 124.748 3.632 . . . . 0.0 113.341 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 622' ' ' ILE . . . . . 0.431 HG13 ' HB ' ' A' ' 604' ' ' VAL . 40.1 pt -130.81 -178.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.4 m -129.0 119.5 24.39 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.222 0.534 . . . . 0.0 111.787 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.486 ' HD3' HG21 ' A' ' 604' ' ' VAL . 47.8 mtpt -114.04 126.04 54.67 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.837 177.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 18.3 tt0 -81.83 -27.05 33.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -123.8 113.63 18.81 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.286 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.662 HG11 HG21 ' A' ' 602' ' ' THR . 3.2 m -106.23 177.83 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.499 176.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.476 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 73.0 mt-30 -97.51 167.0 11.25 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 49.2 m -105.19 -4.92 21.17 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.536 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.1 m 68.15 -31.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 82.31 -139.06 19.32 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 633' ' ' PRO . 46.8 Cg_endo -75.9 154.39 38.3 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.449 2.099 . . . . 0.0 111.27 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.553 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 61.7 Cg_endo -92.07 174.12 2.25 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 123.087 2.525 . . . . 0.0 111.532 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.78 -173.72 1.87 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.033 1.822 . . . . 0.0 109.985 172.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.41 159.87 24.22 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.526 ' HB3' ' C ' ' A' ' 639' ' ' GLY . 14.7 tp -70.56 144.8 51.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.574 ' HG ' ' H ' ' A' ' 638' ' ' ASN . 0.9 OUTLIER -48.96 -71.76 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.574 ' H ' ' HG ' ' A' ' 637' ' ' LEU . 9.5 m120 -94.03 -32.57 13.76 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.622 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -85.15 -154.21 21.81 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.497 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 640' ' ' ASN . . . . . 0.594 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 54.5 t30 -152.05 -173.66 4.61 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.8 p -101.72 133.54 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -93.43 -27.34 16.77 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.211 0.529 . . . . 0.0 110.641 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.714 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 38.5 mm-40 -81.56 153.78 26.57 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.245 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -67.12 122.25 17.39 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.257 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.463 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 16.6 p -76.97 110.53 11.67 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.417 0.627 . . . . 0.0 110.242 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -82.32 157.39 23.83 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.186 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.94 -9.29 59.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.724 0.773 . . . . 0.0 109.696 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.642 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 38.4 tt0 -156.1 124.24 5.73 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.558 ' CE2' HG22 ' A' ' 655' ' ' VAL . 13.9 m-85 -98.44 -63.08 1.16 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 123.471 0.482 . . . . 0.0 111.637 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 112.23 162.04 16.1 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.435 ' CD2' ' HA ' ' A' ' 674' ' ' VAL . 51.6 t-80 -63.68 140.56 58.88 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.0 m 75.78 -4.04 2.45 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.417 1.087 . . . . 0.0 113.546 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 649' ' ' TYR . 5.3 tp10 -81.87 120.14 24.82 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.9 m -91.47 159.46 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-O 122.1 0.952 . . . . 0.0 112.564 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.9 t -127.11 102.61 9.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.871 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.714 ' HB2' ' HG2' ' A' ' 643' ' ' GLU . 29.8 mt-10 -67.69 132.66 47.9 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.153 0.978 . . . . 0.0 112.194 175.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 67.9 m-85 -112.7 171.43 7.53 Favored 'General case' 0 C--N 1.28 -2.447 0 C-N-CA 126.372 1.869 . . . . 0.0 109.596 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 31.4 p90 -151.06 141.9 22.87 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.622 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 7.3 t -105.81 -177.66 3.43 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.746 176.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 34.6 m-80 -70.35 151.39 95.74 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.41 ' C ' ' HD2' ' A' ' 662' ' ' ARG . 52.7 Cg_endo -68.46 26.24 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 124.31 3.34 . . . . 0.0 114.092 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.41 ' HD2' ' C ' ' A' ' 661' ' ' PRO . 13.3 mmm180 -128.35 5.07 5.72 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 660' ' ' ASN . 44.1 m-85 -123.74 164.84 18.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.309 -172.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.428 HD21 ' OE2' ' A' ' 687' ' ' GLU . 90.3 mt -110.18 143.54 40.15 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.423 1.489 . . . . 0.0 107.31 175.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.9 ttt -114.04 102.52 10.26 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.788 ' HG2' HD11 ' A' ' 685' ' ' ILE . 72.3 mmtt -73.18 -63.22 1.23 Allowed 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.882 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -83.35 -168.52 43.45 Favored Glycine 0 N--CA 1.404 -3.486 0 CA-C-N 114.792 -1.095 . . . . 0.0 113.473 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.0 118.04 5.01 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.108 2.538 . . . . 0.0 112.07 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 3.7 p-10 -80.34 19.31 0.78 Allowed 'General case' 0 C--O 1.19 -2.028 0 C-N-CA 122.886 0.475 . . . . 0.0 111.426 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.72 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 7.0 ptmt -162.14 111.17 1.46 Allowed 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 124.861 1.264 . . . . 0.0 108.024 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 35.3 pt -107.63 144.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.986 -174.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.443 ' HB3' ' CG1' ' A' ' 654' ' ' VAL . 0.0 OUTLIER -112.67 142.81 44.85 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 123.677 0.611 . . . . 0.0 110.848 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.0 t -67.41 116.89 8.67 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.683 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.435 ' HA ' ' CD2' ' A' ' 651' ' ' HIS . 34.1 m -109.18 127.7 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 28.2 t70 54.79 -80.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.538 1.135 . . . . 0.0 112.031 -169.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -157.11 31.67 0.54 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -143.02 156.45 44.84 Favored 'General case' 0 C--O 1.212 -0.88 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.463 ' HB3' HD12 ' A' ' 671' ' ' ILE . 97.7 m95 -93.15 166.1 12.5 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 7.9 p -91.81 -169.72 2.36 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 35.1 m -71.54 126.29 29.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.71 0.29 . . . . 0.0 110.413 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.93 160.41 29.32 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.893 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.611 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 24.6 Cg_endo -63.34 -15.33 47.65 Favored 'Trans proline' 0 CA--C 1.498 -1.312 0 C-N-CA 123.663 2.908 . . . . 0.0 115.035 -175.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 22.4 m 43.21 93.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 124.87 1.356 . . . . 0.0 114.411 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 23.3 p -95.75 137.26 35.06 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.662 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.788 HD11 ' HG2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -133.5 147.48 31.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.004 -178.006 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 98.3 t -52.56 133.27 14.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -172.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.428 ' OE2' HD21 ' A' ' 664' ' ' LEU . 6.9 tp10 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.184 1.394 . . . . 0.0 108.963 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 562' ' ' GLU . . . . . 0.476 ' HA ' ' CD ' ' A' ' 570' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.242 0.69 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 76.4 11.86 2.71 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.491 1.516 . . . . 0.0 112.954 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 564' ' ' ALA . . . . . 0.816 ' HB3' ' HB2' ' A' ' 570' ' ' GLU . . . -97.52 105.4 17.54 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -77.78 75.83 1.81 Allowed Glycine 0 C--N 1.306 -1.128 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.836 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 55.48 -165.96 0.11 Allowed 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.094 0.958 . . . . 0.0 112.879 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 613' ' ' HIS . 45.5 mtp180 71.37 -5.23 1.63 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.206 1.402 . . . . 0.0 112.808 176.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -161.66 162.72 30.02 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 74.9 m -98.81 112.72 24.72 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-O 121.876 0.846 . . . . 0.0 112.471 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.816 ' HB2' ' HB3' ' A' ' 564' ' ' ALA . 21.3 tt0 -82.97 -23.58 33.31 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.24 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 32.3 tp 79.02 105.08 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 113.665 -1.607 . . . . 0.0 108.922 -169.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.711 ' HD2' HD12 ' A' ' 616' ' ' LEU . 24.5 Cg_endo -62.94 -172.6 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.062 2.508 . . . . 0.0 113.429 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.89 20.77 0.45 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -170.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.779 HG13 ' H ' ' A' ' 575' ' ' ASP . 26.1 pt 35.19 -94.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 126.523 1.929 . . . . 0.0 115.469 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.779 ' H ' HG13 ' A' ' 574' ' ' ILE . 15.7 t70 -165.1 179.74 6.17 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.82 -27.57 4.98 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -103.52 10.17 37.23 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.622 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.739 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.7 tp -100.14 164.49 11.95 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.65 122.52 1.94 Allowed Pre-proline 0 C--N 1.308 -1.238 0 C-N-CA 124.044 0.938 . . . . 0.0 108.803 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.2 137.51 21.39 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.123 1.882 . . . . 0.0 112.209 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -78.74 -42.11 29.02 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -90.33 113.56 25.46 Favored 'General case' 0 N--CA 1.392 -3.349 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.58 ' HA ' ' OH ' ' A' ' 587' ' ' TYR . 64.1 tttp -135.24 135.44 40.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.311 0.577 . . . . 0.0 111.641 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.621 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 13.1 ptpt -160.43 -160.31 0.76 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.634 1.174 . . . . 0.0 108.489 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -90.34 -64.46 1.13 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.03 0.443 . . . . 0.0 110.656 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -119.98 134.3 55.29 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.645 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 69.3 m-85 -96.39 127.5 42.45 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -84.36 145.33 28.28 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.876 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 1.6 p -55.59 111.36 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 122.17 0.986 . . . . 0.0 112.755 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 115.26 -6.29 21.35 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.862 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -70.23 137.95 51.27 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 4.1 m -104.63 123.89 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-O 122.03 0.919 . . . . 0.0 109.499 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.477 HD11 ' CD2' ' A' ' 587' ' ' TYR . 7.4 mp -107.48 104.79 14.44 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.174 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 28.8 mtpp -82.95 119.33 24.29 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.763 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.45 158.62 16.08 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-O 120.957 0.408 . . . . 0.0 110.684 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 19.6 m -150.59 171.74 16.63 Favored 'General case' 0 N--CA 1.398 -3.044 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.555 ' SG ' HD12 ' A' ' 578' ' ' LEU . 95.3 m -112.87 179.84 3.85 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-O 120.656 0.265 . . . . 0.0 110.333 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -52.23 162.07 0.92 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.302 1.441 . . . . 0.0 112.306 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.45 -41.96 42.61 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.268 3.312 . . . . 0.0 114.283 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 600' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 625' ' ' GLU . . . -96.52 1.71 62.21 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.627 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -103.84 147.82 26.85 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.876 0.846 . . . . 0.0 112.892 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.602 HG21 HG11 ' A' ' 627' ' ' VAL . 17.8 m -98.83 134.95 40.98 Favored 'General case' 0 C--N 1.272 -2.762 0 CA-C-N 113.728 -1.578 . . . . 0.0 109.104 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.579 HD11 ' HG3' ' A' ' 621' ' ' PRO . 7.6 tt -82.48 115.66 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.831 0.824 . . . . 0.0 109.348 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.537 ' HB ' HG13 ' A' ' 622' ' ' ILE . 61.9 t -106.72 101.84 13.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.726 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 137.31 -162.38 25.36 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.0 123.44 10.66 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 122.827 2.351 . . . . 0.0 111.963 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.34 -49.46 11.49 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 175.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 66.5 p -104.31 106.91 17.58 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.58 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.18 161.2 4.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.642 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 22.8 mm-40 -105.08 163.48 12.53 Favored 'General case' 0 CA--C 1.473 -2.003 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.537 ' HA ' HD23 ' A' ' 616' ' ' LEU . 43.4 t -88.01 132.54 34.23 Favored 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 118.646 -1.222 . . . . 0.0 107.78 166.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.642 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 75.2 m-85 -116.61 168.84 9.83 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 613' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' A' ' 567' ' ' ARG . 3.5 p80 -67.64 -5.37 15.4 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -111.23 -9.24 14.33 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 122.007 -0.433 . . . . 0.0 110.266 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 138.61 -177.4 20.17 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.711 HD12 ' HD2' ' A' ' 572' ' ' PRO . 94.3 mt -68.57 140.83 55.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 117.037 0.419 . . . . 0.0 109.899 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 2.5 t -156.31 150.83 20.21 Favored Pre-proline 0 N--CA 1.421 -1.915 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.457 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 59.8 Cg_endo -69.99 -176.64 13.3 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.672 -1.386 . . . . 0.0 112.99 1.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.13 144.98 32.66 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.995 0.426 . . . . 0.0 110.408 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.563 HD23 HG22 ' A' ' 574' ' ' ILE . 8.4 mp -64.76 145.56 98.77 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.248 -172.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.579 ' HG3' HD11 ' A' ' 603' ' ' ILE . 72.3 Cg_endo -71.25 170.22 18.82 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 123.452 2.768 . . . . 0.0 112.54 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 622' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 604' ' ' VAL . 38.8 pt -116.7 -178.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 602' ' ' THR . 73.3 m -126.44 125.8 42.74 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.977 0.418 . . . . 0.0 111.443 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 624' ' ' LYS . 47.8 mtpt -119.31 140.11 50.83 Favored 'General case' 0 C--O 1.194 -1.862 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 600' ' ' GLY . 1.4 tm-20 -90.67 -43.72 9.96 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -95.76 112.02 23.85 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.471 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.602 HG11 HG21 ' A' ' 602' ' ' THR . 7.4 m -123.21 175.63 5.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.489 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.68 170.15 9.2 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 15.5 m -102.03 -11.11 19.15 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 93.0 m 70.6 8.99 6.79 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 112.376 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 60.58 -144.74 47.72 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -82.38 153.6 16.05 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.481 2.12 . . . . 0.0 110.292 173.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.68 ' HG3' HG11 ' A' ' 655' ' ' VAL . 57.0 Cg_endo -71.05 153.53 62.93 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.842 2.362 . . . . 0.0 113.366 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.4 173.99 6.85 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.627 2.884 . . . . 0.0 113.097 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -88.21 153.33 21.32 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 121.173 0.511 . . . . 0.0 110.926 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.59 HD22 ' HB3' ' A' ' 657' ' ' TYR . 23.4 tp -97.04 123.92 40.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' A' ' 683' ' ' VAL . 0.0 OUTLIER -39.66 -46.8 1.89 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -177.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.4 ' N ' HD22 ' A' ' 637' ' ' LEU . 72.2 m-20 -137.92 39.99 2.34 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.263 1.03 . . . . 0.0 109.507 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.629 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.46 -152.96 6.36 Favored Glycine 0 N--CA 1.397 -3.96 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -164.67 -176.58 4.35 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 124.087 0.955 . . . . 0.0 108.682 175.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.601 HG11 HG21 ' A' ' 645' ' ' THR . 6.4 p -95.99 130.31 44.85 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.042 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.637 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.5 ptmt -85.25 -27.4 26.05 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.245 0.545 . . . . 0.0 110.255 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 40.2 mm-40 -80.8 143.6 32.72 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.725 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 644' ' ' LYS . . . . . 0.781 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -52.8 120.76 6.14 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 124.646 1.217 . . . . 0.0 109.39 173.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.601 HG21 HG11 ' A' ' 641' ' ' VAL . 4.1 p -101.35 104.96 15.97 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -172.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -85.17 149.55 25.44 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 113.601 -1.636 . . . . 0.0 108.126 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -80.69 16.62 1.34 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -155.48 105.27 2.44 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.484 ' CE2' HG22 ' A' ' 655' ' ' VAL . 3.4 m-85 -90.85 -88.57 0.18 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 143.02 157.08 7.01 Favored Glycine 0 N--CA 1.424 -2.142 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -175.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.415 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 84.6 t60 -67.12 138.72 57.28 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.511 0.196 . . . . 0.0 111.023 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 68.6 m 69.25 5.88 5.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.702 1.201 . . . . 0.0 113.044 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -92.69 117.54 30.1 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.646 HG21 ' HE3' ' A' ' 670' ' ' LYS . 12.8 m -86.49 159.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.694 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.5 t -129.03 117.54 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.904 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.637 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 20.9 mt-10 -73.02 124.38 25.38 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.773 0.797 . . . . 0.0 112.245 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.59 ' HB3' HD22 ' A' ' 636' ' ' LEU . 34.3 m-85 -104.58 172.62 6.69 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.092 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -146.81 137.26 23.71 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.629 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 70.9 m -95.43 172.85 7.83 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.46 ' HB2' ' HD1' ' A' ' 663' ' ' PHE . 9.8 m120 -63.73 152.56 86.16 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.85 -4.36 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.411 2.74 . . . . 0.0 112.538 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -96.42 -1.27 47.88 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 124.311 1.044 . . . . 0.0 108.865 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.46 ' HD1' ' HB2' ' A' ' 660' ' ' ASN . 45.4 m-85 -131.75 158.02 42.28 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.103 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 89.1 mt -100.17 158.03 16.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.421 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 6.2 ttt -124.6 95.08 4.39 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -176.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -86.95 -44.52 11.57 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.351 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -78.65 -179.64 51.5 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.975 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.24 114.85 2.29 Favored 'Trans proline' 0 C--N 1.334 -0.232 0 C-N-CA 123.138 2.558 . . . . 0.0 111.142 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 17.6 p-10 -73.92 -11.39 60.34 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 2.3 mtpp -121.3 120.06 34.02 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 33.6 pt -111.12 152.59 13.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.532 -1.267 . . . . 0.0 110.924 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -114.66 154.05 29.11 Favored 'General case' 0 N--CA 1.425 -1.688 0 O-C-N 123.881 0.738 . . . . 0.0 109.489 -172.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 2.8 t -85.62 122.55 29.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.057 174.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.415 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 77.9 t -114.42 114.68 47.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.211 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.7 t70 55.16 -78.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.25 1.42 . . . . 0.0 111.765 -171.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -149.1 18.2 1.2 Allowed Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -130.07 150.84 51.16 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.561 ' HB3' HD12 ' A' ' 671' ' ' ILE . 95.8 m95 -87.86 162.96 16.66 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 19.2 p -81.68 -178.15 6.85 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 27.3 m -64.39 130.85 45.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.462 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.0 mp -68.56 162.37 63.11 Favored Pre-proline 0 N--CA 1.446 -0.669 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.573 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 31.6 Cg_endo -67.76 -16.06 45.44 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.808 3.005 . . . . 0.0 114.721 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.513 ' HA ' HD11 ' A' ' 637' ' ' LEU 0.304 13.2 m 44.25 92.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 175.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 3.6 m -67.19 139.6 57.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.329 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.17 148.11 33.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.593 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 44.8 t -65.36 135.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 O-C-N 123.39 0.431 . . . . 0.0 110.731 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.25 1.108 0 O-C-N 123.848 0.718 . . . . 0.0 109.856 179.23 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -96.59 -51.16 4.43 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.394 0.616 . . . . 0.0 109.391 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -136.5 142.8 43.53 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.36 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -80.62 90.76 1.36 Allowed Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.19 -39.29 15.62 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -111.93 23.26 13.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.512 1.149 . . . . 0.0 108.098 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 568' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 569' ' ' CYS . 3.9 tp10 -142.06 -161.93 1.32 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 102.039 -3.319 . . . . 0.0 102.039 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 616' ' ' LEU . 87.4 m -138.81 161.16 37.94 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 119.518 1.054 . . . . 0.0 112.669 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -138.34 117.9 13.0 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 104.538 -2.394 . . . . 0.0 104.538 168.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.659 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 2.0 tt -34.57 121.8 0.55 Allowed Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 125.37 1.468 . . . . 0.0 109.56 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.625 ' HD2' HD22 ' A' ' 616' ' ' LEU . 70.6 Cg_endo -69.58 -169.9 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.36 2.04 . . . . 0.0 111.549 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -87.63 101.36 13.58 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.439 -0.905 . . . . 0.0 109.602 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.813 HG22 HD23 ' A' ' 620' ' ' LEU . 38.9 pt -67.42 -172.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.987 0 CA-C-O 121.759 0.79 . . . . 0.0 110.674 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.805 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 6.4 t70 -66.34 -175.15 0.33 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.046 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.92 -27.3 4.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 O-C-N 121.407 -0.808 . . . . 0.0 109.358 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -109.58 9.94 25.11 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 122.124 -0.36 . . . . 0.0 111.868 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.879 HD11 ' HB3' ' A' ' 595' ' ' PHE . 1.6 tm? -89.99 151.37 21.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.51 ' N ' HD13 ' A' ' 578' ' ' LEU . 7.6 p -148.88 117.16 3.89 Favored Pre-proline 0 C--N 1.294 -1.845 0 C-N-CA 123.907 0.883 . . . . 0.0 109.303 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.612 ' HG3' HD11 ' A' ' 571' ' ' LEU . 64.8 Cg_endo -75.16 148.9 35.31 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.643 2.229 . . . . 0.0 112.909 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.74 -55.99 8.4 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -75.1 108.77 8.06 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.91 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -120.81 97.72 5.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.51 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.8 ptpt -133.44 167.43 20.46 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.118 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.28 -67.18 0.44 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 124.052 0.845 . . . . 0.0 110.992 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -121.92 144.13 49.04 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.659 ' CE1' ' HB2' ' A' ' 571' ' ' LEU . 45.2 m-85 -103.69 132.47 49.91 Favored 'General case' 0 CA--C 1.467 -2.247 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.843 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 588' ' ' LYS . . . . . 0.432 ' HA ' ' OE2' ' A' ' 568' ' ' GLU . 19.4 mtpp -81.24 147.36 29.99 Favored 'General case' 0 C--N 1.273 -2.747 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.521 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.707 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 46.6 t -59.44 112.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.178 0.513 . . . . 0.0 110.23 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 113.08 -6.01 25.39 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.416 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.97 135.63 47.99 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.532 HG12 ' HG3' ' A' ' 610' ' ' GLN . 3.8 m -106.33 134.12 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 C-N-CA 119.77 -0.772 . . . . 0.0 108.974 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 608' ' ' SER . 5.4 mp -113.8 103.69 11.45 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.563 ' HG2' ' HB2' ' A' ' 608' ' ' SER . 84.3 mttt -78.6 103.31 8.46 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.879 ' HB3' HD11 ' A' ' 578' ' ' LEU . 44.3 m-85 -86.69 162.94 17.64 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.757 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 596' ' ' SER . . . . . 0.666 ' HA ' HD12 ' A' ' 603' ' ' ILE . 66.5 m -164.18 -175.35 3.94 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 169.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 603' ' ' ILE . 98.0 m -113.02 171.13 7.72 Favored 'General case' 0 C--N 1.259 -3.359 0 O-C-N 123.563 0.54 . . . . 0.0 110.968 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.601 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 29.3 mmtp -56.94 162.21 3.98 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.873 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 44.3 Cg_exo -39.09 -41.37 1.89 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 125.104 3.869 . . . . 0.0 116.644 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -98.42 6.06 60.99 Favored Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.643 -0.789 . . . . 0.0 114.283 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 56.7 m-85 -109.92 150.65 28.14 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 51.9 m -98.29 125.46 43.4 Favored 'General case' 0 N--CA 1.406 -2.675 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.92 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 596' ' ' SER . 8.0 tt -76.02 128.24 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.586 ' HB ' HG13 ' A' ' 622' ' ' ILE . 84.4 t -119.21 105.12 16.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.264 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 134.39 -168.81 23.31 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.697 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.86 116.58 3.54 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 123.519 2.812 . . . . 0.0 110.347 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -81.92 -43.56 17.95 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.624 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.563 ' HB2' ' HG2' ' A' ' 594' ' ' LYS . 15.0 t -111.79 89.76 3.15 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 119.216 -0.993 . . . . 0.0 112.536 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 609' ' ' VAL . . . . . 0.403 HG22 ' CE2' ' A' ' 595' ' ' PHE . 18.0 m -80.2 165.89 2.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.532 ' HG3' HG12 ' A' ' 592' ' ' VAL . 2.2 mp0 -109.9 154.54 22.93 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.551 0.691 . . . . 0.0 109.664 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 0.0 OUTLIER -86.41 131.66 34.14 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.132 167.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.466 ' CD1' ' HB3' ' A' ' 617' ' ' SER . 86.2 m-85 -117.62 173.71 6.57 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -72.45 -5.0 33.63 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.36 -0.837 . . . . 0.0 113.091 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -108.02 -3.06 19.1 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.436 0.636 . . . . 0.0 110.417 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 130.31 -171.42 20.6 Favored Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.625 HD22 ' HD2' ' A' ' 572' ' ' PRO . 8.2 mp -82.13 141.69 32.88 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 46.3 t -159.7 153.02 18.57 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.48 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 78.8 Cg_endo -76.45 -167.6 6.03 Favored 'Cis proline' 0 N--CA 1.481 0.788 0 C-N-CA 124.047 -1.23 . . . . 0.0 113.317 1.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -50.16 144.01 7.63 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.442 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.813 HD23 HG22 ' A' ' 574' ' ' ILE . 7.7 mp -78.99 148.72 72.4 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.177 -173.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.462 ' HG3' HD11 ' A' ' 603' ' ' ILE . 36.3 Cg_endo -67.35 168.56 17.52 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 124.093 3.195 . . . . 0.0 112.952 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 622' ' ' ILE . . . . . 0.586 HG13 ' HB ' ' A' ' 604' ' ' VAL . 45.6 pt -116.25 -179.66 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 78.5 m -124.6 123.13 39.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.969 0.414 . . . . 0.0 111.632 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.517 ' HG3' HG21 ' A' ' 604' ' ' VAL . 6.4 mmmm -115.92 121.97 43.9 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.517 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 1.6 tm-20 -88.96 -36.72 15.71 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -93.23 78.65 4.51 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.62 HG23 ' HA ' ' A' ' 675' ' ' ASP . 11.8 p -88.07 154.99 3.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.265 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.465 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 78.0 mt-30 -84.71 167.4 16.19 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.488 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 21.5 m -108.19 -8.95 15.62 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.3 m 70.15 -55.36 0.61 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.337 1.055 . . . . 0.0 111.903 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 109.14 -143.71 16.4 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.23 132.84 28.79 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.685 1.59 . . . . 0.0 111.423 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.438 ' HG3' HG11 ' A' ' 655' ' ' VAL . 56.8 Cg_endo -69.29 164.97 32.06 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 123.505 2.803 . . . . 0.0 112.77 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.08 177.74 4.14 Favored 'Trans proline' 0 C--O 1.254 1.29 0 C-N-CA 122.773 2.315 . . . . 0.0 111.314 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -95.24 165.24 12.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.551 HD22 ' HB3' ' A' ' 657' ' ' TYR . 19.3 tp -91.46 156.46 17.7 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.464 HD21 ' H ' ' A' ' 684' ' ' CYS . 1.7 pt? -53.2 -64.27 0.88 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.59 0.632 . . . . 0.0 112.49 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.45 -23.92 11.65 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.384 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -94.67 -152.75 29.68 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.727 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -154.52 -164.92 1.94 Allowed 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.4 p -104.73 136.18 39.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -94.62 -21.14 19.01 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.299 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.508 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 23.9 mm-40 -81.67 154.59 26.02 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -70.3 113.53 7.56 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.435 ' CG2' HG11 ' A' ' 641' ' ' VAL . 1.5 p -70.75 99.89 1.79 Allowed 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.777 0.799 . . . . 0.0 111.837 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -82.85 169.72 15.78 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.166 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.21 -26.41 33.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.049 0.452 . . . . 0.0 111.207 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -128.55 113.61 15.68 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.513 ' CE2' HG12 ' A' ' 655' ' ' VAL . 8.2 m-85 -92.3 -93.12 0.15 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 140.04 164.94 10.1 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.136 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.676 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 69.7 t60 -55.67 -58.62 7.04 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 15.1 m -90.43 15.31 10.91 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-O 121.289 0.566 . . . . 0.0 111.22 -173.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.421 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 4.7 tp10 -97.12 117.49 31.43 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 5.9 m -93.96 151.34 3.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.754 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 29.3 m -114.34 102.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.55 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.523 ' CG ' ' HD2' ' A' ' 670' ' ' LYS . 12.1 mt-10 -66.21 121.78 15.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.942 0.877 . . . . 0.0 112.242 176.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 69.4 m-85 -100.06 168.61 9.73 Favored 'General case' 0 C--N 1.271 -2.836 0 C-N-CA 125.28 1.432 . . . . 0.0 109.441 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -152.61 141.7 21.33 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.679 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 7.5 t -106.49 -171.19 1.85 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.58 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 662' ' ' ARG . 23.9 m120 -77.77 156.39 80.25 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.37 6.16 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 123.797 2.998 . . . . 0.0 113.388 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 660' ' ' ASN . 32.2 mmt180 -105.7 -0.26 25.67 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.254 -176.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -128.27 158.36 38.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.568 0.699 . . . . 0.0 112.322 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.43 133.39 46.13 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 113.749 -1.569 . . . . 0.0 107.511 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.2 ttt -104.0 109.55 21.37 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -92.9 -49.19 6.16 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -86.23 -171.04 47.56 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.36 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.12 119.12 6.11 Favored 'Trans proline' 0 CA--C 1.526 0.108 0 C-N-CA 123.093 2.529 . . . . 0.0 111.13 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.636 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 23.2 p-10 -81.47 0.28 38.46 Favored 'General case' 0 C--O 1.178 -2.666 0 O-C-N 121.996 -0.44 . . . . 0.0 111.33 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 3.8 ptmt -134.74 110.28 9.13 Favored 'General case' 0 C--N 1.267 -3.0 0 CA-C-O 121.801 0.81 . . . . 0.0 109.704 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 46.5 pt -110.25 151.32 12.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.649 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 651' ' ' HIS . 0.3 OUTLIER -113.73 156.8 23.13 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.541 0.526 . . . . 0.0 111.458 -179.146 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.676 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 13.6 t -81.73 99.63 9.05 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.885 0.85 . . . . 0.0 110.624 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.524 ' HA ' ' HD1' ' A' ' 651' ' ' HIS . 36.0 m -90.72 111.66 23.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.975 -1.078 . . . . 0.0 111.878 -177.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.62 ' HA ' HG23 ' A' ' 627' ' ' VAL . 13.1 t70 71.13 -59.5 0.54 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.707 1.203 . . . . 0.0 112.639 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -172.77 22.71 0.07 OUTLIER Glycine 0 C--N 1.295 -1.703 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -142.47 152.0 42.28 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.4 m95 -81.12 173.0 12.98 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.558 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 679' ' ' THR . . . . . 0.458 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 0.5 OUTLIER -96.59 -179.92 4.77 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.067 -179.111 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 27.5 m -69.39 126.17 28.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.725 0.298 . . . . 0.0 110.868 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.4 ' CB ' ' HD2' ' A' ' 682' ' ' PRO . 7.1 mp -60.18 155.94 42.32 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.636 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 10.3 Cg_endo -57.41 -39.67 87.43 Favored 'Trans proline' 0 CA--C 1.5 -1.198 0 C-N-CA 124.434 3.423 . . . . 0.0 115.527 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 682' ' ' PRO 0.275 3.9 m 64.42 122.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.09 0 C-N-CA 125.37 1.468 . . . . 0.0 112.202 -171.8 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.464 ' H ' HD21 ' A' ' 637' ' ' LEU . 21.8 p -119.94 129.17 54.2 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.718 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.409 ' H ' HD13 ' A' ' 685' ' ' ILE . 0.2 OUTLIER -118.76 147.84 22.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.353 -174.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.81 128.71 17.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 123.977 0.798 . . . . 0.0 111.1 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 C--N 1.305 -1.369 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.173 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 . . . . . 0 CA--C 1.511 -0.534 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -99.67 85.98 3.23 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -158.09 -171.62 3.58 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.929 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 135.7 -29.56 2.86 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -129.46 124.41 33.97 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.466 ' HA ' ' HE ' ' A' ' 567' ' ' ARG . 2.6 mmp_? -113.66 -105.21 0.39 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 58.53 -174.09 0.09 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.699 0.8 . . . . 0.0 111.529 -172.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.673 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 88.9 m -127.29 149.28 50.09 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.543 0.687 . . . . 0.0 112.331 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.495 ' O ' HD21 ' A' ' 616' ' ' LEU . 40.0 mt-10 -107.55 -157.12 0.6 Allowed 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.477 HD22 ' HD2' ' A' ' 572' ' ' PRO . 3.1 tm? -125.84 107.38 25.68 Favored Pre-proline 0 C--N 1.28 -2.42 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.477 ' HD2' HD22 ' A' ' 571' ' ' LEU . 48.9 Cg_endo -67.45 176.93 4.35 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.647 2.231 . . . . 0.0 111.785 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -79.76 90.02 5.22 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.843 0.83 . . . . 0.0 109.793 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.817 HG22 ' HG ' ' A' ' 620' ' ' LEU . 38.6 pt -72.88 -169.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.594 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 7.9 t70 -74.82 146.69 41.82 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.17 -22.63 31.53 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 121.662 0.744 . . . . 0.0 110.515 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -93.7 5.46 51.56 Favored 'General case' 0 C--O 1.204 -1.29 0 O-C-N 121.646 -0.659 . . . . 0.0 110.374 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.554 HD12 ' SG ' ' A' ' 623' ' ' CYS . 1.0 OUTLIER -108.02 154.12 22.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.209 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.39 122.51 5.23 Favored Pre-proline 0 C--N 1.304 -1.383 0 C-N-CA 123.304 0.642 . . . . 0.0 109.62 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.92 137.28 26.53 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.054 1.836 . . . . 0.0 112.534 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 581' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 594' ' ' LYS . 10.7 t70 -67.1 -42.52 84.43 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.584 1.154 . . . . 0.0 110.898 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -64.55 -68.94 0.32 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.722 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 53.35 81.49 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.218 1.407 . . . . 0.0 111.315 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 16.5 ptpt -132.89 -177.6 4.57 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.817 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.61 -68.3 0.61 Allowed 'General case' 0 C--N 1.309 -1.164 0 O-C-N 123.158 0.286 . . . . 0.0 111.383 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -120.56 131.06 54.48 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.548 0.689 . . . . 0.0 110.582 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.673 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 66.1 m-85 -94.79 140.34 30.04 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.437 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -91.13 152.51 20.56 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.194 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.69 118.81 3.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 99.71 2.9 56.29 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.834 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -76.16 130.99 39.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 12.7 t -101.81 120.2 51.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.408 0.623 . . . . 0.0 109.386 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.594 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 4.9 mp -98.52 100.12 11.34 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 581' ' ' ASP . 31.0 mtmm -80.27 142.02 34.98 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 173.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.501 ' CZ ' HD12 ' A' ' 620' ' ' LEU . 91.2 m-85 -116.16 173.95 6.31 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-O 121.321 0.582 . . . . 0.0 110.624 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 8.7 p -161.6 168.38 23.59 Favored 'General case' 0 N--CA 1.392 -3.335 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.54 ' SG ' HD12 ' A' ' 578' ' ' LEU . 94.3 m -117.75 -176.06 2.96 Favored 'General case' 0 C--N 1.265 -3.082 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 39.3 mmtm -55.03 166.64 0.77 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.406 1.482 . . . . 0.0 111.85 174.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 71.8 Cg_exo -46.91 -42.9 24.94 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 124.112 3.208 . . . . 0.0 114.612 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -102.69 0.16 49.16 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.385 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 28.4 m-85 -93.16 127.28 38.66 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.53 HG21 HG21 ' A' ' 627' ' ' VAL . 90.4 m -86.82 120.55 28.22 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-N 113.075 -1.875 . . . . 0.0 110.67 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 12.3 tt -77.3 133.05 31.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.715 HG21 ' HD3' ' A' ' 624' ' ' LYS . 91.0 t -133.36 130.37 57.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 124.73 -148.55 16.78 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -80.41 102.06 1.38 Allowed 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.322 2.015 . . . . 0.0 110.426 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 1.8 m-20 -73.88 -23.98 59.65 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.709 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 608' ' ' SER . . . . . . . . . . . . . 27.8 p -129.57 96.11 4.17 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.561 0.696 . . . . 0.0 111.284 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 609' ' ' VAL . . . . . 0.496 HG12 ' HD2' ' A' ' 618' ' ' PRO . 17.0 m -94.93 164.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.593 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 11.6 mm100 -107.67 165.38 11.47 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 4.1 t -92.79 128.64 38.72 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 114.519 -1.219 . . . . 0.0 107.825 165.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 54.6 m-85 -115.37 168.71 9.74 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -60.61 -16.04 34.36 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -108.45 -3.65 18.0 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.775 0.321 . . . . 0.0 111.38 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 133.47 -168.72 23.01 Favored Glycine 0 N--CA 1.434 -1.47 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.381 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.495 HD21 ' O ' ' A' ' 570' ' ' GLU . 2.6 mm? -77.03 121.92 24.21 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 123.152 0.581 . . . . 0.0 109.641 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 35.3 t -147.2 141.47 15.91 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.496 ' HD2' HG12 ' A' ' 609' ' ' VAL . 13.4 Cg_exo -66.22 -179.57 12.43 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.713 -1.37 . . . . 0.0 112.651 0.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.05 163.48 24.61 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.277 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.817 ' HG ' HG22 ' A' ' 574' ' ' ILE . 1.1 mm? -67.61 134.75 92.62 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.994 -169.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.22 172.45 7.53 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 123.832 3.021 . . . . 0.0 111.541 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 45.6 pt -114.03 169.6 5.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.032 0.444 . . . . 0.0 111.327 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.554 ' SG ' HD12 ' A' ' 578' ' ' LEU . 81.7 m -115.61 112.54 22.3 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.301 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.715 ' HD3' HG21 ' A' ' 604' ' ' VAL . 51.9 mtpt -95.61 -28.29 14.9 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 21.6 tt0 69.25 -66.73 0.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.223 1.009 . . . . 0.0 109.546 -176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -88.85 112.02 22.75 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.59 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 2.8 p -127.38 174.52 10.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 16.0 mm100 -93.84 155.78 17.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.564 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 16.2 m -104.92 -8.21 18.79 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.015 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 21.9 m 74.77 -3.26 2.63 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 166.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 64.73 -147.76 51.07 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.421 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.82 144.33 24.39 Favored 'Trans proline' 0 C--O 1.253 1.24 0 C-N-CA 122.658 2.238 . . . . 0.0 112.035 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.553 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 68.6 Cg_endo -70.78 167.38 25.94 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.821 3.014 . . . . 0.0 112.996 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.04 -179.5 4.38 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.792 2.328 . . . . 0.0 111.472 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -99.38 158.58 15.62 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 657' ' ' TYR . 16.0 tp -96.82 133.98 40.72 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 683' ' ' VAL . 2.0 pt? -50.37 -45.4 55.21 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -131.03 33.26 4.19 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.14 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -167.7 -148.32 5.63 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -162.41 177.66 9.34 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.573 HG22 ' CE1' ' A' ' 657' ' ' TYR . 5.2 t -78.54 133.13 30.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.536 ' HB2' ' NZ ' ' A' ' 642' ' ' LYS . 0.0 OUTLIER -90.78 -2.6 57.78 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.22 0.533 . . . . 0.0 110.563 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.514 ' OE2' ' HE3' ' A' ' 642' ' ' LYS . 74.0 mm-40 -104.19 151.9 22.79 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.694 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -50.91 109.77 0.36 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 112.545 -2.116 . . . . 0.0 109.871 169.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.601 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 4.1 p -85.33 102.98 13.84 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 121.906 0.86 . . . . 0.0 112.792 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 53.6 pttt -84.19 156.83 21.87 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.646 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.446 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 4.9 mp0 -74.71 -11.29 60.14 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.955 -173.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.503 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 7.4 tp10 -147.66 118.39 7.56 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.601 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 21.6 m-85 -97.64 -94.75 0.22 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 151.34 167.39 14.78 Favored Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.574 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.712 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 67.6 t60 -61.38 -44.16 97.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.343 0.592 . . . . 0.0 111.7 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 14.6 m -98.01 17.22 18.84 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.396 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 649' ' ' TYR . 2.9 tp10 -101.0 111.54 23.77 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.674 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.803 HG21 ' HB2' ' A' ' 670' ' ' LYS . 10.8 p -87.91 148.31 4.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.961 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -112.16 105.63 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.76 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.79 170.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 19.4 mt-10 -72.5 126.06 28.95 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.71 0.767 . . . . 0.0 109.592 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.586 ' HB3' HD22 ' A' ' 636' ' ' LEU . 49.7 m-85 -102.59 167.69 9.76 Favored 'General case' 0 C--N 1.268 -2.945 0 C-N-CA 124.311 1.044 . . . . 0.0 110.969 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.444 ' CD1' ' HB3' ' A' ' 642' ' ' LYS . 13.6 p90 -148.54 142.47 25.81 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.568 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 33.2 m -107.07 173.83 6.15 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 120.794 0.331 . . . . 0.0 111.861 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.443 ' HB2' ' HD1' ' A' ' 663' ' ' PHE . 7.2 m120 -61.82 150.79 81.39 Favored Pre-proline 0 C--O 1.243 0.763 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.577 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.55 39.14 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 124.826 3.684 . . . . 0.0 113.822 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -155.83 9.22 0.26 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.817 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 87.9 m-85 -126.32 150.17 48.68 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 120.96 0.409 . . . . 0.0 109.912 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 85.1 mt -93.49 134.5 35.69 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.742 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 3.3 ttt -96.25 101.39 13.02 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 685' ' ' ILE . 41.3 tptt -69.16 -65.17 0.74 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.69 -169.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.72 -161.69 37.7 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.704 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.43 124.66 14.64 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 123.239 2.626 . . . . 0.0 110.948 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 5.6 p-10 -76.39 -12.28 60.03 Favored 'General case' 0 C--O 1.171 -3.036 0 CA-C-O 121.672 0.748 . . . . 0.0 110.412 -177.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.803 ' HB2' HG21 ' A' ' 654' ' ' VAL . 0.0 OUTLIER -132.97 123.33 25.71 Favored 'General case' 2 N--CA 1.331 -6.424 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -171.397 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.612 HD12 ' HB3' ' A' ' 678' ' ' TRP . 43.4 pt -122.0 138.95 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.78 -172.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.57 161.03 15.22 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 38.3 t -94.0 104.58 16.61 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 118.451 -1.3 . . . . 0.0 111.876 -176.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . 0.262 32.7 m -81.62 88.36 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-O 123.017 1.389 . . . . 0.0 113.126 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.59 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 24.9 t70 89.98 -61.25 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.871 0 CA-C-N 112.094 -2.321 . . . . 0.0 111.224 170.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -159.0 12.98 0.21 Allowed Glycine 0 C--N 1.268 -3.207 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.707 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.48 130.58 38.77 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.612 ' HB3' HD12 ' A' ' 671' ' ' ILE . 94.6 m95 -72.95 152.77 41.25 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 2.2 p -74.46 176.91 6.37 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 14.2 m -61.56 125.84 25.23 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.068 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 6.3 mp -62.62 154.83 72.22 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.744 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 17.8 Cg_endo -61.73 -19.68 66.2 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 C-N-CA 123.464 2.776 . . . . 0.0 114.136 -177.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.522 ' HA ' HD21 ' A' ' 637' ' ' LEU . 17.2 m 39.78 83.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 175.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.742 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 62.8 m -79.77 146.75 32.16 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.27 -174.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -127.83 149.34 32.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.483 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.82 139.35 21.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 120.792 0.33 . . . . 0.0 111.318 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--O 1.254 1.323 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.155 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 . . . . . 0 C--O 1.236 0.376 0 CA-C-O 120.228 0.061 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 62.0 98.46 0.03 OUTLIER 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.667 1.187 . . . . 0.0 113.623 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -81.34 -13.51 58.3 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.515 176.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 172.26 -126.28 1.26 Allowed Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -167.75 -63.22 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 567' ' ' ARG . 25.8 mmt180 -89.36 69.08 8.06 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.915 0.864 . . . . 0.0 110.78 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.29 171.65 8.79 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.614 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 83.2 m -89.53 148.03 23.63 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.93 0.395 . . . . 0.0 111.237 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.18 134.14 49.01 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 172.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.657 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.4 tt -52.18 111.4 2.48 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.079 0.952 . . . . 0.0 108.885 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.497 ' HG2' HD21 ' A' ' 620' ' ' LEU . 58.8 Cg_endo -76.68 -174.67 2.24 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.913 2.409 . . . . 0.0 111.417 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -87.4 86.96 7.29 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.751 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.877 HG13 ' H ' ' A' ' 575' ' ' ASP . 11.1 pt -55.81 -72.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.739 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.877 ' H ' HG13 ' A' ' 574' ' ' ILE . 12.1 t70 -173.93 -172.36 0.72 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.39 -30.73 2.99 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -95.63 11.31 33.7 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.242 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.7 tt -111.82 139.89 46.92 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.96 121.28 12.36 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.657 ' HG3' HD11 ' A' ' 571' ' ' LEU . 54.8 Cg_endo -75.05 152.39 40.49 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.603 2.202 . . . . 0.0 111.22 174.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.02 -46.02 62.87 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.34 0.591 . . . . 0.0 109.895 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 582' ' ' ARG . . . . . 0.481 ' HA ' ' HD3' ' A' ' 582' ' ' ARG . 2.4 mmt180 -84.15 139.54 32.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.872 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -137.48 107.95 6.52 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 14.2 ptpt -146.9 172.77 13.17 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.66 -65.49 0.78 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -117.22 145.09 44.13 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.5 0.667 . . . . 0.0 110.162 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.614 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 39.3 m-85 -105.27 125.88 51.48 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -78.87 153.4 30.59 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.536 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.41 121.16 7.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.326 0.584 . . . . 0.0 110.156 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 105.73 -8.9 43.72 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.747 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.31 126.19 28.48 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 117.876 0.838 . . . . 0.0 109.864 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 608' ' ' SER . 14.3 t -99.67 121.78 50.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 608' ' ' SER . 5.2 mp -104.24 107.9 19.02 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 9.0 mtmp? -82.31 112.02 18.91 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 64.1 m-85 -90.37 164.88 14.15 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 56.3 m -153.97 179.45 8.9 Favored 'General case' 0 N--CA 1.402 -2.869 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 89.4 m -120.22 177.44 5.01 Favored 'General case' 0 C--N 1.26 -3.31 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.561 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 33.0 mmmt -58.17 164.12 3.86 Favored Pre-proline 0 C--N 1.316 -0.89 0 C-N-CA 123.819 0.847 . . . . 0.0 111.676 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 74.3 Cg_exo -47.69 -42.0 30.39 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 124.356 3.37 . . . . 0.0 114.818 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.8 -0.23 62.4 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.513 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -102.93 151.85 21.99 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-O 121.975 0.893 . . . . 0.0 112.545 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.556 HG21 HG11 ' A' ' 627' ' ' VAL . 54.1 m -108.2 128.74 54.98 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.108 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.451 HD11 ' HG3' ' A' ' 621' ' ' PRO . 11.3 tt -80.08 123.39 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 173.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.782 HG21 ' HD3' ' A' ' 624' ' ' LYS . 53.2 t -114.47 118.57 58.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 120.945 0.403 . . . . 0.0 110.61 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 116.23 -156.43 15.64 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.58 124.95 13.54 Favored 'Trans proline' 0 C--O 1.221 -0.352 0 C-N-CA 123.2 2.6 . . . . 0.0 110.989 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.38 -45.66 11.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.577 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 35.5 p -100.1 119.73 38.76 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 18.2 m -115.22 155.02 16.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 610' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.74 155.62 17.8 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.361 0.601 . . . . 0.0 109.893 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 8.3 t -88.05 125.26 34.46 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.64 168.88 9.49 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.66 3.07 6.85 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.003 0.82 . . . . 0.0 111.972 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -115.93 2.15 13.47 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.825 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 125.69 -174.11 17.61 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.973 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.475 HD23 ' HD3' ' A' ' 572' ' ' PRO . 2.8 mm? -77.81 125.33 29.17 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 618' ' ' PRO . 50.4 m -145.58 152.86 50.3 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.409 ' O ' ' HA ' ' A' ' 617' ' ' SER . 73.0 Cg_endo -72.26 -165.48 3.54 Favored 'Cis proline' 0 N--CA 1.486 1.079 0 CA-C-N 119.764 0.952 . . . . 0.0 114.554 4.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -55.24 137.62 46.9 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.107 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.639 HD23 HG22 ' A' ' 574' ' ' ILE . 5.7 mp -72.61 147.66 89.64 Favored Pre-proline 0 C--N 1.287 -2.116 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.431 -173.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.509 ' HG2' HD11 ' A' ' 578' ' ' LEU . 72.1 Cg_endo -73.36 178.98 5.94 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 123.103 2.535 . . . . 0.0 113.479 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 45.3 pt -127.37 171.34 15.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 96.8 m -115.77 114.67 25.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.967 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.782 ' HD3' HG21 ' A' ' 604' ' ' VAL . 27.3 mtpp -108.89 120.45 42.55 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.682 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -84.34 -24.42 29.78 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -108.78 116.76 32.6 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.029 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 602' ' ' THR . 4.8 m -129.59 -178.56 2.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.317 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -97.22 179.44 4.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.554 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 20.0 m -115.73 -7.15 12.12 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.144 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 66.5 m 72.1 -28.78 0.19 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 83.08 -147.73 24.97 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.9 142.79 39.65 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.984 1.789 . . . . 0.0 110.727 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.538 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 72.2 Cg_endo -73.6 168.79 23.88 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 123.189 2.593 . . . . 0.0 112.095 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.66 -179.3 3.63 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 122.695 2.263 . . . . 0.0 111.846 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -100.81 156.27 17.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.727 HD22 ' HB3' ' A' ' 657' ' ' TYR . 14.8 tp -87.88 150.47 23.48 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 683' ' ' VAL . 0.0 OUTLIER -57.89 -54.25 49.0 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.494 ' HB2' HD22 ' A' ' 637' ' ' LEU . 5.3 m-80 -130.17 41.49 3.4 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 122.34 1.067 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -161.57 -156.82 8.51 Favored Glycine 0 N--CA 1.411 -2.988 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 640' ' ' ASN . . . . . 0.557 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 57.7 t30 -153.12 -176.37 5.75 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.432 HG11 ' CG2' ' A' ' 645' ' ' THR . 7.6 p -95.57 136.18 27.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -89.6 -24.61 21.65 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.895 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -79.07 163.29 25.25 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.394 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -84.01 115.17 22.2 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.432 ' CG2' HG11 ' A' ' 641' ' ' VAL . 12.2 p -69.22 97.43 0.93 Allowed 'General case' 0 N--CA 1.413 -2.285 0 O-C-N 124.177 0.923 . . . . 0.0 112.3 -177.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 48.9 pttt -76.22 160.19 29.93 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.57 -7.0 58.73 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.4 0.619 . . . . 0.0 111.298 -171.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -141.06 105.46 4.85 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.555 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 6.9 m-85 -85.69 -76.31 0.34 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 124.46 163.92 11.8 Favored Glycine 0 C--N 1.284 -2.343 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.158 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.451 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.2 t60 -66.79 142.94 57.19 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.258 5.9 p 62.78 9.74 3.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.889 1.276 . . . . 0.0 114.259 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.453 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 4.2 tp10 -87.58 116.66 25.85 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.618 ' CG2' ' HB2' ' A' ' 670' ' ' LYS . 4.1 p -92.1 152.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.823 0.82 . . . . 0.0 111.22 -176.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 26.9 m -122.27 113.31 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.58 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.691 175.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.538 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 21.7 mt-10 -76.85 131.34 38.58 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.681 0.753 . . . . 0.0 111.6 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.727 ' HB3' HD22 ' A' ' 636' ' ' LEU . 56.6 m-85 -111.36 160.76 16.76 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 125.106 1.362 . . . . 0.0 111.389 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.557 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 10.5 p90 -145.03 134.51 23.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.625 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 27.9 m -100.3 171.34 7.84 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.392 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -60.07 154.23 51.58 Favored Pre-proline 0 C--N 1.314 -0.967 0 O-C-N 124.184 0.927 . . . . 0.0 110.917 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.15 35.69 0.35 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 124.308 3.339 . . . . 0.0 112.864 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -136.83 4.78 2.81 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.674 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 72.0 m-85 -136.23 156.98 47.89 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.1 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.73 ' HG ' ' HG2' ' A' ' 687' ' ' GLU . 80.4 mt -115.07 146.31 41.43 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.816 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -82.52 142.32 31.94 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 118.437 0.562 . . . . 0.0 110.295 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.569 ' HB3' HG23 ' A' ' 683' ' ' VAL . 2.0 tpmt? -92.56 -41.62 10.14 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.303 0.573 . . . . 0.0 109.736 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -116.32 -163.25 13.36 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.765 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.96 129.31 26.92 Favored 'Trans proline' 0 C--O 1.22 -0.402 0 C-N-CA 123.934 3.09 . . . . 0.0 110.51 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 9.5 p-10 -68.66 -14.21 62.87 Favored 'General case' 0 C--O 1.178 -2.696 0 CA-C-O 121.327 0.584 . . . . 0.0 111.534 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.618 ' HB2' ' CG2' ' A' ' 654' ' ' VAL . 12.1 ptmt -130.13 145.57 51.71 Favored 'General case' 0 C--N 1.25 -3.742 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -174.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.663 HD12 ' HB3' ' A' ' 678' ' ' TRP . 35.8 pt -135.22 145.6 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -121.54 148.54 44.35 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.386 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 12.9 t -72.42 113.59 9.62 Favored 'General case' 0 CA--C 1.468 -2.206 0 CA-C-O 122.381 1.086 . . . . 0.0 109.794 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.451 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 44.2 t -105.65 111.58 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.811 0 CA-C-N 112.341 -2.209 . . . . 0.0 108.499 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.78 -75.97 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.619 1.168 . . . . 0.0 111.955 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -157.65 26.29 0.46 Allowed Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.3 143.81 32.96 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.663 ' HB3' HD12 ' A' ' 671' ' ' ILE . 92.4 m95 -87.85 161.48 17.49 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.577 0.626 . . . . 0.0 109.753 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 15.4 p -76.2 172.37 12.96 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.924 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 24.9 m -67.1 135.14 53.14 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.035 0.445 . . . . 0.0 110.931 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.6 ' CD2' HD13 ' A' ' 671' ' ' ILE . 50.9 mt -61.53 151.58 77.21 Favored Pre-proline 0 N--CA 1.42 -1.926 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.154 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.816 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 11.7 Cg_endo -53.25 -18.89 11.31 Favored 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 124.752 3.635 . . . . 0.0 115.362 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 666' ' ' LYS 0.25 16.9 m 41.89 91.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 174.484 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.674 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 4.3 p -87.33 150.38 23.89 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.58 150.74 34.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.648 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.67 135.83 25.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 O-C-N 123.778 0.673 . . . . 0.0 110.762 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.73 ' HG2' ' HG ' ' A' ' 664' ' ' LEU . 42.2 mt-10 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.526 -0.75 . . . . 0.0 109.567 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -49.98 -32.3 14.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.092 0.957 . . . . 0.0 113.034 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -89.31 75.73 7.68 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 121.6 -0.688 . . . . 0.0 109.167 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -92.0 -20.88 34.86 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.749 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -109.28 151.06 27.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.35 142.51 53.97 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.348 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -133.96 -179.96 5.87 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.686 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 55.8 m -86.11 147.79 25.99 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.1 0.476 . . . . 0.0 111.014 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 571' ' ' LEU . 45.9 tt0 -125.47 -8.36 6.9 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.636 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 63.2 tp 79.06 115.33 0.03 OUTLIER Pre-proline 0 C--O 1.244 0.778 0 C-N-CA 125.239 1.416 . . . . 0.0 110.068 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.521 ' HD2' HD12 ' A' ' 571' ' ' LEU . 69.7 Cg_endo -71.5 -168.31 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.668 2.246 . . . . 0.0 110.134 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 573' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 573' ' ' LYS . 32.2 mmtp -87.37 102.93 15.01 Favored 'General case' 0 N--CA 1.41 -2.452 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.728 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.758 HG22 HD23 ' A' ' 620' ' ' LEU . 36.4 pt -70.04 -170.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.973 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.91 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 7.9 t70 -70.75 155.57 40.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.42 -28.16 37.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 121.839 0.828 . . . . 0.0 109.412 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -96.65 6.49 48.61 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.275 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.91 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.8 tm? -97.3 144.07 27.44 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.413 ' N ' HD13 ' A' ' 578' ' ' LEU . 2.3 t -140.37 115.13 7.58 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -76.28 137.71 19.26 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.879 2.386 . . . . 0.0 112.731 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -55.97 -55.95 26.56 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.334 1.454 . . . . 0.0 111.423 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 582' ' ' ARG . . . . . 0.52 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 55.0 mmt-85 -59.07 -59.91 4.71 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.856 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 53.57 82.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.647 1.217 . . . . 0.0 111.068 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.504 ' HE3' ' HB3' ' A' ' 582' ' ' ARG . 15.4 ptpt -143.26 163.71 32.21 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.91 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.16 -57.09 14.31 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 123.837 0.71 . . . . 0.0 111.261 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -124.84 142.82 51.18 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.094 0.473 . . . . 0.0 110.041 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.686 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 95.0 m-85 -102.59 126.73 49.77 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.847 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -79.74 151.75 30.23 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.092 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 45.6 t -60.87 118.06 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 104.18 -5.76 45.95 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.447 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -69.01 129.47 40.03 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 17.8 m -97.26 118.9 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-O 122.509 1.147 . . . . 0.0 109.867 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.403 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 5.6 mp -95.49 96.87 9.37 Favored 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.615 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 57.2 mtmt -80.75 109.86 15.7 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.643 ' HB3' HD11 ' A' ' 578' ' ' LEU . 64.9 m-85 -92.26 162.72 14.18 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 16.9 t -158.26 176.46 12.44 Favored 'General case' 0 N--CA 1.393 -3.286 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 88.3 m -121.24 172.17 8.19 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 70.2 mmtt -53.8 159.95 2.38 Favored Pre-proline 0 C--N 1.319 -0.751 0 C-N-CA 124.024 0.929 . . . . 0.0 112.169 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 12.1 Cg_endo -69.27 109.55 2.24 Favored 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.036 1.824 . . . . 0.0 109.366 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 122.52 -17.33 8.37 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -101.07 157.75 16.53 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 122.128 0.966 . . . . 0.0 112.48 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.56 HG21 HG11 ' A' ' 627' ' ' VAL . 18.5 m -109.04 130.55 55.48 Favored 'General case' 0 N--CA 1.402 -2.869 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.777 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 11.2 tt -85.68 122.01 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.476 HG21 ' HD3' ' A' ' 624' ' ' LYS . 54.0 t -112.72 127.45 69.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 112.95 -166.35 12.13 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.11 126.54 17.37 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.988 2.459 . . . . 0.0 110.761 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -86.13 -38.27 17.91 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.745 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.603 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 34.4 p -114.64 111.27 21.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.995 0.426 . . . . 0.0 110.96 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.2 m -104.79 153.82 6.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 610' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -99.08 147.91 24.58 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.452 ' HA ' HD23 ' A' ' 616' ' ' LEU . 17.6 t -83.23 124.31 30.43 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 170.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.587 ' CD2' ' HB3' ' A' ' 617' ' ' SER . 91.7 m-85 -110.59 171.88 7.2 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.68 7.23 3.18 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -117.58 -9.04 10.87 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 133.07 -174.37 20.61 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 611' ' ' CYS . 91.4 mt -70.9 138.77 50.41 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 122.976 0.51 . . . . 0.0 111.377 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.587 ' HB3' ' CD2' ' A' ' 612' ' ' TYR . 44.7 t -152.55 141.41 14.12 Favored Pre-proline 0 N--CA 1.424 -1.773 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 617' ' ' SER . 60.4 Cg_endo -72.94 -172.01 9.15 Favored 'Cis proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.081 -1.633 . . . . 0.0 113.197 0.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.9 151.73 38.43 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.111 0.481 . . . . 0.0 111.255 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.758 HD23 HG22 ' A' ' 574' ' ' ILE . 6.1 mp -67.13 145.11 98.69 Favored Pre-proline 0 C--N 1.309 -1.169 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -170.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.68 175.21 8.33 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 123.93 3.087 . . . . 0.0 112.018 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 38.4 pt -127.53 174.05 11.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.6 m -121.89 122.32 39.14 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.956 0.408 . . . . 0.0 111.5 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.476 ' HD3' HG21 ' A' ' 604' ' ' VAL . 53.8 mtpt -119.58 125.74 49.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -82.97 -40.03 20.59 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 121.547 0.689 . . . . 0.0 109.715 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -102.05 100.25 10.49 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.879 0.847 . . . . 0.0 110.45 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 602' ' ' THR . 8.0 m -107.76 174.13 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.588 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -98.99 143.99 28.66 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.234 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 38.2 m -97.49 -2.17 42.52 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 98.5 m 74.33 -42.75 0.51 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.958 1.303 . . . . 0.0 113.646 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 105.33 -141.47 15.35 Favored Glycine 0 N--CA 1.417 -2.632 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.8 139.46 13.96 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.259 1.972 . . . . 0.0 110.83 174.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.579 ' HG3' HG11 ' A' ' 655' ' ' VAL . 57.6 Cg_endo -68.33 161.57 44.17 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 123.268 2.645 . . . . 0.0 112.707 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.86 176.45 6.06 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.915 2.41 . . . . 0.0 111.677 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.82 163.11 14.55 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 1.044 HD21 ' SG ' ' A' ' 659' ' ' CYS . 9.1 tp -90.27 156.69 18.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 637' ' ' LEU 0.285 2.1 pt? -77.05 -45.46 27.06 Favored 'General case' 0 N--CA 1.406 -2.672 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.495 -178.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -125.64 33.77 5.04 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.558 0.694 . . . . 0.0 110.904 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.775 ' HA3' HD23 ' A' ' 636' ' ' LEU . . . -160.75 -140.76 2.96 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.556 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -157.87 -169.82 2.96 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.0 p -102.97 132.43 49.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.645 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.9 ptmt -87.22 -13.83 42.76 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.831 0.824 . . . . 0.0 110.256 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.402 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 40.0 mm-40 -88.58 140.39 29.51 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.843 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 644' ' ' LYS . . . . . 0.764 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -55.8 121.34 9.0 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 124.161 0.913 . . . . 0.0 108.631 171.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.41 HG21 HG11 ' A' ' 641' ' ' VAL . 3.7 p -94.67 99.67 11.74 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 53.4 pttt -82.99 167.5 17.88 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.322 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -88.78 1.81 54.59 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.61 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 34.3 tt0 -151.73 108.4 3.49 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.487 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 4.9 m-85 -84.55 -93.93 0.07 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 151.78 159.79 9.13 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 54.3 t60 -51.61 -59.14 4.6 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 37.2 m -91.67 21.08 4.95 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.364 0.602 . . . . 0.0 110.691 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -104.03 113.37 26.86 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 670' ' ' LYS . 8.8 p -94.17 159.47 2.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.868 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.7 t -124.07 114.05 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.879 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.645 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 21.7 mt-10 -71.88 128.43 35.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.489 0.661 . . . . 0.0 111.876 174.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 42.0 m-85 -109.33 170.66 7.91 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 123.58 0.752 . . . . 0.0 110.799 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -148.48 132.2 16.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 1.044 ' SG ' HD21 ' A' ' 636' ' ' LEU . 95.9 m -97.1 172.62 7.72 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.948 176.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -64.9 152.95 89.64 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.003 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.27 35.42 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 124.554 3.503 . . . . 0.0 113.652 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.57 13.48 0.83 Allowed 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.349 -174.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.33 156.56 48.25 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.874 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.449 HD21 ' HG3' ' A' ' 687' ' ' GLU . 83.6 mt -101.07 143.45 31.17 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.716 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 2.5 ttt -107.57 108.88 20.37 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -78.7 -57.82 3.56 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.251 -173.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.24 -174.31 47.56 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.795 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.12 126.38 21.41 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 123.68 2.92 . . . . 0.0 110.868 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.664 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 16.3 p-10 -66.91 -13.05 61.33 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-O 121.026 0.441 . . . . 0.0 110.842 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 16.0 mtpt -118.48 151.38 37.93 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 38.0 pt -138.54 141.43 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -120.87 151.69 39.34 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.918 0.39 . . . . 0.0 111.073 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 19.0 t -81.73 99.73 9.11 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.752 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . 0.278 20.1 m -88.63 75.89 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 O-C-N 120.541 -1.349 . . . . 0.0 112.064 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.1 t70 63.85 66.17 0.67 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.642 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 88.34 -20.21 31.52 Favored Glycine 0 C--N 1.311 -0.846 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.173 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -118.01 113.91 22.36 Favored 'General case' 0 N--CA 1.423 -1.803 0 O-C-N 122.201 -0.588 . . . . 0.0 111.857 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.401 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.9 m95 -65.88 151.63 46.29 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 20.1 p -77.55 173.59 11.84 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.04 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 6.3 m -62.89 128.43 35.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.154 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.09 161.52 39.04 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.392 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.664 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 20.2 Cg_endo -62.6 -17.81 60.43 Favored 'Trans proline' 0 CA--C 1.507 -0.827 0 C-N-CA 123.416 2.744 . . . . 0.0 115.04 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.487 ' HA ' HD21 ' A' ' 637' ' ' LEU 0.258 30.3 m 41.58 94.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 175.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.716 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 69.9 m -92.84 154.95 17.94 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 685' ' ' ILE . 0.1 OUTLIER -140.17 152.46 21.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.609 -177.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.95 136.77 19.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.449 ' HG3' HD21 ' A' ' 664' ' ' LEU . 29.0 tt0 . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--O 1.237 0.435 0 CA-C-O 120.84 0.352 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -87.27 129.2 35.08 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -62.09 121.78 13.91 Favored 'General case' 0 C--O 1.254 1.322 0 O-C-N 123.668 0.605 . . . . 0.0 111.172 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -72.09 123.49 9.56 Favored Glycine 0 N--CA 1.436 -1.348 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.834 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 613' ' ' HIS . 9.7 tp10 -131.35 167.32 19.47 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -177.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -48.29 137.4 11.07 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 125.447 1.499 . . . . 0.0 112.495 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 568' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 586' ' ' GLN . 13.2 pt-20 -101.41 154.46 18.79 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.719 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 71.6 m -62.88 115.76 4.66 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 124.742 1.217 . . . . 0.0 113.201 -174.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.51 -12.85 58.69 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.505 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 41.7 tp 73.17 113.61 0.03 OUTLIER Pre-proline 0 CA--C 1.514 -0.442 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.078 -176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.453 ' HD2' HD12 ' A' ' 616' ' ' LEU . 44.3 Cg_endo -67.94 174.25 8.06 Favored 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.33 2.02 . . . . 0.0 111.052 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 573' ' ' LYS . . . . . 0.595 ' HD2' ' H ' ' A' ' 573' ' ' LYS 0.299 0.0 OUTLIER -73.68 102.2 3.87 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.47 177.217 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.579 HG22 HD23 ' A' ' 620' ' ' LEU . 40.7 pt -70.91 -171.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.671 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.9 t70 -72.93 146.35 46.15 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.69 -33.82 50.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.722 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -92.43 6.21 47.87 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.064 -0.398 . . . . 0.0 111.624 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.638 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.4 OUTLIER -101.64 150.11 23.44 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -176.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 9.7 m -143.79 121.83 6.94 Favored Pre-proline 0 C--N 1.306 -1.302 0 C-N-CA 123.932 0.893 . . . . 0.0 110.118 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 595' ' ' PHE . 26.2 Cg_endo -72.83 142.73 35.81 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.378 1.385 . . . . 0.0 109.398 171.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.69 -33.72 68.67 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.552 0.691 . . . . 0.0 110.301 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 582' ' ' ARG . . . . . 0.499 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 75.5 mmt-85 -75.33 -70.16 0.44 Allowed 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.133 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.442 ' HB2' ' HG2' ' A' ' 580' ' ' PRO 0.296 53.0 tttp 52.29 79.67 0.11 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.768 -170.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.578 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 18.1 ptpt -129.23 164.34 23.67 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.437 -1.711 . . . . 0.0 106.475 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -65.28 -48.32 73.61 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 586' ' ' GLN . . . . . 0.546 ' HB3' ' HG3' ' A' ' 568' ' ' GLU . 22.0 mp0 -131.67 143.44 50.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.153 0.501 . . . . 0.0 110.408 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.719 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 76.9 m-85 -107.72 121.1 44.02 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 124.025 0.93 . . . . 0.0 109.145 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -66.0 144.53 56.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 60.4 t -55.03 120.65 2.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 109.59 -13.83 32.67 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.887 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -71.49 123.74 23.08 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 10.0 p -94.35 134.45 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.537 0 C-N-CA 119.419 -0.912 . . . . 0.0 108.834 174.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 608' ' ' SER . 3.4 mp -108.04 117.47 34.23 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.561 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 57.1 mttp -94.48 103.32 15.29 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.458 ' HB3' HD21 ' A' ' 578' ' ' LEU . 64.3 m-85 -78.29 152.6 32.38 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 22.6 t -148.95 161.28 42.2 Favored 'General case' 0 N--CA 1.391 -3.376 0 N-CA-C 103.36 -2.83 . . . . 0.0 103.36 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 90.7 m -107.41 177.88 4.71 Favored 'General case' 0 C--N 1.25 -3.721 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 36.7 mmtm -56.12 161.34 3.84 Favored Pre-proline 0 N--CA 1.441 -0.891 0 C-N-CA 123.086 0.554 . . . . 0.0 111.209 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 93.1 Cg_exo -43.39 -47.26 9.22 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 124.337 3.358 . . . . 0.0 114.475 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -91.41 4.1 79.83 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 121.173 -0.536 . . . . 0.0 112.584 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -108.25 137.09 46.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 121.893 0.854 . . . . 0.0 112.927 -176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 627' ' ' VAL . 20.5 m -93.65 131.87 38.53 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.723 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.479 HD11 ' HG3' ' A' ' 621' ' ' PRO . 11.9 tt -82.39 122.02 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.424 ' HB ' HG13 ' A' ' 622' ' ' ILE . 59.3 t -110.58 108.96 26.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 128.04 -162.4 21.84 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.53 131.0 26.53 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 123.096 2.531 . . . . 0.0 110.928 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -89.87 -47.86 7.61 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.561 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 62.0 p -106.25 102.62 12.01 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.729 0.776 . . . . 0.0 111.698 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 14.0 m -108.09 140.32 27.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 592' ' ' VAL . 2.0 mp0 -85.45 149.11 25.63 Favored 'General case' 0 CA--C 1.486 -1.509 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.38 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.468 ' HA ' HD23 ' A' ' 616' ' ' LEU . 35.0 t -78.47 124.97 28.72 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 114.733 -1.122 . . . . 0.0 108.362 169.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 93.3 m-85 -112.22 171.02 7.76 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 613' ' ' HIS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 566' ' ' GLU . 0.6 OUTLIER -67.33 -6.4 18.52 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -114.27 -0.25 13.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.285 0.564 . . . . 0.0 110.543 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 129.14 -175.17 18.97 Favored Glycine 0 N--CA 1.425 -2.071 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.721 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 611' ' ' CYS . 87.9 mt -70.04 131.22 44.01 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.442 0.297 . . . . 0.0 110.64 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.464 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 73.2 m -149.28 143.71 17.21 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 177.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 617' ' ' SER . 59.2 Cg_endo -69.1 -169.63 4.88 Favored 'Cis proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.123 -1.199 . . . . 0.0 113.95 0.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.7 151.66 37.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.828 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.579 HD23 HG22 ' A' ' 574' ' ' ILE . 6.4 mp -71.86 143.71 87.11 Favored Pre-proline 0 C--N 1.289 -2.047 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.157 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.479 ' HG3' HD11 ' A' ' 603' ' ' ILE . 98.3 Cg_endo -76.02 179.55 6.2 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.965 3.11 . . . . 0.0 112.917 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 622' ' ' ILE . . . . . 0.424 HG13 ' HB ' ' A' ' 604' ' ' VAL . 46.3 pt -126.27 177.16 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.084 176.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.541 ' SG ' HD12 ' A' ' 578' ' ' LEU . 94.4 m -121.11 115.55 23.31 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 123.424 0.689 . . . . 0.0 110.748 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.582 ' O ' ' HB ' ' A' ' 602' ' ' THR . 43.4 mtmt -121.87 128.53 51.71 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.978 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.25 -41.47 25.02 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -98.13 112.81 24.64 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.183 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 602' ' ' THR . 1.4 m -120.83 178.1 2.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 124.535 1.134 . . . . 0.0 108.349 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -97.59 167.02 11.23 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 14.0 m -105.05 -15.23 15.15 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.673 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 86.0 m 73.35 7.63 5.2 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.457 1.103 . . . . 0.0 113.052 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 57.65 -136.61 50.57 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.765 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.77 153.58 22.93 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.824 2.349 . . . . 0.0 110.991 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.569 ' HG3' HG11 ' A' ' 655' ' ' VAL . 73.7 Cg_endo -79.42 166.75 21.94 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.302 2.001 . . . . 0.0 111.014 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.38 -166.68 0.28 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.399 2.066 . . . . 0.0 110.626 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -113.19 170.78 7.97 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.527 HD23 ' HA3' ' A' ' 639' ' ' GLY . 17.0 tp -85.41 164.05 18.14 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.439 ' H ' HD12 ' A' ' 637' ' ' LEU . 4.8 mp -56.94 -71.65 0.09 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.083 0.944 . . . . 0.0 110.308 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -105.3 -27.1 11.72 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.764 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.632 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -86.2 -150.08 14.89 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.699 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 640' ' ' ASN . . . . . 0.416 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 48.5 t30 -155.1 -171.28 3.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.655 HG22 ' CE2' ' A' ' 657' ' ' TYR . 18.6 t -96.4 127.65 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.729 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -87.64 -21.85 25.06 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.386 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -75.72 169.47 18.06 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.22 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -88.6 131.62 34.88 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.659 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 24.5 p -87.65 118.18 26.97 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.402 0.62 . . . . 0.0 112.222 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -84.6 167.96 15.79 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.417 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 45.2 mt-10 -94.35 -10.14 33.59 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -151.56 101.72 2.82 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.39 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.56 ' CE2' HG22 ' A' ' 655' ' ' VAL . 6.7 m-85 -80.66 -85.74 0.09 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 139.05 160.93 8.54 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.3 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.541 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 60.5 t60 -62.54 130.6 45.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 652' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 39.5 m 69.6 10.24 7.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.67 1.188 . . . . 0.0 113.508 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 7.6 tp10 -88.7 120.71 30.34 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 19.7 m -91.25 160.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-O 122.307 1.051 . . . . 0.0 113.622 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 4.5 t -132.53 112.18 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-N 113.657 -1.61 . . . . 0.0 108.227 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 669' ' ' ASN . 32.5 mt-10 -73.43 135.66 44.18 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.249 1.023 . . . . 0.0 113.226 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.655 ' CE2' HG22 ' A' ' 641' ' ' VAL . 72.3 m-85 -114.75 172.56 6.96 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 126.441 1.896 . . . . 0.0 109.559 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 6.2 p90 -155.42 143.76 20.23 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.632 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.8 t -112.85 174.26 5.98 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.237 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 46.8 m-80 -64.9 155.96 81.45 Favored Pre-proline 0 C--N 1.317 -0.815 0 O-C-N 123.395 0.435 . . . . 0.0 110.378 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 70.5 Cg_endo -73.16 42.91 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 124.181 3.254 . . . . 0.0 113.39 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 662' ' ' ARG . 2.5 ptt180 -151.25 11.15 0.61 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 124.038 0.935 . . . . 0.0 110.473 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.436 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 89.3 m-85 -128.66 152.13 48.73 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.786 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 77.9 mt -101.35 142.04 33.34 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 2.5 ttt -108.71 102.41 11.46 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -79.07 -51.81 9.05 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.262 -170.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.5 -163.42 38.47 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.448 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 668' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 670' ' ' LYS . 63.4 Cg_endo -73.33 120.1 6.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.882 2.388 . . . . 0.0 111.387 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 656' ' ' GLU . 3.3 p-10 -81.33 28.18 0.39 Allowed 'General case' 0 C--O 1.19 -2.044 0 O-C-N 121.991 -0.443 . . . . 0.0 111.416 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.783 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 7.7 ptmt -164.04 108.7 1.0 Allowed 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 125.549 1.54 . . . . 0.0 108.336 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.661 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 38.7 pt -109.15 152.6 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.763 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.753 -173.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 9.7 pt20 -119.07 160.32 22.27 Favored 'General case' 0 N--CA 1.421 -1.919 0 O-C-N 124.094 0.871 . . . . 0.0 110.323 -174.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.5 t -87.17 112.06 21.59 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.399 1.095 . . . . 0.0 110.828 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 84.8 t -103.51 107.04 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.777 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.541 ' H ' ' CE1' ' A' ' 651' ' ' HIS . 25.3 t70 65.1 -69.29 0.1 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 126.456 1.902 . . . . 0.0 111.744 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -158.16 21.54 0.36 Allowed Glycine 0 N--CA 1.422 -2.252 0 O-C-N 123.831 0.707 . . . . 0.0 111.472 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -136.55 149.74 48.26 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.525 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.4 m95 -83.0 161.22 21.81 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 11.9 p -81.85 175.32 10.51 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 120.875 0.369 . . . . 0.0 111.715 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 28.4 m -58.39 125.73 24.55 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.835 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.446 ' HA ' HG21 ' A' ' 671' ' ' ILE . 6.4 mp -62.34 165.16 9.39 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.554 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.606 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 19.8 Cg_endo -63.32 -21.51 71.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.343 2.029 . . . . 0.0 113.13 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 61.8 t 50.0 96.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.564 1.146 . . . . 0.0 112.376 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 22.5 p -97.21 133.32 41.99 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.235 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.56 147.72 32.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.195 -176.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 47.6 t -55.78 135.35 19.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 O-C-N 123.81 0.694 . . . . 0.0 110.628 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.437 -1.115 0 O-C-N 124.381 1.05 . . . . 0.0 108.828 178.826 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.24 0.583 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -140.84 113.95 8.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -96.48 148.04 23.22 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.547 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -155.13 17.92 0.54 Allowed Glycine 0 C--N 1.299 -1.511 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.06 10.4 6.93 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.064 0.459 . . . . 0.0 111.688 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -130.34 83.36 2.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 568' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 586' ' ' GLN . 21.3 mt-10 60.3 -170.27 0.15 Allowed 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.746 1.218 . . . . 0.0 112.803 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 20.1 m -63.45 -54.1 41.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.713 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 586' ' ' GLN . 39.3 tt0 70.05 130.2 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 125.4 1.48 . . . . 0.0 111.363 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.7 tt -66.01 119.88 64.9 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.474 ' HG2' HD11 ' A' ' 620' ' ' LEU . 72.3 Cg_endo -75.6 178.35 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.026 1.817 . . . . 0.0 111.111 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 573' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 573' ' ' LYS . 0.0 OUTLIER -78.37 103.83 8.56 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.416 0.627 . . . . 0.0 109.501 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.693 ' HA ' ' HG ' ' A' ' 620' ' ' LEU . 19.8 pt -75.27 -169.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.121 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.966 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.6 t70 -72.66 154.9 40.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.38 -30.03 45.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.262 0.553 . . . . 0.0 110.759 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -108.38 12.57 26.21 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.966 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.7 OUTLIER -92.82 153.69 18.71 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.511 ' N ' HD13 ' A' ' 578' ' ' LEU . 10.7 t -139.68 121.74 9.98 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.61 ' HD3' HD13 ' A' ' 574' ' ' ILE . 59.9 Cg_endo -80.35 138.32 12.38 Favored 'Trans proline' 0 N--CA 1.431 -2.169 0 C-N-CA 122.09 1.86 . . . . 0.0 111.645 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -65.41 -41.94 93.08 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 125.677 1.591 . . . . 0.0 112.074 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 26.9 mmt-85 -67.49 -65.77 0.65 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 64.8 74.13 0.4 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.691 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -142.7 146.27 34.22 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.77 -47.64 82.61 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 586' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 570' ' ' GLU . 23.3 mp0 -120.18 145.92 46.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.388 0.614 . . . . 0.0 111.527 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.659 ' CZ ' ' HG ' ' A' ' 593' ' ' LEU . 96.7 m-85 -116.64 160.62 20.44 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.893 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 588' ' ' LYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 591' ' ' GLU . 52.7 mtpt -94.65 152.88 18.13 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.478 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 14.6 m -63.98 137.52 24.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.333 173.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 91.38 -12.91 67.9 Favored Glycine 0 C--N 1.292 -1.903 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.874 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 591' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 588' ' ' LYS . 0.7 OUTLIER -66.37 137.68 57.06 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.551 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.589 HG12 ' HG3' ' A' ' 610' ' ' GLN . 20.0 m -110.25 128.26 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.618 0 CA-C-O 121.645 0.736 . . . . 0.0 109.252 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.659 ' HG ' ' CZ ' ' A' ' 587' ' ' TYR 0.4 0.0 OUTLIER -114.47 102.66 10.29 Favored 'General case' 0 N--CA 1.383 -3.806 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.427 176.516 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 35.4 mtmm -71.67 146.26 48.36 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 113.547 -1.661 . . . . 0.0 107.787 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.826 ' HB3' HD11 ' A' ' 578' ' ' LEU . 42.7 m-85 -125.17 171.12 10.58 Favored 'General case' 0 C--N 1.262 -3.234 0 CA-C-O 120.836 0.351 . . . . 0.0 111.491 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 596' ' ' SER . . . . . 0.412 ' HA ' HD12 ' A' ' 603' ' ' ILE . 23.1 t -171.68 -176.79 1.85 Allowed 'General case' 0 N--CA 1.41 -2.426 0 O-C-N 124.757 1.286 . . . . 0.0 107.585 166.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 84.9 m -114.05 162.0 17.01 Favored 'General case' 0 C--N 1.263 -3.179 0 O-C-N 123.607 0.567 . . . . 0.0 112.184 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 32.8 mmtp -52.25 160.64 1.2 Allowed Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 125.457 1.503 . . . . 0.0 113.241 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 37.9 Cg_exo -55.93 112.88 1.2 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.415 2.743 . . . . 0.0 110.576 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 121.93 -27.58 6.14 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.014 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -100.24 163.0 12.6 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-O 122.179 0.99 . . . . 0.0 112.672 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.42 HG23 ' CD2' ' A' ' 651' ' ' HIS . 19.3 m -119.76 130.47 54.98 Favored 'General case' 0 N--CA 1.394 -3.264 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.563 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.496 HD11 ' HG3' ' A' ' 621' ' ' PRO . 7.1 tt -82.19 130.39 35.86 Favored 'Isoleucine or valine' 0 C--O 1.256 1.406 0 CA-C-O 121.009 0.433 . . . . 0.0 109.991 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.468 HG21 ' HG3' ' A' ' 624' ' ' LYS . 93.0 t -126.95 131.2 71.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.11 -156.01 15.84 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -67.4 111.81 2.41 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.502 2.135 . . . . 0.0 111.306 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 5.7 m-80 -87.2 -12.67 46.12 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.341 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.564 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 9.9 p -146.81 102.79 3.57 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.96 0.41 . . . . 0.0 110.68 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 609' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 592' ' ' VAL . 23.8 m -96.95 162.04 2.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.254 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.589 ' HG3' HG12 ' A' ' 592' ' ' VAL . 1.4 mp0 -112.35 153.5 27.16 Favored 'General case' 0 CA--C 1.483 -1.63 0 CA-C-O 121.001 0.429 . . . . 0.0 110.214 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 589' ' ' VAL . 41.0 t -83.97 130.65 34.88 Favored 'General case' 0 N--CA 1.415 -2.221 0 C-N-CA 118.146 -1.421 . . . . 0.0 107.393 166.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 83.8 m-85 -114.24 170.34 8.37 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -64.51 -14.16 55.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -106.84 0.25 23.86 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.669 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.08 -176.31 19.36 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.945 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.407 HD12 HD11 ' A' ' 593' ' ' LEU . 3.0 mm? -74.26 124.81 27.11 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.425 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 68.3 m -147.07 144.94 20.56 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 122.084 -0.385 . . . . 0.0 111.7 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 617' ' ' SER . 48.1 Cg_endo -70.04 -168.77 4.76 Favored 'Cis proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.788 -1.338 . . . . 0.0 112.34 -2.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -80.15 -178.84 6.75 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.069 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.693 ' HG ' ' HA ' ' A' ' 574' ' ' ILE . 1.1 mm? -75.44 140.98 72.7 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -169.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.496 ' HG3' HD11 ' A' ' 603' ' ' ILE . 38.5 Cg_endo -67.9 175.39 6.47 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 124.43 3.42 . . . . 0.0 112.456 176.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.9 pt -114.0 173.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.533 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.0 m -117.79 115.58 25.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.185 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 626' ' ' GLN . 9.2 mmmm -105.4 120.32 41.29 Favored 'General case' 0 CA--C 1.474 -1.978 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.36 -30.12 33.86 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.336 -1.346 . . . . 0.0 107.872 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.475 ' O ' ' HE2' ' A' ' 624' ' ' LYS . 92.2 mt-30 -111.58 116.99 31.75 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.099 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.569 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 9.6 p -124.54 158.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 75.6 mm-40 -89.65 159.8 16.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 53.7 m -101.25 -3.16 29.48 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.515 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 73.2 m 69.42 12.45 8.28 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.309 1.044 . . . . 0.0 112.984 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 53.51 -136.5 40.05 Favored Glycine 0 N--CA 1.448 -0.558 0 O-C-N 123.79 0.681 . . . . 0.0 112.424 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.75 151.39 16.8 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.777 2.318 . . . . 0.0 110.703 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.553 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 63.3 Cg_endo -74.81 163.71 35.08 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.775 2.317 . . . . 0.0 112.788 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.448 ' HG2' HD11 ' A' ' 681' ' ' LEU . 55.3 Cg_endo -73.18 177.8 7.37 Favored 'Trans proline' 0 C--O 1.254 1.315 0 C-N-CA 122.734 2.29 . . . . 0.0 111.526 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -92.42 154.32 18.59 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.789 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 657' ' ' TYR . 20.8 tp -89.67 141.3 28.73 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -45.7 -41.84 11.01 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -176.017 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -129.19 -18.28 3.7 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -99.66 -142.92 13.66 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.795 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.01 -177.12 4.47 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.423 HG22 ' CE1' ' A' ' 657' ' ' TYR . 39.5 t -84.45 132.52 31.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.644 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.3 ptmt -88.1 -16.71 32.77 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.715 0.769 . . . . 0.0 109.986 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.421 ' H ' HG12 ' A' ' 641' ' ' VAL . 6.7 mm-40 -81.7 165.37 21.05 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.604 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -78.14 111.41 14.03 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 23.1 p -64.82 116.33 6.21 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.587 0.708 . . . . 0.0 111.487 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -101.1 168.08 9.82 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.975 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.427 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 35.7 mt-10 -90.77 -13.78 33.28 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.609 0.718 . . . . 0.0 109.148 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -144.58 105.6 4.19 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.124 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.553 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.8 m-85 -87.02 -84.73 0.17 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.948 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 143.52 154.04 6.03 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.774 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.42 ' CD2' HG23 ' A' ' 602' ' ' THR . 49.2 t60 -60.19 131.12 49.81 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 652' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 50.2 m 76.69 -0.69 2.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.393 1.077 . . . . 0.0 113.533 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.427 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 7.3 tp10 -79.85 122.96 27.3 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.729 HG11 ' HE3' ' A' ' 670' ' ' LYS . 0.3 OUTLIER -92.06 151.55 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.725 0 CA-C-O 122.215 1.007 . . . . 0.0 110.606 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -114.02 102.69 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.97 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.646 167.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.644 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 4.0 mt-10 -69.27 138.7 54.1 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.544 ' HB3' HD22 ' A' ' 636' ' ' LEU . 40.5 m-85 -113.12 161.02 17.6 Favored 'General case' 0 C--N 1.259 -3.344 0 C-N-CA 124.964 1.306 . . . . 0.0 110.401 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -145.11 135.02 23.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.666 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.2 t -100.56 -178.95 3.95 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.284 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -63.14 155.79 71.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.63 26.69 0.35 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.627 2.884 . . . . 0.0 113.477 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 662' ' ' ARG . 16.1 mmm180 -129.63 -1.45 4.87 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -118.56 161.38 20.14 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.349 0.595 . . . . 0.0 112.151 -170.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.406 HD11 ' HG3' ' A' ' 687' ' ' GLU . 86.7 mt -124.4 149.0 47.19 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.628 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -92.25 149.47 21.43 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 176.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -108.83 -45.99 3.71 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.177 0.513 . . . . 0.0 109.689 174.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.77 -175.95 42.75 Favored Glycine 0 C--N 1.306 -1.133 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 668' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 682' ' ' PRO . 27.5 Cg_endo -62.0 124.58 14.7 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.134 2.556 . . . . 0.0 111.765 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.601 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 21.3 p-10 -73.67 31.77 0.08 Allowed 'General case' 0 C--O 1.188 -2.167 0 C-N-CA 123.393 0.677 . . . . 0.0 111.084 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.729 ' HE3' HG11 ' A' ' 654' ' ' VAL . 13.7 ptmt -172.32 138.26 0.93 Allowed 'General case' 0 C--N 1.258 -3.375 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -173.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.607 ' N ' HG22 ' A' ' 654' ' ' VAL . 37.3 pt -138.69 139.13 41.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 0.1 OUTLIER -109.35 151.2 26.92 Favored 'General case' 0 C--N 1.27 -2.857 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.015 -178.266 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 3.6 t -69.3 118.07 11.73 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.198 0.999 . . . . 0.0 111.455 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 89.2 t -105.53 82.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.857 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.243 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.569 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 29.1 t70 80.6 -59.24 0.29 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 112.328 -2.215 . . . . 0.0 112.606 171.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -150.36 4.6 0.6 Allowed Glycine 0 C--N 1.292 -1.873 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.285 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.29 153.03 46.34 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.588 ' HB3' HD12 ' A' ' 671' ' ' ILE . 95.7 m95 -84.66 165.55 17.82 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 679' ' ' THR . . . . . 0.459 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 2.1 p -86.61 -178.65 6.44 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 9.6 m -65.57 133.69 51.72 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.574 0.75 . . . . 0.0 110.101 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.448 HD11 ' HG2' ' A' ' 634' ' ' PRO . 8.3 mp -70.83 158.84 87.15 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.628 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 20.8 Cg_endo -61.44 -16.12 45.41 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 124.639 3.559 . . . . 0.0 115.617 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.263 26.9 m 45.24 90.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 18.5 p -92.85 144.96 24.76 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.147 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.69 150.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.029 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.34 140.46 19.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 O-C-N 123.409 0.443 . . . . 0.0 110.754 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.406 ' HG3' HD11 ' A' ' 664' ' ' LEU . 43.6 tt0 . . . . . 0 C--O 1.248 1.012 0 C-N-CA 124.841 1.256 . . . . 0.0 110.759 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.225 -0.233 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -70.04 -42.24 73.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.022 0.439 . . . . 0.0 110.146 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -94.28 83.19 4.18 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 95.43 104.69 2.02 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -112.25 116.97 31.28 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -133.64 139.21 46.35 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 568' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 586' ' ' GLN . 17.6 mm-40 -78.74 104.03 9.09 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.688 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 3.1 m 33.73 -67.57 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 130.121 3.368 . . . . 0.0 115.995 -171.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 585' ' ' ASP . 54.3 mt-10 83.47 176.46 0.07 Allowed 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 128.635 2.774 . . . . 0.0 110.536 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.699 HD11 ' HG3' ' A' ' 580' ' ' PRO . 1.2 tt -119.59 105.83 43.05 Favored Pre-proline 0 N--CA 1.398 -3.038 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.697 ' HG2' HD11 ' A' ' 620' ' ' LEU . 36.7 Cg_endo -66.33 -176.97 0.74 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.885 2.39 . . . . 0.0 111.104 177.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -86.18 84.34 7.51 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.347 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.798 HG13 ' H ' ' A' ' 575' ' ' ASP . 6.8 pt -52.08 -65.68 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.853 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.798 ' H ' HG13 ' A' ' 574' ' ' ILE . 13.3 t70 -176.32 -168.55 0.26 Allowed 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.55 -22.66 4.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -104.08 16.7 25.69 Favored 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.147 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.8 tt -115.21 143.36 45.36 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -176.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.39 121.55 7.09 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-O 121.188 0.518 . . . . 0.0 111.015 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.699 ' HG3' HD11 ' A' ' 571' ' ' LEU . 31.8 Cg_endo -69.29 142.01 48.77 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.835 2.357 . . . . 0.0 112.253 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.74 -48.98 22.75 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 582' ' ' ARG . . . . . 0.814 ' HD2' ' HE3' ' A' ' 584' ' ' LYS . 14.3 tpp180 -88.94 93.65 9.67 Favored 'General case' 0 N--CA 1.379 -3.979 0 N-CA-C 104.864 -2.272 . . . . 0.0 104.864 171.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -112.83 131.64 55.62 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.083 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.814 ' HE3' ' HD2' ' A' ' 582' ' ' ARG . 15.3 ptpt -163.3 -170.49 2.29 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 570' ' ' GLU . 9.2 m-20 -103.4 -39.46 6.77 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 119.332 0.969 . . . . 0.0 110.627 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 586' ' ' GLN . . . . . 0.562 ' HB3' ' HB2' ' A' ' 568' ' ' GLU . 21.2 mp0 -121.62 133.53 54.99 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.688 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 54.5 m-85 -105.59 170.26 8.0 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -172.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -100.87 151.96 21.1 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.3 122.21 16.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 97.58 0.68 59.2 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.251 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 591' ' ' GLU . . . . . 0.467 ' HG2' ' HD2' ' A' ' 587' ' ' TYR . 6.3 tp10 -74.11 129.42 37.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.565 HG22 ' HG3' ' A' ' 610' ' ' GLN . 14.1 t -100.74 115.5 42.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.441 0.639 . . . . 0.0 109.831 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 1.9 mp -95.88 94.05 7.4 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 608' ' ' SER . 0.0 OUTLIER -77.16 122.72 25.41 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 174.724 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 66.8 m-85 -94.93 177.83 5.77 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-O 121.473 0.654 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 19.9 p -167.3 169.54 12.36 Favored 'General case' 0 N--CA 1.403 -2.797 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 81.5 m -115.56 170.88 8.09 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 41.0 mttt -59.43 156.47 30.73 Favored Pre-proline 0 N--CA 1.432 -1.343 0 O-C-N 123.812 0.695 . . . . 0.0 112.748 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.32 110.1 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.475 2.783 . . . . 0.0 110.127 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 123.66 -23.23 6.74 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.492 ' CE1' ' HB2' ' A' ' 625' ' ' GLU . 79.3 m-85 -102.81 160.83 14.25 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 122.381 1.086 . . . . 0.0 113.281 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 627' ' ' VAL . 15.6 m -113.41 129.53 56.52 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.399 174.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.457 HD11 ' HG3' ' A' ' 621' ' ' PRO . 8.8 tt -79.57 121.84 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.843 HG21 ' HD3' ' A' ' 624' ' ' LYS . 91.4 t -117.5 123.44 71.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 122.037 -0.414 . . . . 0.0 110.122 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 122.03 -156.02 16.77 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.97 134.35 27.33 Favored 'Trans proline' 0 C--N 1.327 -0.6 0 C-N-CA 122.509 2.139 . . . . 0.0 110.096 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.74 -44.35 6.78 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.185 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 594' ' ' LYS . 19.3 p -106.74 97.07 6.91 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.329 0.585 . . . . 0.0 112.013 -176.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 609' ' ' VAL . . . . . 0.494 ' HA ' ' HD2' ' A' ' 618' ' ' PRO . 9.4 m -95.31 147.8 5.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.565 ' HG3' HG22 ' A' ' 592' ' ' VAL . 1.0 OUTLIER -102.12 152.33 21.13 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 16.3 t -83.99 116.71 22.96 Favored 'General case' 0 C--N 1.268 -2.956 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.001 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.505 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 90.7 m-85 -102.2 166.4 10.61 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -69.05 -13.52 62.49 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.324 0.583 . . . . 0.0 111.076 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -101.51 -1.49 32.91 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.748 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 136.34 178.28 15.65 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.26 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 616' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.66 121.69 19.26 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.505 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 56.5 m -146.35 147.11 29.96 Favored Pre-proline 0 C--N 1.316 -0.886 0 O-C-N 121.959 -0.463 . . . . 0.0 111.458 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.494 ' HD2' ' HA ' ' A' ' 609' ' ' VAL . 41.4 Cg_endo -67.06 -171.9 5.07 Favored 'Cis proline' 0 N--CA 1.488 1.149 0 C-N-CA 124.353 -1.103 . . . . 0.0 112.958 0.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.8 179.99 3.4 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.195 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.697 HD11 ' HG2' ' A' ' 572' ' ' PRO . 18.9 mt -92.52 147.39 34.23 Favored Pre-proline 0 C--N 1.278 -2.541 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -165.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.556 ' HG2' HD11 ' A' ' 578' ' ' LEU . 63.5 Cg_endo -73.82 -173.24 1.31 Allowed 'Trans proline' 0 C--O 1.253 1.249 0 C-N-CA 123.861 3.041 . . . . 0.0 112.076 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.49 173.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.932 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.2 m -117.05 107.47 14.56 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.303 0.573 . . . . 0.0 111.138 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.843 ' HD3' HG21 ' A' ' 604' ' ' VAL . 59.1 mtpt -109.19 126.34 53.16 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.492 ' HB2' ' CE1' ' A' ' 601' ' ' PHE . 26.8 tt0 -87.44 -35.29 18.35 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -175.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -107.5 112.67 25.54 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.611 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 602' ' ' THR . 6.7 m -121.21 166.13 16.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.128 -177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 15.7 mm100 -89.98 170.66 10.17 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.036 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.521 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 74.8 p -108.86 -19.1 13.52 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.387 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 95.4 m 73.7 4.89 4.81 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.884 1.273 . . . . 0.0 111.16 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 62.55 -137.78 44.84 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.94 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.17 156.69 37.93 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.903 2.402 . . . . 0.0 110.82 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.677 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 71.7 Cg_endo -78.77 160.77 27.69 Favored 'Trans proline' 0 N--CA 1.435 -1.956 0 C-N-CA 122.053 1.835 . . . . 0.0 111.222 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.23 -169.26 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.655 2.236 . . . . 0.0 112.763 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -103.31 157.6 16.9 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.51 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.634 HD23 ' HA3' ' A' ' 639' ' ' GLY . 15.7 tp -92.68 155.26 17.83 Favored 'General case' 0 CA--C 1.478 -1.825 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 637' ' ' LEU 0.285 2.0 pt? -66.93 -47.75 70.73 Favored 'General case' 0 N--CA 1.406 -2.653 0 C-N-CA 119.005 -1.078 . . . . 0.0 113.607 -178.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.616 ' HB2' ' SG ' ' A' ' 684' ' ' CYS . 89.9 m-20 -126.36 27.02 6.28 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.049 -173.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.732 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -160.08 -146.61 4.64 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -161.09 177.54 10.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.795 0.298 . . . . 0.0 111.054 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 655' ' ' VAL . 7.2 p -80.29 133.97 28.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -90.78 -23.93 20.49 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.338 0.59 . . . . 0.0 110.075 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.549 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 5.6 mm-40 -80.71 163.31 23.64 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.369 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 644' ' ' LYS . . . . . 0.596 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.1 OUTLIER -76.35 137.95 40.14 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 175.371 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.413 ' CG2' HG11 ' A' ' 641' ' ' VAL . 20.2 p -87.78 110.42 20.46 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.807 0.813 . . . . 0.0 112.804 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.55 ' HD2' ' HA ' ' A' ' 649' ' ' TYR . 52.1 mttm -72.74 158.19 36.06 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.76 -0.23 56.01 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -152.44 100.58 2.59 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.978 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.677 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 5.3 m-85 -80.44 -81.55 0.12 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 133.35 167.71 11.72 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.158 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 57.6 t60 -67.45 131.04 44.91 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 120.926 0.393 . . . . 0.0 110.284 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 652' ' ' SER . . . . . 0.574 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 73.8 m 65.06 20.06 11.96 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.235 1.014 . . . . 0.0 112.43 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 5.6 tp10 -89.68 116.59 27.92 Favored 'General case' 0 CA--C 1.478 -1.812 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 16.2 m -89.47 155.77 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-O 122.152 0.977 . . . . 0.0 113.188 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.75 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 0.1 OUTLIER -129.3 117.38 43.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-N 112.823 -1.99 . . . . 0.0 109.502 177.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.604 ' HG2' ' HG2' ' A' ' 670' ' ' LYS . 59.1 mt-10 -81.01 130.2 34.9 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 122.389 1.09 . . . . 0.0 113.54 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.572 ' CE1' HG22 ' A' ' 655' ' ' VAL . 75.3 m-85 -108.81 157.91 18.15 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.679 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -134.88 138.55 44.24 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.732 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 26.1 t -105.65 168.69 8.93 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.552 ' HB2' ' CE1' ' A' ' 663' ' ' PHE . 32.0 m-80 -59.72 152.22 58.82 Favored Pre-proline 0 C--O 1.241 0.622 0 O-C-N 123.202 0.314 . . . . 0.0 110.795 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.2 36.12 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 124.343 3.362 . . . . 0.0 115.549 -170.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.75 11.47 0.66 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.561 0.696 . . . . 0.0 110.539 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 660' ' ' ASN . 73.6 m-85 -118.52 162.86 17.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.386 0.612 . . . . 0.0 110.964 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 96.8 mt -110.13 135.7 50.51 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.737 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.3 OUTLIER -100.64 108.88 20.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -75.77 -52.25 10.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.64 -172.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -101.8 -162.7 26.91 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.341 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.89 123.58 10.54 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.434 2.756 . . . . 0.0 112.761 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.474 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 23.0 p-10 -74.4 -7.14 51.92 Favored 'General case' 0 C--O 1.201 -1.5 0 O-C-N 122.1 -0.375 . . . . 0.0 111.503 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -122.88 118.86 28.87 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 42.3 pt -111.4 158.23 11.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 11.0 pt20 -125.15 154.91 40.76 Favored 'General case' 0 C--N 1.281 -2.396 0 O-C-N 123.43 0.456 . . . . 0.0 109.99 -174.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 8.2 t -84.81 110.85 19.12 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 123.119 1.438 . . . . 0.0 110.045 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 97.7 t -95.26 81.38 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.386 -3.67 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.821 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 628' ' ' GLN . 31.5 t70 80.96 -46.37 0.24 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.631 170.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -171.47 19.31 0.06 OUTLIER Glycine 0 C--N 1.298 -1.554 0 O-C-N 123.882 0.739 . . . . 0.0 111.513 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -143.42 143.9 31.8 Favored 'General case' 0 C--O 1.212 -0.879 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.521 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.0 m95 -87.12 153.77 21.26 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 3.7 p -72.1 167.34 20.45 Favored 'General case' 0 C--O 1.255 1.358 0 O-C-N 123.009 0.193 . . . . 0.0 111.399 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.0 m -62.86 129.23 39.52 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 682' ' ' PRO . 6.4 mp -60.19 163.78 7.64 Favored Pre-proline 0 N--CA 1.435 -1.223 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.945 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.737 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 19.5 Cg_endo -60.6 -24.33 78.07 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 122.777 2.318 . . . . 0.0 113.135 -176.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.421 ' HA ' HD21 ' A' ' 637' ' ' LEU . 58.8 t 52.62 92.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 122.175 0.988 . . . . 0.0 111.072 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 638' ' ' ASN . 27.8 p -98.97 134.51 41.72 Favored 'General case' 0 N--CA 1.411 -2.376 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.703 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.91 155.7 35.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.92 -174.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 64.4 t -59.84 129.09 21.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 123.866 0.729 . . . . 0.0 110.562 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.678 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.239 0.542 0 N-CA-C 113.097 0.776 . . . . 0.0 113.097 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -74.53 -16.93 60.81 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . 69.53 32.42 3.4 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 125.151 1.381 . . . . 0.0 112.597 174.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 150.66 155.56 6.94 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.201 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -125.06 101.63 7.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -103.83 -21.89 13.6 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.056 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 56.54 -157.08 0.27 Allowed 'General case' 0 C--N 1.348 0.511 0 C-N-CA 124.12 0.968 . . . . 0.0 110.888 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 587' ' ' TYR . 81.3 m -78.25 140.42 38.88 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -110.01 136.54 49.12 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.6 tt -51.37 117.58 9.43 Favored Pre-proline 0 C--O 1.246 0.903 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.19 -179.34 1.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.723 2.282 . . . . 0.0 111.047 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -90.84 93.2 9.12 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 118.953 -1.099 . . . . 0.0 109.092 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.48 HG22 HD13 ' A' ' 620' ' ' LEU . 36.8 pt -75.78 -175.8 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.189 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.969 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.618 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.1 t70 -71.83 163.15 28.34 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.168 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.35 -30.01 17.1 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.262 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -94.23 4.21 54.2 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.814 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.618 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.8 OUTLIER -100.03 151.26 21.57 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.39 118.01 6.22 Favored Pre-proline 0 C--N 1.309 -1.181 0 C-N-CA 123.849 0.86 . . . . 0.0 110.603 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.51 ' HG3' HD11 ' A' ' 571' ' ' LEU . 40.7 Cg_endo -75.32 139.45 23.48 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.301 2.001 . . . . 0.0 111.566 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.9 -50.25 63.04 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 125.399 1.48 . . . . 0.0 112.202 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 582' ' ' ARG . . . . . 0.405 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 8.7 mpt_? -63.73 -46.45 85.33 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.135 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm 54.45 58.58 4.8 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 124.364 1.04 . . . . 0.0 109.882 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -121.98 160.17 25.44 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.79 -50.82 54.91 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -122.54 151.42 41.39 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.669 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 84.9 m-85 -121.53 119.26 31.45 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -71.1 152.69 43.21 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.561 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 58.1 t -55.91 116.26 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-O 121.19 0.519 . . . . 0.0 110.747 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 109.85 -2.99 30.32 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.594 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -76.29 136.98 39.61 Favored 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 122.34 -0.506 . . . . 0.0 110.953 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.586 HG12 ' HG3' ' A' ' 610' ' ' GLN . 12.0 m -101.81 133.28 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.863 0.84 . . . . 0.0 109.686 176.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.669 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.9 mp -105.41 89.96 3.27 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.557 ' HD2' ' HB3' ' A' ' 608' ' ' SER . 3.6 mmmp? -66.43 127.89 34.05 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -107.09 175.12 5.6 Favored 'General case' 0 C--N 1.267 -3.021 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.801 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 14.4 p -166.49 167.32 15.72 Favored 'General case' 0 N--CA 1.398 -3.041 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.508 ' SG ' HD12 ' A' ' 578' ' ' LEU . 98.8 m -114.69 -172.49 2.13 Favored 'General case' 0 C--N 1.259 -3.337 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -56.74 159.27 7.27 Favored Pre-proline 0 N--CA 1.429 -1.51 0 C-N-CA 123.94 0.896 . . . . 0.0 110.764 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.92 -37.93 47.32 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 124.209 3.273 . . . . 0.0 114.78 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -100.3 4.94 57.2 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.436 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 21.3 m-85 -106.35 141.07 38.28 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 121.605 0.717 . . . . 0.0 111.552 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.499 HG21 HG11 ' A' ' 627' ' ' VAL . 40.7 m -97.56 124.99 42.02 Favored 'General case' 0 N--CA 1.398 -3.073 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.89 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 7.2 tt -79.32 122.25 34.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.805 HG21 ' HD3' ' A' ' 624' ' ' LYS . 99.8 t -118.69 139.11 47.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 106.63 -149.3 16.59 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.9 112.74 3.61 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.321 2.014 . . . . 0.0 111.214 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -85.96 -1.52 57.4 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.614 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.557 ' HB3' ' HD2' ' A' ' 594' ' ' LYS . 33.8 p -150.29 112.89 4.72 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.176 0.512 . . . . 0.0 110.64 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.25 149.8 12.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.586 ' HG3' HG12 ' A' ' 592' ' ' VAL . 2.5 mp0 -102.61 157.6 16.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.271 0.558 . . . . 0.0 110.055 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.561 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 11.3 t -86.56 112.49 21.61 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 610' ' ' GLN . 85.3 m-85 -101.18 169.88 8.63 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -60.62 -18.28 52.24 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -106.78 -1.04 22.98 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.152 0.501 . . . . 0.0 111.608 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.37 -169.7 22.16 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.221 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 569' ' ' CYS . 2.6 mm? -75.14 122.81 24.17 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.439 ' HA ' ' C ' ' A' ' 618' ' ' PRO . 52.4 m -146.99 146.45 25.96 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 122.401 -0.187 . . . . 0.0 110.578 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 617' ' ' SER . 57.0 Cg_endo -69.5 -169.42 4.94 Favored 'Cis proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.057 -1.226 . . . . 0.0 112.804 0.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.72 172.72 10.19 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.469 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.48 HD13 HG22 ' A' ' 574' ' ' ILE . 38.8 mt -74.61 142.65 77.74 Favored Pre-proline 0 C--N 1.292 -1.922 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -169.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.3 176.98 7.16 Favored 'Trans proline' 0 C--O 1.258 1.479 0 C-N-CA 124.049 3.166 . . . . 0.0 111.475 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.1 pt -122.03 165.72 17.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.648 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.557 ' SG ' HD12 ' A' ' 578' ' ' LEU . 85.1 m -110.63 112.25 24.02 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.499 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.805 ' HD3' HG21 ' A' ' 604' ' ' VAL . 52.6 mtpt -108.84 110.46 21.82 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 23.2 tt0 -77.77 -31.65 52.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.24 104.71 17.24 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.333 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 602' ' ' THR . 3.7 m -129.83 175.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.088 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.401 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 1.9 mp0 -98.65 159.08 15.2 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.845 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 52.4 m -104.25 -9.16 18.81 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.364 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 630' ' ' CYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 678' ' ' TRP . 67.6 m 70.4 1.68 3.71 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.093 0.957 . . . . 0.0 113.514 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 62.99 -136.47 43.54 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -75.79 149.96 34.26 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 121.979 1.786 . . . . 0.0 110.658 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.55 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 78.4 Cg_endo -78.21 165.25 26.01 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.548 2.165 . . . . 0.0 111.013 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.464 ' HG2' HD11 ' A' ' 681' ' ' LEU . 33.0 Cg_endo -70.34 165.91 30.05 Favored 'Trans proline' 0 N--CA 1.435 -1.94 0 C-N-CA 121.408 1.405 . . . . 0.0 110.357 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.46 163.8 21.37 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.774 HD21 ' SG ' ' A' ' 659' ' ' CYS . 11.0 tp -83.33 174.42 10.71 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' A' ' 683' ' ' VAL 0.342 0.4 OUTLIER -73.85 -69.71 0.42 Allowed 'General case' 0 N--CA 1.393 -3.281 0 C-N-CA 118.027 -1.469 . . . . 0.0 112.935 -179.871 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -95.1 -33.19 12.76 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -84.33 -143.11 5.73 Favored Glycine 0 N--CA 1.434 -1.455 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.341 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -160.34 -172.69 3.67 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.627 HG22 ' CE2' ' A' ' 657' ' ' TYR . 20.5 t -95.87 133.08 38.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 176.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 658' ' ' TYR . 35.9 pttt -88.73 -26.35 21.82 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.977 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -78.55 151.91 32.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.389 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -67.08 115.08 6.38 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.534 0.683 . . . . 0.0 110.546 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.2 p -74.46 105.45 5.6 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.848 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.633 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 59.7 pttt -87.49 -177.67 5.96 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.77 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.07 -12.36 23.29 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -143.8 108.05 4.78 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.633 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 13.7 m-85 -85.92 -101.19 0.07 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 158.34 162.53 11.9 Favored Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 66.0 t60 -58.49 -52.43 65.67 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 40.0 m -92.53 11.91 24.78 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.177 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -96.57 116.61 29.38 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.482 0.658 . . . . 0.0 109.398 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.725 HG21 ' HE2' ' A' ' 670' ' ' LYS . 1.3 p -92.86 157.39 2.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.785 -177.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 23.9 m -123.7 111.65 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.56 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -74.39 119.61 18.83 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.798 0.809 . . . . 0.0 112.672 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.627 ' CE2' HG22 ' A' ' 641' ' ' VAL . 87.6 m-85 -100.46 173.44 6.57 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.781 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' A' ' 642' ' ' LYS . 29.0 p90 -151.22 137.34 18.32 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.774 ' SG ' HD21 ' A' ' 636' ' ' LEU . 68.0 m -96.91 177.07 5.74 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 662' ' ' ARG . 78.3 m-20 -85.91 157.45 57.32 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.4 24.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 124.504 3.47 . . . . 0.0 114.959 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.415 ' H ' ' C ' ' A' ' 660' ' ' ASN . 23.8 mmt180 -120.35 -6.99 9.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 662' ' ' ARG . 31.1 m-85 -131.72 156.77 45.33 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.87 -174.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 67.8 mt -105.99 166.5 10.45 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.65 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.7 OUTLIER -116.7 112.55 21.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.44 ' HB3' HG23 ' A' ' 683' ' ' VAL . 39.9 ttmt -81.94 -54.02 5.67 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.542 -174.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.13 -173.23 43.63 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.637 -176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.04 122.46 10.97 Favored 'Trans proline' 0 C--N 1.327 -0.557 0 C-N-CA 122.932 2.421 . . . . 0.0 111.141 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.717 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 21.2 p-10 -61.26 -14.66 27.87 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 122.872 0.469 . . . . 0.0 112.051 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.725 ' HE2' HG21 ' A' ' 654' ' ' VAL . 0.0 OUTLIER -128.5 149.22 50.68 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.588 HD12 ' HB3' ' A' ' 678' ' ' TRP . 47.0 pt -140.09 146.44 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -172.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.01 157.0 23.06 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.228 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 11.7 t -80.35 96.56 6.71 Favored 'General case' 0 CA--C 1.472 -2.044 0 CA-C-O 123.197 1.475 . . . . 0.0 110.547 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.03 110.27 17.07 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.599 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.628 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 15.0 t70 59.22 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.616 1.166 . . . . 0.0 111.418 -171.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -153.7 23.47 0.73 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -134.32 131.07 37.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.588 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.8 m95 -76.4 149.89 36.86 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 7.8 p -83.5 178.75 7.87 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 11.7 m -57.32 122.95 13.76 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.712 0.805 . . . . 0.0 111.085 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.464 HD11 ' HG2' ' A' ' 634' ' ' PRO . 7.3 mp -63.97 163.67 21.77 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.717 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 20.1 Cg_endo -61.53 -15.17 39.66 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.876 3.051 . . . . 0.0 115.345 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.548 ' HA ' HD21 ' A' ' 637' ' ' LEU 0.297 28.7 m 50.7 101.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 177.278 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.687 ' SG ' HD21 ' A' ' 636' ' ' LEU . 12.9 m -78.29 132.54 37.52 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.441 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.427 HD12 ' HB2' ' A' ' 666' ' ' LYS . 0.2 OUTLIER -127.68 136.57 60.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.074 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.64 130.79 28.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 123.566 0.541 . . . . 0.0 111.218 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 C--O 1.252 1.22 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.223 -177.372 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.246 0.878 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 71.68 143.16 0.06 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.34 1.456 . . . . 0.0 111.439 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 564' ' ' ALA . . . . . 0.703 ' HB3' ' HG2' ' A' ' 566' ' ' GLU . . . -84.25 -166.6 1.48 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -77.33 -11.22 85.71 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.703 ' HG2' ' HB3' ' A' ' 564' ' ' ALA . 11.8 pt-20 -61.7 162.32 8.73 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.127 1.371 . . . . 0.0 112.307 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -155.69 97.47 1.85 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 568' ' ' GLU . . . . . 0.47 ' HG3' HG23 ' A' ' 589' ' ' VAL . 17.8 tt0 -85.48 177.74 7.66 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.725 -170.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.475 ' HB3' HD21 ' A' ' 616' ' ' LEU . 57.6 m -111.34 153.41 26.04 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -167.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.812 ' HG2' ' HG3' ' A' ' 586' ' ' GLN . 49.0 mt-10 -128.77 146.76 50.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 166.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 571' ' ' LEU . . . . . . . . . . . . . 1.7 tt -53.48 115.13 7.2 Favored Pre-proline 0 C--O 1.245 0.837 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.19 -169.11 0.48 Allowed 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.511 2.141 . . . . 0.0 111.572 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -88.65 92.38 9.17 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 578' ' ' LEU . 37.2 pt -78.06 -170.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.658 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.649 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.4 t70 -77.61 147.4 35.64 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.12 -31.99 38.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 123.445 0.698 . . . . 0.0 111.044 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -98.54 14.63 27.66 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.081 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 5.5 tp -104.41 150.35 24.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.8 t -139.21 122.54 10.77 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.513 ' HG2' ' HA ' ' A' ' 583' ' ' LYS . 50.3 Cg_endo -78.74 144.67 19.65 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.813 2.342 . . . . 0.0 111.737 174.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 581' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 594' ' ' LYS . 7.2 t70 -51.86 -53.79 36.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.815 1.646 . . . . 0.0 111.212 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 582' ' ' ARG . . . . . 0.628 ' HG2' ' HE3' ' A' ' 584' ' ' LYS . 4.5 mpt_? -70.55 -59.86 2.6 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.025 0.44 . . . . 0.0 110.459 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.513 ' HA ' ' HG2' ' A' ' 580' ' ' PRO . 50.2 tttm 60.14 62.29 1.65 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.163 -174.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.628 ' HE3' ' HG2' ' A' ' 582' ' ' ARG . 16.8 ptpt -118.44 160.29 21.97 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.29 -45.33 40.49 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 586' ' ' GLN . . . . . 0.812 ' HG3' ' HG2' ' A' ' 570' ' ' GLU . 18.7 mp0 -118.07 126.98 53.33 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.619 0.247 . . . . 0.0 110.504 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.63 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 86.5 m-85 -100.73 132.51 46.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.675 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -78.09 148.92 34.0 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.496 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 60.0 t -58.65 119.1 2.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 106.04 -1.73 38.21 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.598 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -73.14 134.09 44.32 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 122.362 -0.493 . . . . 0.0 109.731 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.493 HG22 ' HG3' ' A' ' 610' ' ' GLN . 17.6 t -101.0 114.9 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.63 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.4 mp -91.71 92.49 8.45 Favored 'General case' 0 N--CA 1.405 -2.68 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 608' ' ' SER . 58.1 mttp -74.13 136.46 42.92 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 173.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -112.57 163.71 14.18 Favored 'General case' 0 C--N 1.266 -3.026 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.753 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 14.7 m -152.55 172.07 17.15 Favored 'General case' 0 N--CA 1.39 -3.471 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.539 ' SG ' HD12 ' A' ' 578' ' ' LEU . 69.8 m -108.83 178.43 4.48 Favored 'General case' 0 C--N 1.247 -3.862 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 71.0 mmtt -54.29 162.79 1.46 Allowed Pre-proline 0 C--N 1.313 -0.98 0 C-N-CA 124.154 0.982 . . . . 0.0 111.935 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 82.8 Cg_exo -44.58 -44.92 13.53 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.127 3.218 . . . . 0.0 114.358 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -100.09 18.33 55.81 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.822 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -120.11 147.66 44.59 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 121.759 0.79 . . . . 0.0 112.384 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.665 HG21 HG11 ' A' ' 627' ' ' VAL . 23.1 m -100.66 133.44 45.11 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.648 175.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.566 HD11 ' HG3' ' A' ' 621' ' ' PRO . 10.1 tt -88.25 129.35 39.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.891 HG21 ' HD3' ' A' ' 624' ' ' LYS . 75.4 t -121.93 123.48 69.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 123.62 -150.65 16.94 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -73.12 115.68 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.38 2.053 . . . . 0.0 111.209 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -92.31 7.69 41.7 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 594' ' ' LYS . 58.5 p -156.43 113.61 3.17 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.75 0.42 . . . . 0.0 110.01 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 13.7 m -118.1 151.96 20.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.493 ' HG3' HG22 ' A' ' 592' ' ' VAL . 1.5 mp0 -101.27 154.35 18.85 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.449 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.496 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 6.6 t -85.0 112.67 20.81 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 169.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -104.22 170.17 8.06 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -77.88 14.61 1.05 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -125.81 -1.08 7.3 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 171.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.05 -175.36 19.83 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.926 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 569' ' ' CYS . 2.5 mm? -78.8 123.8 27.57 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 5.4 t -150.36 151.91 32.13 Favored Pre-proline 0 C--N 1.309 -1.184 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.616 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.507 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 58.7 Cg_endo -70.03 -178.2 16.64 Favored 'Cis proline' 0 C--N 1.361 1.235 0 C-N-CA 123.812 -1.328 . . . . 0.0 112.717 0.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.13 157.07 23.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.334 0.587 . . . . 0.0 111.103 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.506 HD13 HG22 ' A' ' 574' ' ' ILE . 22.6 mt -66.85 152.41 95.7 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 114.229 -1.35 . . . . 0.0 114.146 -168.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.566 ' HG3' HD11 ' A' ' 603' ' ' ILE . 92.8 Cg_endo -81.46 179.74 5.57 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.065 3.177 . . . . 0.0 111.633 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.6 pt -121.46 174.44 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.592 0.234 . . . . 0.0 110.586 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 98.1 m -119.91 128.84 54.0 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.386 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.891 ' HD3' HG21 ' A' ' 604' ' ' VAL . 26.4 mtpp -124.0 132.31 53.68 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.98 -41.05 15.21 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -96.94 114.58 26.21 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.01 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.665 HG11 HG21 ' A' ' 602' ' ' THR . 11.8 m -123.49 -175.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.24 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -99.41 165.14 11.8 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.557 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 18.6 m -100.36 -11.93 19.86 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 18.0 m 72.96 -0.42 3.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.36 1.064 . . . . 0.0 113.54 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 63.38 -144.67 49.45 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.6 157.1 24.98 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.612 2.208 . . . . 0.0 110.91 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.608 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.5 Cg_endo -75.15 163.69 34.52 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.857 2.371 . . . . 0.0 112.427 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.462 ' HG2' HD11 ' A' ' 681' ' ' LEU . 37.0 Cg_endo -69.61 172.95 11.56 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.589 2.193 . . . . 0.0 111.899 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -86.06 161.23 19.03 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 657' ' ' TYR . 15.1 tp -99.49 145.34 27.58 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 638' ' ' ASN . 1.3 pp -65.68 -37.69 87.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.45 ' N ' HD12 ' A' ' 637' ' ' LEU . 16.7 m120 -138.36 33.96 2.3 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.206 1.003 . . . . 0.0 109.677 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.51 ' HA3' HD23 ' A' ' 636' ' ' LEU . . . -158.1 -150.88 5.88 Favored Glycine 0 N--CA 1.413 -2.841 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.754 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 640' ' ' ASN . . . . . 0.63 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 63.6 t30 -160.56 -177.35 6.14 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.539 HG22 ' CE1' ' A' ' 657' ' ' TYR . 17.9 t -91.55 129.59 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.242 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 174.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.444 ' HB3' ' CD1' ' A' ' 658' ' ' TYR . 10.0 ptmm? -90.16 -14.83 32.74 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.604 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -89.84 168.86 11.74 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.877 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -77.72 110.97 13.03 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 17.8 p -71.23 106.49 3.83 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.523 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 42.6 pttt -87.94 153.41 21.32 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.271 175.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.471 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 11.0 pt-20 -68.32 -12.52 61.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.408 0.683 . . . . 0.0 111.607 -176.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -151.17 102.37 2.93 Favored 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -171.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.608 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 4.2 m-85 -82.49 -70.75 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 120.63 165.64 12.83 Favored Glycine 0 C--N 1.288 -2.106 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.2 t60 -74.02 142.16 45.77 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.439 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 49.6 m 71.32 5.46 5.44 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.307 1.043 . . . . 0.0 112.377 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.435 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 5.5 tp10 -84.1 115.37 22.35 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 670' ' ' LYS . 2.4 p -90.2 152.63 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 30.5 m -120.98 112.05 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.729 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.531 ' CG ' ' HG2' ' A' ' 670' ' ' LYS . 27.3 mt-10 -69.57 119.8 14.37 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.017 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.671 ' HB3' HD22 ' A' ' 636' ' ' LEU . 79.2 m-85 -99.31 173.65 6.68 Favored 'General case' 0 C--N 1.271 -2.809 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.412 173.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.63 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 24.3 p90 -150.88 139.92 21.05 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 173.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.503 ' SG ' HD21 ' A' ' 636' ' ' LEU . 43.6 m -105.1 161.53 14.16 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-O 120.894 0.378 . . . . 0.0 110.521 172.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -57.03 152.04 30.96 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.54 -177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.04 33.69 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 124.738 3.625 . . . . 0.0 113.539 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -136.63 0.79 2.51 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 124.019 0.928 . . . . 0.0 109.008 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -127.18 159.2 34.99 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.811 -173.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.65 ' HG ' ' HB3' ' A' ' 687' ' ' GLU . 84.2 mt -107.81 136.51 47.42 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.793 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 4.2 ttt -95.32 113.68 25.37 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -78.25 -62.83 1.55 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.34 -170.43 46.82 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.653 -0.785 . . . . 0.0 112.878 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.65 123.71 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.028 2.485 . . . . 0.0 111.536 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -64.15 -17.95 63.98 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 122.915 0.486 . . . . 0.0 111.591 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 1.0 OUTLIER -122.32 153.52 38.84 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 681' ' ' LEU . 46.8 pt -143.3 142.53 25.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.25 148.16 34.72 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 48.7 t -82.53 129.14 34.86 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.404 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.613 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 30.7 m -110.4 126.13 67.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 123.061 0.544 . . . . 0.0 110.638 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.535 ' OD1' ' HE2' ' A' ' 624' ' ' LYS . 21.9 t70 60.25 -67.0 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.562 1.145 . . . . 0.0 112.342 -172.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -168.44 21.66 0.09 OUTLIER Glycine 0 C--N 1.301 -1.405 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -132.71 137.9 47.06 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.548 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.6 m95 -81.73 152.22 27.13 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 8.0 p -77.56 -176.86 4.47 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 19.7 m -70.07 127.4 32.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.567 0.223 . . . . 0.0 111.565 -173.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.572 HD12 HD13 ' A' ' 671' ' ' ILE . 5.8 mp -62.91 155.13 73.44 Favored Pre-proline 0 CA--C 1.514 -0.426 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.564 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 5.6 Cg_endo -52.91 -55.04 4.1 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.795 2.997 . . . . 0.0 113.758 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 88.3 t 69.5 119.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.2 1.0 . . . . 0.0 111.198 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.793 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 33.1 m -117.66 155.87 29.16 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.062 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.59 149.39 25.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 123.783 0.833 . . . . 0.0 109.498 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.6 132.33 28.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 O-C-N 123.326 0.392 . . . . 0.0 110.044 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.65 ' HB3' ' HG ' ' A' ' 664' ' ' LEU . 8.2 pt-20 . . . . . 0 C--O 1.251 1.147 0 O-C-N 124.329 1.018 . . . . 0.0 112.332 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -135.24 94.0 3.06 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 121.305 0.574 . . . . 0.0 110.108 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -91.0 -31.92 16.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -141.81 120.27 1.61 Allowed Glycine 0 N--CA 1.41 -3.093 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.262 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.4 -49.34 67.12 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.498 ' HD2' ' HB2' ' A' ' 613' ' ' HIS . 88.2 mtt180 -118.53 104.21 10.46 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 172.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -93.75 167.11 11.86 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.717 0.77 . . . . 0.0 111.876 -172.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.631 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 27.5 m -103.68 -43.18 5.42 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.009 174.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 571' ' ' LEU . 19.9 tt0 60.79 -150.27 0.41 Allowed 'General case' 0 C--O 1.246 0.882 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 -171.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.428 HD11 ' HG3' ' A' ' 580' ' ' PRO . 1.0 OUTLIER -147.35 113.14 4.09 Favored Pre-proline 0 C--N 1.281 -2.372 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -177.65 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.402 ' HD2' HD12 ' A' ' 616' ' ' LEU . 37.2 Cg_endo -66.63 -170.67 0.22 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.253 2.635 . . . . 0.0 112.741 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -86.23 91.28 8.41 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.876 HG13 ' H ' ' A' ' 575' ' ' ASP . 11.5 pt -59.56 -75.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.472 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.876 ' H ' HG13 ' A' ' 574' ' ' ILE . 11.8 t70 -174.77 -173.07 0.68 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 10.9 p -106.16 -20.27 6.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -104.96 13.63 30.71 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.555 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.1 tt -114.62 141.61 47.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -175.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.34 116.9 14.31 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-O 121.42 0.629 . . . . 0.0 111.456 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 574' ' ' ILE . 64.1 Cg_endo -76.9 137.33 17.52 Favored 'Trans proline' 0 C--N 1.328 -0.514 0 C-N-CA 122.764 2.309 . . . . 0.0 111.73 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -56.94 -55.06 39.45 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.61 0.719 . . . . 0.0 109.594 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 582' ' ' ARG . . . . . 0.42 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 75.1 mmt-85 -78.34 117.54 19.68 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -124.67 93.52 3.92 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 10.6 ptpt -138.74 175.56 9.45 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.505 -174.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -87.57 -52.2 5.47 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.544 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -115.45 120.46 39.6 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.434 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.631 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 41.2 m-85 -85.09 126.66 33.77 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.832 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -80.04 143.8 33.73 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.898 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.45 118.04 2.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.444 0.64 . . . . 0.0 109.717 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 104.8 1.02 42.61 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.297 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.62 116.66 18.35 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 6.5 p -92.4 121.56 43.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.933 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 593' ' ' LEU . . . . . . . . . . . . . 5.7 mp -95.78 93.9 7.35 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.009 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 96.2 mttt -78.64 93.82 4.94 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.09 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.539 ' HB3' HD21 ' A' ' 578' ' ' LEU . 65.1 m-85 -78.1 163.87 25.5 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.424 0.63 . . . . 0.0 110.228 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 21.3 m -155.58 171.03 20.63 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 89.1 m -117.59 175.06 5.81 Favored 'General case' 0 C--N 1.259 -3.336 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.3 mmmt -56.48 164.17 2.17 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.573 1.149 . . . . 0.0 112.555 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 94.8 Cg_exo -45.77 -40.17 19.13 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.584 3.522 . . . . 0.0 115.249 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -102.52 7.86 54.22 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.33 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 40.5 m-85 -110.55 132.86 53.82 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-O 121.799 0.809 . . . . 0.0 112.103 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 16.6 m -92.92 126.17 37.88 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.761 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.487 HD11 ' HG3' ' A' ' 621' ' ' PRO . 11.1 tt -78.95 117.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.774 HG21 ' HD3' ' A' ' 624' ' ' LYS . 50.2 t -108.78 117.49 54.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.653 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 122.74 -160.47 17.21 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.22 123.31 10.74 Favored 'Trans proline' 0 C--N 1.328 -0.507 0 C-N-CA 122.733 2.288 . . . . 0.0 110.947 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -86.21 -50.08 7.24 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 4.9 p -100.08 95.33 6.77 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 111.783 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.2 150.69 4.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.607 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 22.8 mm-40 -98.26 160.14 14.48 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 10.5 t -84.25 129.89 34.86 Favored 'General case' 1 C--N 1.243 -4.033 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.575 165.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.607 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 55.5 m-85 -119.19 170.65 8.9 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 613' ' ' HIS . . . . . 0.498 ' HB2' ' HD2' ' A' ' 567' ' ' ARG . 0.1 OUTLIER -67.19 -12.84 61.13 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -104.82 -3.84 23.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.63 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 131.54 -170.18 21.62 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.402 HD12 ' HD2' ' A' ' 572' ' ' PRO . 46.6 mt -74.81 131.34 40.7 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.513 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 22.6 t -149.64 143.56 16.91 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.47 -172.5 10.97 Favored 'Cis proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.212 -1.578 . . . . 0.0 113.585 2.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.5 145.42 2.56 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.703 0.801 . . . . 0.0 110.63 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.654 HD23 HG22 ' A' ' 574' ' ' ILE . 6.5 mp -77.19 147.7 76.83 Favored Pre-proline 0 C--N 1.298 -1.659 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.262 -172.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.487 ' HG3' HD11 ' A' ' 603' ' ' ILE . 93.8 Cg_endo -74.85 -179.67 5.17 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 123.705 2.937 . . . . 0.0 112.913 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.6 pt -130.4 169.52 21.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 84.1 m -110.24 126.25 53.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.017 0.436 . . . . 0.0 110.832 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.774 ' HD3' HG21 ' A' ' 604' ' ' VAL . 28.3 mtpp -124.26 117.54 24.77 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.936 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 3.2 tm-20 -82.45 -36.77 26.26 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -94.26 98.93 11.27 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.843 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 6.2 m -114.28 171.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.514 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 53.5 mm-40 -98.67 169.12 9.72 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 42.6 m -116.14 -7.88 11.82 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.913 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 96.3 m 67.66 3.27 3.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 62.24 -132.2 45.24 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.91 155.3 38.77 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.023 2.482 . . . . 0.0 111.301 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.702 ' HB3' HG11 ' A' ' 655' ' ' VAL . 86.2 Cg_endo -83.56 161.88 14.62 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 122.651 2.234 . . . . 0.0 112.572 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.47 173.91 11.72 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.61 2.207 . . . . 0.0 111.388 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -98.23 161.42 13.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 657' ' ' TYR . 19.7 tp -96.77 128.66 43.94 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -45.66 -42.04 11.04 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.432 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 11.7 m120 -133.35 31.01 3.81 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.475 0.655 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.607 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -151.85 -144.77 3.99 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -165.59 -173.47 2.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 655' ' ' VAL . 5.2 p -94.54 131.06 42.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.649 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 20.4 ptmt -88.91 -16.15 32.57 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.674 0.75 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.29 166.04 15.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.813 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -84.82 120.26 26.24 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.434 ' CG2' HG11 ' A' ' 641' ' ' VAL . 5.6 p -74.3 100.57 3.78 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.464 0.649 . . . . 0.0 112.448 -174.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -68.17 175.86 3.02 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.525 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -98.79 -0.85 41.75 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.746 0.784 . . . . 0.0 109.672 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.438 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 26.4 tt0 -157.92 120.72 3.85 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.564 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 7.0 m-85 -91.76 -86.08 0.23 Allowed 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.981 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 145.83 164.23 10.71 Favored Glycine 0 CA--C 1.488 -1.6 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.522 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 57.8 t60 -56.98 -51.77 67.89 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 25.5 m -99.7 21.76 11.94 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.4 0.619 . . . . 0.0 110.835 -174.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.64 115.27 27.59 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.612 HG21 ' HE3' ' A' ' 670' ' ' LYS . 11.6 m -92.2 147.91 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.691 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.441 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 0.2 OUTLIER -114.73 115.94 51.06 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.843 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.34 177.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.649 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 18.4 mt-10 -77.02 138.52 39.64 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.261 1.029 . . . . 0.0 111.596 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.641 ' CE1' HG22 ' A' ' 655' ' ' VAL . 72.6 m-85 -119.06 167.55 11.67 Favored 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 125.597 1.559 . . . . 0.0 109.589 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -144.91 144.35 31.04 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.607 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 71.1 m -100.83 172.25 7.17 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -69.28 153.46 95.9 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.9 10.5 0.37 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 123.699 2.933 . . . . 0.0 114.396 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.41 3.56 25.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -131.46 164.22 26.24 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.688 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 687' ' ' GLU . 89.0 mt -104.22 165.16 11.23 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.2 ttt -123.91 103.83 8.57 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -82.65 -45.08 14.96 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -170.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -96.26 -173.73 35.71 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.007 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.51 122.01 10.64 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.416 2.744 . . . . 0.0 111.946 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 656' ' ' GLU . 2.4 p-10 -83.53 23.05 0.98 Allowed 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 122.872 0.469 . . . . 0.0 111.065 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.798 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 8.4 ptmt -163.82 107.09 0.97 Allowed 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 125.007 1.323 . . . . 0.0 108.014 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 37.7 pt -107.91 148.79 11.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.346 -174.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.74 154.17 27.78 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.453 0.47 . . . . 0.0 110.392 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 5.0 t -80.53 95.53 6.52 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.766 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.508 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 35.1 m -84.52 117.02 29.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 O-C-N 121.402 -0.811 . . . . 0.0 111.39 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.506 ' OD1' ' HE2' ' A' ' 624' ' ' LYS . 17.6 t70 62.23 -76.67 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.39 1.076 . . . . 0.0 111.118 -173.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -151.38 17.77 0.89 Allowed Glycine 0 N--CA 1.434 -1.477 0 O-C-N 123.792 0.683 . . . . 0.0 111.614 177.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -135.5 141.71 45.34 Favored 'General case' 0 CA--C 1.495 -1.158 0 O-C-N 122.29 -0.535 . . . . 0.0 109.94 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.532 ' HB3' HD12 ' A' ' 671' ' ' ILE . 99.0 m95 -74.34 156.03 37.53 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 3.3 p -81.23 -178.72 7.04 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 16.3 m -65.37 125.85 26.4 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.174 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.86 159.92 23.58 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 26.2 Cg_endo -62.87 -13.22 33.37 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 124.263 3.309 . . . . 0.0 115.284 -176.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.282 30.9 m 48.51 101.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 175.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.9 m -80.74 140.93 35.27 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.56 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.69 146.24 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.352 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 14.8 m -58.07 138.13 19.42 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.504 0 O-C-N 124.439 1.087 . . . . 0.0 112.088 -174.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.544 ' HA ' ' HG ' ' A' ' 664' ' ' LEU . 41.9 tt0 . . . . . 0 C--N 1.314 -0.962 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.5 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 CA--C 1.511 -0.558 0 CA-C-O 121.593 0.711 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -150.07 157.86 43.56 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -83.28 93.7 7.76 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -66.35 -56.89 11.58 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 613' ' ' HIS . 33.1 tt0 -95.77 104.7 16.64 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 169.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.98 123.25 17.05 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.56 -171.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.22 138.59 40.72 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 172.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.64 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 87.2 m -67.3 146.53 54.03 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -117.86 149.24 41.19 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.533 HD22 ' HD2' ' A' ' 572' ' ' PRO . 2.7 tm? -77.76 111.67 19.41 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.533 ' HD2' HD22 ' A' ' 571' ' ' LEU . 84.3 Cg_endo -76.67 -170.02 0.82 Allowed 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.068 2.512 . . . . 0.0 111.625 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -74.43 102.37 4.42 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.526 0.679 . . . . 0.0 110.1 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.674 HG22 ' HG ' ' A' ' 620' ' ' LEU . 27.3 pt -83.53 -166.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.613 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.2 t70 -76.84 143.78 39.5 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.63 -26.91 24.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 C-N-CA 124.048 0.939 . . . . 0.0 111.928 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -103.92 11.02 36.05 Favored 'General case' 0 CA--C 1.494 -1.174 0 O-C-N 121.637 -0.664 . . . . 0.0 111.864 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.674 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 5.6 tp -95.87 153.08 17.94 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.44 120.18 6.13 Favored Pre-proline 0 C--N 1.286 -2.185 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.448 ' HB2' ' O ' ' A' ' 582' ' ' ARG . 56.4 Cg_endo -74.7 137.45 22.46 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.24 1.96 . . . . 0.0 112.08 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -70.8 -42.34 70.41 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 582' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 580' ' ' PRO . 6.1 mmp_? -82.6 123.81 29.57 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 583' ' ' LYS . 34.5 ttmt -137.18 91.64 2.64 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 10.3 ptpt -137.92 172.63 12.65 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.578 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.08 -50.1 51.33 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.702 0.287 . . . . 0.0 111.36 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -132.06 152.85 50.95 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 121.443 0.639 . . . . 0.0 109.827 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.64 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 84.3 m-85 -115.18 119.72 37.32 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.068 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -70.05 142.24 52.72 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.567 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.531 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 1.8 p -61.29 112.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 122.279 1.038 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 121.33 -15.07 9.33 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.541 -174.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -72.03 126.26 29.32 Favored 'General case' 0 CA--C 1.473 -2.017 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 608' ' ' SER . 7.7 p -103.49 118.5 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.34 0 CA-C-O 122.35 1.071 . . . . 0.0 109.709 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.446 HD23 HD23 ' A' ' 571' ' ' LEU . 5.4 mp -91.04 98.52 11.82 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.025 -175.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 607' ' ' ASN . 96.0 mttt -78.21 118.96 20.93 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.546 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -97.9 179.49 4.78 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.387 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 10.5 p -168.67 161.82 11.48 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.586 ' SG ' HD12 ' A' ' 578' ' ' LEU . 90.1 m -105.0 -176.04 2.96 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.504 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.3 mmtp -63.27 162.72 22.47 Favored Pre-proline 0 N--CA 1.429 -1.499 0 C-N-CA 123.218 0.607 . . . . 0.0 111.545 175.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 88.8 Cg_exo -45.72 -40.03 18.76 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 124.498 3.465 . . . . 0.0 115.404 -175.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -97.22 3.69 62.0 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.61 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 45.6 m-85 -108.41 151.56 25.87 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.225 1.012 . . . . 0.0 113.379 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.553 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 2.6 m -103.76 123.6 47.35 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.061 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.457 ' HA ' ' SG ' ' A' ' 597' ' ' CYS . 5.7 tt -78.33 122.51 33.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.697 HG21 ' HG3' ' A' ' 624' ' ' LYS . 55.4 t -115.52 121.0 66.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 122.185 -0.322 . . . . 0.0 110.598 -178.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 119.77 -151.23 17.48 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.132 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.37 115.51 4.37 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.06 2.507 . . . . 0.0 111.214 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 0.2 OUTLIER -82.24 -25.95 33.67 Favored 'General case' 0 C--O 1.197 -1.668 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.835 -178.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.46 ' HB2' ' CG2' ' A' ' 592' ' ' VAL . 64.7 p -123.08 98.54 5.93 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.354 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.1 m -101.21 142.46 15.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 610' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -96.27 151.07 19.86 Favored 'General case' 0 CA--C 1.48 -1.746 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.815 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 35.5 t -75.38 125.07 28.25 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 166.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.488 ' HA ' HG23 ' A' ' 589' ' ' VAL . 90.7 m-85 -116.36 165.1 13.59 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 613' ' ' HIS . . . . . 0.435 ' HB2' ' HG3' ' A' ' 566' ' ' GLU . 0.9 OUTLIER -71.95 2.89 4.9 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -177.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -111.11 -4.74 14.94 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.391 0.615 . . . . 0.0 110.422 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.52 -178.52 18.0 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.123 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.513 HD12 ' CD ' ' A' ' 572' ' ' PRO . 45.7 mt -70.92 120.18 16.12 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.488 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 49.9 m -138.42 146.13 49.84 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-O 120.475 0.179 . . . . 0.0 110.672 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.84 -169.16 7.05 Favored 'Cis proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.182 -1.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.37 169.67 7.05 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.674 ' HG ' HG22 ' A' ' 574' ' ' ILE . 1.3 mm? -74.16 145.75 83.65 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.343 -168.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.24 170.59 17.9 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 123.228 2.619 . . . . 0.0 110.668 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 622' ' ' ILE . . . . . 0.454 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 47.0 pt -113.34 -178.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 602' ' ' THR . 96.1 m -129.13 109.04 10.84 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.425 0.453 . . . . 0.0 111.914 -177.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.697 ' HG3' HG21 ' A' ' 604' ' ' VAL . 18.5 mtmm -97.89 127.12 43.63 Favored 'General case' 0 C--O 1.201 -1.461 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 176.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.504 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 1.4 tm-20 -83.37 -34.5 25.58 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -104.36 107.54 18.52 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.058 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.567 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 10.4 p -125.22 174.51 9.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.402 ' H ' HG22 ' A' ' 627' ' ' VAL . 13.1 mm-40 -88.16 139.62 30.31 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 118.824 0.738 . . . . 0.0 109.352 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 631' ' ' GLY . 17.4 m -93.87 104.54 16.6 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 173.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 55.9 m -60.9 21.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 629' ' ' SER . . . 54.83 -139.06 40.8 Favored Glycine 0 C--O 1.241 0.579 0 CA-C-O 119.734 -0.481 . . . . 0.0 112.906 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.96 154.68 22.86 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.961 2.441 . . . . 0.0 110.782 175.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.505 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 59.9 Cg_endo -74.4 157.71 45.04 Favored 'Trans proline' 0 C--O 1.255 1.355 0 C-N-CA 122.684 2.256 . . . . 0.0 112.922 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.38 -169.47 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 123.47 2.78 . . . . 0.0 111.199 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -109.65 153.08 24.73 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.393 -0.817 . . . . 0.0 110.675 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 657' ' ' TYR . 18.6 tp -80.67 139.86 35.95 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.423 HD13 ' OD1' ' A' ' 638' ' ' ASN . 0.3 OUTLIER -46.26 -47.79 18.06 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -178.578 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.423 ' OD1' HD13 ' A' ' 637' ' ' LEU . 16.4 m120 -116.58 -30.43 5.83 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.519 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.642 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -91.12 -152.23 27.8 Favored Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.222 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -156.35 -174.77 5.09 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.995 0.426 . . . . 0.0 110.545 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 6.0 p -92.68 134.71 29.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.536 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.56 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.2 ptmt -93.86 -24.65 17.66 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.046 0.45 . . . . 0.0 110.61 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 15.2 mm-40 -78.82 151.47 31.89 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.364 -177.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -63.97 109.24 1.72 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.438 ' CG2' HG11 ' A' ' 641' ' ' VAL . 16.7 p -71.59 98.56 1.9 Allowed 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.434 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -81.3 158.03 24.9 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -87.81 0.88 55.2 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.1 108.56 4.84 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.505 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 17.4 m-85 -92.76 -104.75 0.12 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 147.56 168.99 14.48 Favored Glycine 0 CA--C 1.487 -1.657 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.01 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 18.7 t60 -69.65 142.25 53.47 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 17.8 m 75.72 -1.66 2.95 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.549 1.14 . . . . 0.0 111.422 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.433 ' HG3' ' HD2' ' A' ' 649' ' ' TYR . 7.3 tp10 -93.72 114.63 26.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 670' ' ' LYS . 17.8 m -91.84 161.41 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.774 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.622 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.1 m -127.16 110.89 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.512 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.574 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.56 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 17.8 mt-10 -70.16 122.23 19.06 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.105 0.955 . . . . 0.0 111.599 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.537 ' HB3' HD22 ' A' ' 636' ' ' LEU . 76.6 m-85 -102.42 166.89 10.3 Favored 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.032 174.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -146.83 137.04 23.55 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.642 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 8.3 t -102.61 179.09 4.39 Favored 'General case' 0 C--N 1.276 -2.612 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.025 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 662' ' ' ARG . 30.9 m-80 -75.85 155.66 84.81 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.52 33.85 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 124.295 3.33 . . . . 0.0 112.688 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 660' ' ' ASN . 35.4 mtt180 -133.3 4.77 3.74 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.411 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 76.9 m-85 -138.42 163.11 32.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.462 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.1 147.61 38.49 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.467 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.5 OUTLIER -103.34 118.98 37.99 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -176.067 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -80.21 -59.33 2.75 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -95.53 -160.79 33.4 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.067 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.93 116.34 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.03 2.487 . . . . 0.0 112.237 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -63.52 -11.77 26.85 Favored 'General case' 0 C--O 1.195 -1.776 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.946 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -134.62 115.31 13.69 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.238 0.542 . . . . 0.0 111.909 178.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 33.8 pt -109.03 151.58 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.048 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.64 152.12 33.73 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 121.211 0.529 . . . . 0.0 111.399 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 1.5 t -69.72 121.15 16.62 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.03 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.432 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 34.0 m -116.23 86.9 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 CA-C-O 122.293 1.044 . . . . 0.0 113.045 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.567 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 16.5 m-20 75.3 8.05 3.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.795 -1.548 . . . . 0.0 113.913 166.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 142.35 -11.92 2.51 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.285 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -138.63 149.26 45.01 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.52 ' HB3' HD12 ' A' ' 671' ' ' ILE . 93.8 m95 -80.01 158.89 26.41 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 19.0 p -80.17 -180.0 7.35 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.655 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 25.8 m -68.6 126.72 30.55 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 120.717 0.294 . . . . 0.0 110.944 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.441 ' HA ' HG21 ' A' ' 671' ' ' ILE . 6.2 mp -57.94 160.3 8.76 Favored Pre-proline 0 N--CA 1.441 -0.904 0 O-C-N 124.461 1.101 . . . . 0.0 113.011 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.467 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 11.5 Cg_endo -57.31 -42.1 66.0 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.112 2.541 . . . . 0.0 113.283 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 99.8 t 67.55 113.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-O 121.936 0.874 . . . . 0.0 110.467 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 8.1 p -111.54 138.17 48.42 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.996 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.89 148.52 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.283 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.469 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 14.8 m -56.3 138.11 17.26 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.558 0 C-N-CA 124.558 1.143 . . . . 0.0 113.759 -171.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 C--N 1.299 -1.62 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.606 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -175.62 26.46 0.0 OUTLIER 'General case' 0 C--O 1.247 0.958 0 C-N-CA 123.576 0.75 . . . . 0.0 110.549 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -73.6 140.07 45.97 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.208 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 80.84 -41.91 2.62 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 116.243 -0.435 . . . . 0.0 113.991 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.1 72.96 0.62 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.262 1.03 . . . . 0.0 113.669 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -90.87 -23.63 20.48 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.449 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -147.99 -158.37 0.91 Allowed 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.407 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.851 ' HB3' HD11 ' A' ' 616' ' ' LEU . 90.5 m -59.28 133.34 56.01 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -174.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 571' ' ' LEU . 35.6 tt0 -94.63 -61.51 1.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.624 HD11 ' HG3' ' A' ' 580' ' ' PRO . 3.4 tt 150.84 129.88 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 177.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.703 ' HD3' HD13 ' A' ' 616' ' ' LEU . 74.5 Cg_endo -70.55 -170.8 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.76 1.64 . . . . 0.0 111.325 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -92.27 102.19 14.69 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.662 HD13 ' HD3' ' A' ' 580' ' ' PRO . 36.7 pt -76.2 -164.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.601 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.862 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 11.3 t70 -80.86 163.84 23.11 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.14 -28.09 22.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.17 0.509 . . . . 0.0 110.793 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -101.6 9.45 41.14 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 121.734 -0.604 . . . . 0.0 111.424 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.862 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.2 tm? -100.79 146.49 27.21 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.438 ' N ' HD13 ' A' ' 578' ' ' LEU . 16.3 m -140.74 121.14 8.82 Favored Pre-proline 0 C--N 1.3 -1.578 0 C-N-CA 123.754 0.822 . . . . 0.0 109.326 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.662 ' HD3' HD13 ' A' ' 574' ' ' ILE . 55.8 Cg_endo -73.0 136.33 24.7 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.036 1.824 . . . . 0.0 111.484 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.74 -38.82 92.3 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.537 1.135 . . . . 0.0 110.782 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -67.38 -61.07 2.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.739 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 60.6 tttm 51.84 74.57 0.25 Allowed 'General case' 0 C--O 1.241 0.649 0 O-C-N 124.676 1.235 . . . . 0.0 110.895 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 16.9 ptpt -131.12 156.24 45.61 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.289 -1.323 . . . . 0.0 107.445 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -76.55 -31.51 57.64 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -134.21 133.08 40.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.875 0.369 . . . . 0.0 110.838 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.52 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 96.7 m-85 -110.69 142.29 42.8 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -93.13 153.4 18.68 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.602 ' HA ' ' SG ' ' A' ' 611' ' ' CYS 0.269 0.2 OUTLIER -64.64 118.0 6.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 121.839 0.828 . . . . 0.0 111.705 179.493 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 113.34 -3.66 25.11 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.768 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -74.53 134.7 42.19 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.628 HG12 ' HG3' ' A' ' 610' ' ' GLN . 20.3 m -109.82 129.92 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.881 0.848 . . . . 0.0 109.888 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.52 ' HG ' ' CE2' ' A' ' 587' ' ' TYR 0.368 0.0 OUTLIER -116.26 98.56 6.66 Favored 'General case' 0 N--CA 1.385 -3.701 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.269 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 607' ' ' ASN . 24.4 mtpp -61.46 124.6 21.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.044 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.698 ' HB3' HD11 ' A' ' 578' ' ' LEU . 27.7 m-85 -105.44 164.73 11.64 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.702 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 596' ' ' SER . . . . . 0.477 ' HA ' HD12 ' A' ' 603' ' ' ILE . 34.0 p -168.85 166.69 11.31 Favored 'General case' 0 N--CA 1.401 -2.88 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 169.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 70.8 m -98.9 173.26 6.94 Favored 'General case' 0 C--N 1.255 -3.534 0 O-C-N 123.769 0.668 . . . . 0.0 110.831 -177.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.611 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 29.9 mmtp -53.04 163.21 0.9 Allowed Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 124.304 1.041 . . . . 0.0 112.191 176.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 18.7 Cg_endo -60.69 -17.09 47.55 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.852 2.368 . . . . 0.0 115.291 -170.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -110.54 8.63 30.37 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.273 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 30.7 m-85 -113.1 162.43 15.94 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.534 0.683 . . . . 0.0 112.258 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.409 HG21 HG21 ' A' ' 627' ' ' VAL . 8.1 m -112.65 131.95 55.4 Favored 'General case' 0 N--CA 1.416 -2.148 0 C-N-CA 125.533 1.533 . . . . 0.0 110.111 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 596' ' ' SER . 11.4 tt -83.98 122.4 37.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.439 0.638 . . . . 0.0 109.5 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 46.1 t -118.07 109.74 28.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.276 0.56 . . . . 0.0 109.856 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 132.82 -164.43 24.07 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.21 128.76 27.39 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.966 2.444 . . . . 0.0 110.786 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 29.6 m-20 -94.96 -10.17 31.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 122.182 -0.324 . . . . 0.0 110.947 -175.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 608' ' ' SER . . . . . . . . . . . . . 2.8 p -150.24 98.08 2.63 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.335 0.588 . . . . 0.0 111.637 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 20.3 m -93.21 167.56 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.781 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.628 ' HG3' HG12 ' A' ' 592' ' ' VAL . 1.9 mp0 -113.97 156.0 24.83 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.288 0.566 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 0.9 OUTLIER -85.25 130.8 34.53 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 164.441 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.565 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 77.5 m-85 -115.35 175.0 5.71 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -73.23 -12.94 61.04 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.862 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -101.38 -2.32 31.19 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 111.173 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.25 -171.78 21.35 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.851 HD11 ' HB3' ' A' ' 569' ' ' CYS . 5.2 mp -87.36 137.59 32.21 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 118.091 0.945 . . . . 0.0 110.019 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 618' ' ' PRO . 44.7 m -158.38 157.11 28.67 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.152 -176.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 617' ' ' SER . 59.3 Cg_endo -68.92 -168.18 3.85 Favored 'Cis proline' 0 CA--C 1.554 1.498 0 C-N-CA 124.599 -1.001 . . . . 0.0 114.279 1.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.02 160.99 16.78 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.994 0.426 . . . . 0.0 110.748 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 572' ' ' PRO . 2.1 mm? -78.43 144.52 66.11 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.89 162.53 41.78 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.982 2.455 . . . . 0.0 110.924 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 622' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 43.1 pt -110.49 -178.66 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.7 m -129.9 116.63 18.93 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-O 121.28 0.562 . . . . 0.0 111.716 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 624' ' ' LYS . 46.3 mtpt -104.02 130.42 51.68 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 25.3 tt0 -86.85 -39.82 15.48 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -98.22 107.54 20.04 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.138 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 3.5 p -107.13 176.48 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 47.8 mt-30 -93.53 156.14 16.91 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.478 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 15.4 m -99.02 -7.53 26.71 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.658 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 630' ' ' CYS . . . . . 0.452 ' SG ' ' HA2' ' A' ' 676' ' ' GLY . 20.9 m 71.1 -12.4 0.59 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 167.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 65.18 -147.25 50.79 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -79.01 148.76 22.08 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 122.66 2.24 . . . . 0.0 111.846 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.641 ' HG3' HG11 ' A' ' 655' ' ' VAL . 71.6 Cg_endo -76.42 167.69 25.22 Favored 'Trans proline' 0 CA--C 1.556 1.578 0 C-N-CA 123.49 2.793 . . . . 0.0 113.025 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.97 -167.52 0.24 Allowed 'Trans proline' 0 CA--C 1.55 1.292 0 C-N-CA 123.626 2.884 . . . . 0.0 113.587 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -111.99 166.02 11.59 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.605 HD22 ' HB3' ' A' ' 657' ' ' TYR . 18.9 tp -102.55 132.2 48.78 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 638' ' ' ASN . 2.3 pp -51.91 -42.91 63.12 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.778 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 92.6 m-20 -131.09 29.91 4.62 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.717 0.77 . . . . 0.0 109.392 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.662 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -153.61 -150.4 5.45 Favored Glycine 0 N--CA 1.412 -2.953 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -160.55 -166.84 1.73 Allowed 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.5 p -107.53 128.37 62.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -85.44 -22.29 28.36 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.348 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.624 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 8.2 mm-40 -86.89 144.43 26.99 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.158 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 644' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 644' ' ' LYS . 5.9 ttpm? -56.8 112.7 1.38 Allowed 'General case' 0 C--N 1.31 -1.136 0 O-C-N 124.353 1.033 . . . . 0.0 109.938 176.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.46 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 4.9 p -83.72 101.43 11.55 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.599 0.714 . . . . 0.0 111.682 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 49.7 pttt -84.95 160.78 20.02 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.099 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.94 -21.05 60.66 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -152.26 125.01 8.42 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.097 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.551 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 11.3 m-85 -99.27 -75.27 0.57 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 129.19 172.19 13.12 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -175.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.503 ' HB2' HG11 ' A' ' 627' ' ' VAL . 64.6 t60 -60.44 -63.31 1.34 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 19.3 m -87.9 41.82 1.02 Allowed 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 121.333 0.587 . . . . 0.0 111.172 -172.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -120.3 106.28 11.73 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.631 HG21 ' HE2' ' A' ' 670' ' ' LYS . 15.8 m -82.19 154.64 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-O 122.066 0.936 . . . . 0.0 111.548 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.641 HG11 ' HG3' ' A' ' 633' ' ' PRO . 2.8 t -127.45 111.89 26.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 114.13 -1.396 . . . . 0.0 107.995 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.701 ' HG2' ' HG2' ' A' ' 670' ' ' LYS . 36.0 mt-10 -70.09 120.47 15.84 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 122.21 1.005 . . . . 0.0 113.01 175.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.605 ' HB3' HD22 ' A' ' 636' ' ' LEU . 55.4 m-85 -100.21 165.34 11.54 Favored 'General case' 0 C--N 1.263 -3.153 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.717 171.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -146.54 138.29 24.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.662 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 80.1 m -92.3 175.92 6.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 0.8 OUTLIER -67.46 157.55 85.32 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.348 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 70.1 Cg_endo -72.89 37.74 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.909 3.073 . . . . 0.0 113.195 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -153.52 11.82 0.45 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.695 -175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 660' ' ' ASN . 87.0 m-85 -132.88 154.15 50.66 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.37 0.605 . . . . 0.0 110.196 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 85.4 mt -93.68 149.23 21.4 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.2 ttt -112.11 118.76 36.26 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -75.18 -72.04 0.32 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -172.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -90.67 -151.97 26.95 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 113.663 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.36 119.67 6.74 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.3 2.667 . . . . 0.0 111.919 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -74.96 -12.9 60.45 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 121.201 0.524 . . . . 0.0 110.81 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.701 ' HG2' ' HG2' ' A' ' 656' ' ' GLU . 9.1 mtpt -119.24 125.88 50.18 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 40.4 pt -116.74 138.14 48.32 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.605 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.61 161.52 13.66 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 42.8 t -102.2 110.93 23.03 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.492 1.139 . . . . 0.0 111.135 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 77.8 t -86.14 110.08 19.47 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.036 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.13 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.593 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 23.0 t70 60.73 -80.27 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 124.799 1.24 . . . . 0.0 112.43 -171.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.452 ' HA2' ' SG ' ' A' ' 630' ' ' CYS . . . -145.67 14.61 1.79 Allowed Glycine 0 C--N 1.301 -1.389 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 176.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -125.41 115.6 20.54 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.558 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.4 m95 -63.53 146.24 54.08 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 17.8 p -67.36 175.51 2.71 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 2.7 m -60.5 130.2 45.38 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.938 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.48 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 6.0 mp -63.38 152.25 85.6 Favored Pre-proline 0 N--CA 1.433 -1.281 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.48 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 19.3 Cg_endo -58.64 -36.73 96.83 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.648 2.898 . . . . 0.0 114.125 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 66.2 t 69.4 117.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.913 0.885 . . . . 0.0 112.773 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.778 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 4.1 m -96.75 135.35 38.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.446 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.81 144.04 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.928 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 16.8 m -58.15 139.69 17.47 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.064 0 C-N-CA 124.678 1.191 . . . . 0.0 112.843 -174.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.62 -179.38 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -121.04 170.78 9.19 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -60.95 107.56 0.73 Allowed 'General case' 0 C--O 1.254 1.3 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -99.23 -148.49 23.24 Favored Glycine 0 N--CA 1.422 -2.251 0 CA-C-N 115.375 -0.83 . . . . 0.0 113.753 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 47.06 65.57 1.21 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.826 1.65 . . . . 0.0 111.717 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -107.02 4.41 27.02 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.226 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -157.31 162.86 39.15 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.741 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 79.2 m -67.78 119.19 12.09 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.792 0.806 . . . . 0.0 110.943 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.76 -2.31 38.36 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-O 122.419 1.104 . . . . 0.0 108.929 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.675 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 47.4 tp 74.37 115.1 0.03 OUTLIER Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 127.059 2.144 . . . . 0.0 110.337 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.708 ' HG2' HD11 ' A' ' 620' ' ' LEU . 60.8 Cg_endo -67.97 -159.47 0.05 OUTLIER 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 123.696 2.931 . . . . 0.0 111.6 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -89.93 98.98 12.09 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.563 HG22 HD13 ' A' ' 620' ' ' LEU . 40.7 pt -72.83 175.09 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.153 174.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.726 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.7 t70 -65.79 147.81 52.79 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.12 -25.91 31.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 C-N-CA 123.792 0.837 . . . . 0.0 110.786 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -105.9 8.32 32.57 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 122.054 -0.403 . . . . 0.0 111.864 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.726 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 6.5 tp -91.75 148.61 22.12 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 21.7 m -135.66 116.57 11.77 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.492 ' HG2' ' HB2' ' A' ' 583' ' ' LYS . 26.9 Cg_endo -74.23 134.61 19.47 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.472 1.448 . . . . 0.0 109.686 174.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -33.41 75.72 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 582' ' ' ARG . . . . . 0.434 ' HB3' ' HE3' ' A' ' 584' ' ' LYS . 27.0 mmt180 -70.76 -64.75 0.84 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.802 177.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.492 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 27.3 ttpp 47.91 82.34 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.691 1.596 . . . . 0.0 112.334 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.477 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.9 ptpt -133.66 163.91 28.37 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.975 -1.466 . . . . 0.0 107.412 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -72.69 -46.02 55.84 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.957 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -127.36 133.88 50.01 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.577 0.703 . . . . 0.0 110.258 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.741 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 92.8 m-85 -107.37 124.76 50.3 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 124.862 1.265 . . . . 0.0 109.509 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -78.79 149.23 32.66 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.586 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 1.3 p -63.8 119.17 7.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.59 0.709 . . . . 0.0 111.33 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 115.2 -10.38 20.21 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.26 -173.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -70.21 125.97 28.32 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 18.6 t -99.55 116.7 43.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 608' ' ' SER . 9.7 mt -101.84 115.04 29.66 Favored 'General case' 0 CA--C 1.47 -2.121 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.598 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 34.1 mtmm -91.76 99.38 12.27 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -76.81 161.81 28.15 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-O 122.022 0.915 . . . . 0.0 109.147 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 38.5 m -152.46 169.38 22.74 Favored 'General case' 0 C--N 1.253 -3.619 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.483 ' SG ' HD12 ' A' ' 578' ' ' LEU . 87.6 m -107.43 -178.17 3.56 Favored 'General case' 0 C--N 1.247 -3.887 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.594 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 32.1 mmtm -55.67 163.83 1.83 Allowed Pre-proline 0 C--N 1.313 -1.022 0 C-N-CA 123.018 0.527 . . . . 0.0 110.993 172.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 16.6 Cg_endo -59.03 -28.66 88.49 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.36 2.04 . . . . 0.0 114.701 -171.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.88 -2.65 61.04 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.879 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 39.9 m-85 -103.62 136.3 43.58 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 14.4 m -87.87 125.78 34.67 Favored 'General case' 0 N--CA 1.395 -3.201 0 CA-C-N 113.74 -1.573 . . . . 0.0 109.182 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.475 HD11 ' HG3' ' A' ' 621' ' ' PRO . 12.6 tt -80.31 125.69 39.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.67 HG21 ' HD3' ' A' ' 624' ' ' LYS . 82.5 t -117.25 114.58 46.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 123.59 -166.67 16.0 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.178 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.24 115.82 3.37 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.919 2.413 . . . . 0.0 111.535 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -75.99 -49.51 17.47 Favored 'General case' 0 C--O 1.206 -1.201 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.598 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 57.0 p -99.1 113.7 26.05 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.11 0.481 . . . . 0.0 111.626 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.86 157.39 17.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 610' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.36 151.96 22.14 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 121.011 0.434 . . . . 0.0 109.904 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 42.1 t -80.16 129.46 34.51 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.446 ' HA ' HG23 ' A' ' 589' ' ' VAL . 95.6 m-85 -114.64 165.79 12.41 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -61.92 -18.72 61.24 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -97.79 -5.28 35.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.85 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 134.62 -179.75 17.28 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 611' ' ' CYS . 71.9 mt -72.99 128.87 36.74 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 618' ' ' PRO . 67.1 m -146.26 147.07 30.07 Favored Pre-proline 0 C--N 1.294 -1.809 0 CA-C-N 116.816 -0.175 . . . . 0.0 110.681 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 617' ' ' SER . 49.5 Cg_endo -66.64 -175.7 7.74 Favored 'Cis proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.728 -1.363 . . . . 0.0 113.111 0.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.19 163.81 9.67 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 121.033 0.444 . . . . 0.0 110.957 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.708 HD11 ' HG2' ' A' ' 572' ' ' PRO . 24.0 mt -77.39 145.91 73.04 Favored Pre-proline 0 C--N 1.293 -1.869 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.972 -170.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.475 ' HG3' HD11 ' A' ' 603' ' ' ILE . 61.8 Cg_endo -70.91 173.68 11.64 Favored 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 123.537 2.824 . . . . 0.0 111.007 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 622' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 604' ' ' VAL . 44.1 pt -117.7 178.23 2.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.8 m -123.89 123.39 40.32 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.114 0.483 . . . . 0.0 110.604 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.67 ' HD3' HG21 ' A' ' 604' ' ' VAL . 58.2 mtpt -118.92 119.79 35.36 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.563 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 4.3 tm-20 -79.25 -43.12 24.38 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -91.64 91.92 8.23 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.488 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.622 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 5.0 p -109.69 170.82 2.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.275 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.588 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 19.9 mm-40 -91.61 161.17 15.04 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 27.3 m -107.51 -4.9 17.96 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.104 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 80.1 m 71.22 -34.79 0.31 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 88.34 -141.93 17.06 Favored Glycine 0 N--CA 1.415 -2.719 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -74.34 145.7 34.58 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 121.997 1.798 . . . . 0.0 111.831 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.533 ' HG3' HG11 ' A' ' 655' ' ' VAL . 92.2 Cg_endo -82.43 170.86 12.83 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.085 2.523 . . . . 0.0 111.874 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.14 -166.92 0.15 Allowed 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 123.214 2.61 . . . . 0.0 113.108 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -100.45 169.58 8.99 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.56 ' CD2' ' SG ' ' A' ' 659' ' ' CYS . 14.7 tp -91.33 166.16 13.05 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 117.733 -1.587 . . . . 0.0 110.258 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.509 ' N ' ' HG ' ' A' ' 636' ' ' LEU . 4.9 tt -63.45 -67.64 0.41 Allowed 'General case' 0 N--CA 1.396 -3.162 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.716 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -128.08 40.16 3.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.979 0.895 . . . . 0.0 109.169 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -149.21 -142.13 3.55 Favored Glycine 1 N--CA 1.395 -4.067 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.784 176.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -156.66 -172.83 4.21 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.457 HG11 HG23 ' A' ' 645' ' ' THR . 9.0 p -104.0 134.55 44.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.705 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.1 ptmt -86.17 -29.85 22.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.661 0.744 . . . . 0.0 110.439 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 27.6 mm-40 -88.2 159.24 18.24 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.508 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -72.84 118.86 16.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.664 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.457 HG23 HG11 ' A' ' 641' ' ' VAL . 18.1 p -71.6 101.91 2.62 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-O 121.724 0.773 . . . . 0.0 111.21 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -73.29 156.54 38.35 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.484 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.51 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 49.2 mt-10 -85.59 -6.19 59.19 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -140.95 113.27 7.99 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 173.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.531 ' CE2' HG22 ' A' ' 655' ' ' VAL . 4.5 m-85 -96.35 -77.85 0.48 Allowed 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.455 174.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 130.09 163.5 11.1 Favored Glycine 0 CA--C 1.497 -1.091 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.628 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 71.2 t60 -56.51 -57.86 10.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 44.7 m -86.28 20.62 2.31 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -102.66 120.0 39.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 2.9 p -99.16 161.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.252 0.548 . . . . 0.0 110.143 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.8 t -127.37 113.72 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.724 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.705 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 29.5 mt-10 -71.91 124.15 24.26 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.497 0.665 . . . . 0.0 112.45 176.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.549 ' HB3' HD22 ' A' ' 636' ' ' LEU . 87.5 m-85 -108.1 167.33 10.07 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.621 172.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -150.44 141.23 22.76 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.79 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 9.1 m -100.47 173.85 6.38 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.116 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -62.89 155.09 73.47 Favored Pre-proline 0 C--O 1.245 0.828 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.618 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -71.01 29.41 0.21 Allowed 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 124.218 3.279 . . . . 0.0 114.681 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.3 21.8 1.88 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.176 0.989 . . . . 0.0 110.144 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -135.6 157.38 47.03 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.01 175.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.43 132.36 54.2 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 3.1 ttt -97.0 106.41 18.75 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 666' ' ' LYS . 35.9 ttmt -90.97 -42.65 10.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -173.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.89 -178.67 46.13 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.183 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.27 113.64 1.63 Allowed 'Trans proline' 0 N--CA 1.476 0.484 0 C-N-CA 123.613 2.876 . . . . 0.0 112.082 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.532 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 3.1 p30 -63.27 -15.42 57.12 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 2.0 mtpt -120.22 155.32 33.41 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 44.5 pt -139.36 145.95 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 19.6 pm0 -118.64 158.75 24.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.628 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 7.5 t -86.33 104.48 15.88 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.878 1.323 . . . . 0.0 111.344 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.6 106.63 18.07 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.051 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.845 -176.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.622 ' HA ' ' CG2' ' A' ' 627' ' ' VAL 0.253 16.0 t70 64.13 -56.54 0.23 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.7 1.6 . . . . 0.0 114.543 -178.035 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -161.95 4.97 0.08 OUTLIER Glycine 0 C--N 1.288 -2.095 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.651 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -136.37 154.46 50.82 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 123.115 0.566 . . . . 0.0 109.478 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.435 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.3 m95 -80.34 174.72 11.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.836 0.826 . . . . 0.0 111.638 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.11 167.85 10.8 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.705 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 26.7 m -57.16 128.46 37.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.22 0.95 . . . . 0.0 110.937 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.55 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 4.5 mp -65.94 154.46 89.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.541 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.55 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 5.9 Cg_endo -53.68 -32.6 65.92 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.962 3.108 . . . . 0.0 114.874 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.315 30.5 m 42.79 94.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 26.9 p -86.79 162.03 18.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.697 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.62 155.99 23.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.5 140.68 13.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 123.686 0.617 . . . . 0.0 110.764 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--O 1.247 0.93 0 C-N-CA 123.55 0.74 . . . . 0.0 110.831 -179.348 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 CA--C 1.509 -0.611 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 61.75 -179.48 0.12 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.259 1.024 . . . . 0.0 111.402 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -102.58 151.67 22.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -75.9 121.94 6.45 Favored Glycine 0 N--CA 1.441 -1.011 0 O-C-N 123.907 0.754 . . . . 0.0 111.825 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.718 ' HG3' ' HG2' ' A' ' 567' ' ' ARG . 11.2 tp10 -78.29 128.38 33.61 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.423 0.689 . . . . 0.0 111.399 -177.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.718 ' HG2' ' HG3' ' A' ' 566' ' ' GLU . 22.2 mmm180 68.18 57.41 0.48 Allowed 'General case' 0 C--O 1.247 0.941 0 C-N-CA 125.809 1.643 . . . . 0.0 114.423 173.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -143.06 -175.94 4.72 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.778 0.831 . . . . 0.0 109.07 175.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.74 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 89.4 m -100.9 149.6 23.71 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -137.28 14.0 3.02 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 571' ' ' LEU . 1.1 tm? 70.96 101.62 0.04 OUTLIER Pre-proline 0 C--O 1.247 0.935 0 C-N-CA 124.481 1.113 . . . . 0.0 109.881 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.74 -172.34 0.8 Allowed 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.497 2.798 . . . . 0.0 111.613 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.39 95.86 5.2 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.555 HD13 ' HD3' ' A' ' 580' ' ' PRO . 17.2 pt -73.81 -175.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.592 177.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.7 t70 -71.2 148.87 46.87 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.49 -33.0 46.95 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.634 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -98.6 13.02 33.47 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 121.805 -0.56 . . . . 0.0 111.943 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.63 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.6 OUTLIER -106.06 150.75 25.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.527 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.55 119.68 7.78 Favored Pre-proline 0 C--N 1.312 -1.045 0 C-N-CA 124.159 0.983 . . . . 0.0 109.197 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.555 ' HD3' HD13 ' A' ' 574' ' ' ILE . 33.3 Cg_endo -71.43 135.31 26.3 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.321 2.014 . . . . 0.0 112.318 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.57 -47.12 79.91 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 123.556 0.742 . . . . 0.0 110.08 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -64.67 -68.43 0.36 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.466 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 39.1 ttpt 52.38 70.81 0.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.471 1.129 . . . . 0.0 110.685 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -119.94 157.26 29.16 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.93 -37.27 67.24 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.145 0.498 . . . . 0.0 111.805 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -127.42 142.74 51.34 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.74 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 72.3 m-85 -122.65 126.76 48.28 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 588' ' ' LYS . . . . . 0.52 ' HB2' ' HG2' ' A' ' 591' ' ' GLU . 36.9 mttp -69.61 149.26 48.33 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.436 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -71.52 120.19 19.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.22 174.299 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 116.57 -11.11 16.21 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.635 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 591' ' ' GLU . . . . . 0.52 ' HG2' ' HB2' ' A' ' 588' ' ' LYS . 5.8 mm-40 -67.84 142.14 56.23 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.555 HG22 ' HG3' ' A' ' 610' ' ' GLN . 18.7 t -115.64 114.75 47.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.639 HD22 ' CD2' ' A' ' 587' ' ' TYR . 0.2 OUTLIER -105.58 109.64 21.68 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.626 0.727 . . . . 0.0 111.279 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 60.5 mtpt -72.4 141.94 48.7 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.345 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 580' ' ' PRO . 64.1 m-85 -114.23 177.59 4.59 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-O 121.05 0.452 . . . . 0.0 109.955 175.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 10.6 p -163.05 164.46 25.5 Favored 'General case' 0 N--CA 1.405 -2.696 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 94.6 m -111.95 -178.72 3.5 Favored 'General case' 0 C--N 1.266 -3.028 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 598' ' ' LYS . 28.1 mmtp -57.41 159.38 8.91 Favored Pre-proline 0 N--CA 1.436 -1.167 0 C-N-CA 123.281 0.632 . . . . 0.0 110.995 173.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -46.6 -45.01 20.52 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 124.195 3.263 . . . . 0.0 114.057 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 600' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 625' ' ' GLU . . . -90.25 -2.4 73.98 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.979 -175.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 29.3 m-85 -97.41 179.79 4.75 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.613 0.721 . . . . 0.0 112.118 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.677 HG21 HG11 ' A' ' 627' ' ' VAL . 89.3 m -136.47 129.38 30.99 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 595' ' ' PHE . 15.9 tt -86.05 150.23 3.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 1.012 HG21 HG12 ' A' ' 622' ' ' ILE . 4.9 m -119.05 154.22 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.384 -171.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 53.72 -123.94 27.92 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 169.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.72 94.75 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.294 2.663 . . . . 0.0 112.194 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -79.98 -28.48 39.53 Favored 'General case' 0 C--O 1.203 -1.385 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.479 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.501 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 34.1 p -112.81 94.7 5.03 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.515 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 23.6 m -98.53 156.74 3.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.555 ' HG3' HG22 ' A' ' 592' ' ' VAL . 1.5 mp0 -101.56 155.31 18.16 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.066 0.46 . . . . 0.0 110.111 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.484 ' HA ' HD23 ' A' ' 616' ' ' LEU . 44.1 t -82.97 120.26 25.48 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 168.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.577 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 19.7 m-85 -100.59 167.55 10.28 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -54.59 -26.61 33.55 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.065 0.546 . . . . 0.0 112.432 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -108.53 8.21 27.15 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.885 0.374 . . . . 0.0 111.446 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 130.19 -177.73 18.02 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.915 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 611' ' ' CYS . 74.5 mt -69.96 130.05 41.14 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.577 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 70.8 m -146.07 144.51 21.87 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 617' ' ' SER . 53.2 Cg_endo -69.31 -173.82 8.48 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.592 -1.42 . . . . 0.0 112.74 0.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.45 152.14 35.25 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.336 0.588 . . . . 0.0 110.53 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.429 ' CD2' HG22 ' A' ' 574' ' ' ILE . 4.9 mp -71.94 142.26 85.21 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.983 -170.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.9 164.47 34.54 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.832 3.021 . . . . 0.0 113.624 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 622' ' ' ILE . . . . . 1.012 HG12 HG21 ' A' ' 604' ' ' VAL . 33.0 pt -104.97 -176.34 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.506 ' SG ' HD12 ' A' ' 578' ' ' LEU . 74.3 m -125.58 127.47 46.42 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 121.202 0.525 . . . . 0.0 109.701 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.63 ' HG2' ' CG1' ' A' ' 604' ' ' VAL . 12.7 mmmm -86.63 -59.03 2.39 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 1.9 tm-20 80.78 -54.84 0.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.939 1.696 . . . . 0.0 108.508 -172.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -98.73 118.8 36.27 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.328 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.677 HG11 HG21 ' A' ' 602' ' ' THR . 3.9 m -128.32 170.92 17.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.937 178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -88.01 178.04 6.77 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.163 0.506 . . . . 0.0 110.616 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.444 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 7.5 m -105.47 -14.38 15.33 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 11.9 m 72.7 -10.16 0.99 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.135 1.374 . . . . 0.0 113.185 169.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 59.55 -141.9 47.26 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.94 154.3 47.92 Favored 'Trans proline' 0 CA--C 1.549 1.254 0 C-N-CA 122.924 2.416 . . . . 0.0 111.901 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.598 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 92.7 Cg_endo -81.46 167.39 17.27 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 123.415 2.743 . . . . 0.0 111.855 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.15 -175.92 1.42 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.49 2.127 . . . . 0.0 110.741 174.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.64 161.43 14.87 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 657' ' ' TYR . 20.4 tp -85.16 128.84 34.82 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.518 HD21 HG12 ' A' ' 683' ' ' VAL . 1.7 pp -46.88 -37.2 8.47 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.809 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 90.8 m-20 -133.16 28.14 4.13 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.134 0.492 . . . . 0.0 109.683 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.21 -142.61 3.48 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -166.11 -179.31 5.07 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.399 0.679 . . . . 0.0 109.483 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.502 HG22 ' CE1' ' A' ' 657' ' ' TYR . 45.9 t -90.03 133.57 31.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 8.4 ptmm? -90.64 -16.03 29.38 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.548 0.69 . . . . 0.0 110.986 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -91.51 159.8 15.75 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -72.99 123.0 22.63 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.244 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 22.4 p -62.27 110.39 1.62 Allowed 'General case' 0 N--CA 1.411 -2.404 0 O-C-N 123.725 0.64 . . . . 0.0 109.547 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.408 ' HE2' ' CE2' ' A' ' 649' ' ' TYR . 43.8 mtmt -72.69 151.9 41.98 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.97 -14.51 59.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.92 0.867 . . . . 0.0 109.256 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -149.92 112.66 4.78 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.783 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.598 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.0 m-85 -89.83 -61.94 1.58 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 106.32 156.66 21.52 Favored Glycine 0 N--CA 1.421 -2.304 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.539 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.522 ' CD2' ' H ' ' A' ' 675' ' ' ASP . 55.7 t-80 -61.63 136.19 57.91 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 122.596 0.358 . . . . 0.0 110.321 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.5 m 70.82 14.59 6.99 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.334 1.053 . . . . 0.0 112.63 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.466 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 6.0 tp10 -94.93 121.31 36.4 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 174.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.653 HG21 ' HE2' ' A' ' 670' ' ' LYS . 1.4 p -88.47 160.18 2.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-O 121.156 0.503 . . . . 0.0 110.632 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -129.63 113.53 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.57 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 13.8 mt-10 -75.97 129.4 36.84 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.852 0.834 . . . . 0.0 111.261 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.607 ' HB3' HD22 ' A' ' 636' ' ' LEU . 95.4 m-85 -111.12 174.38 5.89 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.125 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -148.02 142.46 26.38 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.652 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 85.6 m -97.73 178.3 5.2 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.403 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 36.6 m-80 -71.62 154.55 93.11 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.38 38.24 0.48 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 124.246 3.298 . . . . 0.0 113.183 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.506 ' HG3' ' CE1' ' A' ' 663' ' ' PHE . 9.0 ptm180 -150.51 13.51 0.74 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.487 -175.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.506 ' CE1' ' HG3' ' A' ' 662' ' ' ARG . 85.2 m-85 -139.13 151.5 46.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.581 0.705 . . . . 0.0 110.772 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 81.1 mt -92.76 152.7 19.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.598 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 1.3 ttt -107.63 109.86 21.59 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.546 ' HB3' HG23 ' A' ' 683' ' ' VAL . 17.1 tppt? -71.57 -61.36 1.81 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.3 -172.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.67 -162.39 30.12 Favored Glycine 0 N--CA 1.431 -1.686 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.498 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.2 119.79 7.06 Favored 'Trans proline' 0 C--N 1.334 -0.198 0 C-N-CA 123.475 2.783 . . . . 0.0 112.407 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 4.4 p30 -64.29 -2.38 2.14 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.653 ' HE2' HG21 ' A' ' 654' ' ' VAL . 0.0 OUTLIER -140.22 143.61 36.1 Favored 'General case' 0 N--CA 1.407 -2.625 0 C-N-CA 122.746 0.419 . . . . 0.0 110.279 177.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 678' ' ' TRP . 34.0 pt -136.46 142.39 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.23 149.92 31.63 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 44.0 t -80.16 125.24 29.57 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-O 123.166 1.46 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.52 118.39 57.04 Favored 'Isoleucine or valine' 1 N--CA 1.377 -4.094 0 CA-C-N 111.72 -2.491 . . . . 0.0 109.206 -174.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.522 ' H ' ' CD2' ' A' ' 651' ' ' HIS . 30.4 t70 63.46 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.938 1.295 . . . . 0.0 110.653 -172.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -161.03 27.99 0.3 Allowed Glycine 0 C--N 1.29 -1.977 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -138.5 146.48 42.04 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.563 ' HB3' HD12 ' A' ' 671' ' ' ILE . 95.6 m95 -87.18 160.58 18.45 Favored 'General case' 0 C--N 1.273 -2.749 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.93 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 679' ' ' THR . . . . . 0.529 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 19.2 p -83.52 -179.9 7.47 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 14.2 m -65.69 124.73 23.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.004 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.446 ' HA ' HG21 ' A' ' 671' ' ' ILE . 7.9 mp -64.05 161.92 35.27 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.557 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 23.6 Cg_endo -62.25 -16.79 53.3 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 123.795 2.997 . . . . 0.0 115.08 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 666' ' ' LYS 0.293 31.6 m 48.21 98.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 177.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.809 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.1 m -80.39 142.3 34.52 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.316 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 666' ' ' LYS . 0.2 OUTLIER -136.95 145.91 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.324 0 C-N-CA 123.765 0.826 . . . . 0.0 108.874 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 28.3 m -50.34 126.26 4.85 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.209 0 C-N-CA 125.473 1.509 . . . . 0.0 114.018 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.438 ' HG2' HD21 ' A' ' 664' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.288 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.629 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -145.18 -7.29 0.63 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.609 177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -144.4 152.23 40.39 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 120.825 0.345 . . . . 0.0 110.413 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -157.11 67.83 0.29 Allowed Glycine 0 C--N 1.298 -1.543 0 N-CA-C 107.719 -2.152 . . . . 0.0 107.719 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.4 -34.65 28.23 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.664 -0.768 . . . . 0.0 111.206 -171.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 567' ' ' ARG . 0.0 OUTLIER -153.43 153.05 31.76 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.214 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -93.36 -170.8 2.47 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 569' ' ' CYS . . . . . . . . . . . . . 76.8 m -85.96 166.63 15.77 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.204 0.526 . . . . 0.0 111.547 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -141.78 150.24 41.45 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.747 HD11 ' HG3' ' A' ' 580' ' ' PRO . 1.0 OUTLIER -73.9 119.17 74.8 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.504 ' HD3' HD12 ' A' ' 616' ' ' LEU . 72.4 Cg_endo -76.07 -162.48 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.658 2.239 . . . . 0.0 111.064 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -87.25 107.4 18.47 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 121.91 -0.494 . . . . 0.0 110.092 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.498 HG22 HD23 ' A' ' 620' ' ' LEU . 28.1 pt -70.71 -169.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.346 176.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 10.9 t70 -77.43 152.94 34.06 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.01 -29.94 42.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.282 0.563 . . . . 0.0 110.232 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -103.35 15.3 29.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.577 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.2 OUTLIER -97.63 157.93 15.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 4.9 p -158.62 110.22 1.64 Allowed Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.336 0.654 . . . . 0.0 110.171 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.747 ' HG3' HD11 ' A' ' 571' ' ' LEU . 59.4 Cg_endo -72.08 148.29 50.31 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.392 2.728 . . . . 0.0 113.206 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.41 -45.0 27.25 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -75.39 109.37 8.87 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 173.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 583' ' ' LYS . 35.2 ttmt -121.6 98.02 5.77 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -146.9 177.82 8.82 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -86.73 -55.73 3.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.705 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -116.09 142.55 46.66 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.58 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 27.1 m-85 -110.88 124.57 52.33 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.551 -174.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -62.56 143.41 57.26 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.266 0.978 . . . . 0.0 108.843 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.748 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 3.4 p -61.71 119.58 6.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-O 121.858 0.837 . . . . 0.0 109.998 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 107.21 -10.3 39.67 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.254 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.47 123.35 23.73 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 3.6 p -102.48 129.19 54.39 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 CA-C-O 121.863 0.84 . . . . 0.0 111.383 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.58 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 4.3 mp -96.98 101.87 13.54 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.432 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 594' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -81.11 103.31 10.83 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.721 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 578' ' ' LEU . 74.0 m-85 -90.1 176.22 6.86 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 122.836 0.455 . . . . 0.0 111.456 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 596' ' ' SER . . . . . 0.505 ' HA ' HD12 ' A' ' 603' ' ' ILE . 33.0 t -177.55 157.99 1.33 Allowed 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 168.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.469 ' SG ' HD22 ' A' ' 578' ' ' LEU . 97.4 m -86.67 177.95 7.19 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.989 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.52 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 72.9 mmtt -57.3 163.12 3.56 Favored Pre-proline 0 N--CA 1.434 -1.265 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.406 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 68.8 Cg_exo -49.31 -45.2 31.16 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.074 3.183 . . . . 0.0 114.129 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -84.03 -3.88 88.81 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.021 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 51.0 m-85 -107.7 154.07 22.01 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.6 0.714 . . . . 0.0 112.101 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 26.2 m -106.26 130.84 54.04 Favored 'General case' 0 N--CA 1.403 -2.809 0 CA-C-N 114.108 -1.406 . . . . 0.0 108.928 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.541 HD11 ' HG3' ' A' ' 621' ' ' PRO . 6.9 tt -80.17 122.68 35.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.428 HG21 ' HG3' ' A' ' 624' ' ' LYS . 92.2 t -119.62 113.88 42.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.173 0.511 . . . . 0.0 109.922 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 131.39 -164.69 23.4 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.06 112.71 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.713 2.275 . . . . 0.0 111.32 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.58 -40.53 29.19 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.126 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.464 ' HB2' HG21 ' A' ' 592' ' ' VAL . 31.3 p -114.23 99.45 7.61 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.661 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 11.3 m -98.98 138.69 22.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 592' ' ' VAL . 2.5 pm0 -110.18 153.24 25.03 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.954 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.748 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 42.8 t -67.93 120.29 13.97 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.347 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.557 ' HE1' ' CG ' ' A' ' 610' ' ' GLN . 12.9 m-30 -105.68 167.53 9.7 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -67.79 1.55 2.48 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -123.32 -0.26 8.82 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.943 0.402 . . . . 0.0 111.325 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.71 173.7 13.38 Favored Glycine 0 C--N 1.311 -0.851 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.797 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 611' ' ' CYS . 30.6 mt -63.0 121.59 13.95 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.48 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 50.0 m -145.06 150.31 45.14 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 617' ' ' SER . 42.5 Cg_endo -70.06 -164.28 2.58 Favored 'Cis proline' 0 CA--C 1.551 1.36 0 C-N-CA 124.615 -0.994 . . . . 0.0 114.599 0.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.16 165.88 24.19 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 122.118 -0.364 . . . . 0.0 111.081 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.498 HD23 HG22 ' A' ' 574' ' ' ILE . 5.6 mp -76.67 139.5 66.94 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.541 ' HG3' HD11 ' A' ' 603' ' ' ILE . 73.7 Cg_endo -71.29 167.2 26.91 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 124.157 3.238 . . . . 0.0 112.372 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 46.7 pt -107.84 174.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.44 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.473 ' SG ' HD22 ' A' ' 578' ' ' LEU . 88.5 m -116.67 123.27 46.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.156 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 602' ' ' THR . 9.0 mmmm -118.81 108.6 15.04 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.207 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.458 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 2.8 tm-20 -73.42 -38.61 65.51 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -100.48 87.03 3.28 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.43 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 7.5 p -95.43 158.68 2.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.079 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -88.33 156.69 19.03 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.962 0.411 . . . . 0.0 110.883 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.598 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 15.0 p -90.58 -12.36 37.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.014 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 630' ' ' CYS . . . . . 0.5 ' SG ' ' HA2' ' A' ' 676' ' ' GLY . 13.8 m 70.54 7.82 6.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.757 0.823 . . . . 0.0 112.438 172.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 55.64 -140.18 41.17 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.495 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -82.5 151.56 15.25 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 122.435 2.09 . . . . 0.0 110.2 171.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.647 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 96.3 Cg_endo -78.81 172.42 15.07 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 123.129 2.552 . . . . 0.0 111.525 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.08 -162.95 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.438 2.092 . . . . 0.0 112.132 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -113.89 150.02 34.27 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.812 HD21 ' SG ' ' A' ' 684' ' ' CYS . 15.1 tp -78.72 159.54 27.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.528 HD11 ' HA ' ' A' ' 683' ' ' VAL 0.433 0.4 OUTLIER -73.45 -48.07 36.51 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 176.943 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 22.0 m120 -123.08 36.65 4.6 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.462 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.739 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -163.49 -141.28 3.08 Favored Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -165.26 -170.46 1.89 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 655' ' ' VAL . 48.5 t -89.23 127.84 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 175.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -83.7 -26.06 30.11 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.55 0.69 . . . . 0.0 109.334 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -74.74 171.43 13.94 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -89.38 130.67 35.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 16.2 p -82.35 104.05 12.37 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.613 0.72 . . . . 0.0 112.119 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.564 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 47.0 pttt -89.94 153.88 20.27 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.34 34.76 1.39 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 121.947 0.88 . . . . 0.0 110.729 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -169.49 92.93 0.26 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.494 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.647 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 11.0 m-85 -85.77 -73.76 0.44 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 121.13 167.28 13.22 Favored Glycine 0 C--N 1.291 -1.945 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -177.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.446 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 75.1 t60 -72.0 136.49 46.75 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.799 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 62.7 m 71.32 10.84 6.71 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.516 0.727 . . . . 0.0 112.438 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.42 118.0 27.74 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 174.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.543 HG11 ' HE2' ' A' ' 670' ' ' LYS . 1.3 p -91.67 154.46 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.713 0 CA-C-O 122.5 1.143 . . . . 0.0 111.26 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.556 HG21 ' HB3' ' A' ' 633' ' ' PRO . 3.8 t -117.48 101.24 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.995 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.592 ' HG3' ' HG2' ' A' ' 670' ' ' LYS . 5.8 tt0 -77.09 120.42 22.16 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 60.4 m-85 -99.05 167.31 10.8 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.179 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.481 ' O ' ' HA3' ' A' ' 639' ' ' GLY . 5.5 p90 -145.08 143.9 30.67 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 173.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.762 ' SG ' HD21 ' A' ' 636' ' ' LEU . 59.5 m -103.55 170.28 8.04 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -64.06 152.42 87.72 Favored Pre-proline 0 C--N 1.317 -0.829 0 O-C-N 123.125 0.266 . . . . 0.0 110.715 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.19 40.11 0.43 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 124.828 3.685 . . . . 0.0 113.393 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 7.6 ptt85 -150.0 10.72 0.71 Allowed 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.537 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.96 158.17 45.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.921 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.491 ' HG ' ' HG2' ' A' ' 687' ' ' GLU . 90.0 mt -100.93 157.29 16.85 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.479 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 3.5 ttt -114.83 102.44 9.99 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.506 ' HE2' HG23 ' A' ' 683' ' ' VAL . 37.6 ttpt -69.9 -53.22 18.93 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.309 -0.859 . . . . 0.0 113.103 -170.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.42 -170.3 31.79 Favored Glycine 0 C--N 1.293 -1.819 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.036 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.73 122.08 11.1 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.979 3.12 . . . . 0.0 110.858 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.876 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 7.9 p-10 -68.46 -20.0 64.6 Favored 'General case' 0 CA--C 1.469 -2.169 0 CA-C-O 121.533 0.682 . . . . 0.0 111.066 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.592 ' HG2' ' HG3' ' A' ' 656' ' ' GLU . 3.4 mtpt -111.71 157.29 20.67 Favored 'General case' 0 C--N 1.253 -3.615 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -173.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.613 HG21 HD23 ' A' ' 681' ' ' LEU . 48.1 pt -139.75 125.43 21.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.44 144.25 33.39 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 28.7 t -81.61 128.95 34.47 Favored 'General case' 0 CA--C 1.465 -2.314 0 CA-C-O 123.142 1.449 . . . . 0.0 111.835 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.4 t -105.33 107.3 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.807 0 CA-C-N 111.263 -2.699 . . . . 0.0 107.655 -175.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.541 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 26.6 t70 55.6 -75.15 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.008 1.723 . . . . 0.0 112.98 -169.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.5 ' HA2' ' SG ' ' A' ' 630' ' ' CYS . . . -149.15 18.54 1.19 Allowed Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -129.61 139.26 51.49 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.546 ' HB3' HD12 ' A' ' 671' ' ' ILE . 92.0 m95 -85.71 164.73 17.46 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.472 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 6.3 p -82.43 -178.54 7.09 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.05 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 44.2 m -71.68 135.81 47.01 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.254 0.55 . . . . 0.0 110.731 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.613 HD23 HG21 ' A' ' 671' ' ' ILE . 47.5 mt -66.08 153.07 92.71 Favored Pre-proline 0 N--CA 1.425 -1.699 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.237 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.876 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 12.3 Cg_endo -55.49 -20.17 25.62 Favored 'Trans proline' 0 N--CA 1.482 0.802 0 C-N-CA 124.637 3.558 . . . . 0.0 115.972 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.528 ' HA ' HD11 ' A' ' 637' ' ' LEU 0.302 16.4 m 46.11 98.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 N-CA-C 115.664 1.728 . . . . 0.0 115.664 177.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.812 ' SG ' HD21 ' A' ' 636' ' ' LEU . 1.7 m -83.28 147.96 27.66 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.975 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.479 ' CD1' ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -138.49 146.97 25.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.243 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 32.0 t -58.56 134.77 23.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 123.828 0.705 . . . . 0.0 109.87 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.491 ' HG2' ' HG ' ' A' ' 664' ' ' LEU . 45.0 mt-10 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.21 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.761 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 62.9 14.34 7.37 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.418 1.087 . . . . 0.0 112.897 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -93.82 -60.06 1.84 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -154.06 68.38 0.3 Allowed Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.65 -47.52 85.3 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.011 -0.595 . . . . 0.0 110.457 -173.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.434 ' HG2' ' HG3' ' A' ' 568' ' ' GLU . 53.1 ttt180 71.6 -64.12 0.4 Allowed 'General case' 0 C--N 1.344 0.369 0 O-C-N 124.302 1.001 . . . . 0.0 111.285 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 568' ' ' GLU . . . . . 0.434 ' HG3' ' HG2' ' A' ' 567' ' ' ARG . 52.0 mt-10 -110.88 147.46 34.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 121.149 0.499 . . . . 0.0 109.85 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 2.6 m -63.72 -55.78 20.64 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 124.786 1.234 . . . . 0.0 111.734 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 61.41 -168.62 0.18 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.064 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.5 HD11 ' HG3' ' A' ' 580' ' ' PRO . 3.5 tt -118.61 118.96 33.17 Favored Pre-proline 0 C--N 1.28 -2.447 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.616 ' HG2' HD21 ' A' ' 620' ' ' LEU . 90.3 Cg_endo -75.41 -165.71 0.31 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.466 2.777 . . . . 0.0 112.335 -177.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.23 108.05 15.38 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.196 0.522 . . . . 0.0 110.382 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.648 HG22 HD23 ' A' ' 620' ' ' LEU . 36.2 pt -78.14 -167.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.319 175.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.95 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 10.2 t70 -81.54 162.09 23.32 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.09 -22.58 18.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.473 0.654 . . . . 0.0 110.516 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -106.63 11.83 30.0 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 121.768 -0.582 . . . . 0.0 110.98 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.95 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.5 tm? -99.13 153.48 18.86 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.485 ' N ' HD13 ' A' ' 578' ' ' LEU . 5.8 p -149.91 113.33 3.38 Favored Pre-proline 0 C--N 1.288 -2.079 0 C-N-CA 124.184 0.994 . . . . 0.0 108.454 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.597 ' HD3' HD13 ' A' ' 574' ' ' ILE . 59.1 Cg_endo -73.82 146.14 37.46 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.509 2.139 . . . . 0.0 112.43 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -77.38 -36.78 53.22 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 582' ' ' ARG . . . . . 0.433 ' HB3' ' HE2' ' A' ' 587' ' ' TYR . 25.3 mmt180 -79.63 132.55 36.28 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 171.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -143.51 89.94 2.12 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.69 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 587' ' ' TYR . 11.1 ptpt -137.71 170.21 16.46 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -77.41 -56.8 4.24 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 14.8 mp0 -120.64 126.43 50.22 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.925 0.393 . . . . 0.0 110.725 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.73 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 19.3 m-85 -90.35 155.53 18.9 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.814 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -93.7 147.41 23.05 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.65 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 5.6 p -66.45 131.16 32.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.852 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 87.42 -1.95 86.22 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.211 -173.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -69.28 135.58 50.67 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 609' ' ' VAL . 11.3 m -98.59 138.91 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.563 HD11 ' CD2' ' A' ' 587' ' ' TYR . 7.1 mp -117.16 111.05 18.93 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.229 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.614 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 92.0 mttt -84.74 122.21 28.78 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.857 ' HB3' HD11 ' A' ' 578' ' ' LEU . 68.7 m-85 -108.08 172.2 6.97 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 596' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 603' ' ' ILE . 14.2 p -171.21 177.41 3.62 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 76.8 m -110.97 177.79 4.55 Favored 'General case' 0 C--N 1.26 -3.293 0 O-C-N 123.739 0.649 . . . . 0.0 110.712 -176.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 598' ' ' LYS . 71.6 mmtt -53.48 160.83 1.7 Allowed Pre-proline 0 N--CA 1.438 -1.034 0 C-N-CA 124.463 1.105 . . . . 0.0 112.564 176.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 51.4 Cg_exo -52.05 -28.11 31.36 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 124.414 3.409 . . . . 0.0 114.575 -175.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -99.61 -4.31 55.98 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.883 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -106.51 159.13 16.4 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 122.328 1.061 . . . . 0.0 113.414 -174.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.614 HG21 HG11 ' A' ' 627' ' ' VAL . 6.2 m -109.25 129.57 55.5 Favored 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.861 174.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.537 HD11 ' HG3' ' A' ' 621' ' ' PRO . 6.4 tt -81.46 119.14 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.363 174.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.737 HG21 ' HD3' ' A' ' 624' ' ' LYS . 62.0 t -109.97 127.51 66.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.06 -159.66 14.14 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.8 115.33 3.71 Favored 'Trans proline' 0 C--N 1.333 -0.278 0 C-N-CA 122.958 2.439 . . . . 0.0 110.69 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 7.5 m120 -84.3 -26.29 28.65 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.355 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.614 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 27.1 p -127.09 95.59 4.34 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.532 0.682 . . . . 0.0 111.087 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 609' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 592' ' ' VAL . 21.5 m -89.42 169.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.485 -0.779 . . . . 0.0 108.997 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.407 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 6.0 mm100 -114.72 163.8 14.97 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 18.7 t -85.05 131.39 34.46 Favored 'General case' 0 C--N 1.276 -2.608 0 C-N-CA 117.808 -1.557 . . . . 0.0 108.223 165.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 7.5 m-85 -109.16 163.0 13.74 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 173.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -68.17 -1.68 6.53 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -117.48 4.47 12.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 120.879 0.371 . . . . 0.0 110.333 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 135.69 -177.45 19.46 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 572' ' ' PRO . 28.4 mt -73.79 133.51 43.26 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.481 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 68.1 m -150.16 154.39 36.41 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.61 -168.78 5.04 Favored 'Cis proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.043 -1.232 . . . . 0.0 113.214 0.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.76 146.69 35.93 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.091 0.472 . . . . 0.0 111.864 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.648 HD23 HG22 ' A' ' 574' ' ' ILE . 6.7 mp -65.14 142.26 98.53 Favored Pre-proline 0 C--N 1.302 -1.47 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.889 -175.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.537 ' HG3' HD11 ' A' ' 603' ' ' ILE . 28.1 Cg_endo -63.9 169.01 10.99 Favored 'Trans proline' 0 C--O 1.252 1.182 0 C-N-CA 124.124 3.216 . . . . 0.0 113.667 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 622' ' ' ILE . . . . . 0.445 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 36.5 pt -114.94 178.91 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.969 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 95.3 m -127.96 124.94 38.52 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.023 0.44 . . . . 0.0 111.267 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.737 ' HD3' HG21 ' A' ' 604' ' ' VAL . 57.9 mtpt -124.41 130.33 52.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -88.54 -37.87 15.37 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -99.82 101.25 12.34 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.803 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.614 HG11 HG21 ' A' ' 602' ' ' THR . 2.7 m -102.03 178.39 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.088 174.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.612 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 76.2 mt-30 -94.55 170.64 9.33 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.559 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 41.6 m -102.93 -8.15 20.92 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.039 0.447 . . . . 0.0 110.649 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 81.7 m 67.36 5.78 4.47 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 54.2 -137.22 41.58 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 123.474 0.484 . . . . 0.0 112.947 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.58 147.01 17.36 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.649 2.233 . . . . 0.0 112.055 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.536 ' HB3' HG21 ' A' ' 655' ' ' VAL . 31.7 Cg_endo -67.32 156.51 65.9 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.118 2.545 . . . . 0.0 112.591 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.501 ' HG2' HD11 ' A' ' 681' ' ' LEU . 38.3 Cg_endo -69.24 175.36 7.77 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 123.324 2.683 . . . . 0.0 112.522 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.86 145.71 26.48 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 657' ' ' TYR . 14.5 tp -80.59 178.33 8.42 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 637' ' ' LEU . 2.4 mp -84.58 -73.03 0.44 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.821 0.819 . . . . 0.0 108.841 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -108.02 32.71 4.56 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.667 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -156.29 -156.79 7.99 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.798 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -156.08 -172.72 4.21 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 123.685 0.794 . . . . 0.0 109.976 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.485 HG22 ' CE1' ' A' ' 657' ' ' TYR . 53.5 t -93.69 137.87 21.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.659 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 20.1 ptmt -87.22 -22.63 25.12 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.088 0.47 . . . . 0.0 110.904 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.22 146.92 28.31 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -67.75 122.39 18.0 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 22.4 p -73.69 98.09 2.82 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.228 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -83.81 165.33 18.9 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.5 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.4 6.82 35.59 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -171.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -156.24 105.9 2.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -96.19 -82.25 0.4 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 130.77 159.62 9.68 Favored Glycine 0 C--N 1.311 -0.84 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.887 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.678 ' ND1' ' HA ' ' A' ' 674' ' ' VAL . 80.6 t60 -77.14 86.43 3.61 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 652' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 651' ' ' HIS . 22.9 t 155.08 -31.19 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 126.941 2.097 . . . . 0.0 106.101 173.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -68.05 118.24 10.95 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.911 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 671' ' ' ILE . 1.1 p -94.74 163.39 2.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.739 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 16.6 m -128.82 115.58 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.442 175.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.659 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 14.7 mt-10 -73.26 126.12 29.37 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.56 0.695 . . . . 0.0 111.111 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.665 ' HB3' HD22 ' A' ' 636' ' ' LEU . 81.4 m-85 -102.12 164.74 11.53 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.022 176.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -148.67 135.63 19.97 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.667 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 50.4 m -99.09 165.75 11.58 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.428 172.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 50.1 m-80 -58.3 155.01 28.98 Favored Pre-proline 0 C--O 1.248 1.021 0 O-C-N 123.677 0.611 . . . . 0.0 109.904 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 59.8 Cg_endo -68.03 24.76 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 124.113 3.209 . . . . 0.0 115.529 -172.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.463 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 24.8 mmm180 -118.11 -4.26 11.02 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 662' ' ' ARG . 51.0 m-85 -128.95 159.76 34.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.723 -170.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 687' ' ' GLU . 81.8 mt -124.38 153.78 41.36 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 125.145 1.378 . . . . 0.0 107.442 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.558 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -84.27 147.17 27.38 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.125 0.488 . . . . 0.0 111.2 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -95.09 -59.44 1.9 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.214 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.5 -158.11 29.76 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.575 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.78 123.64 10.96 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.978 2.452 . . . . 0.0 111.655 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 12.1 p-10 -64.04 -17.38 63.31 Favored 'General case' 0 C--O 1.207 -1.17 0 C-N-CA 122.902 0.481 . . . . 0.0 111.744 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 1.4 mtpt -122.28 154.4 37.62 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.57 HD12 ' HB3' ' A' ' 678' ' ' TRP . 29.9 pt -143.92 142.73 24.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.81 153.08 28.4 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.041 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 3.9 t -68.14 121.06 15.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.015 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.678 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 35.1 m -113.03 113.26 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.55 0.691 . . . . 0.0 111.559 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 32.7 t70 64.87 -73.89 0.05 Allowed 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 124.56 1.144 . . . . 0.0 111.375 -175.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.612 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -152.56 16.21 0.74 Allowed Glycine 0 N--CA 1.422 -2.297 0 C-N-CA 120.392 -0.908 . . . . 0.0 112.456 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.01 158.08 44.63 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.57 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.9 m95 -81.71 177.03 9.14 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 120.892 0.377 . . . . 0.0 110.167 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.98 -179.44 3.95 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.863 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 5.7 m -57.72 120.16 7.9 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.897 0.879 . . . . 0.0 110.915 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.535 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 4.4 mp -64.15 154.26 83.02 Favored Pre-proline 0 N--CA 1.445 -0.719 0 O-C-N 123.761 0.663 . . . . 0.0 112.592 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.558 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 7.5 Cg_endo -55.04 -50.12 14.26 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.206 2.604 . . . . 0.0 113.516 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 92.8 t 68.97 130.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.505 0.722 . . . . 0.0 110.118 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 7.3 p -125.05 154.89 40.63 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.676 -0.64 . . . . 0.0 112.448 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 685' ' ' ILE . 0.2 OUTLIER -139.04 150.58 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.214 0 C-N-CA 125.317 1.447 . . . . 0.0 108.512 -177.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.24 139.25 17.06 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.911 0 C-N-CA 124.76 1.224 . . . . 0.0 112.472 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.51 ' HG3' HD11 ' A' ' 664' ' ' LEU . 45.8 tt0 . . . . . 0 N--CA 1.438 -1.056 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.153 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 CA--C 1.516 -0.353 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -120.01 -170.47 1.97 Allowed 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -67.09 -43.49 82.4 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -72.19 86.51 0.49 Allowed Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.407 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -93.05 27.99 2.28 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.715 0.806 . . . . 0.0 109.388 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.462 ' HD3' ' HA ' ' A' ' 567' ' ' ARG . 37.5 mmt180 83.66 71.43 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 125.553 1.541 . . . . 0.0 110.552 -173.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -126.05 -162.84 1.16 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.735 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.764 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 75.9 m -96.61 150.02 21.13 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.657 0.741 . . . . 0.0 112.685 -174.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -124.25 -4.75 7.86 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.073 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.547 HD23 ' HD2' ' A' ' 572' ' ' PRO . 0.9 OUTLIER 77.97 121.22 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 126.006 1.723 . . . . 0.0 107.438 -178.074 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.614 ' HD3' HD23 ' A' ' 616' ' ' LEU . 56.8 Cg_endo -69.97 -174.65 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.909 1.74 . . . . 0.0 110.931 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 573' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 573' ' ' LYS . 0.3 OUTLIER -89.5 104.23 16.81 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 578' ' ' LEU . 42.0 pt -76.08 -176.57 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.988 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.293 -177.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.6 t70 -72.97 151.94 41.6 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.72 -35.66 68.88 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.363 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -93.54 8.08 42.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.705 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.8 tp -95.89 149.97 20.96 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.03 117.59 9.09 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-O 121.387 0.613 . . . . 0.0 110.41 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.42 131.19 13.55 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.203 1.935 . . . . 0.0 111.053 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.56 -29.84 71.04 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.286 0.565 . . . . 0.0 111.447 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 582' ' ' ARG . . . . . 0.452 ' HG3' HD22 ' A' ' 593' ' ' LEU . 4.5 mmp_? -72.8 -70.95 0.32 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 176.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm 60.47 84.58 0.12 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.416 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.6 ptpt -142.03 174.34 10.69 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.25 -66.16 0.91 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -105.34 141.04 37.55 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.764 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 67.0 m-85 -115.12 125.63 53.69 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.138 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -71.02 144.04 50.55 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.302 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.637 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 32.6 m -63.4 134.66 28.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.576 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 102.0 -18.62 51.76 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.117 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.95 108.84 3.19 Favored 'General case' 0 C--N 1.346 0.451 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 3.4 p -92.47 125.09 45.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.721 0.772 . . . . 0.0 110.199 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 587' ' ' TYR . 11.1 mt -102.88 105.05 15.34 Favored 'General case' 0 N--CA 1.402 -2.856 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.882 -172.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.535 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 54.7 mtpt -75.06 112.61 11.47 Favored 'General case' 0 N--CA 1.41 -2.425 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -94.36 174.13 7.29 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-O 121.813 0.816 . . . . 0.0 109.548 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 20.1 t -162.32 -178.83 6.56 Favored 'General case' 0 N--CA 1.391 -3.414 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.556 ' SG ' HD12 ' A' ' 578' ' ' LEU . 92.3 m -118.1 -179.12 3.67 Favored 'General case' 0 C--N 1.257 -3.452 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -51.01 162.58 0.58 Allowed Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 124.773 1.229 . . . . 0.0 111.639 174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.2 -45.82 24.66 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.923 3.082 . . . . 0.0 113.403 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -89.76 5.03 83.73 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.424 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.64 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 35.4 m-85 -109.57 133.93 52.52 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 45.5 m -89.04 127.92 35.71 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.5 175.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.505 HD11 ' HG3' ' A' ' 621' ' ' PRO . 8.9 tt -84.65 132.89 30.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.834 HG21 ' HD3' ' A' ' 624' ' ' LYS . 90.9 t -129.7 135.43 61.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 114.67 -161.25 12.81 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.96 116.31 4.52 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.003 1.802 . . . . 0.0 109.886 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -83.34 -39.22 21.02 Favored 'General case' 0 C--O 1.206 -1.208 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -176.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.535 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 8.6 p -112.27 98.0 7.01 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.44 0.638 . . . . 0.0 111.96 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.5 m -99.57 145.6 10.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 592' ' ' VAL . 2.6 mp0 -96.46 149.24 21.95 Favored 'General case' 0 CA--C 1.472 -2.024 0 O-C-N 121.866 -0.522 . . . . 0.0 110.415 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 45.4 t -73.3 122.28 21.74 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.37 168.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.596 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 75.9 m-85 -110.98 162.7 14.58 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 171.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -65.16 -2.25 2.77 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -115.52 1.54 13.64 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.537 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.4 169.73 12.35 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.202 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.614 HD23 ' HD3' ' A' ' 572' ' ' PRO . 3.3 mm? -66.42 118.95 10.79 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.596 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 17.4 m -131.77 144.36 52.94 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 618' ' ' PRO . . . . . 0.418 ' C ' ' HA ' ' A' ' 617' ' ' SER . 56.6 Cg_endo -69.77 -165.13 2.8 Favored 'Cis proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.885 -1.298 . . . . 0.0 113.139 -0.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.12 172.79 11.75 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.194 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.522 HD13 HG22 ' A' ' 574' ' ' ILE . 50.8 mt -69.64 148.43 96.78 Favored Pre-proline 0 C--N 1.297 -1.709 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.333 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.505 ' HG3' HD11 ' A' ' 603' ' ' ILE . 72.9 Cg_endo -75.42 -177.85 3.84 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 124.176 3.251 . . . . 0.0 111.362 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.42 166.44 18.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.012 0.434 . . . . 0.0 110.933 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.423 ' HB3' ' CD2' ' A' ' 601' ' ' PHE . 85.7 m -110.64 116.06 30.67 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.376 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.834 ' HD3' HG21 ' A' ' 604' ' ' VAL . 21.0 mtpp -97.03 -22.17 16.96 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 13.6 tt0 68.4 -70.16 0.14 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.178 0.991 . . . . 0.0 108.951 -174.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -103.88 114.51 28.81 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.644 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 7.7 p -111.45 175.25 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.451 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 48.9 mt-30 -84.21 166.64 17.38 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 119.778 1.172 . . . . 0.0 109.311 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.613 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 5.2 p -106.54 -16.95 14.39 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.157 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 71.8 m 70.0 8.55 6.74 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.314 1.046 . . . . 0.0 112.799 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 54.02 -143.84 28.74 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 123.694 0.621 . . . . 0.0 113.093 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.5 148.59 42.87 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.515 2.143 . . . . 0.0 111.215 173.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.555 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 88.1 Cg_endo -82.67 165.1 15.98 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 123.047 2.498 . . . . 0.0 112.442 -178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.16 178.69 4.56 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.952 2.435 . . . . 0.0 111.426 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.92 163.83 12.04 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.636 HD22 ' HB3' ' A' ' 657' ' ' TYR . 17.5 tp -92.52 134.07 35.32 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.575 ' H ' HD12 ' A' ' 637' ' ' LEU . 0.4 OUTLIER -44.54 -61.13 1.66 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.575 1.15 . . . . 0.0 111.349 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.511 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 43.7 m-80 -122.63 31.19 6.18 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-O 121.316 0.579 . . . . 0.0 110.819 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.561 ' C ' ' HB3' ' A' ' 636' ' ' LEU . . . -150.48 -158.28 8.17 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 174.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -154.43 175.07 14.03 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 117.496 0.648 . . . . 0.0 109.87 178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 655' ' ' VAL . 64.3 t -84.44 128.94 38.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.792 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.5 ptmt -84.81 -20.4 30.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.034 0.921 . . . . 0.0 109.643 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' A' ' 642' ' ' LYS . 48.0 mm-40 -91.25 163.49 14.22 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.806 -177.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -73.9 125.71 28.81 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.182 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.425 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 16.0 p -81.72 114.63 20.5 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-O 121.857 0.837 . . . . 0.0 111.455 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 49.9 mtmt -85.09 161.23 19.77 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -99.67 9.56 42.91 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.065 0.936 . . . . 0.0 109.586 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -157.47 96.97 1.58 Allowed 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 113.956 -1.475 . . . . 0.0 107.696 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.555 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 14.4 m-85 -86.63 -76.77 0.34 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.838 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 115.44 169.01 15.65 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.236 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.579 ' HB2' HG11 ' A' ' 627' ' ' VAL . 75.8 t60 -71.33 148.05 47.45 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.311 10.4 p 65.78 2.73 2.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.057 1.343 . . . . 0.0 113.831 -174.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -93.84 112.95 24.88 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.554 HG11 ' CE ' ' A' ' 670' ' ' LYS . 2.5 p -99.16 159.67 3.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-O 121.576 0.703 . . . . 0.0 109.552 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.0 t -121.01 106.97 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.67 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.348 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.792 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 18.4 mt-10 -68.67 124.84 24.74 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.461 0.648 . . . . 0.0 110.457 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.636 ' HB3' HD22 ' A' ' 636' ' ' LEU . 68.2 m-85 -108.92 172.03 7.09 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -150.07 140.72 22.59 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.57 ' SG ' HD21 ' A' ' 636' ' ' LEU . 80.7 m -100.01 163.84 12.26 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 47.4 m-80 -65.3 157.39 77.77 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.401 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 74.2 Cg_endo -71.84 15.6 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 123.931 3.087 . . . . 0.0 113.466 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -108.34 -3.97 17.85 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -134.15 156.33 48.52 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.289 -173.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 687' ' ' GLU . 72.1 mt -98.95 165.58 11.69 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 172.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.5 ttt -119.52 115.14 23.41 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.413 ' HB2' HD12 ' A' ' 685' ' ' ILE . 37.5 ttmt -71.39 -67.85 0.49 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -171.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.76 -161.46 37.49 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 115.551 -0.749 . . . . 0.0 113.18 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.39 123.09 11.81 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.036 2.491 . . . . 0.0 111.133 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 10.4 p-10 -61.48 -16.48 47.59 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 123.263 0.625 . . . . 0.0 111.891 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.62 ' HG2' ' CG ' ' A' ' 656' ' ' GLU . 13.2 mtpt -121.93 153.78 38.02 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 34.9 pt -138.01 144.44 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 17.8 pm0 -122.55 151.59 41.24 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.268 -176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 6.8 t -77.3 108.47 10.45 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.042 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.442 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 35.9 m -102.7 107.9 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.576 0.703 . . . . 0.0 111.569 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.644 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 7.4 t70 68.98 -62.62 0.39 Allowed 'General case' 0 C--O 1.216 -0.67 0 C-N-CA 124.913 1.285 . . . . 0.0 113.057 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -164.12 18.9 0.12 Allowed Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 174.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -138.13 144.04 40.63 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.401 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.3 m95 -75.92 158.03 32.5 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 13.5 p -77.52 174.26 11.07 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.964 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.7 m -65.03 131.85 47.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.215 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.559 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 5.0 mp -63.74 150.38 90.97 Favored Pre-proline 0 N--CA 1.435 -1.194 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.138 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.559 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 10.4 Cg_endo -56.22 -43.23 58.13 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 123.573 2.849 . . . . 0.0 113.368 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 81.5 t 66.08 121.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 122.639 1.209 . . . . 0.0 113.341 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.2 m -93.82 145.13 24.82 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.32 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -138.46 145.28 28.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.222 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.16 132.98 25.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 O-C-N 123.288 0.367 . . . . 0.0 110.951 -174.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.519 ' HG3' HD21 ' A' ' 664' ' ' LEU . 38.5 tt0 . . . . . 0 C--O 1.249 1.039 0 O-C-N 124.035 0.834 . . . . 0.0 109.914 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 CA--C 1.504 -0.824 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -82.45 99.9 9.72 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -107.74 115.35 29.98 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.915 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 142.97 88.01 0.1 OUTLIER Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.773 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.66 86.26 7.37 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.577 0.703 . . . . 0.0 109.175 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 567' ' ' ARG 0.259 16.3 ptt180 -83.72 79.26 9.52 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 122.526 1.155 . . . . 0.0 113.278 -178.18 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -131.51 171.9 12.87 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 112.843 -1.981 . . . . 0.0 107.18 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 569' ' ' CYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 68.3 m -96.36 121.94 38.7 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.198 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -99.67 140.19 34.23 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 571' ' ' LEU . . . . . 0.838 HD11 ' HG3' ' A' ' 580' ' ' PRO . 3.2 tt -58.21 112.48 4.94 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 572' ' ' PRO . . . . . 0.532 ' HD3' HD23 ' A' ' 616' ' ' LEU . 93.3 Cg_endo -83.94 -158.57 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.527 2.818 . . . . 0.0 112.72 -175.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.8 91.95 6.58 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 574' ' ' ILE . . . . . 0.739 HG13 ' H ' ' A' ' 575' ' ' ASP . 6.5 pt -72.47 -88.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.827 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.825 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 17.6 t70 -160.26 173.37 15.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 173.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.87 -29.36 8.34 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-O 121.29 0.566 . . . . 0.0 109.543 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -98.94 3.57 47.13 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.461 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.9 tm? -96.0 147.42 23.71 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -177.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.47 ' N ' HD13 ' A' ' 578' ' ' LEU . 6.1 t -139.55 121.21 9.85 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 580' ' ' PRO . . . . . 0.838 ' HG3' HD11 ' A' ' 571' ' ' LEU . 60.4 Cg_endo -73.86 140.89 29.52 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.369 2.046 . . . . 0.0 112.173 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.57 -38.33 86.84 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 125.525 1.53 . . . . 0.0 110.687 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -75.97 -66.8 0.74 Allowed 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.63 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.454 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 38.8 ttpt 57.52 78.23 0.24 Allowed 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.01 -178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.501 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 18.1 ptpt -132.87 175.47 9.32 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.304 -1.316 . . . . 0.0 107.773 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -76.86 -57.53 3.8 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -122.74 142.05 51.13 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 587' ' ' TYR . . . . . 0.608 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 94.8 m-85 -112.12 126.7 55.47 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -70.21 142.4 52.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.691 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 2.1 p -60.06 116.0 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-O 121.951 0.881 . . . . 0.0 111.329 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 121.29 -22.21 7.97 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.173 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -58.42 139.8 54.84 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.765 0.426 . . . . 0.0 110.416 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 592' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 610' ' ' GLN . 2.1 m -111.6 136.33 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 593' ' ' LEU . . . . . 0.581 ' HG ' ' CE2' ' A' ' 587' ' ' TYR 0.338 0.0 OUTLIER -130.78 113.54 14.23 Favored 'General case' 0 N--CA 1.396 -3.172 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.228 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 594' ' ' LYS . . . . . 0.683 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 64.9 mttm -76.46 147.91 37.57 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.55 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 595' ' ' PHE . . . . . 0.767 ' HB3' HD11 ' A' ' 578' ' ' LEU . 24.8 m-85 -121.61 166.39 14.3 Favored 'General case' 0 C--N 1.261 -3.277 0 C-N-CA 123.822 0.849 . . . . 0.0 110.1 177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 9.5 t -173.59 154.25 2.47 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 170.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 597' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 73.8 m -88.37 176.59 7.13 Favored 'General case' 0 C--N 1.259 -3.352 0 O-C-N 123.863 0.727 . . . . 0.0 110.636 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 598' ' ' LYS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.5 mmtp -55.37 162.38 2.29 Favored Pre-proline 0 N--CA 1.438 -1.061 0 C-N-CA 123.955 0.902 . . . . 0.0 112.257 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 599' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 91.5 Cg_exo -43.79 -44.09 11.67 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 124.51 3.473 . . . . 0.0 115.119 -175.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -88.93 -10.47 66.63 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.27 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 42.1 m-85 -97.54 155.28 17.03 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.893 0.854 . . . . 0.0 112.37 -176.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 602' ' ' THR . . . . . 0.578 HG21 HG11 ' A' ' 627' ' ' VAL . 10.7 m -107.76 126.88 53.16 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.808 174.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.465 ' HA ' ' SG ' ' A' ' 597' ' ' CYS . 5.2 tt -74.09 118.6 19.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.076 172.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 604' ' ' VAL . . . . . 0.672 HG21 ' HD3' ' A' ' 624' ' ' LYS . 67.4 t -111.64 110.78 33.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 133.7 -154.69 21.41 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.78 122.47 7.78 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.92 2.413 . . . . 0.0 112.315 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 1.2 t-20 -79.24 -36.46 39.92 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.38 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 608' ' ' SER . . . . . 0.683 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 52.8 p -125.49 100.63 6.56 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.884 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.3 m -98.03 161.13 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 610' ' ' GLN . . . . . 0.707 ' HG3' HG12 ' A' ' 592' ' ' VAL . 1.9 mp0 -115.87 158.6 22.72 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.691 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 37.3 t -80.95 104.61 11.57 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 118.613 -1.235 . . . . 0.0 107.903 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.548 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 4.7 m-85 -87.64 167.87 13.51 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -74.9 0.06 16.93 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.648 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -116.65 7.48 13.57 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 131.06 174.52 13.69 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.972 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.532 HD23 ' HD3' ' A' ' 572' ' ' PRO . 2.9 mm? -63.73 109.59 1.76 Allowed 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 617' ' ' SER . . . . . 0.548 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 18.8 m -128.05 148.58 68.02 Favored Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -175.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.03 -171.22 8.71 Favored 'Cis proline' 0 CA--C 1.558 1.687 0 C-N-CA 123.644 -1.398 . . . . 0.0 113.476 1.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -57.96 151.58 18.07 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.895 0.379 . . . . 0.0 111.229 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 620' ' ' LEU . . . . . 0.525 ' H ' HD22 ' A' ' 620' ' ' LEU . 1.9 mm? -66.87 137.21 94.7 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.629 -173.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.8 170.83 10.74 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.802 3.001 . . . . 0.0 111.943 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 622' ' ' ILE . . . . . 0.541 HG13 ' HB ' ' A' ' 604' ' ' VAL . 43.1 pt -115.62 179.81 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 86.3 m -123.97 126.96 47.23 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.898 0.38 . . . . 0.0 110.971 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.672 ' HD3' HG21 ' A' ' 604' ' ' VAL . 51.7 mtpt -124.08 121.61 35.65 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 14.0 tt0 -81.1 -28.34 35.24 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -100.77 111.53 23.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.555 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.578 HG11 HG21 ' A' ' 602' ' ' THR . 9.8 m -130.8 172.89 15.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.099 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.545 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 75.1 mt-30 -96.32 164.02 12.83 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 37.8 m -110.79 -1.73 16.47 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.044 0.449 . . . . 0.0 110.139 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 69.7 m 70.77 -38.77 0.43 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.086 1.354 . . . . 0.0 114.435 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 100.68 -143.82 16.43 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -72.81 143.1 36.52 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 121.965 1.777 . . . . 0.0 109.81 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.444 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.4 Cg_endo -74.32 163.12 37.09 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.386 2.057 . . . . 0.0 112.302 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.9 173.29 7.19 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.705 2.27 . . . . 0.0 111.451 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -89.8 162.47 15.49 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.732 HD21 ' SG ' ' A' ' 659' ' ' CYS . 16.8 tp -92.54 166.89 12.29 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 177.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.609 ' H ' HD23 ' A' ' 637' ' ' LEU 0.303 2.0 pt? -82.76 -48.04 11.28 Favored 'General case' 0 N--CA 1.41 -2.462 0 C-N-CA 117.947 -1.501 . . . . 0.0 113.298 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.61 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 16.2 m120 -124.82 34.15 5.06 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.734 0.778 . . . . 0.0 109.897 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -159.52 -139.78 2.75 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.903 174.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 640' ' ' ASN . . . . . 0.499 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 61.7 t30 -162.47 -171.58 2.83 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.598 HG22 ' CE1' ' A' ' 657' ' ' TYR . 11.8 t -96.11 123.57 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.579 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.6 ptmt -79.34 -23.59 43.33 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.18 0.514 . . . . 0.0 109.91 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 12.1 mm-40 -78.96 152.27 31.15 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -79.49 121.53 25.31 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.977 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 33.1 p -68.22 99.05 0.86 Allowed 'General case' 0 N--CA 1.419 -1.977 0 CA-C-O 121.805 0.812 . . . . 0.0 112.617 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 54.6 pttt -89.09 160.79 16.87 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.408 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 40.4 mm-40 -78.73 -5.96 54.59 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -174.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -146.1 104.87 3.86 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' A' ' 655' ' ' VAL . 9.3 m-85 -90.64 -111.24 0.09 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.941 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 168.5 161.06 17.74 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 65.1 t60 -53.76 -57.36 11.16 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 32.9 m -89.98 8.28 33.22 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.927 -174.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -93.58 118.2 31.06 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.672 0.749 . . . . 0.0 110.382 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.609 HG21 ' HE3' ' A' ' 670' ' ' LYS . 4.5 m -89.95 151.66 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.516 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 30.2 m -116.67 104.16 16.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.654 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.579 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 23.5 mt-10 -65.36 124.29 21.87 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 122.218 1.009 . . . . 0.0 111.538 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.598 ' CE1' HG22 ' A' ' 641' ' ' VAL . 65.6 m-85 -102.5 165.64 10.98 Favored 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.431 173.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.499 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 8.8 p90 -146.81 137.32 23.74 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.732 ' SG ' HD21 ' A' ' 636' ' ' LEU . 61.2 m -97.24 165.86 11.84 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -63.6 150.29 90.69 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.41 0.85 1.99 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 124.13 3.22 . . . . 0.0 114.573 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 662' ' ' ARG . 9.6 mmm180 -98.54 -0.98 42.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -130.26 169.19 15.74 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.308 -173.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 88.5 mt -108.88 161.02 15.52 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.4 ttt -117.8 113.53 21.94 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.434 ' HB3' HG23 ' A' ' 683' ' ' VAL . 24.8 ttmm -68.3 -64.01 0.95 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -102.85 -158.24 25.48 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 121.122 -0.561 . . . . 0.0 114.116 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.93 121.51 9.62 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.767 2.978 . . . . 0.0 111.603 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 16.9 p-10 -79.4 -11.8 59.91 Favored 'General case' 0 C--O 1.178 -2.709 0 CA-C-O 120.917 0.389 . . . . 0.0 110.856 -177.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 5.3 ptmt -125.82 112.01 15.53 Favored 'General case' 0 C--N 1.27 -2.874 0 C-N-CA 123.932 0.893 . . . . 0.0 109.51 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 34.4 pt -109.92 151.47 12.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.708 -174.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.19 160.83 21.41 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.565 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 16.9 t -82.39 92.79 7.07 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.491 1.139 . . . . 0.0 111.796 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 83.8 t -80.7 113.93 20.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.667 -1.152 . . . . 0.0 110.151 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 19.7 t70 57.3 -69.52 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.582 1.953 . . . . 0.0 112.593 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -157.67 26.86 0.46 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 111.769 -0.532 . . . . 0.0 111.769 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -145.06 151.13 38.05 Favored 'General case' 0 C--O 1.21 -1.022 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.54 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.3 m95 -82.64 170.7 14.84 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 679' ' ' THR . . . . . 0.453 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 5.5 p -92.65 -174.52 3.67 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 30.0 m -68.94 131.12 44.57 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.792 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.413 HD23 HD12 ' A' ' 636' ' ' LEU . 7.3 mp -67.51 157.51 85.58 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 21.9 Cg_endo -62.8 -21.35 72.99 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 124.346 3.364 . . . . 0.0 115.879 -176.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.533 ' HA ' HD21 ' A' ' 637' ' ' LEU 0.357 22.4 m 49.97 109.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -178.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.705 ' SG ' HD21 ' A' ' 636' ' ' LEU . 3.5 m -88.0 147.36 25.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.549 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.4 151.73 16.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.76 141.63 16.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 C--O 1.255 1.373 0 O-C-N 124.09 0.869 . . . . 0.0 110.625 178.901 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . 0.593 ' HG3' ' HB3' ' A' ' 586' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.774 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 91.5 m -96.39 140.86 30.43 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -126.05 130.26 50.78 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.848 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.2 tt -53.05 119.27 16.05 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.524 ' HG2' HD21 ' A' ' 620' ' ' LEU . 87.8 Cg_endo -78.72 -157.74 0.08 OUTLIER 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.234 2.623 . . . . 0.0 111.566 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -91.09 107.64 19.34 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.489 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.738 HG22 HD23 ' A' ' 620' ' ' LEU . 35.1 pt -79.58 -171.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.477 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.936 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.1 t70 -73.74 159.49 32.88 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.17 -31.91 53.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -98.8 6.35 46.94 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.992 -0.443 . . . . 0.0 111.4 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.936 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.0 tm? -95.54 150.66 20.08 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.486 ' N ' HD13 ' A' ' 578' ' ' LEU . 7.1 m -145.31 118.18 5.33 Favored Pre-proline 0 C--N 1.293 -1.86 0 C-N-CA 125.006 1.322 . . . . 0.0 108.241 176.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.848 ' HG3' HD11 ' A' ' 571' ' ' LEU . 36.8 Cg_endo -70.23 131.03 19.74 Favored 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 121.255 1.304 . . . . 0.0 110.78 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.15 -34.89 79.07 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . 0.443 ' HB2' HD22 ' A' ' 593' ' ' LEU . 55.0 mmt-85 -88.09 104.83 17.04 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 171.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -117.65 97.48 5.88 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.454 ' HG3' ' H ' ' A' ' 585' ' ' ASP 0.288 10.4 ptpt -113.46 -93.39 0.47 Allowed 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.04 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.454 ' H ' ' HG3' ' A' ' 584' ' ' LYS . 5.6 t70 -173.82 -62.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 176.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . 0.593 ' HB3' ' HG3' ' A' ' 568' ' ' GLU . 0.0 OUTLIER -121.14 145.0 48.27 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.963 175.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.658 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 23.7 m-85 -114.84 132.57 56.46 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 -171.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' A' ' 591' ' ' GLU . 33.8 mtmm -90.06 161.11 15.98 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.517 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.41 121.9 16.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.209 0.528 . . . . 0.0 110.309 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 103.29 -0.08 47.16 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.881 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 588' ' ' LYS . 82.0 mm-40 -67.1 122.1 17.05 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 117.756 0.778 . . . . 0.0 109.012 173.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.585 HG12 ' HG3' ' A' ' 610' ' ' GLN . 7.0 m -95.41 117.68 39.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 CA-C-O 122.307 1.051 . . . . 0.0 108.63 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.623 HD21 ' HD2' ' A' ' 587' ' ' TYR . 17.5 mt -101.85 101.46 11.91 Favored 'General case' 0 C--N 1.274 -2.71 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.059 -174.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.599 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 10.3 mtmp? -79.72 113.38 17.83 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.782 ' HB3' HD11 ' A' ' 578' ' ' LEU . 80.4 m-85 -95.91 167.4 11.27 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . 0.415 ' O ' HD22 ' A' ' 578' ' ' LEU . 21.4 t -168.18 -179.18 3.95 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 170.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 77.8 m -118.4 177.36 4.85 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 123.68 0.612 . . . . 0.0 112.488 -173.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 30.1 mmtp -50.59 162.36 0.55 Allowed Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 125.372 1.469 . . . . 0.0 112.27 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 76.7 Cg_exo -47.76 -43.47 28.79 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.248 3.299 . . . . 0.0 113.761 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.66 1.64 63.99 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.957 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 37.4 m-85 -105.57 141.01 37.78 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-O 121.961 0.886 . . . . 0.0 112.777 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.662 HG21 HG11 ' A' ' 627' ' ' VAL . 9.8 m -102.69 126.84 49.94 Favored 'General case' 0 N--CA 1.393 -3.293 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.338 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.451 HD11 ' HG3' ' A' ' 621' ' ' PRO . 10.8 tt -73.18 123.51 28.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.097 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.486 HG21 ' HD3' ' A' ' 624' ' ' LYS . 86.6 t -113.14 126.49 70.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.764 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.07 -145.61 18.46 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.41 124.11 4.62 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.773 2.315 . . . . 0.0 110.864 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.26 -42.93 14.21 Favored 'General case' 0 C--O 1.204 -1.313 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.832 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.599 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 18.6 p -114.14 97.86 6.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.14 0.495 . . . . 0.0 111.983 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . 0.449 ' C ' HE21 ' A' ' 610' ' ' GLN . 11.1 m -92.66 163.18 2.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.596 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -113.18 154.1 27.23 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.374 0.607 . . . . 0.0 110.209 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 6.6 t -85.14 108.75 17.84 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.72 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' ' 617' ' ' SER . 55.3 m-85 -91.57 166.79 12.65 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 175.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -7.58 19.55 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -105.97 -10.59 16.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.998 0.427 . . . . 0.0 111.225 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 140.94 -172.49 23.65 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.532 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.443 ' CD2' ' HB3' ' A' ' 569' ' ' CYS . 2.8 mm? -79.32 127.82 32.56 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.55 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 47.8 t -149.09 147.18 22.99 Favored Pre-proline 0 N--CA 1.429 -1.516 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 609' ' ' VAL . 57.3 Cg_endo -71.33 -175.74 13.4 Favored 'Cis proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.641 -1.4 . . . . 0.0 114.038 1.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -63.26 142.44 58.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.032 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.738 HD23 HG22 ' A' ' 574' ' ' ILE . 8.7 mp -57.58 143.6 74.82 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -173.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.451 ' HG3' HD11 ' A' ' 603' ' ' ILE . 38.2 Cg_endo -68.05 -178.53 1.75 Allowed 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 124.748 3.632 . . . . 0.0 113.341 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . 0.431 HG13 ' HB ' ' A' ' 604' ' ' VAL . 40.1 pt -130.81 -178.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.4 m -129.0 119.5 24.39 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.222 0.534 . . . . 0.0 111.787 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.486 ' HD3' HG21 ' A' ' 604' ' ' VAL . 47.8 mtpt -114.04 126.04 54.67 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.837 177.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 18.3 tt0 -81.83 -27.05 33.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -123.8 113.63 18.81 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.286 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.662 HG11 HG21 ' A' ' 602' ' ' THR . 3.2 m -106.23 177.83 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.499 176.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.476 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 73.0 mt-30 -97.51 167.0 11.25 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 49.2 m -105.19 -4.92 21.17 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.536 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.1 m 68.15 -31.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 82.31 -139.06 19.32 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 633' ' ' PRO . 46.8 Cg_endo -75.9 154.39 38.3 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.449 2.099 . . . . 0.0 111.27 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.553 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 61.7 Cg_endo -92.07 174.12 2.25 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 123.087 2.525 . . . . 0.0 111.532 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.78 -173.72 1.87 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.033 1.822 . . . . 0.0 109.985 172.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.41 159.87 24.22 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.526 ' HB3' ' C ' ' A' ' 639' ' ' GLY . 14.7 tp -70.56 144.8 51.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.574 ' HG ' ' H ' ' A' ' 638' ' ' ASN . 0.9 OUTLIER -48.96 -71.76 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.574 ' H ' ' HG ' ' A' ' 637' ' ' LEU . 9.5 m120 -94.03 -32.57 13.76 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.622 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -85.15 -154.21 21.81 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.497 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . 0.594 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.7 t-20 -152.05 -173.66 4.61 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.8 p -101.72 133.54 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -93.43 -27.34 16.77 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.211 0.529 . . . . 0.0 110.641 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.714 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 38.5 mm-40 -81.56 153.78 26.57 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.245 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -67.12 122.25 17.39 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.257 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.463 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 16.6 p -76.97 110.53 11.67 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.417 0.627 . . . . 0.0 110.242 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -82.32 157.39 23.83 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.186 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.94 -9.29 59.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.724 0.773 . . . . 0.0 109.696 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . 0.642 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 38.4 tt0 -156.1 124.24 5.73 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.558 ' CE2' HG22 ' A' ' 655' ' ' VAL . 13.9 m-85 -98.44 -63.08 1.16 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 123.471 0.482 . . . . 0.0 111.637 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 112.23 162.04 16.1 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.56 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.3 t60 -63.68 140.56 58.88 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.0 m 75.78 -4.04 2.45 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.417 1.087 . . . . 0.0 113.546 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 649' ' ' TYR . 5.3 tp10 -81.87 120.14 24.82 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.9 m -91.47 159.46 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-O 122.1 0.952 . . . . 0.0 112.564 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.9 t -127.11 102.61 9.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.871 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.714 ' HB2' ' HG2' ' A' ' 643' ' ' GLU . 29.8 mt-10 -67.69 132.66 47.9 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.153 0.978 . . . . 0.0 112.194 175.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 67.9 m-85 -112.7 171.43 7.53 Favored 'General case' 0 C--N 1.28 -2.447 0 C-N-CA 126.372 1.869 . . . . 0.0 109.596 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 31.4 p90 -151.06 141.9 22.87 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.622 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 7.3 t -105.81 -177.66 3.43 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.746 176.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 34.6 m-80 -70.35 151.39 95.74 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.41 ' C ' ' HD2' ' A' ' 662' ' ' ARG . 52.7 Cg_endo -68.46 26.24 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 124.31 3.34 . . . . 0.0 114.092 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.41 ' HD2' ' C ' ' A' ' 661' ' ' PRO . 13.3 mmm180 -128.35 5.07 5.72 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 660' ' ' ASN . 44.1 m-85 -123.74 164.84 18.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.309 -172.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.428 HD21 ' OE2' ' A' ' 687' ' ' GLU . 90.3 mt -110.18 143.54 40.15 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.423 1.489 . . . . 0.0 107.31 175.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.9 ttt -114.04 102.52 10.26 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.788 ' HG2' HD11 ' A' ' 685' ' ' ILE . 72.3 mmtt -73.18 -63.22 1.23 Allowed 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.882 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -83.35 -168.52 43.45 Favored Glycine 0 N--CA 1.404 -3.486 0 CA-C-N 114.792 -1.095 . . . . 0.0 113.473 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.0 118.04 5.01 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.108 2.538 . . . . 0.0 112.07 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 3.7 p-10 -80.34 19.31 0.78 Allowed 'General case' 0 C--O 1.19 -2.028 0 C-N-CA 122.886 0.475 . . . . 0.0 111.426 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.72 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 7.0 ptmt -162.14 111.17 1.46 Allowed 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 124.861 1.264 . . . . 0.0 108.024 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 35.3 pt -107.63 144.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.986 -174.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.606 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -112.67 142.81 44.85 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 123.677 0.611 . . . . 0.0 110.848 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.0 t -67.41 116.89 8.67 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.683 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . 0.56 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 34.1 m -109.18 127.7 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.409 ' H ' ' CE1' ' A' ' 651' ' ' HIS . 28.2 t70 54.79 -80.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.538 1.135 . . . . 0.0 112.031 -169.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -157.11 31.67 0.54 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -143.02 156.45 44.84 Favored 'General case' 0 C--O 1.212 -0.88 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.463 ' HB3' HD12 ' A' ' 671' ' ' ILE . 97.7 m95 -93.15 166.1 12.5 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 7.9 p -91.81 -169.72 2.36 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 35.1 m -71.54 126.29 29.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.71 0.29 . . . . 0.0 110.413 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.93 160.41 29.32 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.893 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.611 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 24.6 Cg_endo -63.34 -15.33 47.65 Favored 'Trans proline' 0 CA--C 1.498 -1.312 0 C-N-CA 123.663 2.908 . . . . 0.0 115.035 -175.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 22.4 m 43.21 93.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 124.87 1.356 . . . . 0.0 114.411 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 23.3 p -95.75 137.26 35.06 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.662 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.788 HD11 ' HG2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -133.5 147.48 31.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.004 -178.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 98.3 t -52.56 133.27 14.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -172.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . 0.428 ' OE2' HD21 ' A' ' 664' ' ' LEU . 6.9 tp10 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.184 1.394 . . . . 0.0 108.963 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.423 -1.783 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 74.9 m -98.81 112.72 24.72 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-O 121.876 0.846 . . . . 0.0 112.471 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 571' ' ' LEU . 21.3 tt0 -82.97 -23.58 33.31 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.24 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 32.3 tp 79.02 105.08 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 113.665 -1.607 . . . . 0.0 108.922 -169.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.711 ' HD2' HD12 ' A' ' 616' ' ' LEU . 24.5 Cg_endo -62.94 -172.6 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.062 2.508 . . . . 0.0 113.429 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.89 20.77 0.45 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -170.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.779 HG13 ' H ' ' A' ' 575' ' ' ASP . 26.1 pt 35.19 -94.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 126.523 1.929 . . . . 0.0 115.469 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.779 ' H ' HG13 ' A' ' 574' ' ' ILE . 15.7 t70 -165.1 179.74 6.17 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.82 -27.57 4.98 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -103.52 10.17 37.23 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.622 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.739 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.7 tp -100.14 164.49 11.95 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.65 122.52 1.94 Allowed Pre-proline 0 C--N 1.308 -1.238 0 C-N-CA 124.044 0.938 . . . . 0.0 108.803 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.2 137.51 21.39 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.123 1.882 . . . . 0.0 112.209 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -78.74 -42.11 29.02 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -90.33 113.56 25.46 Favored 'General case' 0 N--CA 1.392 -3.349 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . 0.58 ' HA ' ' OH ' ' A' ' 587' ' ' TYR . 64.1 tttp -135.24 135.44 40.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.311 0.577 . . . . 0.0 111.641 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.621 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 13.1 ptpt -160.43 -160.31 0.76 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.634 1.174 . . . . 0.0 108.489 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -90.34 -64.46 1.13 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.03 0.443 . . . . 0.0 110.656 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.98 134.3 55.29 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.645 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 69.3 m-85 -96.39 127.5 42.45 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -84.36 145.33 28.28 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.876 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 1.6 p -55.59 111.36 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 122.17 0.986 . . . . 0.0 112.755 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 115.26 -6.29 21.35 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.862 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -70.23 137.95 51.27 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 4.1 m -104.63 123.89 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-O 122.03 0.919 . . . . 0.0 109.499 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.477 HD11 ' CD2' ' A' ' 587' ' ' TYR . 7.4 mp -107.48 104.79 14.44 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.174 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 28.8 mtpp -82.95 119.33 24.29 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.763 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.45 158.62 16.08 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-O 120.957 0.408 . . . . 0.0 110.684 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 19.6 m -150.59 171.74 16.63 Favored 'General case' 0 N--CA 1.398 -3.044 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.555 ' SG ' HD12 ' A' ' 578' ' ' LEU . 95.3 m -112.87 179.84 3.85 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-O 120.656 0.265 . . . . 0.0 110.333 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -52.23 162.07 0.92 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.302 1.441 . . . . 0.0 112.306 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.45 -41.96 42.61 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.268 3.312 . . . . 0.0 114.283 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 625' ' ' GLU . . . -96.52 1.71 62.21 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.627 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -103.84 147.82 26.85 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.876 0.846 . . . . 0.0 112.892 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.602 HG21 HG11 ' A' ' 627' ' ' VAL . 17.8 m -98.83 134.95 40.98 Favored 'General case' 0 C--N 1.272 -2.762 0 CA-C-N 113.728 -1.578 . . . . 0.0 109.104 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.579 HD11 ' HG3' ' A' ' 621' ' ' PRO . 7.6 tt -82.48 115.66 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.831 0.824 . . . . 0.0 109.348 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.537 ' HB ' HG13 ' A' ' 622' ' ' ILE . 61.9 t -106.72 101.84 13.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.726 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 137.31 -162.38 25.36 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.0 123.44 10.66 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 122.827 2.351 . . . . 0.0 111.963 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.34 -49.46 11.49 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 175.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 66.5 p -104.31 106.91 17.58 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.58 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.18 161.2 4.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.642 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 22.8 mm-40 -105.08 163.48 12.53 Favored 'General case' 0 CA--C 1.473 -2.003 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.537 ' HA ' HD23 ' A' ' 616' ' ' LEU . 43.4 t -88.01 132.54 34.23 Favored 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 118.646 -1.222 . . . . 0.0 107.78 166.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.642 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 75.2 m-85 -116.61 168.84 9.83 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -67.64 -5.37 15.4 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -111.23 -9.24 14.33 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 122.007 -0.433 . . . . 0.0 110.266 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 138.61 -177.4 20.17 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.711 HD12 ' HD2' ' A' ' 572' ' ' PRO . 94.3 mt -68.57 140.83 55.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 117.037 0.419 . . . . 0.0 109.899 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 2.5 t -156.31 150.83 20.21 Favored Pre-proline 0 N--CA 1.421 -1.915 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.457 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 59.8 Cg_endo -69.99 -176.64 13.3 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.672 -1.386 . . . . 0.0 112.99 1.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.13 144.98 32.66 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.995 0.426 . . . . 0.0 110.408 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.563 HD23 HG22 ' A' ' 574' ' ' ILE . 8.4 mp -64.76 145.56 98.77 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.248 -172.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.579 ' HG3' HD11 ' A' ' 603' ' ' ILE . 72.3 Cg_endo -71.25 170.22 18.82 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 123.452 2.768 . . . . 0.0 112.54 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 604' ' ' VAL . 38.8 pt -116.7 -178.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 602' ' ' THR . 73.3 m -126.44 125.8 42.74 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.977 0.418 . . . . 0.0 111.443 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 624' ' ' LYS . 47.8 mtpt -119.31 140.11 50.83 Favored 'General case' 0 C--O 1.194 -1.862 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 600' ' ' GLY . 1.4 tm-20 -90.67 -43.72 9.96 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -95.76 112.02 23.85 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.471 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.602 HG11 HG21 ' A' ' 602' ' ' THR . 7.4 m -123.21 175.63 5.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.489 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.68 170.15 9.2 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 15.5 m -102.03 -11.11 19.15 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 93.0 m 70.6 8.99 6.79 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 112.376 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 60.58 -144.74 47.72 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -82.38 153.6 16.05 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.481 2.12 . . . . 0.0 110.292 173.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.68 ' HG3' HG11 ' A' ' 655' ' ' VAL . 57.0 Cg_endo -71.05 153.53 62.93 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.842 2.362 . . . . 0.0 113.366 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.4 173.99 6.85 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.627 2.884 . . . . 0.0 113.097 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -88.21 153.33 21.32 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 121.173 0.511 . . . . 0.0 110.926 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.59 HD22 ' HB3' ' A' ' 657' ' ' TYR . 23.4 tp -97.04 123.92 40.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' A' ' 683' ' ' VAL . 0.0 OUTLIER -39.66 -46.8 1.89 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -177.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.4 ' N ' HD22 ' A' ' 637' ' ' LEU . 72.2 m-20 -137.92 39.99 2.34 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.263 1.03 . . . . 0.0 109.507 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.629 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.46 -152.96 6.36 Favored Glycine 0 N--CA 1.397 -3.96 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . 0.404 HD22 ' HA ' ' A' ' 640' ' ' ASN . 0.2 OUTLIER -164.67 -176.58 4.35 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 124.087 0.955 . . . . 0.0 108.682 175.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.601 HG11 HG21 ' A' ' 645' ' ' THR . 6.4 p -95.99 130.31 44.85 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.042 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.637 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.5 ptmt -85.25 -27.4 26.05 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.245 0.545 . . . . 0.0 110.255 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 40.2 mm-40 -80.8 143.6 32.72 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.725 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . 0.781 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -52.8 120.76 6.14 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 124.646 1.217 . . . . 0.0 109.39 173.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.601 HG21 HG11 ' A' ' 641' ' ' VAL . 4.1 p -101.35 104.96 15.97 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -172.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -85.17 149.55 25.44 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 113.601 -1.636 . . . . 0.0 108.126 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -80.69 16.62 1.34 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -155.48 105.27 2.44 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.484 ' CE2' HG22 ' A' ' 655' ' ' VAL . 3.4 m-85 -90.85 -88.57 0.18 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 143.02 157.08 7.01 Favored Glycine 0 N--CA 1.424 -2.142 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -175.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.415 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 84.6 t60 -67.12 138.72 57.28 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.511 0.196 . . . . 0.0 111.023 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 68.6 m 69.25 5.88 5.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.702 1.201 . . . . 0.0 113.044 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -92.69 117.54 30.1 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.646 HG21 ' HE3' ' A' ' 670' ' ' LYS . 12.8 m -86.49 159.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.694 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.5 t -129.03 117.54 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.904 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.637 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 20.9 mt-10 -73.02 124.38 25.38 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.773 0.797 . . . . 0.0 112.245 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.59 ' HB3' HD22 ' A' ' 636' ' ' LEU . 34.3 m-85 -104.58 172.62 6.69 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.092 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -146.81 137.26 23.71 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.629 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 70.9 m -95.43 172.85 7.83 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.46 ' HB2' ' HD1' ' A' ' 663' ' ' PHE . 9.8 m120 -63.73 152.56 86.16 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.85 -4.36 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.411 2.74 . . . . 0.0 112.538 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -96.42 -1.27 47.88 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 124.311 1.044 . . . . 0.0 108.865 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.46 ' HD1' ' HB2' ' A' ' 660' ' ' ASN . 45.4 m-85 -131.75 158.02 42.28 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.103 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 89.1 mt -100.17 158.03 16.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.421 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 6.2 ttt -124.6 95.08 4.39 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -176.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -86.95 -44.52 11.57 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.351 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -78.65 -179.64 51.5 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.975 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.24 114.85 2.29 Favored 'Trans proline' 0 C--N 1.334 -0.232 0 C-N-CA 123.138 2.558 . . . . 0.0 111.142 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 17.6 p-10 -73.92 -11.39 60.34 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 2.3 mtpp -121.3 120.06 34.02 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 33.6 pt -111.12 152.59 13.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.532 -1.267 . . . . 0.0 110.924 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.66 154.05 29.11 Favored 'General case' 0 N--CA 1.425 -1.688 0 O-C-N 123.881 0.738 . . . . 0.0 109.489 -172.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 2.8 t -85.62 122.55 29.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.057 174.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . 0.415 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 77.9 t -114.42 114.68 47.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.211 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.7 t70 55.16 -78.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.25 1.42 . . . . 0.0 111.765 -171.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -149.1 18.2 1.2 Allowed Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -130.07 150.84 51.16 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.561 ' HB3' HD12 ' A' ' 671' ' ' ILE . 95.8 m95 -87.86 162.96 16.66 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 19.2 p -81.68 -178.15 6.85 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 27.3 m -64.39 130.85 45.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.462 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.0 mp -68.56 162.37 63.11 Favored Pre-proline 0 N--CA 1.446 -0.669 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.573 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 31.6 Cg_endo -67.76 -16.06 45.44 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.808 3.005 . . . . 0.0 114.721 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.513 ' HA ' HD11 ' A' ' 637' ' ' LEU 0.304 13.2 m 44.25 92.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 175.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 3.6 m -67.19 139.6 57.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.329 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.17 148.11 33.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.593 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 44.8 t -65.36 135.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 O-C-N 123.39 0.431 . . . . 0.0 110.731 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.25 1.108 0 O-C-N 123.848 0.718 . . . . 0.0 109.856 179.23 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 569' ' ' CYS . 3.9 tp10 . . . . . 0 N--CA 1.432 -1.347 0 N-CA-C 102.039 -3.319 . . . . 0.0 102.039 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 616' ' ' LEU . 87.4 m -138.81 161.16 37.94 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 119.518 1.054 . . . . 0.0 112.669 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -138.34 117.9 13.0 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 104.538 -2.394 . . . . 0.0 104.538 168.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.659 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 2.0 tt -34.57 121.8 0.55 Allowed Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 125.37 1.468 . . . . 0.0 109.56 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.625 ' HD2' HD22 ' A' ' 616' ' ' LEU . 70.6 Cg_endo -69.58 -169.9 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.36 2.04 . . . . 0.0 111.549 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -87.63 101.36 13.58 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.439 -0.905 . . . . 0.0 109.602 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.813 HG22 HD23 ' A' ' 620' ' ' LEU . 38.9 pt -67.42 -172.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.987 0 CA-C-O 121.759 0.79 . . . . 0.0 110.674 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.805 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 6.4 t70 -66.34 -175.15 0.33 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.046 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.92 -27.3 4.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 O-C-N 121.407 -0.808 . . . . 0.0 109.358 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -109.58 9.94 25.11 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 122.124 -0.36 . . . . 0.0 111.868 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.879 HD11 ' HB3' ' A' ' 595' ' ' PHE . 1.6 tm? -89.99 151.37 21.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.51 ' N ' HD13 ' A' ' 578' ' ' LEU . 7.6 p -148.88 117.16 3.89 Favored Pre-proline 0 C--N 1.294 -1.845 0 C-N-CA 123.907 0.883 . . . . 0.0 109.303 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.612 ' HG3' HD11 ' A' ' 571' ' ' LEU . 64.8 Cg_endo -75.16 148.9 35.31 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.643 2.229 . . . . 0.0 112.909 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.74 -55.99 8.4 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -75.1 108.77 8.06 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.91 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -120.81 97.72 5.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.51 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.8 ptpt -133.44 167.43 20.46 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.118 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.28 -67.18 0.44 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 124.052 0.845 . . . . 0.0 110.992 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 144.13 49.04 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.659 ' CE1' ' HB2' ' A' ' 571' ' ' LEU . 45.2 m-85 -103.69 132.47 49.91 Favored 'General case' 0 CA--C 1.467 -2.247 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.843 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . 0.432 ' HA ' ' OE2' ' A' ' 568' ' ' GLU . 19.4 mtpp -81.24 147.36 29.99 Favored 'General case' 0 C--N 1.273 -2.747 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.521 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.707 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 46.6 t -59.44 112.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.178 0.513 . . . . 0.0 110.23 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 113.08 -6.01 25.39 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.416 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.97 135.63 47.99 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.532 HG12 ' HG3' ' A' ' 610' ' ' GLN . 3.8 m -106.33 134.12 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 C-N-CA 119.77 -0.772 . . . . 0.0 108.974 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 608' ' ' SER . 5.4 mp -113.8 103.69 11.45 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.563 ' HG2' ' HB2' ' A' ' 608' ' ' SER . 84.3 mttt -78.6 103.31 8.46 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.879 ' HB3' HD11 ' A' ' 578' ' ' LEU . 44.3 m-85 -86.69 162.94 17.64 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.757 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . 0.666 ' HA ' HD12 ' A' ' 603' ' ' ILE . 66.5 m -164.18 -175.35 3.94 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 169.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 603' ' ' ILE . 98.0 m -113.02 171.13 7.72 Favored 'General case' 0 C--N 1.259 -3.359 0 O-C-N 123.563 0.54 . . . . 0.0 110.968 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.601 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 29.3 mmtp -56.94 162.21 3.98 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.873 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 44.3 Cg_exo -39.09 -41.37 1.89 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 125.104 3.869 . . . . 0.0 116.644 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -98.42 6.06 60.99 Favored Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.643 -0.789 . . . . 0.0 114.283 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 56.7 m-85 -109.92 150.65 28.14 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 51.9 m -98.29 125.46 43.4 Favored 'General case' 0 N--CA 1.406 -2.675 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.92 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 596' ' ' SER . 8.0 tt -76.02 128.24 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.586 ' HB ' HG13 ' A' ' 622' ' ' ILE . 84.4 t -119.21 105.12 16.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.264 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 134.39 -168.81 23.31 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.697 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.86 116.58 3.54 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 123.519 2.812 . . . . 0.0 110.347 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -81.92 -43.56 17.95 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.624 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.563 ' HB2' ' HG2' ' A' ' 594' ' ' LYS . 15.0 t -111.79 89.76 3.15 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 119.216 -0.993 . . . . 0.0 112.536 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . 0.403 HG22 ' CE2' ' A' ' 595' ' ' PHE . 18.0 m -80.2 165.89 2.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.609 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -109.9 154.54 22.93 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.551 0.691 . . . . 0.0 109.664 177.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 0.0 OUTLIER -86.41 131.66 34.14 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.132 167.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.466 ' CD1' ' HB3' ' A' ' 617' ' ' SER . 86.2 m-85 -117.62 173.71 6.57 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -72.45 -5.0 33.63 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.36 -0.837 . . . . 0.0 113.091 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -108.02 -3.06 19.1 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.436 0.636 . . . . 0.0 110.417 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 130.31 -171.42 20.6 Favored Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.625 HD22 ' HD2' ' A' ' 572' ' ' PRO . 8.2 mp -82.13 141.69 32.88 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 46.3 t -159.7 153.02 18.57 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.48 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 78.8 Cg_endo -76.45 -167.6 6.03 Favored 'Cis proline' 0 N--CA 1.481 0.788 0 C-N-CA 124.047 -1.23 . . . . 0.0 113.317 1.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -50.16 144.01 7.63 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.442 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.813 HD23 HG22 ' A' ' 574' ' ' ILE . 7.7 mp -78.99 148.72 72.4 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.177 -173.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.462 ' HG3' HD11 ' A' ' 603' ' ' ILE . 36.3 Cg_endo -67.35 168.56 17.52 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 124.093 3.195 . . . . 0.0 112.952 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . 0.586 HG13 ' HB ' ' A' ' 604' ' ' VAL . 45.6 pt -116.25 -179.66 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 78.5 m -124.6 123.13 39.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.969 0.414 . . . . 0.0 111.632 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.517 ' HG3' HG21 ' A' ' 604' ' ' VAL . 6.4 mmmm -115.92 121.97 43.9 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.517 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 1.6 tm-20 -88.96 -36.72 15.71 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -93.23 78.65 4.51 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.62 HG23 ' HA ' ' A' ' 675' ' ' ASP . 11.8 p -88.07 154.99 3.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.265 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.465 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 78.0 mt-30 -84.71 167.4 16.19 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.488 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 21.5 m -108.19 -8.95 15.62 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.3 m 70.15 -55.36 0.61 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.337 1.055 . . . . 0.0 111.903 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 109.14 -143.71 16.4 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.23 132.84 28.79 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.685 1.59 . . . . 0.0 111.423 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.438 ' HG3' HG11 ' A' ' 655' ' ' VAL . 56.8 Cg_endo -69.29 164.97 32.06 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 123.505 2.803 . . . . 0.0 112.77 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.08 177.74 4.14 Favored 'Trans proline' 0 C--O 1.254 1.29 0 C-N-CA 122.773 2.315 . . . . 0.0 111.314 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -95.24 165.24 12.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.551 HD22 ' HB3' ' A' ' 657' ' ' TYR . 19.3 tp -91.46 156.46 17.7 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.464 HD21 ' H ' ' A' ' 684' ' ' CYS . 1.7 pt? -53.2 -64.27 0.88 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.59 0.632 . . . . 0.0 112.49 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.45 -23.92 11.65 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.384 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -94.67 -152.75 29.68 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.727 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.52 -164.92 1.94 Allowed 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.4 p -104.73 136.18 39.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -94.62 -21.14 19.01 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.299 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.508 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 23.9 mm-40 -81.67 154.59 26.02 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -70.3 113.53 7.56 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.435 ' CG2' HG11 ' A' ' 641' ' ' VAL . 1.5 p -70.75 99.89 1.79 Allowed 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.777 0.799 . . . . 0.0 111.837 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -82.85 169.72 15.78 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.166 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.21 -26.41 33.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.049 0.452 . . . . 0.0 111.207 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -128.55 113.61 15.68 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.513 ' CE2' HG12 ' A' ' 655' ' ' VAL . 8.2 m-85 -92.3 -93.12 0.15 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 140.04 164.94 10.1 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.136 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.676 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 69.7 t60 -55.67 -58.62 7.04 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 15.1 m -90.43 15.31 10.91 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-O 121.289 0.566 . . . . 0.0 111.22 -173.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.421 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 4.7 tp10 -97.12 117.49 31.43 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 5.9 m -93.96 151.34 3.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.754 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 29.3 m -114.34 102.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.55 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.523 ' CG ' ' HD2' ' A' ' 670' ' ' LYS . 12.1 mt-10 -66.21 121.78 15.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.942 0.877 . . . . 0.0 112.242 176.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 69.4 m-85 -100.06 168.61 9.73 Favored 'General case' 0 C--N 1.271 -2.836 0 C-N-CA 125.28 1.432 . . . . 0.0 109.441 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -152.61 141.7 21.33 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.679 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 7.5 t -106.49 -171.19 1.85 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.58 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 662' ' ' ARG . 39.6 m-80 -77.77 156.39 80.25 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.37 6.16 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 123.797 2.998 . . . . 0.0 113.388 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 660' ' ' ASN . 32.2 mmt180 -105.7 -0.26 25.67 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.254 -176.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -128.27 158.36 38.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.568 0.699 . . . . 0.0 112.322 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.43 133.39 46.13 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 113.749 -1.569 . . . . 0.0 107.511 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.2 ttt -104.0 109.55 21.37 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -92.9 -49.19 6.16 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -86.23 -171.04 47.56 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.36 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.12 119.12 6.11 Favored 'Trans proline' 0 CA--C 1.526 0.108 0 C-N-CA 123.093 2.529 . . . . 0.0 111.13 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.636 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 23.2 p-10 -81.47 0.28 38.46 Favored 'General case' 0 C--O 1.178 -2.666 0 O-C-N 121.996 -0.44 . . . . 0.0 111.33 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 3.8 ptmt -134.74 110.28 9.13 Favored 'General case' 0 C--N 1.267 -3.0 0 CA-C-O 121.801 0.81 . . . . 0.0 109.704 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 46.5 pt -110.25 151.32 12.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.649 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.554 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -113.73 156.8 23.13 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.541 0.526 . . . . 0.0 111.458 -179.146 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.676 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 13.6 t -81.73 99.63 9.05 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.885 0.85 . . . . 0.0 110.624 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . 0.524 ' HA ' ' HD1' ' A' ' 651' ' ' HIS . 36.0 m -90.72 111.66 23.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.975 -1.078 . . . . 0.0 111.878 -177.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.62 ' HA ' HG23 ' A' ' 627' ' ' VAL . 13.1 t70 71.13 -59.5 0.54 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.707 1.203 . . . . 0.0 112.639 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -172.77 22.71 0.07 OUTLIER Glycine 0 C--N 1.295 -1.703 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -142.47 152.0 42.28 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.4 m95 -81.12 173.0 12.98 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.558 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . 0.458 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 0.5 OUTLIER -96.59 -179.92 4.77 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.067 -179.111 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 27.5 m -69.39 126.17 28.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.725 0.298 . . . . 0.0 110.868 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.4 ' CB ' ' HD2' ' A' ' 682' ' ' PRO . 7.1 mp -60.18 155.94 42.32 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.636 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 10.3 Cg_endo -57.41 -39.67 87.43 Favored 'Trans proline' 0 CA--C 1.5 -1.198 0 C-N-CA 124.434 3.423 . . . . 0.0 115.527 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 682' ' ' PRO 0.275 3.9 m 64.42 122.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.09 0 C-N-CA 125.37 1.468 . . . . 0.0 112.202 -171.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.464 ' H ' HD21 ' A' ' 637' ' ' LEU . 21.8 p -119.94 129.17 54.2 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.718 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.409 ' H ' HD13 ' A' ' 685' ' ' ILE . 0.2 OUTLIER -118.76 147.84 22.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.353 -174.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.81 128.71 17.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 123.977 0.798 . . . . 0.0 111.1 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 C--N 1.305 -1.369 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.173 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 120.87 0.366 . . . . 0.0 111.529 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.673 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 88.9 m -127.29 149.28 50.09 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.543 0.687 . . . . 0.0 112.331 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.495 ' O ' HD21 ' A' ' 616' ' ' LEU . 40.0 mt-10 -107.55 -157.12 0.6 Allowed 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.477 HD22 ' HD2' ' A' ' 572' ' ' PRO . 3.1 tm? -125.84 107.38 25.68 Favored Pre-proline 0 C--N 1.28 -2.42 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.477 ' HD2' HD22 ' A' ' 571' ' ' LEU . 48.9 Cg_endo -67.45 176.93 4.35 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.647 2.231 . . . . 0.0 111.785 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -79.76 90.02 5.22 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.843 0.83 . . . . 0.0 109.793 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.817 HG22 ' HG ' ' A' ' 620' ' ' LEU . 38.6 pt -72.88 -169.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.594 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 7.9 t70 -74.82 146.69 41.82 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.17 -22.63 31.53 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 121.662 0.744 . . . . 0.0 110.515 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -93.7 5.46 51.56 Favored 'General case' 0 C--O 1.204 -1.29 0 O-C-N 121.646 -0.659 . . . . 0.0 110.374 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.554 HD12 ' SG ' ' A' ' 623' ' ' CYS . 1.0 OUTLIER -108.02 154.12 22.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.209 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.39 122.51 5.23 Favored Pre-proline 0 C--N 1.304 -1.383 0 C-N-CA 123.304 0.642 . . . . 0.0 109.62 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.92 137.28 26.53 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.054 1.836 . . . . 0.0 112.534 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 594' ' ' LYS . 10.7 t70 -67.1 -42.52 84.43 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.584 1.154 . . . . 0.0 110.898 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -64.55 -68.94 0.32 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.722 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 53.35 81.49 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.218 1.407 . . . . 0.0 111.315 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 16.5 ptpt -132.89 -177.6 4.57 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.817 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.61 -68.3 0.61 Allowed 'General case' 0 C--N 1.309 -1.164 0 O-C-N 123.158 0.286 . . . . 0.0 111.383 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 131.06 54.48 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.548 0.689 . . . . 0.0 110.582 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.673 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 66.1 m-85 -94.79 140.34 30.04 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.437 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -91.13 152.51 20.56 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.194 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.69 118.81 3.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 99.71 2.9 56.29 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.834 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -76.16 130.99 39.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.415 HG13 ' NE2' ' A' ' 610' ' ' GLN . 12.7 t -101.81 120.2 51.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.408 0.623 . . . . 0.0 109.386 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.594 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 4.9 mp -98.52 100.12 11.34 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 581' ' ' ASP . 31.0 mtmm -80.27 142.02 34.98 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 173.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.501 ' CZ ' HD12 ' A' ' 620' ' ' LEU . 91.2 m-85 -116.16 173.95 6.31 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-O 121.321 0.582 . . . . 0.0 110.624 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 8.7 p -161.6 168.38 23.59 Favored 'General case' 0 N--CA 1.392 -3.335 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.54 ' SG ' HD12 ' A' ' 578' ' ' LEU . 94.3 m -117.75 -176.06 2.96 Favored 'General case' 0 C--N 1.265 -3.082 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 39.3 mmtm -55.03 166.64 0.77 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.406 1.482 . . . . 0.0 111.85 174.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 71.8 Cg_exo -46.91 -42.9 24.94 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 124.112 3.208 . . . . 0.0 114.612 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -102.69 0.16 49.16 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.385 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 28.4 m-85 -93.16 127.28 38.66 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.53 HG21 HG21 ' A' ' 627' ' ' VAL . 90.4 m -86.82 120.55 28.22 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-N 113.075 -1.875 . . . . 0.0 110.67 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 12.3 tt -77.3 133.05 31.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.715 HG21 ' HD3' ' A' ' 624' ' ' LYS . 91.0 t -133.36 130.37 57.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 124.73 -148.55 16.78 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -80.41 102.06 1.38 Allowed 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.322 2.015 . . . . 0.0 110.426 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 1.8 m-20 -73.88 -23.98 59.65 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.709 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . . . . . . . . . 27.8 p -129.57 96.11 4.17 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.561 0.696 . . . . 0.0 111.284 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . 0.496 HG12 ' HD2' ' A' ' 618' ' ' PRO . 17.0 m -94.93 164.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.593 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 23.6 mm-40 -107.67 165.38 11.47 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 4.1 t -92.79 128.64 38.72 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 114.519 -1.219 . . . . 0.0 107.825 165.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 54.6 m-85 -115.37 168.71 9.74 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -60.61 -16.04 34.36 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -108.45 -3.65 18.0 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.775 0.321 . . . . 0.0 111.38 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 133.47 -168.72 23.01 Favored Glycine 0 N--CA 1.434 -1.47 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.381 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.495 HD21 ' O ' ' A' ' 570' ' ' GLU . 2.6 mm? -77.03 121.92 24.21 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 123.152 0.581 . . . . 0.0 109.641 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 35.3 t -147.2 141.47 15.91 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.496 ' HD2' HG12 ' A' ' 609' ' ' VAL . 13.4 Cg_exo -66.22 -179.57 12.43 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.713 -1.37 . . . . 0.0 112.651 0.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.05 163.48 24.61 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.277 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.817 ' HG ' HG22 ' A' ' 574' ' ' ILE . 1.1 mm? -67.61 134.75 92.62 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.994 -169.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.22 172.45 7.53 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 123.832 3.021 . . . . 0.0 111.541 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 45.6 pt -114.03 169.6 5.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.032 0.444 . . . . 0.0 111.327 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.554 ' SG ' HD12 ' A' ' 578' ' ' LEU . 81.7 m -115.61 112.54 22.3 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.301 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.715 ' HD3' HG21 ' A' ' 604' ' ' VAL . 51.9 mtpt -95.61 -28.29 14.9 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 21.6 tt0 69.25 -66.73 0.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.223 1.009 . . . . 0.0 109.546 -176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -88.85 112.02 22.75 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.59 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 2.8 p -127.38 174.52 10.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 16.0 mm100 -93.84 155.78 17.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.564 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 16.2 m -104.92 -8.21 18.79 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.015 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 21.9 m 74.77 -3.26 2.63 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 166.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 64.73 -147.76 51.07 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.421 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.82 144.33 24.39 Favored 'Trans proline' 0 C--O 1.253 1.24 0 C-N-CA 122.658 2.238 . . . . 0.0 112.035 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.553 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 68.6 Cg_endo -70.78 167.38 25.94 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.821 3.014 . . . . 0.0 112.996 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.04 -179.5 4.38 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.792 2.328 . . . . 0.0 111.472 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -99.38 158.58 15.62 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 657' ' ' TYR . 16.0 tp -96.82 133.98 40.72 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 683' ' ' VAL . 2.0 pt? -50.37 -45.4 55.21 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -131.03 33.26 4.19 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.14 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -167.7 -148.32 5.63 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 641' ' ' VAL . 2.3 t30 -162.41 177.66 9.34 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.573 HG22 ' CE1' ' A' ' 657' ' ' TYR . 5.2 t -78.54 133.13 30.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.536 ' HB2' ' NZ ' ' A' ' 642' ' ' LYS . 0.0 OUTLIER -90.78 -2.6 57.78 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.22 0.533 . . . . 0.0 110.563 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.514 ' OE2' ' HE3' ' A' ' 642' ' ' LYS . 74.0 mm-40 -104.19 151.9 22.79 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.694 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -50.91 109.77 0.36 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 112.545 -2.116 . . . . 0.0 109.871 169.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.601 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 4.1 p -85.33 102.98 13.84 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 121.906 0.86 . . . . 0.0 112.792 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 53.6 pttt -84.19 156.83 21.87 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.646 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.446 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 4.9 mp0 -74.71 -11.29 60.14 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.955 -173.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . 0.503 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 7.4 tp10 -147.66 118.39 7.56 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.601 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 21.6 m-85 -97.64 -94.75 0.22 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 151.34 167.39 14.78 Favored Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.574 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.712 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 67.6 t60 -61.38 -44.16 97.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.343 0.592 . . . . 0.0 111.7 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 14.6 m -98.01 17.22 18.84 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.396 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 649' ' ' TYR . 2.9 tp10 -101.0 111.54 23.77 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.674 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.803 HG21 ' HB2' ' A' ' 670' ' ' LYS . 10.8 p -87.91 148.31 4.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.961 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -112.16 105.63 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.76 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.79 170.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 19.4 mt-10 -72.5 126.06 28.95 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.71 0.767 . . . . 0.0 109.592 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.586 ' HB3' HD22 ' A' ' 636' ' ' LEU . 49.7 m-85 -102.59 167.69 9.76 Favored 'General case' 0 C--N 1.268 -2.945 0 C-N-CA 124.311 1.044 . . . . 0.0 110.969 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.444 ' CD1' ' HB3' ' A' ' 642' ' ' LYS . 13.6 p90 -148.54 142.47 25.81 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.568 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 33.2 m -107.07 173.83 6.15 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 120.794 0.331 . . . . 0.0 111.861 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.443 ' HB2' ' HD1' ' A' ' 663' ' ' PHE . 7.2 m120 -61.82 150.79 81.39 Favored Pre-proline 0 C--O 1.243 0.763 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.577 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.55 39.14 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 124.826 3.684 . . . . 0.0 113.822 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -155.83 9.22 0.26 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.817 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 87.9 m-85 -126.32 150.17 48.68 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 120.96 0.409 . . . . 0.0 109.912 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 85.1 mt -93.49 134.5 35.69 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.742 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 3.3 ttt -96.25 101.39 13.02 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 685' ' ' ILE . 41.3 tptt -69.16 -65.17 0.74 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.69 -169.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.72 -161.69 37.7 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.704 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.43 124.66 14.64 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 123.239 2.626 . . . . 0.0 110.948 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 5.6 p-10 -76.39 -12.28 60.03 Favored 'General case' 0 C--O 1.171 -3.036 0 CA-C-O 121.672 0.748 . . . . 0.0 110.412 -177.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.803 ' HB2' HG21 ' A' ' 654' ' ' VAL . 0.0 OUTLIER -132.97 123.33 25.71 Favored 'General case' 2 N--CA 1.331 -6.424 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -171.397 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.612 HD12 ' HB3' ' A' ' 678' ' ' TRP . 43.4 pt -122.0 138.95 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.78 -172.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.57 161.03 15.22 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 38.3 t -94.0 104.58 16.61 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 118.451 -1.3 . . . . 0.0 111.876 -176.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . 0.262 32.7 m -81.62 88.36 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-O 123.017 1.389 . . . . 0.0 113.126 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.59 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 24.9 t70 89.98 -61.25 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.871 0 CA-C-N 112.094 -2.321 . . . . 0.0 111.224 170.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -159.0 12.98 0.21 Allowed Glycine 0 C--N 1.268 -3.207 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.707 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.48 130.58 38.77 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.612 ' HB3' HD12 ' A' ' 671' ' ' ILE . 94.6 m95 -72.95 152.77 41.25 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 2.2 p -74.46 176.91 6.37 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 14.2 m -61.56 125.84 25.23 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.068 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 6.3 mp -62.62 154.83 72.22 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.744 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 17.8 Cg_endo -61.73 -19.68 66.2 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 C-N-CA 123.464 2.776 . . . . 0.0 114.136 -177.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.522 ' HA ' HD21 ' A' ' 637' ' ' LEU . 17.2 m 39.78 83.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 175.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.742 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 62.8 m -79.77 146.75 32.16 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.27 -174.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -127.83 149.34 32.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.483 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.82 139.35 21.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 120.792 0.33 . . . . 0.0 111.318 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--O 1.254 1.323 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.155 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.614 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 83.2 m -89.53 148.03 23.63 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.93 0.395 . . . . 0.0 111.237 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.18 134.14 49.01 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 172.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.657 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.4 tt -52.18 111.4 2.48 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.079 0.952 . . . . 0.0 108.885 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.497 ' HG2' HD21 ' A' ' 620' ' ' LEU . 58.8 Cg_endo -76.68 -174.67 2.24 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.913 2.409 . . . . 0.0 111.417 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -87.4 86.96 7.29 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.751 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.877 HG13 ' H ' ' A' ' 575' ' ' ASP . 11.1 pt -55.81 -72.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.739 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.877 ' H ' HG13 ' A' ' 574' ' ' ILE . 12.1 t70 -173.93 -172.36 0.72 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.39 -30.73 2.99 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -95.63 11.31 33.7 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.242 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.7 tt -111.82 139.89 46.92 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.96 121.28 12.36 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.657 ' HG3' HD11 ' A' ' 571' ' ' LEU . 54.8 Cg_endo -75.05 152.39 40.49 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.603 2.202 . . . . 0.0 111.22 174.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.02 -46.02 62.87 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.34 0.591 . . . . 0.0 109.895 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . 0.481 ' HA ' ' HD3' ' A' ' 582' ' ' ARG . 2.4 mmt180 -84.15 139.54 32.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.872 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -137.48 107.95 6.52 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 14.2 ptpt -146.9 172.77 13.17 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.66 -65.49 0.78 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.22 145.09 44.13 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.5 0.667 . . . . 0.0 110.162 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.614 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 39.3 m-85 -105.27 125.88 51.48 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -78.87 153.4 30.59 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.536 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.41 121.16 7.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.326 0.584 . . . . 0.0 110.156 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 105.73 -8.9 43.72 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.747 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.31 126.19 28.48 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 117.876 0.838 . . . . 0.0 109.864 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 608' ' ' SER . 14.3 t -99.67 121.78 50.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 608' ' ' SER . 5.2 mp -104.24 107.9 19.02 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 9.0 mtmp? -82.31 112.02 18.91 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 64.1 m-85 -90.37 164.88 14.15 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 56.3 m -153.97 179.45 8.9 Favored 'General case' 0 N--CA 1.402 -2.869 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 89.4 m -120.22 177.44 5.01 Favored 'General case' 0 C--N 1.26 -3.31 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.561 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 33.0 mmmt -58.17 164.12 3.86 Favored Pre-proline 0 C--N 1.316 -0.89 0 C-N-CA 123.819 0.847 . . . . 0.0 111.676 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 74.3 Cg_exo -47.69 -42.0 30.39 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 124.356 3.37 . . . . 0.0 114.818 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.8 -0.23 62.4 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.513 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -102.93 151.85 21.99 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-O 121.975 0.893 . . . . 0.0 112.545 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.556 HG21 HG11 ' A' ' 627' ' ' VAL . 54.1 m -108.2 128.74 54.98 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.108 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.451 HD11 ' HG3' ' A' ' 621' ' ' PRO . 11.3 tt -80.08 123.39 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 173.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.782 HG21 ' HD3' ' A' ' 624' ' ' LYS . 53.2 t -114.47 118.57 58.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 120.945 0.403 . . . . 0.0 110.61 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 116.23 -156.43 15.64 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.58 124.95 13.54 Favored 'Trans proline' 0 C--O 1.221 -0.352 0 C-N-CA 123.2 2.6 . . . . 0.0 110.989 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.465 HD22 ' N ' ' A' ' 607' ' ' ASN . 0.6 OUTLIER -85.38 -45.66 11.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.577 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 35.5 p -100.1 119.73 38.76 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . 0.407 ' C ' HE21 ' A' ' 610' ' ' GLN . 18.2 m -115.22 155.02 16.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.569 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -100.74 155.62 17.8 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.361 0.601 . . . . 0.0 109.893 178.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 8.3 t -88.05 125.26 34.46 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.64 168.88 9.49 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.66 3.07 6.85 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.003 0.82 . . . . 0.0 111.972 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -115.93 2.15 13.47 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.825 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 125.69 -174.11 17.61 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.973 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.475 HD23 ' HD3' ' A' ' 572' ' ' PRO . 2.8 mm? -77.81 125.33 29.17 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 618' ' ' PRO . 50.4 m -145.58 152.86 50.3 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.409 ' O ' ' HA ' ' A' ' 617' ' ' SER . 73.0 Cg_endo -72.26 -165.48 3.54 Favored 'Cis proline' 0 N--CA 1.486 1.079 0 CA-C-N 119.764 0.952 . . . . 0.0 114.554 4.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -55.24 137.62 46.9 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.107 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.639 HD23 HG22 ' A' ' 574' ' ' ILE . 5.7 mp -72.61 147.66 89.64 Favored Pre-proline 0 C--N 1.287 -2.116 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.431 -173.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.509 ' HG2' HD11 ' A' ' 578' ' ' LEU . 72.1 Cg_endo -73.36 178.98 5.94 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 123.103 2.535 . . . . 0.0 113.479 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 45.3 pt -127.37 171.34 15.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 96.8 m -115.77 114.67 25.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.967 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.782 ' HD3' HG21 ' A' ' 604' ' ' VAL . 27.3 mtpp -108.89 120.45 42.55 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.682 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -84.34 -24.42 29.78 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -108.78 116.76 32.6 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.029 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 602' ' ' THR . 4.8 m -129.59 -178.56 2.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.317 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -97.22 179.44 4.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.554 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 20.0 m -115.73 -7.15 12.12 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.144 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 66.5 m 72.1 -28.78 0.19 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 83.08 -147.73 24.97 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.9 142.79 39.65 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.984 1.789 . . . . 0.0 110.727 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.538 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 72.2 Cg_endo -73.6 168.79 23.88 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 123.189 2.593 . . . . 0.0 112.095 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.66 -179.3 3.63 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 122.695 2.263 . . . . 0.0 111.846 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -100.81 156.27 17.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.727 HD22 ' HB3' ' A' ' 657' ' ' TYR . 14.8 tp -87.88 150.47 23.48 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 683' ' ' VAL . 0.0 OUTLIER -57.89 -54.25 49.0 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.494 ' HB2' HD22 ' A' ' 637' ' ' LEU . 5.3 m-80 -130.17 41.49 3.4 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 122.34 1.067 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -161.57 -156.82 8.51 Favored Glycine 0 N--CA 1.411 -2.988 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . 0.557 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.6 t-20 -153.12 -176.37 5.75 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.432 HG11 ' CG2' ' A' ' 645' ' ' THR . 7.6 p -95.57 136.18 27.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -89.6 -24.61 21.65 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.895 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -79.07 163.29 25.25 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.394 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -84.01 115.17 22.2 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.432 ' CG2' HG11 ' A' ' 641' ' ' VAL . 12.2 p -69.22 97.43 0.93 Allowed 'General case' 0 N--CA 1.413 -2.285 0 O-C-N 124.177 0.923 . . . . 0.0 112.3 -177.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 48.9 pttt -76.22 160.19 29.93 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.57 -7.0 58.73 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.4 0.619 . . . . 0.0 111.298 -171.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -141.06 105.46 4.85 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.555 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 6.9 m-85 -85.69 -76.31 0.34 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 124.46 163.92 11.8 Favored Glycine 0 C--N 1.284 -2.343 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.158 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.451 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.2 t60 -66.79 142.94 57.19 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.258 5.9 p 62.78 9.74 3.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.889 1.276 . . . . 0.0 114.259 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.453 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 4.2 tp10 -87.58 116.66 25.85 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.618 ' CG2' ' HB2' ' A' ' 670' ' ' LYS . 4.1 p -92.1 152.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.823 0.82 . . . . 0.0 111.22 -176.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 26.9 m -122.27 113.31 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.58 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.691 175.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.538 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 21.7 mt-10 -76.85 131.34 38.58 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.681 0.753 . . . . 0.0 111.6 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.727 ' HB3' HD22 ' A' ' 636' ' ' LEU . 56.6 m-85 -111.36 160.76 16.76 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 125.106 1.362 . . . . 0.0 111.389 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.557 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 10.5 p90 -145.03 134.51 23.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.625 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 27.9 m -100.3 171.34 7.84 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.392 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -60.07 154.23 51.58 Favored Pre-proline 0 C--N 1.314 -0.967 0 O-C-N 124.184 0.927 . . . . 0.0 110.917 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.15 35.69 0.35 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 124.308 3.339 . . . . 0.0 112.864 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -136.83 4.78 2.81 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.674 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 72.0 m-85 -136.23 156.98 47.89 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.1 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.73 ' HG ' ' HG2' ' A' ' 687' ' ' GLU . 80.4 mt -115.07 146.31 41.43 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.816 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -82.52 142.32 31.94 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 118.437 0.562 . . . . 0.0 110.295 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.569 ' HB3' HG23 ' A' ' 683' ' ' VAL . 2.0 tpmt? -92.56 -41.62 10.14 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.303 0.573 . . . . 0.0 109.736 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -116.32 -163.25 13.36 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.765 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.96 129.31 26.92 Favored 'Trans proline' 0 C--O 1.22 -0.402 0 C-N-CA 123.934 3.09 . . . . 0.0 110.51 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 9.5 p-10 -68.66 -14.21 62.87 Favored 'General case' 0 C--O 1.178 -2.696 0 CA-C-O 121.327 0.584 . . . . 0.0 111.534 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.618 ' HB2' ' CG2' ' A' ' 654' ' ' VAL . 12.1 ptmt -130.13 145.57 51.71 Favored 'General case' 0 C--N 1.25 -3.742 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -174.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.663 HD12 ' HB3' ' A' ' 678' ' ' TRP . 35.8 pt -135.22 145.6 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -121.54 148.54 44.35 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.386 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 12.9 t -72.42 113.59 9.62 Favored 'General case' 0 CA--C 1.468 -2.206 0 CA-C-O 122.381 1.086 . . . . 0.0 109.794 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . 0.451 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 44.2 t -105.65 111.58 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.811 0 CA-C-N 112.341 -2.209 . . . . 0.0 108.499 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.78 -75.97 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.619 1.168 . . . . 0.0 111.955 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -157.65 26.29 0.46 Allowed Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.3 143.81 32.96 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.663 ' HB3' HD12 ' A' ' 671' ' ' ILE . 92.4 m95 -87.85 161.48 17.49 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.577 0.626 . . . . 0.0 109.753 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 15.4 p -76.2 172.37 12.96 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.924 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 24.9 m -67.1 135.14 53.14 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.035 0.445 . . . . 0.0 110.931 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.6 ' CD2' HD13 ' A' ' 671' ' ' ILE . 50.9 mt -61.53 151.58 77.21 Favored Pre-proline 0 N--CA 1.42 -1.926 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.154 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.816 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 11.7 Cg_endo -53.25 -18.89 11.31 Favored 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 124.752 3.635 . . . . 0.0 115.362 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 666' ' ' LYS 0.25 16.9 m 41.89 91.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 174.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.674 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 4.3 p -87.33 150.38 23.89 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.58 150.74 34.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.648 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.67 135.83 25.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 O-C-N 123.778 0.673 . . . . 0.0 110.762 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . 0.73 ' HG2' ' HG ' ' A' ' 664' ' ' LEU . 42.2 mt-10 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.526 -0.75 . . . . 0.0 109.567 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.431 -1.422 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.686 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 55.8 m -86.11 147.79 25.99 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.1 0.476 . . . . 0.0 111.014 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 571' ' ' LEU . 45.9 tt0 -125.47 -8.36 6.9 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.636 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 63.2 tp 79.06 115.33 0.03 OUTLIER Pre-proline 0 C--O 1.244 0.778 0 C-N-CA 125.239 1.416 . . . . 0.0 110.068 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.521 ' HD2' HD12 ' A' ' 571' ' ' LEU . 69.7 Cg_endo -71.5 -168.31 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.668 2.246 . . . . 0.0 110.134 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 573' ' ' LYS . 32.2 mmtp -87.37 102.93 15.01 Favored 'General case' 0 N--CA 1.41 -2.452 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.728 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.758 HG22 HD23 ' A' ' 620' ' ' LEU . 36.4 pt -70.04 -170.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.973 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.91 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 7.9 t70 -70.75 155.57 40.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.42 -28.16 37.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 121.839 0.828 . . . . 0.0 109.412 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -96.65 6.49 48.61 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.275 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.91 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.8 tm? -97.3 144.07 27.44 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.413 ' N ' HD13 ' A' ' 578' ' ' LEU . 2.3 t -140.37 115.13 7.58 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -76.28 137.71 19.26 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.879 2.386 . . . . 0.0 112.731 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -55.97 -55.95 26.56 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.334 1.454 . . . . 0.0 111.423 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . 0.52 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 55.0 mmt-85 -59.07 -59.91 4.71 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.856 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 53.57 82.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.647 1.217 . . . . 0.0 111.068 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.504 ' HE3' ' HB3' ' A' ' 582' ' ' ARG . 15.4 ptpt -143.26 163.71 32.21 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.91 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.16 -57.09 14.31 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 123.837 0.71 . . . . 0.0 111.261 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.84 142.82 51.18 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.094 0.473 . . . . 0.0 110.041 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.686 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 95.0 m-85 -102.59 126.73 49.77 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.847 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -79.74 151.75 30.23 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.092 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 45.6 t -60.87 118.06 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 104.18 -5.76 45.95 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.447 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -69.01 129.47 40.03 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 17.8 m -97.26 118.9 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-O 122.509 1.147 . . . . 0.0 109.867 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.403 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 5.6 mp -95.49 96.87 9.37 Favored 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.615 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 57.2 mtmt -80.75 109.86 15.7 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.643 ' HB3' HD11 ' A' ' 578' ' ' LEU . 64.9 m-85 -92.26 162.72 14.18 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 16.9 t -158.26 176.46 12.44 Favored 'General case' 0 N--CA 1.393 -3.286 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 88.3 m -121.24 172.17 8.19 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 70.2 mmtt -53.8 159.95 2.38 Favored Pre-proline 0 C--N 1.319 -0.751 0 C-N-CA 124.024 0.929 . . . . 0.0 112.169 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 12.1 Cg_endo -69.27 109.55 2.24 Favored 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.036 1.824 . . . . 0.0 109.366 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 122.52 -17.33 8.37 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -101.07 157.75 16.53 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 122.128 0.966 . . . . 0.0 112.48 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.56 HG21 HG11 ' A' ' 627' ' ' VAL . 18.5 m -109.04 130.55 55.48 Favored 'General case' 0 N--CA 1.402 -2.869 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.777 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 11.2 tt -85.68 122.01 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.476 HG21 ' HD3' ' A' ' 624' ' ' LYS . 54.0 t -112.72 127.45 69.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 112.95 -166.35 12.13 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.11 126.54 17.37 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.988 2.459 . . . . 0.0 110.761 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -86.13 -38.27 17.91 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.745 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.603 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 34.4 p -114.64 111.27 21.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.995 0.426 . . . . 0.0 110.96 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.2 m -104.79 153.82 6.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.63 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -99.08 147.91 24.58 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.452 ' HA ' HD23 ' A' ' 616' ' ' LEU . 17.6 t -83.23 124.31 30.43 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 170.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.587 ' CD2' ' HB3' ' A' ' 617' ' ' SER . 91.7 m-85 -110.59 171.88 7.2 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.68 7.23 3.18 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -117.58 -9.04 10.87 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 133.07 -174.37 20.61 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 611' ' ' CYS . 91.4 mt -70.9 138.77 50.41 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 122.976 0.51 . . . . 0.0 111.377 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.587 ' HB3' ' CD2' ' A' ' 612' ' ' TYR . 44.7 t -152.55 141.41 14.12 Favored Pre-proline 0 N--CA 1.424 -1.773 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 617' ' ' SER . 60.4 Cg_endo -72.94 -172.01 9.15 Favored 'Cis proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.081 -1.633 . . . . 0.0 113.197 0.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.9 151.73 38.43 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.111 0.481 . . . . 0.0 111.255 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.758 HD23 HG22 ' A' ' 574' ' ' ILE . 6.1 mp -67.13 145.11 98.69 Favored Pre-proline 0 C--N 1.309 -1.169 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -170.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.68 175.21 8.33 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 123.93 3.087 . . . . 0.0 112.018 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 38.4 pt -127.53 174.05 11.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.6 m -121.89 122.32 39.14 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.956 0.408 . . . . 0.0 111.5 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.476 ' HD3' HG21 ' A' ' 604' ' ' VAL . 53.8 mtpt -119.58 125.74 49.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -82.97 -40.03 20.59 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 121.547 0.689 . . . . 0.0 109.715 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -102.05 100.25 10.49 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.879 0.847 . . . . 0.0 110.45 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 602' ' ' THR . 8.0 m -107.76 174.13 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.588 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -98.99 143.99 28.66 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.234 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 38.2 m -97.49 -2.17 42.52 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 98.5 m 74.33 -42.75 0.51 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.958 1.303 . . . . 0.0 113.646 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 105.33 -141.47 15.35 Favored Glycine 0 N--CA 1.417 -2.632 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.8 139.46 13.96 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.259 1.972 . . . . 0.0 110.83 174.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.579 ' HG3' HG11 ' A' ' 655' ' ' VAL . 57.6 Cg_endo -68.33 161.57 44.17 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 123.268 2.645 . . . . 0.0 112.707 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.86 176.45 6.06 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.915 2.41 . . . . 0.0 111.677 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.82 163.11 14.55 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 1.044 HD21 ' SG ' ' A' ' 659' ' ' CYS . 9.1 tp -90.27 156.69 18.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 637' ' ' LEU 0.285 2.1 pt? -77.05 -45.46 27.06 Favored 'General case' 0 N--CA 1.406 -2.672 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.495 -178.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.488 HD22 ' HG ' ' A' ' 637' ' ' LEU . 42.5 m-80 -125.64 33.77 5.04 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.558 0.694 . . . . 0.0 110.904 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.775 ' HA3' HD23 ' A' ' 636' ' ' LEU . . . -160.75 -140.76 2.96 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.556 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.87 -169.82 2.96 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.0 p -102.97 132.43 49.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.645 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.9 ptmt -87.22 -13.83 42.76 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.831 0.824 . . . . 0.0 110.256 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.402 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 40.0 mm-40 -88.58 140.39 29.51 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.843 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . 0.764 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -55.8 121.34 9.0 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 124.161 0.913 . . . . 0.0 108.631 171.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.41 HG21 HG11 ' A' ' 641' ' ' VAL . 3.7 p -94.67 99.67 11.74 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 53.4 pttt -82.99 167.5 17.88 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.322 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -88.78 1.81 54.59 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . 0.61 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 34.3 tt0 -151.73 108.4 3.49 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.487 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 4.9 m-85 -84.55 -93.93 0.07 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 151.78 159.79 9.13 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 54.3 t60 -51.61 -59.14 4.6 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 37.2 m -91.67 21.08 4.95 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.364 0.602 . . . . 0.0 110.691 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -104.03 113.37 26.86 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 670' ' ' LYS . 8.8 p -94.17 159.47 2.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.868 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.7 t -124.07 114.05 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.879 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.645 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 21.7 mt-10 -71.88 128.43 35.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.489 0.661 . . . . 0.0 111.876 174.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 42.0 m-85 -109.33 170.66 7.91 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 123.58 0.752 . . . . 0.0 110.799 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -148.48 132.2 16.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 1.044 ' SG ' HD21 ' A' ' 636' ' ' LEU . 95.9 m -97.1 172.62 7.72 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.948 176.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -64.9 152.95 89.64 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.003 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.27 35.42 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 124.554 3.503 . . . . 0.0 113.652 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.57 13.48 0.83 Allowed 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.349 -174.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.33 156.56 48.25 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.874 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.449 HD21 ' HG3' ' A' ' 687' ' ' GLU . 83.6 mt -101.07 143.45 31.17 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.716 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 2.5 ttt -107.57 108.88 20.37 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -78.7 -57.82 3.56 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.251 -173.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.24 -174.31 47.56 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.795 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.12 126.38 21.41 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 123.68 2.92 . . . . 0.0 110.868 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.664 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 16.3 p-10 -66.91 -13.05 61.33 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-O 121.026 0.441 . . . . 0.0 110.842 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 16.0 mtpt -118.48 151.38 37.93 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 38.0 pt -138.54 141.43 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.87 151.69 39.34 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.918 0.39 . . . . 0.0 111.073 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 19.0 t -81.73 99.73 9.11 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.752 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . 0.278 20.1 m -88.63 75.89 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 O-C-N 120.541 -1.349 . . . . 0.0 112.064 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.1 t70 63.85 66.17 0.67 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.642 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 88.34 -20.21 31.52 Favored Glycine 0 C--N 1.311 -0.846 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.173 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -118.01 113.91 22.36 Favored 'General case' 0 N--CA 1.423 -1.803 0 O-C-N 122.201 -0.588 . . . . 0.0 111.857 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.401 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.9 m95 -65.88 151.63 46.29 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 20.1 p -77.55 173.59 11.84 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.04 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 6.3 m -62.89 128.43 35.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.154 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.09 161.52 39.04 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.392 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.664 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 20.2 Cg_endo -62.6 -17.81 60.43 Favored 'Trans proline' 0 CA--C 1.507 -0.827 0 C-N-CA 123.416 2.744 . . . . 0.0 115.04 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.487 ' HA ' HD21 ' A' ' 637' ' ' LEU 0.258 30.3 m 41.58 94.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 175.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.716 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 69.9 m -92.84 154.95 17.94 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 685' ' ' ILE . 0.1 OUTLIER -140.17 152.46 21.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.609 -177.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.95 136.77 19.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . 0.449 ' HG3' HD21 ' A' ' 664' ' ' LEU . 29.0 tt0 . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 586' ' ' GLN . 13.2 pt-20 . . . . . 0 N--CA 1.428 -1.533 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.719 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 71.6 m -62.88 115.76 4.66 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 124.742 1.217 . . . . 0.0 113.201 -174.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.51 -12.85 58.69 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.505 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 41.7 tp 73.17 113.61 0.03 OUTLIER Pre-proline 0 CA--C 1.514 -0.442 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.078 -176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.453 ' HD2' HD12 ' A' ' 616' ' ' LEU . 44.3 Cg_endo -67.94 174.25 8.06 Favored 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.33 2.02 . . . . 0.0 111.052 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . 0.595 ' HD2' ' H ' ' A' ' 573' ' ' LYS 0.299 0.0 OUTLIER -73.68 102.2 3.87 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.47 177.217 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.579 HG22 HD23 ' A' ' 620' ' ' LEU . 40.7 pt -70.91 -171.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.671 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.9 t70 -72.93 146.35 46.15 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.69 -33.82 50.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.722 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -92.43 6.21 47.87 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.064 -0.398 . . . . 0.0 111.624 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.638 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.4 OUTLIER -101.64 150.11 23.44 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -176.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 9.7 m -143.79 121.83 6.94 Favored Pre-proline 0 C--N 1.306 -1.302 0 C-N-CA 123.932 0.893 . . . . 0.0 110.118 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 595' ' ' PHE . 26.2 Cg_endo -72.83 142.73 35.81 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.378 1.385 . . . . 0.0 109.398 171.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.69 -33.72 68.67 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.552 0.691 . . . . 0.0 110.301 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . 0.499 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 75.5 mmt-85 -75.33 -70.16 0.44 Allowed 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.133 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . 0.442 ' HB2' ' HG2' ' A' ' 580' ' ' PRO 0.296 53.0 tttp 52.29 79.67 0.11 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.768 -170.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.578 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 18.1 ptpt -129.23 164.34 23.67 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.437 -1.711 . . . . 0.0 106.475 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -65.28 -48.32 73.61 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . 0.546 ' HB3' ' HG3' ' A' ' 568' ' ' GLU . 0.0 OUTLIER -131.67 143.44 50.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.153 0.501 . . . . 0.0 110.408 176.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.719 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 76.9 m-85 -107.72 121.1 44.02 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 124.025 0.93 . . . . 0.0 109.145 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -66.0 144.53 56.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 60.4 t -55.03 120.65 2.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 109.59 -13.83 32.67 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.887 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -71.49 123.74 23.08 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 10.0 p -94.35 134.45 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.537 0 C-N-CA 119.419 -0.912 . . . . 0.0 108.834 174.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 608' ' ' SER . 3.4 mp -108.04 117.47 34.23 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.561 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 57.1 mttp -94.48 103.32 15.29 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.458 ' HB3' HD21 ' A' ' 578' ' ' LEU . 64.3 m-85 -78.29 152.6 32.38 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 22.6 t -148.95 161.28 42.2 Favored 'General case' 0 N--CA 1.391 -3.376 0 N-CA-C 103.36 -2.83 . . . . 0.0 103.36 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 90.7 m -107.41 177.88 4.71 Favored 'General case' 0 C--N 1.25 -3.721 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 36.7 mmtm -56.12 161.34 3.84 Favored Pre-proline 0 N--CA 1.441 -0.891 0 C-N-CA 123.086 0.554 . . . . 0.0 111.209 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 93.1 Cg_exo -43.39 -47.26 9.22 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 124.337 3.358 . . . . 0.0 114.475 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -91.41 4.1 79.83 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 121.173 -0.536 . . . . 0.0 112.584 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -108.25 137.09 46.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 121.893 0.854 . . . . 0.0 112.927 -176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 627' ' ' VAL . 20.5 m -93.65 131.87 38.53 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.723 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.479 HD11 ' HG3' ' A' ' 621' ' ' PRO . 11.9 tt -82.39 122.02 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.424 ' HB ' HG13 ' A' ' 622' ' ' ILE . 59.3 t -110.58 108.96 26.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 128.04 -162.4 21.84 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.53 131.0 26.53 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 123.096 2.531 . . . . 0.0 110.928 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.413 HD22 ' N ' ' A' ' 607' ' ' ASN . 0.7 OUTLIER -89.87 -47.86 7.61 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.561 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 62.0 p -106.25 102.62 12.01 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.729 0.776 . . . . 0.0 111.698 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 14.0 m -108.09 140.32 27.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.658 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -85.45 149.11 25.63 Favored 'General case' 0 CA--C 1.486 -1.509 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.38 178.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.468 ' HA ' HD23 ' A' ' 616' ' ' LEU . 35.0 t -78.47 124.97 28.72 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 114.733 -1.122 . . . . 0.0 108.362 169.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 93.3 m-85 -112.22 171.02 7.76 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.33 -6.4 18.52 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -114.27 -0.25 13.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.285 0.564 . . . . 0.0 110.543 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 129.14 -175.17 18.97 Favored Glycine 0 N--CA 1.425 -2.071 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.721 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 611' ' ' CYS . 87.9 mt -70.04 131.22 44.01 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.442 0.297 . . . . 0.0 110.64 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.464 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 73.2 m -149.28 143.71 17.21 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 177.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 617' ' ' SER . 59.2 Cg_endo -69.1 -169.63 4.88 Favored 'Cis proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.123 -1.199 . . . . 0.0 113.95 0.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.7 151.66 37.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.828 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.579 HD23 HG22 ' A' ' 574' ' ' ILE . 6.4 mp -71.86 143.71 87.11 Favored Pre-proline 0 C--N 1.289 -2.047 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.157 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.479 ' HG3' HD11 ' A' ' 603' ' ' ILE . 98.3 Cg_endo -76.02 179.55 6.2 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.965 3.11 . . . . 0.0 112.917 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . 0.424 HG13 ' HB ' ' A' ' 604' ' ' VAL . 46.3 pt -126.27 177.16 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.084 176.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.541 ' SG ' HD12 ' A' ' 578' ' ' LEU . 94.4 m -121.11 115.55 23.31 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 123.424 0.689 . . . . 0.0 110.748 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.582 ' O ' ' HB ' ' A' ' 602' ' ' THR . 43.4 mtmt -121.87 128.53 51.71 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.978 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.25 -41.47 25.02 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -98.13 112.81 24.64 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.183 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 602' ' ' THR . 1.4 m -120.83 178.1 2.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 124.535 1.134 . . . . 0.0 108.349 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.464 ' NE2' ' HA3' ' A' ' 676' ' ' GLY . 21.2 mt-30 -97.59 167.02 11.23 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 14.0 m -105.05 -15.23 15.15 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.673 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 86.0 m 73.35 7.63 5.2 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.457 1.103 . . . . 0.0 113.052 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 57.65 -136.61 50.57 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.765 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.77 153.58 22.93 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.824 2.349 . . . . 0.0 110.991 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.569 ' HG3' HG11 ' A' ' 655' ' ' VAL . 73.7 Cg_endo -79.42 166.75 21.94 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.302 2.001 . . . . 0.0 111.014 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.38 -166.68 0.28 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.399 2.066 . . . . 0.0 110.626 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -113.19 170.78 7.97 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.527 HD23 ' HA3' ' A' ' 639' ' ' GLY . 17.0 tp -85.41 164.05 18.14 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.439 ' H ' HD12 ' A' ' 637' ' ' LEU . 4.8 mp -56.94 -71.65 0.09 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.083 0.944 . . . . 0.0 110.308 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -105.3 -27.1 11.72 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.764 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.632 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -86.2 -150.08 14.89 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.699 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . 0.416 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.4 t-20 -155.1 -171.28 3.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.655 HG22 ' CE2' ' A' ' 657' ' ' TYR . 18.6 t -96.4 127.65 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.729 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -87.64 -21.85 25.06 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.386 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -75.72 169.47 18.06 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.22 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -88.6 131.62 34.88 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.659 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 24.5 p -87.65 118.18 26.97 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.402 0.62 . . . . 0.0 112.222 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -84.6 167.96 15.79 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.417 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 45.2 mt-10 -94.35 -10.14 33.59 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -151.56 101.72 2.82 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.39 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.56 ' CE2' HG22 ' A' ' 655' ' ' VAL . 6.7 m-85 -80.66 -85.74 0.09 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 139.05 160.93 8.54 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.3 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.541 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 60.5 t60 -62.54 130.6 45.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 39.5 m 69.6 10.24 7.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.67 1.188 . . . . 0.0 113.508 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 7.6 tp10 -88.7 120.71 30.34 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 19.7 m -91.25 160.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-O 122.307 1.051 . . . . 0.0 113.622 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 4.5 t -132.53 112.18 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-N 113.657 -1.61 . . . . 0.0 108.227 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 669' ' ' ASN . 32.5 mt-10 -73.43 135.66 44.18 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.249 1.023 . . . . 0.0 113.226 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.655 ' CE2' HG22 ' A' ' 641' ' ' VAL . 72.3 m-85 -114.75 172.56 6.96 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 126.441 1.896 . . . . 0.0 109.559 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 6.2 p90 -155.42 143.76 20.23 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.632 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.8 t -112.85 174.26 5.98 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.237 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 46.8 m-80 -64.9 155.96 81.45 Favored Pre-proline 0 C--N 1.317 -0.815 0 O-C-N 123.395 0.435 . . . . 0.0 110.378 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 70.5 Cg_endo -73.16 42.91 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 124.181 3.254 . . . . 0.0 113.39 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 662' ' ' ARG . 2.5 ptt180 -151.25 11.15 0.61 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 124.038 0.935 . . . . 0.0 110.473 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.436 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 89.3 m-85 -128.66 152.13 48.73 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.786 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 77.9 mt -101.35 142.04 33.34 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 2.5 ttt -108.71 102.41 11.46 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -79.07 -51.81 9.05 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.262 -170.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.5 -163.42 38.47 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.448 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 670' ' ' LYS . 63.4 Cg_endo -73.33 120.1 6.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.882 2.388 . . . . 0.0 111.387 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 656' ' ' GLU . 3.3 p-10 -81.33 28.18 0.39 Allowed 'General case' 0 C--O 1.19 -2.044 0 O-C-N 121.991 -0.443 . . . . 0.0 111.416 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.783 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 7.7 ptmt -164.04 108.7 1.0 Allowed 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 125.549 1.54 . . . . 0.0 108.336 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.661 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 38.7 pt -109.15 152.6 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.763 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.753 -173.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 9.7 pt20 -119.07 160.32 22.27 Favored 'General case' 0 N--CA 1.421 -1.919 0 O-C-N 124.094 0.871 . . . . 0.0 110.323 -174.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.5 t -87.17 112.06 21.59 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.399 1.095 . . . . 0.0 110.828 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 84.8 t -103.51 107.04 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.777 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.541 ' H ' ' CE1' ' A' ' 651' ' ' HIS . 25.3 t70 65.1 -69.29 0.1 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 126.456 1.902 . . . . 0.0 111.744 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.464 ' HA3' ' NE2' ' A' ' 628' ' ' GLN . . . -158.16 21.54 0.36 Allowed Glycine 0 N--CA 1.422 -2.252 0 O-C-N 123.831 0.707 . . . . 0.0 111.472 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -136.55 149.74 48.26 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.525 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.4 m95 -83.0 161.22 21.81 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 11.9 p -81.85 175.32 10.51 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 120.875 0.369 . . . . 0.0 111.715 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 28.4 m -58.39 125.73 24.55 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.835 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.446 ' HA ' HG21 ' A' ' 671' ' ' ILE . 6.4 mp -62.34 165.16 9.39 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.554 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.606 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 19.8 Cg_endo -63.32 -21.51 71.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.343 2.029 . . . . 0.0 113.13 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 61.8 t 50.0 96.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.564 1.146 . . . . 0.0 112.376 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 22.5 p -97.21 133.32 41.99 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.235 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.56 147.72 32.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.195 -176.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 47.6 t -55.78 135.35 19.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 O-C-N 123.81 0.694 . . . . 0.0 110.628 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.437 -1.115 0 O-C-N 124.381 1.05 . . . . 0.0 108.828 178.826 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 586' ' ' GLN . 21.3 mt-10 . . . . . 0 C--O 1.245 0.828 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 20.1 m -63.45 -54.1 41.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.713 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 586' ' ' GLN . 39.3 tt0 70.05 130.2 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 125.4 1.48 . . . . 0.0 111.363 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.7 tt -66.01 119.88 64.9 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.474 ' HG2' HD11 ' A' ' 620' ' ' LEU . 72.3 Cg_endo -75.6 178.35 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.026 1.817 . . . . 0.0 111.111 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 573' ' ' LYS . 0.0 OUTLIER -78.37 103.83 8.56 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.416 0.627 . . . . 0.0 109.501 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.693 ' HA ' ' HG ' ' A' ' 620' ' ' LEU . 19.8 pt -75.27 -169.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.121 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.966 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.6 t70 -72.66 154.9 40.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.38 -30.03 45.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.262 0.553 . . . . 0.0 110.759 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -108.38 12.57 26.21 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.966 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.7 OUTLIER -92.82 153.69 18.71 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.511 ' N ' HD13 ' A' ' 578' ' ' LEU . 10.7 t -139.68 121.74 9.98 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.61 ' HD3' HD13 ' A' ' 574' ' ' ILE . 59.9 Cg_endo -80.35 138.32 12.38 Favored 'Trans proline' 0 N--CA 1.431 -2.169 0 C-N-CA 122.09 1.86 . . . . 0.0 111.645 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -65.41 -41.94 93.08 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 125.677 1.591 . . . . 0.0 112.074 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 26.9 mmt-85 -67.49 -65.77 0.65 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 64.8 74.13 0.4 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.691 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -142.7 146.27 34.22 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.77 -47.64 82.61 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -120.18 145.92 46.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.388 0.614 . . . . 0.0 111.527 179.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.659 ' CZ ' ' HG ' ' A' ' 593' ' ' LEU . 96.7 m-85 -116.64 160.62 20.44 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.893 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 591' ' ' GLU . 52.7 mtpt -94.65 152.88 18.13 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.478 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 14.6 m -63.98 137.52 24.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.333 173.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 91.38 -12.91 67.9 Favored Glycine 0 C--N 1.292 -1.903 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.874 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 588' ' ' LYS . 0.7 OUTLIER -66.37 137.68 57.06 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.589 HG12 ' HG3' ' A' ' 610' ' ' GLN . 20.0 m -110.25 128.26 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.618 0 CA-C-O 121.645 0.736 . . . . 0.0 109.252 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.659 ' HG ' ' CZ ' ' A' ' 587' ' ' TYR 0.4 0.0 OUTLIER -114.47 102.66 10.29 Favored 'General case' 0 N--CA 1.383 -3.806 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.427 176.516 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 35.4 mtmm -71.67 146.26 48.36 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 113.547 -1.661 . . . . 0.0 107.787 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.826 ' HB3' HD11 ' A' ' 578' ' ' LEU . 42.7 m-85 -125.17 171.12 10.58 Favored 'General case' 0 C--N 1.262 -3.234 0 CA-C-O 120.836 0.351 . . . . 0.0 111.491 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . 0.412 ' HA ' HD12 ' A' ' 603' ' ' ILE . 23.1 t -171.68 -176.79 1.85 Allowed 'General case' 0 N--CA 1.41 -2.426 0 O-C-N 124.757 1.286 . . . . 0.0 107.585 166.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 84.9 m -114.05 162.0 17.01 Favored 'General case' 0 C--N 1.263 -3.179 0 O-C-N 123.607 0.567 . . . . 0.0 112.184 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 32.8 mmtp -52.25 160.64 1.2 Allowed Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 125.457 1.503 . . . . 0.0 113.241 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 37.9 Cg_exo -55.93 112.88 1.2 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.415 2.743 . . . . 0.0 110.576 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 121.93 -27.58 6.14 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.014 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -100.24 163.0 12.6 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-O 122.179 0.99 . . . . 0.0 112.672 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.42 HG23 ' CD2' ' A' ' 651' ' ' HIS . 19.3 m -119.76 130.47 54.98 Favored 'General case' 0 N--CA 1.394 -3.264 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.563 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.496 HD11 ' HG3' ' A' ' 621' ' ' PRO . 7.1 tt -82.19 130.39 35.86 Favored 'Isoleucine or valine' 0 C--O 1.256 1.406 0 CA-C-O 121.009 0.433 . . . . 0.0 109.991 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.468 HG21 ' HG3' ' A' ' 624' ' ' LYS . 93.0 t -126.95 131.2 71.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.11 -156.01 15.84 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -67.4 111.81 2.41 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.502 2.135 . . . . 0.0 111.306 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 6.0 m120 -87.2 -12.67 46.12 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.341 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.564 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 9.9 p -146.81 102.79 3.57 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.96 0.41 . . . . 0.0 110.68 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 592' ' ' VAL . 23.8 m -96.95 162.04 2.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.254 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.589 ' HG3' HG12 ' A' ' 592' ' ' VAL . 1.8 mp0 -112.35 153.5 27.16 Favored 'General case' 0 CA--C 1.483 -1.63 0 CA-C-O 121.001 0.429 . . . . 0.0 110.214 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 589' ' ' VAL . 41.0 t -83.97 130.65 34.88 Favored 'General case' 0 N--CA 1.415 -2.221 0 C-N-CA 118.146 -1.421 . . . . 0.0 107.393 166.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 83.8 m-85 -114.24 170.34 8.37 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -64.51 -14.16 55.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -106.84 0.25 23.86 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.669 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.08 -176.31 19.36 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.945 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.407 HD12 HD11 ' A' ' 593' ' ' LEU . 3.0 mm? -74.26 124.81 27.11 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.425 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 68.3 m -147.07 144.94 20.56 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 122.084 -0.385 . . . . 0.0 111.7 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 617' ' ' SER . 48.1 Cg_endo -70.04 -168.77 4.76 Favored 'Cis proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.788 -1.338 . . . . 0.0 112.34 -2.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -80.15 -178.84 6.75 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.069 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.693 ' HG ' ' HA ' ' A' ' 574' ' ' ILE . 1.1 mm? -75.44 140.98 72.7 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -169.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.496 ' HG3' HD11 ' A' ' 603' ' ' ILE . 38.5 Cg_endo -67.9 175.39 6.47 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 124.43 3.42 . . . . 0.0 112.456 176.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.9 pt -114.0 173.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.533 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.0 m -117.79 115.58 25.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.185 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 626' ' ' GLN . 9.2 mmmm -105.4 120.32 41.29 Favored 'General case' 0 CA--C 1.474 -1.978 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.36 -30.12 33.86 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.336 -1.346 . . . . 0.0 107.872 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.475 ' O ' ' HE2' ' A' ' 624' ' ' LYS . 92.2 mt-30 -111.58 116.99 31.75 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.099 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.569 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 9.6 p -124.54 158.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 75.6 mm-40 -89.65 159.8 16.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 53.7 m -101.25 -3.16 29.48 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.515 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 73.2 m 69.42 12.45 8.28 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.309 1.044 . . . . 0.0 112.984 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 53.51 -136.5 40.05 Favored Glycine 0 N--CA 1.448 -0.558 0 O-C-N 123.79 0.681 . . . . 0.0 112.424 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.75 151.39 16.8 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.777 2.318 . . . . 0.0 110.703 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.553 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 63.3 Cg_endo -74.81 163.71 35.08 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.775 2.317 . . . . 0.0 112.788 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.448 ' HG2' HD11 ' A' ' 681' ' ' LEU . 55.3 Cg_endo -73.18 177.8 7.37 Favored 'Trans proline' 0 C--O 1.254 1.315 0 C-N-CA 122.734 2.29 . . . . 0.0 111.526 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -92.42 154.32 18.59 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.789 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 657' ' ' TYR . 20.8 tp -89.67 141.3 28.73 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -45.7 -41.84 11.01 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -176.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -129.19 -18.28 3.7 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -99.66 -142.92 13.66 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.795 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . 0.419 HD22 ' H ' ' A' ' 641' ' ' VAL . 0.6 OUTLIER -165.01 -177.12 4.47 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.423 HG22 ' CE1' ' A' ' 657' ' ' TYR . 39.5 t -84.45 132.52 31.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.644 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.3 ptmt -88.1 -16.71 32.77 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.715 0.769 . . . . 0.0 109.986 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.421 ' H ' HG12 ' A' ' 641' ' ' VAL . 6.7 mm-40 -81.7 165.37 21.05 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.604 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -78.14 111.41 14.03 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 23.1 p -64.82 116.33 6.21 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.587 0.708 . . . . 0.0 111.487 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -101.1 168.08 9.82 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.975 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.427 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 35.7 mt-10 -90.77 -13.78 33.28 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.609 0.718 . . . . 0.0 109.148 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -144.58 105.6 4.19 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.124 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.553 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.8 m-85 -87.02 -84.73 0.17 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.948 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 143.52 154.04 6.03 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.774 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.42 ' CD2' HG23 ' A' ' 602' ' ' THR . 49.2 t60 -60.19 131.12 49.81 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 50.2 m 76.69 -0.69 2.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.393 1.077 . . . . 0.0 113.533 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.427 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 7.3 tp10 -79.85 122.96 27.3 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.729 HG11 ' HE3' ' A' ' 670' ' ' LYS . 0.3 OUTLIER -92.06 151.55 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.725 0 CA-C-O 122.215 1.007 . . . . 0.0 110.606 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -114.02 102.69 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.97 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.646 167.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.644 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 4.0 mt-10 -69.27 138.7 54.1 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.544 ' HB3' HD22 ' A' ' 636' ' ' LEU . 40.5 m-85 -113.12 161.02 17.6 Favored 'General case' 0 C--N 1.259 -3.344 0 C-N-CA 124.964 1.306 . . . . 0.0 110.401 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -145.11 135.02 23.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.666 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.2 t -100.56 -178.95 3.95 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.284 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -63.14 155.79 71.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.63 26.69 0.35 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.627 2.884 . . . . 0.0 113.477 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 662' ' ' ARG . 16.1 mmm180 -129.63 -1.45 4.87 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -118.56 161.38 20.14 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.349 0.595 . . . . 0.0 112.151 -170.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.406 HD11 ' HG3' ' A' ' 687' ' ' GLU . 86.7 mt -124.4 149.0 47.19 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.628 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -92.25 149.47 21.43 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 176.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -108.83 -45.99 3.71 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.177 0.513 . . . . 0.0 109.689 174.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.77 -175.95 42.75 Favored Glycine 0 C--N 1.306 -1.133 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 682' ' ' PRO . 27.5 Cg_endo -62.0 124.58 14.7 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.134 2.556 . . . . 0.0 111.765 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.601 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 21.3 p-10 -73.67 31.77 0.08 Allowed 'General case' 0 C--O 1.188 -2.167 0 C-N-CA 123.393 0.677 . . . . 0.0 111.084 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.729 ' HE3' HG11 ' A' ' 654' ' ' VAL . 13.7 ptmt -172.32 138.26 0.93 Allowed 'General case' 0 C--N 1.258 -3.375 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -173.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.607 ' N ' HG22 ' A' ' 654' ' ' VAL . 37.3 pt -138.69 139.13 41.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.58 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -109.35 151.2 26.92 Favored 'General case' 0 C--N 1.27 -2.857 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.015 -178.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 3.6 t -69.3 118.07 11.73 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.198 0.999 . . . . 0.0 111.455 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 89.2 t -105.53 82.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.857 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.243 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.569 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 29.1 t70 80.6 -59.24 0.29 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 112.328 -2.215 . . . . 0.0 112.606 171.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -150.36 4.6 0.6 Allowed Glycine 0 C--N 1.292 -1.873 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.285 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.29 153.03 46.34 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.588 ' HB3' HD12 ' A' ' 671' ' ' ILE . 95.7 m95 -84.66 165.55 17.82 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . 0.459 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 2.1 p -86.61 -178.65 6.44 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 9.6 m -65.57 133.69 51.72 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.574 0.75 . . . . 0.0 110.101 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.448 HD11 ' HG2' ' A' ' 634' ' ' PRO . 8.3 mp -70.83 158.84 87.15 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.628 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 20.8 Cg_endo -61.44 -16.12 45.41 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 124.639 3.559 . . . . 0.0 115.617 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.263 26.9 m 45.24 90.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 18.5 p -92.85 144.96 24.76 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.147 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.69 150.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.029 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.34 140.46 19.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 O-C-N 123.409 0.443 . . . . 0.0 110.754 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . 0.406 ' HG3' HD11 ' A' ' 664' ' ' LEU . 43.6 tt0 . . . . . 0 C--O 1.248 1.012 0 C-N-CA 124.841 1.256 . . . . 0.0 110.759 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 586' ' ' GLN . 17.6 mm-40 . . . . . 0 N--CA 1.437 -1.085 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.688 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 3.1 m 33.73 -67.57 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 130.121 3.368 . . . . 0.0 115.995 -171.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 585' ' ' ASP . 54.3 mt-10 83.47 176.46 0.07 Allowed 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 128.635 2.774 . . . . 0.0 110.536 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.699 HD11 ' HG3' ' A' ' 580' ' ' PRO . 1.2 tt -119.59 105.83 43.05 Favored Pre-proline 0 N--CA 1.398 -3.038 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.697 ' HG2' HD11 ' A' ' 620' ' ' LEU . 36.7 Cg_endo -66.33 -176.97 0.74 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.885 2.39 . . . . 0.0 111.104 177.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -86.18 84.34 7.51 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.347 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.798 HG13 ' H ' ' A' ' 575' ' ' ASP . 6.8 pt -52.08 -65.68 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.853 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.798 ' H ' HG13 ' A' ' 574' ' ' ILE . 13.3 t70 -176.32 -168.55 0.26 Allowed 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.55 -22.66 4.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . 0.416 ' HD2' ' HD2' ' A' ' 598' ' ' LYS . 26.9 m80 -104.08 16.7 25.69 Favored 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.147 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.8 tt -115.21 143.36 45.36 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -176.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.39 121.55 7.09 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-O 121.188 0.518 . . . . 0.0 111.015 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.699 ' HG3' HD11 ' A' ' 571' ' ' LEU . 31.8 Cg_endo -69.29 142.01 48.77 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.835 2.357 . . . . 0.0 112.253 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.74 -48.98 22.75 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . 0.814 ' HD2' ' HE3' ' A' ' 584' ' ' LYS . 14.3 tpp180 -88.94 93.65 9.67 Favored 'General case' 0 N--CA 1.379 -3.979 0 N-CA-C 104.864 -2.272 . . . . 0.0 104.864 171.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -112.83 131.64 55.62 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.083 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.814 ' HE3' ' HD2' ' A' ' 582' ' ' ARG . 15.3 ptpt -163.3 -170.49 2.29 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 570' ' ' GLU . 9.2 m-20 -103.4 -39.46 6.77 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 119.332 0.969 . . . . 0.0 110.627 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . 0.562 ' HB3' ' HB2' ' A' ' 568' ' ' GLU . 0.0 OUTLIER -121.62 133.53 54.99 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.688 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 54.5 m-85 -105.59 170.26 8.0 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -172.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -100.87 151.96 21.1 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.3 122.21 16.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 97.58 0.68 59.2 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.251 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . 0.467 ' HG2' ' HD2' ' A' ' 587' ' ' TYR . 6.3 tp10 -74.11 129.42 37.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.565 HG22 ' HG3' ' A' ' 610' ' ' GLN . 14.1 t -100.74 115.5 42.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.441 0.639 . . . . 0.0 109.831 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 1.9 mp -95.88 94.05 7.4 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 608' ' ' SER . 0.0 OUTLIER -77.16 122.72 25.41 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 174.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 66.8 m-85 -94.93 177.83 5.77 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-O 121.473 0.654 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 19.9 p -167.3 169.54 12.36 Favored 'General case' 0 N--CA 1.403 -2.797 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 81.5 m -115.56 170.88 8.09 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.416 ' HD2' ' HD2' ' A' ' 577' ' ' HIS . 41.0 mttt -59.43 156.47 30.73 Favored Pre-proline 0 N--CA 1.432 -1.343 0 O-C-N 123.812 0.695 . . . . 0.0 112.748 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.32 110.1 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.475 2.783 . . . . 0.0 110.127 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 123.66 -23.23 6.74 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.492 ' CE1' ' HB2' ' A' ' 625' ' ' GLU . 79.3 m-85 -102.81 160.83 14.25 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 122.381 1.086 . . . . 0.0 113.281 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 627' ' ' VAL . 15.6 m -113.41 129.53 56.52 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.399 174.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.457 HD11 ' HG3' ' A' ' 621' ' ' PRO . 8.8 tt -79.57 121.84 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.843 HG21 ' HD3' ' A' ' 624' ' ' LYS . 91.4 t -117.5 123.44 71.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 122.037 -0.414 . . . . 0.0 110.122 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 122.03 -156.02 16.77 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.97 134.35 27.33 Favored 'Trans proline' 0 C--N 1.327 -0.6 0 C-N-CA 122.509 2.139 . . . . 0.0 110.096 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.431 HD22 ' N ' ' A' ' 607' ' ' ASN . 0.7 OUTLIER -97.74 -44.35 6.78 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.185 -177.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 594' ' ' LYS . 19.3 p -106.74 97.07 6.91 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.329 0.585 . . . . 0.0 112.013 -176.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . 0.494 ' HA ' ' HD2' ' A' ' 618' ' ' PRO . 9.4 m -95.31 147.8 5.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.673 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -102.12 152.33 21.13 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 16.3 t -83.99 116.71 22.96 Favored 'General case' 0 C--N 1.268 -2.956 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.001 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.505 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 90.7 m-85 -102.2 166.4 10.61 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -69.05 -13.52 62.49 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.324 0.583 . . . . 0.0 111.076 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -101.51 -1.49 32.91 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.748 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 136.34 178.28 15.65 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.26 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.66 121.69 19.26 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.505 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 56.5 m -146.35 147.11 29.96 Favored Pre-proline 0 C--N 1.316 -0.886 0 O-C-N 121.959 -0.463 . . . . 0.0 111.458 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.494 ' HD2' ' HA ' ' A' ' 609' ' ' VAL . 41.4 Cg_endo -67.06 -171.9 5.07 Favored 'Cis proline' 0 N--CA 1.488 1.149 0 C-N-CA 124.353 -1.103 . . . . 0.0 112.958 0.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.8 179.99 3.4 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.195 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.697 HD11 ' HG2' ' A' ' 572' ' ' PRO . 18.9 mt -92.52 147.39 34.23 Favored Pre-proline 0 C--N 1.278 -2.541 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -165.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.556 ' HG2' HD11 ' A' ' 578' ' ' LEU . 63.5 Cg_endo -73.82 -173.24 1.31 Allowed 'Trans proline' 0 C--O 1.253 1.249 0 C-N-CA 123.861 3.041 . . . . 0.0 112.076 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.49 173.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.932 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.2 m -117.05 107.47 14.56 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.303 0.573 . . . . 0.0 111.138 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.843 ' HD3' HG21 ' A' ' 604' ' ' VAL . 59.1 mtpt -109.19 126.34 53.16 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.492 ' HB2' ' CE1' ' A' ' 601' ' ' PHE . 26.8 tt0 -87.44 -35.29 18.35 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -175.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -107.5 112.67 25.54 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.611 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 602' ' ' THR . 6.7 m -121.21 166.13 16.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.128 -177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 15.7 mm100 -89.98 170.66 10.17 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.036 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.521 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 74.8 p -108.86 -19.1 13.52 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.387 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 95.4 m 73.7 4.89 4.81 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.884 1.273 . . . . 0.0 111.16 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 62.55 -137.78 44.84 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.94 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.17 156.69 37.93 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.903 2.402 . . . . 0.0 110.82 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.677 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 71.7 Cg_endo -78.77 160.77 27.69 Favored 'Trans proline' 0 N--CA 1.435 -1.956 0 C-N-CA 122.053 1.835 . . . . 0.0 111.222 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.23 -169.26 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.655 2.236 . . . . 0.0 112.763 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -103.31 157.6 16.9 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.51 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.634 HD23 ' HA3' ' A' ' 639' ' ' GLY . 15.7 tp -92.68 155.26 17.83 Favored 'General case' 0 CA--C 1.478 -1.825 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 637' ' ' LEU 0.285 2.0 pt? -66.93 -47.75 70.73 Favored 'General case' 0 N--CA 1.406 -2.653 0 C-N-CA 119.005 -1.078 . . . . 0.0 113.607 -178.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.616 ' HB2' ' SG ' ' A' ' 684' ' ' CYS . 89.9 m-20 -126.36 27.02 6.28 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.049 -173.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.732 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -160.08 -146.61 4.64 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.09 177.54 10.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.795 0.298 . . . . 0.0 111.054 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 655' ' ' VAL . 7.2 p -80.29 133.97 28.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -90.78 -23.93 20.49 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.338 0.59 . . . . 0.0 110.075 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.549 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 5.6 mm-40 -80.71 163.31 23.64 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.369 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . 0.596 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.1 OUTLIER -76.35 137.95 40.14 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 175.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.413 ' CG2' HG11 ' A' ' 641' ' ' VAL . 20.2 p -87.78 110.42 20.46 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.807 0.813 . . . . 0.0 112.804 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.55 ' HD2' ' HA ' ' A' ' 649' ' ' TYR . 52.1 mttm -72.74 158.19 36.06 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.76 -0.23 56.01 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -152.44 100.58 2.59 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.978 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.677 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 5.3 m-85 -80.44 -81.55 0.12 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 133.35 167.71 11.72 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.158 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 57.6 t60 -67.45 131.04 44.91 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 120.926 0.393 . . . . 0.0 110.284 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . 0.574 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 73.8 m 65.06 20.06 11.96 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.235 1.014 . . . . 0.0 112.43 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 5.6 tp10 -89.68 116.59 27.92 Favored 'General case' 0 CA--C 1.478 -1.812 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 16.2 m -89.47 155.77 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-O 122.152 0.977 . . . . 0.0 113.188 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.75 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 0.1 OUTLIER -129.3 117.38 43.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-N 112.823 -1.99 . . . . 0.0 109.502 177.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.604 ' HG2' ' HG2' ' A' ' 670' ' ' LYS . 59.1 mt-10 -81.01 130.2 34.9 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 122.389 1.09 . . . . 0.0 113.54 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.572 ' CE1' HG22 ' A' ' 655' ' ' VAL . 75.3 m-85 -108.81 157.91 18.15 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.679 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -134.88 138.55 44.24 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.732 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 26.1 t -105.65 168.69 8.93 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.552 ' HB2' ' CE1' ' A' ' 663' ' ' PHE . 32.0 m-80 -59.72 152.22 58.82 Favored Pre-proline 0 C--O 1.241 0.622 0 O-C-N 123.202 0.314 . . . . 0.0 110.795 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.2 36.12 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 124.343 3.362 . . . . 0.0 115.549 -170.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.75 11.47 0.66 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.561 0.696 . . . . 0.0 110.539 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 660' ' ' ASN . 73.6 m-85 -118.52 162.86 17.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.386 0.612 . . . . 0.0 110.964 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 96.8 mt -110.13 135.7 50.51 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.737 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.3 OUTLIER -100.64 108.88 20.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -75.77 -52.25 10.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.64 -172.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -101.8 -162.7 26.91 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.341 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.89 123.58 10.54 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.434 2.756 . . . . 0.0 112.761 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.474 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 23.0 p-10 -74.4 -7.14 51.92 Favored 'General case' 0 C--O 1.201 -1.5 0 O-C-N 122.1 -0.375 . . . . 0.0 111.503 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -122.88 118.86 28.87 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 42.3 pt -111.4 158.23 11.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 11.0 pt20 -125.15 154.91 40.76 Favored 'General case' 0 C--N 1.281 -2.396 0 O-C-N 123.43 0.456 . . . . 0.0 109.99 -174.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 8.2 t -84.81 110.85 19.12 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 123.119 1.438 . . . . 0.0 110.045 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 97.7 t -95.26 81.38 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.386 -3.67 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.821 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 628' ' ' GLN . 31.5 t70 80.96 -46.37 0.24 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.631 170.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -171.47 19.31 0.06 OUTLIER Glycine 0 C--N 1.298 -1.554 0 O-C-N 123.882 0.739 . . . . 0.0 111.513 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -143.42 143.9 31.8 Favored 'General case' 0 C--O 1.212 -0.879 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.521 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.0 m95 -87.12 153.77 21.26 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 3.7 p -72.1 167.34 20.45 Favored 'General case' 0 C--O 1.255 1.358 0 O-C-N 123.009 0.193 . . . . 0.0 111.399 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.0 m -62.86 129.23 39.52 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 682' ' ' PRO . 6.4 mp -60.19 163.78 7.64 Favored Pre-proline 0 N--CA 1.435 -1.223 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.945 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.737 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 19.5 Cg_endo -60.6 -24.33 78.07 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 122.777 2.318 . . . . 0.0 113.135 -176.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.421 ' HA ' HD21 ' A' ' 637' ' ' LEU . 58.8 t 52.62 92.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 122.175 0.988 . . . . 0.0 111.072 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 638' ' ' ASN . 27.8 p -98.97 134.51 41.72 Favored 'General case' 0 N--CA 1.411 -2.376 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.703 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.91 155.7 35.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.92 -174.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 64.4 t -59.84 129.09 21.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 123.866 0.729 . . . . 0.0 110.562 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.678 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 120.743 0.306 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 587' ' ' TYR . 81.3 m -78.25 140.42 38.88 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -110.01 136.54 49.12 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.6 tt -51.37 117.58 9.43 Favored Pre-proline 0 C--O 1.246 0.903 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.19 -179.34 1.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.723 2.282 . . . . 0.0 111.047 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -90.84 93.2 9.12 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 118.953 -1.099 . . . . 0.0 109.092 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.48 HG22 HD13 ' A' ' 620' ' ' LEU . 36.8 pt -75.78 -175.8 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.189 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.969 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.618 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.1 t70 -71.83 163.15 28.34 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.168 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.35 -30.01 17.1 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.262 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -94.23 4.21 54.2 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.814 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.618 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.8 OUTLIER -100.03 151.26 21.57 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.39 118.01 6.22 Favored Pre-proline 0 C--N 1.309 -1.181 0 C-N-CA 123.849 0.86 . . . . 0.0 110.603 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.51 ' HG3' HD11 ' A' ' 571' ' ' LEU . 40.7 Cg_endo -75.32 139.45 23.48 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.301 2.001 . . . . 0.0 111.566 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.9 -50.25 63.04 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 125.399 1.48 . . . . 0.0 112.202 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . 0.405 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 8.7 mpt_? -63.73 -46.45 85.33 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.135 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm 54.45 58.58 4.8 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 124.364 1.04 . . . . 0.0 109.882 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -121.98 160.17 25.44 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.79 -50.82 54.91 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.54 151.42 41.39 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.669 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 84.9 m-85 -121.53 119.26 31.45 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -71.1 152.69 43.21 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.561 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 58.1 t -55.91 116.26 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-O 121.19 0.519 . . . . 0.0 110.747 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 109.85 -2.99 30.32 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.594 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -76.29 136.98 39.61 Favored 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 122.34 -0.506 . . . . 0.0 110.953 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.586 HG12 ' HG3' ' A' ' 610' ' ' GLN . 12.0 m -101.81 133.28 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.863 0.84 . . . . 0.0 109.686 176.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.669 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.9 mp -105.41 89.96 3.27 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.557 ' HD2' ' HB3' ' A' ' 608' ' ' SER . 3.6 mmmp? -66.43 127.89 34.05 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -107.09 175.12 5.6 Favored 'General case' 0 C--N 1.267 -3.021 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.801 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 14.4 p -166.49 167.32 15.72 Favored 'General case' 0 N--CA 1.398 -3.041 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.508 ' SG ' HD12 ' A' ' 578' ' ' LEU . 98.8 m -114.69 -172.49 2.13 Favored 'General case' 0 C--N 1.259 -3.337 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -56.74 159.27 7.27 Favored Pre-proline 0 N--CA 1.429 -1.51 0 C-N-CA 123.94 0.896 . . . . 0.0 110.764 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.92 -37.93 47.32 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 124.209 3.273 . . . . 0.0 114.78 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -100.3 4.94 57.2 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.436 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 21.3 m-85 -106.35 141.07 38.28 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 121.605 0.717 . . . . 0.0 111.552 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.499 HG21 HG11 ' A' ' 627' ' ' VAL . 40.7 m -97.56 124.99 42.02 Favored 'General case' 0 N--CA 1.398 -3.073 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.89 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 7.2 tt -79.32 122.25 34.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.805 HG21 ' HD3' ' A' ' 624' ' ' LYS . 99.8 t -118.69 139.11 47.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 106.63 -149.3 16.59 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.9 112.74 3.61 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.321 2.014 . . . . 0.0 111.214 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.406 ' N ' HD22 ' A' ' 607' ' ' ASN . 0.7 OUTLIER -85.96 -1.52 57.4 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.614 -178.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.557 ' HB3' ' HD2' ' A' ' 594' ' ' LYS . 33.8 p -150.29 112.89 4.72 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.176 0.512 . . . . 0.0 110.64 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . 0.408 ' C ' HE21 ' A' ' 610' ' ' GLN . 16.8 m -109.25 149.8 12.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.664 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -102.61 157.6 16.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.271 0.558 . . . . 0.0 110.055 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.561 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 11.3 t -86.56 112.49 21.61 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 610' ' ' GLN . 85.3 m-85 -101.18 169.88 8.63 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -60.62 -18.28 52.24 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -106.78 -1.04 22.98 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.152 0.501 . . . . 0.0 111.608 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.37 -169.7 22.16 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.221 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 569' ' ' CYS . 2.6 mm? -75.14 122.81 24.17 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.439 ' HA ' ' C ' ' A' ' 618' ' ' PRO . 52.4 m -146.99 146.45 25.96 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 122.401 -0.187 . . . . 0.0 110.578 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 617' ' ' SER . 57.0 Cg_endo -69.5 -169.42 4.94 Favored 'Cis proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.057 -1.226 . . . . 0.0 112.804 0.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.72 172.72 10.19 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.469 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.48 HD13 HG22 ' A' ' 574' ' ' ILE . 38.8 mt -74.61 142.65 77.74 Favored Pre-proline 0 C--N 1.292 -1.922 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -169.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.3 176.98 7.16 Favored 'Trans proline' 0 C--O 1.258 1.479 0 C-N-CA 124.049 3.166 . . . . 0.0 111.475 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.1 pt -122.03 165.72 17.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.648 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.557 ' SG ' HD12 ' A' ' 578' ' ' LEU . 85.1 m -110.63 112.25 24.02 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.499 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.805 ' HD3' HG21 ' A' ' 604' ' ' VAL . 52.6 mtpt -108.84 110.46 21.82 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 23.2 tt0 -77.77 -31.65 52.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.24 104.71 17.24 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.333 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 602' ' ' THR . 3.7 m -129.83 175.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.088 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.401 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 1.9 mp0 -98.65 159.08 15.2 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.845 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 52.4 m -104.25 -9.16 18.81 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.364 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 678' ' ' TRP . 67.6 m 70.4 1.68 3.71 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.093 0.957 . . . . 0.0 113.514 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 62.99 -136.47 43.54 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -75.79 149.96 34.26 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 121.979 1.786 . . . . 0.0 110.658 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.55 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 78.4 Cg_endo -78.21 165.25 26.01 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.548 2.165 . . . . 0.0 111.013 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.464 ' HG2' HD11 ' A' ' 681' ' ' LEU . 33.0 Cg_endo -70.34 165.91 30.05 Favored 'Trans proline' 0 N--CA 1.435 -1.94 0 C-N-CA 121.408 1.405 . . . . 0.0 110.357 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.46 163.8 21.37 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.774 HD21 ' SG ' ' A' ' 659' ' ' CYS . 11.0 tp -83.33 174.42 10.71 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' A' ' 683' ' ' VAL 0.342 0.4 OUTLIER -73.85 -69.71 0.42 Allowed 'General case' 0 N--CA 1.393 -3.281 0 C-N-CA 118.027 -1.469 . . . . 0.0 112.935 -179.871 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -95.1 -33.19 12.76 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -84.33 -143.11 5.73 Favored Glycine 0 N--CA 1.434 -1.455 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.341 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.34 -172.69 3.67 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.627 HG22 ' CE2' ' A' ' 657' ' ' TYR . 20.5 t -95.87 133.08 38.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 176.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 658' ' ' TYR . 35.9 pttt -88.73 -26.35 21.82 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.977 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -78.55 151.91 32.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.389 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -67.08 115.08 6.38 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.534 0.683 . . . . 0.0 110.546 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.2 p -74.46 105.45 5.6 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.848 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.633 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 59.7 pttt -87.49 -177.67 5.96 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.77 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.07 -12.36 23.29 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -143.8 108.05 4.78 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.633 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 13.7 m-85 -85.92 -101.19 0.07 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 158.34 162.53 11.9 Favored Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 66.0 t60 -58.49 -52.43 65.67 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 40.0 m -92.53 11.91 24.78 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.177 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -96.57 116.61 29.38 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.482 0.658 . . . . 0.0 109.398 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.725 HG21 ' HE2' ' A' ' 670' ' ' LYS . 1.3 p -92.86 157.39 2.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.785 -177.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 23.9 m -123.7 111.65 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.56 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -74.39 119.61 18.83 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.798 0.809 . . . . 0.0 112.672 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.627 ' CE2' HG22 ' A' ' 641' ' ' VAL . 87.6 m-85 -100.46 173.44 6.57 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.781 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' A' ' 642' ' ' LYS . 29.0 p90 -151.22 137.34 18.32 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.774 ' SG ' HD21 ' A' ' 636' ' ' LEU . 68.0 m -96.91 177.07 5.74 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 662' ' ' ARG . 78.3 m-20 -85.91 157.45 57.32 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.4 24.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 124.504 3.47 . . . . 0.0 114.959 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.415 ' H ' ' C ' ' A' ' 660' ' ' ASN . 23.8 mmt180 -120.35 -6.99 9.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 662' ' ' ARG . 31.1 m-85 -131.72 156.77 45.33 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.87 -174.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 67.8 mt -105.99 166.5 10.45 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.65 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.7 OUTLIER -116.7 112.55 21.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.44 ' HB3' HG23 ' A' ' 683' ' ' VAL . 39.9 ttmt -81.94 -54.02 5.67 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.542 -174.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.13 -173.23 43.63 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.637 -176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.04 122.46 10.97 Favored 'Trans proline' 0 C--N 1.327 -0.557 0 C-N-CA 122.932 2.421 . . . . 0.0 111.141 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.717 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 21.2 p-10 -61.26 -14.66 27.87 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 122.872 0.469 . . . . 0.0 112.051 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.725 ' HE2' HG21 ' A' ' 654' ' ' VAL . 0.0 OUTLIER -128.5 149.22 50.68 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.588 HD12 ' HB3' ' A' ' 678' ' ' TRP . 47.0 pt -140.09 146.44 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -172.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.491 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.3 OUTLIER -114.01 157.0 23.06 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.228 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 11.7 t -80.35 96.56 6.71 Favored 'General case' 0 CA--C 1.472 -2.044 0 CA-C-O 123.197 1.475 . . . . 0.0 110.547 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.03 110.27 17.07 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.599 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.628 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 15.0 t70 59.22 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.616 1.166 . . . . 0.0 111.418 -171.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -153.7 23.47 0.73 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -134.32 131.07 37.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.588 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.8 m95 -76.4 149.89 36.86 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 7.8 p -83.5 178.75 7.87 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 11.7 m -57.32 122.95 13.76 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.712 0.805 . . . . 0.0 111.085 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.464 HD11 ' HG2' ' A' ' 634' ' ' PRO . 7.3 mp -63.97 163.67 21.77 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.717 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 20.1 Cg_endo -61.53 -15.17 39.66 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.876 3.051 . . . . 0.0 115.345 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.548 ' HA ' HD21 ' A' ' 637' ' ' LEU 0.297 28.7 m 50.7 101.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 177.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.687 ' SG ' HD21 ' A' ' 636' ' ' LEU . 12.9 m -78.29 132.54 37.52 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.441 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.427 HD12 ' HB2' ' A' ' 666' ' ' LYS . 0.2 OUTLIER -127.68 136.57 60.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.64 130.79 28.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 123.566 0.541 . . . . 0.0 111.218 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 C--O 1.252 1.22 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.223 -177.372 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . 0.47 ' HG3' HG23 ' A' ' 589' ' ' VAL . 17.8 tt0 . . . . . 0 N--CA 1.435 -1.224 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.475 ' HB3' HD21 ' A' ' 616' ' ' LEU . 57.6 m -111.34 153.41 26.04 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -167.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.812 ' HG2' ' HG3' ' A' ' 586' ' ' GLN . 49.0 mt-10 -128.77 146.76 50.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 166.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . . . . . . . . . 1.7 tt -53.48 115.13 7.2 Favored Pre-proline 0 C--O 1.245 0.837 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.19 -169.11 0.48 Allowed 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.511 2.141 . . . . 0.0 111.572 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -88.65 92.38 9.17 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 578' ' ' LEU . 37.2 pt -78.06 -170.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.658 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.649 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.4 t70 -77.61 147.4 35.64 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.12 -31.99 38.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 123.445 0.698 . . . . 0.0 111.044 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -98.54 14.63 27.66 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.081 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 5.5 tp -104.41 150.35 24.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.8 t -139.21 122.54 10.77 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.513 ' HG2' ' HA ' ' A' ' 583' ' ' LYS . 50.3 Cg_endo -78.74 144.67 19.65 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.813 2.342 . . . . 0.0 111.737 174.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 594' ' ' LYS . 7.2 t70 -51.86 -53.79 36.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.815 1.646 . . . . 0.0 111.212 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . 0.628 ' HG2' ' HE3' ' A' ' 584' ' ' LYS . 4.5 mpt_? -70.55 -59.86 2.6 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.025 0.44 . . . . 0.0 110.459 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . 0.513 ' HA ' ' HG2' ' A' ' 580' ' ' PRO . 50.2 tttm 60.14 62.29 1.65 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.163 -174.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.628 ' HE3' ' HG2' ' A' ' 582' ' ' ARG . 16.8 ptpt -118.44 160.29 21.97 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.29 -45.33 40.49 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . 0.812 ' HG3' ' HG2' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -118.07 126.98 53.33 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.619 0.247 . . . . 0.0 110.504 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.63 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 86.5 m-85 -100.73 132.51 46.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.675 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -78.09 148.92 34.0 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.496 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 60.0 t -58.65 119.1 2.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 106.04 -1.73 38.21 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.598 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -73.14 134.09 44.32 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 122.362 -0.493 . . . . 0.0 109.731 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.493 HG22 ' HG3' ' A' ' 610' ' ' GLN . 17.6 t -101.0 114.9 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.63 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.4 mp -91.71 92.49 8.45 Favored 'General case' 0 N--CA 1.405 -2.68 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 608' ' ' SER . 58.1 mttp -74.13 136.46 42.92 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 173.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -112.57 163.71 14.18 Favored 'General case' 0 C--N 1.266 -3.026 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.753 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 14.7 m -152.55 172.07 17.15 Favored 'General case' 0 N--CA 1.39 -3.471 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.539 ' SG ' HD12 ' A' ' 578' ' ' LEU . 69.8 m -108.83 178.43 4.48 Favored 'General case' 0 C--N 1.247 -3.862 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 71.0 mmtt -54.29 162.79 1.46 Allowed Pre-proline 0 C--N 1.313 -0.98 0 C-N-CA 124.154 0.982 . . . . 0.0 111.935 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 82.8 Cg_exo -44.58 -44.92 13.53 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.127 3.218 . . . . 0.0 114.358 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -100.09 18.33 55.81 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.822 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -120.11 147.66 44.59 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 121.759 0.79 . . . . 0.0 112.384 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.665 HG21 HG11 ' A' ' 627' ' ' VAL . 23.1 m -100.66 133.44 45.11 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.648 175.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.566 HD11 ' HG3' ' A' ' 621' ' ' PRO . 10.1 tt -88.25 129.35 39.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.891 HG21 ' HD3' ' A' ' 624' ' ' LYS . 75.4 t -121.93 123.48 69.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 123.62 -150.65 16.94 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -73.12 115.68 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.38 2.053 . . . . 0.0 111.209 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -92.31 7.69 41.7 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 594' ' ' LYS . 58.5 p -156.43 113.61 3.17 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.75 0.42 . . . . 0.0 110.01 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 13.7 m -118.1 151.96 20.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.578 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -101.27 154.35 18.85 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.449 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.496 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 6.6 t -85.0 112.67 20.81 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 169.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -104.22 170.17 8.06 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -77.88 14.61 1.05 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -125.81 -1.08 7.3 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 171.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.05 -175.36 19.83 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.926 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 569' ' ' CYS . 2.5 mm? -78.8 123.8 27.57 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 5.4 t -150.36 151.91 32.13 Favored Pre-proline 0 C--N 1.309 -1.184 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.616 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.507 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 58.7 Cg_endo -70.03 -178.2 16.64 Favored 'Cis proline' 0 C--N 1.361 1.235 0 C-N-CA 123.812 -1.328 . . . . 0.0 112.717 0.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.13 157.07 23.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.334 0.587 . . . . 0.0 111.103 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.506 HD13 HG22 ' A' ' 574' ' ' ILE . 22.6 mt -66.85 152.41 95.7 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 114.229 -1.35 . . . . 0.0 114.146 -168.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.566 ' HG3' HD11 ' A' ' 603' ' ' ILE . 92.8 Cg_endo -81.46 179.74 5.57 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.065 3.177 . . . . 0.0 111.633 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.6 pt -121.46 174.44 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.592 0.234 . . . . 0.0 110.586 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 98.1 m -119.91 128.84 54.0 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.386 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.891 ' HD3' HG21 ' A' ' 604' ' ' VAL . 26.4 mtpp -124.0 132.31 53.68 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.98 -41.05 15.21 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -96.94 114.58 26.21 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.01 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.665 HG11 HG21 ' A' ' 602' ' ' THR . 11.8 m -123.49 -175.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.24 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -99.41 165.14 11.8 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.557 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 18.6 m -100.36 -11.93 19.86 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 18.0 m 72.96 -0.42 3.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.36 1.064 . . . . 0.0 113.54 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 63.38 -144.67 49.45 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.6 157.1 24.98 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.612 2.208 . . . . 0.0 110.91 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.608 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.5 Cg_endo -75.15 163.69 34.52 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.857 2.371 . . . . 0.0 112.427 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.462 ' HG2' HD11 ' A' ' 681' ' ' LEU . 37.0 Cg_endo -69.61 172.95 11.56 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.589 2.193 . . . . 0.0 111.899 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -86.06 161.23 19.03 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 657' ' ' TYR . 15.1 tp -99.49 145.34 27.58 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 638' ' ' ASN . 1.3 pp -65.68 -37.69 87.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.45 ' N ' HD12 ' A' ' 637' ' ' LEU . 46.4 m-80 -138.36 33.96 2.3 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.206 1.003 . . . . 0.0 109.677 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.51 ' HA3' HD23 ' A' ' 636' ' ' LEU . . . -158.1 -150.88 5.88 Favored Glycine 0 N--CA 1.413 -2.841 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.754 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . 0.63 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 2.1 t-20 -160.56 -177.35 6.14 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.539 HG22 ' CE1' ' A' ' 657' ' ' TYR . 17.9 t -91.55 129.59 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.242 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 174.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.444 ' HB3' ' CD1' ' A' ' 658' ' ' TYR . 10.0 ptmm? -90.16 -14.83 32.74 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.604 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -89.84 168.86 11.74 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.877 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -77.72 110.97 13.03 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 17.8 p -71.23 106.49 3.83 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.523 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 42.6 pttt -87.94 153.41 21.32 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.271 175.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.471 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 11.0 pt-20 -68.32 -12.52 61.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.408 0.683 . . . . 0.0 111.607 -176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -151.17 102.37 2.93 Favored 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -171.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.608 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 4.2 m-85 -82.49 -70.75 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 120.63 165.64 12.83 Favored Glycine 0 C--N 1.288 -2.106 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.2 t60 -74.02 142.16 45.77 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.439 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 49.6 m 71.32 5.46 5.44 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.307 1.043 . . . . 0.0 112.377 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.435 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 5.5 tp10 -84.1 115.37 22.35 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 670' ' ' LYS . 2.4 p -90.2 152.63 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 30.5 m -120.98 112.05 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.729 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.531 ' CG ' ' HG2' ' A' ' 670' ' ' LYS . 27.3 mt-10 -69.57 119.8 14.37 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.017 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.671 ' HB3' HD22 ' A' ' 636' ' ' LEU . 79.2 m-85 -99.31 173.65 6.68 Favored 'General case' 0 C--N 1.271 -2.809 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.412 173.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.63 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 24.3 p90 -150.88 139.92 21.05 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 173.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.503 ' SG ' HD21 ' A' ' 636' ' ' LEU . 43.6 m -105.1 161.53 14.16 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-O 120.894 0.378 . . . . 0.0 110.521 172.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -57.03 152.04 30.96 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.54 -177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.04 33.69 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 124.738 3.625 . . . . 0.0 113.539 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -136.63 0.79 2.51 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 124.019 0.928 . . . . 0.0 109.008 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -127.18 159.2 34.99 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.811 -173.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.65 ' HG ' ' HB3' ' A' ' 687' ' ' GLU . 84.2 mt -107.81 136.51 47.42 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.793 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 4.2 ttt -95.32 113.68 25.37 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -78.25 -62.83 1.55 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.34 -170.43 46.82 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.653 -0.785 . . . . 0.0 112.878 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.65 123.71 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.028 2.485 . . . . 0.0 111.536 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -64.15 -17.95 63.98 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 122.915 0.486 . . . . 0.0 111.591 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 1.0 OUTLIER -122.32 153.52 38.84 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 681' ' ' LEU . 46.8 pt -143.3 142.53 25.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.25 148.16 34.72 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 48.7 t -82.53 129.14 34.86 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.404 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . 0.613 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 30.7 m -110.4 126.13 67.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 123.061 0.544 . . . . 0.0 110.638 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.535 ' OD1' ' HE2' ' A' ' 624' ' ' LYS . 21.9 t70 60.25 -67.0 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.562 1.145 . . . . 0.0 112.342 -172.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -168.44 21.66 0.09 OUTLIER Glycine 0 C--N 1.301 -1.405 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -132.71 137.9 47.06 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.548 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.6 m95 -81.73 152.22 27.13 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 8.0 p -77.56 -176.86 4.47 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 19.7 m -70.07 127.4 32.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.567 0.223 . . . . 0.0 111.565 -173.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.572 HD12 HD13 ' A' ' 671' ' ' ILE . 5.8 mp -62.91 155.13 73.44 Favored Pre-proline 0 CA--C 1.514 -0.426 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.564 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 5.6 Cg_endo -52.91 -55.04 4.1 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.795 2.997 . . . . 0.0 113.758 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 88.3 t 69.5 119.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.2 1.0 . . . . 0.0 111.198 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.793 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 33.1 m -117.66 155.87 29.16 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.062 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.59 149.39 25.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 123.783 0.833 . . . . 0.0 109.498 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.6 132.33 28.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 O-C-N 123.326 0.392 . . . . 0.0 110.044 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . 0.65 ' HB3' ' HG ' ' A' ' 664' ' ' LEU . 8.2 pt-20 . . . . . 0 C--O 1.251 1.147 0 O-C-N 124.329 1.018 . . . . 0.0 112.332 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 N--CA 1.443 -0.819 0 CA-C-O 121.717 0.77 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.631 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 27.5 m -103.68 -43.18 5.42 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.009 174.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 571' ' ' LEU . 19.9 tt0 60.79 -150.27 0.41 Allowed 'General case' 0 C--O 1.246 0.882 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 -171.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.428 HD11 ' HG3' ' A' ' 580' ' ' PRO . 1.0 OUTLIER -147.35 113.14 4.09 Favored Pre-proline 0 C--N 1.281 -2.372 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -177.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.402 ' HD2' HD12 ' A' ' 616' ' ' LEU . 37.2 Cg_endo -66.63 -170.67 0.22 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.253 2.635 . . . . 0.0 112.741 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -86.23 91.28 8.41 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.876 HG13 ' H ' ' A' ' 575' ' ' ASP . 11.5 pt -59.56 -75.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.472 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.876 ' H ' HG13 ' A' ' 574' ' ' ILE . 11.8 t70 -174.77 -173.07 0.68 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 10.9 p -106.16 -20.27 6.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -104.96 13.63 30.71 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.555 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.1 tt -114.62 141.61 47.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -175.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.34 116.9 14.31 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-O 121.42 0.629 . . . . 0.0 111.456 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 574' ' ' ILE . 64.1 Cg_endo -76.9 137.33 17.52 Favored 'Trans proline' 0 C--N 1.328 -0.514 0 C-N-CA 122.764 2.309 . . . . 0.0 111.73 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -56.94 -55.06 39.45 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.61 0.719 . . . . 0.0 109.594 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . 0.42 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 75.1 mmt-85 -78.34 117.54 19.68 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -124.67 93.52 3.92 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 10.6 ptpt -138.74 175.56 9.45 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.505 -174.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -87.57 -52.2 5.47 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.544 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.45 120.46 39.6 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.434 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.631 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 41.2 m-85 -85.09 126.66 33.77 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.832 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -80.04 143.8 33.73 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.898 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.45 118.04 2.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.444 0.64 . . . . 0.0 109.717 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 104.8 1.02 42.61 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.297 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.62 116.66 18.35 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 6.5 p -92.4 121.56 43.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.933 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . . . . . . . . . 5.7 mp -95.78 93.9 7.35 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.009 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 96.2 mttt -78.64 93.82 4.94 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.09 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.539 ' HB3' HD21 ' A' ' 578' ' ' LEU . 65.1 m-85 -78.1 163.87 25.5 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.424 0.63 . . . . 0.0 110.228 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 21.3 m -155.58 171.03 20.63 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 89.1 m -117.59 175.06 5.81 Favored 'General case' 0 C--N 1.259 -3.336 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.3 mmmt -56.48 164.17 2.17 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.573 1.149 . . . . 0.0 112.555 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 94.8 Cg_exo -45.77 -40.17 19.13 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.584 3.522 . . . . 0.0 115.249 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -102.52 7.86 54.22 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.33 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 40.5 m-85 -110.55 132.86 53.82 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-O 121.799 0.809 . . . . 0.0 112.103 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 16.6 m -92.92 126.17 37.88 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.761 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.487 HD11 ' HG3' ' A' ' 621' ' ' PRO . 11.1 tt -78.95 117.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.774 HG21 ' HD3' ' A' ' 624' ' ' LYS . 50.2 t -108.78 117.49 54.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.653 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 122.74 -160.47 17.21 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.22 123.31 10.74 Favored 'Trans proline' 0 C--N 1.328 -0.507 0 C-N-CA 122.733 2.288 . . . . 0.0 110.947 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.438 HD22 ' N ' ' A' ' 607' ' ' ASN . 0.7 OUTLIER -86.21 -50.08 7.24 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 4.9 p -100.08 95.33 6.77 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 111.783 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.2 150.69 4.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.607 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 22.8 mm-40 -98.26 160.14 14.48 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 10.5 t -84.25 129.89 34.86 Favored 'General case' 1 C--N 1.243 -4.033 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.575 165.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.607 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 55.5 m-85 -119.19 170.65 8.9 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.19 -12.84 61.13 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -104.82 -3.84 23.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.63 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 131.54 -170.18 21.62 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.402 HD12 ' HD2' ' A' ' 572' ' ' PRO . 46.6 mt -74.81 131.34 40.7 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.513 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 22.6 t -149.64 143.56 16.91 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.47 -172.5 10.97 Favored 'Cis proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.212 -1.578 . . . . 0.0 113.585 2.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.5 145.42 2.56 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.703 0.801 . . . . 0.0 110.63 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.654 HD23 HG22 ' A' ' 574' ' ' ILE . 6.5 mp -77.19 147.7 76.83 Favored Pre-proline 0 C--N 1.298 -1.659 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.262 -172.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.487 ' HG3' HD11 ' A' ' 603' ' ' ILE . 93.8 Cg_endo -74.85 -179.67 5.17 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 123.705 2.937 . . . . 0.0 112.913 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.6 pt -130.4 169.52 21.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 84.1 m -110.24 126.25 53.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.017 0.436 . . . . 0.0 110.832 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.774 ' HD3' HG21 ' A' ' 604' ' ' VAL . 28.3 mtpp -124.26 117.54 24.77 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.936 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 3.2 tm-20 -82.45 -36.77 26.26 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -94.26 98.93 11.27 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.843 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 6.2 m -114.28 171.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.514 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 53.5 mm-40 -98.67 169.12 9.72 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 42.6 m -116.14 -7.88 11.82 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.913 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 96.3 m 67.66 3.27 3.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 62.24 -132.2 45.24 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.91 155.3 38.77 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.023 2.482 . . . . 0.0 111.301 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.702 ' HB3' HG11 ' A' ' 655' ' ' VAL . 86.2 Cg_endo -83.56 161.88 14.62 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 122.651 2.234 . . . . 0.0 112.572 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.47 173.91 11.72 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.61 2.207 . . . . 0.0 111.388 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -98.23 161.42 13.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 657' ' ' TYR . 19.7 tp -96.77 128.66 43.94 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -45.66 -42.04 11.04 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.432 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 34.5 m-80 -133.35 31.01 3.81 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.475 0.655 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.607 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -151.85 -144.77 3.99 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.59 -173.47 2.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 655' ' ' VAL . 5.2 p -94.54 131.06 42.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.649 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 20.4 ptmt -88.91 -16.15 32.57 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.674 0.75 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.29 166.04 15.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.813 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -84.82 120.26 26.24 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.434 ' CG2' HG11 ' A' ' 641' ' ' VAL . 5.6 p -74.3 100.57 3.78 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.464 0.649 . . . . 0.0 112.448 -174.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -68.17 175.86 3.02 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.525 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -98.79 -0.85 41.75 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.746 0.784 . . . . 0.0 109.672 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . 0.438 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 26.4 tt0 -157.92 120.72 3.85 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.564 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 7.0 m-85 -91.76 -86.08 0.23 Allowed 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.981 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 145.83 164.23 10.71 Favored Glycine 0 CA--C 1.488 -1.6 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.522 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 57.8 t60 -56.98 -51.77 67.89 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 25.5 m -99.7 21.76 11.94 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.4 0.619 . . . . 0.0 110.835 -174.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.64 115.27 27.59 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.612 HG21 ' HE3' ' A' ' 670' ' ' LYS . 11.6 m -92.2 147.91 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.691 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.441 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 0.2 OUTLIER -114.73 115.94 51.06 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.843 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.34 177.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.649 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 18.4 mt-10 -77.02 138.52 39.64 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.261 1.029 . . . . 0.0 111.596 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.641 ' CE1' HG22 ' A' ' 655' ' ' VAL . 72.6 m-85 -119.06 167.55 11.67 Favored 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 125.597 1.559 . . . . 0.0 109.589 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -144.91 144.35 31.04 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.607 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 71.1 m -100.83 172.25 7.17 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -69.28 153.46 95.9 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.9 10.5 0.37 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 123.699 2.933 . . . . 0.0 114.396 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.41 3.56 25.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -131.46 164.22 26.24 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.688 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 687' ' ' GLU . 89.0 mt -104.22 165.16 11.23 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.2 ttt -123.91 103.83 8.57 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -82.65 -45.08 14.96 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -170.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -96.26 -173.73 35.71 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.007 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.51 122.01 10.64 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.416 2.744 . . . . 0.0 111.946 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 656' ' ' GLU . 2.4 p-10 -83.53 23.05 0.98 Allowed 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 122.872 0.469 . . . . 0.0 111.065 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.798 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 8.4 ptmt -163.82 107.09 0.97 Allowed 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 125.007 1.323 . . . . 0.0 108.014 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 37.7 pt -107.91 148.79 11.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.346 -174.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.561 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -113.74 154.17 27.78 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.453 0.47 . . . . 0.0 110.392 179.288 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 5.0 t -80.53 95.53 6.52 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.766 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . 0.508 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 35.1 m -84.52 117.02 29.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 O-C-N 121.402 -0.811 . . . . 0.0 111.39 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.506 ' OD1' ' HE2' ' A' ' 624' ' ' LYS . 17.6 t70 62.23 -76.67 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.39 1.076 . . . . 0.0 111.118 -173.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -151.38 17.77 0.89 Allowed Glycine 0 N--CA 1.434 -1.477 0 O-C-N 123.792 0.683 . . . . 0.0 111.614 177.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -135.5 141.71 45.34 Favored 'General case' 0 CA--C 1.495 -1.158 0 O-C-N 122.29 -0.535 . . . . 0.0 109.94 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.532 ' HB3' HD12 ' A' ' 671' ' ' ILE . 99.0 m95 -74.34 156.03 37.53 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 3.3 p -81.23 -178.72 7.04 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 16.3 m -65.37 125.85 26.4 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.174 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.86 159.92 23.58 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 26.2 Cg_endo -62.87 -13.22 33.37 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 124.263 3.309 . . . . 0.0 115.284 -176.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.282 30.9 m 48.51 101.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 175.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.9 m -80.74 140.93 35.27 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.56 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.69 146.24 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.352 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 14.8 m -58.07 138.13 19.42 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.504 0 O-C-N 124.439 1.087 . . . . 0.0 112.088 -174.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . 0.544 ' HA ' ' HG ' ' A' ' 664' ' ' LEU . 41.9 tt0 . . . . . 0 C--N 1.314 -0.962 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.5 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.433 -1.317 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.64 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 87.2 m -67.3 146.53 54.03 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -117.86 149.24 41.19 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.533 HD22 ' HD2' ' A' ' 572' ' ' PRO . 2.7 tm? -77.76 111.67 19.41 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.533 ' HD2' HD22 ' A' ' 571' ' ' LEU . 84.3 Cg_endo -76.67 -170.02 0.82 Allowed 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.068 2.512 . . . . 0.0 111.625 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -74.43 102.37 4.42 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.526 0.679 . . . . 0.0 110.1 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.674 HG22 ' HG ' ' A' ' 620' ' ' LEU . 27.3 pt -83.53 -166.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.613 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.2 t70 -76.84 143.78 39.5 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.63 -26.91 24.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 C-N-CA 124.048 0.939 . . . . 0.0 111.928 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -103.92 11.02 36.05 Favored 'General case' 0 CA--C 1.494 -1.174 0 O-C-N 121.637 -0.664 . . . . 0.0 111.864 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.674 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 5.6 tp -95.87 153.08 17.94 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.44 120.18 6.13 Favored Pre-proline 0 C--N 1.286 -2.185 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.448 ' HB2' ' O ' ' A' ' 582' ' ' ARG . 56.4 Cg_endo -74.7 137.45 22.46 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.24 1.96 . . . . 0.0 112.08 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -70.8 -42.34 70.41 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 580' ' ' PRO . 6.1 mmp_? -82.6 123.81 29.57 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 583' ' ' LYS . 34.5 ttmt -137.18 91.64 2.64 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 10.3 ptpt -137.92 172.63 12.65 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.578 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.08 -50.1 51.33 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.702 0.287 . . . . 0.0 111.36 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.06 152.85 50.95 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 121.443 0.639 . . . . 0.0 109.827 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.64 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 84.3 m-85 -115.18 119.72 37.32 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.068 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -70.05 142.24 52.72 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.567 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.531 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 1.8 p -61.29 112.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 122.279 1.038 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 121.33 -15.07 9.33 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.541 -174.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -72.03 126.26 29.32 Favored 'General case' 0 CA--C 1.473 -2.017 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 608' ' ' SER . 7.7 p -103.49 118.5 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.34 0 CA-C-O 122.35 1.071 . . . . 0.0 109.709 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.446 HD23 HD23 ' A' ' 571' ' ' LEU . 5.4 mp -91.04 98.52 11.82 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.025 -175.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 607' ' ' ASN . 96.0 mttt -78.21 118.96 20.93 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.546 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -97.9 179.49 4.78 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.387 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 10.5 p -168.67 161.82 11.48 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.586 ' SG ' HD12 ' A' ' 578' ' ' LEU . 90.1 m -105.0 -176.04 2.96 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.504 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.3 mmtp -63.27 162.72 22.47 Favored Pre-proline 0 N--CA 1.429 -1.499 0 C-N-CA 123.218 0.607 . . . . 0.0 111.545 175.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 88.8 Cg_exo -45.72 -40.03 18.76 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 124.498 3.465 . . . . 0.0 115.404 -175.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -97.22 3.69 62.0 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.61 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 45.6 m-85 -108.41 151.56 25.87 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.225 1.012 . . . . 0.0 113.379 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.553 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 2.6 m -103.76 123.6 47.35 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.061 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.457 ' HA ' ' SG ' ' A' ' 597' ' ' CYS . 5.7 tt -78.33 122.51 33.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.697 HG21 ' HG3' ' A' ' 624' ' ' LYS . 55.4 t -115.52 121.0 66.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 122.185 -0.322 . . . . 0.0 110.598 -178.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 119.77 -151.23 17.48 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.132 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.37 115.51 4.37 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.06 2.507 . . . . 0.0 111.214 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 0.2 OUTLIER -82.24 -25.95 33.67 Favored 'General case' 0 C--O 1.197 -1.668 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.835 -178.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.46 ' HB2' ' CG2' ' A' ' 592' ' ' VAL . 64.7 p -123.08 98.54 5.93 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.354 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.1 m -101.21 142.46 15.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.665 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -96.27 151.07 19.86 Favored 'General case' 0 CA--C 1.48 -1.746 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.815 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 35.5 t -75.38 125.07 28.25 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 166.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.488 ' HA ' HG23 ' A' ' 589' ' ' VAL . 90.7 m-85 -116.36 165.1 13.59 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.95 2.89 4.9 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -177.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -111.11 -4.74 14.94 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.391 0.615 . . . . 0.0 110.422 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.52 -178.52 18.0 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.123 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.513 HD12 ' CD ' ' A' ' 572' ' ' PRO . 45.7 mt -70.92 120.18 16.12 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.488 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 49.9 m -138.42 146.13 49.84 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-O 120.475 0.179 . . . . 0.0 110.672 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.84 -169.16 7.05 Favored 'Cis proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.182 -1.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.37 169.67 7.05 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.674 ' HG ' HG22 ' A' ' 574' ' ' ILE . 1.3 mm? -74.16 145.75 83.65 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.343 -168.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.24 170.59 17.9 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 123.228 2.619 . . . . 0.0 110.668 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . 0.454 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 47.0 pt -113.34 -178.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 602' ' ' THR . 96.1 m -129.13 109.04 10.84 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.425 0.453 . . . . 0.0 111.914 -177.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.697 ' HG3' HG21 ' A' ' 604' ' ' VAL . 18.5 mtmm -97.89 127.12 43.63 Favored 'General case' 0 C--O 1.201 -1.461 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 176.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.504 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 1.4 tm-20 -83.37 -34.5 25.58 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.36 107.54 18.52 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.058 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.567 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 10.4 p -125.22 174.51 9.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.402 ' H ' HG22 ' A' ' 627' ' ' VAL . 13.1 mm-40 -88.16 139.62 30.31 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 118.824 0.738 . . . . 0.0 109.352 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 631' ' ' GLY . 17.4 m -93.87 104.54 16.6 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 173.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 55.9 m -60.9 21.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 629' ' ' SER . . . 54.83 -139.06 40.8 Favored Glycine 0 C--O 1.241 0.579 0 CA-C-O 119.734 -0.481 . . . . 0.0 112.906 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.96 154.68 22.86 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.961 2.441 . . . . 0.0 110.782 175.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.505 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 59.9 Cg_endo -74.4 157.71 45.04 Favored 'Trans proline' 0 C--O 1.255 1.355 0 C-N-CA 122.684 2.256 . . . . 0.0 112.922 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.38 -169.47 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 123.47 2.78 . . . . 0.0 111.199 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -109.65 153.08 24.73 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.393 -0.817 . . . . 0.0 110.675 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 657' ' ' TYR . 18.6 tp -80.67 139.86 35.95 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.423 HD13 ' OD1' ' A' ' 638' ' ' ASN . 0.3 OUTLIER -46.26 -47.79 18.06 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -178.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.423 ' OD1' HD13 ' A' ' 637' ' ' LEU . 16.4 m120 -116.58 -30.43 5.83 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.519 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.642 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -91.12 -152.23 27.8 Favored Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.222 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.35 -174.77 5.09 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.995 0.426 . . . . 0.0 110.545 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 6.0 p -92.68 134.71 29.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.536 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.56 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.2 ptmt -93.86 -24.65 17.66 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.046 0.45 . . . . 0.0 110.61 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 15.2 mm-40 -78.82 151.47 31.89 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.364 -177.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -63.97 109.24 1.72 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.438 ' CG2' HG11 ' A' ' 641' ' ' VAL . 16.7 p -71.59 98.56 1.9 Allowed 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.434 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -81.3 158.03 24.9 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -87.81 0.88 55.2 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.1 108.56 4.84 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.505 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 17.4 m-85 -92.76 -104.75 0.12 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 147.56 168.99 14.48 Favored Glycine 0 CA--C 1.487 -1.657 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.01 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 18.7 t60 -69.65 142.25 53.47 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 17.8 m 75.72 -1.66 2.95 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.549 1.14 . . . . 0.0 111.422 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.433 ' HG3' ' HD2' ' A' ' 649' ' ' TYR . 7.3 tp10 -93.72 114.63 26.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 670' ' ' LYS . 17.8 m -91.84 161.41 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.774 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.622 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.1 m -127.16 110.89 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.512 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.574 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.56 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 17.8 mt-10 -70.16 122.23 19.06 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.105 0.955 . . . . 0.0 111.599 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.537 ' HB3' HD22 ' A' ' 636' ' ' LEU . 76.6 m-85 -102.42 166.89 10.3 Favored 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.032 174.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -146.83 137.04 23.55 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.642 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 8.3 t -102.61 179.09 4.39 Favored 'General case' 0 C--N 1.276 -2.612 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.025 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 662' ' ' ARG . 30.9 m-80 -75.85 155.66 84.81 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.52 33.85 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 124.295 3.33 . . . . 0.0 112.688 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 660' ' ' ASN . 35.4 mtt180 -133.3 4.77 3.74 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.411 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 76.9 m-85 -138.42 163.11 32.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.462 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.1 147.61 38.49 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.467 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.5 OUTLIER -103.34 118.98 37.99 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -176.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -80.21 -59.33 2.75 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -95.53 -160.79 33.4 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.067 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.93 116.34 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.03 2.487 . . . . 0.0 112.237 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.503 ' ND2' ' HG3' ' A' ' 670' ' ' LYS . 4.9 p-10 -63.52 -11.77 26.85 Favored 'General case' 0 C--O 1.195 -1.776 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.946 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -134.62 115.31 13.69 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.238 0.542 . . . . 0.0 111.909 178.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 33.8 pt -109.03 151.58 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.048 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.536 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -115.64 152.12 33.73 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 121.211 0.529 . . . . 0.0 111.399 -179.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 1.5 t -69.72 121.15 16.62 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.03 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . 0.432 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 34.0 m -116.23 86.9 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 CA-C-O 122.293 1.044 . . . . 0.0 113.045 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.567 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 16.5 m-20 75.3 8.05 3.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.795 -1.548 . . . . 0.0 113.913 166.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 142.35 -11.92 2.51 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.285 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -138.63 149.26 45.01 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.52 ' HB3' HD12 ' A' ' 671' ' ' ILE . 93.8 m95 -80.01 158.89 26.41 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 19.0 p -80.17 -180.0 7.35 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.655 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 25.8 m -68.6 126.72 30.55 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 120.717 0.294 . . . . 0.0 110.944 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.441 ' HA ' HG21 ' A' ' 671' ' ' ILE . 6.2 mp -57.94 160.3 8.76 Favored Pre-proline 0 N--CA 1.441 -0.904 0 O-C-N 124.461 1.101 . . . . 0.0 113.011 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.467 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 11.5 Cg_endo -57.31 -42.1 66.0 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.112 2.541 . . . . 0.0 113.283 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 99.8 t 67.55 113.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-O 121.936 0.874 . . . . 0.0 110.467 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 8.1 p -111.54 138.17 48.42 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.996 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.89 148.52 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.283 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.469 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 14.8 m -56.3 138.11 17.26 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.558 0 C-N-CA 124.558 1.143 . . . . 0.0 113.759 -171.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 C--N 1.299 -1.62 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.606 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.428 -1.55 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.851 ' HB3' HD11 ' A' ' 616' ' ' LEU . 90.5 m -59.28 133.34 56.01 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -174.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 571' ' ' LEU . 35.6 tt0 -94.63 -61.51 1.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.624 HD11 ' HG3' ' A' ' 580' ' ' PRO . 3.4 tt 150.84 129.88 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 177.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.703 ' HD3' HD13 ' A' ' 616' ' ' LEU . 74.5 Cg_endo -70.55 -170.8 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.76 1.64 . . . . 0.0 111.325 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -92.27 102.19 14.69 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.662 HD13 ' HD3' ' A' ' 580' ' ' PRO . 36.7 pt -76.2 -164.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.601 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.862 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 11.3 t70 -80.86 163.84 23.11 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.14 -28.09 22.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.17 0.509 . . . . 0.0 110.793 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -101.6 9.45 41.14 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 121.734 -0.604 . . . . 0.0 111.424 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.862 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.2 tm? -100.79 146.49 27.21 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.438 ' N ' HD13 ' A' ' 578' ' ' LEU . 16.3 m -140.74 121.14 8.82 Favored Pre-proline 0 C--N 1.3 -1.578 0 C-N-CA 123.754 0.822 . . . . 0.0 109.326 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.662 ' HD3' HD13 ' A' ' 574' ' ' ILE . 55.8 Cg_endo -73.0 136.33 24.7 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.036 1.824 . . . . 0.0 111.484 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.74 -38.82 92.3 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.537 1.135 . . . . 0.0 110.782 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -67.38 -61.07 2.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.739 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 60.6 tttm 51.84 74.57 0.25 Allowed 'General case' 0 C--O 1.241 0.649 0 O-C-N 124.676 1.235 . . . . 0.0 110.895 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 16.9 ptpt -131.12 156.24 45.61 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.289 -1.323 . . . . 0.0 107.445 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -76.55 -31.51 57.64 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . 0.41 HE21 ' N ' ' A' ' 586' ' ' GLN . 0.0 OUTLIER -134.21 133.08 40.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.875 0.369 . . . . 0.0 110.838 174.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.52 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 96.7 m-85 -110.69 142.29 42.8 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -93.13 153.4 18.68 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.602 ' HA ' ' SG ' ' A' ' 611' ' ' CYS 0.269 0.2 OUTLIER -64.64 118.0 6.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 121.839 0.828 . . . . 0.0 111.705 179.493 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 113.34 -3.66 25.11 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.768 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -74.53 134.7 42.19 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.628 HG12 ' HG3' ' A' ' 610' ' ' GLN . 20.3 m -109.82 129.92 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.881 0.848 . . . . 0.0 109.888 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.52 ' HG ' ' CE2' ' A' ' 587' ' ' TYR 0.368 0.0 OUTLIER -116.26 98.56 6.66 Favored 'General case' 0 N--CA 1.385 -3.701 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.269 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 607' ' ' ASN . 24.4 mtpp -61.46 124.6 21.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.044 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.698 ' HB3' HD11 ' A' ' 578' ' ' LEU . 27.7 m-85 -105.44 164.73 11.64 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.702 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . 0.477 ' HA ' HD12 ' A' ' 603' ' ' ILE . 34.0 p -168.85 166.69 11.31 Favored 'General case' 0 N--CA 1.401 -2.88 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 169.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 70.8 m -98.9 173.26 6.94 Favored 'General case' 0 C--N 1.255 -3.534 0 O-C-N 123.769 0.668 . . . . 0.0 110.831 -177.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.611 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 29.9 mmtp -53.04 163.21 0.9 Allowed Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 124.304 1.041 . . . . 0.0 112.191 176.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 18.7 Cg_endo -60.69 -17.09 47.55 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.852 2.368 . . . . 0.0 115.291 -170.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -110.54 8.63 30.37 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.273 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 30.7 m-85 -113.1 162.43 15.94 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.534 0.683 . . . . 0.0 112.258 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.409 HG21 HG21 ' A' ' 627' ' ' VAL . 8.1 m -112.65 131.95 55.4 Favored 'General case' 0 N--CA 1.416 -2.148 0 C-N-CA 125.533 1.533 . . . . 0.0 110.111 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 596' ' ' SER . 11.4 tt -83.98 122.4 37.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.439 0.638 . . . . 0.0 109.5 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 46.1 t -118.07 109.74 28.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.276 0.56 . . . . 0.0 109.856 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 132.82 -164.43 24.07 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.21 128.76 27.39 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.966 2.444 . . . . 0.0 110.786 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 6.8 m120 -94.96 -10.17 31.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 122.182 -0.324 . . . . 0.0 110.947 -175.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . . . . . . . . . 2.8 p -150.24 98.08 2.63 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.335 0.588 . . . . 0.0 111.637 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 20.3 m -93.21 167.56 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.781 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.628 ' HG3' HG12 ' A' ' 592' ' ' VAL . 2.0 mp0 -113.97 156.0 24.83 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.288 0.566 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 0.9 OUTLIER -85.25 130.8 34.53 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 164.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.565 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 77.5 m-85 -115.35 175.0 5.71 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -73.23 -12.94 61.04 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.862 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -101.38 -2.32 31.19 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 111.173 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.25 -171.78 21.35 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.851 HD11 ' HB3' ' A' ' 569' ' ' CYS . 5.2 mp -87.36 137.59 32.21 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 118.091 0.945 . . . . 0.0 110.019 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 618' ' ' PRO . 44.7 m -158.38 157.11 28.67 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.152 -176.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 617' ' ' SER . 59.3 Cg_endo -68.92 -168.18 3.85 Favored 'Cis proline' 0 CA--C 1.554 1.498 0 C-N-CA 124.599 -1.001 . . . . 0.0 114.279 1.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.02 160.99 16.78 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.994 0.426 . . . . 0.0 110.748 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 572' ' ' PRO . 2.1 mm? -78.43 144.52 66.11 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.89 162.53 41.78 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.982 2.455 . . . . 0.0 110.924 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 43.1 pt -110.49 -178.66 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.7 m -129.9 116.63 18.93 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-O 121.28 0.562 . . . . 0.0 111.716 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 624' ' ' LYS . 46.3 mtpt -104.02 130.42 51.68 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 25.3 tt0 -86.85 -39.82 15.48 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -98.22 107.54 20.04 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.138 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 3.5 p -107.13 176.48 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.473 ' NE2' ' HA3' ' A' ' 676' ' ' GLY . 48.2 mt-30 -93.53 156.14 16.91 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.478 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 15.4 m -99.02 -7.53 26.71 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.658 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . 0.452 ' SG ' ' HA2' ' A' ' 676' ' ' GLY . 20.9 m 71.1 -12.4 0.59 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 167.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 65.18 -147.25 50.79 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -79.01 148.76 22.08 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 122.66 2.24 . . . . 0.0 111.846 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.641 ' HG3' HG11 ' A' ' 655' ' ' VAL . 71.6 Cg_endo -76.42 167.69 25.22 Favored 'Trans proline' 0 CA--C 1.556 1.578 0 C-N-CA 123.49 2.793 . . . . 0.0 113.025 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.97 -167.52 0.24 Allowed 'Trans proline' 0 CA--C 1.55 1.292 0 C-N-CA 123.626 2.884 . . . . 0.0 113.587 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -111.99 166.02 11.59 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.605 HD22 ' HB3' ' A' ' 657' ' ' TYR . 18.9 tp -102.55 132.2 48.78 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 638' ' ' ASN . 2.3 pp -51.91 -42.91 63.12 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.778 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 15.3 m120 -131.09 29.91 4.62 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.717 0.77 . . . . 0.0 109.392 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.662 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -153.61 -150.4 5.45 Favored Glycine 0 N--CA 1.412 -2.953 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.55 -166.84 1.73 Allowed 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.5 p -107.53 128.37 62.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -85.44 -22.29 28.36 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.348 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.624 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 8.2 mm-40 -86.89 144.43 26.99 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.158 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 644' ' ' LYS . 5.9 ttpm? -56.8 112.7 1.38 Allowed 'General case' 0 C--N 1.31 -1.136 0 O-C-N 124.353 1.033 . . . . 0.0 109.938 176.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.46 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 4.9 p -83.72 101.43 11.55 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.599 0.714 . . . . 0.0 111.682 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 49.7 pttt -84.95 160.78 20.02 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.099 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.94 -21.05 60.66 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -152.26 125.01 8.42 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.097 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.551 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 11.3 m-85 -99.27 -75.27 0.57 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 129.19 172.19 13.12 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -175.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.503 ' HB2' HG11 ' A' ' 627' ' ' VAL . 64.6 t60 -60.44 -63.31 1.34 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 19.3 m -87.9 41.82 1.02 Allowed 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 121.333 0.587 . . . . 0.0 111.172 -172.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -120.3 106.28 11.73 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.631 HG21 ' HE2' ' A' ' 670' ' ' LYS . 15.8 m -82.19 154.64 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-O 122.066 0.936 . . . . 0.0 111.548 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.641 HG11 ' HG3' ' A' ' 633' ' ' PRO . 2.8 t -127.45 111.89 26.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 114.13 -1.396 . . . . 0.0 107.995 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.701 ' HG2' ' HG2' ' A' ' 670' ' ' LYS . 36.0 mt-10 -70.09 120.47 15.84 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 122.21 1.005 . . . . 0.0 113.01 175.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.605 ' HB3' HD22 ' A' ' 636' ' ' LEU . 55.4 m-85 -100.21 165.34 11.54 Favored 'General case' 0 C--N 1.263 -3.153 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.717 171.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -146.54 138.29 24.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.662 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 80.1 m -92.3 175.92 6.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 0.8 OUTLIER -67.46 157.55 85.32 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 70.1 Cg_endo -72.89 37.74 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.909 3.073 . . . . 0.0 113.195 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -153.52 11.82 0.45 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.695 -175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 660' ' ' ASN . 87.0 m-85 -132.88 154.15 50.66 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.37 0.605 . . . . 0.0 110.196 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 85.4 mt -93.68 149.23 21.4 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.2 ttt -112.11 118.76 36.26 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -75.18 -72.04 0.32 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -172.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -90.67 -151.97 26.95 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 113.663 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.36 119.67 6.74 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.3 2.667 . . . . 0.0 111.919 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -74.96 -12.9 60.45 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 121.201 0.524 . . . . 0.0 110.81 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.701 ' HG2' ' HG2' ' A' ' 656' ' ' GLU . 9.1 mtpt -119.24 125.88 50.18 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 40.4 pt -116.74 138.14 48.32 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.605 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.599 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -102.61 161.52 13.66 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 42.8 t -102.2 110.93 23.03 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.492 1.139 . . . . 0.0 111.135 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 77.8 t -86.14 110.08 19.47 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.036 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.13 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.593 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 23.0 t70 60.73 -80.27 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 124.799 1.24 . . . . 0.0 112.43 -171.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.473 ' HA3' ' NE2' ' A' ' 628' ' ' GLN . . . -145.67 14.61 1.79 Allowed Glycine 0 C--N 1.301 -1.389 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 176.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -125.41 115.6 20.54 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.558 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.4 m95 -63.53 146.24 54.08 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 17.8 p -67.36 175.51 2.71 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 2.7 m -60.5 130.2 45.38 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.938 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.48 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 6.0 mp -63.38 152.25 85.6 Favored Pre-proline 0 N--CA 1.433 -1.281 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.48 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 19.3 Cg_endo -58.64 -36.73 96.83 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.648 2.898 . . . . 0.0 114.125 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 66.2 t 69.4 117.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.913 0.885 . . . . 0.0 112.773 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.778 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 4.1 m -96.75 135.35 38.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.446 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.81 144.04 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.928 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 16.8 m -58.15 139.69 17.47 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.064 0 C-N-CA 124.678 1.191 . . . . 0.0 112.843 -174.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.62 -179.38 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 N--CA 1.411 -2.388 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.741 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 79.2 m -67.78 119.19 12.09 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.792 0.806 . . . . 0.0 110.943 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.76 -2.31 38.36 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-O 122.419 1.104 . . . . 0.0 108.929 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.675 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 47.4 tp 74.37 115.1 0.03 OUTLIER Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 127.059 2.144 . . . . 0.0 110.337 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.708 ' HG2' HD11 ' A' ' 620' ' ' LEU . 60.8 Cg_endo -67.97 -159.47 0.05 OUTLIER 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 123.696 2.931 . . . . 0.0 111.6 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -89.93 98.98 12.09 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.563 HG22 HD13 ' A' ' 620' ' ' LEU . 40.7 pt -72.83 175.09 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.153 174.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.726 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.7 t70 -65.79 147.81 52.79 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.12 -25.91 31.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 C-N-CA 123.792 0.837 . . . . 0.0 110.786 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -105.9 8.32 32.57 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 122.054 -0.403 . . . . 0.0 111.864 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.726 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 6.5 tp -91.75 148.61 22.12 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 21.7 m -135.66 116.57 11.77 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.492 ' HG2' ' HB2' ' A' ' 583' ' ' LYS . 26.9 Cg_endo -74.23 134.61 19.47 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.472 1.448 . . . . 0.0 109.686 174.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -33.41 75.72 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . 0.434 ' HB3' ' HE3' ' A' ' 584' ' ' LYS . 27.0 mmt180 -70.76 -64.75 0.84 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.802 177.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . 0.492 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 27.3 ttpp 47.91 82.34 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.691 1.596 . . . . 0.0 112.334 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.477 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.9 ptpt -133.66 163.91 28.37 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.975 -1.466 . . . . 0.0 107.412 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -72.69 -46.02 55.84 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.957 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.36 133.88 50.01 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.577 0.703 . . . . 0.0 110.258 177.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.741 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 92.8 m-85 -107.37 124.76 50.3 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 124.862 1.265 . . . . 0.0 109.509 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -78.79 149.23 32.66 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.586 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 1.3 p -63.8 119.17 7.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.59 0.709 . . . . 0.0 111.33 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 115.2 -10.38 20.21 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.26 -173.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -70.21 125.97 28.32 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.439 HG13 ' NE2' ' A' ' 610' ' ' GLN . 18.6 t -99.55 116.7 43.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 608' ' ' SER . 9.7 mt -101.84 115.04 29.66 Favored 'General case' 0 CA--C 1.47 -2.121 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.598 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 34.1 mtmm -91.76 99.38 12.27 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -76.81 161.81 28.15 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-O 122.022 0.915 . . . . 0.0 109.147 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 38.5 m -152.46 169.38 22.74 Favored 'General case' 0 C--N 1.253 -3.619 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.483 ' SG ' HD12 ' A' ' 578' ' ' LEU . 87.6 m -107.43 -178.17 3.56 Favored 'General case' 0 C--N 1.247 -3.887 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.594 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 32.1 mmtm -55.67 163.83 1.83 Allowed Pre-proline 0 C--N 1.313 -1.022 0 C-N-CA 123.018 0.527 . . . . 0.0 110.993 172.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 16.6 Cg_endo -59.03 -28.66 88.49 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.36 2.04 . . . . 0.0 114.701 -171.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.88 -2.65 61.04 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.879 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 39.9 m-85 -103.62 136.3 43.58 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 14.4 m -87.87 125.78 34.67 Favored 'General case' 0 N--CA 1.395 -3.201 0 CA-C-N 113.74 -1.573 . . . . 0.0 109.182 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.475 HD11 ' HG3' ' A' ' 621' ' ' PRO . 12.6 tt -80.31 125.69 39.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.67 HG21 ' HD3' ' A' ' 624' ' ' LYS . 82.5 t -117.25 114.58 46.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 123.59 -166.67 16.0 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.178 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.24 115.82 3.37 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.919 2.413 . . . . 0.0 111.535 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.99 -49.51 17.47 Favored 'General case' 0 C--O 1.206 -1.201 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.598 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 57.0 p -99.1 113.7 26.05 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.11 0.481 . . . . 0.0 111.626 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.86 157.39 17.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.56 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -103.36 151.96 22.14 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 121.011 0.434 . . . . 0.0 109.904 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 42.1 t -80.16 129.46 34.51 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.446 ' HA ' HG23 ' A' ' 589' ' ' VAL . 95.6 m-85 -114.64 165.79 12.41 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -61.92 -18.72 61.24 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -97.79 -5.28 35.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.85 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 134.62 -179.75 17.28 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 611' ' ' CYS . 71.9 mt -72.99 128.87 36.74 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 618' ' ' PRO . 67.1 m -146.26 147.07 30.07 Favored Pre-proline 0 C--N 1.294 -1.809 0 CA-C-N 116.816 -0.175 . . . . 0.0 110.681 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 617' ' ' SER . 49.5 Cg_endo -66.64 -175.7 7.74 Favored 'Cis proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.728 -1.363 . . . . 0.0 113.111 0.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.19 163.81 9.67 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 121.033 0.444 . . . . 0.0 110.957 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.708 HD11 ' HG2' ' A' ' 572' ' ' PRO . 24.0 mt -77.39 145.91 73.04 Favored Pre-proline 0 C--N 1.293 -1.869 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.972 -170.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.475 ' HG3' HD11 ' A' ' 603' ' ' ILE . 61.8 Cg_endo -70.91 173.68 11.64 Favored 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 123.537 2.824 . . . . 0.0 111.007 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 604' ' ' VAL . 44.1 pt -117.7 178.23 2.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.8 m -123.89 123.39 40.32 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.114 0.483 . . . . 0.0 110.604 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.67 ' HD3' HG21 ' A' ' 604' ' ' VAL . 58.2 mtpt -118.92 119.79 35.36 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.563 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 4.3 tm-20 -79.25 -43.12 24.38 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -91.64 91.92 8.23 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.488 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.622 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 5.0 p -109.69 170.82 2.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.275 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.588 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 19.9 mm-40 -91.61 161.17 15.04 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 27.3 m -107.51 -4.9 17.96 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.104 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 80.1 m 71.22 -34.79 0.31 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 88.34 -141.93 17.06 Favored Glycine 0 N--CA 1.415 -2.719 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -74.34 145.7 34.58 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 121.997 1.798 . . . . 0.0 111.831 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.533 ' HG3' HG11 ' A' ' 655' ' ' VAL . 92.2 Cg_endo -82.43 170.86 12.83 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.085 2.523 . . . . 0.0 111.874 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.14 -166.92 0.15 Allowed 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 123.214 2.61 . . . . 0.0 113.108 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -100.45 169.58 8.99 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.56 ' CD2' ' SG ' ' A' ' 659' ' ' CYS . 14.7 tp -91.33 166.16 13.05 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 117.733 -1.587 . . . . 0.0 110.258 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.509 ' N ' ' HG ' ' A' ' 636' ' ' LEU . 4.9 tt -63.45 -67.64 0.41 Allowed 'General case' 0 N--CA 1.396 -3.162 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.716 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.429 HD22 ' CD2' ' A' ' 637' ' ' LEU . 8.7 m-80 -128.08 40.16 3.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.979 0.895 . . . . 0.0 109.169 177.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -149.21 -142.13 3.55 Favored Glycine 1 N--CA 1.395 -4.067 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.784 176.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.66 -172.83 4.21 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.457 HG11 HG23 ' A' ' 645' ' ' THR . 9.0 p -104.0 134.55 44.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.705 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.1 ptmt -86.17 -29.85 22.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.661 0.744 . . . . 0.0 110.439 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 27.6 mm-40 -88.2 159.24 18.24 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.508 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -72.84 118.86 16.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.664 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.457 HG23 HG11 ' A' ' 641' ' ' VAL . 18.1 p -71.6 101.91 2.62 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-O 121.724 0.773 . . . . 0.0 111.21 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -73.29 156.54 38.35 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.484 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.51 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 49.2 mt-10 -85.59 -6.19 59.19 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -140.95 113.27 7.99 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 173.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.531 ' CE2' HG22 ' A' ' 655' ' ' VAL . 4.5 m-85 -96.35 -77.85 0.48 Allowed 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.455 174.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 130.09 163.5 11.1 Favored Glycine 0 CA--C 1.497 -1.091 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.628 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 71.2 t60 -56.51 -57.86 10.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 44.7 m -86.28 20.62 2.31 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -102.66 120.0 39.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 2.9 p -99.16 161.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.252 0.548 . . . . 0.0 110.143 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.8 t -127.37 113.72 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.724 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.705 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 29.5 mt-10 -71.91 124.15 24.26 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.497 0.665 . . . . 0.0 112.45 176.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.549 ' HB3' HD22 ' A' ' 636' ' ' LEU . 87.5 m-85 -108.1 167.33 10.07 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.621 172.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -150.44 141.23 22.76 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.79 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 9.1 m -100.47 173.85 6.38 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.116 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -62.89 155.09 73.47 Favored Pre-proline 0 C--O 1.245 0.828 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.618 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -71.01 29.41 0.21 Allowed 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 124.218 3.279 . . . . 0.0 114.681 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.3 21.8 1.88 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.176 0.989 . . . . 0.0 110.144 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -135.6 157.38 47.03 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.01 175.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.43 132.36 54.2 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 3.1 ttt -97.0 106.41 18.75 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 666' ' ' LYS . 35.9 ttmt -90.97 -42.65 10.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -173.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.89 -178.67 46.13 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.183 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.27 113.64 1.63 Allowed 'Trans proline' 0 N--CA 1.476 0.484 0 C-N-CA 123.613 2.876 . . . . 0.0 112.082 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.532 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 5.3 p-10 -63.27 -15.42 57.12 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 2.0 mtpt -120.22 155.32 33.41 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 44.5 pt -139.36 145.95 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.64 HE21 ' N ' ' A' ' 672' ' ' GLN . 0.0 OUTLIER -118.64 158.75 24.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.096 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.628 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 7.5 t -86.33 104.48 15.88 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.878 1.323 . . . . 0.0 111.344 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.6 106.63 18.07 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.051 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.845 -176.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.622 ' HA ' ' CG2' ' A' ' 627' ' ' VAL 0.253 16.0 t70 64.13 -56.54 0.23 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.7 1.6 . . . . 0.0 114.543 -178.035 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -161.95 4.97 0.08 OUTLIER Glycine 0 C--N 1.288 -2.095 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.651 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -136.37 154.46 50.82 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 123.115 0.566 . . . . 0.0 109.478 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.435 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.3 m95 -80.34 174.72 11.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.836 0.826 . . . . 0.0 111.638 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.11 167.85 10.8 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.705 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 26.7 m -57.16 128.46 37.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.22 0.95 . . . . 0.0 110.937 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.55 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 4.5 mp -65.94 154.46 89.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.541 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.55 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 5.9 Cg_endo -53.68 -32.6 65.92 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.962 3.108 . . . . 0.0 114.874 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.315 30.5 m 42.79 94.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 26.9 p -86.79 162.03 18.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.697 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.62 155.99 23.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.5 140.68 13.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 123.686 0.617 . . . . 0.0 110.764 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--O 1.247 0.93 0 C-N-CA 123.55 0.74 . . . . 0.0 110.831 -179.348 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 CA--C 1.514 -0.407 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.74 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 89.4 m -100.9 149.6 23.71 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -137.28 14.0 3.02 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 571' ' ' LEU . 1.1 tm? 70.96 101.62 0.04 OUTLIER Pre-proline 0 C--O 1.247 0.935 0 C-N-CA 124.481 1.113 . . . . 0.0 109.881 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.74 -172.34 0.8 Allowed 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.497 2.798 . . . . 0.0 111.613 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.39 95.86 5.2 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.555 HD13 ' HD3' ' A' ' 580' ' ' PRO . 17.2 pt -73.81 -175.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.592 177.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.7 t70 -71.2 148.87 46.87 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.49 -33.0 46.95 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.634 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -98.6 13.02 33.47 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 121.805 -0.56 . . . . 0.0 111.943 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.63 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.6 OUTLIER -106.06 150.75 25.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.527 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.55 119.68 7.78 Favored Pre-proline 0 C--N 1.312 -1.045 0 C-N-CA 124.159 0.983 . . . . 0.0 109.197 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.555 ' HD3' HD13 ' A' ' 574' ' ' ILE . 33.3 Cg_endo -71.43 135.31 26.3 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.321 2.014 . . . . 0.0 112.318 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.57 -47.12 79.91 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 123.556 0.742 . . . . 0.0 110.08 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -64.67 -68.43 0.36 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . 0.466 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 39.1 ttpt 52.38 70.81 0.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.471 1.129 . . . . 0.0 110.685 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -119.94 157.26 29.16 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.93 -37.27 67.24 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.145 0.498 . . . . 0.0 111.805 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.42 142.74 51.34 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.74 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 72.3 m-85 -122.65 126.76 48.28 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . 0.52 ' HB2' ' HG2' ' A' ' 591' ' ' GLU . 36.9 mttp -69.61 149.26 48.33 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.436 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -71.52 120.19 19.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.22 174.299 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 116.57 -11.11 16.21 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.635 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . 0.52 ' HG2' ' HB2' ' A' ' 588' ' ' LYS . 5.8 mm-40 -67.84 142.14 56.23 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.555 HG22 ' HG3' ' A' ' 610' ' ' GLN . 18.7 t -115.64 114.75 47.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.639 HD22 ' CD2' ' A' ' 587' ' ' TYR . 0.2 OUTLIER -105.58 109.64 21.68 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.626 0.727 . . . . 0.0 111.279 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 60.5 mtpt -72.4 141.94 48.7 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.345 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 580' ' ' PRO . 64.1 m-85 -114.23 177.59 4.59 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-O 121.05 0.452 . . . . 0.0 109.955 175.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 10.6 p -163.05 164.46 25.5 Favored 'General case' 0 N--CA 1.405 -2.696 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 94.6 m -111.95 -178.72 3.5 Favored 'General case' 0 C--N 1.266 -3.028 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 598' ' ' LYS . 28.1 mmtp -57.41 159.38 8.91 Favored Pre-proline 0 N--CA 1.436 -1.167 0 C-N-CA 123.281 0.632 . . . . 0.0 110.995 173.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -46.6 -45.01 20.52 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 124.195 3.263 . . . . 0.0 114.057 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 625' ' ' GLU . . . -90.25 -2.4 73.98 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.979 -175.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 29.3 m-85 -97.41 179.79 4.75 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.613 0.721 . . . . 0.0 112.118 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.677 HG21 HG11 ' A' ' 627' ' ' VAL . 89.3 m -136.47 129.38 30.99 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 595' ' ' PHE . 15.9 tt -86.05 150.23 3.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 1.012 HG21 HG12 ' A' ' 622' ' ' ILE . 4.9 m -119.05 154.22 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.384 -171.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 53.72 -123.94 27.92 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 169.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.72 94.75 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.294 2.663 . . . . 0.0 112.194 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -79.98 -28.48 39.53 Favored 'General case' 0 C--O 1.203 -1.385 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.479 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.501 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 34.1 p -112.81 94.7 5.03 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.515 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . 0.428 ' C ' HE21 ' A' ' 610' ' ' GLN . 23.6 m -98.53 156.74 3.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.634 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -101.56 155.31 18.16 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.066 0.46 . . . . 0.0 110.111 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.484 ' HA ' HD23 ' A' ' 616' ' ' LEU . 44.1 t -82.97 120.26 25.48 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 168.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.577 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 19.7 m-85 -100.59 167.55 10.28 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -54.59 -26.61 33.55 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.065 0.546 . . . . 0.0 112.432 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -108.53 8.21 27.15 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.885 0.374 . . . . 0.0 111.446 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 130.19 -177.73 18.02 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.915 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 611' ' ' CYS . 74.5 mt -69.96 130.05 41.14 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.577 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 70.8 m -146.07 144.51 21.87 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 617' ' ' SER . 53.2 Cg_endo -69.31 -173.82 8.48 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.592 -1.42 . . . . 0.0 112.74 0.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.45 152.14 35.25 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.336 0.588 . . . . 0.0 110.53 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.429 ' CD2' HG22 ' A' ' 574' ' ' ILE . 4.9 mp -71.94 142.26 85.21 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.983 -170.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.9 164.47 34.54 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.832 3.021 . . . . 0.0 113.624 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . 1.012 HG12 HG21 ' A' ' 604' ' ' VAL . 33.0 pt -104.97 -176.34 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.506 ' SG ' HD12 ' A' ' 578' ' ' LEU . 74.3 m -125.58 127.47 46.42 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 121.202 0.525 . . . . 0.0 109.701 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.63 ' HG2' ' CG1' ' A' ' 604' ' ' VAL . 12.7 mmmm -86.63 -59.03 2.39 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 1.9 tm-20 80.78 -54.84 0.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.939 1.696 . . . . 0.0 108.508 -172.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -98.73 118.8 36.27 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.328 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.677 HG11 HG21 ' A' ' 602' ' ' THR . 3.9 m -128.32 170.92 17.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.937 178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.475 HE21 ' HA3' ' A' ' 676' ' ' GLY . 46.9 mt-30 -88.01 178.04 6.77 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.163 0.506 . . . . 0.0 110.616 -176.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.444 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 7.5 m -105.47 -14.38 15.33 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 11.9 m 72.7 -10.16 0.99 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.135 1.374 . . . . 0.0 113.185 169.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 59.55 -141.9 47.26 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.94 154.3 47.92 Favored 'Trans proline' 0 CA--C 1.549 1.254 0 C-N-CA 122.924 2.416 . . . . 0.0 111.901 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.598 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 92.7 Cg_endo -81.46 167.39 17.27 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 123.415 2.743 . . . . 0.0 111.855 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.15 -175.92 1.42 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.49 2.127 . . . . 0.0 110.741 174.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.64 161.43 14.87 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 657' ' ' TYR . 20.4 tp -85.16 128.84 34.82 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.518 HD21 HG12 ' A' ' 683' ' ' VAL . 1.7 pp -46.88 -37.2 8.47 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.809 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 12.5 m120 -133.16 28.14 4.13 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.134 0.492 . . . . 0.0 109.683 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.21 -142.61 3.48 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -166.11 -179.31 5.07 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.399 0.679 . . . . 0.0 109.483 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.502 HG22 ' CE1' ' A' ' 657' ' ' TYR . 45.9 t -90.03 133.57 31.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 8.4 ptmm? -90.64 -16.03 29.38 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.548 0.69 . . . . 0.0 110.986 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -91.51 159.8 15.75 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -72.99 123.0 22.63 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.244 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 22.4 p -62.27 110.39 1.62 Allowed 'General case' 0 N--CA 1.411 -2.404 0 O-C-N 123.725 0.64 . . . . 0.0 109.547 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.408 ' HE2' ' CE2' ' A' ' 649' ' ' TYR . 43.8 mtmt -72.69 151.9 41.98 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.97 -14.51 59.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.92 0.867 . . . . 0.0 109.256 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -149.92 112.66 4.78 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.783 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.598 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.0 m-85 -89.83 -61.94 1.58 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 106.32 156.66 21.52 Favored Glycine 0 N--CA 1.421 -2.304 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.539 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.574 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 79.0 t60 -61.63 136.19 57.91 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 122.596 0.358 . . . . 0.0 110.321 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.5 m 70.82 14.59 6.99 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.334 1.053 . . . . 0.0 112.63 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.466 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 6.0 tp10 -94.93 121.31 36.4 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 174.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.653 HG21 ' HE2' ' A' ' 670' ' ' LYS . 1.4 p -88.47 160.18 2.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-O 121.156 0.503 . . . . 0.0 110.632 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -129.63 113.53 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.57 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 13.8 mt-10 -75.97 129.4 36.84 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.852 0.834 . . . . 0.0 111.261 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.607 ' HB3' HD22 ' A' ' 636' ' ' LEU . 95.4 m-85 -111.12 174.38 5.89 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.125 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -148.02 142.46 26.38 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.652 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 85.6 m -97.73 178.3 5.2 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.403 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 36.6 m-80 -71.62 154.55 93.11 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.38 38.24 0.48 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 124.246 3.298 . . . . 0.0 113.183 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.506 ' HG3' ' CE1' ' A' ' 663' ' ' PHE . 9.0 ptm180 -150.51 13.51 0.74 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.487 -175.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.506 ' CE1' ' HG3' ' A' ' 662' ' ' ARG . 85.2 m-85 -139.13 151.5 46.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.581 0.705 . . . . 0.0 110.772 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 81.1 mt -92.76 152.7 19.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.598 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 1.3 ttt -107.63 109.86 21.59 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.546 ' HB3' HG23 ' A' ' 683' ' ' VAL . 17.1 tppt? -71.57 -61.36 1.81 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.3 -172.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.67 -162.39 30.12 Favored Glycine 0 N--CA 1.431 -1.686 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.498 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.2 119.79 7.06 Favored 'Trans proline' 0 C--N 1.334 -0.198 0 C-N-CA 123.475 2.783 . . . . 0.0 112.407 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 4.6 p-10 -64.29 -2.38 2.14 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.653 ' HE2' HG21 ' A' ' 654' ' ' VAL . 0.0 OUTLIER -140.22 143.61 36.1 Favored 'General case' 0 N--CA 1.407 -2.625 0 C-N-CA 122.746 0.419 . . . . 0.0 110.279 177.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 678' ' ' TRP . 34.0 pt -136.46 142.39 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.562 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -112.23 149.92 31.63 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 44.0 t -80.16 125.24 29.57 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-O 123.166 1.46 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.52 118.39 57.04 Favored 'Isoleucine or valine' 1 N--CA 1.377 -4.094 0 CA-C-N 111.72 -2.491 . . . . 0.0 109.206 -174.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.574 ' H ' ' CE1' ' A' ' 651' ' ' HIS . 30.4 t70 63.46 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.938 1.295 . . . . 0.0 110.653 -172.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.475 ' HA3' HE21 ' A' ' 628' ' ' GLN . . . -161.03 27.99 0.3 Allowed Glycine 0 C--N 1.29 -1.977 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -138.5 146.48 42.04 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.563 ' HB3' HD12 ' A' ' 671' ' ' ILE . 95.6 m95 -87.18 160.58 18.45 Favored 'General case' 0 C--N 1.273 -2.749 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.93 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . 0.529 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 19.2 p -83.52 -179.9 7.47 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 14.2 m -65.69 124.73 23.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.004 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.446 ' HA ' HG21 ' A' ' 671' ' ' ILE . 7.9 mp -64.05 161.92 35.27 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.557 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 23.6 Cg_endo -62.25 -16.79 53.3 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 123.795 2.997 . . . . 0.0 115.08 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 666' ' ' LYS 0.293 31.6 m 48.21 98.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 177.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.809 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.1 m -80.39 142.3 34.52 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.316 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 666' ' ' LYS . 0.2 OUTLIER -136.95 145.91 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.324 0 C-N-CA 123.765 0.826 . . . . 0.0 108.874 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 28.3 m -50.34 126.26 4.85 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.209 0 C-N-CA 125.473 1.509 . . . . 0.0 114.018 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . 0.438 ' HG2' HD21 ' A' ' 664' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.288 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . . . . . . . . . 76.8 m -85.96 166.63 15.77 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.204 0.526 . . . . 0.0 111.547 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -141.78 150.24 41.45 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.747 HD11 ' HG3' ' A' ' 580' ' ' PRO . 1.0 OUTLIER -73.9 119.17 74.8 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.504 ' HD3' HD12 ' A' ' 616' ' ' LEU . 72.4 Cg_endo -76.07 -162.48 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.658 2.239 . . . . 0.0 111.064 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -87.25 107.4 18.47 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 121.91 -0.494 . . . . 0.0 110.092 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.498 HG22 HD23 ' A' ' 620' ' ' LEU . 28.1 pt -70.71 -169.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.346 176.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 10.9 t70 -77.43 152.94 34.06 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.01 -29.94 42.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.282 0.563 . . . . 0.0 110.232 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -103.35 15.3 29.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.577 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.2 OUTLIER -97.63 157.93 15.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 4.9 p -158.62 110.22 1.64 Allowed Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.336 0.654 . . . . 0.0 110.171 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.747 ' HG3' HD11 ' A' ' 571' ' ' LEU . 59.4 Cg_endo -72.08 148.29 50.31 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.392 2.728 . . . . 0.0 113.206 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.41 -45.0 27.25 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -75.39 109.37 8.87 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 173.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 583' ' ' LYS . 35.2 ttmt -121.6 98.02 5.77 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -146.9 177.82 8.82 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.427 ' HB3' ' NE2' ' A' ' 586' ' ' GLN . 7.1 t70 -86.73 -55.73 3.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.705 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . 0.427 ' NE2' ' HB3' ' A' ' 585' ' ' ASP . 0.0 OUTLIER -116.09 142.55 46.66 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.431 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.58 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 27.1 m-85 -110.88 124.57 52.33 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.551 -174.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -62.56 143.41 57.26 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.266 0.978 . . . . 0.0 108.843 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.748 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 3.4 p -61.71 119.58 6.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-O 121.858 0.837 . . . . 0.0 109.998 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 107.21 -10.3 39.67 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.254 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.47 123.35 23.73 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 3.6 p -102.48 129.19 54.39 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 CA-C-O 121.863 0.84 . . . . 0.0 111.383 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.58 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 4.3 mp -96.98 101.87 13.54 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.432 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -81.11 103.31 10.83 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.721 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 578' ' ' LEU . 74.0 m-85 -90.1 176.22 6.86 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 122.836 0.455 . . . . 0.0 111.456 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . 0.505 ' HA ' HD12 ' A' ' 603' ' ' ILE . 33.0 t -177.55 157.99 1.33 Allowed 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 168.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.469 ' SG ' HD22 ' A' ' 578' ' ' LEU . 97.4 m -86.67 177.95 7.19 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.989 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.52 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 72.9 mmtt -57.3 163.12 3.56 Favored Pre-proline 0 N--CA 1.434 -1.265 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.406 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 68.8 Cg_exo -49.31 -45.2 31.16 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.074 3.183 . . . . 0.0 114.129 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -84.03 -3.88 88.81 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.021 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 51.0 m-85 -107.7 154.07 22.01 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.6 0.714 . . . . 0.0 112.101 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 26.2 m -106.26 130.84 54.04 Favored 'General case' 0 N--CA 1.403 -2.809 0 CA-C-N 114.108 -1.406 . . . . 0.0 108.928 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.541 HD11 ' HG3' ' A' ' 621' ' ' PRO . 6.9 tt -80.17 122.68 35.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.428 HG21 ' HG3' ' A' ' 624' ' ' LYS . 92.2 t -119.62 113.88 42.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.173 0.511 . . . . 0.0 109.922 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 131.39 -164.69 23.4 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.06 112.71 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.713 2.275 . . . . 0.0 111.32 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.4 HD22 HD13 ' A' ' 603' ' ' ILE . 6.3 m120 -79.58 -40.53 29.19 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.126 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.464 ' HB2' HG21 ' A' ' 592' ' ' VAL . 31.3 p -114.23 99.45 7.61 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.661 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 11.3 m -98.98 138.69 22.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 592' ' ' VAL . 0.0 OUTLIER -110.18 153.24 25.03 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.954 -178.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.748 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 42.8 t -67.93 120.29 13.97 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.347 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.557 ' HE1' ' CG ' ' A' ' 610' ' ' GLN . 12.9 m-30 -105.68 167.53 9.7 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -67.79 1.55 2.48 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -123.32 -0.26 8.82 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.943 0.402 . . . . 0.0 111.325 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.71 173.7 13.38 Favored Glycine 0 C--N 1.311 -0.851 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.797 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 611' ' ' CYS . 30.6 mt -63.0 121.59 13.95 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.48 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 50.0 m -145.06 150.31 45.14 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 617' ' ' SER . 42.5 Cg_endo -70.06 -164.28 2.58 Favored 'Cis proline' 0 CA--C 1.551 1.36 0 C-N-CA 124.615 -0.994 . . . . 0.0 114.599 0.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.16 165.88 24.19 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 122.118 -0.364 . . . . 0.0 111.081 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.498 HD23 HG22 ' A' ' 574' ' ' ILE . 5.6 mp -76.67 139.5 66.94 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.541 ' HG3' HD11 ' A' ' 603' ' ' ILE . 73.7 Cg_endo -71.29 167.2 26.91 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 124.157 3.238 . . . . 0.0 112.372 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 46.7 pt -107.84 174.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.44 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.473 ' SG ' HD22 ' A' ' 578' ' ' LEU . 88.5 m -116.67 123.27 46.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.156 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 602' ' ' THR . 9.0 mmmm -118.81 108.6 15.04 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.207 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.458 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 2.8 tm-20 -73.42 -38.61 65.51 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -100.48 87.03 3.28 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.43 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 7.5 p -95.43 158.68 2.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.079 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -88.33 156.69 19.03 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.962 0.411 . . . . 0.0 110.883 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.598 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 15.0 p -90.58 -12.36 37.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.014 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . 0.5 ' SG ' ' HA2' ' A' ' 676' ' ' GLY . 13.8 m 70.54 7.82 6.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.757 0.823 . . . . 0.0 112.438 172.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 55.64 -140.18 41.17 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.495 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -82.5 151.56 15.25 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 122.435 2.09 . . . . 0.0 110.2 171.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.647 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 96.3 Cg_endo -78.81 172.42 15.07 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 123.129 2.552 . . . . 0.0 111.525 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.08 -162.95 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.438 2.092 . . . . 0.0 112.132 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -113.89 150.02 34.27 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.812 HD21 ' SG ' ' A' ' 684' ' ' CYS . 15.1 tp -78.72 159.54 27.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.528 HD11 ' HA ' ' A' ' 683' ' ' VAL 0.433 0.4 OUTLIER -73.45 -48.07 36.51 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 176.943 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 22.0 m120 -123.08 36.65 4.6 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.462 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.739 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -163.49 -141.28 3.08 Favored Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -165.26 -170.46 1.89 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 655' ' ' VAL . 48.5 t -89.23 127.84 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 175.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -83.7 -26.06 30.11 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.55 0.69 . . . . 0.0 109.334 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -74.74 171.43 13.94 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -89.38 130.67 35.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 16.2 p -82.35 104.05 12.37 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.613 0.72 . . . . 0.0 112.119 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.564 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 47.0 pttt -89.94 153.88 20.27 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.34 34.76 1.39 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 121.947 0.88 . . . . 0.0 110.729 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -169.49 92.93 0.26 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.494 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.647 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 11.0 m-85 -85.77 -73.76 0.44 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 121.13 167.28 13.22 Favored Glycine 0 C--N 1.291 -1.945 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -177.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.446 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 75.1 t60 -72.0 136.49 46.75 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.799 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 62.7 m 71.32 10.84 6.71 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.516 0.727 . . . . 0.0 112.438 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.42 118.0 27.74 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 174.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.543 HG11 ' HE2' ' A' ' 670' ' ' LYS . 1.3 p -91.67 154.46 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.713 0 CA-C-O 122.5 1.143 . . . . 0.0 111.26 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.556 HG21 ' HB3' ' A' ' 633' ' ' PRO . 3.8 t -117.48 101.24 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.995 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.592 ' HG3' ' HG2' ' A' ' 670' ' ' LYS . 5.8 tt0 -77.09 120.42 22.16 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 60.4 m-85 -99.05 167.31 10.8 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.179 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.481 ' O ' ' HA3' ' A' ' 639' ' ' GLY . 5.5 p90 -145.08 143.9 30.67 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 173.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.762 ' SG ' HD21 ' A' ' 636' ' ' LEU . 59.5 m -103.55 170.28 8.04 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -64.06 152.42 87.72 Favored Pre-proline 0 C--N 1.317 -0.829 0 O-C-N 123.125 0.266 . . . . 0.0 110.715 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.19 40.11 0.43 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 124.828 3.685 . . . . 0.0 113.393 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 7.6 ptt85 -150.0 10.72 0.71 Allowed 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.537 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.96 158.17 45.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.921 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.491 ' HG ' ' HG2' ' A' ' 687' ' ' GLU . 90.0 mt -100.93 157.29 16.85 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.479 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 3.5 ttt -114.83 102.44 9.99 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.506 ' HE2' HG23 ' A' ' 683' ' ' VAL . 37.6 ttpt -69.9 -53.22 18.93 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.309 -0.859 . . . . 0.0 113.103 -170.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.42 -170.3 31.79 Favored Glycine 0 C--N 1.293 -1.819 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.036 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.73 122.08 11.1 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.979 3.12 . . . . 0.0 110.858 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.876 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 7.9 p-10 -68.46 -20.0 64.6 Favored 'General case' 0 CA--C 1.469 -2.169 0 CA-C-O 121.533 0.682 . . . . 0.0 111.066 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.592 ' HG2' ' HG3' ' A' ' 656' ' ' GLU . 3.4 mtpt -111.71 157.29 20.67 Favored 'General case' 0 C--N 1.253 -3.615 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -173.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.613 HG21 HD23 ' A' ' 681' ' ' LEU . 48.1 pt -139.75 125.43 21.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.582 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -106.44 144.25 33.39 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 28.7 t -81.61 128.95 34.47 Favored 'General case' 0 CA--C 1.465 -2.314 0 CA-C-O 123.142 1.449 . . . . 0.0 111.835 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.4 t -105.33 107.3 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.807 0 CA-C-N 111.263 -2.699 . . . . 0.0 107.655 -175.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.541 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 26.6 t70 55.6 -75.15 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.008 1.723 . . . . 0.0 112.98 -169.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.5 ' HA2' ' SG ' ' A' ' 630' ' ' CYS . . . -149.15 18.54 1.19 Allowed Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -129.61 139.26 51.49 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.546 ' HB3' HD12 ' A' ' 671' ' ' ILE . 92.0 m95 -85.71 164.73 17.46 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.472 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 6.3 p -82.43 -178.54 7.09 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.05 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 44.2 m -71.68 135.81 47.01 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.254 0.55 . . . . 0.0 110.731 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.613 HD23 HG21 ' A' ' 671' ' ' ILE . 47.5 mt -66.08 153.07 92.71 Favored Pre-proline 0 N--CA 1.425 -1.699 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.237 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.876 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 12.3 Cg_endo -55.49 -20.17 25.62 Favored 'Trans proline' 0 N--CA 1.482 0.802 0 C-N-CA 124.637 3.558 . . . . 0.0 115.972 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.528 ' HA ' HD11 ' A' ' 637' ' ' LEU 0.302 16.4 m 46.11 98.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 N-CA-C 115.664 1.728 . . . . 0.0 115.664 177.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.812 ' SG ' HD21 ' A' ' 636' ' ' LEU . 1.7 m -83.28 147.96 27.66 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.975 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.479 ' CD1' ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -138.49 146.97 25.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.243 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 32.0 t -58.56 134.77 23.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 123.828 0.705 . . . . 0.0 109.87 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . 0.491 ' HG2' ' HG ' ' A' ' 664' ' ' LEU . 45.0 mt-10 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.21 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 . . . . . 0 N--CA 1.428 -1.531 0 CA-C-O 121.149 0.499 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 2.6 m -63.72 -55.78 20.64 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 124.786 1.234 . . . . 0.0 111.734 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 61.41 -168.62 0.18 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.064 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.5 HD11 ' HG3' ' A' ' 580' ' ' PRO . 3.5 tt -118.61 118.96 33.17 Favored Pre-proline 0 C--N 1.28 -2.447 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.616 ' HG2' HD21 ' A' ' 620' ' ' LEU . 90.3 Cg_endo -75.41 -165.71 0.31 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.466 2.777 . . . . 0.0 112.335 -177.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.23 108.05 15.38 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.196 0.522 . . . . 0.0 110.382 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.648 HG22 HD23 ' A' ' 620' ' ' LEU . 36.2 pt -78.14 -167.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.319 175.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.95 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 10.2 t70 -81.54 162.09 23.32 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.09 -22.58 18.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.473 0.654 . . . . 0.0 110.516 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -106.63 11.83 30.0 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 121.768 -0.582 . . . . 0.0 110.98 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.95 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.5 tm? -99.13 153.48 18.86 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.485 ' N ' HD13 ' A' ' 578' ' ' LEU . 5.8 p -149.91 113.33 3.38 Favored Pre-proline 0 C--N 1.288 -2.079 0 C-N-CA 124.184 0.994 . . . . 0.0 108.454 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.597 ' HD3' HD13 ' A' ' 574' ' ' ILE . 59.1 Cg_endo -73.82 146.14 37.46 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.509 2.139 . . . . 0.0 112.43 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -77.38 -36.78 53.22 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . 0.433 ' HB3' ' HE2' ' A' ' 587' ' ' TYR . 25.3 mmt180 -79.63 132.55 36.28 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 171.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -143.51 89.94 2.12 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.69 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 587' ' ' TYR . 11.1 ptpt -137.71 170.21 16.46 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -77.41 -56.8 4.24 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.64 126.43 50.22 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.925 0.393 . . . . 0.0 110.725 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.73 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 19.3 m-85 -90.35 155.53 18.9 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.814 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -93.7 147.41 23.05 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.65 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 5.6 p -66.45 131.16 32.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.852 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 87.42 -1.95 86.22 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.211 -173.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -69.28 135.58 50.67 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 609' ' ' VAL . 11.3 m -98.59 138.91 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.563 HD11 ' CD2' ' A' ' 587' ' ' TYR . 7.1 mp -117.16 111.05 18.93 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.229 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.614 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 92.0 mttt -84.74 122.21 28.78 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.857 ' HB3' HD11 ' A' ' 578' ' ' LEU . 68.7 m-85 -108.08 172.2 6.97 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 603' ' ' ILE . 14.2 p -171.21 177.41 3.62 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 76.8 m -110.97 177.79 4.55 Favored 'General case' 0 C--N 1.26 -3.293 0 O-C-N 123.739 0.649 . . . . 0.0 110.712 -176.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 598' ' ' LYS . 71.6 mmtt -53.48 160.83 1.7 Allowed Pre-proline 0 N--CA 1.438 -1.034 0 C-N-CA 124.463 1.105 . . . . 0.0 112.564 176.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 51.4 Cg_exo -52.05 -28.11 31.36 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 124.414 3.409 . . . . 0.0 114.575 -175.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -99.61 -4.31 55.98 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.883 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -106.51 159.13 16.4 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 122.328 1.061 . . . . 0.0 113.414 -174.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.614 HG21 HG11 ' A' ' 627' ' ' VAL . 6.2 m -109.25 129.57 55.5 Favored 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.861 174.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.537 HD11 ' HG3' ' A' ' 621' ' ' PRO . 6.4 tt -81.46 119.14 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.363 174.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.737 HG21 ' HD3' ' A' ' 624' ' ' LYS . 62.0 t -109.97 127.51 66.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.06 -159.66 14.14 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.8 115.33 3.71 Favored 'Trans proline' 0 C--N 1.333 -0.278 0 C-N-CA 122.958 2.439 . . . . 0.0 110.69 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 7.5 m120 -84.3 -26.29 28.65 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.355 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.614 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 27.1 p -127.09 95.59 4.34 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.532 0.682 . . . . 0.0 111.087 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 592' ' ' VAL . 21.5 m -89.42 169.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.485 -0.779 . . . . 0.0 108.997 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.407 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 12.0 mm-40 -114.72 163.8 14.97 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 18.7 t -85.05 131.39 34.46 Favored 'General case' 0 C--N 1.276 -2.608 0 C-N-CA 117.808 -1.557 . . . . 0.0 108.223 165.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 7.5 m-85 -109.16 163.0 13.74 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 173.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -68.17 -1.68 6.53 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -117.48 4.47 12.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 120.879 0.371 . . . . 0.0 110.333 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 135.69 -177.45 19.46 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 572' ' ' PRO . 28.4 mt -73.79 133.51 43.26 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.481 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 68.1 m -150.16 154.39 36.41 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.61 -168.78 5.04 Favored 'Cis proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.043 -1.232 . . . . 0.0 113.214 0.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.76 146.69 35.93 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.091 0.472 . . . . 0.0 111.864 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.648 HD23 HG22 ' A' ' 574' ' ' ILE . 6.7 mp -65.14 142.26 98.53 Favored Pre-proline 0 C--N 1.302 -1.47 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.889 -175.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.537 ' HG3' HD11 ' A' ' 603' ' ' ILE . 28.1 Cg_endo -63.9 169.01 10.99 Favored 'Trans proline' 0 C--O 1.252 1.182 0 C-N-CA 124.124 3.216 . . . . 0.0 113.667 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . 0.445 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 36.5 pt -114.94 178.91 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.969 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 95.3 m -127.96 124.94 38.52 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.023 0.44 . . . . 0.0 111.267 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.737 ' HD3' HG21 ' A' ' 604' ' ' VAL . 57.9 mtpt -124.41 130.33 52.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -88.54 -37.87 15.37 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -99.82 101.25 12.34 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.803 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.614 HG11 HG21 ' A' ' 602' ' ' THR . 2.7 m -102.03 178.39 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.088 174.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.612 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 76.2 mt-30 -94.55 170.64 9.33 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.559 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 41.6 m -102.93 -8.15 20.92 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.039 0.447 . . . . 0.0 110.649 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 81.7 m 67.36 5.78 4.47 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 54.2 -137.22 41.58 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 123.474 0.484 . . . . 0.0 112.947 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.58 147.01 17.36 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.649 2.233 . . . . 0.0 112.055 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.536 ' HB3' HG21 ' A' ' 655' ' ' VAL . 31.7 Cg_endo -67.32 156.51 65.9 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.118 2.545 . . . . 0.0 112.591 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.501 ' HG2' HD11 ' A' ' 681' ' ' LEU . 38.3 Cg_endo -69.24 175.36 7.77 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 123.324 2.683 . . . . 0.0 112.522 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.86 145.71 26.48 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 657' ' ' TYR . 14.5 tp -80.59 178.33 8.42 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 637' ' ' LEU . 2.4 mp -84.58 -73.03 0.44 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.821 0.819 . . . . 0.0 108.841 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -108.02 32.71 4.56 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.667 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -156.29 -156.79 7.99 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.798 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.08 -172.72 4.21 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 123.685 0.794 . . . . 0.0 109.976 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.485 HG22 ' CE1' ' A' ' 657' ' ' TYR . 53.5 t -93.69 137.87 21.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.659 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 20.1 ptmt -87.22 -22.63 25.12 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.088 0.47 . . . . 0.0 110.904 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.22 146.92 28.31 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -67.75 122.39 18.0 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 22.4 p -73.69 98.09 2.82 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.228 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -83.81 165.33 18.9 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.5 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.4 6.82 35.59 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -171.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -156.24 105.9 2.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -96.19 -82.25 0.4 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 130.77 159.62 9.68 Favored Glycine 0 C--N 1.311 -0.84 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.887 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.678 ' ND1' ' HA ' ' A' ' 674' ' ' VAL . 80.6 t60 -77.14 86.43 3.61 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 651' ' ' HIS . 22.9 t 155.08 -31.19 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 126.941 2.097 . . . . 0.0 106.101 173.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -68.05 118.24 10.95 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.911 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 671' ' ' ILE . 1.1 p -94.74 163.39 2.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.739 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 16.6 m -128.82 115.58 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.442 175.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.659 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 14.7 mt-10 -73.26 126.12 29.37 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.56 0.695 . . . . 0.0 111.111 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.665 ' HB3' HD22 ' A' ' 636' ' ' LEU . 81.4 m-85 -102.12 164.74 11.53 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.022 176.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -148.67 135.63 19.97 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.667 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 50.4 m -99.09 165.75 11.58 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.428 172.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 50.1 m-80 -58.3 155.01 28.98 Favored Pre-proline 0 C--O 1.248 1.021 0 O-C-N 123.677 0.611 . . . . 0.0 109.904 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 59.8 Cg_endo -68.03 24.76 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 124.113 3.209 . . . . 0.0 115.529 -172.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.463 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 24.8 mmm180 -118.11 -4.26 11.02 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 662' ' ' ARG . 51.0 m-85 -128.95 159.76 34.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.723 -170.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 687' ' ' GLU . 81.8 mt -124.38 153.78 41.36 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 125.145 1.378 . . . . 0.0 107.442 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.558 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -84.27 147.17 27.38 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.125 0.488 . . . . 0.0 111.2 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -95.09 -59.44 1.9 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.214 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.5 -158.11 29.76 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.575 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.78 123.64 10.96 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.978 2.452 . . . . 0.0 111.655 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 12.1 p-10 -64.04 -17.38 63.31 Favored 'General case' 0 C--O 1.207 -1.17 0 C-N-CA 122.902 0.481 . . . . 0.0 111.744 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 1.4 mtpt -122.28 154.4 37.62 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.57 HD12 ' HB3' ' A' ' 678' ' ' TRP . 29.9 pt -143.92 142.73 24.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.451 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -112.81 153.08 28.4 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.041 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 3.9 t -68.14 121.06 15.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.015 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . 0.678 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 35.1 m -113.03 113.26 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.55 0.691 . . . . 0.0 111.559 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 32.7 t70 64.87 -73.89 0.05 Allowed 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 124.56 1.144 . . . . 0.0 111.375 -175.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.612 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -152.56 16.21 0.74 Allowed Glycine 0 N--CA 1.422 -2.297 0 C-N-CA 120.392 -0.908 . . . . 0.0 112.456 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.01 158.08 44.63 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.57 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.9 m95 -81.71 177.03 9.14 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 120.892 0.377 . . . . 0.0 110.167 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.98 -179.44 3.95 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.863 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 5.7 m -57.72 120.16 7.9 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.897 0.879 . . . . 0.0 110.915 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.535 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 4.4 mp -64.15 154.26 83.02 Favored Pre-proline 0 N--CA 1.445 -0.719 0 O-C-N 123.761 0.663 . . . . 0.0 112.592 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.558 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 7.5 Cg_endo -55.04 -50.12 14.26 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.206 2.604 . . . . 0.0 113.516 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 92.8 t 68.97 130.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.505 0.722 . . . . 0.0 110.118 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 7.3 p -125.05 154.89 40.63 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.676 -0.64 . . . . 0.0 112.448 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 685' ' ' ILE . 0.2 OUTLIER -139.04 150.58 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.214 0 C-N-CA 125.317 1.447 . . . . 0.0 108.512 -177.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.24 139.25 17.06 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.911 0 C-N-CA 124.76 1.224 . . . . 0.0 112.472 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . 0.51 ' HG3' HD11 ' A' ' 664' ' ' LEU . 45.8 tt0 . . . . . 0 N--CA 1.438 -1.056 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.153 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.764 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 75.9 m -96.61 150.02 21.13 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.657 0.741 . . . . 0.0 112.685 -174.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -124.25 -4.75 7.86 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.073 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.547 HD23 ' HD2' ' A' ' 572' ' ' PRO . 0.9 OUTLIER 77.97 121.22 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 126.006 1.723 . . . . 0.0 107.438 -178.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.614 ' HD3' HD23 ' A' ' 616' ' ' LEU . 56.8 Cg_endo -69.97 -174.65 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.909 1.74 . . . . 0.0 110.931 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 573' ' ' LYS . 0.3 OUTLIER -89.5 104.23 16.81 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 578' ' ' LEU . 42.0 pt -76.08 -176.57 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.988 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.293 -177.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.6 t70 -72.97 151.94 41.6 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.72 -35.66 68.88 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.363 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -93.54 8.08 42.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.705 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.8 tp -95.89 149.97 20.96 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.03 117.59 9.09 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-O 121.387 0.613 . . . . 0.0 110.41 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.42 131.19 13.55 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.203 1.935 . . . . 0.0 111.053 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.56 -29.84 71.04 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.286 0.565 . . . . 0.0 111.447 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . 0.452 ' HG3' HD22 ' A' ' 593' ' ' LEU . 4.5 mmp_? -72.8 -70.95 0.32 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 176.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm 60.47 84.58 0.12 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.416 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.6 ptpt -142.03 174.34 10.69 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.25 -66.16 0.91 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . 0.444 HE21 ' N ' ' A' ' 586' ' ' GLN . 0.0 OUTLIER -105.34 141.04 37.55 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.764 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 67.0 m-85 -115.12 125.63 53.69 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.138 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -71.02 144.04 50.55 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.302 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.637 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 32.6 m -63.4 134.66 28.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.576 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 102.0 -18.62 51.76 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.117 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.95 108.84 3.19 Favored 'General case' 0 C--N 1.346 0.451 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 3.4 p -92.47 125.09 45.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.721 0.772 . . . . 0.0 110.199 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 587' ' ' TYR . 11.1 mt -102.88 105.05 15.34 Favored 'General case' 0 N--CA 1.402 -2.856 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.882 -172.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.535 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 54.7 mtpt -75.06 112.61 11.47 Favored 'General case' 0 N--CA 1.41 -2.425 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -94.36 174.13 7.29 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-O 121.813 0.816 . . . . 0.0 109.548 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 20.1 t -162.32 -178.83 6.56 Favored 'General case' 0 N--CA 1.391 -3.414 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.556 ' SG ' HD12 ' A' ' 578' ' ' LEU . 92.3 m -118.1 -179.12 3.67 Favored 'General case' 0 C--N 1.257 -3.452 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -51.01 162.58 0.58 Allowed Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 124.773 1.229 . . . . 0.0 111.639 174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.2 -45.82 24.66 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.923 3.082 . . . . 0.0 113.403 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -89.76 5.03 83.73 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.424 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.64 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 35.4 m-85 -109.57 133.93 52.52 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 45.5 m -89.04 127.92 35.71 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.5 175.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.505 HD11 ' HG3' ' A' ' 621' ' ' PRO . 8.9 tt -84.65 132.89 30.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.834 HG21 ' HD3' ' A' ' 624' ' ' LYS . 90.9 t -129.7 135.43 61.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 114.67 -161.25 12.81 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.96 116.31 4.52 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.003 1.802 . . . . 0.0 109.886 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.448 HD22 ' N ' ' A' ' 607' ' ' ASN . 0.7 OUTLIER -83.34 -39.22 21.02 Favored 'General case' 0 C--O 1.206 -1.208 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -176.278 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.535 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 8.6 p -112.27 98.0 7.01 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.44 0.638 . . . . 0.0 111.96 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.5 m -99.57 145.6 10.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.644 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -96.46 149.24 21.95 Favored 'General case' 0 CA--C 1.472 -2.024 0 O-C-N 121.866 -0.522 . . . . 0.0 110.415 -177.251 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 45.4 t -73.3 122.28 21.74 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.37 168.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.596 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 75.9 m-85 -110.98 162.7 14.58 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 171.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -65.16 -2.25 2.77 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -115.52 1.54 13.64 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.537 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.4 169.73 12.35 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.202 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.614 HD23 ' HD3' ' A' ' 572' ' ' PRO . 3.3 mm? -66.42 118.95 10.79 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.596 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 17.4 m -131.77 144.36 52.94 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . 0.418 ' C ' ' HA ' ' A' ' 617' ' ' SER . 56.6 Cg_endo -69.77 -165.13 2.8 Favored 'Cis proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.885 -1.298 . . . . 0.0 113.139 -0.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.12 172.79 11.75 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.194 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.522 HD13 HG22 ' A' ' 574' ' ' ILE . 50.8 mt -69.64 148.43 96.78 Favored Pre-proline 0 C--N 1.297 -1.709 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.333 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.505 ' HG3' HD11 ' A' ' 603' ' ' ILE . 72.9 Cg_endo -75.42 -177.85 3.84 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 124.176 3.251 . . . . 0.0 111.362 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.42 166.44 18.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.012 0.434 . . . . 0.0 110.933 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.423 ' HB3' ' CD2' ' A' ' 601' ' ' PHE . 85.7 m -110.64 116.06 30.67 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.376 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.834 ' HD3' HG21 ' A' ' 604' ' ' VAL . 21.0 mtpp -97.03 -22.17 16.96 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 13.6 tt0 68.4 -70.16 0.14 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.178 0.991 . . . . 0.0 108.951 -174.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -103.88 114.51 28.81 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.644 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 7.7 p -111.45 175.25 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.451 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 48.9 mt-30 -84.21 166.64 17.38 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 119.778 1.172 . . . . 0.0 109.311 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.613 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 5.2 p -106.54 -16.95 14.39 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.157 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 71.8 m 70.0 8.55 6.74 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.314 1.046 . . . . 0.0 112.799 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 54.02 -143.84 28.74 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 123.694 0.621 . . . . 0.0 113.093 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.5 148.59 42.87 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.515 2.143 . . . . 0.0 111.215 173.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.555 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 88.1 Cg_endo -82.67 165.1 15.98 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 123.047 2.498 . . . . 0.0 112.442 -178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.16 178.69 4.56 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.952 2.435 . . . . 0.0 111.426 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.92 163.83 12.04 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.636 HD22 ' HB3' ' A' ' 657' ' ' TYR . 17.5 tp -92.52 134.07 35.32 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.575 ' H ' HD12 ' A' ' 637' ' ' LEU . 0.4 OUTLIER -44.54 -61.13 1.66 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.575 1.15 . . . . 0.0 111.349 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.511 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 43.7 m-80 -122.63 31.19 6.18 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-O 121.316 0.579 . . . . 0.0 110.819 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.561 ' C ' ' HB3' ' A' ' 636' ' ' LEU . . . -150.48 -158.28 8.17 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 174.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.43 175.07 14.03 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 117.496 0.648 . . . . 0.0 109.87 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 655' ' ' VAL . 64.3 t -84.44 128.94 38.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.792 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.5 ptmt -84.81 -20.4 30.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.034 0.921 . . . . 0.0 109.643 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' A' ' 642' ' ' LYS . 48.0 mm-40 -91.25 163.49 14.22 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.806 -177.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -73.9 125.71 28.81 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.182 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.425 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 16.0 p -81.72 114.63 20.5 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-O 121.857 0.837 . . . . 0.0 111.455 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 49.9 mtmt -85.09 161.23 19.77 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -99.67 9.56 42.91 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.065 0.936 . . . . 0.0 109.586 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -157.47 96.97 1.58 Allowed 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 113.956 -1.475 . . . . 0.0 107.696 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.555 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 14.4 m-85 -86.63 -76.77 0.34 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.838 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 115.44 169.01 15.65 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.236 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.579 ' HB2' HG11 ' A' ' 627' ' ' VAL . 75.8 t60 -71.33 148.05 47.45 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.311 10.4 p 65.78 2.73 2.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.057 1.343 . . . . 0.0 113.831 -174.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -93.84 112.95 24.88 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.554 HG11 ' CE ' ' A' ' 670' ' ' LYS . 2.5 p -99.16 159.67 3.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-O 121.576 0.703 . . . . 0.0 109.552 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.0 t -121.01 106.97 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.67 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.348 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.792 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 18.4 mt-10 -68.67 124.84 24.74 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.461 0.648 . . . . 0.0 110.457 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.636 ' HB3' HD22 ' A' ' 636' ' ' LEU . 68.2 m-85 -108.92 172.03 7.09 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -150.07 140.72 22.59 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.57 ' SG ' HD21 ' A' ' 636' ' ' LEU . 80.7 m -100.01 163.84 12.26 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 47.4 m-80 -65.3 157.39 77.77 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.401 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 74.2 Cg_endo -71.84 15.6 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 123.931 3.087 . . . . 0.0 113.466 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -108.34 -3.97 17.85 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -134.15 156.33 48.52 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.289 -173.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 687' ' ' GLU . 72.1 mt -98.95 165.58 11.69 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 172.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.5 ttt -119.52 115.14 23.41 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.413 ' HB2' HD12 ' A' ' 685' ' ' ILE . 37.5 ttmt -71.39 -67.85 0.49 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -171.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.76 -161.46 37.49 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 115.551 -0.749 . . . . 0.0 113.18 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.39 123.09 11.81 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.036 2.491 . . . . 0.0 111.133 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 10.4 p-10 -61.48 -16.48 47.59 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 123.263 0.625 . . . . 0.0 111.891 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.62 ' HG2' ' CG ' ' A' ' 656' ' ' GLU . 13.2 mtpt -121.93 153.78 38.02 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 34.9 pt -138.01 144.44 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.487 HE21 ' N ' ' A' ' 672' ' ' GLN . 0.0 OUTLIER -122.55 151.59 41.24 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.268 -176.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 6.8 t -77.3 108.47 10.45 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.042 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . 0.442 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 35.9 m -102.7 107.9 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.576 0.703 . . . . 0.0 111.569 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . 0.644 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 7.4 t70 68.98 -62.62 0.39 Allowed 'General case' 0 C--O 1.216 -0.67 0 C-N-CA 124.913 1.285 . . . . 0.0 113.057 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -164.12 18.9 0.12 Allowed Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 174.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -138.13 144.04 40.63 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.401 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.3 m95 -75.92 158.03 32.5 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 13.5 p -77.52 174.26 11.07 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.964 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.7 m -65.03 131.85 47.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.215 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.559 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 5.0 mp -63.74 150.38 90.97 Favored Pre-proline 0 N--CA 1.435 -1.194 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.138 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.559 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 10.4 Cg_endo -56.22 -43.23 58.13 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 123.573 2.849 . . . . 0.0 113.368 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 81.5 t 66.08 121.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 122.639 1.209 . . . . 0.0 113.341 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.2 m -93.82 145.13 24.82 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.32 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -138.46 145.28 28.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.16 132.98 25.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 O-C-N 123.288 0.367 . . . . 0.0 110.951 -174.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . 0.519 ' HG3' HD21 ' A' ' 664' ' ' LEU . 38.5 tt0 . . . . . 0 C--O 1.249 1.039 0 O-C-N 124.035 0.834 . . . . 0.0 109.914 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 569' ' ' CYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 68.3 m -96.36 121.94 38.7 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.198 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -99.67 140.19 34.23 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 571' ' ' LEU . . . . . 0.838 HD11 ' HG3' ' A' ' 580' ' ' PRO . 3.2 tt -58.21 112.48 4.94 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 572' ' ' PRO . . . . . 0.532 ' HD3' HD23 ' A' ' 616' ' ' LEU . 93.3 Cg_endo -83.94 -158.57 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.527 2.818 . . . . 0.0 112.72 -175.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.8 91.95 6.58 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 574' ' ' ILE . . . . . 0.739 HG13 ' H ' ' A' ' 575' ' ' ASP . 6.5 pt -72.47 -88.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.827 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.825 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 17.6 t70 -160.26 173.37 15.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 173.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.87 -29.36 8.34 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-O 121.29 0.566 . . . . 0.0 109.543 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -98.94 3.57 47.13 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.461 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.9 tm? -96.0 147.42 23.71 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -177.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.47 ' N ' HD13 ' A' ' 578' ' ' LEU . 6.1 t -139.55 121.21 9.85 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 580' ' ' PRO . . . . . 0.838 ' HG3' HD11 ' A' ' 571' ' ' LEU . 60.4 Cg_endo -73.86 140.89 29.52 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.369 2.046 . . . . 0.0 112.173 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.57 -38.33 86.84 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 125.525 1.53 . . . . 0.0 110.687 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -75.97 -66.8 0.74 Allowed 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.63 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . 0.454 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 38.8 ttpt 57.52 78.23 0.24 Allowed 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.01 -178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.501 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 18.1 ptpt -132.87 175.47 9.32 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.304 -1.316 . . . . 0.0 107.773 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -76.86 -57.53 3.8 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.74 142.05 51.13 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 587' ' ' TYR . . . . . 0.608 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 94.8 m-85 -112.12 126.7 55.47 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -70.21 142.4 52.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.691 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 2.1 p -60.06 116.0 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-O 121.951 0.881 . . . . 0.0 111.329 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 121.29 -22.21 7.97 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.173 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -58.42 139.8 54.84 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.765 0.426 . . . . 0.0 110.416 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 592' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 610' ' ' GLN . 2.1 m -111.6 136.33 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 593' ' ' LEU . . . . . 0.581 ' HG ' ' CE2' ' A' ' 587' ' ' TYR 0.338 0.0 OUTLIER -130.78 113.54 14.23 Favored 'General case' 0 N--CA 1.396 -3.172 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.228 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 594' ' ' LYS . . . . . 0.683 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 64.9 mttm -76.46 147.91 37.57 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.55 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 595' ' ' PHE . . . . . 0.767 ' HB3' HD11 ' A' ' 578' ' ' LEU . 24.8 m-85 -121.61 166.39 14.3 Favored 'General case' 0 C--N 1.261 -3.277 0 C-N-CA 123.822 0.849 . . . . 0.0 110.1 177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 9.5 t -173.59 154.25 2.47 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 170.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 597' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 73.8 m -88.37 176.59 7.13 Favored 'General case' 0 C--N 1.259 -3.352 0 O-C-N 123.863 0.727 . . . . 0.0 110.636 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 598' ' ' LYS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.5 mmtp -55.37 162.38 2.29 Favored Pre-proline 0 N--CA 1.438 -1.061 0 C-N-CA 123.955 0.902 . . . . 0.0 112.257 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 599' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 91.5 Cg_exo -43.79 -44.09 11.67 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 124.51 3.473 . . . . 0.0 115.119 -175.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -88.93 -10.47 66.63 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.27 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 42.1 m-85 -97.54 155.28 17.03 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.893 0.854 . . . . 0.0 112.37 -176.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 602' ' ' THR . . . . . 0.578 HG21 HG11 ' A' ' 627' ' ' VAL . 10.7 m -107.76 126.88 53.16 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.808 174.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.465 ' HA ' ' SG ' ' A' ' 597' ' ' CYS . 5.2 tt -74.09 118.6 19.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.076 172.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . 0.672 HG21 ' HD3' ' A' ' 624' ' ' LYS . 67.4 t -111.64 110.78 33.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 133.7 -154.69 21.41 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.78 122.47 7.78 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.92 2.413 . . . . 0.0 112.315 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 1.2 t-20 -79.24 -36.46 39.92 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.38 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 608' ' ' SER . . . . . 0.683 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 52.8 p -125.49 100.63 6.56 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.884 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.3 m -98.03 161.13 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 610' ' ' GLN . . . . . 0.707 ' HG3' HG12 ' A' ' 592' ' ' VAL . 1.9 mp0 -115.87 158.6 22.72 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.691 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 37.3 t -80.95 104.61 11.57 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 118.613 -1.235 . . . . 0.0 107.903 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 612' ' ' TYR . . . . . 0.548 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 4.7 m-85 -87.64 167.87 13.51 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -74.9 0.06 16.93 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.648 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -116.65 7.48 13.57 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 131.06 174.52 13.69 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.972 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.532 HD23 ' HD3' ' A' ' 572' ' ' PRO . 2.9 mm? -63.73 109.59 1.76 Allowed 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 617' ' ' SER . . . . . 0.548 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 18.8 m -128.05 148.58 68.02 Favored Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -175.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.03 -171.22 8.71 Favored 'Cis proline' 0 CA--C 1.558 1.687 0 C-N-CA 123.644 -1.398 . . . . 0.0 113.476 1.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -57.96 151.58 18.07 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.895 0.379 . . . . 0.0 111.229 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 620' ' ' LEU . . . . . 0.525 ' H ' HD22 ' A' ' 620' ' ' LEU . 1.9 mm? -66.87 137.21 94.7 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.629 -173.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.8 170.83 10.74 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.802 3.001 . . . . 0.0 111.943 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 622' ' ' ILE . . . . . 0.541 HG13 ' HB ' ' A' ' 604' ' ' VAL . 43.1 pt -115.62 179.81 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 86.3 m -123.97 126.96 47.23 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.898 0.38 . . . . 0.0 110.971 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 624' ' ' LYS . . . . . 0.672 ' HD3' HG21 ' A' ' 604' ' ' VAL . 51.7 mtpt -124.08 121.61 35.65 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 14.0 tt0 -81.1 -28.34 35.24 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -100.77 111.53 23.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.555 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.578 HG11 HG21 ' A' ' 602' ' ' THR . 9.8 m -130.8 172.89 15.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.099 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 628' ' ' GLN . . . . . 0.545 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 25.8 mt-30 -96.32 164.02 12.83 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 37.8 m -110.79 -1.73 16.47 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.044 0.449 . . . . 0.0 110.139 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 69.7 m 70.77 -38.77 0.43 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.086 1.354 . . . . 0.0 114.435 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 100.68 -143.82 16.43 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -72.81 143.1 36.52 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 121.965 1.777 . . . . 0.0 109.81 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.444 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.4 Cg_endo -74.32 163.12 37.09 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.386 2.057 . . . . 0.0 112.302 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.9 173.29 7.19 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.705 2.27 . . . . 0.0 111.451 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -89.8 162.47 15.49 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.732 HD21 ' SG ' ' A' ' 659' ' ' CYS . 16.8 tp -92.54 166.89 12.29 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 177.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.609 ' H ' HD23 ' A' ' 637' ' ' LEU 0.303 2.0 pt? -82.76 -48.04 11.28 Favored 'General case' 0 N--CA 1.41 -2.462 0 C-N-CA 117.947 -1.501 . . . . 0.0 113.298 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.61 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 41.9 m-80 -124.82 34.15 5.06 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.734 0.778 . . . . 0.0 109.897 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -159.52 -139.78 2.75 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.903 174.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . 0.499 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.8 t-20 -162.47 -171.58 2.83 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.598 HG22 ' CE1' ' A' ' 657' ' ' TYR . 11.8 t -96.11 123.57 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.579 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.6 ptmt -79.34 -23.59 43.33 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.18 0.514 . . . . 0.0 109.91 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 12.1 mm-40 -78.96 152.27 31.15 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -79.49 121.53 25.31 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.977 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 33.1 p -68.22 99.05 0.86 Allowed 'General case' 0 N--CA 1.419 -1.977 0 CA-C-O 121.805 0.812 . . . . 0.0 112.617 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 54.6 pttt -89.09 160.79 16.87 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.408 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 40.4 mm-40 -78.73 -5.96 54.59 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -174.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -146.1 104.87 3.86 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' A' ' 655' ' ' VAL . 9.3 m-85 -90.64 -111.24 0.09 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.941 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 168.5 161.06 17.74 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 65.1 t60 -53.76 -57.36 11.16 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 32.9 m -89.98 8.28 33.22 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.927 -174.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -93.58 118.2 31.06 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.672 0.749 . . . . 0.0 110.382 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.609 HG21 ' HE3' ' A' ' 670' ' ' LYS . 4.5 m -89.95 151.66 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.516 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 30.2 m -116.67 104.16 16.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.654 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.579 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 23.5 mt-10 -65.36 124.29 21.87 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 122.218 1.009 . . . . 0.0 111.538 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.598 ' CE1' HG22 ' A' ' 641' ' ' VAL . 65.6 m-85 -102.5 165.64 10.98 Favored 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.431 173.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.499 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 8.8 p90 -146.81 137.32 23.74 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.732 ' SG ' HD21 ' A' ' 636' ' ' LEU . 61.2 m -97.24 165.86 11.84 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -63.6 150.29 90.69 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.41 0.85 1.99 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 124.13 3.22 . . . . 0.0 114.573 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 662' ' ' ARG . 9.6 mmm180 -98.54 -0.98 42.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -130.26 169.19 15.74 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.308 -173.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 88.5 mt -108.88 161.02 15.52 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.4 ttt -117.8 113.53 21.94 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.434 ' HB3' HG23 ' A' ' 683' ' ' VAL . 24.8 ttmm -68.3 -64.01 0.95 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -102.85 -158.24 25.48 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 121.122 -0.561 . . . . 0.0 114.116 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.93 121.51 9.62 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.767 2.978 . . . . 0.0 111.603 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 16.9 p-10 -79.4 -11.8 59.91 Favored 'General case' 0 C--O 1.178 -2.709 0 CA-C-O 120.917 0.389 . . . . 0.0 110.856 -177.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 5.3 ptmt -125.82 112.01 15.53 Favored 'General case' 0 C--N 1.27 -2.874 0 C-N-CA 123.932 0.893 . . . . 0.0 109.51 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 34.4 pt -109.92 151.47 12.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.708 -174.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.19 160.83 21.41 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.565 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 16.9 t -82.39 92.79 7.07 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.491 1.139 . . . . 0.0 111.796 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 83.8 t -80.7 113.93 20.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.667 -1.152 . . . . 0.0 110.151 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 19.7 t70 57.3 -69.52 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.582 1.953 . . . . 0.0 112.593 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -157.67 26.86 0.46 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 111.769 -0.532 . . . . 0.0 111.769 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -145.06 151.13 38.05 Favored 'General case' 0 C--O 1.21 -1.022 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.54 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.3 m95 -82.64 170.7 14.84 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . 0.453 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 5.5 p -92.65 -174.52 3.67 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 30.0 m -68.94 131.12 44.57 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.792 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.413 HD23 HD12 ' A' ' 636' ' ' LEU . 7.3 mp -67.51 157.51 85.58 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 21.9 Cg_endo -62.8 -21.35 72.99 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 124.346 3.364 . . . . 0.0 115.879 -176.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.533 ' HA ' HD21 ' A' ' 637' ' ' LEU 0.357 22.4 m 49.97 109.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -178.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.705 ' SG ' HD21 ' A' ' 636' ' ' LEU . 3.5 m -88.0 147.36 25.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.549 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.4 151.73 16.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.76 141.63 16.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 C--O 1.255 1.373 0 O-C-N 124.09 0.869 . . . . 0.0 110.625 178.901 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 N--CA 1.446 -0.649 0 CA-C-O 120.691 0.282 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -69.73 -41.53 75.18 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . 0.706 ' HB3' ' HG3' ' A' ' 566' ' ' GLU . . . -94.46 7.49 45.37 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.979 0.419 . . . . 0.0 110.586 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 76.53 15.58 81.41 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.706 ' HG3' ' HB3' ' A' ' 564' ' ' ALA . 0.0 OUTLIER -79.11 99.97 7.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.256 0.55 . . . . 0.0 112.215 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -177.07 -63.1 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 175.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . 0.593 ' HG3' ' HB3' ' A' ' 586' ' ' GLN . 0.0 OUTLIER 174.79 -173.26 0.07 Allowed 'General case' 0 C--O 1.244 0.774 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 174.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 91.5 m -96.39 140.86 30.43 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -126.05 130.26 50.78 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.848 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.2 tt -53.05 119.27 16.05 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.524 ' HG2' HD21 ' A' ' 620' ' ' LEU . 87.8 Cg_endo -78.72 -157.74 0.08 OUTLIER 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.234 2.623 . . . . 0.0 111.566 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -91.09 107.64 19.34 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.489 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.738 HG22 HD23 ' A' ' 620' ' ' LEU . 35.1 pt -79.58 -171.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.477 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.936 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.1 t70 -73.74 159.49 32.88 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 10.5 p -68.17 -31.91 53.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -98.8 6.35 46.94 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 121.992 -0.443 . . . . 0.0 111.4 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.936 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.0 tm? -95.54 150.66 20.08 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.486 ' N ' HD13 ' A' ' 578' ' ' LEU . 7.1 m -145.31 118.18 5.33 Favored Pre-proline 0 C--N 1.293 -1.86 0 C-N-CA 125.006 1.322 . . . . 0.0 108.241 176.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.848 ' HG3' HD11 ' A' ' 571' ' ' LEU . 36.8 Cg_endo -70.23 131.03 19.74 Favored 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 121.255 1.304 . . . . 0.0 110.78 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.15 -34.89 79.07 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . 0.443 ' HB2' HD22 ' A' ' 593' ' ' LEU . 55.0 mmt-85 -88.09 104.83 17.04 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 171.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -117.65 97.48 5.88 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.454 ' HG3' ' H ' ' A' ' 585' ' ' ASP 0.288 10.4 ptpt -113.46 -93.39 0.47 Allowed 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.04 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.454 ' H ' ' HG3' ' A' ' 584' ' ' LYS . 5.6 t70 -173.82 -62.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 176.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . 0.593 ' HB3' ' HG3' ' A' ' 568' ' ' GLU . 0.0 OUTLIER -121.14 145.0 48.27 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.963 175.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.658 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 23.7 m-85 -114.84 132.57 56.46 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 -171.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' A' ' 591' ' ' GLU . 33.8 mtmm -90.06 161.11 15.98 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.517 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.41 121.9 16.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.209 0.528 . . . . 0.0 110.309 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 103.29 -0.08 47.16 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.881 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 588' ' ' LYS . 82.0 mm-40 -67.1 122.1 17.05 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 117.756 0.778 . . . . 0.0 109.012 173.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.585 HG12 ' HG3' ' A' ' 610' ' ' GLN . 7.0 m -95.41 117.68 39.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 CA-C-O 122.307 1.051 . . . . 0.0 108.63 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.623 HD21 ' HD2' ' A' ' 587' ' ' TYR . 17.5 mt -101.85 101.46 11.91 Favored 'General case' 0 C--N 1.274 -2.71 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.059 -174.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.599 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 10.3 mtmp? -79.72 113.38 17.83 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.782 ' HB3' HD11 ' A' ' 578' ' ' LEU . 80.4 m-85 -95.91 167.4 11.27 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . 0.415 ' O ' HD22 ' A' ' 578' ' ' LEU . 21.4 t -168.18 -179.18 3.95 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 170.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 77.8 m -118.4 177.36 4.85 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 123.68 0.612 . . . . 0.0 112.488 -173.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 30.1 mmtp -50.59 162.36 0.55 Allowed Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 125.372 1.469 . . . . 0.0 112.27 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 76.7 Cg_exo -47.76 -43.47 28.79 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.248 3.299 . . . . 0.0 113.761 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.66 1.64 63.99 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.957 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 37.4 m-85 -105.57 141.01 37.78 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-O 121.961 0.886 . . . . 0.0 112.777 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.662 HG21 HG11 ' A' ' 627' ' ' VAL . 9.8 m -102.69 126.84 49.94 Favored 'General case' 0 N--CA 1.393 -3.293 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.338 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.451 HD11 ' HG3' ' A' ' 621' ' ' PRO . 10.8 tt -73.18 123.51 28.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.097 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.486 HG21 ' HD3' ' A' ' 624' ' ' LYS . 86.6 t -113.14 126.49 70.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.764 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.07 -145.61 18.46 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -81.41 124.11 4.62 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.773 2.315 . . . . 0.0 110.864 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -85.26 -42.93 14.21 Favored 'General case' 0 C--O 1.204 -1.313 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.832 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.599 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 18.6 p -114.14 97.86 6.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.14 0.495 . . . . 0.0 111.983 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . 0.449 ' C ' HE21 ' A' ' 610' ' ' GLN . 11.1 m -92.66 163.18 2.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.596 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -113.18 154.1 27.23 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.374 0.607 . . . . 0.0 110.209 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 6.6 t -85.14 108.75 17.84 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.72 170.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' ' 617' ' ' SER . 55.3 m-85 -91.57 166.79 12.65 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 175.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.28 -7.58 19.55 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -105.97 -10.59 16.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.998 0.427 . . . . 0.0 111.225 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 140.94 -172.49 23.65 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.532 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.443 ' CD2' ' HB3' ' A' ' 569' ' ' CYS . 2.8 mm? -79.32 127.82 32.56 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.55 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 47.8 t -149.09 147.18 22.99 Favored Pre-proline 0 N--CA 1.429 -1.516 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 609' ' ' VAL . 57.3 Cg_endo -71.33 -175.74 13.4 Favored 'Cis proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.641 -1.4 . . . . 0.0 114.038 1.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -63.26 142.44 58.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.032 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.738 HD23 HG22 ' A' ' 574' ' ' ILE . 8.7 mp -57.58 143.6 74.82 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -173.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.451 ' HG3' HD11 ' A' ' 603' ' ' ILE . 38.2 Cg_endo -68.05 -178.53 1.75 Allowed 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 124.748 3.632 . . . . 0.0 113.341 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . 0.431 HG13 ' HB ' ' A' ' 604' ' ' VAL . 40.1 pt -130.81 -178.87 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.4 m -129.0 119.5 24.39 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.222 0.534 . . . . 0.0 111.787 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.486 ' HD3' HG21 ' A' ' 604' ' ' VAL . 47.8 mtpt -114.04 126.04 54.67 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.837 177.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 18.3 tt0 -81.83 -27.05 33.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -123.8 113.63 18.81 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.286 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.662 HG11 HG21 ' A' ' 602' ' ' THR . 3.2 m -106.23 177.83 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.499 176.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.476 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 73.0 mt-30 -97.51 167.0 11.25 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.465 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 49.2 m -105.19 -4.92 21.17 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.536 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.1 m 68.15 -31.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 82.31 -139.06 19.32 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 633' ' ' PRO . 46.8 Cg_endo -75.9 154.39 38.3 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.449 2.099 . . . . 0.0 111.27 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.553 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 61.7 Cg_endo -92.07 174.12 2.25 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 123.087 2.525 . . . . 0.0 111.532 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.78 -173.72 1.87 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.033 1.822 . . . . 0.0 109.985 172.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.41 159.87 24.22 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.526 ' HB3' ' C ' ' A' ' 639' ' ' GLY . 14.7 tp -70.56 144.8 51.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.574 ' HG ' ' H ' ' A' ' 638' ' ' ASN . 0.9 OUTLIER -48.96 -71.76 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.574 ' H ' ' HG ' ' A' ' 637' ' ' LEU . 9.5 m120 -94.03 -32.57 13.76 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.622 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -85.15 -154.21 21.81 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.497 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . 0.594 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.7 t-20 -152.05 -173.66 4.61 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.8 p -101.72 133.54 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -93.43 -27.34 16.77 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.211 0.529 . . . . 0.0 110.641 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.714 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 38.5 mm-40 -81.56 153.78 26.57 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.245 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -67.12 122.25 17.39 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.257 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.463 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 16.6 p -76.97 110.53 11.67 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.417 0.627 . . . . 0.0 110.242 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -82.32 157.39 23.83 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.186 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.94 -9.29 59.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.724 0.773 . . . . 0.0 109.696 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.642 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 38.4 tt0 -156.1 124.24 5.73 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.558 ' CE2' HG22 ' A' ' 655' ' ' VAL . 13.9 m-85 -98.44 -63.08 1.16 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 123.471 0.482 . . . . 0.0 111.637 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 112.23 162.04 16.1 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.56 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.3 t60 -63.68 140.56 58.88 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.0 m 75.78 -4.04 2.45 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.417 1.087 . . . . 0.0 113.546 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 649' ' ' TYR . 5.3 tp10 -81.87 120.14 24.82 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.9 m -91.47 159.46 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-O 122.1 0.952 . . . . 0.0 112.564 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.9 t -127.11 102.61 9.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.871 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.714 ' HB2' ' HG2' ' A' ' 643' ' ' GLU . 29.8 mt-10 -67.69 132.66 47.9 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 122.153 0.978 . . . . 0.0 112.194 175.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 67.9 m-85 -112.7 171.43 7.53 Favored 'General case' 0 C--N 1.28 -2.447 0 C-N-CA 126.372 1.869 . . . . 0.0 109.596 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 31.4 p90 -151.06 141.9 22.87 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 175.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.622 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 7.3 t -105.81 -177.66 3.43 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.765 -1.174 . . . . 0.0 108.746 176.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 34.6 m-80 -70.35 151.39 95.74 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.41 ' C ' ' HD2' ' A' ' 662' ' ' ARG . 52.7 Cg_endo -68.46 26.24 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 124.31 3.34 . . . . 0.0 114.092 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.41 ' HD2' ' C ' ' A' ' 661' ' ' PRO . 13.3 mmm180 -128.35 5.07 5.72 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 660' ' ' ASN . 44.1 m-85 -123.74 164.84 18.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.309 -172.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.428 HD21 ' OE2' ' A' ' 687' ' ' GLU . 90.3 mt -110.18 143.54 40.15 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 125.423 1.489 . . . . 0.0 107.31 175.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.9 ttt -114.04 102.52 10.26 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.788 ' HG2' HD11 ' A' ' 685' ' ' ILE . 72.3 mmtt -73.18 -63.22 1.23 Allowed 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.882 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -83.35 -168.52 43.45 Favored Glycine 0 N--CA 1.404 -3.486 0 CA-C-N 114.792 -1.095 . . . . 0.0 113.473 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.0 118.04 5.01 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.108 2.538 . . . . 0.0 112.07 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 3.7 p-10 -80.34 19.31 0.78 Allowed 'General case' 0 C--O 1.19 -2.028 0 C-N-CA 122.886 0.475 . . . . 0.0 111.426 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.72 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 7.0 ptmt -162.14 111.17 1.46 Allowed 'General case' 0 N--CA 1.414 -2.226 0 C-N-CA 124.861 1.264 . . . . 0.0 108.024 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 35.3 pt -107.63 144.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.986 -174.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.606 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -112.67 142.81 44.85 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 123.677 0.611 . . . . 0.0 110.848 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.0 t -67.41 116.89 8.67 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.683 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.56 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 34.1 m -109.18 127.7 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.409 ' H ' ' CE1' ' A' ' 651' ' ' HIS . 28.2 t70 54.79 -80.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.538 1.135 . . . . 0.0 112.031 -169.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -157.11 31.67 0.54 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -143.02 156.45 44.84 Favored 'General case' 0 C--O 1.212 -0.88 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.463 ' HB3' HD12 ' A' ' 671' ' ' ILE . 97.7 m95 -93.15 166.1 12.5 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 7.9 p -91.81 -169.72 2.36 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 35.1 m -71.54 126.29 29.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.71 0.29 . . . . 0.0 110.413 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.0 mp -61.93 160.41 29.32 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.893 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.611 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 24.6 Cg_endo -63.34 -15.33 47.65 Favored 'Trans proline' 0 CA--C 1.498 -1.312 0 C-N-CA 123.663 2.908 . . . . 0.0 115.035 -175.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 22.4 m 43.21 93.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 124.87 1.356 . . . . 0.0 114.411 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 23.3 p -95.75 137.26 35.06 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.662 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.788 HD11 ' HG2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -133.5 147.48 31.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.004 -178.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 98.3 t -52.56 133.27 14.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -172.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.428 ' OE2' HD21 ' A' ' 664' ' ' LEU . 6.9 tp10 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.184 1.394 . . . . 0.0 108.963 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . 0.476 ' HA ' ' CD ' ' A' ' 570' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.242 0.69 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 76.4 11.86 2.71 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.491 1.516 . . . . 0.0 112.954 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . 0.816 ' HB3' ' HB2' ' A' ' 570' ' ' GLU . . . -97.52 105.4 17.54 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -77.78 75.83 1.81 Allowed Glycine 0 C--N 1.306 -1.128 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.836 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 55.48 -165.96 0.11 Allowed 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.094 0.958 . . . . 0.0 112.879 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 613' ' ' HIS . 45.5 mtp180 71.37 -5.23 1.63 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.206 1.402 . . . . 0.0 112.808 176.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -161.66 162.72 30.02 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 74.9 m -98.81 112.72 24.72 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-O 121.876 0.846 . . . . 0.0 112.471 -175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.816 ' HB2' ' HB3' ' A' ' 564' ' ' ALA . 21.3 tt0 -82.97 -23.58 33.31 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.24 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 32.3 tp 79.02 105.08 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 113.665 -1.607 . . . . 0.0 108.922 -169.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.711 ' HD2' HD12 ' A' ' 616' ' ' LEU . 24.5 Cg_endo -62.94 -172.6 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.062 2.508 . . . . 0.0 113.429 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.89 20.77 0.45 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -170.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.779 HG13 ' H ' ' A' ' 575' ' ' ASP . 26.1 pt 35.19 -94.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 126.523 1.929 . . . . 0.0 115.469 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.779 ' H ' HG13 ' A' ' 574' ' ' ILE . 15.7 t70 -165.1 179.74 6.17 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.82 -27.57 4.98 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -103.52 10.17 37.23 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.622 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.739 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.7 tp -100.14 164.49 11.95 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.65 122.52 1.94 Allowed Pre-proline 0 C--N 1.308 -1.238 0 C-N-CA 124.044 0.938 . . . . 0.0 108.803 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.2 137.51 21.39 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.123 1.882 . . . . 0.0 112.209 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -78.74 -42.11 29.02 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -90.33 113.56 25.46 Favored 'General case' 0 N--CA 1.392 -3.349 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.58 ' HA ' ' OH ' ' A' ' 587' ' ' TYR . 64.1 tttp -135.24 135.44 40.94 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.311 0.577 . . . . 0.0 111.641 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.621 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 13.1 ptpt -160.43 -160.31 0.76 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.634 1.174 . . . . 0.0 108.489 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -90.34 -64.46 1.13 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.03 0.443 . . . . 0.0 110.656 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.98 134.3 55.29 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.645 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 69.3 m-85 -96.39 127.5 42.45 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -84.36 145.33 28.28 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.876 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 1.6 p -55.59 111.36 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 122.17 0.986 . . . . 0.0 112.755 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 115.26 -6.29 21.35 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.862 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -70.23 137.95 51.27 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 171.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 4.1 m -104.63 123.89 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-O 122.03 0.919 . . . . 0.0 109.499 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.477 HD11 ' CD2' ' A' ' 587' ' ' TYR . 7.4 mp -107.48 104.79 14.44 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.174 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 28.8 mtpp -82.95 119.33 24.29 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.763 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.45 158.62 16.08 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-O 120.957 0.408 . . . . 0.0 110.684 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 19.6 m -150.59 171.74 16.63 Favored 'General case' 0 N--CA 1.398 -3.044 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.555 ' SG ' HD12 ' A' ' 578' ' ' LEU . 95.3 m -112.87 179.84 3.85 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-O 120.656 0.265 . . . . 0.0 110.333 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -52.23 162.07 0.92 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.302 1.441 . . . . 0.0 112.306 173.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.45 -41.96 42.61 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.268 3.312 . . . . 0.0 114.283 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 625' ' ' GLU . . . -96.52 1.71 62.21 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.627 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -103.84 147.82 26.85 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.876 0.846 . . . . 0.0 112.892 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.602 HG21 HG11 ' A' ' 627' ' ' VAL . 17.8 m -98.83 134.95 40.98 Favored 'General case' 0 C--N 1.272 -2.762 0 CA-C-N 113.728 -1.578 . . . . 0.0 109.104 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.579 HD11 ' HG3' ' A' ' 621' ' ' PRO . 7.6 tt -82.48 115.66 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.831 0.824 . . . . 0.0 109.348 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.537 ' HB ' HG13 ' A' ' 622' ' ' ILE . 61.9 t -106.72 101.84 13.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.726 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 137.31 -162.38 25.36 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.0 123.44 10.66 Favored 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 122.827 2.351 . . . . 0.0 111.963 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.34 -49.46 11.49 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 175.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 66.5 p -104.31 106.91 17.58 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.58 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.18 161.2 4.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.642 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 22.8 mm-40 -105.08 163.48 12.53 Favored 'General case' 0 CA--C 1.473 -2.003 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.537 ' HA ' HD23 ' A' ' 616' ' ' LEU . 43.4 t -88.01 132.54 34.23 Favored 'General case' 0 C--N 1.275 -2.672 0 C-N-CA 118.646 -1.222 . . . . 0.0 107.78 166.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.642 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 75.2 m-85 -116.61 168.84 9.83 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' A' ' 567' ' ' ARG . 3.5 p80 -67.64 -5.37 15.4 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -111.23 -9.24 14.33 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 122.007 -0.433 . . . . 0.0 110.266 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 138.61 -177.4 20.17 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.711 HD12 ' HD2' ' A' ' 572' ' ' PRO . 94.3 mt -68.57 140.83 55.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 117.037 0.419 . . . . 0.0 109.899 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 2.5 t -156.31 150.83 20.21 Favored Pre-proline 0 N--CA 1.421 -1.915 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.457 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 59.8 Cg_endo -69.99 -176.64 13.3 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.672 -1.386 . . . . 0.0 112.99 1.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.13 144.98 32.66 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.995 0.426 . . . . 0.0 110.408 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.563 HD23 HG22 ' A' ' 574' ' ' ILE . 8.4 mp -64.76 145.56 98.77 Favored Pre-proline 0 C--N 1.299 -1.592 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.248 -172.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.579 ' HG3' HD11 ' A' ' 603' ' ' ILE . 72.3 Cg_endo -71.25 170.22 18.82 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 123.452 2.768 . . . . 0.0 112.54 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 604' ' ' VAL . 38.8 pt -116.7 -178.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 602' ' ' THR . 73.3 m -126.44 125.8 42.74 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.977 0.418 . . . . 0.0 111.443 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 624' ' ' LYS . 47.8 mtpt -119.31 140.11 50.83 Favored 'General case' 0 C--O 1.194 -1.862 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 600' ' ' GLY . 1.4 tm-20 -90.67 -43.72 9.96 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -95.76 112.02 23.85 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.471 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.602 HG11 HG21 ' A' ' 602' ' ' THR . 7.4 m -123.21 175.63 5.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.489 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.68 170.15 9.2 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 15.5 m -102.03 -11.11 19.15 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 93.0 m 70.6 8.99 6.79 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 112.376 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 60.58 -144.74 47.72 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -82.38 153.6 16.05 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.481 2.12 . . . . 0.0 110.292 173.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.68 ' HG3' HG11 ' A' ' 655' ' ' VAL . 57.0 Cg_endo -71.05 153.53 62.93 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.842 2.362 . . . . 0.0 113.366 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.4 173.99 6.85 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.627 2.884 . . . . 0.0 113.097 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -88.21 153.33 21.32 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 121.173 0.511 . . . . 0.0 110.926 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.59 HD22 ' HB3' ' A' ' 657' ' ' TYR . 23.4 tp -97.04 123.92 40.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' A' ' 683' ' ' VAL . 0.0 OUTLIER -39.66 -46.8 1.89 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -177.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.4 ' N ' HD22 ' A' ' 637' ' ' LEU . 72.2 m-20 -137.92 39.99 2.34 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.263 1.03 . . . . 0.0 109.507 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.629 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.46 -152.96 6.36 Favored Glycine 0 N--CA 1.397 -3.96 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . 0.404 HD22 ' HA ' ' A' ' 640' ' ' ASN . 0.2 OUTLIER -164.67 -176.58 4.35 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 124.087 0.955 . . . . 0.0 108.682 175.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.601 HG11 HG21 ' A' ' 645' ' ' THR . 6.4 p -95.99 130.31 44.85 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.042 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.637 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.5 ptmt -85.25 -27.4 26.05 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.245 0.545 . . . . 0.0 110.255 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 40.2 mm-40 -80.8 143.6 32.72 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.725 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . 0.781 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -52.8 120.76 6.14 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 124.646 1.217 . . . . 0.0 109.39 173.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.601 HG21 HG11 ' A' ' 641' ' ' VAL . 4.1 p -101.35 104.96 15.97 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -172.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -85.17 149.55 25.44 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 113.601 -1.636 . . . . 0.0 108.126 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -80.69 16.62 1.34 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -155.48 105.27 2.44 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.484 ' CE2' HG22 ' A' ' 655' ' ' VAL . 3.4 m-85 -90.85 -88.57 0.18 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 143.02 157.08 7.01 Favored Glycine 0 N--CA 1.424 -2.142 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -175.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.415 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 84.6 t60 -67.12 138.72 57.28 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.511 0.196 . . . . 0.0 111.023 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 68.6 m 69.25 5.88 5.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.702 1.201 . . . . 0.0 113.044 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -92.69 117.54 30.1 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.646 HG21 ' HE3' ' A' ' 670' ' ' LYS . 12.8 m -86.49 159.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.694 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.5 t -129.03 117.54 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.904 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.637 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 20.9 mt-10 -73.02 124.38 25.38 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.773 0.797 . . . . 0.0 112.245 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.59 ' HB3' HD22 ' A' ' 636' ' ' LEU . 34.3 m-85 -104.58 172.62 6.69 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.092 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -146.81 137.26 23.71 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.629 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 70.9 m -95.43 172.85 7.83 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.46 ' HB2' ' HD1' ' A' ' 663' ' ' PHE . 9.8 m120 -63.73 152.56 86.16 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.85 -4.36 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.411 2.74 . . . . 0.0 112.538 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -96.42 -1.27 47.88 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 124.311 1.044 . . . . 0.0 108.865 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.46 ' HD1' ' HB2' ' A' ' 660' ' ' ASN . 45.4 m-85 -131.75 158.02 42.28 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.103 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 89.1 mt -100.17 158.03 16.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.421 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 6.2 ttt -124.6 95.08 4.39 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -176.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -86.95 -44.52 11.57 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.351 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -78.65 -179.64 51.5 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.975 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.24 114.85 2.29 Favored 'Trans proline' 0 C--N 1.334 -0.232 0 C-N-CA 123.138 2.558 . . . . 0.0 111.142 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 17.6 p-10 -73.92 -11.39 60.34 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 120.724 0.297 . . . . 0.0 111.428 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 2.3 mtpp -121.3 120.06 34.02 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 33.6 pt -111.12 152.59 13.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.532 -1.267 . . . . 0.0 110.924 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.66 154.05 29.11 Favored 'General case' 0 N--CA 1.425 -1.688 0 O-C-N 123.881 0.738 . . . . 0.0 109.489 -172.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 2.8 t -85.62 122.55 29.88 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.057 174.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.415 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 77.9 t -114.42 114.68 47.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.211 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.7 t70 55.16 -78.54 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.25 1.42 . . . . 0.0 111.765 -171.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -149.1 18.2 1.2 Allowed Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -130.07 150.84 51.16 Favored 'General case' 0 C--O 1.209 -1.057 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.561 ' HB3' HD12 ' A' ' 671' ' ' ILE . 95.8 m95 -87.86 162.96 16.66 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 19.2 p -81.68 -178.15 6.85 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 27.3 m -64.39 130.85 45.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.462 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.0 mp -68.56 162.37 63.11 Favored Pre-proline 0 N--CA 1.446 -0.669 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.573 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 31.6 Cg_endo -67.76 -16.06 45.44 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 123.808 3.005 . . . . 0.0 114.721 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.513 ' HA ' HD11 ' A' ' 637' ' ' LEU 0.304 13.2 m 44.25 92.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 175.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 3.6 m -67.19 139.6 57.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.329 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.17 148.11 33.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.593 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 44.8 t -65.36 135.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 O-C-N 123.39 0.431 . . . . 0.0 110.731 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.25 1.108 0 O-C-N 123.848 0.718 . . . . 0.0 109.856 179.23 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -96.59 -51.16 4.43 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.394 0.616 . . . . 0.0 109.391 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -136.5 142.8 43.53 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.36 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -80.62 90.76 1.36 Allowed Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.19 -39.29 15.62 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -111.93 23.26 13.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.512 1.149 . . . . 0.0 108.098 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 569' ' ' CYS . 3.9 tp10 -142.06 -161.93 1.32 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 102.039 -3.319 . . . . 0.0 102.039 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 616' ' ' LEU . 87.4 m -138.81 161.16 37.94 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 119.518 1.054 . . . . 0.0 112.669 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -138.34 117.9 13.0 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 104.538 -2.394 . . . . 0.0 104.538 168.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.659 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 2.0 tt -34.57 121.8 0.55 Allowed Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 125.37 1.468 . . . . 0.0 109.56 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.625 ' HD2' HD22 ' A' ' 616' ' ' LEU . 70.6 Cg_endo -69.58 -169.9 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.36 2.04 . . . . 0.0 111.549 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -87.63 101.36 13.58 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.439 -0.905 . . . . 0.0 109.602 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.813 HG22 HD23 ' A' ' 620' ' ' LEU . 38.9 pt -67.42 -172.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.987 0 CA-C-O 121.759 0.79 . . . . 0.0 110.674 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.805 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 6.4 t70 -66.34 -175.15 0.33 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.046 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.92 -27.3 4.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 O-C-N 121.407 -0.808 . . . . 0.0 109.358 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -109.58 9.94 25.11 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 122.124 -0.36 . . . . 0.0 111.868 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.879 HD11 ' HB3' ' A' ' 595' ' ' PHE . 1.6 tm? -89.99 151.37 21.71 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.51 ' N ' HD13 ' A' ' 578' ' ' LEU . 7.6 p -148.88 117.16 3.89 Favored Pre-proline 0 C--N 1.294 -1.845 0 C-N-CA 123.907 0.883 . . . . 0.0 109.303 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.612 ' HG3' HD11 ' A' ' 571' ' ' LEU . 64.8 Cg_endo -75.16 148.9 35.31 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.643 2.229 . . . . 0.0 112.909 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.74 -55.99 8.4 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -75.1 108.77 8.06 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.91 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -120.81 97.72 5.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 174.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.51 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.8 ptpt -133.44 167.43 20.46 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.118 -176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.28 -67.18 0.44 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 124.052 0.845 . . . . 0.0 110.992 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 144.13 49.04 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.659 ' CE1' ' HB2' ' A' ' 571' ' ' LEU . 45.2 m-85 -103.69 132.47 49.91 Favored 'General case' 0 CA--C 1.467 -2.247 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.843 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . 0.432 ' HA ' ' OE2' ' A' ' 568' ' ' GLU . 19.4 mtpp -81.24 147.36 29.99 Favored 'General case' 0 C--N 1.273 -2.747 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.521 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.707 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 46.6 t -59.44 112.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.178 0.513 . . . . 0.0 110.23 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 113.08 -6.01 25.39 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.416 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.97 135.63 47.99 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.532 HG12 ' HG3' ' A' ' 610' ' ' GLN . 3.8 m -106.33 134.12 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 C-N-CA 119.77 -0.772 . . . . 0.0 108.974 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 608' ' ' SER . 5.4 mp -113.8 103.69 11.45 Favored 'General case' 0 C--N 1.273 -2.745 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.563 ' HG2' ' HB2' ' A' ' 608' ' ' SER . 84.3 mttt -78.6 103.31 8.46 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.879 ' HB3' HD11 ' A' ' 578' ' ' LEU . 44.3 m-85 -86.69 162.94 17.64 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.757 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . 0.666 ' HA ' HD12 ' A' ' 603' ' ' ILE . 66.5 m -164.18 -175.35 3.94 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 169.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 603' ' ' ILE . 98.0 m -113.02 171.13 7.72 Favored 'General case' 0 C--N 1.259 -3.359 0 O-C-N 123.563 0.54 . . . . 0.0 110.968 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.601 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 29.3 mmtp -56.94 162.21 3.98 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.873 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 44.3 Cg_exo -39.09 -41.37 1.89 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 125.104 3.869 . . . . 0.0 116.644 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -98.42 6.06 60.99 Favored Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.643 -0.789 . . . . 0.0 114.283 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 56.7 m-85 -109.92 150.65 28.14 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 51.9 m -98.29 125.46 43.4 Favored 'General case' 0 N--CA 1.406 -2.675 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.92 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 596' ' ' SER . 8.0 tt -76.02 128.24 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.586 ' HB ' HG13 ' A' ' 622' ' ' ILE . 84.4 t -119.21 105.12 16.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.264 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 134.39 -168.81 23.31 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.697 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.86 116.58 3.54 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 123.519 2.812 . . . . 0.0 110.347 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -81.92 -43.56 17.95 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.624 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.563 ' HB2' ' HG2' ' A' ' 594' ' ' LYS . 15.0 t -111.79 89.76 3.15 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 119.216 -0.993 . . . . 0.0 112.536 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . 0.403 HG22 ' CE2' ' A' ' 595' ' ' PHE . 18.0 m -80.2 165.89 2.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.609 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -109.9 154.54 22.93 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.551 0.691 . . . . 0.0 109.664 177.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 0.0 OUTLIER -86.41 131.66 34.14 Favored 'General case' 0 C--N 1.265 -3.071 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.132 167.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.466 ' CD1' ' HB3' ' A' ' 617' ' ' SER . 86.2 m-85 -117.62 173.71 6.57 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -72.45 -5.0 33.63 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.36 -0.837 . . . . 0.0 113.091 -176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -108.02 -3.06 19.1 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.436 0.636 . . . . 0.0 110.417 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 130.31 -171.42 20.6 Favored Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.625 HD22 ' HD2' ' A' ' 572' ' ' PRO . 8.2 mp -82.13 141.69 32.88 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 46.3 t -159.7 153.02 18.57 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.48 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 78.8 Cg_endo -76.45 -167.6 6.03 Favored 'Cis proline' 0 N--CA 1.481 0.788 0 C-N-CA 124.047 -1.23 . . . . 0.0 113.317 1.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -50.16 144.01 7.63 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.442 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.813 HD23 HG22 ' A' ' 574' ' ' ILE . 7.7 mp -78.99 148.72 72.4 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.177 -173.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.462 ' HG3' HD11 ' A' ' 603' ' ' ILE . 36.3 Cg_endo -67.35 168.56 17.52 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 124.093 3.195 . . . . 0.0 112.952 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . 0.586 HG13 ' HB ' ' A' ' 604' ' ' VAL . 45.6 pt -116.25 -179.66 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 78.5 m -124.6 123.13 39.4 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.969 0.414 . . . . 0.0 111.632 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.517 ' HG3' HG21 ' A' ' 604' ' ' VAL . 6.4 mmmm -115.92 121.97 43.9 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.517 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 1.6 tm-20 -88.96 -36.72 15.71 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -93.23 78.65 4.51 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.62 HG23 ' HA ' ' A' ' 675' ' ' ASP . 11.8 p -88.07 154.99 3.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.265 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.465 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 78.0 mt-30 -84.71 167.4 16.19 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.488 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 21.5 m -108.19 -8.95 15.62 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.3 m 70.15 -55.36 0.61 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.337 1.055 . . . . 0.0 111.903 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 109.14 -143.71 16.4 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.23 132.84 28.79 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.685 1.59 . . . . 0.0 111.423 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.438 ' HG3' HG11 ' A' ' 655' ' ' VAL . 56.8 Cg_endo -69.29 164.97 32.06 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 123.505 2.803 . . . . 0.0 112.77 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.08 177.74 4.14 Favored 'Trans proline' 0 C--O 1.254 1.29 0 C-N-CA 122.773 2.315 . . . . 0.0 111.314 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -95.24 165.24 12.49 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.551 HD22 ' HB3' ' A' ' 657' ' ' TYR . 19.3 tp -91.46 156.46 17.7 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 176.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.464 HD21 ' H ' ' A' ' 684' ' ' CYS . 1.7 pt? -53.2 -64.27 0.88 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.59 0.632 . . . . 0.0 112.49 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.45 -23.92 11.65 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.384 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -94.67 -152.75 29.68 Favored Glycine 0 N--CA 1.439 -1.155 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.727 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.52 -164.92 1.94 Allowed 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.4 p -104.73 136.18 39.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -94.62 -21.14 19.01 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.299 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.508 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 23.9 mm-40 -81.67 154.59 26.02 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -70.3 113.53 7.56 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.435 ' CG2' HG11 ' A' ' 641' ' ' VAL . 1.5 p -70.75 99.89 1.79 Allowed 'General case' 0 N--CA 1.42 -1.949 0 CA-C-O 121.777 0.799 . . . . 0.0 111.837 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -82.85 169.72 15.78 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.166 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.21 -26.41 33.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.049 0.452 . . . . 0.0 111.207 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -128.55 113.61 15.68 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.513 ' CE2' HG12 ' A' ' 655' ' ' VAL . 8.2 m-85 -92.3 -93.12 0.15 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 140.04 164.94 10.1 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.136 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.676 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 69.7 t60 -55.67 -58.62 7.04 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 15.1 m -90.43 15.31 10.91 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-O 121.289 0.566 . . . . 0.0 111.22 -173.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.421 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 4.7 tp10 -97.12 117.49 31.43 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 5.9 m -93.96 151.34 3.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.754 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 29.3 m -114.34 102.23 13.56 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.55 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.523 ' CG ' ' HD2' ' A' ' 670' ' ' LYS . 12.1 mt-10 -66.21 121.78 15.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.942 0.877 . . . . 0.0 112.242 176.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 69.4 m-85 -100.06 168.61 9.73 Favored 'General case' 0 C--N 1.271 -2.836 0 C-N-CA 125.28 1.432 . . . . 0.0 109.441 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -152.61 141.7 21.33 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.679 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 7.5 t -106.49 -171.19 1.85 Allowed 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.58 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 662' ' ' ARG . 39.6 m-80 -77.77 156.39 80.25 Favored Pre-proline 0 C--N 1.295 -1.766 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.37 6.16 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 123.797 2.998 . . . . 0.0 113.388 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 660' ' ' ASN . 32.2 mmt180 -105.7 -0.26 25.67 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.254 -176.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -128.27 158.36 38.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.568 0.699 . . . . 0.0 112.322 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.43 133.39 46.13 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 113.749 -1.569 . . . . 0.0 107.511 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.2 ttt -104.0 109.55 21.37 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -92.9 -49.19 6.16 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -86.23 -171.04 47.56 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.36 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.12 119.12 6.11 Favored 'Trans proline' 0 CA--C 1.526 0.108 0 C-N-CA 123.093 2.529 . . . . 0.0 111.13 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.636 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 23.2 p-10 -81.47 0.28 38.46 Favored 'General case' 0 C--O 1.178 -2.666 0 O-C-N 121.996 -0.44 . . . . 0.0 111.33 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 3.8 ptmt -134.74 110.28 9.13 Favored 'General case' 0 C--N 1.267 -3.0 0 CA-C-O 121.801 0.81 . . . . 0.0 109.704 -176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 46.5 pt -110.25 151.32 12.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.649 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.554 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -113.73 156.8 23.13 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.541 0.526 . . . . 0.0 111.458 -179.146 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.676 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 13.6 t -81.73 99.63 9.05 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.885 0.85 . . . . 0.0 110.624 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.524 ' HA ' ' HD1' ' A' ' 651' ' ' HIS . 36.0 m -90.72 111.66 23.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.975 -1.078 . . . . 0.0 111.878 -177.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.62 ' HA ' HG23 ' A' ' 627' ' ' VAL . 13.1 t70 71.13 -59.5 0.54 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.707 1.203 . . . . 0.0 112.639 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -172.77 22.71 0.07 OUTLIER Glycine 0 C--N 1.295 -1.703 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -142.47 152.0 42.28 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.4 m95 -81.12 173.0 12.98 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.558 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . 0.458 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 0.5 OUTLIER -96.59 -179.92 4.77 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.067 -179.111 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 27.5 m -69.39 126.17 28.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.725 0.298 . . . . 0.0 110.868 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.4 ' CB ' ' HD2' ' A' ' 682' ' ' PRO . 7.1 mp -60.18 155.94 42.32 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.636 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 10.3 Cg_endo -57.41 -39.67 87.43 Favored 'Trans proline' 0 CA--C 1.5 -1.198 0 C-N-CA 124.434 3.423 . . . . 0.0 115.527 -176.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 682' ' ' PRO 0.275 3.9 m 64.42 122.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.09 0 C-N-CA 125.37 1.468 . . . . 0.0 112.202 -171.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.464 ' H ' HD21 ' A' ' 637' ' ' LEU . 21.8 p -119.94 129.17 54.2 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.718 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.409 ' H ' HD13 ' A' ' 685' ' ' ILE . 0.2 OUTLIER -118.76 147.84 22.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.353 -174.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.81 128.71 17.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 123.977 0.798 . . . . 0.0 111.1 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 C--N 1.305 -1.369 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.173 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 . . . . . 0 CA--C 1.511 -0.534 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -99.67 85.98 3.23 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -158.09 -171.62 3.58 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.929 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 135.7 -29.56 2.86 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -129.46 124.41 33.97 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.466 ' HA ' ' HE ' ' A' ' 567' ' ' ARG . 2.6 mmp_? -113.66 -105.21 0.39 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 58.53 -174.09 0.09 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.699 0.8 . . . . 0.0 111.529 -172.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.673 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 88.9 m -127.29 149.28 50.09 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.543 0.687 . . . . 0.0 112.331 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.495 ' O ' HD21 ' A' ' 616' ' ' LEU . 40.0 mt-10 -107.55 -157.12 0.6 Allowed 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.477 HD22 ' HD2' ' A' ' 572' ' ' PRO . 3.1 tm? -125.84 107.38 25.68 Favored Pre-proline 0 C--N 1.28 -2.42 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.477 ' HD2' HD22 ' A' ' 571' ' ' LEU . 48.9 Cg_endo -67.45 176.93 4.35 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.647 2.231 . . . . 0.0 111.785 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -79.76 90.02 5.22 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.843 0.83 . . . . 0.0 109.793 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.817 HG22 ' HG ' ' A' ' 620' ' ' LEU . 38.6 pt -72.88 -169.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.594 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 7.9 t70 -74.82 146.69 41.82 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.17 -22.63 31.53 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-O 121.662 0.744 . . . . 0.0 110.515 176.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -93.7 5.46 51.56 Favored 'General case' 0 C--O 1.204 -1.29 0 O-C-N 121.646 -0.659 . . . . 0.0 110.374 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.554 HD12 ' SG ' ' A' ' 623' ' ' CYS . 1.0 OUTLIER -108.02 154.12 22.12 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.209 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.39 122.51 5.23 Favored Pre-proline 0 C--N 1.304 -1.383 0 C-N-CA 123.304 0.642 . . . . 0.0 109.62 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.92 137.28 26.53 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 122.054 1.836 . . . . 0.0 112.534 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 594' ' ' LYS . 10.7 t70 -67.1 -42.52 84.43 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.584 1.154 . . . . 0.0 110.898 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -64.55 -68.94 0.32 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.722 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 53.35 81.49 0.09 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 125.218 1.407 . . . . 0.0 111.315 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 16.5 ptpt -132.89 -177.6 4.57 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.817 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.61 -68.3 0.61 Allowed 'General case' 0 C--N 1.309 -1.164 0 O-C-N 123.158 0.286 . . . . 0.0 111.383 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 131.06 54.48 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.548 0.689 . . . . 0.0 110.582 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.673 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 66.1 m-85 -94.79 140.34 30.04 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.437 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -91.13 152.51 20.56 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.194 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.69 118.81 3.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 99.71 2.9 56.29 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.834 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -76.16 130.99 39.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.415 HG13 ' NE2' ' A' ' 610' ' ' GLN . 12.7 t -101.81 120.2 51.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.408 0.623 . . . . 0.0 109.386 -176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.594 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 4.9 mp -98.52 100.12 11.34 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 581' ' ' ASP . 31.0 mtmm -80.27 142.02 34.98 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 173.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.501 ' CZ ' HD12 ' A' ' 620' ' ' LEU . 91.2 m-85 -116.16 173.95 6.31 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-O 121.321 0.582 . . . . 0.0 110.624 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 8.7 p -161.6 168.38 23.59 Favored 'General case' 0 N--CA 1.392 -3.335 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.54 ' SG ' HD12 ' A' ' 578' ' ' LEU . 94.3 m -117.75 -176.06 2.96 Favored 'General case' 0 C--N 1.265 -3.082 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 39.3 mmtm -55.03 166.64 0.77 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.406 1.482 . . . . 0.0 111.85 174.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 71.8 Cg_exo -46.91 -42.9 24.94 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 124.112 3.208 . . . . 0.0 114.612 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -102.69 0.16 49.16 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.385 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 28.4 m-85 -93.16 127.28 38.66 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.53 HG21 HG21 ' A' ' 627' ' ' VAL . 90.4 m -86.82 120.55 28.22 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-N 113.075 -1.875 . . . . 0.0 110.67 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 12.3 tt -77.3 133.05 31.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.715 HG21 ' HD3' ' A' ' 624' ' ' LYS . 91.0 t -133.36 130.37 57.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 124.73 -148.55 16.78 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -80.41 102.06 1.38 Allowed 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.322 2.015 . . . . 0.0 110.426 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 1.8 m-20 -73.88 -23.98 59.65 Favored 'General case' 0 C--O 1.202 -1.423 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.709 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . . . . . . . . . 27.8 p -129.57 96.11 4.17 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.561 0.696 . . . . 0.0 111.284 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . 0.496 HG12 ' HD2' ' A' ' 618' ' ' PRO . 17.0 m -94.93 164.39 2.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.593 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 23.6 mm-40 -107.67 165.38 11.47 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 4.1 t -92.79 128.64 38.72 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 114.519 -1.219 . . . . 0.0 107.825 165.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 54.6 m-85 -115.37 168.71 9.74 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -60.61 -16.04 34.36 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -108.45 -3.65 18.0 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 120.775 0.321 . . . . 0.0 111.38 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 133.47 -168.72 23.01 Favored Glycine 0 N--CA 1.434 -1.47 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.381 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.495 HD21 ' O ' ' A' ' 570' ' ' GLU . 2.6 mm? -77.03 121.92 24.21 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 123.152 0.581 . . . . 0.0 109.641 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 35.3 t -147.2 141.47 15.91 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.496 ' HD2' HG12 ' A' ' 609' ' ' VAL . 13.4 Cg_exo -66.22 -179.57 12.43 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.713 -1.37 . . . . 0.0 112.651 0.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.05 163.48 24.61 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.277 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.817 ' HG ' HG22 ' A' ' 574' ' ' ILE . 1.1 mm? -67.61 134.75 92.62 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.994 -169.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.22 172.45 7.53 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 123.832 3.021 . . . . 0.0 111.541 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 45.6 pt -114.03 169.6 5.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.032 0.444 . . . . 0.0 111.327 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.554 ' SG ' HD12 ' A' ' 578' ' ' LEU . 81.7 m -115.61 112.54 22.3 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.301 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.715 ' HD3' HG21 ' A' ' 604' ' ' VAL . 51.9 mtpt -95.61 -28.29 14.9 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 21.6 tt0 69.25 -66.73 0.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.223 1.009 . . . . 0.0 109.546 -176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -88.85 112.02 22.75 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.59 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 2.8 p -127.38 174.52 10.92 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 16.0 mm100 -93.84 155.78 17.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.564 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 16.2 m -104.92 -8.21 18.79 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.015 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 21.9 m 74.77 -3.26 2.63 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 166.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 64.73 -147.76 51.07 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.421 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.82 144.33 24.39 Favored 'Trans proline' 0 C--O 1.253 1.24 0 C-N-CA 122.658 2.238 . . . . 0.0 112.035 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.553 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 68.6 Cg_endo -70.78 167.38 25.94 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.821 3.014 . . . . 0.0 112.996 -178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.04 -179.5 4.38 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.792 2.328 . . . . 0.0 111.472 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -99.38 158.58 15.62 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 657' ' ' TYR . 16.0 tp -96.82 133.98 40.72 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 683' ' ' VAL . 2.0 pt? -50.37 -45.4 55.21 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -131.03 33.26 4.19 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.14 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -167.7 -148.32 5.63 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 641' ' ' VAL . 2.3 t30 -162.41 177.66 9.34 Favored 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.573 HG22 ' CE1' ' A' ' 657' ' ' TYR . 5.2 t -78.54 133.13 30.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.536 ' HB2' ' NZ ' ' A' ' 642' ' ' LYS . 0.0 OUTLIER -90.78 -2.6 57.78 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.22 0.533 . . . . 0.0 110.563 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.514 ' OE2' ' HE3' ' A' ' 642' ' ' LYS . 74.0 mm-40 -104.19 151.9 22.79 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.694 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -50.91 109.77 0.36 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 112.545 -2.116 . . . . 0.0 109.871 169.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.601 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 4.1 p -85.33 102.98 13.84 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 121.906 0.86 . . . . 0.0 112.792 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 53.6 pttt -84.19 156.83 21.87 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.646 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.446 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 4.9 mp0 -74.71 -11.29 60.14 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.955 -173.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.503 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 7.4 tp10 -147.66 118.39 7.56 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.601 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 21.6 m-85 -97.64 -94.75 0.22 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 151.34 167.39 14.78 Favored Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.574 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.712 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 67.6 t60 -61.38 -44.16 97.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.343 0.592 . . . . 0.0 111.7 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 14.6 m -98.01 17.22 18.84 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.396 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 649' ' ' TYR . 2.9 tp10 -101.0 111.54 23.77 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.674 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.803 HG21 ' HB2' ' A' ' 670' ' ' LYS . 10.8 p -87.91 148.31 4.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.961 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -112.16 105.63 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.76 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.79 170.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 19.4 mt-10 -72.5 126.06 28.95 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.71 0.767 . . . . 0.0 109.592 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.586 ' HB3' HD22 ' A' ' 636' ' ' LEU . 49.7 m-85 -102.59 167.69 9.76 Favored 'General case' 0 C--N 1.268 -2.945 0 C-N-CA 124.311 1.044 . . . . 0.0 110.969 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.444 ' CD1' ' HB3' ' A' ' 642' ' ' LYS . 13.6 p90 -148.54 142.47 25.81 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.568 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 33.2 m -107.07 173.83 6.15 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 120.794 0.331 . . . . 0.0 111.861 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.443 ' HB2' ' HD1' ' A' ' 663' ' ' PHE . 7.2 m120 -61.82 150.79 81.39 Favored Pre-proline 0 C--O 1.243 0.763 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.577 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.55 39.14 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 124.826 3.684 . . . . 0.0 113.822 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -155.83 9.22 0.26 Allowed 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.817 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 87.9 m-85 -126.32 150.17 48.68 Favored 'General case' 0 CA--C 1.492 -1.265 0 CA-C-O 120.96 0.409 . . . . 0.0 109.912 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 85.1 mt -93.49 134.5 35.69 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.742 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 3.3 ttt -96.25 101.39 13.02 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 685' ' ' ILE . 41.3 tptt -69.16 -65.17 0.74 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.69 -169.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.72 -161.69 37.7 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.704 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.43 124.66 14.64 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 123.239 2.626 . . . . 0.0 110.948 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 5.6 p-10 -76.39 -12.28 60.03 Favored 'General case' 0 C--O 1.171 -3.036 0 CA-C-O 121.672 0.748 . . . . 0.0 110.412 -177.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.803 ' HB2' HG21 ' A' ' 654' ' ' VAL . 0.0 OUTLIER -132.97 123.33 25.71 Favored 'General case' 2 N--CA 1.331 -6.424 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -171.397 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.612 HD12 ' HB3' ' A' ' 678' ' ' TRP . 43.4 pt -122.0 138.95 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.78 -172.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.57 161.03 15.22 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 38.3 t -94.0 104.58 16.61 Favored 'General case' 0 C--N 1.28 -2.416 0 C-N-CA 118.451 -1.3 . . . . 0.0 111.876 -176.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . 0.262 32.7 m -81.62 88.36 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-O 123.017 1.389 . . . . 0.0 113.126 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.59 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 24.9 t70 89.98 -61.25 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.871 0 CA-C-N 112.094 -2.321 . . . . 0.0 111.224 170.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -159.0 12.98 0.21 Allowed Glycine 0 C--N 1.268 -3.207 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.707 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.48 130.58 38.77 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.612 ' HB3' HD12 ' A' ' 671' ' ' ILE . 94.6 m95 -72.95 152.77 41.25 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 2.2 p -74.46 176.91 6.37 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 14.2 m -61.56 125.84 25.23 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.068 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 6.3 mp -62.62 154.83 72.22 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.744 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 17.8 Cg_endo -61.73 -19.68 66.2 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 C-N-CA 123.464 2.776 . . . . 0.0 114.136 -177.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.522 ' HA ' HD21 ' A' ' 637' ' ' LEU . 17.2 m 39.78 83.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 175.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.742 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 62.8 m -79.77 146.75 32.16 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.27 -174.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -127.83 149.34 32.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.483 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.82 139.35 21.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 120.792 0.33 . . . . 0.0 111.318 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--O 1.254 1.323 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.155 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 . . . . . 0 C--O 1.236 0.376 0 CA-C-O 120.228 0.061 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 62.0 98.46 0.03 OUTLIER 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.667 1.187 . . . . 0.0 113.623 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -81.34 -13.51 58.3 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.515 176.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 172.26 -126.28 1.26 Allowed Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -167.75 -63.22 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 567' ' ' ARG . 25.8 mmt180 -89.36 69.08 8.06 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.915 0.864 . . . . 0.0 110.78 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -93.29 171.65 8.79 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.614 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 83.2 m -89.53 148.03 23.63 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.93 0.395 . . . . 0.0 111.237 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -128.18 134.14 49.01 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 172.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.657 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.4 tt -52.18 111.4 2.48 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.079 0.952 . . . . 0.0 108.885 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.497 ' HG2' HD21 ' A' ' 620' ' ' LEU . 58.8 Cg_endo -76.68 -174.67 2.24 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.913 2.409 . . . . 0.0 111.417 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -87.4 86.96 7.29 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.751 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.877 HG13 ' H ' ' A' ' 575' ' ' ASP . 11.1 pt -55.81 -72.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.739 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.877 ' H ' HG13 ' A' ' 574' ' ' ILE . 12.1 t70 -173.93 -172.36 0.72 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.39 -30.73 2.99 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -95.63 11.31 33.7 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.242 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.7 tt -111.82 139.89 46.92 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.96 121.28 12.36 Favored Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.657 ' HG3' HD11 ' A' ' 571' ' ' LEU . 54.8 Cg_endo -75.05 152.39 40.49 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.603 2.202 . . . . 0.0 111.22 174.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.02 -46.02 62.87 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.34 0.591 . . . . 0.0 109.895 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . 0.481 ' HA ' ' HD3' ' A' ' 582' ' ' ARG . 2.4 mmt180 -84.15 139.54 32.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.872 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -137.48 107.95 6.52 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 14.2 ptpt -146.9 172.77 13.17 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.66 -65.49 0.78 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.22 145.09 44.13 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.5 0.667 . . . . 0.0 110.162 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.614 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 39.3 m-85 -105.27 125.88 51.48 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -78.87 153.4 30.59 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.536 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 56.1 t -60.41 121.16 7.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.326 0.584 . . . . 0.0 110.156 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 105.73 -8.9 43.72 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.747 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -67.31 126.19 28.48 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-N 117.876 0.838 . . . . 0.0 109.864 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 608' ' ' SER . 14.3 t -99.67 121.78 50.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 608' ' ' SER . 5.2 mp -104.24 107.9 19.02 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 9.0 mtmp? -82.31 112.02 18.91 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 173.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 64.1 m-85 -90.37 164.88 14.15 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 56.3 m -153.97 179.45 8.9 Favored 'General case' 0 N--CA 1.402 -2.869 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 89.4 m -120.22 177.44 5.01 Favored 'General case' 0 C--N 1.26 -3.31 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.561 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 33.0 mmmt -58.17 164.12 3.86 Favored Pre-proline 0 C--N 1.316 -0.89 0 C-N-CA 123.819 0.847 . . . . 0.0 111.676 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 74.3 Cg_exo -47.69 -42.0 30.39 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 124.356 3.37 . . . . 0.0 114.818 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.8 -0.23 62.4 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.513 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -102.93 151.85 21.99 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-O 121.975 0.893 . . . . 0.0 112.545 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.556 HG21 HG11 ' A' ' 627' ' ' VAL . 54.1 m -108.2 128.74 54.98 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.108 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.451 HD11 ' HG3' ' A' ' 621' ' ' PRO . 11.3 tt -80.08 123.39 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 173.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.782 HG21 ' HD3' ' A' ' 624' ' ' LYS . 53.2 t -114.47 118.57 58.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 120.945 0.403 . . . . 0.0 110.61 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 116.23 -156.43 15.64 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.58 124.95 13.54 Favored 'Trans proline' 0 C--O 1.221 -0.352 0 C-N-CA 123.2 2.6 . . . . 0.0 110.989 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.465 HD22 ' N ' ' A' ' 607' ' ' ASN . 0.6 OUTLIER -85.38 -45.66 11.67 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.577 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 35.5 p -100.1 119.73 38.76 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.036 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . 0.407 ' C ' HE21 ' A' ' 610' ' ' GLN . 18.2 m -115.22 155.02 16.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.569 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -100.74 155.62 17.8 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.361 0.601 . . . . 0.0 109.893 178.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 8.3 t -88.05 125.26 34.46 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -114.64 168.88 9.49 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.66 3.07 6.85 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 119.003 0.82 . . . . 0.0 111.972 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -115.93 2.15 13.47 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.825 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 125.69 -174.11 17.61 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.973 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.475 HD23 ' HD3' ' A' ' 572' ' ' PRO . 2.8 mm? -77.81 125.33 29.17 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 618' ' ' PRO . 50.4 m -145.58 152.86 50.3 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.409 ' O ' ' HA ' ' A' ' 617' ' ' SER . 73.0 Cg_endo -72.26 -165.48 3.54 Favored 'Cis proline' 0 N--CA 1.486 1.079 0 CA-C-N 119.764 0.952 . . . . 0.0 114.554 4.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -55.24 137.62 46.9 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.107 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.639 HD23 HG22 ' A' ' 574' ' ' ILE . 5.7 mp -72.61 147.66 89.64 Favored Pre-proline 0 C--N 1.287 -2.116 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.431 -173.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.509 ' HG2' HD11 ' A' ' 578' ' ' LEU . 72.1 Cg_endo -73.36 178.98 5.94 Favored 'Trans proline' 0 C--O 1.248 0.986 0 C-N-CA 123.103 2.535 . . . . 0.0 113.479 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 45.3 pt -127.37 171.34 15.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 96.8 m -115.77 114.67 25.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.967 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.782 ' HD3' HG21 ' A' ' 604' ' ' VAL . 27.3 mtpp -108.89 120.45 42.55 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.682 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -84.34 -24.42 29.78 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -108.78 116.76 32.6 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.029 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 602' ' ' THR . 4.8 m -129.59 -178.56 2.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.317 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -97.22 179.44 4.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.554 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 20.0 m -115.73 -7.15 12.12 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.144 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 66.5 m 72.1 -28.78 0.19 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 83.08 -147.73 24.97 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.9 142.79 39.65 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.984 1.789 . . . . 0.0 110.727 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.538 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 72.2 Cg_endo -73.6 168.79 23.88 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 123.189 2.593 . . . . 0.0 112.095 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.66 -179.3 3.63 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 122.695 2.263 . . . . 0.0 111.846 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -100.81 156.27 17.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.727 HD22 ' HB3' ' A' ' 657' ' ' TYR . 14.8 tp -87.88 150.47 23.48 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 683' ' ' VAL . 0.0 OUTLIER -57.89 -54.25 49.0 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.494 ' HB2' HD22 ' A' ' 637' ' ' LEU . 5.3 m-80 -130.17 41.49 3.4 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-O 122.34 1.067 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -161.57 -156.82 8.51 Favored Glycine 0 N--CA 1.411 -2.988 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . 0.557 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.6 t-20 -153.12 -176.37 5.75 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.432 HG11 ' CG2' ' A' ' 645' ' ' THR . 7.6 p -95.57 136.18 27.36 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -89.6 -24.61 21.65 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.895 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -79.07 163.29 25.25 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.394 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -84.01 115.17 22.2 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.432 ' CG2' HG11 ' A' ' 641' ' ' VAL . 12.2 p -69.22 97.43 0.93 Allowed 'General case' 0 N--CA 1.413 -2.285 0 O-C-N 124.177 0.923 . . . . 0.0 112.3 -177.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 48.9 pttt -76.22 160.19 29.93 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.57 -7.0 58.73 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.4 0.619 . . . . 0.0 111.298 -171.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -141.06 105.46 4.85 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.555 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 6.9 m-85 -85.69 -76.31 0.34 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 124.46 163.92 11.8 Favored Glycine 0 C--N 1.284 -2.343 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.158 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.451 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.2 t60 -66.79 142.94 57.19 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.258 5.9 p 62.78 9.74 3.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.889 1.276 . . . . 0.0 114.259 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.453 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 4.2 tp10 -87.58 116.66 25.85 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.618 ' CG2' ' HB2' ' A' ' 670' ' ' LYS . 4.1 p -92.1 152.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.823 0.82 . . . . 0.0 111.22 -176.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 26.9 m -122.27 113.31 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.58 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.691 175.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.538 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 21.7 mt-10 -76.85 131.34 38.58 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.681 0.753 . . . . 0.0 111.6 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.727 ' HB3' HD22 ' A' ' 636' ' ' LEU . 56.6 m-85 -111.36 160.76 16.76 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 125.106 1.362 . . . . 0.0 111.389 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.557 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 10.5 p90 -145.03 134.51 23.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.625 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 27.9 m -100.3 171.34 7.84 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.392 176.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -60.07 154.23 51.58 Favored Pre-proline 0 C--N 1.314 -0.967 0 O-C-N 124.184 0.927 . . . . 0.0 110.917 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.15 35.69 0.35 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 124.308 3.339 . . . . 0.0 112.864 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -136.83 4.78 2.81 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.674 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 72.0 m-85 -136.23 156.98 47.89 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.1 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.73 ' HG ' ' HG2' ' A' ' 687' ' ' GLU . 80.4 mt -115.07 146.31 41.43 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.816 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -82.52 142.32 31.94 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 118.437 0.562 . . . . 0.0 110.295 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.569 ' HB3' HG23 ' A' ' 683' ' ' VAL . 2.0 tpmt? -92.56 -41.62 10.14 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.303 0.573 . . . . 0.0 109.736 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -116.32 -163.25 13.36 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.765 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.96 129.31 26.92 Favored 'Trans proline' 0 C--O 1.22 -0.402 0 C-N-CA 123.934 3.09 . . . . 0.0 110.51 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 9.5 p-10 -68.66 -14.21 62.87 Favored 'General case' 0 C--O 1.178 -2.696 0 CA-C-O 121.327 0.584 . . . . 0.0 111.534 -177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.618 ' HB2' ' CG2' ' A' ' 654' ' ' VAL . 12.1 ptmt -130.13 145.57 51.71 Favored 'General case' 0 C--N 1.25 -3.742 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -174.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.663 HD12 ' HB3' ' A' ' 678' ' ' TRP . 35.8 pt -135.22 145.6 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -121.54 148.54 44.35 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.386 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 12.9 t -72.42 113.59 9.62 Favored 'General case' 0 CA--C 1.468 -2.206 0 CA-C-O 122.381 1.086 . . . . 0.0 109.794 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.451 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 44.2 t -105.65 111.58 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.811 0 CA-C-N 112.341 -2.209 . . . . 0.0 108.499 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.78 -75.97 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.619 1.168 . . . . 0.0 111.955 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -157.65 26.29 0.46 Allowed Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -142.3 143.81 32.96 Favored 'General case' 0 C--O 1.211 -0.959 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.663 ' HB3' HD12 ' A' ' 671' ' ' ILE . 92.4 m95 -87.85 161.48 17.49 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 118.577 0.626 . . . . 0.0 109.753 177.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 15.4 p -76.2 172.37 12.96 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.924 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 24.9 m -67.1 135.14 53.14 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.035 0.445 . . . . 0.0 110.931 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.6 ' CD2' HD13 ' A' ' 671' ' ' ILE . 50.9 mt -61.53 151.58 77.21 Favored Pre-proline 0 N--CA 1.42 -1.926 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.154 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.816 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 11.7 Cg_endo -53.25 -18.89 11.31 Favored 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 124.752 3.635 . . . . 0.0 115.362 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 666' ' ' LYS 0.25 16.9 m 41.89 91.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 174.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.674 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 4.3 p -87.33 150.38 23.89 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.58 150.74 34.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.648 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.67 135.83 25.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 O-C-N 123.778 0.673 . . . . 0.0 110.762 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.73 ' HG2' ' HG ' ' A' ' 664' ' ' LEU . 42.2 mt-10 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.526 -0.75 . . . . 0.0 109.567 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -49.98 -32.3 14.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.092 0.957 . . . . 0.0 113.034 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -89.31 75.73 7.68 Favored 'General case' 0 C--N 1.315 -0.918 0 O-C-N 121.6 -0.688 . . . . 0.0 109.167 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -92.0 -20.88 34.86 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.749 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -109.28 151.06 27.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.35 142.51 53.97 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.348 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -133.96 -179.96 5.87 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.686 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 55.8 m -86.11 147.79 25.99 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.1 0.476 . . . . 0.0 111.014 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 571' ' ' LEU . 45.9 tt0 -125.47 -8.36 6.9 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.636 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 63.2 tp 79.06 115.33 0.03 OUTLIER Pre-proline 0 C--O 1.244 0.778 0 C-N-CA 125.239 1.416 . . . . 0.0 110.068 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.521 ' HD2' HD12 ' A' ' 571' ' ' LEU . 69.7 Cg_endo -71.5 -168.31 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.668 2.246 . . . . 0.0 110.134 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 573' ' ' LYS . 32.2 mmtp -87.37 102.93 15.01 Favored 'General case' 0 N--CA 1.41 -2.452 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.728 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.758 HG22 HD23 ' A' ' 620' ' ' LEU . 36.4 pt -70.04 -170.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.973 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.91 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 7.9 t70 -70.75 155.57 40.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.42 -28.16 37.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 121.839 0.828 . . . . 0.0 109.412 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -96.65 6.49 48.61 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.275 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.91 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.8 tm? -97.3 144.07 27.44 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.413 ' N ' HD13 ' A' ' 578' ' ' LEU . 2.3 t -140.37 115.13 7.58 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -76.28 137.71 19.26 Favored 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 122.879 2.386 . . . . 0.0 112.731 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -55.97 -55.95 26.56 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.334 1.454 . . . . 0.0 111.423 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . 0.52 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 55.0 mmt-85 -59.07 -59.91 4.71 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.856 -178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 53.57 82.84 0.08 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.647 1.217 . . . . 0.0 111.068 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.504 ' HE3' ' HB3' ' A' ' 582' ' ' ARG . 15.4 ptpt -143.26 163.71 32.21 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.91 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.16 -57.09 14.31 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 123.837 0.71 . . . . 0.0 111.261 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.84 142.82 51.18 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.094 0.473 . . . . 0.0 110.041 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.686 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 95.0 m-85 -102.59 126.73 49.77 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.847 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -79.74 151.75 30.23 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.092 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 45.6 t -60.87 118.06 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 104.18 -5.76 45.95 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.447 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -69.01 129.47 40.03 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . . . . . . . . . 17.8 m -97.26 118.9 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-O 122.509 1.147 . . . . 0.0 109.867 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.403 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 5.6 mp -95.49 96.87 9.37 Favored 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.615 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 57.2 mtmt -80.75 109.86 15.7 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.643 ' HB3' HD11 ' A' ' 578' ' ' LEU . 64.9 m-85 -92.26 162.72 14.18 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 16.9 t -158.26 176.46 12.44 Favored 'General case' 0 N--CA 1.393 -3.286 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 88.3 m -121.24 172.17 8.19 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.442 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 70.2 mmtt -53.8 159.95 2.38 Favored Pre-proline 0 C--N 1.319 -0.751 0 C-N-CA 124.024 0.929 . . . . 0.0 112.169 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 12.1 Cg_endo -69.27 109.55 2.24 Favored 'Trans proline' 0 N--CA 1.441 -1.56 0 C-N-CA 122.036 1.824 . . . . 0.0 109.366 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 122.52 -17.33 8.37 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -101.07 157.75 16.53 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 122.128 0.966 . . . . 0.0 112.48 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.56 HG21 HG11 ' A' ' 627' ' ' VAL . 18.5 m -109.04 130.55 55.48 Favored 'General case' 0 N--CA 1.402 -2.869 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.777 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 11.2 tt -85.68 122.01 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.476 HG21 ' HD3' ' A' ' 624' ' ' LYS . 54.0 t -112.72 127.45 69.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 112.95 -166.35 12.13 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.11 126.54 17.37 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.988 2.459 . . . . 0.0 110.761 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -86.13 -38.27 17.91 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.745 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.603 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 34.4 p -114.64 111.27 21.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.995 0.426 . . . . 0.0 110.96 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.2 m -104.79 153.82 6.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.63 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -99.08 147.91 24.58 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.452 ' HA ' HD23 ' A' ' 616' ' ' LEU . 17.6 t -83.23 124.31 30.43 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 170.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.587 ' CD2' ' HB3' ' A' ' 617' ' ' SER . 91.7 m-85 -110.59 171.88 7.2 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.68 7.23 3.18 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -117.58 -9.04 10.87 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 133.07 -174.37 20.61 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 611' ' ' CYS . 91.4 mt -70.9 138.77 50.41 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 122.976 0.51 . . . . 0.0 111.377 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.587 ' HB3' ' CD2' ' A' ' 612' ' ' TYR . 44.7 t -152.55 141.41 14.12 Favored Pre-proline 0 N--CA 1.424 -1.773 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 617' ' ' SER . 60.4 Cg_endo -72.94 -172.01 9.15 Favored 'Cis proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.081 -1.633 . . . . 0.0 113.197 0.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.9 151.73 38.43 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.111 0.481 . . . . 0.0 111.255 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.758 HD23 HG22 ' A' ' 574' ' ' ILE . 6.1 mp -67.13 145.11 98.69 Favored Pre-proline 0 C--N 1.309 -1.169 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -170.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.68 175.21 8.33 Favored 'Trans proline' 0 C--O 1.245 0.872 0 C-N-CA 123.93 3.087 . . . . 0.0 112.018 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 38.4 pt -127.53 174.05 11.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.6 m -121.89 122.32 39.14 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.956 0.408 . . . . 0.0 111.5 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.476 ' HD3' HG21 ' A' ' 604' ' ' VAL . 53.8 mtpt -119.58 125.74 49.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -82.97 -40.03 20.59 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 121.547 0.689 . . . . 0.0 109.715 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -102.05 100.25 10.49 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.879 0.847 . . . . 0.0 110.45 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 602' ' ' THR . 8.0 m -107.76 174.13 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.588 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -98.99 143.99 28.66 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.234 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 38.2 m -97.49 -2.17 42.52 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 98.5 m 74.33 -42.75 0.51 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.958 1.303 . . . . 0.0 113.646 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 105.33 -141.47 15.35 Favored Glycine 0 N--CA 1.417 -2.632 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.8 139.46 13.96 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.259 1.972 . . . . 0.0 110.83 174.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.579 ' HG3' HG11 ' A' ' 655' ' ' VAL . 57.6 Cg_endo -68.33 161.57 44.17 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 123.268 2.645 . . . . 0.0 112.707 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.86 176.45 6.06 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.915 2.41 . . . . 0.0 111.677 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.82 163.11 14.55 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 1.044 HD21 ' SG ' ' A' ' 659' ' ' CYS . 9.1 tp -90.27 156.69 18.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 637' ' ' LEU 0.285 2.1 pt? -77.05 -45.46 27.06 Favored 'General case' 0 N--CA 1.406 -2.672 0 C-N-CA 118.377 -1.329 . . . . 0.0 113.495 -178.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.488 HD22 ' HG ' ' A' ' 637' ' ' LEU . 42.5 m-80 -125.64 33.77 5.04 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.558 0.694 . . . . 0.0 110.904 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.775 ' HA3' HD23 ' A' ' 636' ' ' LEU . . . -160.75 -140.76 2.96 Favored Glycine 0 N--CA 1.416 -2.651 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.556 174.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.87 -169.82 2.96 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.0 p -102.97 132.43 49.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.645 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.9 ptmt -87.22 -13.83 42.76 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.831 0.824 . . . . 0.0 110.256 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.402 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 40.0 mm-40 -88.58 140.39 29.51 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.843 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . 0.764 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -55.8 121.34 9.0 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 124.161 0.913 . . . . 0.0 108.631 171.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.41 HG21 HG11 ' A' ' 641' ' ' VAL . 3.7 p -94.67 99.67 11.74 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 53.4 pttt -82.99 167.5 17.88 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.322 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -88.78 1.81 54.59 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -173.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.61 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 34.3 tt0 -151.73 108.4 3.49 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.487 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 4.9 m-85 -84.55 -93.93 0.07 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 151.78 159.79 9.13 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 54.3 t60 -51.61 -59.14 4.6 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 37.2 m -91.67 21.08 4.95 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.364 0.602 . . . . 0.0 110.691 -173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -104.03 113.37 26.86 Favored 'General case' 0 N--CA 1.414 -2.26 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 670' ' ' LYS . 8.8 p -94.17 159.47 2.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.868 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.7 t -124.07 114.05 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.879 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.645 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 21.7 mt-10 -71.88 128.43 35.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.489 0.661 . . . . 0.0 111.876 174.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 641' ' ' VAL . 42.0 m-85 -109.33 170.66 7.91 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 123.58 0.752 . . . . 0.0 110.799 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -148.48 132.2 16.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 1.044 ' SG ' HD21 ' A' ' 636' ' ' LEU . 95.9 m -97.1 172.62 7.72 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.948 176.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -64.9 152.95 89.64 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.003 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.27 35.42 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 124.554 3.503 . . . . 0.0 113.652 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.57 13.48 0.83 Allowed 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.349 -174.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.33 156.56 48.25 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.874 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.449 HD21 ' HG3' ' A' ' 687' ' ' GLU . 83.6 mt -101.07 143.45 31.17 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.716 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 2.5 ttt -107.57 108.88 20.37 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -78.7 -57.82 3.56 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.251 -173.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.24 -174.31 47.56 Favored Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.795 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -58.12 126.38 21.41 Favored 'Trans proline' 0 CA--C 1.51 -0.699 0 C-N-CA 123.68 2.92 . . . . 0.0 110.868 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.664 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 16.3 p-10 -66.91 -13.05 61.33 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-O 121.026 0.441 . . . . 0.0 110.842 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 16.0 mtpt -118.48 151.38 37.93 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 38.0 pt -138.54 141.43 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.87 151.69 39.34 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 120.918 0.39 . . . . 0.0 111.073 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 19.0 t -81.73 99.73 9.11 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.752 -175.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . 0.278 20.1 m -88.63 75.89 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 O-C-N 120.541 -1.349 . . . . 0.0 112.064 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.1 t70 63.85 66.17 0.67 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.642 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 88.34 -20.21 31.52 Favored Glycine 0 C--N 1.311 -0.846 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.173 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -118.01 113.91 22.36 Favored 'General case' 0 N--CA 1.423 -1.803 0 O-C-N 122.201 -0.588 . . . . 0.0 111.857 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.401 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.9 m95 -65.88 151.63 46.29 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 20.1 p -77.55 173.59 11.84 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.04 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 6.3 m -62.89 128.43 35.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.154 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.09 161.52 39.04 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.392 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.664 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 20.2 Cg_endo -62.6 -17.81 60.43 Favored 'Trans proline' 0 CA--C 1.507 -0.827 0 C-N-CA 123.416 2.744 . . . . 0.0 115.04 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.487 ' HA ' HD21 ' A' ' 637' ' ' LEU 0.258 30.3 m 41.58 94.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 175.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.716 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 69.9 m -92.84 154.95 17.94 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 685' ' ' ILE . 0.1 OUTLIER -140.17 152.46 21.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.609 -177.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.95 136.77 19.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.449 ' HG3' HD21 ' A' ' 664' ' ' LEU . 29.0 tt0 . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--O 1.237 0.435 0 CA-C-O 120.84 0.352 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -87.27 129.2 35.08 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -62.09 121.78 13.91 Favored 'General case' 0 C--O 1.254 1.322 0 O-C-N 123.668 0.605 . . . . 0.0 111.172 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -72.09 123.49 9.56 Favored Glycine 0 N--CA 1.436 -1.348 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.834 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 613' ' ' HIS . 9.7 tp10 -131.35 167.32 19.47 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -177.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -48.29 137.4 11.07 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 125.447 1.499 . . . . 0.0 112.495 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 586' ' ' GLN . 13.2 pt-20 -101.41 154.46 18.79 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.719 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 71.6 m -62.88 115.76 4.66 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 124.742 1.217 . . . . 0.0 113.201 -174.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -81.51 -12.85 58.69 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.505 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 41.7 tp 73.17 113.61 0.03 OUTLIER Pre-proline 0 CA--C 1.514 -0.442 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.078 -176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.453 ' HD2' HD12 ' A' ' 616' ' ' LEU . 44.3 Cg_endo -67.94 174.25 8.06 Favored 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.33 2.02 . . . . 0.0 111.052 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . 0.595 ' HD2' ' H ' ' A' ' 573' ' ' LYS 0.299 0.0 OUTLIER -73.68 102.2 3.87 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.47 177.217 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.579 HG22 HD23 ' A' ' 620' ' ' LEU . 40.7 pt -70.91 -171.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.671 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.9 t70 -72.93 146.35 46.15 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.69 -33.82 50.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.722 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -92.43 6.21 47.87 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.064 -0.398 . . . . 0.0 111.624 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.638 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.4 OUTLIER -101.64 150.11 23.44 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -176.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 9.7 m -143.79 121.83 6.94 Favored Pre-proline 0 C--N 1.306 -1.302 0 C-N-CA 123.932 0.893 . . . . 0.0 110.118 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 595' ' ' PHE . 26.2 Cg_endo -72.83 142.73 35.81 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.378 1.385 . . . . 0.0 109.398 171.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.69 -33.72 68.67 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.552 0.691 . . . . 0.0 110.301 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . 0.499 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 75.5 mmt-85 -75.33 -70.16 0.44 Allowed 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.133 176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.442 ' HB2' ' HG2' ' A' ' 580' ' ' PRO 0.296 53.0 tttp 52.29 79.67 0.11 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.768 -170.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.578 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 18.1 ptpt -129.23 164.34 23.67 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.437 -1.711 . . . . 0.0 106.475 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -65.28 -48.32 73.61 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . 0.546 ' HB3' ' HG3' ' A' ' 568' ' ' GLU . 0.0 OUTLIER -131.67 143.44 50.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.153 0.501 . . . . 0.0 110.408 176.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.719 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 76.9 m-85 -107.72 121.1 44.02 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 124.025 0.93 . . . . 0.0 109.145 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -66.0 144.53 56.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 60.4 t -55.03 120.65 2.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 109.59 -13.83 32.67 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.887 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -71.49 123.74 23.08 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 10.0 p -94.35 134.45 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.537 0 C-N-CA 119.419 -0.912 . . . . 0.0 108.834 174.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 608' ' ' SER . 3.4 mp -108.04 117.47 34.23 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.561 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 57.1 mttp -94.48 103.32 15.29 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.458 ' HB3' HD21 ' A' ' 578' ' ' LEU . 64.3 m-85 -78.29 152.6 32.38 Favored 'General case' 0 C--N 1.274 -2.715 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 22.6 t -148.95 161.28 42.2 Favored 'General case' 0 N--CA 1.391 -3.376 0 N-CA-C 103.36 -2.83 . . . . 0.0 103.36 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 90.7 m -107.41 177.88 4.71 Favored 'General case' 0 C--N 1.25 -3.721 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 36.7 mmtm -56.12 161.34 3.84 Favored Pre-proline 0 N--CA 1.441 -0.891 0 C-N-CA 123.086 0.554 . . . . 0.0 111.209 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 93.1 Cg_exo -43.39 -47.26 9.22 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 124.337 3.358 . . . . 0.0 114.475 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -91.41 4.1 79.83 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 121.173 -0.536 . . . . 0.0 112.584 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -108.25 137.09 46.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 121.893 0.854 . . . . 0.0 112.927 -176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 627' ' ' VAL . 20.5 m -93.65 131.87 38.53 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.723 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.479 HD11 ' HG3' ' A' ' 621' ' ' PRO . 11.9 tt -82.39 122.02 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.424 ' HB ' HG13 ' A' ' 622' ' ' ILE . 59.3 t -110.58 108.96 26.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 128.04 -162.4 21.84 Favored Glycine 0 N--CA 1.422 -2.281 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.53 131.0 26.53 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 123.096 2.531 . . . . 0.0 110.928 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.413 HD22 ' N ' ' A' ' 607' ' ' ASN . 0.7 OUTLIER -89.87 -47.86 7.61 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.561 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 62.0 p -106.25 102.62 12.01 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.729 0.776 . . . . 0.0 111.698 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 14.0 m -108.09 140.32 27.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.658 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -85.45 149.11 25.63 Favored 'General case' 0 CA--C 1.486 -1.509 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.38 178.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.468 ' HA ' HD23 ' A' ' 616' ' ' LEU . 35.0 t -78.47 124.97 28.72 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 114.733 -1.122 . . . . 0.0 108.362 169.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 93.3 m-85 -112.22 171.02 7.76 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 566' ' ' GLU . 0.6 OUTLIER -67.33 -6.4 18.52 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -114.27 -0.25 13.95 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.285 0.564 . . . . 0.0 110.543 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 129.14 -175.17 18.97 Favored Glycine 0 N--CA 1.425 -2.071 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.721 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 611' ' ' CYS . 87.9 mt -70.04 131.22 44.01 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.442 0.297 . . . . 0.0 110.64 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.464 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 73.2 m -149.28 143.71 17.21 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 177.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 617' ' ' SER . 59.2 Cg_endo -69.1 -169.63 4.88 Favored 'Cis proline' 0 CA--C 1.545 1.059 0 C-N-CA 124.123 -1.199 . . . . 0.0 113.95 0.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.7 151.66 37.73 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.828 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.579 HD23 HG22 ' A' ' 574' ' ' ILE . 6.4 mp -71.86 143.71 87.11 Favored Pre-proline 0 C--N 1.289 -2.047 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.157 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.479 ' HG3' HD11 ' A' ' 603' ' ' ILE . 98.3 Cg_endo -76.02 179.55 6.2 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 123.965 3.11 . . . . 0.0 112.917 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . 0.424 HG13 ' HB ' ' A' ' 604' ' ' VAL . 46.3 pt -126.27 177.16 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.084 176.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.541 ' SG ' HD12 ' A' ' 578' ' ' LEU . 94.4 m -121.11 115.55 23.31 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 123.424 0.689 . . . . 0.0 110.748 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.582 ' O ' ' HB ' ' A' ' 602' ' ' THR . 43.4 mtmt -121.87 128.53 51.71 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.978 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.25 -41.47 25.02 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -98.13 112.81 24.64 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.183 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 602' ' ' THR . 1.4 m -120.83 178.1 2.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 124.535 1.134 . . . . 0.0 108.349 175.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.464 ' NE2' ' HA3' ' A' ' 676' ' ' GLY . 21.2 mt-30 -97.59 167.02 11.23 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 14.0 m -105.05 -15.23 15.15 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.673 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 86.0 m 73.35 7.63 5.2 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.457 1.103 . . . . 0.0 113.052 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 57.65 -136.61 50.57 Favored Glycine 0 N--CA 1.437 -1.269 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.765 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.77 153.58 22.93 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 122.824 2.349 . . . . 0.0 110.991 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.569 ' HG3' HG11 ' A' ' 655' ' ' VAL . 73.7 Cg_endo -79.42 166.75 21.94 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.302 2.001 . . . . 0.0 111.014 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.38 -166.68 0.28 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.399 2.066 . . . . 0.0 110.626 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -113.19 170.78 7.97 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.527 HD23 ' HA3' ' A' ' 639' ' ' GLY . 17.0 tp -85.41 164.05 18.14 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.439 ' H ' HD12 ' A' ' 637' ' ' LEU . 4.8 mp -56.94 -71.65 0.09 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.083 0.944 . . . . 0.0 110.308 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -105.3 -27.1 11.72 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.764 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.632 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -86.2 -150.08 14.89 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.699 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . 0.416 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.4 t-20 -155.1 -171.28 3.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.655 HG22 ' CE2' ' A' ' 657' ' ' TYR . 18.6 t -96.4 127.65 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.729 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -87.64 -21.85 25.06 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.386 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -75.72 169.47 18.06 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.22 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -88.6 131.62 34.88 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.659 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 24.5 p -87.65 118.18 26.97 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 121.402 0.62 . . . . 0.0 112.222 -176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -84.6 167.96 15.79 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.417 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 45.2 mt-10 -94.35 -10.14 33.59 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -151.56 101.72 2.82 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.39 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.56 ' CE2' HG22 ' A' ' 655' ' ' VAL . 6.7 m-85 -80.66 -85.74 0.09 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 139.05 160.93 8.54 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.3 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.541 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 60.5 t60 -62.54 130.6 45.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 39.5 m 69.6 10.24 7.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.67 1.188 . . . . 0.0 113.508 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 7.6 tp10 -88.7 120.71 30.34 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 19.7 m -91.25 160.27 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 CA-C-O 122.307 1.051 . . . . 0.0 113.622 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 4.5 t -132.53 112.18 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-N 113.657 -1.61 . . . . 0.0 108.227 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 669' ' ' ASN . 32.5 mt-10 -73.43 135.66 44.18 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.249 1.023 . . . . 0.0 113.226 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.655 ' CE2' HG22 ' A' ' 641' ' ' VAL . 72.3 m-85 -114.75 172.56 6.96 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 126.441 1.896 . . . . 0.0 109.559 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 6.2 p90 -155.42 143.76 20.23 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.632 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.8 t -112.85 174.26 5.98 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.237 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 46.8 m-80 -64.9 155.96 81.45 Favored Pre-proline 0 C--N 1.317 -0.815 0 O-C-N 123.395 0.435 . . . . 0.0 110.378 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 70.5 Cg_endo -73.16 42.91 0.67 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 124.181 3.254 . . . . 0.0 113.39 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 662' ' ' ARG . 2.5 ptt180 -151.25 11.15 0.61 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 124.038 0.935 . . . . 0.0 110.473 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.436 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 89.3 m-85 -128.66 152.13 48.73 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.786 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 77.9 mt -101.35 142.04 33.34 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 2.5 ttt -108.71 102.41 11.46 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -79.07 -51.81 9.05 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.262 -170.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.5 -163.42 38.47 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.448 -176.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 670' ' ' LYS . 63.4 Cg_endo -73.33 120.1 6.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.882 2.388 . . . . 0.0 111.387 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 656' ' ' GLU . 3.3 p-10 -81.33 28.18 0.39 Allowed 'General case' 0 C--O 1.19 -2.044 0 O-C-N 121.991 -0.443 . . . . 0.0 111.416 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.783 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 7.7 ptmt -164.04 108.7 1.0 Allowed 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 125.549 1.54 . . . . 0.0 108.336 -176.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.661 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 38.7 pt -109.15 152.6 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.763 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.753 -173.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 9.7 pt20 -119.07 160.32 22.27 Favored 'General case' 0 N--CA 1.421 -1.919 0 O-C-N 124.094 0.871 . . . . 0.0 110.323 -174.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 3.5 t -87.17 112.06 21.59 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.399 1.095 . . . . 0.0 110.828 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 84.8 t -103.51 107.04 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.777 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.541 ' H ' ' CE1' ' A' ' 651' ' ' HIS . 25.3 t70 65.1 -69.29 0.1 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 126.456 1.902 . . . . 0.0 111.744 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.464 ' HA3' ' NE2' ' A' ' 628' ' ' GLN . . . -158.16 21.54 0.36 Allowed Glycine 0 N--CA 1.422 -2.252 0 O-C-N 123.831 0.707 . . . . 0.0 111.472 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -136.55 149.74 48.26 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.525 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.4 m95 -83.0 161.22 21.81 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 11.9 p -81.85 175.32 10.51 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 120.875 0.369 . . . . 0.0 111.715 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 28.4 m -58.39 125.73 24.55 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.835 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.446 ' HA ' HG21 ' A' ' 671' ' ' ILE . 6.4 mp -62.34 165.16 9.39 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.554 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.606 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 19.8 Cg_endo -63.32 -21.51 71.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.343 2.029 . . . . 0.0 113.13 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 61.8 t 50.0 96.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.564 1.146 . . . . 0.0 112.376 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 22.5 p -97.21 133.32 41.99 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.235 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.56 147.72 32.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.195 -176.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 47.6 t -55.78 135.35 19.09 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 O-C-N 123.81 0.694 . . . . 0.0 110.628 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.437 -1.115 0 O-C-N 124.381 1.05 . . . . 0.0 108.828 178.826 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.24 0.583 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -140.84 113.95 8.49 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -96.48 148.04 23.22 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.547 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -155.13 17.92 0.54 Allowed Glycine 0 C--N 1.299 -1.511 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.06 10.4 6.93 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.064 0.459 . . . . 0.0 111.688 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -130.34 83.36 2.12 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 586' ' ' GLN . 21.3 mt-10 60.3 -170.27 0.15 Allowed 'General case' 0 C--O 1.245 0.828 0 C-N-CA 124.746 1.218 . . . . 0.0 112.803 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 20.1 m -63.45 -54.1 41.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.713 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 586' ' ' GLN . 39.3 tt0 70.05 130.2 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 125.4 1.48 . . . . 0.0 111.363 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.7 tt -66.01 119.88 64.9 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.474 ' HG2' HD11 ' A' ' 620' ' ' LEU . 72.3 Cg_endo -75.6 178.35 7.49 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.026 1.817 . . . . 0.0 111.111 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 573' ' ' LYS . 0.0 OUTLIER -78.37 103.83 8.56 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.416 0.627 . . . . 0.0 109.501 -179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.693 ' HA ' ' HG ' ' A' ' 620' ' ' LEU . 19.8 pt -75.27 -169.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.121 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.966 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.6 t70 -72.66 154.9 40.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.38 -30.03 45.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.262 0.553 . . . . 0.0 110.759 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -108.38 12.57 26.21 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.966 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.7 OUTLIER -92.82 153.69 18.71 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.511 ' N ' HD13 ' A' ' 578' ' ' LEU . 10.7 t -139.68 121.74 9.98 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.61 ' HD3' HD13 ' A' ' 574' ' ' ILE . 59.9 Cg_endo -80.35 138.32 12.38 Favored 'Trans proline' 0 N--CA 1.431 -2.169 0 C-N-CA 122.09 1.86 . . . . 0.0 111.645 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -65.41 -41.94 93.08 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 125.677 1.591 . . . . 0.0 112.074 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 26.9 mmt-85 -67.49 -65.77 0.65 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 64.8 74.13 0.4 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.691 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -142.7 146.27 34.22 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.77 -47.64 82.61 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -120.18 145.92 46.5 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.388 0.614 . . . . 0.0 111.527 179.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.659 ' CZ ' ' HG ' ' A' ' 593' ' ' LEU . 96.7 m-85 -116.64 160.62 20.44 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.893 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 591' ' ' GLU . 52.7 mtpt -94.65 152.88 18.13 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.478 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 14.6 m -63.98 137.52 24.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.333 173.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 91.38 -12.91 67.9 Favored Glycine 0 C--N 1.292 -1.903 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.874 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 588' ' ' LYS . 0.7 OUTLIER -66.37 137.68 57.06 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.589 HG12 ' HG3' ' A' ' 610' ' ' GLN . 20.0 m -110.25 128.26 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.618 0 CA-C-O 121.645 0.736 . . . . 0.0 109.252 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.659 ' HG ' ' CZ ' ' A' ' 587' ' ' TYR 0.4 0.0 OUTLIER -114.47 102.66 10.29 Favored 'General case' 0 N--CA 1.383 -3.806 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.427 176.516 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 35.4 mtmm -71.67 146.26 48.36 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 113.547 -1.661 . . . . 0.0 107.787 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.826 ' HB3' HD11 ' A' ' 578' ' ' LEU . 42.7 m-85 -125.17 171.12 10.58 Favored 'General case' 0 C--N 1.262 -3.234 0 CA-C-O 120.836 0.351 . . . . 0.0 111.491 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . 0.412 ' HA ' HD12 ' A' ' 603' ' ' ILE . 23.1 t -171.68 -176.79 1.85 Allowed 'General case' 0 N--CA 1.41 -2.426 0 O-C-N 124.757 1.286 . . . . 0.0 107.585 166.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . . . . . . . . . 84.9 m -114.05 162.0 17.01 Favored 'General case' 0 C--N 1.263 -3.179 0 O-C-N 123.607 0.567 . . . . 0.0 112.184 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 32.8 mmtp -52.25 160.64 1.2 Allowed Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 125.457 1.503 . . . . 0.0 113.241 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 37.9 Cg_exo -55.93 112.88 1.2 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 123.415 2.743 . . . . 0.0 110.576 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 121.93 -27.58 6.14 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 120.328 -0.939 . . . . 0.0 111.014 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -100.24 163.0 12.6 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-O 122.179 0.99 . . . . 0.0 112.672 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.42 HG23 ' CD2' ' A' ' 651' ' ' HIS . 19.3 m -119.76 130.47 54.98 Favored 'General case' 0 N--CA 1.394 -3.264 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.563 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.496 HD11 ' HG3' ' A' ' 621' ' ' PRO . 7.1 tt -82.19 130.39 35.86 Favored 'Isoleucine or valine' 0 C--O 1.256 1.406 0 CA-C-O 121.009 0.433 . . . . 0.0 109.991 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.468 HG21 ' HG3' ' A' ' 624' ' ' LYS . 93.0 t -126.95 131.2 71.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.11 -156.01 15.84 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -67.4 111.81 2.41 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.502 2.135 . . . . 0.0 111.306 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 6.0 m120 -87.2 -12.67 46.12 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.341 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.564 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 9.9 p -146.81 102.79 3.57 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.96 0.41 . . . . 0.0 110.68 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 592' ' ' VAL . 23.8 m -96.95 162.04 2.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.254 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.589 ' HG3' HG12 ' A' ' 592' ' ' VAL . 1.8 mp0 -112.35 153.5 27.16 Favored 'General case' 0 CA--C 1.483 -1.63 0 CA-C-O 121.001 0.429 . . . . 0.0 110.214 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 589' ' ' VAL . 41.0 t -83.97 130.65 34.88 Favored 'General case' 0 N--CA 1.415 -2.221 0 C-N-CA 118.146 -1.421 . . . . 0.0 107.393 166.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 83.8 m-85 -114.24 170.34 8.37 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -64.51 -14.16 55.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -106.84 0.25 23.86 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.669 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.08 -176.31 19.36 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.945 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.407 HD12 HD11 ' A' ' 593' ' ' LEU . 3.0 mm? -74.26 124.81 27.11 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.425 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 68.3 m -147.07 144.94 20.56 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 122.084 -0.385 . . . . 0.0 111.7 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 617' ' ' SER . 48.1 Cg_endo -70.04 -168.77 4.76 Favored 'Cis proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.788 -1.338 . . . . 0.0 112.34 -2.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -80.15 -178.84 6.75 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.069 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.693 ' HG ' ' HA ' ' A' ' 574' ' ' ILE . 1.1 mm? -75.44 140.98 72.7 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -169.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.496 ' HG3' HD11 ' A' ' 603' ' ' ILE . 38.5 Cg_endo -67.9 175.39 6.47 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 124.43 3.42 . . . . 0.0 112.456 176.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.9 pt -114.0 173.66 3.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.533 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.0 m -117.79 115.58 25.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.185 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 626' ' ' GLN . 9.2 mmmm -105.4 120.32 41.29 Favored 'General case' 0 CA--C 1.474 -1.978 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.36 -30.12 33.86 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 118.336 -1.346 . . . . 0.0 107.872 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.475 ' O ' ' HE2' ' A' ' 624' ' ' LYS . 92.2 mt-30 -111.58 116.99 31.75 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.099 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.569 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 9.6 p -124.54 158.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 75.6 mm-40 -89.65 159.8 16.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 53.7 m -101.25 -3.16 29.48 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.515 -176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 73.2 m 69.42 12.45 8.28 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.309 1.044 . . . . 0.0 112.984 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 53.51 -136.5 40.05 Favored Glycine 0 N--CA 1.448 -0.558 0 O-C-N 123.79 0.681 . . . . 0.0 112.424 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.75 151.39 16.8 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.777 2.318 . . . . 0.0 110.703 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.553 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 63.3 Cg_endo -74.81 163.71 35.08 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.775 2.317 . . . . 0.0 112.788 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.448 ' HG2' HD11 ' A' ' 681' ' ' LEU . 55.3 Cg_endo -73.18 177.8 7.37 Favored 'Trans proline' 0 C--O 1.254 1.315 0 C-N-CA 122.734 2.29 . . . . 0.0 111.526 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -92.42 154.32 18.59 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.789 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 657' ' ' TYR . 20.8 tp -89.67 141.3 28.73 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . 0.252 0.0 OUTLIER -45.7 -41.84 11.01 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -176.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -129.19 -18.28 3.7 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -99.66 -142.92 13.66 Favored Glycine 0 C--N 1.309 -0.959 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.795 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . 0.419 HD22 ' H ' ' A' ' 641' ' ' VAL . 0.6 OUTLIER -165.01 -177.12 4.47 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.423 HG22 ' CE1' ' A' ' 657' ' ' TYR . 39.5 t -84.45 132.52 31.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.644 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.3 ptmt -88.1 -16.71 32.77 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.715 0.769 . . . . 0.0 109.986 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.421 ' H ' HG12 ' A' ' 641' ' ' VAL . 6.7 mm-40 -81.7 165.37 21.05 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.604 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -78.14 111.41 14.03 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 23.1 p -64.82 116.33 6.21 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.587 0.708 . . . . 0.0 111.487 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -101.1 168.08 9.82 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.975 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.427 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 35.7 mt-10 -90.77 -13.78 33.28 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.609 0.718 . . . . 0.0 109.148 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -144.58 105.6 4.19 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.124 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.553 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.8 m-85 -87.02 -84.73 0.17 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.948 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 143.52 154.04 6.03 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.774 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.42 ' CD2' HG23 ' A' ' 602' ' ' THR . 49.2 t60 -60.19 131.12 49.81 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 50.2 m 76.69 -0.69 2.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.393 1.077 . . . . 0.0 113.533 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.427 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 7.3 tp10 -79.85 122.96 27.3 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.729 HG11 ' HE3' ' A' ' 670' ' ' LYS . 0.3 OUTLIER -92.06 151.55 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.725 0 CA-C-O 122.215 1.007 . . . . 0.0 110.606 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -114.02 102.69 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.97 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.646 167.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.644 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 4.0 mt-10 -69.27 138.7 54.1 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.544 ' HB3' HD22 ' A' ' 636' ' ' LEU . 40.5 m-85 -113.12 161.02 17.6 Favored 'General case' 0 C--N 1.259 -3.344 0 C-N-CA 124.964 1.306 . . . . 0.0 110.401 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -145.11 135.02 23.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.666 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.2 t -100.56 -178.95 3.95 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.284 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -63.14 155.79 71.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.63 26.69 0.35 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.627 2.884 . . . . 0.0 113.477 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 662' ' ' ARG . 16.1 mmm180 -129.63 -1.45 4.87 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -118.56 161.38 20.14 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.349 0.595 . . . . 0.0 112.151 -170.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.406 HD11 ' HG3' ' A' ' 687' ' ' GLU . 86.7 mt -124.4 149.0 47.19 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.628 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -92.25 149.47 21.43 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 176.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -108.83 -45.99 3.71 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.177 0.513 . . . . 0.0 109.689 174.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.77 -175.95 42.75 Favored Glycine 0 C--N 1.306 -1.133 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 682' ' ' PRO . 27.5 Cg_endo -62.0 124.58 14.7 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.134 2.556 . . . . 0.0 111.765 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.601 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 21.3 p-10 -73.67 31.77 0.08 Allowed 'General case' 0 C--O 1.188 -2.167 0 C-N-CA 123.393 0.677 . . . . 0.0 111.084 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.729 ' HE3' HG11 ' A' ' 654' ' ' VAL . 13.7 ptmt -172.32 138.26 0.93 Allowed 'General case' 0 C--N 1.258 -3.375 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -173.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.607 ' N ' HG22 ' A' ' 654' ' ' VAL . 37.3 pt -138.69 139.13 41.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.58 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -109.35 151.2 26.92 Favored 'General case' 0 C--N 1.27 -2.857 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.015 -178.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 3.6 t -69.3 118.07 11.73 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.198 0.999 . . . . 0.0 111.455 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 89.2 t -105.53 82.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.402 -2.857 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.243 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.569 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 29.1 t70 80.6 -59.24 0.29 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 112.328 -2.215 . . . . 0.0 112.606 171.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -150.36 4.6 0.6 Allowed Glycine 0 C--N 1.292 -1.873 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.285 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.29 153.03 46.34 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.588 ' HB3' HD12 ' A' ' 671' ' ' ILE . 95.7 m95 -84.66 165.55 17.82 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . 0.459 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 2.1 p -86.61 -178.65 6.44 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 9.6 m -65.57 133.69 51.72 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.574 0.75 . . . . 0.0 110.101 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.448 HD11 ' HG2' ' A' ' 634' ' ' PRO . 8.3 mp -70.83 158.84 87.15 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.628 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 20.8 Cg_endo -61.44 -16.12 45.41 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 124.639 3.559 . . . . 0.0 115.617 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.263 26.9 m 45.24 90.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 18.5 p -92.85 144.96 24.76 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.147 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.69 150.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.029 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.3 p -62.34 140.46 19.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 O-C-N 123.409 0.443 . . . . 0.0 110.754 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.406 ' HG3' HD11 ' A' ' 664' ' ' LEU . 43.6 tt0 . . . . . 0 C--O 1.248 1.012 0 C-N-CA 124.841 1.256 . . . . 0.0 110.759 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.225 -0.233 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -70.04 -42.24 73.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.022 0.439 . . . . 0.0 110.146 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -94.28 83.19 4.18 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 95.43 104.69 2.02 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -112.25 116.97 31.28 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -133.64 139.21 46.35 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 586' ' ' GLN . 17.6 mm-40 -78.74 104.03 9.09 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.688 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 3.1 m 33.73 -67.57 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 130.121 3.368 . . . . 0.0 115.995 -171.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 585' ' ' ASP . 54.3 mt-10 83.47 176.46 0.07 Allowed 'General case' 0 CA--C 1.485 -1.527 0 C-N-CA 128.635 2.774 . . . . 0.0 110.536 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.699 HD11 ' HG3' ' A' ' 580' ' ' PRO . 1.2 tt -119.59 105.83 43.05 Favored Pre-proline 0 N--CA 1.398 -3.038 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.697 ' HG2' HD11 ' A' ' 620' ' ' LEU . 36.7 Cg_endo -66.33 -176.97 0.74 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.885 2.39 . . . . 0.0 111.104 177.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -86.18 84.34 7.51 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.347 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.798 HG13 ' H ' ' A' ' 575' ' ' ASP . 6.8 pt -52.08 -65.68 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 113.498 -1.683 . . . . 0.0 111.853 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.798 ' H ' HG13 ' A' ' 574' ' ' ILE . 13.3 t70 -176.32 -168.55 0.26 Allowed 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.55 -22.66 4.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . 0.416 ' HD2' ' HD2' ' A' ' 598' ' ' LYS . 26.9 m80 -104.08 16.7 25.69 Favored 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.147 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.8 tt -115.21 143.36 45.36 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -176.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.39 121.55 7.09 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-O 121.188 0.518 . . . . 0.0 111.015 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.699 ' HG3' HD11 ' A' ' 571' ' ' LEU . 31.8 Cg_endo -69.29 142.01 48.77 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.835 2.357 . . . . 0.0 112.253 174.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.74 -48.98 22.75 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . 0.814 ' HD2' ' HE3' ' A' ' 584' ' ' LYS . 14.3 tpp180 -88.94 93.65 9.67 Favored 'General case' 0 N--CA 1.379 -3.979 0 N-CA-C 104.864 -2.272 . . . . 0.0 104.864 171.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -112.83 131.64 55.62 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.083 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.814 ' HE3' ' HD2' ' A' ' 582' ' ' ARG . 15.3 ptpt -163.3 -170.49 2.29 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 570' ' ' GLU . 9.2 m-20 -103.4 -39.46 6.77 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 119.332 0.969 . . . . 0.0 110.627 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . 0.562 ' HB3' ' HB2' ' A' ' 568' ' ' GLU . 0.0 OUTLIER -121.62 133.53 54.99 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.688 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 54.5 m-85 -105.59 170.26 8.0 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -172.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -100.87 151.96 21.1 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.3 122.21 16.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 97.58 0.68 59.2 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.251 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . 0.467 ' HG2' ' HD2' ' A' ' 587' ' ' TYR . 6.3 tp10 -74.11 129.42 37.81 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.565 HG22 ' HG3' ' A' ' 610' ' ' GLN . 14.1 t -100.74 115.5 42.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.441 0.639 . . . . 0.0 109.831 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 1.9 mp -95.88 94.05 7.4 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 608' ' ' SER . 0.0 OUTLIER -77.16 122.72 25.41 Favored 'General case' 0 C--O 1.201 -1.464 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 174.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 580' ' ' PRO . 66.8 m-85 -94.93 177.83 5.77 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-O 121.473 0.654 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 19.9 p -167.3 169.54 12.36 Favored 'General case' 0 N--CA 1.403 -2.797 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 81.5 m -115.56 170.88 8.09 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.416 ' HD2' ' HD2' ' A' ' 577' ' ' HIS . 41.0 mttt -59.43 156.47 30.73 Favored Pre-proline 0 N--CA 1.432 -1.343 0 O-C-N 123.812 0.695 . . . . 0.0 112.748 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.32 110.1 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.475 2.783 . . . . 0.0 110.127 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 123.66 -23.23 6.74 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.492 ' CE1' ' HB2' ' A' ' 625' ' ' GLU . 79.3 m-85 -102.81 160.83 14.25 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 122.381 1.086 . . . . 0.0 113.281 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 627' ' ' VAL . 15.6 m -113.41 129.53 56.52 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.399 174.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.457 HD11 ' HG3' ' A' ' 621' ' ' PRO . 8.8 tt -79.57 121.84 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.843 HG21 ' HD3' ' A' ' 624' ' ' LYS . 91.4 t -117.5 123.44 71.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 122.037 -0.414 . . . . 0.0 110.122 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 122.03 -156.02 16.77 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.97 134.35 27.33 Favored 'Trans proline' 0 C--N 1.327 -0.6 0 C-N-CA 122.509 2.139 . . . . 0.0 110.096 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.431 HD22 ' N ' ' A' ' 607' ' ' ASN . 0.7 OUTLIER -97.74 -44.35 6.78 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.185 -177.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 594' ' ' LYS . 19.3 p -106.74 97.07 6.91 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.329 0.585 . . . . 0.0 112.013 -176.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . 0.494 ' HA ' ' HD2' ' A' ' 618' ' ' PRO . 9.4 m -95.31 147.8 5.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.673 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -102.12 152.33 21.13 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 16.3 t -83.99 116.71 22.96 Favored 'General case' 0 C--N 1.268 -2.956 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.001 168.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.505 ' CD2' ' HB2' ' A' ' 617' ' ' SER . 90.7 m-85 -102.2 166.4 10.61 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -69.05 -13.52 62.49 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.324 0.583 . . . . 0.0 111.076 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -101.51 -1.49 32.91 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.748 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 136.34 178.28 15.65 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.26 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.66 121.69 19.26 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.505 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 56.5 m -146.35 147.11 29.96 Favored Pre-proline 0 C--N 1.316 -0.886 0 O-C-N 121.959 -0.463 . . . . 0.0 111.458 -178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.494 ' HD2' ' HA ' ' A' ' 609' ' ' VAL . 41.4 Cg_endo -67.06 -171.9 5.07 Favored 'Cis proline' 0 N--CA 1.488 1.149 0 C-N-CA 124.353 -1.103 . . . . 0.0 112.958 0.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.8 179.99 3.4 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.195 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.697 HD11 ' HG2' ' A' ' 572' ' ' PRO . 18.9 mt -92.52 147.39 34.23 Favored Pre-proline 0 C--N 1.278 -2.541 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -165.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.556 ' HG2' HD11 ' A' ' 578' ' ' LEU . 63.5 Cg_endo -73.82 -173.24 1.31 Allowed 'Trans proline' 0 C--O 1.253 1.249 0 C-N-CA 123.861 3.041 . . . . 0.0 112.076 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.49 173.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.932 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 92.2 m -117.05 107.47 14.56 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.303 0.573 . . . . 0.0 111.138 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.843 ' HD3' HG21 ' A' ' 604' ' ' VAL . 59.1 mtpt -109.19 126.34 53.16 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.492 ' HB2' ' CE1' ' A' ' 601' ' ' PHE . 26.8 tt0 -87.44 -35.29 18.35 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -175.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -107.5 112.67 25.54 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.611 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 602' ' ' THR . 6.7 m -121.21 166.13 16.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.128 -177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 15.7 mm100 -89.98 170.66 10.17 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.036 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.521 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 74.8 p -108.86 -19.1 13.52 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.387 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 95.4 m 73.7 4.89 4.81 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.884 1.273 . . . . 0.0 111.16 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 62.55 -137.78 44.84 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.94 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.17 156.69 37.93 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.903 2.402 . . . . 0.0 110.82 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.677 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 71.7 Cg_endo -78.77 160.77 27.69 Favored 'Trans proline' 0 N--CA 1.435 -1.956 0 C-N-CA 122.053 1.835 . . . . 0.0 111.222 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.23 -169.26 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.655 2.236 . . . . 0.0 112.763 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -103.31 157.6 16.9 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.51 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.634 HD23 ' HA3' ' A' ' 639' ' ' GLY . 15.7 tp -92.68 155.26 17.83 Favored 'General case' 0 CA--C 1.478 -1.825 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 637' ' ' LEU 0.285 2.0 pt? -66.93 -47.75 70.73 Favored 'General case' 0 N--CA 1.406 -2.653 0 C-N-CA 119.005 -1.078 . . . . 0.0 113.607 -178.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.616 ' HB2' ' SG ' ' A' ' 684' ' ' CYS . 89.9 m-20 -126.36 27.02 6.28 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.049 -173.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.732 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -160.08 -146.61 4.64 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.09 177.54 10.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.795 0.298 . . . . 0.0 111.054 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 655' ' ' VAL . 7.2 p -80.29 133.97 28.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -90.78 -23.93 20.49 Favored 'General case' 0 CA--C 1.499 -0.991 0 CA-C-O 121.338 0.59 . . . . 0.0 110.075 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.549 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 5.6 mm-40 -80.71 163.31 23.64 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.369 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . 0.596 ' H ' ' HD3' ' A' ' 644' ' ' LYS . 0.1 OUTLIER -76.35 137.95 40.14 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 175.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.413 ' CG2' HG11 ' A' ' 641' ' ' VAL . 20.2 p -87.78 110.42 20.46 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.807 0.813 . . . . 0.0 112.804 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.55 ' HD2' ' HA ' ' A' ' 649' ' ' TYR . 52.1 mttm -72.74 158.19 36.06 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.76 -0.23 56.01 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -152.44 100.58 2.59 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.978 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.677 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 5.3 m-85 -80.44 -81.55 0.12 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 133.35 167.71 11.72 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.158 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 57.6 t60 -67.45 131.04 44.91 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 120.926 0.393 . . . . 0.0 110.284 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . 0.574 ' HA ' ' HB2' ' A' ' 672' ' ' GLN . 73.8 m 65.06 20.06 11.96 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.235 1.014 . . . . 0.0 112.43 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 5.6 tp10 -89.68 116.59 27.92 Favored 'General case' 0 CA--C 1.478 -1.812 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 16.2 m -89.47 155.77 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 CA-C-O 122.152 0.977 . . . . 0.0 113.188 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.75 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 0.1 OUTLIER -129.3 117.38 43.02 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-N 112.823 -1.99 . . . . 0.0 109.502 177.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.604 ' HG2' ' HG2' ' A' ' 670' ' ' LYS . 59.1 mt-10 -81.01 130.2 34.9 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 122.389 1.09 . . . . 0.0 113.54 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.572 ' CE1' HG22 ' A' ' 655' ' ' VAL . 75.3 m-85 -108.81 157.91 18.15 Favored 'General case' 0 C--N 1.271 -2.826 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.679 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -134.88 138.55 44.24 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.732 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 26.1 t -105.65 168.69 8.93 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.552 ' HB2' ' CE1' ' A' ' 663' ' ' PHE . 32.0 m-80 -59.72 152.22 58.82 Favored Pre-proline 0 C--O 1.241 0.622 0 O-C-N 123.202 0.314 . . . . 0.0 110.795 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.2 36.12 0.29 Allowed 'Trans proline' 0 N--CA 1.488 1.194 0 C-N-CA 124.343 3.362 . . . . 0.0 115.549 -170.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.75 11.47 0.66 Allowed 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.561 0.696 . . . . 0.0 110.539 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 660' ' ' ASN . 73.6 m-85 -118.52 162.86 17.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.386 0.612 . . . . 0.0 110.964 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 96.8 mt -110.13 135.7 50.51 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.737 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.3 OUTLIER -100.64 108.88 20.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -75.77 -52.25 10.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.64 -172.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -101.8 -162.7 26.91 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 121.257 -0.497 . . . . 0.0 112.341 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.89 123.58 10.54 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.434 2.756 . . . . 0.0 112.761 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.474 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 23.0 p-10 -74.4 -7.14 51.92 Favored 'General case' 0 C--O 1.201 -1.5 0 O-C-N 122.1 -0.375 . . . . 0.0 111.503 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -122.88 118.86 28.87 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 42.3 pt -111.4 158.23 11.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 652' ' ' SER . 11.0 pt20 -125.15 154.91 40.76 Favored 'General case' 0 C--N 1.281 -2.396 0 O-C-N 123.43 0.456 . . . . 0.0 109.99 -174.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 8.2 t -84.81 110.85 19.12 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 123.119 1.438 . . . . 0.0 110.045 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 97.7 t -95.26 81.38 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.386 -3.67 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.821 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 628' ' ' GLN . 31.5 t70 80.96 -46.37 0.24 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.631 170.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -171.47 19.31 0.06 OUTLIER Glycine 0 C--N 1.298 -1.554 0 O-C-N 123.882 0.739 . . . . 0.0 111.513 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -143.42 143.9 31.8 Favored 'General case' 0 C--O 1.212 -0.879 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.521 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.0 m95 -87.12 153.77 21.26 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 3.7 p -72.1 167.34 20.45 Favored 'General case' 0 C--O 1.255 1.358 0 O-C-N 123.009 0.193 . . . . 0.0 111.399 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.0 m -62.86 129.23 39.52 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.482 ' HB3' ' HD2' ' A' ' 682' ' ' PRO . 6.4 mp -60.19 163.78 7.64 Favored Pre-proline 0 N--CA 1.435 -1.223 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.945 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.737 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 19.5 Cg_endo -60.6 -24.33 78.07 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 122.777 2.318 . . . . 0.0 113.135 -176.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.421 ' HA ' HD21 ' A' ' 637' ' ' LEU . 58.8 t 52.62 92.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 122.175 0.988 . . . . 0.0 111.072 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 638' ' ' ASN . 27.8 p -98.97 134.51 41.72 Favored 'General case' 0 N--CA 1.411 -2.376 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.703 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.91 155.7 35.64 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.92 -174.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 64.4 t -59.84 129.09 21.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 123.866 0.729 . . . . 0.0 110.562 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.678 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.239 0.542 0 N-CA-C 113.097 0.776 . . . . 0.0 113.097 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -74.53 -16.93 60.81 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . 69.53 32.42 3.4 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 125.151 1.381 . . . . 0.0 112.597 174.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 150.66 155.56 6.94 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.201 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -125.06 101.63 7.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -103.83 -21.89 13.6 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.056 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 56.54 -157.08 0.27 Allowed 'General case' 0 C--N 1.348 0.511 0 C-N-CA 124.12 0.968 . . . . 0.0 110.888 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 587' ' ' TYR . 81.3 m -78.25 140.42 38.88 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -110.01 136.54 49.12 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 580' ' ' PRO . 2.6 tt -51.37 117.58 9.43 Favored Pre-proline 0 C--O 1.246 0.903 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.19 -179.34 1.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.723 2.282 . . . . 0.0 111.047 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -90.84 93.2 9.12 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 118.953 -1.099 . . . . 0.0 109.092 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.48 HG22 HD13 ' A' ' 620' ' ' LEU . 36.8 pt -75.78 -175.8 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.189 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.969 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.618 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.1 t70 -71.83 163.15 28.34 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.168 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.35 -30.01 17.1 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.262 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -94.23 4.21 54.2 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.814 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.618 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.8 OUTLIER -100.03 151.26 21.57 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.39 118.01 6.22 Favored Pre-proline 0 C--N 1.309 -1.181 0 C-N-CA 123.849 0.86 . . . . 0.0 110.603 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.51 ' HG3' HD11 ' A' ' 571' ' ' LEU . 40.7 Cg_endo -75.32 139.45 23.48 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.301 2.001 . . . . 0.0 111.566 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.9 -50.25 63.04 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 125.399 1.48 . . . . 0.0 112.202 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . 0.405 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 8.7 mpt_? -63.73 -46.45 85.33 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.135 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm 54.45 58.58 4.8 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 124.364 1.04 . . . . 0.0 109.882 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -121.98 160.17 25.44 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.79 -50.82 54.91 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.54 151.42 41.39 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.669 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 84.9 m-85 -121.53 119.26 31.45 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -71.1 152.69 43.21 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.561 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 58.1 t -55.91 116.26 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-O 121.19 0.519 . . . . 0.0 110.747 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 109.85 -2.99 30.32 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.594 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -76.29 136.98 39.61 Favored 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 122.34 -0.506 . . . . 0.0 110.953 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.586 HG12 ' HG3' ' A' ' 610' ' ' GLN . 12.0 m -101.81 133.28 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-O 121.863 0.84 . . . . 0.0 109.686 176.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.669 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.9 mp -105.41 89.96 3.27 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.557 ' HD2' ' HB3' ' A' ' 608' ' ' SER . 3.6 mmmp? -66.43 127.89 34.05 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -107.09 175.12 5.6 Favored 'General case' 0 C--N 1.267 -3.021 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.801 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 14.4 p -166.49 167.32 15.72 Favored 'General case' 0 N--CA 1.398 -3.041 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.508 ' SG ' HD12 ' A' ' 578' ' ' LEU . 98.8 m -114.69 -172.49 2.13 Favored 'General case' 0 C--N 1.259 -3.337 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -56.74 159.27 7.27 Favored Pre-proline 0 N--CA 1.429 -1.51 0 C-N-CA 123.94 0.896 . . . . 0.0 110.764 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.92 -37.93 47.32 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 124.209 3.273 . . . . 0.0 114.78 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -100.3 4.94 57.2 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.436 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 21.3 m-85 -106.35 141.07 38.28 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 121.605 0.717 . . . . 0.0 111.552 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.499 HG21 HG11 ' A' ' 627' ' ' VAL . 40.7 m -97.56 124.99 42.02 Favored 'General case' 0 N--CA 1.398 -3.073 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.89 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . . . . . . . . . 7.2 tt -79.32 122.25 34.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 173.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.805 HG21 ' HD3' ' A' ' 624' ' ' LYS . 99.8 t -118.69 139.11 47.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 106.63 -149.3 16.59 Favored Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.9 112.74 3.61 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.321 2.014 . . . . 0.0 111.214 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.406 ' N ' HD22 ' A' ' 607' ' ' ASN . 0.7 OUTLIER -85.96 -1.52 57.4 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.614 -178.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.557 ' HB3' ' HD2' ' A' ' 594' ' ' LYS . 33.8 p -150.29 112.89 4.72 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.176 0.512 . . . . 0.0 110.64 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . 0.408 ' C ' HE21 ' A' ' 610' ' ' GLN . 16.8 m -109.25 149.8 12.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.664 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -102.61 157.6 16.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.271 0.558 . . . . 0.0 110.055 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.561 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 11.3 t -86.56 112.49 21.61 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 610' ' ' GLN . 85.3 m-85 -101.18 169.88 8.63 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -60.62 -18.28 52.24 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -106.78 -1.04 22.98 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.152 0.501 . . . . 0.0 111.608 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.37 -169.7 22.16 Favored Glycine 0 N--CA 1.435 -1.402 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.221 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 569' ' ' CYS . 2.6 mm? -75.14 122.81 24.17 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.439 ' HA ' ' C ' ' A' ' 618' ' ' PRO . 52.4 m -146.99 146.45 25.96 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 122.401 -0.187 . . . . 0.0 110.578 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 617' ' ' SER . 57.0 Cg_endo -69.5 -169.42 4.94 Favored 'Cis proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.057 -1.226 . . . . 0.0 112.804 0.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.72 172.72 10.19 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.469 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.48 HD13 HG22 ' A' ' 574' ' ' ILE . 38.8 mt -74.61 142.65 77.74 Favored Pre-proline 0 C--N 1.292 -1.922 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -169.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.3 176.98 7.16 Favored 'Trans proline' 0 C--O 1.258 1.479 0 C-N-CA 124.049 3.166 . . . . 0.0 111.475 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.1 pt -122.03 165.72 17.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.648 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.557 ' SG ' HD12 ' A' ' 578' ' ' LEU . 85.1 m -110.63 112.25 24.02 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.499 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.805 ' HD3' HG21 ' A' ' 604' ' ' VAL . 52.6 mtpt -108.84 110.46 21.82 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 23.2 tt0 -77.77 -31.65 52.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.24 104.71 17.24 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.333 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 602' ' ' THR . 3.7 m -129.83 175.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.088 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.401 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 1.9 mp0 -98.65 159.08 15.2 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.845 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 52.4 m -104.25 -9.16 18.81 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.364 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 678' ' ' TRP . 67.6 m 70.4 1.68 3.71 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.093 0.957 . . . . 0.0 113.514 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 62.99 -136.47 43.54 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -75.79 149.96 34.26 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 121.979 1.786 . . . . 0.0 110.658 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.55 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 78.4 Cg_endo -78.21 165.25 26.01 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.548 2.165 . . . . 0.0 111.013 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.464 ' HG2' HD11 ' A' ' 681' ' ' LEU . 33.0 Cg_endo -70.34 165.91 30.05 Favored 'Trans proline' 0 N--CA 1.435 -1.94 0 C-N-CA 121.408 1.405 . . . . 0.0 110.357 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.46 163.8 21.37 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.774 HD21 ' SG ' ' A' ' 659' ' ' CYS . 11.0 tp -83.33 174.42 10.71 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' A' ' 683' ' ' VAL 0.342 0.4 OUTLIER -73.85 -69.71 0.42 Allowed 'General case' 0 N--CA 1.393 -3.281 0 C-N-CA 118.027 -1.469 . . . . 0.0 112.935 -179.871 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -95.1 -33.19 12.76 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -84.33 -143.11 5.73 Favored Glycine 0 N--CA 1.434 -1.455 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.341 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.34 -172.69 3.67 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.627 HG22 ' CE2' ' A' ' 657' ' ' TYR . 20.5 t -95.87 133.08 38.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 176.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 658' ' ' TYR . 35.9 pttt -88.73 -26.35 21.82 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.977 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -78.55 151.91 32.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.389 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -67.08 115.08 6.38 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.534 0.683 . . . . 0.0 110.546 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.2 p -74.46 105.45 5.6 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.848 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.633 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 59.7 pttt -87.49 -177.67 5.96 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.77 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -97.07 -12.36 23.29 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -143.8 108.05 4.78 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.633 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 13.7 m-85 -85.92 -101.19 0.07 Allowed 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 158.34 162.53 11.9 Favored Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 66.0 t60 -58.49 -52.43 65.67 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 40.0 m -92.53 11.91 24.78 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.177 -174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -96.57 116.61 29.38 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.482 0.658 . . . . 0.0 109.398 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.725 HG21 ' HE2' ' A' ' 670' ' ' LYS . 1.3 p -92.86 157.39 2.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.785 -177.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 23.9 m -123.7 111.65 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.56 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -74.39 119.61 18.83 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.798 0.809 . . . . 0.0 112.672 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.627 ' CE2' HG22 ' A' ' 641' ' ' VAL . 87.6 m-85 -100.46 173.44 6.57 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.781 176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' A' ' 642' ' ' LYS . 29.0 p90 -151.22 137.34 18.32 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 172.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.774 ' SG ' HD21 ' A' ' 636' ' ' LEU . 68.0 m -96.91 177.07 5.74 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 662' ' ' ARG . 78.3 m-20 -85.91 157.45 57.32 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.4 24.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 124.504 3.47 . . . . 0.0 114.959 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.415 ' H ' ' C ' ' A' ' 660' ' ' ASN . 23.8 mmt180 -120.35 -6.99 9.81 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 662' ' ' ARG . 31.1 m-85 -131.72 156.77 45.33 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.87 -174.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 67.8 mt -105.99 166.5 10.45 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.65 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.7 OUTLIER -116.7 112.55 21.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.44 ' HB3' HG23 ' A' ' 683' ' ' VAL . 39.9 ttmt -81.94 -54.02 5.67 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.542 -174.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.13 -173.23 43.63 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.637 -176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.04 122.46 10.97 Favored 'Trans proline' 0 C--N 1.327 -0.557 0 C-N-CA 122.932 2.421 . . . . 0.0 111.141 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.717 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 21.2 p-10 -61.26 -14.66 27.87 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 122.872 0.469 . . . . 0.0 112.051 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.725 ' HE2' HG21 ' A' ' 654' ' ' VAL . 0.0 OUTLIER -128.5 149.22 50.68 Favored 'General case' 0 N--CA 1.411 -2.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.923 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.588 HD12 ' HB3' ' A' ' 678' ' ' TRP . 47.0 pt -140.09 146.44 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -172.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.491 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.3 OUTLIER -114.01 157.0 23.06 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.228 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 11.7 t -80.35 96.56 6.71 Favored 'General case' 0 CA--C 1.472 -2.044 0 CA-C-O 123.197 1.475 . . . . 0.0 110.547 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.03 110.27 17.07 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.599 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.628 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 15.0 t70 59.22 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.616 1.166 . . . . 0.0 111.418 -171.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -153.7 23.47 0.73 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -134.32 131.07 37.92 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.588 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.8 m95 -76.4 149.89 36.86 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 7.8 p -83.5 178.75 7.87 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 11.7 m -57.32 122.95 13.76 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.712 0.805 . . . . 0.0 111.085 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.464 HD11 ' HG2' ' A' ' 634' ' ' PRO . 7.3 mp -63.97 163.67 21.77 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.717 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 20.1 Cg_endo -61.53 -15.17 39.66 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.876 3.051 . . . . 0.0 115.345 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.548 ' HA ' HD21 ' A' ' 637' ' ' LEU 0.297 28.7 m 50.7 101.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 177.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.687 ' SG ' HD21 ' A' ' 636' ' ' LEU . 12.9 m -78.29 132.54 37.52 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.441 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.427 HD12 ' HB2' ' A' ' 666' ' ' LYS . 0.2 OUTLIER -127.68 136.57 60.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 176.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.64 130.79 28.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 123.566 0.541 . . . . 0.0 111.218 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 C--O 1.252 1.22 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.223 -177.372 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.246 0.878 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 71.68 143.16 0.06 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.34 1.456 . . . . 0.0 111.439 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . 0.703 ' HB3' ' HG2' ' A' ' 566' ' ' GLU . . . -84.25 -166.6 1.48 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -77.33 -11.22 85.71 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.703 ' HG2' ' HB3' ' A' ' 564' ' ' ALA . 11.8 pt-20 -61.7 162.32 8.73 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.127 1.371 . . . . 0.0 112.307 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -155.69 97.47 1.85 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . 0.47 ' HG3' HG23 ' A' ' 589' ' ' VAL . 17.8 tt0 -85.48 177.74 7.66 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.725 -170.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.475 ' HB3' HD21 ' A' ' 616' ' ' LEU . 57.6 m -111.34 153.41 26.04 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -167.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.812 ' HG2' ' HG3' ' A' ' 586' ' ' GLN . 49.0 mt-10 -128.77 146.76 50.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 166.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . . . . . . . . . 1.7 tt -53.48 115.13 7.2 Favored Pre-proline 0 C--O 1.245 0.837 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.19 -169.11 0.48 Allowed 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.511 2.141 . . . . 0.0 111.572 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -88.65 92.38 9.17 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 578' ' ' LEU . 37.2 pt -78.06 -170.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.658 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.649 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.4 t70 -77.61 147.4 35.64 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.12 -31.99 38.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 123.445 0.698 . . . . 0.0 111.044 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -98.54 14.63 27.66 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.081 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 5.5 tp -104.41 150.35 24.61 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.8 t -139.21 122.54 10.77 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.513 ' HG2' ' HA ' ' A' ' 583' ' ' LYS . 50.3 Cg_endo -78.74 144.67 19.65 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.813 2.342 . . . . 0.0 111.737 174.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 594' ' ' LYS . 7.2 t70 -51.86 -53.79 36.45 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.815 1.646 . . . . 0.0 111.212 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . 0.628 ' HG2' ' HE3' ' A' ' 584' ' ' LYS . 4.5 mpt_? -70.55 -59.86 2.6 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.025 0.44 . . . . 0.0 110.459 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.513 ' HA ' ' HG2' ' A' ' 580' ' ' PRO . 50.2 tttm 60.14 62.29 1.65 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.163 -174.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.628 ' HE3' ' HG2' ' A' ' 582' ' ' ARG . 16.8 ptpt -118.44 160.29 21.97 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.29 -45.33 40.49 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . 0.812 ' HG3' ' HG2' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -118.07 126.98 53.33 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.619 0.247 . . . . 0.0 110.504 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.63 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 86.5 m-85 -100.73 132.51 46.09 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.675 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -78.09 148.92 34.0 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.496 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 60.0 t -58.65 119.1 2.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 106.04 -1.73 38.21 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.598 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -73.14 134.09 44.32 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 122.362 -0.493 . . . . 0.0 109.731 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.493 HG22 ' HG3' ' A' ' 610' ' ' GLN . 17.6 t -101.0 114.9 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.63 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 3.4 mp -91.71 92.49 8.45 Favored 'General case' 0 N--CA 1.405 -2.68 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 608' ' ' SER . 58.1 mttp -74.13 136.46 42.92 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 173.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -112.57 163.71 14.18 Favored 'General case' 0 C--N 1.266 -3.026 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.753 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 14.7 m -152.55 172.07 17.15 Favored 'General case' 0 N--CA 1.39 -3.471 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.539 ' SG ' HD12 ' A' ' 578' ' ' LEU . 69.8 m -108.83 178.43 4.48 Favored 'General case' 0 C--N 1.247 -3.862 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 71.0 mmtt -54.29 162.79 1.46 Allowed Pre-proline 0 C--N 1.313 -0.98 0 C-N-CA 124.154 0.982 . . . . 0.0 111.935 176.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 82.8 Cg_exo -44.58 -44.92 13.53 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.127 3.218 . . . . 0.0 114.358 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -100.09 18.33 55.81 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.822 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -120.11 147.66 44.59 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 121.759 0.79 . . . . 0.0 112.384 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.665 HG21 HG11 ' A' ' 627' ' ' VAL . 23.1 m -100.66 133.44 45.11 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.648 175.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.566 HD11 ' HG3' ' A' ' 621' ' ' PRO . 10.1 tt -88.25 129.35 39.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.891 HG21 ' HD3' ' A' ' 624' ' ' LYS . 75.4 t -121.93 123.48 69.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 123.62 -150.65 16.94 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -73.12 115.68 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.38 2.053 . . . . 0.0 111.209 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -92.31 7.69 41.7 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 594' ' ' LYS . 58.5 p -156.43 113.61 3.17 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.75 0.42 . . . . 0.0 110.01 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 13.7 m -118.1 151.96 20.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.578 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -101.27 154.35 18.85 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.449 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.496 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 6.6 t -85.0 112.67 20.81 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 169.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -104.22 170.17 8.06 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -77.88 14.61 1.05 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -125.81 -1.08 7.3 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 171.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.05 -175.36 19.83 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.926 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 569' ' ' CYS . 2.5 mm? -78.8 123.8 27.57 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 618' ' ' PRO . 5.4 t -150.36 151.91 32.13 Favored Pre-proline 0 C--N 1.309 -1.184 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.616 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.507 ' HA ' ' OG ' ' A' ' 617' ' ' SER . 58.7 Cg_endo -70.03 -178.2 16.64 Favored 'Cis proline' 0 C--N 1.361 1.235 0 C-N-CA 123.812 -1.328 . . . . 0.0 112.717 0.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.13 157.07 23.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.334 0.587 . . . . 0.0 111.103 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.506 HD13 HG22 ' A' ' 574' ' ' ILE . 22.6 mt -66.85 152.41 95.7 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 114.229 -1.35 . . . . 0.0 114.146 -168.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.566 ' HG3' HD11 ' A' ' 603' ' ' ILE . 92.8 Cg_endo -81.46 179.74 5.57 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.065 3.177 . . . . 0.0 111.633 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 43.6 pt -121.46 174.44 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 120.592 0.234 . . . . 0.0 110.586 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 98.1 m -119.91 128.84 54.0 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.386 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.891 ' HD3' HG21 ' A' ' 604' ' ' VAL . 26.4 mtpp -124.0 132.31 53.68 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.98 -41.05 15.21 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -96.94 114.58 26.21 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.01 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.665 HG11 HG21 ' A' ' 602' ' ' THR . 11.8 m -123.49 -175.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.24 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -99.41 165.14 11.8 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.557 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 18.6 m -100.36 -11.93 19.86 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.231 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 18.0 m 72.96 -0.42 3.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.36 1.064 . . . . 0.0 113.54 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 63.38 -144.67 49.45 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.6 157.1 24.98 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.612 2.208 . . . . 0.0 110.91 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.608 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.5 Cg_endo -75.15 163.69 34.52 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.857 2.371 . . . . 0.0 112.427 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.462 ' HG2' HD11 ' A' ' 681' ' ' LEU . 37.0 Cg_endo -69.61 172.95 11.56 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.589 2.193 . . . . 0.0 111.899 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -86.06 161.23 19.03 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 657' ' ' TYR . 15.1 tp -99.49 145.34 27.58 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 638' ' ' ASN . 1.3 pp -65.68 -37.69 87.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.45 ' N ' HD12 ' A' ' 637' ' ' LEU . 46.4 m-80 -138.36 33.96 2.3 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.206 1.003 . . . . 0.0 109.677 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.51 ' HA3' HD23 ' A' ' 636' ' ' LEU . . . -158.1 -150.88 5.88 Favored Glycine 0 N--CA 1.413 -2.841 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.754 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . 0.63 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 2.1 t-20 -160.56 -177.35 6.14 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.539 HG22 ' CE1' ' A' ' 657' ' ' TYR . 17.9 t -91.55 129.59 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.242 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 174.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.444 ' HB3' ' CD1' ' A' ' 658' ' ' TYR . 10.0 ptmm? -90.16 -14.83 32.74 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.604 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -89.84 168.86 11.74 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.877 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -77.72 110.97 13.03 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 17.8 p -71.23 106.49 3.83 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.523 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 42.6 pttt -87.94 153.41 21.32 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.271 175.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.471 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 11.0 pt-20 -68.32 -12.52 61.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.408 0.683 . . . . 0.0 111.607 -176.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -151.17 102.37 2.93 Favored 'General case' 0 N--CA 1.406 -2.658 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -171.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.608 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 4.2 m-85 -82.49 -70.75 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 120.63 165.64 12.83 Favored Glycine 0 C--N 1.288 -2.106 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 674' ' ' VAL . 86.2 t60 -74.02 142.16 45.77 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.439 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 49.6 m 71.32 5.46 5.44 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.307 1.043 . . . . 0.0 112.377 178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.435 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 5.5 tp10 -84.1 115.37 22.35 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 670' ' ' LYS . 2.4 p -90.2 152.63 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 30.5 m -120.98 112.05 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.729 178.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.531 ' CG ' ' HG2' ' A' ' 670' ' ' LYS . 27.3 mt-10 -69.57 119.8 14.37 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.017 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.671 ' HB3' HD22 ' A' ' 636' ' ' LEU . 79.2 m-85 -99.31 173.65 6.68 Favored 'General case' 0 C--N 1.271 -2.809 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.412 173.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.63 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 24.3 p90 -150.88 139.92 21.05 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 173.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.503 ' SG ' HD21 ' A' ' 636' ' ' LEU . 43.6 m -105.1 161.53 14.16 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-O 120.894 0.378 . . . . 0.0 110.521 172.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -57.03 152.04 30.96 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.54 -177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.04 33.69 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 124.738 3.625 . . . . 0.0 113.539 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -136.63 0.79 2.51 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 124.019 0.928 . . . . 0.0 109.008 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -127.18 159.2 34.99 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.811 -173.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.65 ' HG ' ' HB3' ' A' ' 687' ' ' GLU . 84.2 mt -107.81 136.51 47.42 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.793 ' HG3' ' SG ' ' A' ' 684' ' ' CYS . 4.2 ttt -95.32 113.68 25.37 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -78.25 -62.83 1.55 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.34 -170.43 46.82 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.653 -0.785 . . . . 0.0 112.878 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.65 123.71 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.028 2.485 . . . . 0.0 111.536 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -64.15 -17.95 63.98 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 122.915 0.486 . . . . 0.0 111.591 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 1.0 OUTLIER -122.32 153.52 38.84 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.572 HD13 HD12 ' A' ' 681' ' ' LEU . 46.8 pt -143.3 142.53 25.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.25 148.16 34.72 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 48.7 t -82.53 129.14 34.86 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.404 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.613 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 30.7 m -110.4 126.13 67.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 123.061 0.544 . . . . 0.0 110.638 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.535 ' OD1' ' HE2' ' A' ' 624' ' ' LYS . 21.9 t70 60.25 -67.0 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.562 1.145 . . . . 0.0 112.342 -172.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -168.44 21.66 0.09 OUTLIER Glycine 0 C--N 1.301 -1.405 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -132.71 137.9 47.06 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.548 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.6 m95 -81.73 152.22 27.13 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 8.0 p -77.56 -176.86 4.47 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 19.7 m -70.07 127.4 32.7 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.567 0.223 . . . . 0.0 111.565 -173.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.572 HD12 HD13 ' A' ' 671' ' ' ILE . 5.8 mp -62.91 155.13 73.44 Favored Pre-proline 0 CA--C 1.514 -0.426 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.564 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 5.6 Cg_endo -52.91 -55.04 4.1 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.795 2.997 . . . . 0.0 113.758 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 88.3 t 69.5 119.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.2 1.0 . . . . 0.0 111.198 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.793 ' SG ' ' HG3' ' A' ' 665' ' ' MET . 33.1 m -117.66 155.87 29.16 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.062 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.59 149.39 25.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 C-N-CA 123.783 0.833 . . . . 0.0 109.498 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.6 132.33 28.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 O-C-N 123.326 0.392 . . . . 0.0 110.044 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.65 ' HB3' ' HG ' ' A' ' 664' ' ' LEU . 8.2 pt-20 . . . . . 0 C--O 1.251 1.147 0 O-C-N 124.329 1.018 . . . . 0.0 112.332 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -135.24 94.0 3.06 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-O 121.305 0.574 . . . . 0.0 110.108 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -91.0 -31.92 16.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -141.81 120.27 1.61 Allowed Glycine 0 N--CA 1.41 -3.093 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.262 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.4 -49.34 67.12 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.498 ' HD2' ' HB2' ' A' ' 613' ' ' HIS . 88.2 mtt180 -118.53 104.21 10.46 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 172.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -93.75 167.11 11.86 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.717 0.77 . . . . 0.0 111.876 -172.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.631 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 27.5 m -103.68 -43.18 5.42 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.009 174.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 571' ' ' LEU . 19.9 tt0 60.79 -150.27 0.41 Allowed 'General case' 0 C--O 1.246 0.882 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 -171.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.428 HD11 ' HG3' ' A' ' 580' ' ' PRO . 1.0 OUTLIER -147.35 113.14 4.09 Favored Pre-proline 0 C--N 1.281 -2.372 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -177.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.402 ' HD2' HD12 ' A' ' 616' ' ' LEU . 37.2 Cg_endo -66.63 -170.67 0.22 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.253 2.635 . . . . 0.0 112.741 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -86.23 91.28 8.41 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.876 HG13 ' H ' ' A' ' 575' ' ' ASP . 11.5 pt -59.56 -75.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.472 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.876 ' H ' HG13 ' A' ' 574' ' ' ILE . 11.8 t70 -174.77 -173.07 0.68 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 10.9 p -106.16 -20.27 6.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -104.96 13.63 30.71 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.555 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.1 tt -114.62 141.61 47.55 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -175.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.34 116.9 14.31 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-O 121.42 0.629 . . . . 0.0 111.456 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 574' ' ' ILE . 64.1 Cg_endo -76.9 137.33 17.52 Favored 'Trans proline' 0 C--N 1.328 -0.514 0 C-N-CA 122.764 2.309 . . . . 0.0 111.73 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -56.94 -55.06 39.45 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.61 0.719 . . . . 0.0 109.594 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . 0.42 ' HB2' ' HE2' ' A' ' 587' ' ' TYR . 75.1 mmt-85 -78.34 117.54 19.68 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -124.67 93.52 3.92 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 10.6 ptpt -138.74 175.56 9.45 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.505 -174.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -87.57 -52.2 5.47 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.544 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.45 120.46 39.6 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.434 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.631 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 41.2 m-85 -85.09 126.66 33.77 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.832 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -80.04 143.8 33.73 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.898 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.45 118.04 2.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.444 0.64 . . . . 0.0 109.717 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 104.8 1.02 42.61 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.297 -176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.62 116.66 18.35 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 6.5 p -92.4 121.56 43.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.933 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . . . . . . . . . 5.7 mp -95.78 93.9 7.35 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.009 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 96.2 mttt -78.64 93.82 4.94 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.09 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.539 ' HB3' HD21 ' A' ' 578' ' ' LEU . 65.1 m-85 -78.1 163.87 25.5 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.424 0.63 . . . . 0.0 110.228 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 21.3 m -155.58 171.03 20.63 Favored 'General case' 0 N--CA 1.408 -2.567 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 89.1 m -117.59 175.06 5.81 Favored 'General case' 0 C--N 1.259 -3.336 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.3 mmmt -56.48 164.17 2.17 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.573 1.149 . . . . 0.0 112.555 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 94.8 Cg_exo -45.77 -40.17 19.13 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.584 3.522 . . . . 0.0 115.249 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -102.52 7.86 54.22 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.33 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 40.5 m-85 -110.55 132.86 53.82 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-O 121.799 0.809 . . . . 0.0 112.103 -178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 16.6 m -92.92 126.17 37.88 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.761 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.487 HD11 ' HG3' ' A' ' 621' ' ' PRO . 11.1 tt -78.95 117.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.774 HG21 ' HD3' ' A' ' 624' ' ' LYS . 50.2 t -108.78 117.49 54.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.653 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 122.74 -160.47 17.21 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.22 123.31 10.74 Favored 'Trans proline' 0 C--N 1.328 -0.507 0 C-N-CA 122.733 2.288 . . . . 0.0 110.947 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.438 HD22 ' N ' ' A' ' 607' ' ' ASN . 0.7 OUTLIER -86.21 -50.08 7.24 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 4.9 p -100.08 95.33 6.77 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 111.783 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.2 150.69 4.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.607 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 22.8 mm-40 -98.26 160.14 14.48 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . . . . . . . . . 10.5 t -84.25 129.89 34.86 Favored 'General case' 1 C--N 1.243 -4.033 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.575 165.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.607 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 55.5 m-85 -119.19 170.65 8.9 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . 0.498 ' HB2' ' HD2' ' A' ' 567' ' ' ARG . 1.0 OUTLIER -67.19 -12.84 61.13 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -104.82 -3.84 23.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.63 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 131.54 -170.18 21.62 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.402 HD12 ' HD2' ' A' ' 572' ' ' PRO . 46.6 mt -74.81 131.34 40.7 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.513 ' HB3' ' CD1' ' A' ' 612' ' ' TYR . 22.6 t -149.64 143.56 16.91 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -75.47 -172.5 10.97 Favored 'Cis proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.212 -1.578 . . . . 0.0 113.585 2.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.5 145.42 2.56 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.703 0.801 . . . . 0.0 110.63 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.654 HD23 HG22 ' A' ' 574' ' ' ILE . 6.5 mp -77.19 147.7 76.83 Favored Pre-proline 0 C--N 1.298 -1.659 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.262 -172.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.487 ' HG3' HD11 ' A' ' 603' ' ' ILE . 93.8 Cg_endo -74.85 -179.67 5.17 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 123.705 2.937 . . . . 0.0 112.913 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 40.6 pt -130.4 169.52 21.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 84.1 m -110.24 126.25 53.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.017 0.436 . . . . 0.0 110.832 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.774 ' HD3' HG21 ' A' ' 604' ' ' VAL . 28.3 mtpp -124.26 117.54 24.77 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.936 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 3.2 tm-20 -82.45 -36.77 26.26 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -94.26 98.93 11.27 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.843 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 6.2 m -114.28 171.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.514 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 53.5 mm-40 -98.67 169.12 9.72 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 42.6 m -116.14 -7.88 11.82 Favored 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.913 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 96.3 m 67.66 3.27 3.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 648' ' ' GLU . . . 62.24 -132.2 45.24 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.91 155.3 38.77 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.023 2.482 . . . . 0.0 111.301 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.702 ' HB3' HG11 ' A' ' 655' ' ' VAL . 86.2 Cg_endo -83.56 161.88 14.62 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 122.651 2.234 . . . . 0.0 112.572 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.47 173.91 11.72 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.61 2.207 . . . . 0.0 111.388 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -98.23 161.42 13.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 657' ' ' TYR . 19.7 tp -96.77 128.66 43.94 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -45.66 -42.04 11.04 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.432 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 34.5 m-80 -133.35 31.01 3.81 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.475 0.655 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.607 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -151.85 -144.77 3.99 Favored Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.59 -173.47 2.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 655' ' ' VAL . 5.2 p -94.54 131.06 42.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.649 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 20.4 ptmt -88.91 -16.15 32.57 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.674 0.75 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.29 166.04 15.19 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.813 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -84.82 120.26 26.24 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.434 ' CG2' HG11 ' A' ' 641' ' ' VAL . 5.6 p -74.3 100.57 3.78 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 121.464 0.649 . . . . 0.0 112.448 -174.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -68.17 175.86 3.02 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.525 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -98.79 -0.85 41.75 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.746 0.784 . . . . 0.0 109.672 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.438 ' HA ' ' HA2' ' A' ' 631' ' ' GLY . 26.4 tt0 -157.92 120.72 3.85 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.564 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 7.0 m-85 -91.76 -86.08 0.23 Allowed 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.981 173.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 145.83 164.23 10.71 Favored Glycine 0 CA--C 1.488 -1.6 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.522 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 57.8 t60 -56.98 -51.77 67.89 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 25.5 m -99.7 21.76 11.94 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.4 0.619 . . . . 0.0 110.835 -174.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.64 115.27 27.59 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.612 HG21 ' HE3' ' A' ' 670' ' ' LYS . 11.6 m -92.2 147.91 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.691 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.441 177.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 0.2 OUTLIER -114.73 115.94 51.06 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.843 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.34 177.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.649 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 18.4 mt-10 -77.02 138.52 39.64 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.261 1.029 . . . . 0.0 111.596 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.641 ' CE1' HG22 ' A' ' 655' ' ' VAL . 72.6 m-85 -119.06 167.55 11.67 Favored 'General case' 0 C--N 1.278 -2.504 0 C-N-CA 125.597 1.559 . . . . 0.0 109.589 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -144.91 144.35 31.04 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.607 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 71.1 m -100.83 172.25 7.17 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -69.28 153.46 95.9 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.9 10.5 0.37 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 123.699 2.933 . . . . 0.0 114.396 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.41 3.56 25.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -131.46 164.22 26.24 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.688 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 687' ' ' GLU . 89.0 mt -104.22 165.16 11.23 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 174.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.2 ttt -123.91 103.83 8.57 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -82.65 -45.08 14.96 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -170.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -96.26 -173.73 35.71 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.007 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.51 122.01 10.64 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.416 2.744 . . . . 0.0 111.946 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 656' ' ' GLU . 2.4 p-10 -83.53 23.05 0.98 Allowed 'General case' 0 C--O 1.199 -1.558 0 C-N-CA 122.872 0.469 . . . . 0.0 111.065 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.798 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 8.4 ptmt -163.82 107.09 0.97 Allowed 'General case' 0 C--N 1.283 -2.307 0 C-N-CA 125.007 1.323 . . . . 0.0 108.014 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 37.7 pt -107.91 148.79 11.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.346 -174.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.561 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -113.74 154.17 27.78 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.453 0.47 . . . . 0.0 110.392 179.288 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 5.0 t -80.53 95.53 6.52 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.766 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.508 ' HA ' ' CE1' ' A' ' 651' ' ' HIS . 35.1 m -84.52 117.02 29.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 O-C-N 121.402 -0.811 . . . . 0.0 111.39 -177.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.506 ' OD1' ' HE2' ' A' ' 624' ' ' LYS . 17.6 t70 62.23 -76.67 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.39 1.076 . . . . 0.0 111.118 -173.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -151.38 17.77 0.89 Allowed Glycine 0 N--CA 1.434 -1.477 0 O-C-N 123.792 0.683 . . . . 0.0 111.614 177.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -135.5 141.71 45.34 Favored 'General case' 0 CA--C 1.495 -1.158 0 O-C-N 122.29 -0.535 . . . . 0.0 109.94 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.532 ' HB3' HD12 ' A' ' 671' ' ' ILE . 99.0 m95 -74.34 156.03 37.53 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 3.3 p -81.23 -178.72 7.04 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 16.3 m -65.37 125.85 26.4 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.174 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.86 159.92 23.58 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 26.2 Cg_endo -62.87 -13.22 33.37 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 124.263 3.309 . . . . 0.0 115.284 -176.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.282 30.9 m 48.51 101.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 175.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.9 m -80.74 140.93 35.27 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.56 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.69 146.24 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.352 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 14.8 m -58.07 138.13 19.42 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.504 0 O-C-N 124.439 1.087 . . . . 0.0 112.088 -174.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.544 ' HA ' ' HG ' ' A' ' 664' ' ' LEU . 41.9 tt0 . . . . . 0 C--N 1.314 -0.962 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.5 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 CA--C 1.511 -0.558 0 CA-C-O 121.593 0.711 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -150.07 157.86 43.56 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -83.28 93.7 7.76 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -66.35 -56.89 11.58 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 613' ' ' HIS . 33.1 tt0 -95.77 104.7 16.64 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 169.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.98 123.25 17.05 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.56 -171.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.22 138.59 40.72 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 172.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.64 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 87.2 m -67.3 146.53 54.03 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -117.86 149.24 41.19 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.533 HD22 ' HD2' ' A' ' 572' ' ' PRO . 2.7 tm? -77.76 111.67 19.41 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.533 ' HD2' HD22 ' A' ' 571' ' ' LEU . 84.3 Cg_endo -76.67 -170.02 0.82 Allowed 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.068 2.512 . . . . 0.0 111.625 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -74.43 102.37 4.42 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.526 0.679 . . . . 0.0 110.1 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.674 HG22 ' HG ' ' A' ' 620' ' ' LEU . 27.3 pt -83.53 -166.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.757 -1.111 . . . . 0.0 108.613 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.2 t70 -76.84 143.78 39.5 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.63 -26.91 24.37 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 C-N-CA 124.048 0.939 . . . . 0.0 111.928 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -103.92 11.02 36.05 Favored 'General case' 0 CA--C 1.494 -1.174 0 O-C-N 121.637 -0.664 . . . . 0.0 111.864 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.674 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 5.6 tp -95.87 153.08 17.94 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.44 120.18 6.13 Favored Pre-proline 0 C--N 1.286 -2.185 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.448 ' HB2' ' O ' ' A' ' 582' ' ' ARG . 56.4 Cg_endo -74.7 137.45 22.46 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.24 1.96 . . . . 0.0 112.08 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -70.8 -42.34 70.41 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 580' ' ' PRO . 6.1 mmp_? -82.6 123.81 29.57 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 583' ' ' LYS . 34.5 ttmt -137.18 91.64 2.64 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 10.3 ptpt -137.92 172.63 12.65 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.578 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.08 -50.1 51.33 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.702 0.287 . . . . 0.0 111.36 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.06 152.85 50.95 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 121.443 0.639 . . . . 0.0 109.827 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.64 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 84.3 m-85 -115.18 119.72 37.32 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.068 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -70.05 142.24 52.72 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.567 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.531 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 1.8 p -61.29 112.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 122.279 1.038 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 121.33 -15.07 9.33 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.541 -174.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -72.03 126.26 29.32 Favored 'General case' 0 CA--C 1.473 -2.017 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 608' ' ' SER . 7.7 p -103.49 118.5 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.34 0 CA-C-O 122.35 1.071 . . . . 0.0 109.709 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.446 HD23 HD23 ' A' ' 571' ' ' LEU . 5.4 mp -91.04 98.52 11.82 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.025 -175.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 607' ' ' ASN . 96.0 mttt -78.21 118.96 20.93 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.546 176.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -97.9 179.49 4.78 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.387 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 10.5 p -168.67 161.82 11.48 Favored 'General case' 0 N--CA 1.408 -2.534 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.586 ' SG ' HD12 ' A' ' 578' ' ' LEU . 90.1 m -105.0 -176.04 2.96 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.504 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.3 mmtp -63.27 162.72 22.47 Favored Pre-proline 0 N--CA 1.429 -1.499 0 C-N-CA 123.218 0.607 . . . . 0.0 111.545 175.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 88.8 Cg_exo -45.72 -40.03 18.76 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 124.498 3.465 . . . . 0.0 115.404 -175.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -97.22 3.69 62.0 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.61 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 45.6 m-85 -108.41 151.56 25.87 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.225 1.012 . . . . 0.0 113.379 -175.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.553 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 2.6 m -103.76 123.6 47.35 Favored 'General case' 0 C--N 1.273 -2.735 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.061 177.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.457 ' HA ' ' SG ' ' A' ' 597' ' ' CYS . 5.7 tt -78.33 122.51 33.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.697 HG21 ' HG3' ' A' ' 624' ' ' LYS . 55.4 t -115.52 121.0 66.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 122.185 -0.322 . . . . 0.0 110.598 -178.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 119.77 -151.23 17.48 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.132 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.37 115.51 4.37 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.06 2.507 . . . . 0.0 111.214 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 0.2 OUTLIER -82.24 -25.95 33.67 Favored 'General case' 0 C--O 1.197 -1.668 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.835 -178.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.46 ' HB2' ' CG2' ' A' ' 592' ' ' VAL . 64.7 p -123.08 98.54 5.93 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 121.73 0.776 . . . . 0.0 111.354 -176.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.1 m -101.21 142.46 15.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.665 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -96.27 151.07 19.86 Favored 'General case' 0 CA--C 1.48 -1.746 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.815 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 35.5 t -75.38 125.07 28.25 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 166.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.488 ' HA ' HG23 ' A' ' 589' ' ' VAL . 90.7 m-85 -116.36 165.1 13.59 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 174.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . 0.435 ' HB2' ' HG3' ' A' ' 566' ' ' GLU . 0.9 OUTLIER -71.95 2.89 4.9 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -177.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -111.11 -4.74 14.94 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.391 0.615 . . . . 0.0 110.422 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.52 -178.52 18.0 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.123 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.513 HD12 ' CD ' ' A' ' 572' ' ' PRO . 45.7 mt -70.92 120.18 16.12 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.488 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 49.9 m -138.42 146.13 49.84 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-O 120.475 0.179 . . . . 0.0 110.672 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.84 -169.16 7.05 Favored 'Cis proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.182 -1.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.37 169.67 7.05 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.674 ' HG ' HG22 ' A' ' 574' ' ' ILE . 1.3 mm? -74.16 145.75 83.65 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.343 -168.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.24 170.59 17.9 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 123.228 2.619 . . . . 0.0 110.668 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . 0.454 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 47.0 pt -113.34 -178.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 602' ' ' THR . 96.1 m -129.13 109.04 10.84 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.425 0.453 . . . . 0.0 111.914 -177.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.697 ' HG3' HG21 ' A' ' 604' ' ' VAL . 18.5 mtmm -97.89 127.12 43.63 Favored 'General case' 0 C--O 1.201 -1.461 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 176.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.504 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 1.4 tm-20 -83.37 -34.5 25.58 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.36 107.54 18.52 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.058 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.567 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 10.4 p -125.22 174.51 9.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.402 ' H ' HG22 ' A' ' 627' ' ' VAL . 13.1 mm-40 -88.16 139.62 30.31 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 118.824 0.738 . . . . 0.0 109.352 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 631' ' ' GLY . 17.4 m -93.87 104.54 16.6 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 173.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 55.9 m -60.9 21.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 629' ' ' SER . . . 54.83 -139.06 40.8 Favored Glycine 0 C--O 1.241 0.579 0 CA-C-O 119.734 -0.481 . . . . 0.0 112.906 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.96 154.68 22.86 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 122.961 2.441 . . . . 0.0 110.782 175.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.505 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 59.9 Cg_endo -74.4 157.71 45.04 Favored 'Trans proline' 0 C--O 1.255 1.355 0 C-N-CA 122.684 2.256 . . . . 0.0 112.922 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.38 -169.47 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 123.47 2.78 . . . . 0.0 111.199 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -109.65 153.08 24.73 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.393 -0.817 . . . . 0.0 110.675 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 657' ' ' TYR . 18.6 tp -80.67 139.86 35.95 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.423 HD13 ' OD1' ' A' ' 638' ' ' ASN . 0.3 OUTLIER -46.26 -47.79 18.06 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -178.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.423 ' OD1' HD13 ' A' ' 637' ' ' LEU . 16.4 m120 -116.58 -30.43 5.83 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.519 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.642 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -91.12 -152.23 27.8 Favored Glycine 0 N--CA 1.433 -1.514 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.222 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.35 -174.77 5.09 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.995 0.426 . . . . 0.0 110.545 178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 6.0 p -92.68 134.71 29.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.536 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.56 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.2 ptmt -93.86 -24.65 17.66 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.046 0.45 . . . . 0.0 110.61 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 15.2 mm-40 -78.82 151.47 31.89 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.364 -177.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -63.97 109.24 1.72 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.438 ' CG2' HG11 ' A' ' 641' ' ' VAL . 16.7 p -71.59 98.56 1.9 Allowed 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.434 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -81.3 158.03 24.9 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 172.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -87.81 0.88 55.2 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.1 108.56 4.84 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.505 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 17.4 m-85 -92.76 -104.75 0.12 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 147.56 168.99 14.48 Favored Glycine 0 CA--C 1.487 -1.657 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.01 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 18.7 t60 -69.65 142.25 53.47 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 17.8 m 75.72 -1.66 2.95 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.549 1.14 . . . . 0.0 111.422 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.433 ' HG3' ' HD2' ' A' ' 649' ' ' TYR . 7.3 tp10 -93.72 114.63 26.96 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 670' ' ' LYS . 17.8 m -91.84 161.41 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.774 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.622 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.1 m -127.16 110.89 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.512 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.574 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.56 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 17.8 mt-10 -70.16 122.23 19.06 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.105 0.955 . . . . 0.0 111.599 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.537 ' HB3' HD22 ' A' ' 636' ' ' LEU . 76.6 m-85 -102.42 166.89 10.3 Favored 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.032 174.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -146.83 137.04 23.55 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.642 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 8.3 t -102.61 179.09 4.39 Favored 'General case' 0 C--N 1.276 -2.612 0 C-N-CA 118.879 -1.128 . . . . 0.0 108.025 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 662' ' ' ARG . 30.9 m-80 -75.85 155.66 84.81 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.52 33.85 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 124.295 3.33 . . . . 0.0 112.688 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 660' ' ' ASN . 35.4 mtt180 -133.3 4.77 3.74 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.411 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 76.9 m-85 -138.42 163.11 32.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.462 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.1 147.61 38.49 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.467 ' HG2' ' HB2' ' A' ' 682' ' ' PRO . 0.5 OUTLIER -103.34 118.98 37.99 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -176.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -80.21 -59.33 2.75 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -95.53 -160.79 33.4 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.067 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.93 116.34 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.03 2.487 . . . . 0.0 112.237 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.503 ' ND2' ' HG3' ' A' ' 670' ' ' LYS . 4.9 p-10 -63.52 -11.77 26.85 Favored 'General case' 0 C--O 1.195 -1.776 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.946 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 0.0 OUTLIER -134.62 115.31 13.69 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.238 0.542 . . . . 0.0 111.909 178.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 33.8 pt -109.03 151.58 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.048 -174.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.536 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -115.64 152.12 33.73 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 121.211 0.529 . . . . 0.0 111.399 -179.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 1.5 t -69.72 121.15 16.62 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.03 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.432 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 34.0 m -116.23 86.9 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 CA-C-O 122.293 1.044 . . . . 0.0 113.045 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.567 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 16.5 m-20 75.3 8.05 3.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.795 -1.548 . . . . 0.0 113.913 166.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 142.35 -11.92 2.51 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.285 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -138.63 149.26 45.01 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.52 ' HB3' HD12 ' A' ' 671' ' ' ILE . 93.8 m95 -80.01 158.89 26.41 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 19.0 p -80.17 -180.0 7.35 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.655 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 25.8 m -68.6 126.72 30.55 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 120.717 0.294 . . . . 0.0 110.944 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.441 ' HA ' HG21 ' A' ' 671' ' ' ILE . 6.2 mp -57.94 160.3 8.76 Favored Pre-proline 0 N--CA 1.441 -0.904 0 O-C-N 124.461 1.101 . . . . 0.0 113.011 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.467 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 11.5 Cg_endo -57.31 -42.1 66.0 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.112 2.541 . . . . 0.0 113.283 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 99.8 t 67.55 113.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-O 121.936 0.874 . . . . 0.0 110.467 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 8.1 p -111.54 138.17 48.42 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.996 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.89 148.52 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.283 0 CA-C-N 114.515 -1.22 . . . . 0.0 108.469 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 14.8 m -56.3 138.11 17.26 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.558 0 C-N-CA 124.558 1.143 . . . . 0.0 113.759 -171.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 C--N 1.299 -1.62 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.606 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -175.62 26.46 0.0 OUTLIER 'General case' 0 C--O 1.247 0.958 0 C-N-CA 123.576 0.75 . . . . 0.0 110.549 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -73.6 140.07 45.97 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.208 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 80.84 -41.91 2.62 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 116.243 -0.435 . . . . 0.0 113.991 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -71.1 72.96 0.62 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.262 1.03 . . . . 0.0 113.669 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -90.87 -23.63 20.48 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.449 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -147.99 -158.37 0.91 Allowed 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.407 -177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.851 ' HB3' HD11 ' A' ' 616' ' ' LEU . 90.5 m -59.28 133.34 56.01 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -174.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 571' ' ' LEU . 35.6 tt0 -94.63 -61.51 1.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.624 HD11 ' HG3' ' A' ' 580' ' ' PRO . 3.4 tt 150.84 129.88 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 177.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.703 ' HD3' HD13 ' A' ' 616' ' ' LEU . 74.5 Cg_endo -70.55 -170.8 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.76 1.64 . . . . 0.0 111.325 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -92.27 102.19 14.69 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.662 HD13 ' HD3' ' A' ' 580' ' ' PRO . 36.7 pt -76.2 -164.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.601 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.862 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 11.3 t70 -80.86 163.84 23.11 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.14 -28.09 22.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.17 0.509 . . . . 0.0 110.793 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -101.6 9.45 41.14 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 121.734 -0.604 . . . . 0.0 111.424 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.862 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.2 tm? -100.79 146.49 27.21 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.438 ' N ' HD13 ' A' ' 578' ' ' LEU . 16.3 m -140.74 121.14 8.82 Favored Pre-proline 0 C--N 1.3 -1.578 0 C-N-CA 123.754 0.822 . . . . 0.0 109.326 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.662 ' HD3' HD13 ' A' ' 574' ' ' ILE . 55.8 Cg_endo -73.0 136.33 24.7 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.036 1.824 . . . . 0.0 111.484 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -64.74 -38.82 92.3 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.537 1.135 . . . . 0.0 110.782 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -67.38 -61.07 2.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.739 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 60.6 tttm 51.84 74.57 0.25 Allowed 'General case' 0 C--O 1.241 0.649 0 O-C-N 124.676 1.235 . . . . 0.0 110.895 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 16.9 ptpt -131.12 156.24 45.61 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.289 -1.323 . . . . 0.0 107.445 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -76.55 -31.51 57.64 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . 0.41 HE21 ' N ' ' A' ' 586' ' ' GLN . 0.0 OUTLIER -134.21 133.08 40.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.875 0.369 . . . . 0.0 110.838 174.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.52 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 96.7 m-85 -110.69 142.29 42.8 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -93.13 153.4 18.68 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.602 ' HA ' ' SG ' ' A' ' 611' ' ' CYS 0.269 0.2 OUTLIER -64.64 118.0 6.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 121.839 0.828 . . . . 0.0 111.705 179.493 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 113.34 -3.66 25.11 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.768 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -74.53 134.7 42.19 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.628 HG12 ' HG3' ' A' ' 610' ' ' GLN . 20.3 m -109.82 129.92 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.881 0.848 . . . . 0.0 109.888 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.52 ' HG ' ' CE2' ' A' ' 587' ' ' TYR 0.368 0.0 OUTLIER -116.26 98.56 6.66 Favored 'General case' 0 N--CA 1.385 -3.701 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.269 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 607' ' ' ASN . 24.4 mtpp -61.46 124.6 21.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.044 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.698 ' HB3' HD11 ' A' ' 578' ' ' LEU . 27.7 m-85 -105.44 164.73 11.64 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.702 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . 0.477 ' HA ' HD12 ' A' ' 603' ' ' ILE . 34.0 p -168.85 166.69 11.31 Favored 'General case' 0 N--CA 1.401 -2.88 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 169.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 70.8 m -98.9 173.26 6.94 Favored 'General case' 0 C--N 1.255 -3.534 0 O-C-N 123.769 0.668 . . . . 0.0 110.831 -177.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.611 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 29.9 mmtp -53.04 163.21 0.9 Allowed Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 124.304 1.041 . . . . 0.0 112.191 176.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 18.7 Cg_endo -60.69 -17.09 47.55 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.852 2.368 . . . . 0.0 115.291 -170.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -110.54 8.63 30.37 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.273 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 30.7 m-85 -113.1 162.43 15.94 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.534 0.683 . . . . 0.0 112.258 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.409 HG21 HG21 ' A' ' 627' ' ' VAL . 8.1 m -112.65 131.95 55.4 Favored 'General case' 0 N--CA 1.416 -2.148 0 C-N-CA 125.533 1.533 . . . . 0.0 110.111 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 596' ' ' SER . 11.4 tt -83.98 122.4 37.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-O 121.439 0.638 . . . . 0.0 109.5 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 622' ' ' ILE . 46.1 t -118.07 109.74 28.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.276 0.56 . . . . 0.0 109.856 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 132.82 -164.43 24.07 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.21 128.76 27.39 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.966 2.444 . . . . 0.0 110.786 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 6.8 m120 -94.96 -10.17 31.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 122.182 -0.324 . . . . 0.0 110.947 -175.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . . . . . . . . . 2.8 p -150.24 98.08 2.63 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.335 0.588 . . . . 0.0 111.637 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 20.3 m -93.21 167.56 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.781 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.628 ' HG3' HG12 ' A' ' 592' ' ' VAL . 2.0 mp0 -113.97 156.0 24.83 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.288 0.566 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 0.9 OUTLIER -85.25 130.8 34.53 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 164.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.565 ' CE1' ' HB2' ' A' ' 610' ' ' GLN . 77.5 m-85 -115.35 175.0 5.71 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -73.23 -12.94 61.04 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.862 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -101.38 -2.32 31.19 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 111.173 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.25 -171.78 21.35 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.851 HD11 ' HB3' ' A' ' 569' ' ' CYS . 5.2 mp -87.36 137.59 32.21 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 118.091 0.945 . . . . 0.0 110.019 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 618' ' ' PRO . 44.7 m -158.38 157.11 28.67 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.152 -176.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 617' ' ' SER . 59.3 Cg_endo -68.92 -168.18 3.85 Favored 'Cis proline' 0 CA--C 1.554 1.498 0 C-N-CA 124.599 -1.001 . . . . 0.0 114.279 1.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -64.02 160.99 16.78 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.994 0.426 . . . . 0.0 110.748 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.507 HD11 ' HG2' ' A' ' 572' ' ' PRO . 2.1 mm? -78.43 144.52 66.11 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.89 162.53 41.78 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.982 2.455 . . . . 0.0 110.924 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 43.1 pt -110.49 -178.66 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.7 m -129.9 116.63 18.93 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-O 121.28 0.562 . . . . 0.0 111.716 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 624' ' ' LYS . 46.3 mtpt -104.02 130.42 51.68 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 25.3 tt0 -86.85 -39.82 15.48 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -98.22 107.54 20.04 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.138 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 3.5 p -107.13 176.48 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.473 ' NE2' ' HA3' ' A' ' 676' ' ' GLY . 48.2 mt-30 -93.53 156.14 16.91 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.478 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 15.4 m -99.02 -7.53 26.71 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.658 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . 0.452 ' SG ' ' HA2' ' A' ' 676' ' ' GLY . 20.9 m 71.1 -12.4 0.59 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 167.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 65.18 -147.25 50.79 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -79.01 148.76 22.08 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 122.66 2.24 . . . . 0.0 111.846 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.641 ' HG3' HG11 ' A' ' 655' ' ' VAL . 71.6 Cg_endo -76.42 167.69 25.22 Favored 'Trans proline' 0 CA--C 1.556 1.578 0 C-N-CA 123.49 2.793 . . . . 0.0 113.025 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.97 -167.52 0.24 Allowed 'Trans proline' 0 CA--C 1.55 1.292 0 C-N-CA 123.626 2.884 . . . . 0.0 113.587 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -111.99 166.02 11.59 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.605 HD22 ' HB3' ' A' ' 657' ' ' TYR . 18.9 tp -102.55 132.2 48.78 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 638' ' ' ASN . 2.3 pp -51.91 -42.91 63.12 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.778 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 15.3 m120 -131.09 29.91 4.62 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.717 0.77 . . . . 0.0 109.392 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.662 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -153.61 -150.4 5.45 Favored Glycine 0 N--CA 1.412 -2.953 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.55 -166.84 1.73 Allowed 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 7.5 p -107.53 128.37 62.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -85.44 -22.29 28.36 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.348 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.624 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 8.2 mm-40 -86.89 144.43 26.99 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.158 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 644' ' ' LYS . 5.9 ttpm? -56.8 112.7 1.38 Allowed 'General case' 0 C--N 1.31 -1.136 0 O-C-N 124.353 1.033 . . . . 0.0 109.938 176.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.46 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 4.9 p -83.72 101.43 11.55 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.599 0.714 . . . . 0.0 111.682 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 49.7 pttt -84.95 160.78 20.02 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.099 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.94 -21.05 60.66 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -152.26 125.01 8.42 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.097 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.551 ' HA ' ' HE3' ' A' ' 646' ' ' LYS . 11.3 m-85 -99.27 -75.27 0.57 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 129.19 172.19 13.12 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -175.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.503 ' HB2' HG11 ' A' ' 627' ' ' VAL . 64.6 t60 -60.44 -63.31 1.34 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 19.3 m -87.9 41.82 1.02 Allowed 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 121.333 0.587 . . . . 0.0 111.172 -172.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -120.3 106.28 11.73 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.631 HG21 ' HE2' ' A' ' 670' ' ' LYS . 15.8 m -82.19 154.64 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-O 122.066 0.936 . . . . 0.0 111.548 176.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.641 HG11 ' HG3' ' A' ' 633' ' ' PRO . 2.8 t -127.45 111.89 26.49 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 114.13 -1.396 . . . . 0.0 107.995 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.701 ' HG2' ' HG2' ' A' ' 670' ' ' LYS . 36.0 mt-10 -70.09 120.47 15.84 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 122.21 1.005 . . . . 0.0 113.01 175.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.605 ' HB3' HD22 ' A' ' 636' ' ' LEU . 55.4 m-85 -100.21 165.34 11.54 Favored 'General case' 0 C--N 1.263 -3.153 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.717 171.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -146.54 138.29 24.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.662 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 80.1 m -92.3 175.92 6.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 0.8 OUTLIER -67.46 157.55 85.32 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 70.1 Cg_endo -72.89 37.74 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.909 3.073 . . . . 0.0 113.195 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -153.52 11.82 0.45 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.695 -175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 660' ' ' ASN . 87.0 m-85 -132.88 154.15 50.66 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.37 0.605 . . . . 0.0 110.196 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 85.4 mt -93.68 149.23 21.4 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.2 ttt -112.11 118.76 36.26 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -75.18 -72.04 0.32 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -172.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -90.67 -151.97 26.95 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 113.663 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.36 119.67 6.74 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.3 2.667 . . . . 0.0 111.919 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -74.96 -12.9 60.45 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 121.201 0.524 . . . . 0.0 110.81 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.701 ' HG2' ' HG2' ' A' ' 656' ' ' GLU . 9.1 mtpt -119.24 125.88 50.18 Favored 'General case' 0 N--CA 1.41 -2.451 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 40.4 pt -116.74 138.14 48.32 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.605 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.599 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.6 OUTLIER -102.61 161.52 13.66 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 42.8 t -102.2 110.93 23.03 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 122.492 1.139 . . . . 0.0 111.135 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 77.8 t -86.14 110.08 19.47 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.036 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.13 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.593 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 23.0 t70 60.73 -80.27 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 124.799 1.24 . . . . 0.0 112.43 -171.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.473 ' HA3' ' NE2' ' A' ' 628' ' ' GLN . . . -145.67 14.61 1.79 Allowed Glycine 0 C--N 1.301 -1.389 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 176.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -125.41 115.6 20.54 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.558 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.4 m95 -63.53 146.24 54.08 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 17.8 p -67.36 175.51 2.71 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 2.7 m -60.5 130.2 45.38 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.938 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.48 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 6.0 mp -63.38 152.25 85.6 Favored Pre-proline 0 N--CA 1.433 -1.281 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.48 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 19.3 Cg_endo -58.64 -36.73 96.83 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.648 2.898 . . . . 0.0 114.125 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 66.2 t 69.4 117.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.913 0.885 . . . . 0.0 112.773 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.778 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 4.1 m -96.75 135.35 38.81 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.446 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.81 144.04 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.928 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 16.8 m -58.15 139.69 17.47 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.064 0 C-N-CA 124.678 1.191 . . . . 0.0 112.843 -174.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 . . . . . 0 C--N 1.313 -1.02 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.62 -179.38 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -121.04 170.78 9.19 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -60.95 107.56 0.73 Allowed 'General case' 0 C--O 1.254 1.3 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -99.23 -148.49 23.24 Favored Glycine 0 N--CA 1.422 -2.251 0 CA-C-N 115.375 -0.83 . . . . 0.0 113.753 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 47.06 65.57 1.21 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.826 1.65 . . . . 0.0 111.717 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -107.02 4.41 27.02 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.226 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -157.31 162.86 39.15 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.741 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 79.2 m -67.78 119.19 12.09 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.792 0.806 . . . . 0.0 110.943 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -98.76 -2.31 38.36 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-O 122.419 1.104 . . . . 0.0 108.929 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.675 ' HB2' ' CE1' ' A' ' 587' ' ' TYR . 47.4 tp 74.37 115.1 0.03 OUTLIER Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 127.059 2.144 . . . . 0.0 110.337 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.708 ' HG2' HD11 ' A' ' 620' ' ' LEU . 60.8 Cg_endo -67.97 -159.47 0.05 OUTLIER 'Trans proline' 0 C--O 1.254 1.294 0 C-N-CA 123.696 2.931 . . . . 0.0 111.6 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -89.93 98.98 12.09 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.563 HG22 HD13 ' A' ' 620' ' ' LEU . 40.7 pt -72.83 175.09 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.153 174.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.726 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 13.7 t70 -65.79 147.81 52.79 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.12 -25.91 31.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 C-N-CA 123.792 0.837 . . . . 0.0 110.786 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -105.9 8.32 32.57 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 122.054 -0.403 . . . . 0.0 111.864 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.726 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 6.5 tp -91.75 148.61 22.12 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 21.7 m -135.66 116.57 11.77 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.492 ' HG2' ' HB2' ' A' ' 583' ' ' LYS . 26.9 Cg_endo -74.23 134.61 19.47 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 121.472 1.448 . . . . 0.0 109.686 174.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -33.41 75.72 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . 0.434 ' HB3' ' HE3' ' A' ' 584' ' ' LYS . 27.0 mmt180 -70.76 -64.75 0.84 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.802 177.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.492 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 27.3 ttpp 47.91 82.34 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.691 1.596 . . . . 0.0 112.334 -177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.477 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.9 ptpt -133.66 163.91 28.37 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.975 -1.466 . . . . 0.0 107.412 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -72.69 -46.02 55.84 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.957 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.36 133.88 50.01 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.577 0.703 . . . . 0.0 110.258 177.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.741 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 92.8 m-85 -107.37 124.76 50.3 Favored 'General case' 0 C--N 1.28 -2.422 0 C-N-CA 124.862 1.265 . . . . 0.0 109.509 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -78.79 149.23 32.66 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.586 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 1.3 p -63.8 119.17 7.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.59 0.709 . . . . 0.0 111.33 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 115.2 -10.38 20.21 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.26 -173.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -70.21 125.97 28.32 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.439 HG13 ' NE2' ' A' ' 610' ' ' GLN . 18.6 t -99.55 116.7 43.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 608' ' ' SER . 9.7 mt -101.84 115.04 29.66 Favored 'General case' 0 CA--C 1.47 -2.121 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.598 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 34.1 mtmm -91.76 99.38 12.27 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -76.81 161.81 28.15 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-O 122.022 0.915 . . . . 0.0 109.147 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 38.5 m -152.46 169.38 22.74 Favored 'General case' 0 C--N 1.253 -3.619 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.483 ' SG ' HD12 ' A' ' 578' ' ' LEU . 87.6 m -107.43 -178.17 3.56 Favored 'General case' 0 C--N 1.247 -3.887 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.594 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 32.1 mmtm -55.67 163.83 1.83 Allowed Pre-proline 0 C--N 1.313 -1.022 0 C-N-CA 123.018 0.527 . . . . 0.0 110.993 172.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 16.6 Cg_endo -59.03 -28.66 88.49 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.36 2.04 . . . . 0.0 114.701 -171.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -95.88 -2.65 61.04 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.879 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 39.9 m-85 -103.62 136.3 43.58 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 14.4 m -87.87 125.78 34.67 Favored 'General case' 0 N--CA 1.395 -3.201 0 CA-C-N 113.74 -1.573 . . . . 0.0 109.182 175.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.475 HD11 ' HG3' ' A' ' 621' ' ' PRO . 12.6 tt -80.31 125.69 39.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.67 HG21 ' HD3' ' A' ' 624' ' ' LYS . 82.5 t -117.25 114.58 46.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 123.59 -166.67 16.0 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.178 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.24 115.82 3.37 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.919 2.413 . . . . 0.0 111.535 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.99 -49.51 17.47 Favored 'General case' 0 C--O 1.206 -1.201 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.598 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 57.0 p -99.1 113.7 26.05 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 121.11 0.481 . . . . 0.0 111.626 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.8 m -116.86 157.39 17.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.56 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -103.36 151.96 22.14 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 121.011 0.434 . . . . 0.0 109.904 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 42.1 t -80.16 129.46 34.51 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.446 ' HA ' HG23 ' A' ' 589' ' ' VAL . 95.6 m-85 -114.64 165.79 12.41 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -61.92 -18.72 61.24 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -97.79 -5.28 35.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.85 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 134.62 -179.75 17.28 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 611' ' ' CYS . 71.9 mt -72.99 128.87 36.74 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 618' ' ' PRO . 67.1 m -146.26 147.07 30.07 Favored Pre-proline 0 C--N 1.294 -1.809 0 CA-C-N 116.816 -0.175 . . . . 0.0 110.681 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 617' ' ' SER . 49.5 Cg_endo -66.64 -175.7 7.74 Favored 'Cis proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.728 -1.363 . . . . 0.0 113.111 0.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.19 163.81 9.67 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 121.033 0.444 . . . . 0.0 110.957 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.708 HD11 ' HG2' ' A' ' 572' ' ' PRO . 24.0 mt -77.39 145.91 73.04 Favored Pre-proline 0 C--N 1.293 -1.869 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.972 -170.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.475 ' HG3' HD11 ' A' ' 603' ' ' ILE . 61.8 Cg_endo -70.91 173.68 11.64 Favored 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 123.537 2.824 . . . . 0.0 111.007 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 604' ' ' VAL . 44.1 pt -117.7 178.23 2.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 94.8 m -123.89 123.39 40.32 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.114 0.483 . . . . 0.0 110.604 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.67 ' HD3' HG21 ' A' ' 604' ' ' VAL . 58.2 mtpt -118.92 119.79 35.36 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.563 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 4.3 tm-20 -79.25 -43.12 24.38 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -91.64 91.92 8.23 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.488 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.622 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 5.0 p -109.69 170.82 2.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.275 -177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.588 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 19.9 mm-40 -91.61 161.17 15.04 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 27.3 m -107.51 -4.9 17.96 Favored 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.104 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 80.1 m 71.22 -34.79 0.31 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 88.34 -141.93 17.06 Favored Glycine 0 N--CA 1.415 -2.719 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -74.34 145.7 34.58 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 121.997 1.798 . . . . 0.0 111.831 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.533 ' HG3' HG11 ' A' ' 655' ' ' VAL . 92.2 Cg_endo -82.43 170.86 12.83 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.085 2.523 . . . . 0.0 111.874 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.14 -166.92 0.15 Allowed 'Trans proline' 0 CA--C 1.55 1.312 0 C-N-CA 123.214 2.61 . . . . 0.0 113.108 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -100.45 169.58 8.99 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.56 ' CD2' ' SG ' ' A' ' 659' ' ' CYS . 14.7 tp -91.33 166.16 13.05 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 117.733 -1.587 . . . . 0.0 110.258 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.509 ' N ' ' HG ' ' A' ' 636' ' ' LEU . 4.9 tt -63.45 -67.64 0.41 Allowed 'General case' 0 N--CA 1.396 -3.162 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.716 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.429 HD22 ' CD2' ' A' ' 637' ' ' LEU . 8.7 m-80 -128.08 40.16 3.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.979 0.895 . . . . 0.0 109.169 177.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -149.21 -142.13 3.55 Favored Glycine 1 N--CA 1.395 -4.067 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.784 176.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.66 -172.83 4.21 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.457 HG11 HG23 ' A' ' 645' ' ' THR . 9.0 p -104.0 134.55 44.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.705 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.1 ptmt -86.17 -29.85 22.92 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.661 0.744 . . . . 0.0 110.439 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 27.6 mm-40 -88.2 159.24 18.24 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.508 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -72.84 118.86 16.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.664 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.457 HG23 HG11 ' A' ' 641' ' ' VAL . 18.1 p -71.6 101.91 2.62 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-O 121.724 0.773 . . . . 0.0 111.21 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -73.29 156.54 38.35 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.484 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.51 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 49.2 mt-10 -85.59 -6.19 59.19 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -140.95 113.27 7.99 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 173.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.531 ' CE2' HG22 ' A' ' 655' ' ' VAL . 4.5 m-85 -96.35 -77.85 0.48 Allowed 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.455 174.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 130.09 163.5 11.1 Favored Glycine 0 CA--C 1.497 -1.091 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.628 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 71.2 t60 -56.51 -57.86 10.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 44.7 m -86.28 20.62 2.31 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -102.66 120.0 39.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 2.9 p -99.16 161.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.252 0.548 . . . . 0.0 110.143 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 2.8 t -127.37 113.72 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.724 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.705 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 29.5 mt-10 -71.91 124.15 24.26 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.497 0.665 . . . . 0.0 112.45 176.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.549 ' HB3' HD22 ' A' ' 636' ' ' LEU . 87.5 m-85 -108.1 167.33 10.07 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.621 172.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -150.44 141.23 22.76 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.79 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 9.1 m -100.47 173.85 6.38 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.116 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -62.89 155.09 73.47 Favored Pre-proline 0 C--O 1.245 0.828 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.618 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -71.01 29.41 0.21 Allowed 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 124.218 3.279 . . . . 0.0 114.681 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.3 21.8 1.88 Allowed 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.176 0.989 . . . . 0.0 110.144 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -135.6 157.38 47.03 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.01 175.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.43 132.36 54.2 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 3.1 ttt -97.0 106.41 18.75 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 666' ' ' LYS . 35.9 ttmt -90.97 -42.65 10.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -173.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.89 -178.67 46.13 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.183 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.27 113.64 1.63 Allowed 'Trans proline' 0 N--CA 1.476 0.484 0 C-N-CA 123.613 2.876 . . . . 0.0 112.082 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.532 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 5.3 p-10 -63.27 -15.42 57.12 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 2.0 mtpt -120.22 155.32 33.41 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 44.5 pt -139.36 145.95 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.64 HE21 ' N ' ' A' ' 672' ' ' GLN . 0.0 OUTLIER -118.64 158.75 24.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.096 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.628 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 7.5 t -86.33 104.48 15.88 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 122.878 1.323 . . . . 0.0 111.344 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.6 106.63 18.07 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.051 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.845 -176.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.622 ' HA ' ' CG2' ' A' ' 627' ' ' VAL 0.253 16.0 t70 64.13 -56.54 0.23 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.7 1.6 . . . . 0.0 114.543 -178.035 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.588 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -161.95 4.97 0.08 OUTLIER Glycine 0 C--N 1.288 -2.095 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.651 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -136.37 154.46 50.82 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 123.115 0.566 . . . . 0.0 109.478 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.435 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.3 m95 -80.34 174.72 11.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.836 0.826 . . . . 0.0 111.638 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.11 167.85 10.8 Favored 'General case' 0 N--CA 1.414 -2.26 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.705 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 26.7 m -57.16 128.46 37.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.22 0.95 . . . . 0.0 110.937 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.55 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 4.5 mp -65.94 154.46 89.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.541 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.55 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 5.9 Cg_endo -53.68 -32.6 65.92 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.962 3.108 . . . . 0.0 114.874 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . 0.315 30.5 m 42.79 94.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 26.9 p -86.79 162.03 18.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.697 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.62 155.99 23.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.5 140.68 13.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 O-C-N 123.686 0.617 . . . . 0.0 110.764 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--O 1.247 0.93 0 C-N-CA 123.55 0.74 . . . . 0.0 110.831 -179.348 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 CA--C 1.509 -0.611 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 61.75 -179.48 0.12 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.259 1.024 . . . . 0.0 111.402 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -102.58 151.67 22.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -75.9 121.94 6.45 Favored Glycine 0 N--CA 1.441 -1.011 0 O-C-N 123.907 0.754 . . . . 0.0 111.825 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.718 ' HG3' ' HG2' ' A' ' 567' ' ' ARG . 11.2 tp10 -78.29 128.38 33.61 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.423 0.689 . . . . 0.0 111.399 -177.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.718 ' HG2' ' HG3' ' A' ' 566' ' ' GLU . 22.2 mmm180 68.18 57.41 0.48 Allowed 'General case' 0 C--O 1.247 0.941 0 C-N-CA 125.809 1.643 . . . . 0.0 114.423 173.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -143.06 -175.94 4.72 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.778 0.831 . . . . 0.0 109.07 175.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.74 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 89.4 m -100.9 149.6 23.71 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -137.28 14.0 3.02 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 571' ' ' LEU . 1.1 tm? 70.96 101.62 0.04 OUTLIER Pre-proline 0 C--O 1.247 0.935 0 C-N-CA 124.481 1.113 . . . . 0.0 109.881 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.74 -172.34 0.8 Allowed 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.497 2.798 . . . . 0.0 111.613 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.39 95.86 5.2 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 177.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.555 HD13 ' HD3' ' A' ' 580' ' ' PRO . 17.2 pt -73.81 -175.11 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.592 177.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 14.7 t70 -71.2 148.87 46.87 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.49 -33.0 46.95 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.634 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -98.6 13.02 33.47 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 121.805 -0.56 . . . . 0.0 111.943 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.63 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.6 OUTLIER -106.06 150.75 25.47 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.527 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.55 119.68 7.78 Favored Pre-proline 0 C--N 1.312 -1.045 0 C-N-CA 124.159 0.983 . . . . 0.0 109.197 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.555 ' HD3' HD13 ' A' ' 574' ' ' ILE . 33.3 Cg_endo -71.43 135.31 26.3 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.321 2.014 . . . . 0.0 112.318 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.57 -47.12 79.91 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 123.556 0.742 . . . . 0.0 110.08 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -64.67 -68.43 0.36 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.466 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 39.1 ttpt 52.38 70.81 0.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.471 1.129 . . . . 0.0 110.685 -178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -119.94 157.26 29.16 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.93 -37.27 67.24 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.145 0.498 . . . . 0.0 111.805 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.42 142.74 51.34 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.74 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 72.3 m-85 -122.65 126.76 48.28 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . 0.52 ' HB2' ' HG2' ' A' ' 591' ' ' GLU . 36.9 mttp -69.61 149.26 48.33 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.436 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -71.52 120.19 19.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.22 174.299 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 116.57 -11.11 16.21 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.635 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . 0.52 ' HG2' ' HB2' ' A' ' 588' ' ' LYS . 5.8 mm-40 -67.84 142.14 56.23 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.555 HG22 ' HG3' ' A' ' 610' ' ' GLN . 18.7 t -115.64 114.75 47.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.639 HD22 ' CD2' ' A' ' 587' ' ' TYR . 0.2 OUTLIER -105.58 109.64 21.68 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.626 0.727 . . . . 0.0 111.279 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 60.5 mtpt -72.4 141.94 48.7 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.345 173.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 580' ' ' PRO . 64.1 m-85 -114.23 177.59 4.59 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-O 121.05 0.452 . . . . 0.0 109.955 175.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 10.6 p -163.05 164.46 25.5 Favored 'General case' 0 N--CA 1.405 -2.696 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 94.6 m -111.95 -178.72 3.5 Favored 'General case' 0 C--N 1.266 -3.028 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 598' ' ' LYS . 28.1 mmtp -57.41 159.38 8.91 Favored Pre-proline 0 N--CA 1.436 -1.167 0 C-N-CA 123.281 0.632 . . . . 0.0 110.995 173.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -46.6 -45.01 20.52 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 124.195 3.263 . . . . 0.0 114.057 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 625' ' ' GLU . . . -90.25 -2.4 73.98 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.979 -175.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 29.3 m-85 -97.41 179.79 4.75 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.613 0.721 . . . . 0.0 112.118 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.677 HG21 HG11 ' A' ' 627' ' ' VAL . 89.3 m -136.47 129.38 30.99 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 595' ' ' PHE . 15.9 tt -86.05 150.23 3.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 1.012 HG21 HG12 ' A' ' 622' ' ' ILE . 4.9 m -119.05 154.22 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.384 -171.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 53.72 -123.94 27.92 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 169.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.72 94.75 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.294 2.663 . . . . 0.0 112.194 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -79.98 -28.48 39.53 Favored 'General case' 0 C--O 1.203 -1.385 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.479 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.501 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 34.1 p -112.81 94.7 5.03 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.515 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . 0.428 ' C ' HE21 ' A' ' 610' ' ' GLN . 23.6 m -98.53 156.74 3.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.634 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -101.56 155.31 18.16 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.066 0.46 . . . . 0.0 110.111 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.484 ' HA ' HD23 ' A' ' 616' ' ' LEU . 44.1 t -82.97 120.26 25.48 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 168.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.577 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 19.7 m-85 -100.59 167.55 10.28 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -54.59 -26.61 33.55 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.065 0.546 . . . . 0.0 112.432 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -108.53 8.21 27.15 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.885 0.374 . . . . 0.0 111.446 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 130.19 -177.73 18.02 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.915 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 611' ' ' CYS . 74.5 mt -69.96 130.05 41.14 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.577 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 70.8 m -146.07 144.51 21.87 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 617' ' ' SER . 53.2 Cg_endo -69.31 -173.82 8.48 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.592 -1.42 . . . . 0.0 112.74 0.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.45 152.14 35.25 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 121.336 0.588 . . . . 0.0 110.53 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.429 ' CD2' HG22 ' A' ' 574' ' ' ILE . 4.9 mp -71.94 142.26 85.21 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.983 -170.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.9 164.47 34.54 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.832 3.021 . . . . 0.0 113.624 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . 1.012 HG12 HG21 ' A' ' 604' ' ' VAL . 33.0 pt -104.97 -176.34 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.506 ' SG ' HD12 ' A' ' 578' ' ' LEU . 74.3 m -125.58 127.47 46.42 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 121.202 0.525 . . . . 0.0 109.701 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.63 ' HG2' ' CG1' ' A' ' 604' ' ' VAL . 12.7 mmmm -86.63 -59.03 2.39 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 1.9 tm-20 80.78 -54.84 0.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.939 1.696 . . . . 0.0 108.508 -172.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -98.73 118.8 36.27 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.328 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.677 HG11 HG21 ' A' ' 602' ' ' THR . 3.9 m -128.32 170.92 17.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.937 178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.475 HE21 ' HA3' ' A' ' 676' ' ' GLY . 46.9 mt-30 -88.01 178.04 6.77 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.163 0.506 . . . . 0.0 110.616 -176.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.444 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 7.5 m -105.47 -14.38 15.33 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 11.9 m 72.7 -10.16 0.99 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.135 1.374 . . . . 0.0 113.185 169.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 59.55 -141.9 47.26 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.94 154.3 47.92 Favored 'Trans proline' 0 CA--C 1.549 1.254 0 C-N-CA 122.924 2.416 . . . . 0.0 111.901 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.598 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 92.7 Cg_endo -81.46 167.39 17.27 Favored 'Trans proline' 0 C--O 1.252 1.194 0 C-N-CA 123.415 2.743 . . . . 0.0 111.855 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.15 -175.92 1.42 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.49 2.127 . . . . 0.0 110.741 174.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.64 161.43 14.87 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 657' ' ' TYR . 20.4 tp -85.16 128.84 34.82 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.518 HD21 HG12 ' A' ' 683' ' ' VAL . 1.7 pp -46.88 -37.2 8.47 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.809 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 12.5 m120 -133.16 28.14 4.13 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.134 0.492 . . . . 0.0 109.683 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.21 -142.61 3.48 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -166.11 -179.31 5.07 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.399 0.679 . . . . 0.0 109.483 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.502 HG22 ' CE1' ' A' ' 657' ' ' TYR . 45.9 t -90.03 133.57 31.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 8.4 ptmm? -90.64 -16.03 29.38 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.548 0.69 . . . . 0.0 110.986 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -91.51 159.8 15.75 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -72.99 123.0 22.63 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.244 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 22.4 p -62.27 110.39 1.62 Allowed 'General case' 0 N--CA 1.411 -2.404 0 O-C-N 123.725 0.64 . . . . 0.0 109.547 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.408 ' HE2' ' CE2' ' A' ' 649' ' ' TYR . 43.8 mtmt -72.69 151.9 41.98 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -76.97 -14.51 59.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.92 0.867 . . . . 0.0 109.256 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -149.92 112.66 4.78 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.783 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.598 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 6.0 m-85 -89.83 -61.94 1.58 Allowed 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 106.32 156.66 21.52 Favored Glycine 0 N--CA 1.421 -2.304 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.539 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.574 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 79.0 t60 -61.63 136.19 57.91 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 122.596 0.358 . . . . 0.0 110.321 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.5 m 70.82 14.59 6.99 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.334 1.053 . . . . 0.0 112.63 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.466 ' CG ' ' HD2' ' A' ' 649' ' ' TYR . 6.0 tp10 -94.93 121.31 36.4 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 174.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.653 HG21 ' HE2' ' A' ' 670' ' ' LYS . 1.4 p -88.47 160.18 2.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-O 121.156 0.503 . . . . 0.0 110.632 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 31.2 m -129.63 113.53 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.57 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 670' ' ' LYS . 13.8 mt-10 -75.97 129.4 36.84 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.852 0.834 . . . . 0.0 111.261 176.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.607 ' HB3' HD22 ' A' ' 636' ' ' LEU . 95.4 m-85 -111.12 174.38 5.89 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.125 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -148.02 142.46 26.38 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.652 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 85.6 m -97.73 178.3 5.2 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.403 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 36.6 m-80 -71.62 154.55 93.11 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.38 38.24 0.48 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 124.246 3.298 . . . . 0.0 113.183 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.506 ' HG3' ' CE1' ' A' ' 663' ' ' PHE . 9.0 ptm180 -150.51 13.51 0.74 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.487 -175.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.506 ' CE1' ' HG3' ' A' ' 662' ' ' ARG . 85.2 m-85 -139.13 151.5 46.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.581 0.705 . . . . 0.0 110.772 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 81.1 mt -92.76 152.7 19.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.598 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 1.3 ttt -107.63 109.86 21.59 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.546 ' HB3' HG23 ' A' ' 683' ' ' VAL . 17.1 tppt? -71.57 -61.36 1.81 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.3 -172.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.67 -162.39 30.12 Favored Glycine 0 N--CA 1.431 -1.686 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.498 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.2 119.79 7.06 Favored 'Trans proline' 0 C--N 1.334 -0.198 0 C-N-CA 123.475 2.783 . . . . 0.0 112.407 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 4.6 p-10 -64.29 -2.38 2.14 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.653 ' HE2' HG21 ' A' ' 654' ' ' VAL . 0.0 OUTLIER -140.22 143.61 36.1 Favored 'General case' 0 N--CA 1.407 -2.625 0 C-N-CA 122.746 0.419 . . . . 0.0 110.279 177.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 678' ' ' TRP . 34.0 pt -136.46 142.39 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.562 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -112.23 149.92 31.63 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 44.0 t -80.16 125.24 29.57 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-O 123.166 1.46 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.52 118.39 57.04 Favored 'Isoleucine or valine' 1 N--CA 1.377 -4.094 0 CA-C-N 111.72 -2.491 . . . . 0.0 109.206 -174.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.574 ' H ' ' CE1' ' A' ' 651' ' ' HIS . 30.4 t70 63.46 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.938 1.295 . . . . 0.0 110.653 -172.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.475 ' HA3' HE21 ' A' ' 628' ' ' GLN . . . -161.03 27.99 0.3 Allowed Glycine 0 C--N 1.29 -1.977 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -138.5 146.48 42.04 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.563 ' HB3' HD12 ' A' ' 671' ' ' ILE . 95.6 m95 -87.18 160.58 18.45 Favored 'General case' 0 C--N 1.273 -2.749 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.93 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . 0.529 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 19.2 p -83.52 -179.9 7.47 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 14.2 m -65.69 124.73 23.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.004 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.446 ' HA ' HG21 ' A' ' 671' ' ' ILE . 7.9 mp -64.05 161.92 35.27 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.557 ' HB2' ' HG2' ' A' ' 665' ' ' MET . 23.6 Cg_endo -62.25 -16.79 53.3 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 123.795 2.997 . . . . 0.0 115.08 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 666' ' ' LYS 0.293 31.6 m 48.21 98.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 177.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.809 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.1 m -80.39 142.3 34.52 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.316 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 666' ' ' LYS . 0.2 OUTLIER -136.95 145.91 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.324 0 C-N-CA 123.765 0.826 . . . . 0.0 108.874 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 28.3 m -50.34 126.26 4.85 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.209 0 C-N-CA 125.473 1.509 . . . . 0.0 114.018 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.438 ' HG2' HD21 ' A' ' 664' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.288 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.629 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -145.18 -7.29 0.63 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.609 177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -144.4 152.23 40.39 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 120.825 0.345 . . . . 0.0 110.413 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -157.11 67.83 0.29 Allowed Glycine 0 C--N 1.298 -1.543 0 N-CA-C 107.719 -2.152 . . . . 0.0 107.719 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.4 -34.65 28.23 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.664 -0.768 . . . . 0.0 111.206 -171.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 567' ' ' ARG . 0.0 OUTLIER -153.43 153.05 31.76 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.214 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -93.36 -170.8 2.47 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . . . . . . . . . 76.8 m -85.96 166.63 15.77 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.204 0.526 . . . . 0.0 111.547 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -141.78 150.24 41.45 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.747 HD11 ' HG3' ' A' ' 580' ' ' PRO . 1.0 OUTLIER -73.9 119.17 74.8 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.504 ' HD3' HD12 ' A' ' 616' ' ' LEU . 72.4 Cg_endo -76.07 -162.48 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.658 2.239 . . . . 0.0 111.064 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -87.25 107.4 18.47 Favored 'General case' 0 N--CA 1.423 -1.82 0 O-C-N 121.91 -0.494 . . . . 0.0 110.092 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.498 HG22 HD23 ' A' ' 620' ' ' LEU . 28.1 pt -70.71 -169.88 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.346 176.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 10.9 t70 -77.43 152.94 34.06 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.01 -29.94 42.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.282 0.563 . . . . 0.0 110.232 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -103.35 15.3 29.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.577 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 0.2 OUTLIER -97.63 157.93 15.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 4.9 p -158.62 110.22 1.64 Allowed Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.336 0.654 . . . . 0.0 110.171 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.747 ' HG3' HD11 ' A' ' 571' ' ' LEU . 59.4 Cg_endo -72.08 148.29 50.31 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.392 2.728 . . . . 0.0 113.206 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.41 -45.0 27.25 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -75.39 109.37 8.87 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 173.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 583' ' ' LYS . 35.2 ttmt -121.6 98.02 5.77 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -146.9 177.82 8.82 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.427 ' HB3' ' NE2' ' A' ' 586' ' ' GLN . 7.1 t70 -86.73 -55.73 3.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.705 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . 0.427 ' NE2' ' HB3' ' A' ' 585' ' ' ASP . 0.0 OUTLIER -116.09 142.55 46.66 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.431 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.58 ' CE2' ' HG ' ' A' ' 593' ' ' LEU . 27.1 m-85 -110.88 124.57 52.33 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.551 -174.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -62.56 143.41 57.26 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 124.266 0.978 . . . . 0.0 108.843 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.748 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 3.4 p -61.71 119.58 6.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-O 121.858 0.837 . . . . 0.0 109.998 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 107.21 -10.3 39.67 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.254 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.47 123.35 23.73 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 3.6 p -102.48 129.19 54.39 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 CA-C-O 121.863 0.84 . . . . 0.0 111.383 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.58 ' HG ' ' CE2' ' A' ' 587' ' ' TYR . 4.3 mp -96.98 101.87 13.54 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.432 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -81.11 103.31 10.83 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.721 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 578' ' ' LEU . 74.0 m-85 -90.1 176.22 6.86 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 122.836 0.455 . . . . 0.0 111.456 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . 0.505 ' HA ' HD12 ' A' ' 603' ' ' ILE . 33.0 t -177.55 157.99 1.33 Allowed 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 168.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.469 ' SG ' HD22 ' A' ' 578' ' ' LEU . 97.4 m -86.67 177.95 7.19 Favored 'General case' 0 C--N 1.265 -3.095 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.989 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.52 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 72.9 mmtt -57.3 163.12 3.56 Favored Pre-proline 0 N--CA 1.434 -1.265 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.406 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 68.8 Cg_exo -49.31 -45.2 31.16 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 124.074 3.183 . . . . 0.0 114.129 -176.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -84.03 -3.88 88.81 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.021 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 625' ' ' GLU . 51.0 m-85 -107.7 154.07 22.01 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.6 0.714 . . . . 0.0 112.101 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 624' ' ' LYS . 26.2 m -106.26 130.84 54.04 Favored 'General case' 0 N--CA 1.403 -2.809 0 CA-C-N 114.108 -1.406 . . . . 0.0 108.928 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.541 HD11 ' HG3' ' A' ' 621' ' ' PRO . 6.9 tt -80.17 122.68 35.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.428 HG21 ' HG3' ' A' ' 624' ' ' LYS . 92.2 t -119.62 113.88 42.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.173 0.511 . . . . 0.0 109.922 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 131.39 -164.69 23.4 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.06 112.71 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.713 2.275 . . . . 0.0 111.32 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.4 HD22 HD13 ' A' ' 603' ' ' ILE . 6.3 m120 -79.58 -40.53 29.19 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.126 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.464 ' HB2' HG21 ' A' ' 592' ' ' VAL . 31.3 p -114.23 99.45 7.61 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.661 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 11.3 m -98.98 138.69 22.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 592' ' ' VAL . 0.0 OUTLIER -110.18 153.24 25.03 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.954 -178.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.748 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 42.8 t -67.93 120.29 13.97 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.347 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.557 ' HE1' ' CG ' ' A' ' 610' ' ' GLN . 12.9 m-30 -105.68 167.53 9.7 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -67.79 1.55 2.48 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -123.32 -0.26 8.82 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.943 0.402 . . . . 0.0 111.325 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.71 173.7 13.38 Favored Glycine 0 C--N 1.311 -0.851 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.797 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 611' ' ' CYS . 30.6 mt -63.0 121.59 13.95 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.48 ' HB2' ' CD2' ' A' ' 612' ' ' TYR . 50.0 m -145.06 150.31 45.14 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 617' ' ' SER . 42.5 Cg_endo -70.06 -164.28 2.58 Favored 'Cis proline' 0 CA--C 1.551 1.36 0 C-N-CA 124.615 -0.994 . . . . 0.0 114.599 0.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.16 165.88 24.19 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 122.118 -0.364 . . . . 0.0 111.081 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.498 HD23 HG22 ' A' ' 574' ' ' ILE . 5.6 mp -76.67 139.5 66.94 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -172.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.541 ' HG3' HD11 ' A' ' 603' ' ' ILE . 73.7 Cg_endo -71.29 167.2 26.91 Favored 'Trans proline' 0 C--O 1.241 0.64 0 C-N-CA 124.157 3.238 . . . . 0.0 112.372 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 46.7 pt -107.84 174.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.44 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.473 ' SG ' HD22 ' A' ' 578' ' ' LEU . 88.5 m -116.67 123.27 46.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.156 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 602' ' ' THR . 9.0 mmmm -118.81 108.6 15.04 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.207 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.458 ' HB2' ' CE2' ' A' ' 601' ' ' PHE . 2.8 tm-20 -73.42 -38.61 65.51 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -100.48 87.03 3.28 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.43 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 7.5 p -95.43 158.68 2.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.079 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -88.33 156.69 19.03 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.962 0.411 . . . . 0.0 110.883 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.598 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 15.0 p -90.58 -12.36 37.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.014 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . 0.5 ' SG ' ' HA2' ' A' ' 676' ' ' GLY . 13.8 m 70.54 7.82 6.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.757 0.823 . . . . 0.0 112.438 172.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 55.64 -140.18 41.17 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.495 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -82.5 151.56 15.25 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 122.435 2.09 . . . . 0.0 110.2 171.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.647 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 96.3 Cg_endo -78.81 172.42 15.07 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 123.129 2.552 . . . . 0.0 111.525 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.08 -162.95 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.438 2.092 . . . . 0.0 112.132 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -113.89 150.02 34.27 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.812 HD21 ' SG ' ' A' ' 684' ' ' CYS . 15.1 tp -78.72 159.54 27.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.528 HD11 ' HA ' ' A' ' 683' ' ' VAL 0.433 0.4 OUTLIER -73.45 -48.07 36.51 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 176.943 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 22.0 m120 -123.08 36.65 4.6 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.462 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.739 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -163.49 -141.28 3.08 Favored Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -165.26 -170.46 1.89 Allowed 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 655' ' ' VAL . 48.5 t -89.23 127.84 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 175.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -83.7 -26.06 30.11 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.55 0.69 . . . . 0.0 109.334 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -74.74 171.43 13.94 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -89.38 130.67 35.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 16.2 p -82.35 104.05 12.37 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.613 0.72 . . . . 0.0 112.119 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.564 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 47.0 pttt -89.94 153.88 20.27 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.34 34.76 1.39 Allowed 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 121.947 0.88 . . . . 0.0 110.729 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -169.49 92.93 0.26 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.494 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.647 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 11.0 m-85 -85.77 -73.76 0.44 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 121.13 167.28 13.22 Favored Glycine 0 C--N 1.291 -1.945 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -177.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.446 ' CE1' ' H ' ' A' ' 675' ' ' ASP . 75.1 t60 -72.0 136.49 46.75 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.799 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 62.7 m 71.32 10.84 6.71 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.516 0.727 . . . . 0.0 112.438 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.42 118.0 27.74 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 174.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.543 HG11 ' HE2' ' A' ' 670' ' ' LYS . 1.3 p -91.67 154.46 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.713 0 CA-C-O 122.5 1.143 . . . . 0.0 111.26 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.556 HG21 ' HB3' ' A' ' 633' ' ' PRO . 3.8 t -117.48 101.24 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.995 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 172.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.592 ' HG3' ' HG2' ' A' ' 670' ' ' LYS . 5.8 tt0 -77.09 120.42 22.16 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 60.4 m-85 -99.05 167.31 10.8 Favored 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.179 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.481 ' O ' ' HA3' ' A' ' 639' ' ' GLY . 5.5 p90 -145.08 143.9 30.67 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 173.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.762 ' SG ' HD21 ' A' ' 636' ' ' LEU . 59.5 m -103.55 170.28 8.04 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -64.06 152.42 87.72 Favored Pre-proline 0 C--N 1.317 -0.829 0 O-C-N 123.125 0.266 . . . . 0.0 110.715 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.19 40.11 0.43 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 124.828 3.685 . . . . 0.0 113.393 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 7.6 ptt85 -150.0 10.72 0.71 Allowed 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.537 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.96 158.17 45.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.921 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.491 ' HG ' ' HG2' ' A' ' 687' ' ' GLU . 90.0 mt -100.93 157.29 16.85 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.479 ' HG3' ' SG ' ' A' ' 659' ' ' CYS . 3.5 ttt -114.83 102.44 9.99 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.506 ' HE2' HG23 ' A' ' 683' ' ' VAL . 37.6 ttpt -69.9 -53.22 18.93 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.309 -0.859 . . . . 0.0 113.103 -170.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.42 -170.3 31.79 Favored Glycine 0 C--N 1.293 -1.819 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.036 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.73 122.08 11.1 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.979 3.12 . . . . 0.0 110.858 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.876 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 7.9 p-10 -68.46 -20.0 64.6 Favored 'General case' 0 CA--C 1.469 -2.169 0 CA-C-O 121.533 0.682 . . . . 0.0 111.066 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.592 ' HG2' ' HG3' ' A' ' 656' ' ' GLU . 3.4 mtpt -111.71 157.29 20.67 Favored 'General case' 0 C--N 1.253 -3.615 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -173.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.613 HG21 HD23 ' A' ' 681' ' ' LEU . 48.1 pt -139.75 125.43 21.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.582 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -106.44 144.25 33.39 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 28.7 t -81.61 128.95 34.47 Favored 'General case' 0 CA--C 1.465 -2.314 0 CA-C-O 123.142 1.449 . . . . 0.0 111.835 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.4 t -105.33 107.3 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.807 0 CA-C-N 111.263 -2.699 . . . . 0.0 107.655 -175.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.541 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 26.6 t70 55.6 -75.15 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.008 1.723 . . . . 0.0 112.98 -169.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.5 ' HA2' ' SG ' ' A' ' 630' ' ' CYS . . . -149.15 18.54 1.19 Allowed Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -129.61 139.26 51.49 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.546 ' HB3' HD12 ' A' ' 671' ' ' ILE . 92.0 m95 -85.71 164.73 17.46 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.472 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 6.3 p -82.43 -178.54 7.09 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.05 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 44.2 m -71.68 135.81 47.01 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.254 0.55 . . . . 0.0 110.731 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.613 HD23 HG21 ' A' ' 671' ' ' ILE . 47.5 mt -66.08 153.07 92.71 Favored Pre-proline 0 N--CA 1.425 -1.699 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.237 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.876 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 12.3 Cg_endo -55.49 -20.17 25.62 Favored 'Trans proline' 0 N--CA 1.482 0.802 0 C-N-CA 124.637 3.558 . . . . 0.0 115.972 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.528 ' HA ' HD11 ' A' ' 637' ' ' LEU 0.302 16.4 m 46.11 98.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 N-CA-C 115.664 1.728 . . . . 0.0 115.664 177.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.812 ' SG ' HD21 ' A' ' 636' ' ' LEU . 1.7 m -83.28 147.96 27.66 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.975 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.479 ' CD1' ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -138.49 146.97 25.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.243 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 32.0 t -58.56 134.77 23.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 123.828 0.705 . . . . 0.0 109.87 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.491 ' HG2' ' HG ' ' A' ' 664' ' ' LEU . 45.0 mt-10 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.21 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.761 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . 62.9 14.34 7.37 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.418 1.087 . . . . 0.0 112.897 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -93.82 -60.06 1.84 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -154.06 68.38 0.3 Allowed Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 107.954 -2.058 . . . . 0.0 107.954 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.65 -47.52 85.3 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.011 -0.595 . . . . 0.0 110.457 -173.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.434 ' HG2' ' HG3' ' A' ' 568' ' ' GLU . 53.1 ttt180 71.6 -64.12 0.4 Allowed 'General case' 0 C--N 1.344 0.369 0 O-C-N 124.302 1.001 . . . . 0.0 111.285 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . 0.434 ' HG3' ' HG2' ' A' ' 567' ' ' ARG . 52.0 mt-10 -110.88 147.46 34.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 121.149 0.499 . . . . 0.0 109.85 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 2.6 m -63.72 -55.78 20.64 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 124.786 1.234 . . . . 0.0 111.734 -175.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 61.41 -168.62 0.18 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.064 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.5 HD11 ' HG3' ' A' ' 580' ' ' PRO . 3.5 tt -118.61 118.96 33.17 Favored Pre-proline 0 C--N 1.28 -2.447 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.616 ' HG2' HD21 ' A' ' 620' ' ' LEU . 90.3 Cg_endo -75.41 -165.71 0.31 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.466 2.777 . . . . 0.0 112.335 -177.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.23 108.05 15.38 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.196 0.522 . . . . 0.0 110.382 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.648 HG22 HD23 ' A' ' 620' ' ' LEU . 36.2 pt -78.14 -167.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.319 175.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.95 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 10.2 t70 -81.54 162.09 23.32 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 14.9 p -74.09 -22.58 18.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.473 0.654 . . . . 0.0 110.516 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -106.63 11.83 30.0 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 121.768 -0.582 . . . . 0.0 110.98 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.95 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.5 tm? -99.13 153.48 18.86 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -177.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.485 ' N ' HD13 ' A' ' 578' ' ' LEU . 5.8 p -149.91 113.33 3.38 Favored Pre-proline 0 C--N 1.288 -2.079 0 C-N-CA 124.184 0.994 . . . . 0.0 108.454 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.597 ' HD3' HD13 ' A' ' 574' ' ' ILE . 59.1 Cg_endo -73.82 146.14 37.46 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.509 2.139 . . . . 0.0 112.43 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -77.38 -36.78 53.22 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . 0.433 ' HB3' ' HE2' ' A' ' 587' ' ' TYR . 25.3 mmt180 -79.63 132.55 36.28 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 171.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -143.51 89.94 2.12 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 119.282 -0.967 . . . . 0.0 108.69 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 587' ' ' TYR . 11.1 ptpt -137.71 170.21 16.46 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -77.41 -56.8 4.24 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.64 126.43 50.22 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.925 0.393 . . . . 0.0 110.725 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.73 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 19.3 m-85 -90.35 155.53 18.9 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.814 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -93.7 147.41 23.05 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.65 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 5.6 p -66.45 131.16 32.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.852 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 87.42 -1.95 86.22 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.211 -173.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -69.28 135.58 50.67 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 609' ' ' VAL . 11.3 m -98.59 138.91 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.724 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.563 HD11 ' CD2' ' A' ' 587' ' ' TYR . 7.1 mp -117.16 111.05 18.93 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.229 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.614 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 92.0 mttt -84.74 122.21 28.78 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.857 ' HB3' HD11 ' A' ' 578' ' ' LEU . 68.7 m-85 -108.08 172.2 6.97 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 603' ' ' ILE . 14.2 p -171.21 177.41 3.62 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 76.8 m -110.97 177.79 4.55 Favored 'General case' 0 C--N 1.26 -3.293 0 O-C-N 123.739 0.649 . . . . 0.0 110.712 -176.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 598' ' ' LYS . 71.6 mmtt -53.48 160.83 1.7 Allowed Pre-proline 0 N--CA 1.438 -1.034 0 C-N-CA 124.463 1.105 . . . . 0.0 112.564 176.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 51.4 Cg_exo -52.05 -28.11 31.36 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 124.414 3.409 . . . . 0.0 114.575 -175.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -99.61 -4.31 55.98 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.883 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -106.51 159.13 16.4 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 122.328 1.061 . . . . 0.0 113.414 -174.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.614 HG21 HG11 ' A' ' 627' ' ' VAL . 6.2 m -109.25 129.57 55.5 Favored 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.861 174.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.537 HD11 ' HG3' ' A' ' 621' ' ' PRO . 6.4 tt -81.46 119.14 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.363 174.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.737 HG21 ' HD3' ' A' ' 624' ' ' LYS . 62.0 t -109.97 127.51 66.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 118.06 -159.66 14.14 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.8 115.33 3.71 Favored 'Trans proline' 0 C--N 1.333 -0.278 0 C-N-CA 122.958 2.439 . . . . 0.0 110.69 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 7.5 m120 -84.3 -26.29 28.65 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.355 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.614 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 27.1 p -127.09 95.59 4.34 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.532 0.682 . . . . 0.0 111.087 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 592' ' ' VAL . 21.5 m -89.42 169.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.485 -0.779 . . . . 0.0 108.997 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.407 ' HB2' ' CE1' ' A' ' 612' ' ' TYR . 12.0 mm-40 -114.72 163.8 14.97 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 18.7 t -85.05 131.39 34.46 Favored 'General case' 0 C--N 1.276 -2.608 0 C-N-CA 117.808 -1.557 . . . . 0.0 108.223 165.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 7.5 m-85 -109.16 163.0 13.74 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 173.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -68.17 -1.68 6.53 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -117.48 4.47 12.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 120.879 0.371 . . . . 0.0 110.333 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 135.69 -177.45 19.46 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 572' ' ' PRO . 28.4 mt -73.79 133.51 43.26 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.481 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 68.1 m -150.16 154.39 36.41 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.61 -168.78 5.04 Favored 'Cis proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.043 -1.232 . . . . 0.0 113.214 0.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.76 146.69 35.93 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.091 0.472 . . . . 0.0 111.864 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.648 HD23 HG22 ' A' ' 574' ' ' ILE . 6.7 mp -65.14 142.26 98.53 Favored Pre-proline 0 C--N 1.302 -1.47 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.889 -175.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.537 ' HG3' HD11 ' A' ' 603' ' ' ILE . 28.1 Cg_endo -63.9 169.01 10.99 Favored 'Trans proline' 0 C--O 1.252 1.182 0 C-N-CA 124.124 3.216 . . . . 0.0 113.667 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . 0.445 ' CG1' ' HB ' ' A' ' 604' ' ' VAL . 36.5 pt -114.94 178.91 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.969 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 95.3 m -127.96 124.94 38.52 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.023 0.44 . . . . 0.0 111.267 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.737 ' HD3' HG21 ' A' ' 604' ' ' VAL . 57.9 mtpt -124.41 130.33 52.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -88.54 -37.87 15.37 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -99.82 101.25 12.34 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.803 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.614 HG11 HG21 ' A' ' 602' ' ' THR . 2.7 m -102.03 178.39 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.088 174.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.612 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 76.2 mt-30 -94.55 170.64 9.33 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.559 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 41.6 m -102.93 -8.15 20.92 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.039 0.447 . . . . 0.0 110.649 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 81.7 m 67.36 5.78 4.47 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 54.2 -137.22 41.58 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 123.474 0.484 . . . . 0.0 112.947 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.58 147.01 17.36 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.649 2.233 . . . . 0.0 112.055 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.536 ' HB3' HG21 ' A' ' 655' ' ' VAL . 31.7 Cg_endo -67.32 156.51 65.9 Favored 'Trans proline' 0 C--O 1.246 0.883 0 C-N-CA 123.118 2.545 . . . . 0.0 112.591 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.501 ' HG2' HD11 ' A' ' 681' ' ' LEU . 38.3 Cg_endo -69.24 175.36 7.77 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 123.324 2.683 . . . . 0.0 112.522 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.86 145.71 26.48 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 657' ' ' TYR . 14.5 tp -80.59 178.33 8.42 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 637' ' ' LEU . 2.4 mp -84.58 -73.03 0.44 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.821 0.819 . . . . 0.0 108.841 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -108.02 32.71 4.56 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.667 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -156.29 -156.79 7.99 Favored Glycine 0 N--CA 1.426 -1.997 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.798 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.08 -172.72 4.21 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 123.685 0.794 . . . . 0.0 109.976 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.485 HG22 ' CE1' ' A' ' 657' ' ' TYR . 53.5 t -93.69 137.87 21.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.659 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 20.1 ptmt -87.22 -22.63 25.12 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.088 0.47 . . . . 0.0 110.904 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -83.22 146.92 28.31 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -67.75 122.39 18.0 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 22.4 p -73.69 98.09 2.82 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.228 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -83.81 165.33 18.9 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.5 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -88.4 6.82 35.59 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -171.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -156.24 105.9 2.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -96.19 -82.25 0.4 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 176.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 130.77 159.62 9.68 Favored Glycine 0 C--N 1.311 -0.84 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.887 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.678 ' ND1' ' HA ' ' A' ' 674' ' ' VAL . 80.6 t60 -77.14 86.43 3.61 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 651' ' ' HIS . 22.9 t 155.08 -31.19 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 126.941 2.097 . . . . 0.0 106.101 173.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -68.05 118.24 10.95 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.911 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 671' ' ' ILE . 1.1 p -94.74 163.39 2.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.739 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 16.6 m -128.82 115.58 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.358 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.442 175.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.659 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 14.7 mt-10 -73.26 126.12 29.37 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.56 0.695 . . . . 0.0 111.111 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.665 ' HB3' HD22 ' A' ' 636' ' ' LEU . 81.4 m-85 -102.12 164.74 11.53 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.022 176.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -148.67 135.63 19.97 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.667 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 50.4 m -99.09 165.75 11.58 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.428 172.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 50.1 m-80 -58.3 155.01 28.98 Favored Pre-proline 0 C--O 1.248 1.021 0 O-C-N 123.677 0.611 . . . . 0.0 109.904 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 59.8 Cg_endo -68.03 24.76 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 124.113 3.209 . . . . 0.0 115.529 -172.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.463 ' HB2' ' CD1' ' A' ' 663' ' ' PHE . 24.8 mmm180 -118.11 -4.26 11.02 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 662' ' ' ARG . 51.0 m-85 -128.95 159.76 34.84 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.723 -170.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.51 HD11 ' HG3' ' A' ' 687' ' ' GLU . 81.8 mt -124.38 153.78 41.36 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 125.145 1.378 . . . . 0.0 107.442 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.558 ' HG3' ' HB2' ' A' ' 682' ' ' PRO . 0.0 OUTLIER -84.27 147.17 27.38 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.125 0.488 . . . . 0.0 111.2 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -95.09 -59.44 1.9 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.214 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -98.5 -158.11 29.76 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.575 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.78 123.64 10.96 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.978 2.452 . . . . 0.0 111.655 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 12.1 p-10 -64.04 -17.38 63.31 Favored 'General case' 0 C--O 1.207 -1.17 0 C-N-CA 122.902 0.481 . . . . 0.0 111.744 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 1.4 mtpt -122.28 154.4 37.62 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.57 HD12 ' HB3' ' A' ' 678' ' ' TRP . 29.9 pt -143.92 142.73 24.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.451 ' H ' ' NE2' ' A' ' 672' ' ' GLN . 0.5 OUTLIER -112.81 153.08 28.4 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.041 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 3.9 t -68.14 121.06 15.37 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.015 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.678 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 35.1 m -113.03 113.26 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-O 121.55 0.691 . . . . 0.0 111.559 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 32.7 t70 64.87 -73.89 0.05 Allowed 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 124.56 1.144 . . . . 0.0 111.375 -175.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.612 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -152.56 16.21 0.74 Allowed Glycine 0 N--CA 1.422 -2.297 0 C-N-CA 120.392 -0.908 . . . . 0.0 112.456 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.01 158.08 44.63 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.57 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.9 m95 -81.71 177.03 9.14 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-O 120.892 0.377 . . . . 0.0 110.167 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.98 -179.44 3.95 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.863 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 5.7 m -57.72 120.16 7.9 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.897 0.879 . . . . 0.0 110.915 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.535 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 4.4 mp -64.15 154.26 83.02 Favored Pre-proline 0 N--CA 1.445 -0.719 0 O-C-N 123.761 0.663 . . . . 0.0 112.592 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.558 ' HB2' ' HG3' ' A' ' 665' ' ' MET . 7.5 Cg_endo -55.04 -50.12 14.26 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.206 2.604 . . . . 0.0 113.516 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 92.8 t 68.97 130.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.505 0.722 . . . . 0.0 110.118 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 663' ' ' PHE . 7.3 p -125.05 154.89 40.63 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.676 -0.64 . . . . 0.0 112.448 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 685' ' ' ILE . 0.2 OUTLIER -139.04 150.58 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.214 0 C-N-CA 125.317 1.447 . . . . 0.0 108.512 -177.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.24 139.25 17.06 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.911 0 C-N-CA 124.76 1.224 . . . . 0.0 112.472 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.51 ' HG3' HD11 ' A' ' 664' ' ' LEU . 45.8 tt0 . . . . . 0 N--CA 1.438 -1.056 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.153 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 CA--C 1.516 -0.353 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -120.01 -170.47 1.97 Allowed 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -67.09 -43.49 82.4 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . -72.19 86.51 0.49 Allowed Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.407 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -93.05 27.99 2.28 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.715 0.806 . . . . 0.0 109.388 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.462 ' HD3' ' HA ' ' A' ' 567' ' ' ARG . 37.5 mmt180 83.66 71.43 0.02 OUTLIER 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 125.553 1.541 . . . . 0.0 110.552 -173.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -126.05 -162.84 1.16 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.735 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.764 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 75.9 m -96.61 150.02 21.13 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.657 0.741 . . . . 0.0 112.685 -174.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -124.25 -4.75 7.86 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.073 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.547 HD23 ' HD2' ' A' ' 572' ' ' PRO . 0.9 OUTLIER 77.97 121.22 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 126.006 1.723 . . . . 0.0 107.438 -178.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.614 ' HD3' HD23 ' A' ' 616' ' ' LEU . 56.8 Cg_endo -69.97 -174.65 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.909 1.74 . . . . 0.0 110.931 175.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 573' ' ' LYS . 0.3 OUTLIER -89.5 104.23 16.81 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 578' ' ' LEU . 42.0 pt -76.08 -176.57 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.988 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.293 -177.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 12.6 t70 -72.97 151.94 41.6 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.72 -35.66 68.88 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.363 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -93.54 8.08 42.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.705 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 2.8 tp -95.89 149.97 20.96 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.03 117.59 9.09 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-O 121.387 0.613 . . . . 0.0 110.41 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.42 131.19 13.55 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.203 1.935 . . . . 0.0 111.053 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.56 -29.84 71.04 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.286 0.565 . . . . 0.0 111.447 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . 0.452 ' HG3' HD22 ' A' ' 593' ' ' LEU . 4.5 mmp_? -72.8 -70.95 0.32 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 176.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm 60.47 84.58 0.12 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.416 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 15.6 ptpt -142.03 174.34 10.69 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.25 -66.16 0.91 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . 0.444 HE21 ' N ' ' A' ' 586' ' ' GLN . 0.0 OUTLIER -105.34 141.04 37.55 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.431 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.764 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 67.0 m-85 -115.12 125.63 53.69 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.138 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -71.02 144.04 50.55 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.302 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.637 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 32.6 m -63.4 134.66 28.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.576 177.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 102.0 -18.62 51.76 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.117 -172.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.95 108.84 3.19 Favored 'General case' 0 C--N 1.346 0.451 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 610' ' ' GLN . 3.4 p -92.47 125.09 45.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.721 0.772 . . . . 0.0 110.199 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 587' ' ' TYR . 11.1 mt -102.88 105.05 15.34 Favored 'General case' 0 N--CA 1.402 -2.856 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.882 -172.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.535 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 54.7 mtpt -75.06 112.61 11.47 Favored 'General case' 0 N--CA 1.41 -2.425 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -94.36 174.13 7.29 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-O 121.813 0.816 . . . . 0.0 109.548 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 20.1 t -162.32 -178.83 6.56 Favored 'General case' 0 N--CA 1.391 -3.414 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.556 ' SG ' HD12 ' A' ' 578' ' ' LEU . 92.3 m -118.1 -179.12 3.67 Favored 'General case' 0 C--N 1.257 -3.452 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -51.01 162.58 0.58 Allowed Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 124.773 1.229 . . . . 0.0 111.639 174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.2 -45.82 24.66 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.923 3.082 . . . . 0.0 113.403 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -89.76 5.03 83.73 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.424 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.64 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 35.4 m-85 -109.57 133.93 52.52 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . . . . . . . . . 45.5 m -89.04 127.92 35.71 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 113.716 -1.584 . . . . 0.0 110.5 175.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.505 HD11 ' HG3' ' A' ' 621' ' ' PRO . 8.9 tt -84.65 132.89 30.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.834 HG21 ' HD3' ' A' ' 624' ' ' LYS . 90.9 t -129.7 135.43 61.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 114.67 -161.25 12.81 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.96 116.31 4.52 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.003 1.802 . . . . 0.0 109.886 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.448 HD22 ' N ' ' A' ' 607' ' ' ASN . 0.7 OUTLIER -83.34 -39.22 21.02 Favored 'General case' 0 C--O 1.206 -1.208 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -176.278 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.535 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 8.6 p -112.27 98.0 7.01 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.44 0.638 . . . . 0.0 111.96 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 17.5 m -99.57 145.6 10.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.644 HE21 ' N ' ' A' ' 610' ' ' GLN . 0.0 OUTLIER -96.46 149.24 21.95 Favored 'General case' 0 CA--C 1.472 -2.024 0 O-C-N 121.866 -0.522 . . . . 0.0 110.415 -177.251 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 45.4 t -73.3 122.28 21.74 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.37 168.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.596 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 75.9 m-85 -110.98 162.7 14.58 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 171.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -65.16 -2.25 2.77 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -115.52 1.54 13.64 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.537 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 132.4 169.73 12.35 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.202 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.614 HD23 ' HD3' ' A' ' 572' ' ' PRO . 3.3 mm? -66.42 118.95 10.79 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.596 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 17.4 m -131.77 144.36 52.94 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . 0.418 ' C ' ' HA ' ' A' ' 617' ' ' SER . 56.6 Cg_endo -69.77 -165.13 2.8 Favored 'Cis proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.885 -1.298 . . . . 0.0 113.139 -0.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.12 172.79 11.75 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.194 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.522 HD13 HG22 ' A' ' 574' ' ' ILE . 50.8 mt -69.64 148.43 96.78 Favored Pre-proline 0 C--N 1.297 -1.709 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.333 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.505 ' HG3' HD11 ' A' ' 603' ' ' ILE . 72.9 Cg_endo -75.42 -177.85 3.84 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 124.176 3.251 . . . . 0.0 111.362 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.42 166.44 18.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.012 0.434 . . . . 0.0 110.933 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.423 ' HB3' ' CD2' ' A' ' 601' ' ' PHE . 85.7 m -110.64 116.06 30.67 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.376 176.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.834 ' HD3' HG21 ' A' ' 604' ' ' VAL . 21.0 mtpp -97.03 -22.17 16.96 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 13.6 tt0 68.4 -70.16 0.14 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.178 0.991 . . . . 0.0 108.951 -174.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -103.88 114.51 28.81 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.644 ' CG2' ' HA ' ' A' ' 675' ' ' ASP . 7.7 p -111.45 175.25 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.451 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 48.9 mt-30 -84.21 166.64 17.38 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 119.778 1.172 . . . . 0.0 109.311 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.613 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 5.2 p -106.54 -16.95 14.39 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.157 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 71.8 m 70.0 8.55 6.74 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.314 1.046 . . . . 0.0 112.799 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 54.02 -143.84 28.74 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 123.694 0.621 . . . . 0.0 113.093 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.5 148.59 42.87 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.515 2.143 . . . . 0.0 111.215 173.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.555 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 88.1 Cg_endo -82.67 165.1 15.98 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 123.047 2.498 . . . . 0.0 112.442 -178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.16 178.69 4.56 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.952 2.435 . . . . 0.0 111.426 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.92 163.83 12.04 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.636 HD22 ' HB3' ' A' ' 657' ' ' TYR . 17.5 tp -92.52 134.07 35.32 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.575 ' H ' HD12 ' A' ' 637' ' ' LEU . 0.4 OUTLIER -44.54 -61.13 1.66 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.575 1.15 . . . . 0.0 111.349 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.511 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 43.7 m-80 -122.63 31.19 6.18 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-O 121.316 0.579 . . . . 0.0 110.819 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.561 ' C ' ' HB3' ' A' ' 636' ' ' LEU . . . -150.48 -158.28 8.17 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 174.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.43 175.07 14.03 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 117.496 0.648 . . . . 0.0 109.87 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 655' ' ' VAL . 64.3 t -84.44 128.94 38.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.792 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 19.5 ptmt -84.81 -20.4 30.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.034 0.921 . . . . 0.0 109.643 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' A' ' 642' ' ' LYS . 48.0 mm-40 -91.25 163.49 14.22 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.806 -177.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -73.9 125.71 28.81 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.182 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.425 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 16.0 p -81.72 114.63 20.5 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-O 121.857 0.837 . . . . 0.0 111.455 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 49.9 mtmt -85.09 161.23 19.77 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -99.67 9.56 42.91 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.065 0.936 . . . . 0.0 109.586 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -157.47 96.97 1.58 Allowed 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 113.956 -1.475 . . . . 0.0 107.696 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.555 ' CE1' ' HD3' ' A' ' 633' ' ' PRO . 14.4 m-85 -86.63 -76.77 0.34 Allowed 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.838 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 115.44 169.01 15.65 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.236 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.579 ' HB2' HG11 ' A' ' 627' ' ' VAL . 75.8 t60 -71.33 148.05 47.45 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.311 10.4 p 65.78 2.73 2.24 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.057 1.343 . . . . 0.0 113.831 -174.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -93.84 112.95 24.88 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.554 HG11 ' CE ' ' A' ' 670' ' ' LYS . 2.5 p -99.16 159.67 3.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-O 121.576 0.703 . . . . 0.0 109.552 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 3.0 t -121.01 106.97 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.67 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.348 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.792 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 18.4 mt-10 -68.67 124.84 24.74 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.461 0.648 . . . . 0.0 110.457 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.636 ' HB3' HD22 ' A' ' 636' ' ' LEU . 68.2 m-85 -108.92 172.03 7.09 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -150.07 140.72 22.59 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.57 ' SG ' HD21 ' A' ' 636' ' ' LEU . 80.7 m -100.01 163.84 12.26 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 661' ' ' PRO . 47.4 m-80 -65.3 157.39 77.77 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.401 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 74.2 Cg_endo -71.84 15.6 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 123.931 3.087 . . . . 0.0 113.466 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -108.34 -3.97 17.85 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -134.15 156.33 48.52 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.289 -173.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 687' ' ' GLU . 72.1 mt -98.95 165.58 11.69 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 172.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 5.5 ttt -119.52 115.14 23.41 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.413 ' HB2' HD12 ' A' ' 685' ' ' ILE . 37.5 ttmt -71.39 -67.85 0.49 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -171.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.76 -161.46 37.49 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 115.551 -0.749 . . . . 0.0 113.18 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.39 123.09 11.81 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.036 2.491 . . . . 0.0 111.133 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 10.4 p-10 -61.48 -16.48 47.59 Favored 'General case' 0 C--O 1.208 -1.118 0 C-N-CA 123.263 0.625 . . . . 0.0 111.891 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.62 ' HG2' ' CG ' ' A' ' 656' ' ' GLU . 13.2 mtpt -121.93 153.78 38.02 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -175.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 34.9 pt -138.01 144.44 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.103 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.487 HE21 ' N ' ' A' ' 672' ' ' GLN . 0.0 OUTLIER -122.55 151.59 41.24 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.268 -176.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 6.8 t -77.3 108.47 10.45 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.042 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.442 ' HA ' ' ND1' ' A' ' 651' ' ' HIS . 35.9 m -102.7 107.9 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.576 0.703 . . . . 0.0 111.569 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.644 ' HA ' ' CG2' ' A' ' 627' ' ' VAL . 7.4 t70 68.98 -62.62 0.39 Allowed 'General case' 0 C--O 1.216 -0.67 0 C-N-CA 124.913 1.285 . . . . 0.0 113.057 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -164.12 18.9 0.12 Allowed Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 174.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -138.13 144.04 40.63 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.401 ' HB3' HD12 ' A' ' 671' ' ' ILE . 98.3 m95 -75.92 158.03 32.5 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 13.5 p -77.52 174.26 11.07 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.964 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.7 m -65.03 131.85 47.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.215 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.559 ' HG ' ' HD2' ' A' ' 682' ' ' PRO . 5.0 mp -63.74 150.38 90.97 Favored Pre-proline 0 N--CA 1.435 -1.194 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.138 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.559 ' HD2' ' HG ' ' A' ' 681' ' ' LEU . 10.4 Cg_endo -56.22 -43.23 58.13 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 123.573 2.849 . . . . 0.0 113.368 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 81.5 t 66.08 121.45 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 122.639 1.209 . . . . 0.0 113.341 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 638' ' ' ASN . 3.2 m -93.82 145.13 24.82 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.32 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 666' ' ' LYS . 0.1 OUTLIER -138.46 145.28 28.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.16 132.98 25.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 O-C-N 123.288 0.367 . . . . 0.0 110.951 -174.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.519 ' HG3' HD21 ' A' ' 664' ' ' LEU . 38.5 tt0 . . . . . 0 C--O 1.249 1.039 0 O-C-N 124.035 0.834 . . . . 0.0 109.914 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 562' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 CA--C 1.504 -0.824 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -82.45 99.9 9.72 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 564' ' ' ALA . . . . . . . . . . . . . . . -107.74 115.35 29.98 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.915 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 565' ' ' GLY . . . . . . . . . . . . . . . 142.97 88.01 0.1 OUTLIER Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.773 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -85.66 86.26 7.37 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.577 0.703 . . . . 0.0 109.175 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 567' ' ' ARG 0.259 16.3 ptt180 -83.72 79.26 9.52 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 122.526 1.155 . . . . 0.0 113.278 -178.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 568' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -131.51 171.9 12.87 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 112.843 -1.981 . . . . 0.0 107.18 175.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 569' ' ' CYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 587' ' ' TYR . 68.3 m -96.36 121.94 38.7 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.198 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -99.67 140.19 34.23 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 571' ' ' LEU . . . . . 0.838 HD11 ' HG3' ' A' ' 580' ' ' PRO . 3.2 tt -58.21 112.48 4.94 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 572' ' ' PRO . . . . . 0.532 ' HD3' HD23 ' A' ' 616' ' ' LEU . 93.3 Cg_endo -83.94 -158.57 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.527 2.818 . . . . 0.0 112.72 -175.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 573' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -81.8 91.95 6.58 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 574' ' ' ILE . . . . . 0.739 HG13 ' H ' ' A' ' 575' ' ' ASP . 6.5 pt -72.47 -88.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.827 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.825 ' HB3' ' HB2' ' A' ' 578' ' ' LEU . 17.6 t70 -160.26 173.37 15.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 173.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 576' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.87 -29.36 8.34 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 CA-C-O 121.29 0.566 . . . . 0.0 109.543 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 577' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -98.94 3.57 47.13 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.461 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.825 ' HB2' ' HB3' ' A' ' 575' ' ' ASP . 1.9 tm? -96.0 147.42 23.71 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -177.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.47 ' N ' HD13 ' A' ' 578' ' ' LEU . 6.1 t -139.55 121.21 9.85 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 580' ' ' PRO . . . . . 0.838 ' HG3' HD11 ' A' ' 571' ' ' LEU . 60.4 Cg_endo -73.86 140.89 29.52 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.369 2.046 . . . . 0.0 112.173 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 581' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.57 -38.33 86.84 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 125.525 1.53 . . . . 0.0 110.687 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 582' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -75.97 -66.8 0.74 Allowed 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.63 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.454 ' HB2' ' HG2' ' A' ' 580' ' ' PRO . 38.8 ttpt 57.52 78.23 0.24 Allowed 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.01 -178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.501 ' HG2' ' CE2' ' A' ' 587' ' ' TYR . 18.1 ptpt -132.87 175.47 9.32 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.304 -1.316 . . . . 0.0 107.773 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -76.86 -57.53 3.8 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 586' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.74 142.05 51.13 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 587' ' ' TYR . . . . . 0.608 ' HB2' ' HB2' ' A' ' 569' ' ' CYS . 94.8 m-85 -112.12 126.7 55.47 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 588' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -70.21 142.4 52.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.691 ' HA ' ' SG ' ' A' ' 611' ' ' CYS . 2.1 p -60.06 116.0 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-O 121.951 0.881 . . . . 0.0 111.329 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . 121.29 -22.21 7.97 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.173 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 591' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -58.42 139.8 54.84 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.765 0.426 . . . . 0.0 110.416 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 592' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 610' ' ' GLN . 2.1 m -111.6 136.33 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 593' ' ' LEU . . . . . 0.581 ' HG ' ' CE2' ' A' ' 587' ' ' TYR 0.338 0.0 OUTLIER -130.78 113.54 14.23 Favored 'General case' 0 N--CA 1.396 -3.172 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.228 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 594' ' ' LYS . . . . . 0.683 ' HG2' ' HB3' ' A' ' 608' ' ' SER . 64.9 mttm -76.46 147.91 37.57 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.55 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 595' ' ' PHE . . . . . 0.767 ' HB3' HD11 ' A' ' 578' ' ' LEU . 24.8 m-85 -121.61 166.39 14.3 Favored 'General case' 0 C--N 1.261 -3.277 0 C-N-CA 123.822 0.849 . . . . 0.0 110.1 177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 596' ' ' SER . . . . . . . . . . . . . 9.5 t -173.59 154.25 2.47 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 170.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 597' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 73.8 m -88.37 176.59 7.13 Favored 'General case' 0 C--N 1.259 -3.352 0 O-C-N 123.863 0.727 . . . . 0.0 110.636 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 598' ' ' LYS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 599' ' ' PRO . 31.5 mmtp -55.37 162.38 2.29 Favored Pre-proline 0 N--CA 1.438 -1.061 0 C-N-CA 123.955 0.902 . . . . 0.0 112.257 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 599' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 598' ' ' LYS . 91.5 Cg_exo -43.79 -44.09 11.67 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 124.51 3.473 . . . . 0.0 115.119 -175.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -88.93 -10.47 66.63 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.27 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 625' ' ' GLU . 42.1 m-85 -97.54 155.28 17.03 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.893 0.854 . . . . 0.0 112.37 -176.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 602' ' ' THR . . . . . 0.578 HG21 HG11 ' A' ' 627' ' ' VAL . 10.7 m -107.76 126.88 53.16 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.808 174.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.465 ' HA ' ' SG ' ' A' ' 597' ' ' CYS . 5.2 tt -74.09 118.6 19.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.076 172.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . 0.672 HG21 ' HD3' ' A' ' 624' ' ' LYS . 67.4 t -111.64 110.78 33.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 133.7 -154.69 21.41 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 606' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.78 122.47 7.78 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.92 2.413 . . . . 0.0 112.315 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 594' ' ' LYS . 1.2 t-20 -79.24 -36.46 39.92 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.38 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 608' ' ' SER . . . . . 0.683 ' HB3' ' HG2' ' A' ' 594' ' ' LYS . 52.8 p -125.49 100.63 6.56 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.884 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 609' ' ' VAL . . . . . . . . . . . . . 15.3 m -98.03 161.13 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 610' ' ' GLN . . . . . 0.707 ' HG3' HG12 ' A' ' 592' ' ' VAL . 1.9 mp0 -115.87 158.6 22.72 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.691 ' SG ' ' HA ' ' A' ' 589' ' ' VAL . 37.3 t -80.95 104.61 11.57 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 118.613 -1.235 . . . . 0.0 107.903 169.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.548 ' CD1' ' HB2' ' A' ' 617' ' ' SER . 4.7 m-85 -87.64 167.87 13.51 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -74.9 0.06 16.93 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.648 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -116.65 7.48 13.57 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' GLY . . . . . . . . . . . . . . . 131.06 174.52 13.69 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.972 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.532 HD23 ' HD3' ' A' ' 572' ' ' PRO . 2.9 mm? -63.73 109.59 1.76 Allowed 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' SER . . . . . 0.548 ' HB2' ' CD1' ' A' ' 612' ' ' TYR . 18.8 m -128.05 148.58 68.02 Favored Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -175.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.03 -171.22 8.71 Favored 'Cis proline' 0 CA--C 1.558 1.687 0 C-N-CA 123.644 -1.398 . . . . 0.0 113.476 1.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -57.96 151.58 18.07 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.895 0.379 . . . . 0.0 111.229 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' LEU . . . . . 0.525 ' H ' HD22 ' A' ' 620' ' ' LEU . 1.9 mm? -66.87 137.21 94.7 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.629 -173.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.8 170.83 10.74 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.802 3.001 . . . . 0.0 111.943 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' ILE . . . . . 0.541 HG13 ' HB ' ' A' ' 604' ' ' VAL . 43.1 pt -115.62 179.81 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 86.3 m -123.97 126.96 47.23 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.898 0.38 . . . . 0.0 110.971 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.672 ' HD3' HG21 ' A' ' 604' ' ' VAL . 51.7 mtpt -124.08 121.61 35.65 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 601' ' ' PHE . 14.0 tt0 -81.1 -28.34 35.24 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -100.77 111.53 23.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.555 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.578 HG11 HG21 ' A' ' 602' ' ' THR . 9.8 m -130.8 172.89 15.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.099 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.545 ' HB2' ' HA2' ' A' ' 676' ' ' GLY . 25.8 mt-30 -96.32 164.02 12.83 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -177.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 37.8 m -110.79 -1.73 16.47 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.044 0.449 . . . . 0.0 110.139 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 69.7 m 70.77 -38.77 0.43 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.086 1.354 . . . . 0.0 114.435 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . 100.68 -143.82 16.43 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -72.81 143.1 36.52 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 121.965 1.777 . . . . 0.0 109.81 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.444 ' HD3' ' CE1' ' A' ' 649' ' ' TYR . 73.4 Cg_endo -74.32 163.12 37.09 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 122.386 2.057 . . . . 0.0 112.302 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.9 173.29 7.19 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.705 2.27 . . . . 0.0 111.451 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -89.8 162.47 15.49 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.732 HD21 ' SG ' ' A' ' 659' ' ' CYS . 16.8 tp -92.54 166.89 12.29 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 177.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.609 ' H ' HD23 ' A' ' 637' ' ' LEU 0.303 2.0 pt? -82.76 -48.04 11.28 Favored 'General case' 0 N--CA 1.41 -2.462 0 C-N-CA 117.947 -1.501 . . . . 0.0 113.298 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.61 ' HB2' ' HB2' ' A' ' 684' ' ' CYS . 41.9 m-80 -124.82 34.15 5.06 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.734 0.778 . . . . 0.0 109.897 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -159.52 -139.78 2.75 Favored Glycine 0 N--CA 1.424 -2.15 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.903 174.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . 0.499 ' HB3' ' CE1' ' A' ' 658' ' ' TYR . 1.8 t-20 -162.47 -171.58 2.83 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.598 HG22 ' CE1' ' A' ' 657' ' ' TYR . 11.8 t -96.11 123.57 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.579 ' HD3' ' HB3' ' A' ' 656' ' ' GLU . 18.6 ptmt -79.34 -23.59 43.33 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.18 0.514 . . . . 0.0 109.91 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 656' ' ' GLU . 12.1 mm-40 -78.96 152.27 31.15 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -79.49 121.53 25.31 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.977 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 33.1 p -68.22 99.05 0.86 Allowed 'General case' 0 N--CA 1.419 -1.977 0 CA-C-O 121.805 0.812 . . . . 0.0 112.617 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 649' ' ' TYR . 54.6 pttt -89.09 160.79 16.87 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.408 ' O ' ' HA2' ' A' ' 631' ' ' GLY . 40.4 mm-40 -78.73 -5.96 54.59 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -174.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -146.1 104.87 3.86 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' A' ' 655' ' ' VAL . 9.3 m-85 -90.64 -111.24 0.09 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.941 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 673' ' ' CYS . . . 168.5 161.06 17.74 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.581 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 65.1 t60 -53.76 -57.36 11.16 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 32.9 m -89.98 8.28 33.22 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.927 -174.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -93.58 118.2 31.06 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.672 0.749 . . . . 0.0 110.382 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.609 HG21 ' HE3' ' A' ' 670' ' ' LYS . 4.5 m -89.95 151.66 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.516 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 30.2 m -116.67 104.16 16.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.654 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.579 ' HB3' ' HD3' ' A' ' 642' ' ' LYS . 23.5 mt-10 -65.36 124.29 21.87 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 122.218 1.009 . . . . 0.0 111.538 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.598 ' CE1' HG22 ' A' ' 641' ' ' VAL . 65.6 m-85 -102.5 165.64 10.98 Favored 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.431 173.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.499 ' CE1' ' HB3' ' A' ' 640' ' ' ASN . 8.8 p90 -146.81 137.32 23.74 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.732 ' SG ' HD21 ' A' ' 636' ' ' LEU . 61.2 m -97.24 165.86 11.84 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 176.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -63.6 150.29 90.69 Favored Pre-proline 0 C--N 1.294 -1.833 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.41 0.85 1.99 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 124.13 3.22 . . . . 0.0 114.573 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 662' ' ' ARG . 9.6 mmm180 -98.54 -0.98 42.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -130.26 169.19 15.74 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.308 -173.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 88.5 mt -108.88 161.02 15.52 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . . . . . . . . . 4.4 ttt -117.8 113.53 21.94 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.434 ' HB3' HG23 ' A' ' 683' ' ' VAL . 24.8 ttmm -68.3 -64.01 0.95 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -102.85 -158.24 25.48 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 121.122 -0.561 . . . . 0.0 114.116 -173.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.93 121.51 9.62 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.767 2.978 . . . . 0.0 111.603 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 682' ' ' PRO . 16.9 p-10 -79.4 -11.8 59.91 Favored 'General case' 0 C--O 1.178 -2.709 0 CA-C-O 120.917 0.389 . . . . 0.0 110.856 -177.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 5.3 ptmt -125.82 112.01 15.53 Favored 'General case' 0 C--N 1.27 -2.874 0 C-N-CA 123.932 0.893 . . . . 0.0 109.51 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 34.4 pt -109.92 151.47 12.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.708 -174.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.19 160.83 21.41 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.565 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 16.9 t -82.39 92.79 7.07 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.491 1.139 . . . . 0.0 111.796 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 83.8 t -80.7 113.93 20.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 114.667 -1.152 . . . . 0.0 110.151 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 19.7 t70 57.3 -69.52 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.582 1.953 . . . . 0.0 112.593 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 628' ' ' GLN . . . -157.67 26.86 0.46 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 111.769 -0.532 . . . . 0.0 111.769 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -145.06 151.13 38.05 Favored 'General case' 0 C--O 1.21 -1.022 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.54 ' HB3' HD12 ' A' ' 671' ' ' ILE . 96.3 m95 -82.64 170.7 14.84 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . 0.453 ' OG1' ' HB ' ' A' ' 671' ' ' ILE . 5.5 p -92.65 -174.52 3.67 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 30.0 m -68.94 131.12 44.57 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.792 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.413 HD23 HD12 ' A' ' 636' ' ' LEU . 7.3 mp -67.51 157.51 85.58 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.565 ' HB3' ' HA ' ' A' ' 669' ' ' ASN . 21.9 Cg_endo -62.8 -21.35 72.99 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 124.346 3.364 . . . . 0.0 115.879 -176.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.533 ' HA ' HD21 ' A' ' 637' ' ' LEU 0.357 22.4 m 49.97 109.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 -178.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.705 ' SG ' HD21 ' A' ' 636' ' ' LEU . 3.5 m -88.0 147.36 25.05 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.549 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.4 151.73 16.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.76 141.63 16.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 C--O 1.255 1.373 0 O-C-N 124.09 0.869 . . . . 0.0 110.625 178.901 . . . . . . . . 0 0 . 1 stop_ save_